Citrus Sinensis ID: 005415
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | 2.2.26 [Sep-21-2011] | |||||||
| Q09690 | 1087 | Dual specificity protein | yes | no | 0.350 | 0.224 | 0.429 | 5e-51 | |
| Q54BC9 | 915 | Probable serine/threonine | yes | no | 0.318 | 0.242 | 0.455 | 1e-50 | |
| Q9P6P3 | 534 | Serine/threonine-protein | no | no | 0.373 | 0.486 | 0.419 | 3e-50 | |
| P14680 | 807 | Dual specificity protein | yes | no | 0.373 | 0.322 | 0.411 | 8e-50 | |
| Q54QV3 | 1458 | Probable serine/threonine | no | no | 0.355 | 0.170 | 0.422 | 3e-49 | |
| A8X4H1 | 904 | Dual specificity tyrosine | N/A | no | 0.362 | 0.279 | 0.425 | 9e-49 | |
| Q8WQL7 | 882 | Dual specificity tyrosine | yes | no | 0.362 | 0.286 | 0.422 | 6e-48 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.325 | 0.359 | 0.437 | 1e-47 | |
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | no | 0.337 | 0.325 | 0.422 | 1e-47 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | no | 0.325 | 0.436 | 0.437 | 8e-47 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 202 bits (515), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 107/249 (42%), Positives = 156/249 (62%), Gaps = 5/249 (2%)
Query: 397 GFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD 455
GF+ E D ++L IA RY V ++LG +F +V + D TG V LKII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 456 QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
Q+L E K+L+ + + DP DE+ +++ D+FY +HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKG-- 796
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ ++ ITRQ ++ L L+ +IHCDLKPENIL+ + ++K+ID GSSCF+ +
Sbjct: 797 --LPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ Y+QSR YR+PEVI+G+ Y ID+WSLGCI+AE++TG LFP + LA I+ +
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLACIMEI 914
Query: 636 LGPIDLEML 644
GP D ++
Sbjct: 915 FGPPDHSLI 923
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q54BC9|DYRK2_DICDI Probable serine/threonine-protein kinase dyrk2 OS=Dictyostelium discoideum GN=dyrk2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 103/226 (45%), Positives = 139/226 (61%), Gaps = 4/226 (1%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA R+ + LG +F +V + D TG V LKI++N K F +Q+L EIK+L+ + ND
Sbjct: 601 IAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHNQALTEIKILEYLKTND 660
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
P I+ L +YFY HL + ELL NLY+F K N G + L ++ Q L
Sbjct: 661 PNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG----YNLNLVRRFGAQIL 716
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
+L +L IIH DLKPENIL+KS + IK+ID GSSCF+ + + Y+QSR YR+PEV
Sbjct: 717 TSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENEQIFTYIQSRFYRSPEV 776
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
I+G YD+ ID+WSLGCIL E++TG LFP LA I+ +LG
Sbjct: 777 ILGTKYDKSIDIWSLGCILVEIFTGVPLFPGSDEPEQLACIMEVLG 822
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (509), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 114/272 (41%), Positives = 155/272 (56%), Gaps = 12/272 (4%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L T +Y + + LG F +V + QDL T V +K+IKN F++Q + E+ +L+L
Sbjct: 121 LLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILEL 180
Query: 467 VN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ G L ++
Sbjct: 181 LNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRG----LHLSLVRS 236
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L L IIHCDLKPENIL++ +K+ID GS+C + + Y+QSR
Sbjct: 237 FATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSACHERQTVYTYIQSRF 296
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
YR+PEVI+GL Y+ ID+WSLGCILAEL+ G LFP ++ L RI+ MLG ML
Sbjct: 297 YRSPEVILGLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLGNPPTWMLE 356
Query: 646 QGQEIYKYFT-------KEYDLYYINEVCFAN 670
G+ KY+ K Y+L I + N
Sbjct: 357 MGKNSKKYYNSGFVNGRKTYELKSIEQFSIEN 388
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P14680|YAK1_YEAST Dual specificity protein kinase YAK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YAK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 8e-50, Method: Compositional matrix adjust.
Identities = 111/270 (41%), Positives = 161/270 (59%), Gaps = 10/270 (3%)
Query: 393 KNRTGFEE-NKDLPIILNTVIA----GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 447
K GF+ N D + +N V+ +Y V + LG F +V + Q+L T + +K++
Sbjct: 341 KCNNGFDNINSDYILYVNDVLGVEQNRKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVV 400
Query: 448 KNDKDFFDQSLDEIKLLKLVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
K+ ++ QS+ E K+L+L+N K DP ++HH LR+YD F H HL +V ELL NLYE
Sbjct: 401 KSRTEYLTQSITEAKILELLNQKIDPTNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELL 460
Query: 507 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566
K N+ G ++ ++ T Q L++L L +IHCDLKPENIL+ + + E+KIID
Sbjct: 461 KQNKFHG----LSIQLIRTFTTQILDSLCVLKESKLIHCDLKPENILLCAPDKPELKIID 516
Query: 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
GSSC + + Y+QSR YRAPE+I+G+PY ID+WSLGCI+AEL+ G +FP +
Sbjct: 517 FGSSCEEARTVYTYIQSRFYRAPEIILGIPYSTSIDMWSLGCIVAELFLGIPIFPGASEY 576
Query: 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTK 656
L RII LG M+ G+ K+ K
Sbjct: 577 NQLTRIIDTLGYPPSWMIDMGKNSGKFMKK 606
|
Negative regulator of the cell cycle acting downstream of the cAMP-dependent protein kinase. Part of a glucose-sensing system involved in growth control in response to glucose availability. Phosphorylates POP2. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54QV3|YAKA_DICDI Probable serine/threonine-protein kinase yakA OS=Dictyostelium discoideum GN=yakA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (500), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 107/253 (42%), Positives = 152/253 (60%), Gaps = 5/253 (1%)
Query: 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK 465
II N +Y V + LG F +V + ++ T V +KI+KN + +F Q EI+ LK
Sbjct: 195 IITNNESGQKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLK 254
Query: 466 LVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+N ++DP D++HILRL D F H HL IV ELL NL+E K N G + ++
Sbjct: 255 SLNDQHDPEDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRG----LSTNLIK 310
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
V Q L+AL L + IIHCDLKPENIL+++ IKIID GS+C++ L Y+QSR
Sbjct: 311 VFLIQILDALIVLANANIIHCDLKPENILLQNVNSPAIKIIDFGSACYEKSTLYTYIQSR 370
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
YR+PEV++G Y ID+WSLGCI AEL+ G LFP ++ ++RI+ M G ++L
Sbjct: 371 HYRSPEVLVGTVYCASIDMWSLGCISAELFLGLPLFPGNSEYNQISRIVEMRGIFPSDLL 430
Query: 645 MQGQEIYKYFTKE 657
+G+ +YF +
Sbjct: 431 DKGKSSTRYFHRH 443
|
General sensor of environmental conditions, such as heat stress, effecting changes through pkaC. Essential for survival to nitrosoative and oxidative stresses. Required for cell cycle control, not only at the onset but also during development (aggregation process and postaggregative development). Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8X4H1|MBK1_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis briggsae GN=mbk-1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 112/263 (42%), Positives = 159/263 (60%), Gaps = 10/263 (3%)
Query: 406 IILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 462
I+ N I + YV +G +F +V +A D T +V +KIIKN K FFDQ+ EI
Sbjct: 354 ILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTVTKEEVAIKIIKNKKTFFDQAQIEIH 413
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
LL+L N +D ++++I+ L +F H HL +V ELL NLY+ K G +L
Sbjct: 414 LLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTNFRG----VSLNL 469
Query: 523 LQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q + L +L S L IIHCDLKPEN+L+ + +R +I++ID GSSC + Y
Sbjct: 470 ARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQTGHRIYQY 529
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+QSR YR+PEV++G+ YD KID+WSLGCIL E+ TGE LF + V + +I+ +LG
Sbjct: 530 IQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKIVEVLGMPP 589
Query: 641 LEMLMQGQEIYKYFTKEYD-LYY 662
EML G + +KYF K D +YY
Sbjct: 590 KEMLDIGPKTHKYFDKTEDGIYY 612
|
Possible role in the function of olfactory neurons. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 111/263 (42%), Positives = 158/263 (60%), Gaps = 10/263 (3%)
Query: 406 IILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 462
I+ N I + YV +G +F +V +A D +V +KIIKN K FFDQ+ EI
Sbjct: 315 ILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTLNKEEVAIKIIKNKKTFFDQAQIEIH 374
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
LL+L N +D ++++I+ L +F H HL +V ELL NLY+ K G +L
Sbjct: 375 LLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTSFRG----VSLNL 430
Query: 523 LQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q + L +L S L IIHCDLKPEN+L+ + +R +I++ID GSSC + Y
Sbjct: 431 ARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQTGHRIYQY 490
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+QSR YR+PEV++G+ YD KID+WSLGCIL E+ TGE LF + V + +I+ +LG
Sbjct: 491 IQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKIVEVLGMPP 550
Query: 641 LEMLMQGQEIYKYFTKEYD-LYY 662
EML G + +KYF K D +YY
Sbjct: 551 KEMLDIGPKTHKYFDKTEDGIYY 573
|
Possible role in the function of olfactory neurons. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (487), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 101/231 (43%), Positives = 142/231 (61%), Gaps = 4/231 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 210 VLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEA 269
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ + D + H+++ + D+FY HL I ELL NLYE K N G F L ++
Sbjct: 270 LRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHG----FNLSIVRRF 325
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L L+ IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 326 TFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQVTVKVIDFGSSCYEHQKVYTYIQSRFY 385
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
R+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP + V LA I+ +LG
Sbjct: 386 RSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACIMEVLG 436
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (486), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 101/239 (42%), Positives = 145/239 (60%), Gaps = 4/239 (1%)
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
++N + II + IA RY + E +G +F +V +A D T V +KII+N K F +Q++
Sbjct: 181 DDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLNQAV 240
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
E+ +L + + D H+++ + DY Y +HL I EL+ NLYE K N +G F
Sbjct: 241 VELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG----F 296
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
++ ++ ++ L L+ IIHCDLKPENIL+K IK+ID GSSC+ +
Sbjct: 297 SMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDRKIY 356
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
Y+QSR YR+PEVI+GL Y ID+WSLGCILAEL+TG LFP + V LA I+ +LG
Sbjct: 357 TYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACIMEVLG 415
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 101/231 (43%), Positives = 141/231 (61%), Gaps = 4/231 (1%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 95 VLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEA 154
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ K D + ++++ + D+FY H I ELL NLYE K N G F+L ++
Sbjct: 155 LRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQG----FSLSIVRRF 210
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 211 TLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCYEHQKVYTYIQSRFY 270
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
R+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I+ +LG
Sbjct: 271 RSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLG 321
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | ||||||
| 297736602 | 728 | unnamed protein product [Vitis vinifera] | 0.931 | 0.891 | 0.630 | 0.0 | |
| 224101151 | 725 | predicted protein [Populus trichocarpa] | 0.890 | 0.856 | 0.611 | 0.0 | |
| 356551440 | 710 | PREDICTED: dual specificity tyrosine-pho | 0.913 | 0.897 | 0.583 | 0.0 | |
| 255585370 | 609 | ATP binding protein, putative [Ricinus c | 0.466 | 0.533 | 0.834 | 1e-158 | |
| 359486399 | 596 | PREDICTED: probable serine/threonine-pro | 0.456 | 0.533 | 0.824 | 1e-154 | |
| 357492707 | 612 | Dual specificity tyrosine-phosphorylatio | 0.826 | 0.941 | 0.539 | 1e-153 | |
| 224109312 | 591 | predicted protein [Populus trichocarpa] | 0.417 | 0.492 | 0.859 | 1e-151 | |
| 356501164 | 593 | PREDICTED: probable serine/threonine-pro | 0.439 | 0.516 | 0.831 | 1e-149 | |
| 357125722 | 715 | PREDICTED: dual specificity protein kina | 0.869 | 0.847 | 0.466 | 1e-149 | |
| 226506060 | 725 | ATP binding protein [Zea mays] gi|195616 | 0.880 | 0.846 | 0.469 | 1e-149 |
| >gi|297736602|emb|CBI25473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/673 (63%), Positives = 506/673 (75%), Gaps = 24/673 (3%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPV---KIPAS 60
++ SDV+ V+EFLRK G E+ESAL++D+ E+ + SFD+E F+FP++PP +IPAS
Sbjct: 1 MAVSDVDAVLEFLRKYGLSESESALRQDVSER-GGVASFDFESFVFPMVPPPPPVRIPAS 59
Query: 61 LRQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEAS 120
R+ E G D SS S D+FVSL SS +D SSEFTNPYG+ S + NS AS
Sbjct: 60 SRRMEEAVGDTDSSSVCS-------DDFVSLGSSATDAYSSEFTNPYGVHSATQANSTAS 112
Query: 121 SESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
S+SL +F TARDY D+QND YW+DEKD+ YF T +GGS+ FGCPSEDKF+MT E D+
Sbjct: 113 SDSLCEFGTARDYSDFDMQNDLYWYDEKDDDYFNTSCFGGSESFGCPSEDKFVMTLEKDK 172
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
E+ L + +SEG + +T+YL+KPC+F++ ++ ++ VTDYY + QP+ G
Sbjct: 173 QSESQLTLIHKSEGYPTLPTTNYLEKPCVFNLTSMDGVNDIPVTDYYHLGEHFQPD-GAR 231
Query: 238 KEKLKDCAAYGCSEPLCKCCAG----EGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCD 293
+ + CA Y CS PLCKCCAG G DY ++ E DL Q VVG TDCD
Sbjct: 232 EGDHESCAVYSCSVPLCKCCAGAEGFRGGDPVDYSQMNFAETDLDGSQLKVVGKIPTDCD 291
Query: 294 LAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNG 353
A KS YS KR S+ D I FK +SDLH + E + DGEV G
Sbjct: 292 SASEYKINKSFDYSI-KRSSANDLIGEFKSTSDLHIENTEPN---GNYGYEVGDDGEVAG 347
Query: 354 ALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
+E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI+LNTV+
Sbjct: 348 ECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPIVLNTVL 407
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK+DP
Sbjct: 408 AGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKYVNKHDP 467
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
ADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVITRQCLE
Sbjct: 468 ADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVITRQCLE 527
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSYRAPEVI
Sbjct: 528 ALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSYRAPEVI 587
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++GQE YK
Sbjct: 588 LGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVRGQETYK 647
Query: 653 YFTKEYDLYYINE 665
YFTKEYDLY+INE
Sbjct: 648 YFTKEYDLYHINE 660
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101151|ref|XP_002312161.1| predicted protein [Populus trichocarpa] gi|222851981|gb|EEE89528.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/692 (61%), Positives = 501/692 (72%), Gaps = 71/692 (10%)
Query: 8 DVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTEVD 67
DVE V++FLRKNG ++AE ALKEDM+E+ +LGSFD+EKFLF VLPPV++PAS+R +V+
Sbjct: 14 DVEAVLDFLRKNGLRDAELALKEDMIERSNELGSFDFEKFLF-VLPPVRVPASVRPLDVE 72
Query: 68 EGGADRSSRSSSASSSDDDEFVSLASSTS--DLCSSEFTNPYGLRSTSHGNSEASSESLS 125
EGG SS+ S DDEFVSL SSTS ++ SSEF+NPYGL STS NSE SS+ LS
Sbjct: 73 EGGGAVERLRSSSGSPSDDEFVSLGSSTSASEVYSSEFSNPYGLHSTSQANSETSSDRLS 132
Query: 126 QFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFENP 182
QF TARDY D+QND YW+DEK+EG+FM+P + G D+FGCPSEDKF+MTSE + FEN
Sbjct: 133 QFGTARDYPDFDMQNDSYWYDEKEEGHFMSPCFNGPDYFGCPSEDKFVMTSETGKQFENS 192
Query: 183 LAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYR-FEKTNQPEAGGIKEKL 241
L +YD+SEG ++ + DYLDK CL+++ +N+ E +Y+ F+K NQ E G I
Sbjct: 193 LGLYDKSEG-ETQGNIDYLDKQCLYNVTSVNNKNEAQSMNYHHDFDKKNQLE-GDID--- 247
Query: 242 KDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTE 301
+D ++ ++ + G+I+ D Y SSK DL D Q VG+S TD D P
Sbjct: 248 RDGSSAHNAKFFTETGGIYGRISVDCIYTSSKGPDLGDFQLK-VGESPTDYDTVP----- 301
Query: 302 KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRD-GEVNGALHEGKA 360
+H + + ID+ + D G VNG HE A
Sbjct: 302 -------------------------VHMENKNANYYENGIDDFEVGDGGGVNGEAHELAA 336
Query: 361 DAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNR------------------------- 395
V +LLM+ N E+E E+F+LR+IHRKNR
Sbjct: 337 AIGGEDVNANELLMYYNQEDEYEVFNLRVIHRKNRSCGHGIDPADSTLFSWRSDACAMQV 396
Query: 396 --TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF 453
TGFEENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DLHTG+DVCLKIIKNDKDF
Sbjct: 397 KWTGFEENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVIQAHDLHTGIDVCLKIIKNDKDF 456
Query: 454 FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG 513
FDQSLDEIKLLK+VNK DPADE HILRLYDYFYH EHLFIVCELL+ANLYEFQKFNQESG
Sbjct: 457 FDQSLDEIKLLKIVNKLDPADERHILRLYDYFYHQEHLFIVCELLKANLYEFQKFNQESG 516
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
GEAYFTL RLQVITRQCLEALEYLH LGIIHCDLKPEN+LIKSY++CEIK+IDLGSSCF+
Sbjct: 517 GEAYFTLSRLQVITRQCLEALEYLHDLGIIHCDLKPENVLIKSYRKCEIKVIDLGSSCFK 576
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMIL R+I
Sbjct: 577 SDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILTRMI 636
Query: 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
GMLGP+D EML GQE +KYFT+EYDLY++NE
Sbjct: 637 GMLGPLDPEMLETGQETHKYFTEEYDLYHLNE 668
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551440|ref|XP_003544083.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/673 (58%), Positives = 472/673 (70%), Gaps = 36/673 (5%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTE 65
S+ VE V+EFLRKNG EAESAL++D++E DLG+FDYEKF FP++PP +
Sbjct: 4 SNGVEAVLEFLRKNGLSEAESALRQDIIEN-NDLGNFDYEKFFFPMVPPPPPVRVRSFSR 62
Query: 66 VDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSH--GNSEASSES 123
+ E AD + S S DEFVS+ S TS + SSEF NPYG+RS+S +S +SSE
Sbjct: 63 LSELSAD-----GNCSKSSSDEFVSIGSPTSRVSSSEFINPYGIRSSSQTQNDSASSSER 117
Query: 124 LSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
LSQF TARDY ++QN+ YW++EKD+ YFMTPS+ G DFF C SEDKF+MT+E + +
Sbjct: 118 LSQFGTARDYHDFEMQNEPYWYNEKDDDYFMTPSFEGPDFFACQSEDKFVMTAETENQHD 177
Query: 181 NPL-AVYDQSEGL-HSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIK 238
N L VY+ E L + ++DK CL++ + D +Y + N E
Sbjct: 178 NSLDLVYNSEEFLLKGNGNGGFMDKACLYNHSSVRDGNATYSKEYCHVDNNNLFEGELEG 237
Query: 239 EKLKDCAAYGCSEPLCKCCAGEGKINND---YGYLSSKEADLIDLQHNVVGDSSTDCDLA 295
+ K A C P CK G G + D +GY + KE I L+ + + +L
Sbjct: 238 KAEKHTVACSCEVPFCKSSPG-GSCSLDPTNFGYPNLKE---IHLKFGDINSFDSTSELT 293
Query: 296 PHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGAL 355
+ + + SSK + G DL K +KDL P +D RDG G L
Sbjct: 294 VNQSFDYYTKNDSSKE---------YNGPYDLTIKVNQKDL-PNGLDTYKARDG---GEL 340
Query: 356 HEGKADAE---EHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 412
E D E + T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+
Sbjct: 341 AEECQDPEITADGEDTTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVL 400
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AGRYYVTEYLGSAAFS+V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLKLVNK+DP
Sbjct: 401 AGRYYVTEYLGSAAFSRVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKLVNKHDP 460
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
AD HH LRLYDYFYH EHLFIV ELL+ANLYEFQKF QESGGE YFTL RLQ+ITRQCLE
Sbjct: 461 ADLHHFLRLYDYFYHQEHLFIVTELLQANLYEFQKFKQESGGEEYFTLNRLQLITRQCLE 520
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
AL+YLHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV+
Sbjct: 521 ALQYLHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVM 580
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652
+GL YD+KID+WSLGCILAEL +GEVLFPNDAVVMILAR+IGM G ID+EML++GQE +K
Sbjct: 581 LGLQYDEKIDIWSLGCILAELCSGEVLFPNDAVVMILARMIGMFGSIDMEMLVKGQETHK 640
Query: 653 YFTKEYDLYYINE 665
YFTKEYD+YY+NE
Sbjct: 641 YFTKEYDIYYVNE 653
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585370|ref|XP_002533381.1| ATP binding protein, putative [Ricinus communis] gi|223526774|gb|EEF28999.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 273/327 (83%), Positives = 294/327 (89%), Gaps = 2/327 (0%)
Query: 341 IDNSDTRDGEVNGALHEGKADAEEHG--VATPDLLMFDNLEEECEIFHLRIIHRKNRTGF 398
+ +S + GE N E +A EE V T DLLM D E+E E+F LRIIHRKNRTGF
Sbjct: 221 MKSSKDKIGEANEEADELRATEEEEDGEVNTNDLLMLDAQEDEYEVFDLRIIHRKNRTGF 280
Query: 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
EENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DL+TG+DVCLKIIKNDKDFFDQSL
Sbjct: 281 EENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVVQAHDLYTGIDVCLKIIKNDKDFFDQSL 340
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
DEIKLLKLVNK+DPADE HI+RLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF
Sbjct: 341 DEIKLLKLVNKHDPADERHIIRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYF 400
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
TL RLQVITRQCLEALEYLH LGIIHCDLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLC
Sbjct: 401 TLSRLQVITRQCLEALEYLHHLGIIHCDLKPENILIKSYRRCEIKVIDLGSSCFQSDNLC 460
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
LYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLGP
Sbjct: 461 LYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILARVIGMLGP 520
Query: 639 IDLEMLMQGQEIYKYFTKEYDLYYINE 665
IDLEML++GQE +KYFT EYDLYY+NE
Sbjct: 521 IDLEMLVRGQETHKYFTTEYDLYYVNE 547
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486399|ref|XP_002272072.2| PREDICTED: probable serine/threonine-protein kinase dyrk2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1424), Expect = e-154, Method: Compositional matrix adjust.
Identities = 263/319 (82%), Positives = 292/319 (91%), Gaps = 1/319 (0%)
Query: 348 DGEVNGALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPI 406
DGEV G +E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI
Sbjct: 210 DGEVAGECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPI 269
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
+LNTV+AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK
Sbjct: 270 VLNTVLAGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKY 329
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
VNK+DPADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVI
Sbjct: 330 VNKHDPADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVI 389
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
TRQCLEALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSY
Sbjct: 390 TRQCLEALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSY 449
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
RAPEVI+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++
Sbjct: 450 RAPEVILGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVR 509
Query: 647 GQEIYKYFTKEYDLYYINE 665
GQE YKYFTKEYDLY+INE
Sbjct: 510 GQETYKYFTKEYDLYHINE 528
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492707|ref|XP_003616642.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Medicago truncatula] gi|355517977|gb|AES99600.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-153, Method: Compositional matrix adjust.
Identities = 345/639 (53%), Positives = 432/639 (67%), Gaps = 63/639 (9%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEKIR-DLGSFDYEKFLFPVLPPV---KIPASL 61
S+ VE V EFLRKNG EAESAL++D+++K DL SFDYEKF FP++PP K+ +
Sbjct: 4 SNSVEAVFEFLRKNGLSEAESALRQDIIDKHNNDLASFDYEKFFFPMVPPPPPVKLRSFS 63
Query: 62 RQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSS----EFTNPYGLRSTSH--G 115
R +E G + S+S+S SS +++FVS+ASSTS S EF NPYG+ S+S
Sbjct: 64 RPSEFTSGDG-QFSKSNSVSS--EEQFVSIASSTSPSRSRVSSSEFINPYGINSSSQTQN 120
Query: 116 NSEASSESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYG-GSDFFGCPSEDKFIM 171
+SE+SS+ LSQF TARDY D+Q++ YW++E D+ G DFFGC SEDKFI+
Sbjct: 121 DSESSSDRLSQFGTARDYHEFDMQHEPYWYNENDDDDDFMTPDFDGPDFFGCQSEDKFIL 180
Query: 172 TSEADRLFENPLAVYDQSEGLHSEASTDYLDKP---CLFHIVPLNDDKEVGVTDYYRFEK 228
SE + ++ ++ E + E + Y+DK CL + D+ DY
Sbjct: 181 NSETENQQDDSRDLHYNFEEIQLEGNEGYIDKSMEQCLCNHSSGGDENATYSKDYCH--- 237
Query: 229 TNQPEAGGIKEKLKDCAAYGCSEPLCKCCAG------EGKINNDYGYLSSKEADLIDLQH 282
G KE + A+ C P CK G E +N + YL+ KE L +L
Sbjct: 238 ------GAEKEAI----AHNCEVPFCKSSPGSGGSCSEDPMN--FSYLNLKEIKL-NLND 284
Query: 283 NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342
+ D ++ D P + SS + +K DL + E DL P I+
Sbjct: 285 FHMKDINS-FDSVPVLTMKHSS--------------DCYKDPYDLTIEVVETDL-PNGIE 328
Query: 343 NSDTRDG-EVNGALH--EGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFE 399
+ + RD ++N LH E AD E++ T D L+ ++E E+F LRI+HRKNRTGFE
Sbjct: 329 SYEVRDDRDLNEELHVPEVAADGEDNN--TDDDLLKYIQDDEYEVFELRIVHRKNRTGFE 386
Query: 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD 459
ENK++PI+LN+V+AGRYYVTEYLGSAAFS+V QA DL G+DVCLKIIKNDKDFFDQSLD
Sbjct: 387 ENKEVPIVLNSVMAGRYYVTEYLGSAAFSRVVQAHDLQMGIDVCLKIIKNDKDFFDQSLD 446
Query: 460 EIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
EIKLLKLVNK+DP D+HHILRLYDYFYH EHLFIV ELLRANLYEFQKFNQESGGEAYFT
Sbjct: 447 EIKLLKLVNKHDPGDKHHILRLYDYFYHQEHLFIVTELLRANLYEFQKFNQESGGEAYFT 506
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
L RLQ+ITRQCLEAL+YLH+LGI+HCDLKPEN+LIKSY++CEIKIIDLGSSCF+TDNLCL
Sbjct: 507 LKRLQLITRQCLEALQYLHNLGIVHCDLKPENVLIKSYKKCEIKIIDLGSSCFKTDNLCL 566
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
YVQSRSYRAPEV++GL YD+KID+WSLGCILAEL +GEV
Sbjct: 567 YVQSRSYRAPEVMLGLQYDEKIDIWSLGCILAELCSGEV 605
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224109312|ref|XP_002315156.1| predicted protein [Populus trichocarpa] gi|222864196|gb|EEF01327.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 257/299 (85%), Positives = 280/299 (93%)
Query: 367 VATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAA 426
V +LLM+ N E+E E+F+LR+IHRKNRTGFEENKDLPI+LNTVIAGRYYVTEYLGSAA
Sbjct: 236 VNAAELLMYYNQEDEYEVFNLRVIHRKNRTGFEENKDLPIVLNTVIAGRYYVTEYLGSAA 295
Query: 427 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486
FSKV QA DLHTG+DVCLKIIKNDKDFFDQSLDEIKLLK+VNK+DPADE HILRLYDYFY
Sbjct: 296 FSKVIQAHDLHTGIDVCLKIIKNDKDFFDQSLDEIKLLKIVNKHDPADERHILRLYDYFY 355
Query: 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546
H EHLFIVCELL+ANLYEFQKF+QES G+AYFTL RLQVITRQCLEALEYLH LGIIHCD
Sbjct: 356 HQEHLFIVCELLKANLYEFQKFSQESDGKAYFTLSRLQVITRQCLEALEYLHHLGIIHCD 415
Query: 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSL 606
LKPENILIKSY+RCEIK+IDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSL
Sbjct: 416 LKPENILIKSYRRCEIKVIDLGSSCFKSDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSL 475
Query: 607 GCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
GCILAEL +GEVLFPNDAVVMILAR+IGMLGPI EML+ GQE +KYFT+EYDLYY NE
Sbjct: 476 GCILAELCSGEVLFPNDAVVMILARMIGMLGPIHSEMLVMGQETHKYFTEEYDLYYSNE 534
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501164|ref|XP_003519398.1| PREDICTED: probable serine/threonine-protein kinase dyrk2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1382), Expect = e-149, Method: Compositional matrix adjust.
Identities = 257/309 (83%), Positives = 283/309 (91%), Gaps = 3/309 (0%)
Query: 357 EGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRY 416
E AD E+ T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+AGRY
Sbjct: 231 EITADGED---TTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVLAGRY 287
Query: 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
YVTEYLGSAAFS+V QA DL TG+D CLKIIKNDKDFFDQSLDEIKLLKLVNK+DPAD+H
Sbjct: 288 YVTEYLGSAAFSRVVQAHDLQTGIDFCLKIIKNDKDFFDQSLDEIKLLKLVNKHDPADKH 347
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
HILRLYDYFYH EHLFIV ELLRANLYEFQKFNQESGGEAYFTL RLQ+ITRQCLEAL+Y
Sbjct: 348 HILRLYDYFYHQEHLFIVTELLRANLYEFQKFNQESGGEAYFTLNRLQLITRQCLEALQY 407
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP 596
LHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV++GL
Sbjct: 408 LHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVMLGLQ 467
Query: 597 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 656
YD+KIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLG ID+EML++GQE +KYFTK
Sbjct: 468 YDEKIDLWSLGCILAELCSGEVLFPNDAVVMILARMIGMLGSIDMEMLVKGQETHKYFTK 527
Query: 657 EYDLYYINE 665
EYD+YY+NE
Sbjct: 528 EYDIYYVNE 536
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357125722|ref|XP_003564539.1| PREDICTED: dual specificity protein kinase YAK1-like isoform 2 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-149, Method: Compositional matrix adjust.
Identities = 333/714 (46%), Positives = 413/714 (57%), Gaps = 108/714 (15%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL ++GF SAL++D++++ D G D L P LPP+++PAS
Sbjct: 1 MAAPGLDEVMAFLTEHGFASTASALRDDVLDRSAD-GESDSTATLGPQLPPLRLPASASG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASSES 123
+ + S+S+S S A + S NPYG+ S H S+ SS
Sbjct: 60 GAGGGVALEAPASPGSSSNS----ASSSAFVSMSSSPSGLLNPYGVWSPPHSQSDGSSSE 115
Query: 124 LSQFDTARDYDLQNDFY---WHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
+ +F TAR YD + F+ W + D + P G D EDKF+
Sbjct: 116 M-EFGTARQYDTTDLFFQEGWLYD-DHLFHSKPDDDGRD----KEEDKFVHGGSG----- 164
Query: 181 NPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEK 240
++E L ++ +DD+ R E G E
Sbjct: 165 -------RTEML----------------VLNADDDR--------RHEHAGNNSCEGCAE- 192
Query: 241 LKDCAAYGCSEPLCKCCAGEGK---------------------INNDYGYLSSKEADLID 279
Y CS PLC CC GE K +++ L DL
Sbjct: 193 -----VYTCSSPLCGCCGGELKNEEGLQVVSNSSSVVYGRYKVMDDQTEILDECGLDLFQ 247
Query: 280 LQHNVVGDSSTDCDLAPHPGT-----EKSSSYSSSKRGSSIDWI---------------E 319
L+ +V DS +CDL PG E + + SS D
Sbjct: 248 LKQSV--DSVLECDLPRDPGQGDEHLELNVVEKELQMLSSFDRFIPHVTDNIKLHDSTEN 305
Query: 320 GFKGSSDLHFKGAEKDLMPAEIDNSDTRD-------GEVNGALHEGKA-DAEEHGVATPD 371
+ SSD + L P ++ D D G +N + A AE+ + +
Sbjct: 306 NLESSSDKEYLKESYSLHPFP-ESGDPDDPYEFGDIGPLNTGVKSSTALIAEKEDMESNI 364
Query: 372 LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVF 431
L N + E E+F LRI+HRKNRTGFEENKD PI+LN+VIAGRYYVTEYLGSAAFSKV
Sbjct: 365 DLALSNFQREYEVFELRIVHRKNRTGFEENKDFPIVLNSVIAGRYYVTEYLGSAAFSKVV 424
Query: 432 QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491
QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP+DEHH+LRLYDYFYH EHL
Sbjct: 425 QAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPSDEHHVLRLYDYFYHQEHL 484
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
FIV ELLRANLYEFQK+NQE GGE YFTL R+QVI RQCLEAL YLH L I+HCDLKPEN
Sbjct: 485 FIVTELLRANLYEFQKYNQEFGGEVYFTLPRIQVIARQCLEALVYLHHLRIVHCDLKPEN 544
Query: 552 ILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILA 611
ILIKSY+RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCILA
Sbjct: 545 ILIKSYRRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCILA 604
Query: 612 ELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
EL TGEVLFPN+ + M+LAR+IG++GPID+EML GQE +KYFT +YDL+ NE
Sbjct: 605 ELCTGEVLFPNEPLPMMLARMIGIIGPIDMEMLALGQEAHKYFTDDYDLFTKNE 658
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226506060|ref|NP_001148168.1| ATP binding protein [Zea mays] gi|195616354|gb|ACG30007.1| ATP binding protein [Zea mays] gi|414879861|tpg|DAA56992.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1377), Expect = e-149, Method: Compositional matrix adjust.
Identities = 336/716 (46%), Positives = 414/716 (57%), Gaps = 102/716 (14%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL +GF A SAL++D++E+ G ++ L P LPP+++PAS
Sbjct: 1 MAAPGLDKVMAFLTDHGFAGAASALRDDVLERTA-AGDESHDAALDPHLPPLRMPASAGG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDE------FVSLASSTSDLCSSEFTNPYGLRSTSHGNS 117
G + + AS FVSL S+ S L NPYGL S H S
Sbjct: 60 AGAGAGAGAGAGTPTPASPGSSSGSASSSAFVSLRSTPSGLL-----NPYGLWSPRHSQS 114
Query: 118 EASSESLSQFDTARDYDLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
+ASS + +F TAR YD + F+ ++D Y D
Sbjct: 115 DASSSEM-EFGTARQYDTTDLFF---QEDWLY-------------------------DDH 145
Query: 178 LFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGI 237
LF + L D + D D I ++G +R E GG
Sbjct: 146 LFPSKLDDEDDEGKEEDKFVLDAHDGSEQVEI------GKLGAGHNHRHEHI-----GG- 193
Query: 238 KEKLKDCA-AYGCSEPLCKCCAGEGKINN-DYGYLSSKEA----DLIDLQHNVVGDSSTD 291
++ + CA Y CS PLC CC G K + D SS ++D Q ++ D + D
Sbjct: 194 -DRCEGCAEVYICSSPLCGCCGGGLKNDGLDVARSSSSTVYGRYKIMDDQTEILDDCAQD 252
Query: 292 -------------CDLAPHPG----------TEKS----SSYSSSKRGSSIDWIEG--FK 322
C + PG EK SS+ + + D+ E
Sbjct: 253 AFQLKQSRDIMFECGMTRDPGRGYDDSGLSVVEKELQILSSFDTVVNHGTYDFTENGELN 312
Query: 323 GSSDLHFKGAEKDLMP-----------AEIDNSD--TRDGEVNGALHEGKADAEEHGVAT 369
GS D + K + P ++D +D G +N + A E T
Sbjct: 313 GSCDKNLKSSIHKEYPKGHRIQPFPESGDLDEADEFRHVGSLNTDVQHSTALKAEEDAET 372
Query: 370 PDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSK 429
L + E E+F LRIIHRKNRTGFEENKD PI+LN+V+AGRYY+TEYLGSAAFSK
Sbjct: 373 NIDLALSDFHREYEVFELRIIHRKNRTGFEENKDFPIVLNSVVAGRYYITEYLGSAAFSK 432
Query: 430 VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489
V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK DP DEHH+LRLYDYFYH E
Sbjct: 433 VVQAHDLRTGMDVCLKIIKNDKDFFDQSLDEIKLLKFVNKYDPLDEHHVLRLYDYFYHQE 492
Query: 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549
HLFIV ELLRANLYEFQK+NQESGGE YFTL R+QVI RQCLEAL YLH L IIHCDLKP
Sbjct: 493 HLFIVTELLRANLYEFQKYNQESGGEVYFTLPRIQVIARQCLEALVYLHRLRIIHCDLKP 552
Query: 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCI 609
ENILIKSY RCEIK+IDLGSSCF TDNLCLYVQSRSYRAPEVI+GLPYDQ+ID+WSLGCI
Sbjct: 553 ENILIKSYSRCEIKVIDLGSSCFLTDNLCLYVQSRSYRAPEVILGLPYDQRIDIWSLGCI 612
Query: 610 LAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
L+EL+TGEVLFPN+ V ++LA++IG+ GPID+EML GQE KYFT +YDL+ NE
Sbjct: 613 LSELYTGEVLFPNEPVSVMLAQMIGITGPIDMEMLELGQETQKYFTDDYDLFTENE 668
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | ||||||
| TAIR|locus:2047741 | 570 | AT2G40120 [Arabidopsis thalian | 0.434 | 0.531 | 0.805 | 8.9e-169 | |
| TAIR|locus:2206840 | 1169 | AT1G73460 [Arabidopsis thalian | 0.486 | 0.289 | 0.646 | 5.7e-125 | |
| TAIR|locus:2089774 | 1138 | AT3G17750 [Arabidopsis thalian | 0.411 | 0.252 | 0.738 | 9.2e-124 | |
| TAIR|locus:2206855 | 1152 | AT1G73450 [Arabidopsis thalian | 0.482 | 0.291 | 0.649 | 3.1e-123 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.354 | 0.390 | 0.411 | 3.7e-50 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.354 | 0.413 | 0.411 | 3.7e-50 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.344 | 0.440 | 0.420 | 7.7e-50 | |
| UNIPROTKB|Q9NR20 | 520 | DYRK4 "Dual specificity tyrosi | 0.344 | 0.461 | 0.420 | 7.7e-50 | |
| ASPGD|ASPL0000065013 | 885 | AN7104 [Emericella nidulans (t | 0.375 | 0.296 | 0.431 | 1.1e-49 | |
| MGI|MGI:1330292 | 632 | Dyrk4 "dual-specificity tyrosi | 0.351 | 0.387 | 0.427 | 1.3e-49 |
| TAIR|locus:2047741 AT2G40120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1316 (468.3 bits), Expect = 8.9e-169, Sum P(2) = 8.9e-169
Identities = 244/303 (80%), Positives = 275/303 (90%)
Query: 363 EEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYL 422
++ V ++ + +E+E E+F+LRIIH KNRTGFEENKDLPI++NTVI GRYY+TEY+
Sbjct: 208 DQLNVTDEEVDVVHEVEDEYEVFNLRIIHWKNRTGFEENKDLPIVINTVIGGRYYITEYI 267
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482
GSAAFSKV QAQDLH GVDVCLKIIKNDKDFFDQSLDEIKLLK VNK+DPADEHHILRLY
Sbjct: 268 GSAAFSKVVQAQDLHNGVDVCLKIIKNDKDFFDQSLDEIKLLKHVNKHDPADEHHILRLY 327
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI 542
DYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF L RLQVITRQCL+AL +LH LGI
Sbjct: 328 DYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYFNLSRLQVITRQCLDALVFLHGLGI 387
Query: 543 IHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKID 602
IHCDLKPENILIKSY+RC +KIIDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYD+KID
Sbjct: 388 IHCDLKPENILIKSYKRCAVKIIDLGSSCFRSDNLCLYVQSRSYRAPEVILGLPYDEKID 447
Query: 603 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY 662
LWSLGCILAEL +GEVLFPN+AV MILARI+ +LGPI+ EML +GQE +KYFTKEYDLY+
Sbjct: 448 LWSLGCILAELCSGEVLFPNEAVAMILARIVAVLGPIETEMLEKGQETHKYFTKEYDLYH 507
Query: 663 INE 665
+NE
Sbjct: 508 LNE 510
|
|
| TAIR|locus:2206840 AT1G73460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 5.7e-125, Sum P(3) = 5.7e-125
Identities = 221/342 (64%), Positives = 269/342 (78%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D +D+ + E + A D EE + EEE E
Sbjct: 769 SSLSNYACEERKHADKEDDRNDSSEIEDDNAT---ALDDEEAVAVQEQVRQIKAQEEEFE 825
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 826 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 885
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 886 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 945
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 946 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 1005
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 1006 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1065
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
+ +LAR++G++G D EML +G++ +KYFTK LY N+
Sbjct: 1066 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQ 1107
|
|
| TAIR|locus:2089774 AT3G17750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 9.2e-124, Sum P(2) = 9.2e-124
Identities = 212/287 (73%), Positives = 253/287 (88%)
Query: 379 EEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT 438
E++ E F+L+I+HRKNRTGFEE+K+ ++LN+VIAGRY+VTE+LGSAAFSK QA DLHT
Sbjct: 790 EQDFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEHLGSAAFSKAIQAHDLHT 849
Query: 439 GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498
G+DVC+KIIKN+KDFFDQSLDEIKLLK VN++DPAD++H+LRLYDYFY EHL IVCELL
Sbjct: 850 GIDVCVKIIKNNKDFFDQSLDEIKLLKYVNQHDPADKYHLLRLYDYFYFREHLLIVCELL 909
Query: 499 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+ANLYEFQKFN+ESGGE YFT+ RLQ IT QCLEAL +LH LG+IHCDLKPENILIKSY
Sbjct: 910 KANLYEFQKFNRESGGEVYFTMPRLQSITIQCLEALNFLHGLGLIHCDLKPENILIKSYS 969
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
RCEIK+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 970 RCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAELCTGNV 1029
Query: 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
LF ND+ +LAR+IG++G ID EML +G++ KYFTK + LY N+
Sbjct: 1030 LFQNDSPATLLARVIGIIGSIDQEMLAKGRDTCKYFTKNHLLYERNQ 1076
|
|
| TAIR|locus:2206855 AT1G73450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
Identities = 222/342 (64%), Positives = 268/342 (78%)
Query: 324 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383
SS ++ E+ E D+S+ DG H D EE + EEE E
Sbjct: 755 SSLSNYARGERKHAEKENDSSEREDG------HATALDDEEAVAVQEQVRQIKAQEEEFE 808
Query: 384 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 443
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 809 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 868
Query: 444 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 869 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 928
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 929 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 988
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 989 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1048
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
+ +LAR++G++G D EML +G++ +KYFTK LY N+
Sbjct: 1049 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQ 1090
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.7e-50, Sum P(2) = 3.7e-50
Identities = 104/253 (41%), Positives = 155/253 (61%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 189 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 248
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 249 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 308
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 309 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 364
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 365 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 424
Query: 625 VVMILARIIGMLG 637
V LA I+ +LG
Sbjct: 425 EVEQLACIMEVLG 437
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.7e-50, Sum P(2) = 3.7e-50
Identities = 104/253 (41%), Positives = 155/253 (61%)
Query: 387 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 153 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 212
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 213 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 272
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 273 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 328
Query: 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 329 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 388
Query: 625 VVMILARIIGMLG 637
V LA I+ +LG
Sbjct: 389 EVEQLACIMEVLG 401
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 7.7e-50, Sum P(2) = 7.7e-50
Identities = 103/245 (42%), Positives = 148/245 (60%)
Query: 394 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 452
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 196 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 255
Query: 453 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 512
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 256 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 315
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 316 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 431
Query: 633 IGMLG 637
+ +LG
Sbjct: 432 MEVLG 436
|
|
| UNIPROTKB|Q9NR20 DYRK4 "Dual specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 7.7e-50, Sum P(2) = 7.7e-50
Identities = 103/245 (42%), Positives = 148/245 (60%)
Query: 394 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 452
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 81 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 140
Query: 453 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 512
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 141 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 200
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 201 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 256
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I
Sbjct: 257 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 316
Query: 633 IGMLG 637
+ +LG
Sbjct: 317 MEVLG 321
|
|
| ASPGD|ASPL0000065013 AN7104 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 1.1e-49, P = 1.1e-49
Identities = 119/276 (43%), Positives = 167/276 (60%)
Query: 393 KNRTGFE-ENKDLPIILNTVI----AG---RYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
KN G++ E+ D + +N ++ AG RY + + LG F +V + Q+L T V +
Sbjct: 311 KN-DGYDNEDSDYILYVNDILGSEEAGHKNRYLILDVLGQGTFGQVVKCQNLKTQEVVAV 369
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKN-DPADEHHILRLYDYFYHLEHLFIVCELLRANLY 503
K+IKN +F+QS+ E+ +L L+N D D+HH+LRL D F H +HL +V ELL NLY
Sbjct: 370 KVIKNKTAYFNQSMMEVSVLDLLNSRYDKNDDHHLLRLKDTFIHRQHLCLVFELLSVNLY 429
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
E K NQ G TL R V +Q L AL L+ +IHCDLKPENIL+K+ + IK
Sbjct: 430 ELIKQNQFRGLST--TLVR--VFAQQLLNALSLLNKAHLIHCDLKPENILLKNLESPIIK 485
Query: 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ID GS+C + + Y+QSR YR+PEV++GLPY ID+WSLGCI+ EL+ G LFP
Sbjct: 486 VIDFGSACDERQTVYTYIQSRFYRSPEVLLGLPYSSAIDMWSLGCIVVELFLGLPLFPGS 545
Query: 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 659
+ + RI+ MLG ML G++ ++F K D
Sbjct: 546 SEYNQVCRIVEMLGLPPTWMLEMGKQSGEFFEKTQD 581
|
|
| MGI|MGI:1330292 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 1.3e-49, Sum P(2) = 1.3e-49
Identities = 109/255 (42%), Positives = 156/255 (61%)
Query: 387 LRIIHRK-NRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 444
L ++ K ++T F+ E+ +L+ IA RY V E +G +F +V + D V L
Sbjct: 188 LNVVPEKFSKTSFDDEHGSYMKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVAL 247
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 248 KIIRNKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYE 307
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI-- 562
K N G F L ++ T L+ L L+ IIHCDLKPENI++ YQR ++
Sbjct: 308 LMKNNSFHG----FNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVL--YQRGQVTV 361
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
K+ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP
Sbjct: 362 KVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPG 421
Query: 623 DAVVMILARIIGMLG 637
+ V LA I+ +LG
Sbjct: 422 ENEVEQLACIMEVLG 436
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_VIII0583 | hypothetical protein (726 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 697 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-59 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-44 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-38 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-34 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-34 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-29 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-28 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-28 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-26 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-25 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-25 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-24 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-21 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.004 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 9e-59
Identities = 84/226 (37%), Positives = 120/226 (53%), Gaps = 21/226 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPA 473
Y + E LG +F KV+ A+D TG V +K+IK K ++ L EIK+LK +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK----- 55
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD F + L++V E +L++ K + + RQ L
Sbjct: 56 --HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQIL 107
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
ALEYLHS GI+H DLKPENIL+ +K+ D G + L +V + Y AP
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDE--DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
EV++G Y + +D+WSLG IL EL TG+ FP D ++ L + IG
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 78/227 (34%), Positives = 117/227 (51%), Gaps = 24/227 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
LGS +F V++A+ TG V +KI+K + EI++L+ ++ H +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-------HPN 59
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL D F +HL++V E +L+++ + + I Q L LEY
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEY 113
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVII 593
LHS GIIH DLKPENIL+ + +KI D G + + L +V + Y APEV++
Sbjct: 114 LHSNGIIHRDLKPENILLD--ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 594 -GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
G Y K+D+WSLG IL EL TG+ F + ++ L I +LGP
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP 218
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 5e-44
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F V+ A+D TG V +KIIK + ++ L EI++LK +N +I+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIV 54
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY F HL++V E +L + K N+ + + I Q LE LEYLH
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH 109
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGL 595
S GIIH DLKPENIL+ S +K+ D G S L V + +Y APEV++G
Sbjct: 110 SNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 596 P-YDQKIDLWSLGCILAEL 613
Y +K D+WSLG IL EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVN-KND 471
Y +G + V++A+D TG V +K IK + +L EIKLLK +N N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++L D F H L++V E + +LY+ K Q ++ Q L
Sbjct: 60 ------IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-----LPESLIKSYLYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-CFQTDNLCL--YVQSRSYRA 588
+ L + HS GI+H DLKPEN+LI +K+ D G + F + YV +R YRA
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLIN--TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
PE+++G Y +D+WS+GCI AEL + LFP + + L +I LG
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG 216
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 30/234 (12%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDP 472
Y E LG + V++A+D TG V LK I+ D + +L EI LLK +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L D + L++V E +L ++ + ++ I Q L
Sbjct: 57 ---HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----LSPNLIKSIMYQLL 108
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ------TDNLCLYVQSR 584
L Y HS I+H DLKP+NILI +K+ D G + F T V +
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTHE----VVTL 162
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YRAPE+++G Y +D+WS+GCI AE+ TG+ LFP D+ + L +I +LG
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 76/233 (32%), Positives = 117/233 (50%), Gaps = 25/233 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
RY + +G A VF+A+D TG V LK + +Q+L EIK L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQAC--- 56
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+H ++++L D F H +V E + ++L E + + +++ R
Sbjct: 57 ----QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP-----LPEAQVKSYMRM 107
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRS 585
L+ + Y+H+ GI+H DLKP N+LI + +KI D G + F + LY V +R
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRW 165
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YRAPE++ G YD +DLW++GCI AEL G LFP + + LA + LG
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 88/250 (35%), Positives = 122/250 (48%), Gaps = 39/250 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + + +GS A+ V A D TG V +K I N FD +D EIKLL+ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57
Query: 469 KNDPADEH-HILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +I+ L D ++IV EL+ +L++ K Q T
Sbjct: 58 -------HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP------LTDDH 104
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDN 576
+Q Q L L+YLHS +IH DLKP NIL+ S C++KI D G +
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGF 162
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIG 634
L YV +R YRAPE+++ Y + ID+WS+GCI AEL T + LFP D + L I+
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVE 221
Query: 635 MLGPIDLEML 644
+LG E L
Sbjct: 222 VLGTPSEEDL 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 24/215 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y V + LG F V+ A++ TG V +K +K +++ +L E+K L+ +N++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L + F + L+ V E + NLY+ K + F+ ++ I Q L+
Sbjct: 59 ---NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGK----PFSESVIRSIIYQILQG 111
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYR 587
L ++H G H DLKPEN+L+ + +KI D G S TD YV +R YR
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD----YVSTRWYR 165
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP 621
APE+++ Y +D+W+LGCI+AEL+T LFP
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 17/202 (8%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
E +G F +V++A+ TG +V +K+IK K+ ++ ++EI++LK +I
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNI 59
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ Y + + L+IV E +L + K ++ T ++ + ++ L+ LEYL
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-----LTESQIAYVCKELLKGLEYL 114
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
HS GIIH D+K NIL+ S E+K+ID G S +D V + + APEVI G
Sbjct: 115 HSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 596 PYDQKIDLWSLGCILAELWTGE 617
PYD K D+WSLG EL G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 84/245 (34%), Positives = 129/245 (52%), Gaps = 35/245 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNK 469
RY +GS A+ +V A D TG V +K K + F ++ E++LLK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHM-- 71
Query: 470 NDPADEHHILRLYDYFYHLEHL------FIVCELLRANLY---EFQKFNQESGGEAYFTL 520
D +++ L D F L ++V L+ A+L + QK + +
Sbjct: 72 ----DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--------- 118
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+Q + Q L L+Y+HS GIIH DLKP NI + CE+KI+D G + D + Y
Sbjct: 119 -HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDEMTGY 175
Query: 581 VQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
V +R YRAPE+++ + Y+Q +D+WS+GCI+AEL TG+ LFP + L RI+ ++G
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 640 DLEML 644
D E+L
Sbjct: 236 DEELL 240
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 74/236 (31%), Positives = 117/236 (49%), Gaps = 23/236 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKN 470
+Y V +G A+ V + ++ TG V +K K +D+D +L E+K+L+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I+ L + F L++V E + L E + + ++ Q
Sbjct: 58 ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-----VRSYIWQ 108
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLYVQSRS 585
L+A+ Y HS IIH D+KPENIL+ +K+ D G L YV +R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
YRAPE+++G Y + +D+W++GCI+AEL GE LFP D+ + L I LGP+
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKNDP 472
Y +G A+ V++A+DL+TG V LK ++ ++ S L EI LLK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56
Query: 473 ADEH-HILRLYD--YFYHLEH---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ EH +I+RL D + + L +V E + +L + + G ++ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE----TIKDL 112
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
RQ L +++LHS I+H DLKP+NIL+ S + +KI D G + F+ L V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM-ALTSVVVT 169
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YRAPEV++ Y +D+WS+GCI AEL+ LF + L +I ++G
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 88/262 (33%), Positives = 131/262 (50%), Gaps = 41/262 (15%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK 465
+ RY + +GS A V A D TG +V +K K + F + + E+ L+K
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMK 70
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
LVN KN I+ L + F + +++V EL+ ANL Q + E
Sbjct: 71 LVNHKN-------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLC--QVIQMDLDHE--- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCF 572
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G +S
Sbjct: 119 ---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFM 173
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
T YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + +I
Sbjct: 174 MTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 633 IGMLGPIDLEMLMQGQEIYKYF 654
I LG E + + Q + +
Sbjct: 230 IEQLGTPSDEFMSRLQPTVRNY 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 85/241 (35%), Positives = 123/241 (51%), Gaps = 34/241 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + E +G ++ V A D HTG V +K I D F+ D EIKLL+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN---DVFEHVSDATRILREIKLLRLLR 57
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D + HI+ L + +++V EL+ ++L++ K N + E + Q
Sbjct: 58 HPDIVEIKHIM-LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH------QFFLY 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------SSCFQTDNLC 578
Q L AL+Y+H+ + H DLKP+NIL + C++KI D G ++ F TD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD--- 165
Query: 579 LYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
YV +R YRAPE+ Y ID+WS+GCI AE+ TG+ LFP VV L I +L
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 637 G 637
G
Sbjct: 225 G 225
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 73/235 (31%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFDQSLD-EIKLLK-LVNKNDPADE 475
E LG +F V+ A D TG + +K + D + ++L+ EI++L L + N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN----- 60
Query: 476 HHILRLYDYFYHLE--HLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I+R Y E L I E L + L +F K E ++ TR
Sbjct: 61 --IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EP---------VIRKYTR 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q LE L YLHS GI+H D+K NIL+ S +K+ D G + + ++ + S R
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFGCA-KRLGDIETGEGTGSVRG 165
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
APEVI G Y + D+WSLGC + E+ TG+ + M IG G
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 74/243 (30%), Positives = 122/243 (50%), Gaps = 35/243 (14%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKNDP 472
Y +G + +V++A++ TG V LK I+ N+K+ F ++ EIKLL+ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLY---EFQKFNQESG----GEAYFTLGRLQ 524
H +I+RL + IV + ++Y E+ + +G E FT +++
Sbjct: 57 ---HPNIVRLKE---------IVTSKGKGSIYMVFEYMDHDL-TGLLDSPEVKFTESQIK 103
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+Q LE L+YLHS GI+H D+K NILI + +K+ D G + T +R
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNR 161
Query: 585 S----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
YR PE+++G Y ++D+WS+GCILAEL+ G+ +F + L +I + G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 640 DLE 642
E
Sbjct: 222 TDE 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 76/237 (32%), Positives = 122/237 (51%), Gaps = 22/237 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 473
Y + +G FS+V +AQ TG +K +K +Q +L EI+ L+ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55
Query: 474 DEHHILRLYDYFYHLEH--LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ILRL + + + L +V EL+ NLYE K G + R++ Q L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCLYVQSRSYRAP 589
++L+++H GI H D+KPENILIK +K+ D GS + Y+ +R YRAP
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167
Query: 590 EVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
E ++ G Y K+D+W++GC+ E+ + LFP + +A+I +LG D E+L
Sbjct: 168 ECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 79/236 (33%), Positives = 119/236 (50%), Gaps = 21/236 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQ-SLDEIKLLKLVNK 469
+ RY Y+G A+ V A TGV V +K I + F Q +L EIK+L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA-YFTLGRLQVITR 528
+ I+R + ++IV EL+ +LY+ K S YF
Sbjct: 63 ENIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDN---LCLYVQ 582
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + D+ L YV
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 583 SRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+R YRAPE+++ Y + ID+WS+GCILAE+ + LFP + L I+G+LG
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 1e-29
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 27/232 (11%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ LG +F +V+ A+D V LK++ + ++ L EI++L +N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLN----- 55
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++LYD+F L++V E + + ++ G + + I Q L A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGG--SLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---------LCLYVQSR 584
LEYLHS GIIH D+KPENIL+ +K+ID G + D V +
Sbjct: 114 LEYLHSKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 585 SYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y APEV++GL D+WSLG L EL TG F + ++ +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 86/239 (35%), Positives = 123/239 (51%), Gaps = 24/239 (10%)
Query: 407 ILNTV--IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEI 461
I TV I RY + +G AF V A+D TG +V +K I ++ E+
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 462 KLLK-LVNKNDPADEHHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
KLLK L ++N I+ L D F LE ++ V ELL +L+ + E F
Sbjct: 61 KLLKHLRHEN-------IISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQF- 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
+Q Q L L+Y+HS G++H DLKP NILI + C++KI D G + Q +
Sbjct: 110 ---IQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN--ENCDLKICDFGLARIQDPQMTG 164
Query: 580 YVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ YD ++D+WS GCI AE+ G+ LFP V + I +LG
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 69/228 (30%), Positives = 116/228 (50%), Gaps = 21/228 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + + +G +F KV+ + G LK I ++K+ + +L+E+K+LK +N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLN-- 57
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y+ F L IV E +L + K Q+ G+ F ++
Sbjct: 58 -----HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGK-PFPEEQILDWFV 110
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRS 585
Q AL+YLHS I+H D+KP+NI + S +K+ D G S T +L V +
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPY 168
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE+ PY+ K D+WSLGC+L EL T + F + ++ + +I+
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 78/262 (29%), Positives = 125/262 (47%), Gaps = 37/262 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVN 468
RY E +GS A+ V A D +G V +K I + FD ++L E+K+L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFK 62
Query: 469 KNDPADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ I+ + D + +++V +L+ ++L+ +Q T ++
Sbjct: 63 HDN------IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP------LTEEHIR 110
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCFQTDNL 577
Q L L+Y+HS +IH DLKP N+L+ + CE++I D G S +
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN--EDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 578 CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
YV +R YRAPE+++ LP Y ID+WS+GCI AE+ LFP V L I+ +L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 637 GPIDLEML--MQGQEIYKYFTK 656
G E+L + + KY
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQN 250
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 33/271 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D G++V +K K + F +Q+ E+ LLK VN
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 470 NDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+ I+ L + F + +++V EL+ ANL Q + E E R+
Sbjct: 80 KN------IISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIHMELDHE------RM 125
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YV 581
+ Q L +++LHS GIIH DLKP NI++KS C +KI+D G + N + YV
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTACTNFMMTPYV 183
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+R YRAPEVI+G+ Y + +D+WS+GCI+ EL G V+F + ++I LG
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIF 672
E + + Q + + + Y + F +F
Sbjct: 244 EFMNRLQPTVRNYVENRPQYP--GISFEELF 272
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 83/267 (31%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----FDQSLDEIKLLKLVNK 469
RY +GS A+ V A D TG+ V +K K + F ++ E++LLK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ + +++V L+ A+L K + T +Q + Q
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L L+Y+HS IIH DLKP N+ + + CE+KI+D G + D + YV +R YRAP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARHTDDEMTGYVATRWYRAP 186
Query: 590 EVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
E+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G E+L +
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL---K 243
Query: 649 EIYKYFTKEY--DLYYINEVCFANIFI 673
+I + Y L + ++ FAN+FI
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFI 270
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 7e-28
Identities = 80/249 (32%), Positives = 128/249 (51%), Gaps = 39/249 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-------DEIKLLKLV 467
RY +GS A+ V A D V +K K + F QSL E++LLK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKHM 71
Query: 468 NKNDPADEHHILRLYDYFY------HLEHLFIVCELLRA---NLYEFQKFNQESGGEAYF 518
+++ L D F + +++V L+ A N+ + QK + E
Sbjct: 72 K------HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE------- 118
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + Q L L+Y+HS GIIH DLKP N+ + + CE++I+D G + D +
Sbjct: 119 ---HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN--EDCELRILDFGLARQADDEMT 173
Query: 579 LYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ + Y+Q +D+WS+GCI+AEL G+ LFP + + L RI+ ++G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
Query: 638 PIDLEMLMQ 646
E+L +
Sbjct: 234 TPSPEVLKK 242
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV + TG +K++K + + +L E +L +N H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--------H 52
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
I++L+ F E L++V E GGE F+ R +
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYA-------------PGGELFSHLSKEGRFSEERARFYA 99
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCL-YVQSR 584
+ + ALEYLHSLGII+ DLKPENIL+ IK+ D G + + + +
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y APEV++G Y + +D WSLG +L E+ TG+ F + I +I+
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPAD 474
Y E +G A +V++A D TG +V +K ++ K + ++EI ++K + N
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPN---- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ YD + + L++V E + L + N ++ + R+ L+
Sbjct: 77 ---IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQG 128
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------Y 586
LEYLHS +IH D+K +NIL+ +K+ D G F L R+ +
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFG---FAA-QLTKEKSKRNSVVGTPYW 182
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
APEVI Y K+D+WSLG + E+ GE
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 80/258 (31%), Positives = 121/258 (46%), Gaps = 62/258 (24%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I +Y + + LG A+ V++A D T V LK I D F + D EI L+
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF---DAFRNATDAQRTFREIMFLQ 61
Query: 466 LVNKNDPADEHHILRLYD----------Y--FYHLE---HLFIVCELLRAN-LYEFQKFN 509
+ + +I++L + Y F ++E H I RAN L + K
Sbjct: 62 ELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHK-- 109
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG- 568
+ I Q L+AL+Y+HS +IH DLKP NIL+ S C +K+ D G
Sbjct: 110 --------------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGL 153
Query: 569 SSCFQTDNLCL-------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF 620
+ YV +R YRAPE+++G Y + +D+WS+GCIL E+ G+ LF
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
Query: 621 PNDAVVMILARIIGMLGP 638
P + + L +II ++GP
Sbjct: 214 PGTSTLNQLEKIIEVIGP 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 78/234 (33%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQS-LDEIKLLKLVN 468
RY + LG ++ V++A+D TG V +K IK KD + + L EIKLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V E + +L + K T ++
Sbjct: 61 -------HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYM 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQ--SR 584
L LEYLHS I+H DLKP N+LI S +K+ D G + F + N + Q +R
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YRAPE++ G Y +D+WS+GCI AEL P D+ + L +I LG
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 80/247 (32%), Positives = 127/247 (51%), Gaps = 30/247 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
RY + + LG A+ V A++ T V +K I N K ++L E+KLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 470 NDPADEHHILRLYD----YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+ +I LYD + + L++ EL+ A+L++ + Q +A+F Q
Sbjct: 61 HK-----NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHF-----QS 109
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-------LC 578
Q L L+Y+HS ++H DLKP N+L+ + CE+KI D G + ++N +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFMT 167
Query: 579 LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y + ID+WS+GCILAEL + +F V L +I+ +LG
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
Query: 638 PIDLEML 644
D E L
Sbjct: 228 TPDEETL 234
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 426 AFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
A+ +VF A+ TG +K+IK K+ DQ L E +L ++++L
Sbjct: 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP------YVVKL 58
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLEA 533
Y F ++L++V E L GG+ L G L ++ + + A
Sbjct: 59 YYSFQGKKNLYLVMEYLP-------------GGDLASLLENVGSLDEDVARIYIAEIVLA 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------- 585
LEYLHS GIIH DLKP+NILI S +K+ D G S + +
Sbjct: 106 LEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y APEVI+G + + +D WSLGCIL E G F + I I+
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 72/238 (30%), Positives = 123/238 (51%), Gaps = 27/238 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y E +G + KV++A+D +TG V LK + +++ +L EI LL++++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI- 61
Query: 473 ADEHHILRLYDYFYHLEH---------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
+I+RL D +EH L++V E L ++L +F N G +
Sbjct: 62 ----YIVRLLD----VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA-KTI 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--- 580
+ Q L+ + + H G++H DLKP+N+L+ + +KI DLG + + Y
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+ + YRAPEV++G Y +D+WS+GCI AE+ + LFP D+ + L I +LG
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 27/254 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E++LLK + +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 472 PADEHHILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ L D F L ++V + +L + K E E R+Q
Sbjct: 76 ------VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSED-----RIQF 122
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ Q L+ L+Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV +R
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 586 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG--PIDLE 642
YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G +
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 643 MLMQGQEIYKYFTK 656
+Q ++ Y K
Sbjct: 241 QKLQSEDAKNYVKK 254
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 34/231 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLK-LVNKNDPADEH 476
E LG ++ V++ ++ TG V LK I D + S + EI L+K L ++N
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN------ 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL+D + L +V E + +L ++ + G ++ T Q L+ + +
Sbjct: 60 -IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSYRA 588
H ++H DLKP+N+LI +R E+K+ D G + F + + L+ YRA
Sbjct: 116 CHENRVLHRDLKPQNLLIN--KRGELKLADFGLARAFGIPVNTFSNEVVTLW-----YRA 168
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIG 634
P+V++G Y ID+WS+GCI+AE+ TG LFP D ++ I RI+G
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 74/240 (30%), Positives = 123/240 (51%), Gaps = 35/240 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
RY + +GS A+ V A D TG V +K + + F ++ E+ LLK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--- 72
Query: 472 PADEHHILRLYDYF------YHLEHLFIVCELLRANLYEFQ--KFNQESGGEAYFTLGRL 523
+++ L D F + ++V ++ +L + +++ ++
Sbjct: 73 ---HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----------KV 119
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
Q + Q L L+Y+HS GIIH DLKP N+ + + CE+KI+D G + + YV +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVT 177
Query: 584 RSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPN----DAVVMILARIIGMLGP 638
R YRAPEVI+ + Y+Q +D+WS+GCI+AE+ TG+ LF D + IL ++ G+ GP
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-KVTGVPGP 236
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 66/235 (28%), Positives = 99/235 (42%), Gaps = 53/235 (22%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA------ 473
+ +G +FS V A++ T + +KI LD+ +L+K K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI-----------LDKRQLIKE-KKVKYVKIEKEV 54
Query: 474 ---DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H I++LY F E+L+ V E A E ++ ++ G +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEY--APNGELLQYIRKYGS---LDEKCTRFYAA 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---------- 578
+ L ALEYLHS GIIH DLKPENIL+ IKI D G++ N
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 579 -----LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
+ R Y +PE++ P + DLW+LGCI+ ++ TG+ F
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 68/230 (29%), Positives = 113/230 (49%), Gaps = 30/230 (13%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V R+ + LG F KV +A D +KI++N + + EI+ ++ V +
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 471 DPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEF----QKFNQESGGEAYFTLGRLQV 525
DPAD ++++ YF + H+ IV L ++ F+ + F G
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTG---- 241
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQR--------------CEIKIIDLGSS 570
AL+Y H+ L ++H DLKPENIL+++ C ++I DLG
Sbjct: 242 ------VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 571 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
C + + V +R YR+PEV++GL + D+WS+GCI+ EL+TG++L+
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 19/254 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + ++IV EL+ ANL Q E E R+ + Q
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL--CQVIQMELDHE------RMSYLLYQ 134
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
APEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG E + +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 648 QEIYKYFTKEYDLY 661
Q + + + Y
Sbjct: 253 QPTVRTYVENRPKY 266
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 73/238 (30%), Positives = 112/238 (47%), Gaps = 35/238 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVNKNDPADE 475
+G AF V+ D G V LK + N F + E+K+L ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
IL+ D F E +++V EL++++L++ Q + ++V Q L
Sbjct: 65 LDILQPPHIDPF---EEIYVVTELMQSDLHKIIVSPQP------LSSDHVKVFLYQILRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRS 585
L+YLHS GI+H D+KP N+L+ S C +KI D G S T V ++
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEPDESKHMTQE----VVTQY 169
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
YRAPE+++G Y +D+WS+GCI AEL +LF + + L I +LG LE
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 74/243 (30%), Positives = 115/243 (47%), Gaps = 45/243 (18%)
Query: 418 VTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNK 469
VTE+ +G + V++A+D +G V LK ++ N++D SL EI LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-- 63
Query: 470 NDPADEHH--ILRLYDYFY--HLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR 522
H I+ L + HL+ +F+V CE A+L + F+ +
Sbjct: 64 ------RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQ 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
++ + Q L L+YLH IIH DLK N+L+ + +KI D G L +
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT--DKGCLKIADFG----LARTYGLPAK 163
Query: 583 SRS-------YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
+ YRAPE+++G Y ID+W++GCILAEL + L P + + L II
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223
Query: 635 MLG 637
+LG
Sbjct: 224 LLG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 74/233 (31%), Positives = 117/233 (50%), Gaps = 29/233 (12%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEH 476
E +G + V++A++ TG V LK I+ D + ++ EI LLK +N +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN----- 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++L D + L++V E L +L +F + SG L ++ Q L+ L +
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQSRSYRA 588
HS ++H DLKP+N+LI + IK+ D G + + + + L+ YRA
Sbjct: 116 CHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRA 168
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
PE+++G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 75/230 (32%), Positives = 118/230 (51%), Gaps = 19/230 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 469
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ + +++V EL+ ANL Q E E R+ + Q
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIQMELDHE------RMSYLLYQ 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 587
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
APEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 78/239 (32%), Positives = 119/239 (49%), Gaps = 37/239 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK-LVN 468
+Y E +G + VF+A++ T V LK ++ D D D+ +L EI LLK L +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 58
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
KN I+RLYD + + L +V E +L +K+ G+ + ++
Sbjct: 59 KN-------IVRLYDVLHSDKKLTLVFEYCDQDL---KKYFDSCNGDIDPEI--VKSFMF 106
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLY 580
Q L+ L + HS ++H DLKP+N+LI + E+K+ D G + C+ + + L+
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVRCYSAEVVTLW 164
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637
YR P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 26/228 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
+G A+ V A++ T V +K I N FD +D EIKLL+ ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 476 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ + F ++IV EL+ +L++ + +Q + Q Q L
Sbjct: 70 KDIMPPPHREAF---NDVYIVYELMDTDLHQIIRSSQT------LSDDHCQYFLYQLLRG 120
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L+Y+HS ++H DLKP N+L+ + C++KI D G ++ + D + YV +R YRAPE
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 591 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+++ Y ID+WS+GCI AEL + LFP V L I +LG
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG 226
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
Y + + +G AF V++ +L TG V +K I K ++ + EI LLK +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--- 57
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+I++ + L+I+ E LR + +F F ES Y
Sbjct: 58 ---HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYV-------- 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQS 583
Q L+ L YLH G+IH D+K NIL +K+ D G + D V +
Sbjct: 106 -YQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ APEVI D+WSLGC + EL TG
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KV++A++ TG K+I K++++ D + EI++L + +I+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILA------TCNHPYIV 72
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+L FY L+I+ E + + G T ++QVI RQ LEAL+YLHS
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHS 128
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII--- 593
+ IIH DLK N+L+ +IK+ D G S L ++ + + APEV++
Sbjct: 129 MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 594 --GLPYDQKIDLWSLGCILAEL 613
PYD K D+WSLG L E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
+G F KV+ A +L TG + +K I+ ND + DE+K+L+L+ H
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-------HP 59
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR------LQVITRQC 530
++++ Y H E ++I F ++ E GR ++V T Q
Sbjct: 60 NLVKYYGVEVHREKVYI-----------FMEYCSGGTLEELLEHGRILDEHVIRVYTLQL 108
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-------S 583
LE L YLHS GI+H D+KP NI + IK+ D G + +N + +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 584 RSYRAPEVIIGLPYDQK---IDLWSLGCILAELWTGEVLFPN 622
+Y APEVI G D+WSLGC++ E+ TG+ +
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNK 469
+ + E +G +F +V++A D T V +K+I +++ DEI+ ++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQV 525
P +I + Y F L+I+ E +L + K ++ +
Sbjct: 57 RSP----YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAF 102
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQ 582
I R+ L LEYLH G IH D+K NIL+ ++K+ D G S T + +V
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ + APEVI YD+K D+WSLG EL GE
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 70/218 (32%), Positives = 112/218 (51%), Gaps = 24/218 (11%)
Query: 430 VFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYF 485
V++A+D TG V LK +K +K+ F SL EI LLKL + N I+ + +
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-------IVTVKEVV 73
Query: 486 Y--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGII 543
+L+ +++V E + +L + ++ F ++ + Q L + +LH I+
Sbjct: 74 VGSNLDKIYMVMEYVEHDLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ---SRSYRAPEVIIGLP-YDQ 599
H DLK N+L+ + R +KI D G + L Y Q + YRAPE+++G Y
Sbjct: 129 HRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
ID+WS+GCI AEL T + LFP + + L +I +LG
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 73/228 (32%), Positives = 114/228 (50%), Gaps = 25/228 (10%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPAD 474
E +G + V++A+D TG V LK I+ + + D+ ++ EI LLK +N P
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN--HP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL D + L++V E L +L K +S ++ Q L+ +
Sbjct: 59 --NIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRSYRAPE 590
Y HS ++H DLKP+N+LI +K+ D G + F + Y V + YRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 169
Query: 591 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+++G Y +D+WS+GCI AE+ LFP D+ + L RI LG
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 69/211 (32%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG + V++ + TG LK I D++F Q L E+K L+ + +++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------CESPYVV 62
Query: 480 RLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+ Y FY + IV E L L + K E L I RQ L+ L
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-----EPV-----LAYIARQILKGL 112
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRSYRAPE 590
+YLH+ IIH D+KP N+LI S E+KI D G S T + C +V + +Y +PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I G Y D+WSLG L E G+ FP
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK--FP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 71/237 (29%), Positives = 119/237 (50%), Gaps = 34/237 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + + TG V +K ++DK ++ EI++LK +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L + F + L++V E + L + +K+ +G R++
Sbjct: 58 ----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNG----LDESRVRKYLF 107
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYV 581
Q L +E+ HS IIH D+KPENIL+ Q +K+ D G + TD YV
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFGFARTLAAPGEVYTD----YV 161
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+R YRAPE+++G Y + +D+W++GC++ E+ TGE LFP D+ + L II LG
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V + LG ++ V++ + L LK + + K+ D +++EI++L VN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVN-- 57
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITR- 528
+I+ + F L IV E +L + ++ L Q I R
Sbjct: 58 ----HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRI 108
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SR 584
Q L L+ LH I+H DLK NIL+ +KI DLG S N+ Q +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKNM-AKTQIGTP 165
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
Y APEV G PY K D+WSLGC+L E+ T F
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E LG ++ V++A TG V +K++ ++D + EI +LK D +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-KEISILK------QCDSPY 59
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I++ Y ++ L+IV E A + + K ++ E + I Q L+ LEY
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE-----EIAAILYQTLKGLEY 114
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII 593
LHS IH D+K NIL+ + + K+ D G S TD + + + + APEVI
Sbjct: 115 LHSNKKIHRDIKAGNILLN--EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 594 GLPYDQKIDLWSLGCILAELWTGEV----LFPNDAVVMI 628
+ Y+ K D+WSLG E+ G+ + P A+ MI
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 66/237 (27%), Positives = 124/237 (52%), Gaps = 20/237 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKND 471
++ V +G A+ V + + T V +K K+ +++ + +L E+K+L+ + + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ L + F L++V E + N+ E + +G +++ Q +
Sbjct: 62 ------IVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPP----EKVRSYIYQLI 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD----NLCLYVQSRSYR 587
+A+ + H I+H D+KPEN+LI +K+ D G + ++ N YV +R YR
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
+PE+++G PY + +D+WS+GCIL EL G+ LFP ++ + L I +LGP+ E +
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 32/243 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + V++A+D T + LK I+ D+ ++ EI LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK------ 56
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ H I+RL D + + L++V E L +L K + +S + ++ Q
Sbjct: 57 --EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYV 581
L + Y HS ++H DLKP+N+LI + +K+ D G + F + + L+
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEVVTLW- 168
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
YRAPE+++G Y +D+WS+GCI AE+ + LFP D+ + L +I +LG +
Sbjct: 169 ----YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 641 LEM 643
E
Sbjct: 225 EET 227
|
Length = 294 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-21
Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 391 HRKNRTGFEEN-KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
H N E+ K + +N Y + +G+ +F V++A + T V +K +
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY------HLEHLF--IVCELLRAN 501
D + ++ L +K L +N I+ L DY+Y + +++F +V E +
Sbjct: 102 DPQYKNRELLIMKNLNHIN---------IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
++++ K + L +L + Q AL Y+HS I H DLKP+N+LI
Sbjct: 153 VHKYMKHYARNNHALPLFLVKL--YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT- 209
Query: 562 IKIIDLGSS--CFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+K+ D GS+ Y+ SR YRAPE+++G Y IDLWSLGCI+AE+ G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
Query: 619 LFPNDAVVMILARIIGMLG 637
+F + V L RII +LG
Sbjct: 270 IFSGQSSVDQLVRIIQVLG 288
|
Length = 440 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 55/236 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G LKI+ K + L+E ++L+ + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--------H 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL----GRL-----QVI 526
++ LY F +L++V E + GGE F+ GR +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYV-------------PGGE-LFSHLRKSGRFPEPVARFY 106
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q + ALEYLHSL I++ DLKPEN+L+ S IKI D G V+ R+
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFG--------FAKRVKGRTY 156
Query: 586 -------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
Y APE+I+ Y + +D W+LG ++ E+ G F +D + I +I+
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 52/137 (37%), Positives = 79/137 (57%), Gaps = 15/137 (10%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQT---DNLCLYV 581
I Q L+A+ + H IH D+KPENILI K Q IK+ D G + T D+ YV
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYV 161
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+R YRAPE+++G Y +D+W++GC+ AEL TG+ L+P + V L I LG
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--- 218
Query: 641 LEMLMQGQEIY---KYF 654
+++ + Q+I+ ++F
Sbjct: 219 -DLIPRHQQIFSTNQFF 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE-IKLLKLVNKNDPADEHHILR 480
LG F +V + LK +K + E I K + + + I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEE--CNHPFIVK 57
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLE 532
LY F ++++++ E GGE + L G + +
Sbjct: 58 LYRTFKDKKYIYMLMEYCL-------------GGELWTILRDRGLFDEYTARFYIACVVL 104
Query: 533 ALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS----- 585
A EYLH+ GII+ DLKPEN+L+ S Y +K++D G + ++S
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFA--------KKLKSGQKTWTF 152
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGP 638
Y APE+I+ YD +D WSLG +L EL TG F D + I I+ G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 639 ID 640
++
Sbjct: 213 LE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 47/238 (19%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFD-QSLDEIKLLKLVN-K 469
Y + LG F +V++A+ + TG V LK ++ N+KD F +L EIK+LK +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 470 N---------DPADEHHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
N + D+ R +Y +++H +L + L E
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-----DL--SGLLENPSVK--------L 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------- 568
T +++ Q LE + YLH I+H D+K NILI + + +KI D G
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGILKIADFGLARPYDGPPP 170
Query: 569 ----SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP 621
T V +R YR PE+++G Y +D+W +GC+ AE++T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 29/238 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y +G A+ V++A+D H+G V LK ++ + L ++ + L+ + + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFT--------LG 521
+I+RL D VC R + F+ +Q+ Y
Sbjct: 61 HPNIVRLMD----------VCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE 108
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
++ + RQ L L++LH+ I+H DLKPENIL+ S ++K+ D G + + + L
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMALTP 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 73/227 (32%), Positives = 104/227 (45%), Gaps = 23/227 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ V + TG + +K I+ + + Q L E+ +L N P +I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSP----YIV 62
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
Y FY+ + I E + +L + K Q E LG+ I L+ L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--RILGK---IAVAVLKGLTYLH 117
Query: 539 S-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAPEVIIGLP 596
IIH D+KP NIL+ S R +IK+ D G S ++L +V + SY APE I G
Sbjct: 118 EKHKIIHRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 597 YDQKIDLWSLGCILAELWTGEVLFPN-----DAVVMILARIIGMLGP 638
Y K D+WSLG L EL TG +P D + +L I+ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ+ TGV K+I ++ + + EI +L D +I++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA------SCDHPNIVK 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
L D FY+ +L+I+ E + E T +++V+ +Q LEAL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII---- 593
IIH DLK NIL +IK+ D G S T + ++ + + APEV++
Sbjct: 123 KIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 594 -GLPYDQKIDLWSLGCILAEL 613
PYD K D+WSLG L E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 47/218 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG AF KV++AQ TG+ KII+ ++ + + EI +L +I+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS------ECKHPNIVG 66
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---------EAYFTLGRLQVITRQCL 531
LY+ +++ L+I+ E GG E T +++ + RQ L
Sbjct: 67 LYEAYFYENKLWILIEFC-------------DGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
EAL +LHS +IH DLK NIL+ ++K+ D G S L Q R
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLT--LDGDVKLADFGVSAKNKSTL----QKRDTFIGTP 167
Query: 586 -YRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ APEV+ PYD K D+WSLG L EL E
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLK-LVNKNDPADE 475
E +G + V++ ++ TG V +K I+ ++ ++ EI LLK L + N
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN----- 60
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L D L+++ E L +L +K+ Y ++ Q L+ +
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVI 592
+ HS ++H DLKP+N+LI + + IK+ D G + + +Y V + YRAPEV+
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 593 IGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+G P Y +D+WS+G I AE+ T + LF D+ + L RI +LG
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 39/252 (15%)
Query: 421 YLGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFD---QS-LDEIKLLK-LVNKNDPA 473
+G + +V++A ++ G + +K K DK+ + QS EI LL+ L ++N
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN--- 63
Query: 474 DEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
++ L + F LEH ++++ + +L++ KF++++ ++ + Q
Sbjct: 64 ----VVSLVEVF--LEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQ 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLG-SSCFQTDNLCLY-----V 581
L + YLHS ++H DLKP NIL+ +R +KI DLG + F L V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-----NDAVVMI----LAR 631
+ YRAPE+++G Y + ID+W++GCI AEL T E +F L R
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 632 IIGMLGPIDLEM 643
I +LG +
Sbjct: 237 IFEVLGTPTEKD 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSL-DEIKLLKLVNKNDP 472
+ LG+ AFS +QA+D+ TG + +K + ++++ ++L EI+L+ +N
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---- 61
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFTLGRLQVIT 527
HI+R+ H + E + L ++ F +E+ Y T
Sbjct: 62 --HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVIINY---------T 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-------LY 580
Q L L YLH IIH D+K N+LI S + ++I D G++
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ + ++ APEV+ G Y + D+WS+GC++ E+ T + + + LA I
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 71/260 (27%), Positives = 115/260 (44%), Gaps = 48/260 (18%)
Query: 412 IAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---------DKDFFDQ----- 456
I+ RY +LG + KV +A D TG V +K +K D+
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 515
+L E+K++ + +I+ L D + + + +V +++ ++L + +++
Sbjct: 66 TTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIMASDLKKV--VDRK---- 113
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQT 574
T +++ I Q L L LH +H DL P NI I S C KI D G + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC--KIADFGLARRYGY 171
Query: 575 DNLC------LYVQSRS----------YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
+Q R YRAPE+++G Y +D+WS+GCI AEL TG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 618 VLFPNDAVVMILARIIGMLG 637
LFP + + L RI +LG
Sbjct: 232 PLFPGENEIDQLGRIFELLG 251
|
Length = 335 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLD-EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ +K + D D + +L+ EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE----- 64
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAYFTLGR--LQVIT 527
R+ Y+ C L F ++ GG +AY L + T
Sbjct: 65 ----RIVQYYG--------CLRDDETLSIFMEYM--PGGSVKDQLKAYGALTETVTRKYT 110
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE +EYLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
Y E +G A+ V++ + + TG V LKII D D S E+ LL + ++ P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 474 DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ I + Y + L+I+ E L++A E Y +
Sbjct: 63 N---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA----------EKY-----IS 104
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
VI R+ L AL+Y+H +G+IH D+K NIL+ + +K+ D G + L Q+
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVA-------ALLNQNS 155
Query: 585 SYR----------APEVII-GLPYDQKIDLWSLGCILAELWTGE 617
S R APEVI G YD K D+WSLG + E+ TG
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPA 473
Y + E +G A + V+ A L V +K I +K D+ E++ + N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----- 57
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++ Y F + L++V L +L + K + GG + + ++ L
Sbjct: 58 --HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---TVLKEVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 585
+ LEYLHS G IH D+K NIL+ +KI D G S D + R
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 586 -YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV----LFPNDAVVMIL 629
+ APEV+ + YD K D+WS G EL TG P +++ L
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 38/235 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY LG + VF A D V +K I+ D +L EIK+++ +
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL--- 59
Query: 471 DPADEHHILRLYDYF--------------YHLEHLFIVCELLRANLYEFQKFNQESGGEA 516
D +I+++Y+ L ++IV E + +L Q E
Sbjct: 60 ---DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV--LEQGPLSEE 114
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---- 572
+ L Q L L+Y+HS ++H DLKP N+ I + +KI D G +
Sbjct: 115 HARL-----FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPH 168
Query: 573 --QTDNLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPND 623
L + ++ YR+P +++ P Y + ID+W+ GCI AE+ TG+ LF
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ + V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L E L+IV E + +L + + N+ +L L Q
Sbjct: 60 --HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIA 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YR 587
+EYL S IH DL N L+ +KI D G S D Y + R R
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYD--DDYYRKRGGKLPIR 168
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ------ESGGEAYFTLGR 522
+ +++RL+D VC + R + F+ +Q + E
Sbjct: 62 EHPNVVRLFD----------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 111
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCL 579
++ + Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + FQ L
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQM-ALTS 168
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
V + YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 46/221 (20%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + + +GS + V++A+D+ TG V +K+IK D F+ EI +LK +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN-- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCE------------LLRANLYEFQKFNQESGGEAYFTLG 521
I+ + + + L+IV E + R L E Q AY
Sbjct: 62 ----IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI--------AY---- 105
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC--- 578
+ R+ L+ L YLH G IH D+K NIL+ ++K+ D G S T +
Sbjct: 106 ----VCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRK 159
Query: 579 LYVQSRSYRAPEVI---IGLPYDQKIDLWSLG--CI-LAEL 613
++ + + APEV YD K D+W+LG I LAEL
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 28/227 (12%)
Query: 420 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 473
+ LG AF +V++ V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I++L E L IV E + +L ++ + N+ +L L Q
Sbjct: 60 --HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIA 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---YR- 587
+EYL S IH DL N L+ +KI D G S D+ Y R
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRW 170
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 24/224 (10%)
Query: 414 GRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLK 465
G+ V ++ +G + +V++A+D TG V LK ++ N+K+ F ++ EIK+L+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 466 LVNKNDPADEHHIL----RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N + + I+ D+ ++V E + +L ESG +F+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESG-LVHFSED 116
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY 580
++ +Q LE L Y H +H D+K NIL+ + + +IK+ D G + + ++ Y
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLARLYNSEESRPY 174
Query: 581 ---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF 620
V + YR PE+++G Y ID+WS GCIL EL+T + +F
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
G + + + +G FS V++A L G V LK ++ D L EI LLK
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK---- 57
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
D ++++ F L IV EL A +L K ++ + +
Sbjct: 58 --QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR----LIPERTIWKY 111
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 583
Q ALE++HS I+H D+KP N+ I + +K+ DLG F +T V +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 426 AFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKN--DPADEHHILRLY 482
AF V+ A+ TG +K++ K+D + +++ +K + ++ +LY
Sbjct: 8 AFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ--------CLEAL 534
F ++L++V E L +GG+ + L + + +
Sbjct: 64 YSFQSKDYLYLVMEYL-------------NGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG 594
E LH GIIH D+KPEN+LI Q +K+ D G S +N +V + Y APE I+G
Sbjct: 111 EDLHQRGIIHRDIKPENLLID--QTGHLKLTDFGLSRNGLENK-KFVGTPDYLAPETILG 167
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF----PNDAVVMILARIIG 634
+ D+ D WSLGC++ E G F P+ IL+R I
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 68/226 (30%), Positives = 98/226 (43%), Gaps = 53/226 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND----KDFFDQSLDEIKLLKLVN 468
E +G + +V+ A ++ TG V++ I KD EI+ LK
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK--- 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIV----CELLRANLYEFQKF-NQESGGEAYFTLGRL 523
L+HL IV E L F ++ S G T GR
Sbjct: 64 ------------------DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ T Q LE L YLHS GI+H DLK +N+L+ + C KI D G S ++D++
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--KISDFGIS-KKSDDIY 162
Query: 579 LYVQSRSYR------APEVI--IGLPYDQKIDLWSLGCILAELWTG 616
Q+ S + APEVI Y K+D+WSLGC++ E++ G
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG AF +V++ T V +K +K ++F L+E ++K +
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKL---- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I+RL E L+IV E + +L +F + + E TL L + Q
Sbjct: 59 --SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQI 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---- 586
+ +EYL S +H DL N L+ KI D G L + Y
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVV--KISDFG--------LSRDIYEDDYYRKR 161
Query: 587 ---------RAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG-- 634
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221
Query: 635 -----MLGPIDLEMLMQ 646
P +L LM
Sbjct: 222 RLPRPENCPDELYELML 238
|
Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFD-QSLDEIKLLKLVNKNDPADEHHI 478
+G F +VF+A+ T V LK + +N+K+ F +L EIK+L+L+ + + I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 479 LR----LYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
R Y+ + +L F CE A L + FTL ++ + + L
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--------FTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLY---VQSRSY 586
L Y+H I+H D+K NILI + +K+ D G S + Y V + Y
Sbjct: 132 LYYIHRNKILHRDMKAANILIT--KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWT 615
R PE+++G Y ID+W GCI+AE+WT
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 19/228 (8%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ VF+ + T V LK I+ +++ ++ E+ LLK + +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-- 64
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L+D + L +V E L ++L +++ G ++ +++ Q L
Sbjct: 65 ----IVTLHDIIHTERCLTLVFEYLDSDL---KQYLDNCGN--LMSMHNVKIFMFQLLRG 115
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 590
L Y H I+H DLKP+N+LI ++ E+K+ D G + T V + YR P+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 591 VIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
V++G Y ID+W +GCIL E+ TG +FP V L I +LG
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKND 471
R Y+ + +G + V A D TG V +K + K + L +E+ +++
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR------ 71
Query: 472 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA--YFTLGRLQ--- 524
D H I+ +Y + + L++V E L GG T R+
Sbjct: 72 --DYQHPNIVEMYSSYLVGDELWVVMEFL-------------EGGALTDIVTHTRMNEEQ 116
Query: 525 --VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---- 578
+ L+AL +LH+ G+IH D+K ++IL+ S R +K+ D G C Q
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG-FCAQVSKEVPRRK 173
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
V + + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS----LDEIKLLKLVNKND 471
+ + +G AF KV Q T +K + K S L+E ++L+ +N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 526
++ L+ F E++++V +L LR +L + KF++E +++
Sbjct: 61 -----FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----------QVKFW 105
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSR 584
+ + ALEYLHS GIIH D+KP+NIL+ ++ + I D + T + +
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
Y APEV+ Y +D WSLG E G+ +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L LY F E+LF V E L ++ Q ++ F L R + + L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-------FDLPRATFYAAEIICGL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEV 591
++LHS GI++ DLK +NIL+ IKI D G + C + + Y APE+
Sbjct: 110 QFLHSKGIVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
++G Y+ +D WS G +L E+ G+ F
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 70/254 (27%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNKNDPADEH 476
+G AF +V+ +D TG +K+++ D + ++I ++ L + + P
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRK-SDMIKR--NQIAHVRAERDILADADSP---- 61
Query: 477 HILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I++LY F EHL++V E L L F +E A F I L
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE---TARF------YIAELVL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------------CFQTDNL 577
AL+ +H LG IH D+KP+NILI + IK+ D G
Sbjct: 113 -ALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 578 CLYVQSR------------------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
V R Y APEV+ G PY + D WSLG IL E+ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 620 FPNDAVVMILARII 633
F +D + +II
Sbjct: 230 FYSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKII----------KNDKD-FFDQSLDEIKL 463
Y V E+LGS AF V++ + + G + + LK I K ++D + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 464 LK--LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTL 520
+K L + N I+R Y F + L+IV +L+ A L E +E FT
Sbjct: 62 IKEQLRHPN-------IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTE 112
Query: 521 GRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
R+ I Q + AL YLH I+H DL P NI++ + I L L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
V + Y PE++ PY +K D+W+ GCIL ++ T + F
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 23/230 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y E LG ++ VF+ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G ++ +++ Q L
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDL---KQYMDDCG--NIMSMHNVKIFLYQIL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
P+V++G Y +ID+W +GCI E+ +G LFP V L I +LG
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
+ LG AF +V++ +V +K +K D ++ L E +++K +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEF---QKFNQESGGEAYFTLGRLQVITRQ 529
H +++RL E L++V E + +L ++ + S ++ +L L Q
Sbjct: 55 -HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL N L+ KI D G L V Y
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVV--KISDFG--------LSRDVYDDDYYRK 163
Query: 588 -----------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + + K D+WS G +L E++T G +P
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK------LVNKNDPADE 475
+G + +VF A+ TG V LK +K K L+E++ + K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLL-FKLNEVRHVLTERDILTTTKSE---- 61
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG----GEAYFTLGRLQVITRQCL 531
+++L F E+L++ E + +F+ G A F + +
Sbjct: 62 -WLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEM-------F 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA++ LH LG IH DLKPEN LI IK+ D G S V S Y APEV
Sbjct: 112 EAVDALHELGYIHRDLKPENFLID--ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV 169
Query: 592 IIGLPYDQKIDLWSLGCILAELWTG 616
+ G YD +D WSLGC+L E G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 52/234 (22%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G + + E +G + KV++A+ TG V +KI+ +D ++ +E +L+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR-----KY 59
Query: 473 ADEHHILRLYDYFYHLEH------LFIVCELLRA----NLYEFQKFNQESGGE---AYFT 519
++ +I Y F L++V EL +L + + + E AY
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
I R+ L L YLH +IH D+K +NIL+ E+K++D G +
Sbjct: 118 ------ILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFG--------VSA 161
Query: 580 YVQSRSYR-----------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ S R APEVI YD + D+WSLG EL G+
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 22/243 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
+Y +G AF V + V +K I + KD + +E ++LKL++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I+ Y+ F + L IV E ++ Q+ L Q L
Sbjct: 61 ------IIEYYENFLEDKALMIVMEYAPGGTLA--EYIQKRCNSLLDEDTILHFFV-QIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAP 589
AL ++H+ I+H DLK +NIL+ ++ +KI D G S + Y V + Y +P
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLE 642
E+ G PY+QK D+W+LGC+L EL + + F + ++ +I+ G PI DL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 643 MLM 645
L+
Sbjct: 231 QLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y V +G +F + Q +++ +K I+ K + + L P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP-- 58
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ + F HL+IV E QK + G + + LQ + CL +
Sbjct: 59 --NIVAFKESFEADGHLYIVMEYCDGGDL-MQKIKLQRG-KLFPEDTILQWFVQMCL-GV 113
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---CLYVQSRSYRAPEV 591
+++H ++H D+K +NI + Q ++K+ D GS+ T C YV + Y PE+
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWT 615
+PY+ K D+WSLGCIL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG ++ V++ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
D H I+ L+D + + L +V E L +L +++ + G + +++ Q L
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDCGN--SINMHNVKLFLFQLL 114
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 588
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 415 RYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R Y+ ++ G + V A + HTG V +K + D Q E+ ++V D
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRD- 75
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
HH ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 76 --YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIATV 123
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQ 582
L AL YLH+ G+IH D+K ++IL+ S R IK+ D G C Q V
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGF-CAQVSKEVPKRKSLVG 180
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+ + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 36/222 (16%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL--DEIKLLKLVNKNDP 472
+Y E +G A V+ A D+ TG +V +K + N + + L +EI +++ NK+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMR-ENKHP- 76
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQV 525
+I+ D + + L++V E L +GG E G++
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAA 119
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYV 581
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q V
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMV 176
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ + APEV+ Y K+D+WSLG + E+ GE + N+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 44/121 (36%), Positives = 63/121 (52%), Gaps = 13/121 (10%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
RQ L+ L YLH+ GIIH D+K NIL+ + + IKI D G S N L ++ R
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANS-LSTKTNGAR 169
Query: 588 ----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
APEV+ Y +K D+WSLGC++ E+ TG+ FP+ + + +I
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229
Query: 638 P 638
P
Sbjct: 230 P 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ G +K +K D D ++ E ++L L +N P H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTH- 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
LY F EHLF V E L F Q+ G F L R + + L++L
Sbjct: 61 ---LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG---RFDLYRATFYAAEIVCGLQFL 112
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
HS GII+ DLK +N+++ IKI D G + F + + + Y APE++ G
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLFPND 623
L Y +D WS G +L E+ G+ F D
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q + T LK I+ + +L E +L VN P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CP----F 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F E L++V + + Q+ E F L R + T + L ALE
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-------EGRFDLSRARFYTAELLCALE 107
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRAP 589
LH +I+ DLKPENIL+ YQ I + D G +T+ C + Y AP
Sbjct: 108 NLHKFNVIYRDLKPENILL-DYQG-HIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAP 162
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTG 616
E+++G Y + +D W+LG +L E+ TG
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 22/233 (9%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLK-LVNK 469
A Y E LG +++ V++ G V LK+I K ++ ++ E LLK L +
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
N I+ L+D + E L V E + +L ++ Q GG + + ++ Q
Sbjct: 64 N-------IVLLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNV---RLFMFQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 586
L L Y+H I+H DLKP+N+LI E+K+ D G + + V + Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLWY 169
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLG 637
R P+V++G Y +D+W GCI E+ G+ FP + V L +I +LG
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D + ++ E ++L L K H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------HP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +L+ F + LF V E + ++ Q+ + A F + + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-------GL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
++LH GII+ DLK +N+L+ S IKI D G + + V + + Y A
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PE++ PY +D W+LG +L E+ G+ F D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + +L+E K+L+ V+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F + L +V L+ ++ +N GE F R Q + LE+L
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 595
H I++ DLKPEN+L+ + +I DLG + + + Y APEV+ G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 596 PYDQKIDLWSLGCILAELWTGEVLF 620
YD +D ++LGC L E+ G F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-SLDEIKLLK-LVNKNDP 472
+Y E +G A VF A D+ TG +V +K I K + ++EI ++K L N N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
I+ D F + LF+V E L + E ++ + R+CL+
Sbjct: 78 -----IVNFLDSFLVGDELFVVMEYLAGGSL------TDVVTETCMDEAQIAAVCRECLQ 126
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRA 588
ALE+LH+ +IH D+K +N+L+ +K+ D G C Q V + + A
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PEV+ Y K+D+WSLG + E+ GE + N+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFD---QSLDEIKLL-KLVNKNDP 472
E LGS +F V++ +L G +K + + + + Q EI LL KL + N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I++ ++L+I EL+ A L +K+ F +++ TR
Sbjct: 64 -----IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGS-------FPEPVIRLYTR 109
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSY 586
Q L LEYLH +H D+K NIL+ + +K+ D G + + + S +
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADFGMAKQVVEFSFAKSFKGSPYW 167
Query: 587 RAPEVIIGL-PYDQKIDLWSLGCILAELWTG 616
APEVI Y D+WSLGC + E+ TG
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D ++ E ++L L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-----PGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVI 592
+LHS GII+ DLK +N+++ + IKI D G + F + + Y APE+I
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLF 620
PY + +D W+ G +L E+ G+ F
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKN 470
A Y E LG +++ V++ + G V LK+I+ ++ ++ E LLK +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I+ L+D + E L +V E + +L ++ ++ GG +++ Q
Sbjct: 64 N------IVLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGG---LHPENVKLFLFQL 112
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQ 582
L L Y+H I+H DLKP+N+LI E+K+ D G S + + + L+
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLW-- 168
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP 621
YR P+V++G Y +D+W +GCI E+ G FP
Sbjct: 169 ---YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL-------GRLQVITRQCL 531
+ Y + L+I+ E L GG A L ++ I R+ L
Sbjct: 65 TKYYGSYLKDTKLWIIMEYL-------------GGGSALDLLEPGPLDETQIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ + E+K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K +K D D + ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL------AWEHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
L L+ F EHLF V E L F Q SG F R + + + L++
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG---RFDEARARFYAAEIICGLQF 111
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ------TDNLCLYVQSRSYRAPE 590
LH GII+ DLK +N+L+ IKI D G C + Y APE
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFC---GTPDYIAPE 166
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
++ G Y++ +D WS G +L E+ G+ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
A+ +H I++L+ F L+++ + LR F + S E FT ++ +
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSK-EVMFTEEDVKFYLAEL 107
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSR 584
AL++LHSLGII+ DLKPENIL+ + IK+ D G S D+ C V+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 163
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGM 635
Y APEV+ + Q D WS G ++ E+ TG + F + + MIL +GM
Sbjct: 164 -YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V +K + + + + L+ NKN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP--- 76
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 77 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
++LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
V+ Y K+D+WSLG + E+ GE + N+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+Y E +G A V+ A D+ TG +V ++ + + + + L+ NKN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 590
E+LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
V+ Y K+D+WSLG + E+ GE + N+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 35/216 (16%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLK-LVNKNDPAD 474
+ LG +++ V++ + TG V LK I+ + + F ++ E LLK L + N
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKHAN---- 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ L+D + + L +V E L +L Q + GG ++ +++ Q L L
Sbjct: 65 ---IVTLHDIIHTKKTLTLVFEYLDTDLK--QYMDDCGGG---LSMHNVRLFLFQLLRGL 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSY 586
Y H ++H DLKP+N+LI +R E+K+ D G S + + + L+ Y
Sbjct: 117 AYCHQRRVLHRDLKPQNLLIS--ERGELKLADFGLARAKSVPSKTYSNEVVTLW-----Y 169
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP 621
R P+V++G Y +D+W +GCI E+ TG LFP
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +V++ D T V +KII +++ DEI+ + + + D +I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL--GRLQ-----VITRQCL 531
R Y + L+I+ E L GG A L G L+ I R+ L
Sbjct: 65 TRYYGSYLKGTKLWIIMEYL-------------GGGSALDLLKPGPLEETYIATILREIL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGE 617
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA- 473
RY + + LG +F V+ +D + LK++K + + E+ + V N A
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLK------EIPVGELNPNETVQANQEAQ 54
Query: 474 -----DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
D I++ + F + I+ E + + + G+ TL QV
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK---TLSENQVCEW 111
Query: 529 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 583
Q L + Y+H I+H DLK +NI +K+ +KI D G S D + +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE + YD K D+WSLGCIL E+ F + ++ RI+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 42/112 (37%), Positives = 57/112 (50%), Gaps = 11/112 (9%)
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAP 589
L+ L YLHS IIH D+KP NIL+ + ++K+ D G S ++L + + Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
E I G PY D+WSLG L E+ FP + LGPI+L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG--------EPPLGPIEL 216
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 42/129 (32%), Positives = 74/129 (57%), Gaps = 9/129 (6%)
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQ 558
++ +F + ++ + G ++ + Q L+ + YLH+ ++H DLKP NIL+ + +
Sbjct: 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 147
Query: 559 RCEIKIIDLG-SSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILA 611
R +KI D+G + F + +L V + YRAPE+++G Y + ID+W++GCI A
Sbjct: 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207
Query: 612 ELWTGEVLF 620
EL T E +F
Sbjct: 208 ELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 23/107 (21%)
Query: 520 LGRLQV--ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
LG QV + RQ L A++Y+H GIIH D+K EN+L+ + +I + D G++CF
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARG-- 312
Query: 578 CLYVQSRS------------YRAPEVIIGLPYDQKIDLWSLGCILAE 612
S S APEV+ G PY +D+WS G ++ E
Sbjct: 313 -----SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
E LG+ +F +V A+ TG +K +K EI +K V H+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR---------EILKMKQVQ--------HVA 66
Query: 480 RLYDYFYHLEHLFIV---CELLRAN-LYEFQKFNQESGGEAYFTL---GRL--QVITRQC 530
+ L H FIV C N +Y +F GGE + L GR V
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEF--VVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 531 LE---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
E A EYLHS II+ DLKPEN+L+ + +K+ D G + D + Y
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLD--NKGHVKVTDFGFAKKVPDRTFTLCGTPEYL 182
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APEVI + + +D W++G +L E G F +D I +I+
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK-LVNKNDPADEHHIL 479
LG + V+ A+DL T V + +K I + Q L +EI L L ++N I+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN-------IV 68
Query: 480 RLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ I E LLR+ K+ E + T+Q
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRS------KWGPLKDNEQ-----TIIFYTKQI 117
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQ 582
LE L+YLH I+H D+K +N+L+ +Y +KI D G+S C +T +
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTET-----FTG 171
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLF 620
+ Y APEVI P Y D+WSLGC + E+ TG+ F
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 24/234 (10%)
Query: 416 YYVTEYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + +G +F VF+ D + + K ++ ++++DE ++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQV--ITRQ 529
D +I+R Y+ F L IV E +L++ K + L QV Q
Sbjct: 57 -DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQ 109
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSY 586
L L +LHS I+H D+K N+ + +Y +KI DLG + +DN V + Y
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPI 639
+PE+ PY++K D+W+LG +L E TG+ F N+ +IL I G+ P+
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 415 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
R + Y +G + V A++ H+G V +K++ D Q E+ ++V D
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRD- 74
Query: 473 ADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITR 528
+++ +Y + E L+++ E L+ ++ + N+E ++ +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----------QIATVCE 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSR 584
L+AL YLHS G+IH D+K ++IL+ R +K+ D G C Q V +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF-CAQISKDVPKRKSLVGTP 181
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ APEVI PY ++D+WSLG ++ E+ GE + +D+ V + R+
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 37/212 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 478
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 479 LRLYDYFYHLEHLFIVCE---------LLRANLY-EFQKFNQESGGEAYFTLGRLQVITR 528
+ Y + L+I+ E LLRA + EFQ + + +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------------IATMLK 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V +
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI YD K D+WSLG EL GE
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 40/101 (39%), Positives = 62/101 (61%), Gaps = 9/101 (8%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTD-----NLCLY 580
Q L+ + YLH+ ++H DLKP NIL+ + +R +KI D+G + F + +L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 581 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF 620
V + YRAPE+++G Y + ID+W++GCI AEL T E +F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLG--------RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +F L R + + AL YLHS+ I++ DLKPENIL+ S + +
Sbjct: 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G Q+D + + Y APEVI PYD +D W LG +L E+ G
Sbjct: 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q +TG + C K+ K K +L E ++L+ VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ L F HL +V L+ ++ +N GE + R+ + Q + +L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
HS+ I++ D+KPEN+L+ C + + L + + Y APE++ PY
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 598 DQKIDLWSLGCILAELWTGEVLFPN 622
+D +++GC + E+ G F +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKN 470
Y V E +G +F V + + G + K I +K+ Q + E+ +L +L + N
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPN 60
Query: 471 DPADEHHILRLYDYFYHLEH--LFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRL 523
I+R YD + L+IV E L + + +K + Y +
Sbjct: 61 -------IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YIEEEFI 107
Query: 524 QVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEI------KIIDLGSSCF 572
I Q L AL H+ ++H DLKP NI + + ++ KI+ SS
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+T YV + Y +PE + + YD+K D+WSLGC++ EL
Sbjct: 168 KT-----YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 512 SGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE +FT ++V + + AL++LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCFQTDNL---CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+ D G S F + + + Y APEVI G +D+ +D WSLG + EL TG
Sbjct: 146 LTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D+ TG ++ K ++ D + + S + EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 476 HHILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAY--FTLGRLQVITRQCLE 532
+ LR E L I E + + Q +AY T + TRQ LE
Sbjct: 70 YGCLR-----DRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQILE 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSY 586
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WSLGC + E+ T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 477
E LG V++A L T + +K+I D + Q + E+++L D +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY------KCDSPY 60
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
I+ Y F+ + I E + + + E LGR+ V ++ L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH------VLGRIAVAV---VKGLTYL 111
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLP 596
SL I+H D+KP N+L+ + R ++K+ D G S +++ YV + +Y APE I G
Sbjct: 112 WSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 597 YDQKIDLWSLGCILAELWTGEVLFP 621
Y D+WSLG EL G +P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 42/122 (34%), Positives = 57/122 (46%), Gaps = 26/122 (21%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--------------------- 571
ALEYLH+ GI+H DLKP+N+LI S IK+ D G S
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
F +C + Y APEVI+ Y + +D W++G IL E G V F D + +
Sbjct: 171 FLDKQVC---GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 632 II 633
+I
Sbjct: 228 VI 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 43/108 (39%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L I ++ALEYLHS L +IH D+KP N+LI + ++K+ D G S + D++ +
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTI 162
Query: 582 Q--SRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ Y APE I YD K D+WSLG + EL TG FP D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 50/219 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD---EHHI 478
LG + KVFQ + + TG D K F + L + +++ N+ D A E +I
Sbjct: 4 LGKGGYGKVFQVRKV-TGAD-------TGKIFAMKVLKKATIVR--NQKDTAHTKAERNI 53
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR--- 528
L ++H FIV +L+ Y FQ SGGE + L R +
Sbjct: 54 LE------AVKHPFIV-DLI----YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA 102
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQ---TDNL 577
+ ALE+LH GII+ DLKPENIL+ + +K+ D G S + T
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTF 160
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
C ++ Y APE+++ + + +D WSLG ++ ++ TG
Sbjct: 161 CGTIE---YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 520 LGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
LG+ I+ L L YL I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 101 LGK---ISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMA 155
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+V +RSY +PE + G Y + D+WSLG L E+ G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
+GS A V++ TG LK+I ++ Q EI++L+ VN P ++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH--PN----VV 135
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ +D F H + ++ E + E E L + RQ L + YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE---------QFLADVARQILSGIAYLHR 186
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLC-LYVQSRSYRAPEVI---- 592
I+H D+KP N+LI S + +KI D G S QT + C V + +Y +PE I
Sbjct: 187 RHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 593 -IGLPYDQKI-DLWSLGCILAELWTGEVLFP 621
G YD D+WSLG + E + G F
Sbjct: 245 NHGA-YDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK-LVNKNDPAD 474
LG AF +V+ D TG ++ +K ++ D + + S + EI+LLK L+++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 475 EHHILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVIT 527
R+ Y+ L L I E + + Q ++Y L + T
Sbjct: 65 -----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYT 112
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 581
RQ LE + YLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ +G +K++K D D + ++ E ++L L A H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL------ARNHP 56
Query: 478 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
L +LY F + LF V E + ++ QK + F R + + AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------FDEARARFYAAEITSAL 109
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEV 591
+LH GII+ DLK +N+L+ C K+ D G N + + Y APE+
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
+ + Y +D W++G +L E+ G F
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 49/217 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK---LVNKNDPADEHHI 478
+G +F KV A+ K D F+ +K+L+ ++ K + + HI
Sbjct: 3 IGKGSFGKVLLAKH------------KADGKFY-----AVKVLQKKAILKKKE---QKHI 42
Query: 479 LRLYDYFY-HLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGR----LQVI 526
+ + +++H F+V L Y FQ + +GGE +F L R +
Sbjct: 43 MAERNVLLKNVKHPFLVG--LH---YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR 97
Query: 527 TR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCL 579
R + AL YLHSL II+ DLKPENIL+ S + + + D G +
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTST 155
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ---ESGGEAYFTLGRL 523
+++ Y F L IV EL A + F+K + E YF
Sbjct: 64 ------VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV---- 113
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q ALE++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 114 -----QLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-QSLDEIKLLKLVNKNDPADEHHILR 480
+G +F KV A+ K+D F+ + L + +LK +N E ++L
Sbjct: 3 IGKGSFGKVLLAKR------------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL- 49
Query: 481 LYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR----- 528
+L+H F+V L Y FQ + +GGE +F L R +
Sbjct: 50 ----LKNLKHPFLVG--LH---YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQ 582
+ A+ YLHSL II+ DLKPENIL+ S + + + D G + +
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I L+ L YLHS IH D+K NIL+ + +K+ D GS+ +V +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLT--EPGTVKLADFGSASL-VSPANSFVGTPY 176
Query: 586 YRAPEVIIGL---PYDQKIDLWSLG--CI-LAE 612
+ APEVI+ + YD K+D+WSLG CI LAE
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-EIKLLKLVNKNDPADEHHILR 480
LGS F +V++ + V V +KI+K+D Q E++ LK + H++
Sbjct: 14 LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLIS 66
Query: 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
L+ E ++I+ EL+ +L F + S + L + Q E + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLR----SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRAPEVIIG 594
IH DL NIL+ C K+ D G + +++ Y+ S + APE
Sbjct: 123 QNSIHRDLAARNILVGEDLVC--KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASH 178
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E++T G+V +P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +K++K D D D ++ E ++L L K+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-----F 57
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ L+ F + LF V E + +++ Q+ + F R + + AL
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-------FDEPRSRFYAAEVTLALM 110
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-------TDNLCLYVQSRSYRA 588
+LH G+I+ DLK +NIL+ + C K+ D G C + T C + Y A
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHC--KLADFGM-CKEGILNGVTTTTFC---GTPDYIA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PE++ L Y +D W+LG ++ E+ G+ F D
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
ALEYLHS I++ DLKPENIL+ IK+ D G + D + Y APEVI
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI 170
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+++ +D W+LG ++ E+ G F +D I +I+
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 526 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQS 583
I +E L YL++ I+H D+KP NIL+ S R +IK+ D G S +++ +V +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGT 165
Query: 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
+Y +PE I G Y K D+WSLG + EL G+ FP
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGK--FP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 475
LG AF +V+ D TG ++ +K + D D + S + EI+LLK + +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVITRQCLEA 533
+ LR + + L I E + + Q +AY L + TRQ L+
Sbjct: 70 YGCLRDPEE----KKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQILQG 118
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSYR 587
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PEVI G Y +K D+WS+ C + E+ T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 54/158 (34%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y YF +FI EL+ L + K Q G LG++ V ++AL Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ--GPIPEDILGKMTVAI---VKALHY 129
Query: 537 L---HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
L H G+IH D+KP NIL+ + +K+ D G S D+ ++RS Y A
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDA--SGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMA 182
Query: 589 PEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPN 622
PE I YD + D+WSLG L EL TG+ + N
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 29/178 (16%)
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVIT 527
D H ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIAAVC 122
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
L+AL LH+ G+IH D+K ++IL+ R +K+ D G C Q V R
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGF-CAQVSK---EVPRRKSL 176
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+ APE+I LPY ++D+WSLG ++ E+ GE + N+ + + I L P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-----SGKPPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y+ Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAP 589
+LHS GII+ DLK +N+++ S IKI D G +N+ V +++ Y AP
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
E+I PY + +D W+ G +L E+ G+ F
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 512 SGGEAYFTLGR----LQVITR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE ++ L R L+ R + AL YLHSL I++ DLKPENIL+ S + I
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIV 136
Query: 564 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G + + + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
+V +RSY +PE + G Y + D+WS+G L EL G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
I R L A++YLH IIH D+K ENI I ++ + D G++CF D ++
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN--HPGDVCLGDFGAACFPVD----INANKY 240
Query: 586 Y--------RAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VLFPNDAV 625
Y APE++ PY +D+WS G +L E+ T LF D +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + + +G FS+V++A L V LK ++ D + EI LLK +N +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR-- 528
+++ D F L IV EL A +L + K YF + + R
Sbjct: 64 ------VIKYLDSFIEDNELNIVLELADAGDLSQMIK---------YFKKQKRLIPERTV 108
Query: 529 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 580
Q A+E++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-------NTRHP 55
Query: 478 ILRLYDY-FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y F + L V E AN GGE +F L R +V T
Sbjct: 56 FLTALKYAFQTHDRLCFVMEY--AN-----------GGELFFHLSRERVFTEERARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLCL--YVQSR 584
+ + ALEYLHS +++ D+K EN+++ + IKI D G C + +D + + +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFG-LCKEGISDGATMKTFCGTP 159
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ T +KI+K D D + ++ E ++L L +K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-----PPF 62
Query: 478 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ +L+ F ++ L+ V E + +Y Q+ + +A F + V L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-------GLF 115
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--DNLCL--YVQSRSYRAPEV 591
+LH GII+ DLK +N+++ S IKI D G C + D + + + Y APE+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
I PY + +D W+ G +L E+ G+ F
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-------HP 55
Query: 478 ILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
L Y + L V E +GGE +F L R +V +
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 102
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQ 582
+ + AL YLHS +++ DLK EN+++ + IKI D G S C
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 32/187 (17%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLY 503
KIIK K+F + E + +L+ N + ++LY L+ ++ + ++ +L+
Sbjct: 47 KIIKA-KNF---NAIEPMVHQLMKDNP-----NFIKLYYSVTTLKGHVLIMDYIKDGDLF 97
Query: 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+ K + ++ I RQ +EAL LH IIH D+K EN+L + I
Sbjct: 98 DLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-KDRIY 150
Query: 564 IIDLGSSCFQTDNLCLYVQSRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ D G LC + + S Y +PE I G YD D W++G + EL TG
Sbjct: 151 LCDYG--------LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
Query: 617 EVLFPND 623
+ F D
Sbjct: 203 KHPFKED 209
|
Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 17/241 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
RY + + +G +F K++ A+ +K I K + K + L+ K +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
I+ + F LFIV E ++ N++ G F+ ++ Q L
Sbjct: 61 ---IVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRG--VLFSEDQILSWFVQISLGL 114
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEV 591
+++H I+H D+K +NI + K+ D G + D++ L V + Y +PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLEML 644
PY+ K D+WSLGC+L EL T + F + + ++ +I G PI DL L
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233
Query: 645 M 645
+
Sbjct: 234 I 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ +G +KI+K + KD +L E ++LK N P
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NTRHP----F 56
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ L F + L V E + +GGE +F L R +V + +
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYV-------------NGGELFFHLSRERVFSEDRTRFYGAE 103
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 586
+ AL+YLHS I++ DLK EN+++ + IKI D G + + + Y
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLD--KDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ +D ++ EI +LK +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS---- 70
Query: 473 ADEHH--ILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
HH I Y F H + L++V E A + + G A +
Sbjct: 71 ---HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG--SVTDLVKNTKGNA-LKEDWIA 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LY 580
I R+ L L +LH+ +IH D+K +N+L+ + E+K++D G S Q D +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTVGRRNTF 181
Query: 581 VQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
+ + + APEVI YD + D+WSLG E+ G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ T V +K +K + + F L E +++K + +
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAF----LQEAQIMKKLRHD------K 62
Query: 478 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY E ++IV E + +L +F K SG L +L + Q E + Y
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK----SGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPEVI 592
L S IH DL NIL+ C KI D G + + D ++ + APE
Sbjct: 119 LESRNYIHRDLAARNILVGENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
+ K D+WS G +L E+ T G V +P GM LE + +G
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYP------------GMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C ++ K + +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQF 61
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++ L + + L +V ++ +F +N + G F R + L LE L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLEDL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
H ++ DLKPENIL+ Y I + L + +++ V + Y APEV+ Y
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 598 DQKIDLWSLGCILAELWTGEVLF 620
D W LGC++ E+ G+ F
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
+V +RSY +PE + G Y + D+WS+G L E+ G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 461 IKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL 520
I+ + L N N P+ ++R+ D +V ++LY + + S +
Sbjct: 106 IEAMLLQNVNHPS----VIRMKDTLVSGAITCMVLPHYSSDLYTY--LTKRSRP---LPI 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +I +Q LE L YLH+ IIH D+K ENI I ++ I DLG++ F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFL 214
Query: 581 --VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+ APEV+ Y+ K D+WS G +L E+
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 23/200 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A+D+ T V +K + K + + + E+K L+ + + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE--- 89
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 90 ----YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 140
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASIASPANS-FVGTPYWMAPEVILAMD 197
Query: 596 --PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 51/153 (33%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF---TLGRLQVITRQCLEAL 534
I++ Y + +I EL+ +L +F K+ E ++ LG++ V T ++AL
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGKIAVAT---VKAL 120
Query: 535 EYL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS--RSYRAPEV 591
YL L IIH D+KP NIL+ + IK+ D G S D++ + R Y APE
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD--RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 592 I---IGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I YD + D+WSLG L E+ TG+ +P
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
Y + + +GS + V++A++LHTG +KIIK + D F EI ++K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK------ECK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + E L+I E Q +G L LQ+ + R+ L+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTG-----PLSELQIAYVCRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ ++K+ D G + T + ++ + + AP
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAEL 613
EV Y+Q D+W++G EL
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 507 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566
KF+ + G F R + LE LH I++ DLKPENIL+ Y I+I D
Sbjct: 88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISD 145
Query: 567 LGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 620
LG + + + V + Y APEV+ Y D W LGC++ E+ G+ F
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 48/213 (22%)
Query: 464 LKLVNKNDPADEH------------------HILRLYDY-FYHLEHLFIVCEL-----LR 499
+KL+ + P +EH +I+ L D LF V E LR
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQ 558
L G GRL + Q L+AL H+ GI+H DLKP+NI++ ++
Sbjct: 68 EVL-------AADGALPAGETGRLML---QVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 559 RCEIKIID-----LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGC 608
R K++D L D L + + +Y APE + G P DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 609 ILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
I E TG+ + +V IL + L P+D+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQ---QLSPVDV 207
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 492 FIVCELLRANLYEFQKFNQES-------GGEAYFTLGRLQVITRQCLE--------ALEY 536
FIVC Y F ++ S GG+ ++ L + V + + LE+
Sbjct: 58 FIVCMS-----YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAPEVII-G 594
+H+ +++ DLKP NIL+ + ++I DLG +C F V + Y APEV+ G
Sbjct: 113 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
+ YD D +SLGC+L +L G F
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS---- 60
Query: 473 ADEHH--ILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTL 520
HH I Y F + L++V E A +L + K N TL
Sbjct: 61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---------TL 108
Query: 521 GR--LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S Q D
Sbjct: 109 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTV 165
Query: 579 ----LYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 616
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 22/130 (16%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
+GGE + F +Q+ + + + ALE+LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 145
Query: 564 IIDLG-SSCFQTD------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELW 614
+ D G S F D + C ++ Y AP+++ G +D+ +D WS+G ++ EL
Sbjct: 146 LTDFGLSKEFHEDEVERAYSFCGTIE---YMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 615 TGEVLFPNDA 624
TG F D
Sbjct: 203 TGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKI----IKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LG F +V Q TG + C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVN------SR 60
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++ L + + L +V L+ +F ++ GEA F GR + LE
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLED 117
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIG 594
LH I++ DLKPENIL+ + I+I DLG + + + V + Y APEV+
Sbjct: 118 LHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
Y D W+LGC+L E+ G+ F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKND 471
LGS F V H G +DV +K+I+ ++ DF + E K++ KL + N
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPN- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+++LY +FIV E + L + + + G + L + + C
Sbjct: 61 ------LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVC 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
EA+EYL S G IH DL N L+ +K+ D G + + D+ Y S+ +
Sbjct: 111 -EAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PEV + K D+WS G ++ E+++ G++ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 74/280 (26%), Positives = 99/280 (35%), Gaps = 96/280 (34%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG +VF + TG LK++ DK + + + +K V E IL
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL--DK----KEMIKRNKVKRV-----LTEQEILAT 57
Query: 482 YDYFYHLEHLFIVCELLRANLY-EFQK-----FNQE--SGGEAYFTLGRLQVITRQCLE- 532
D H F+ LY FQ + GGE + L Q +CL
Sbjct: 58 LD------HPFLP------TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSE 102
Query: 533 ------------ALEYLHSLGIIHCDLKPENILIK------------SYQ-----RCEIK 563
ALEYLH LGI++ DLKPENIL+ S Q K
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 564 IIDLGSSCFQTDNLCLYV-------QSRS------YRAPEVIIGLPYDQKIDLWSLGCIL 610
+ GS +++ +S S Y APEVI G + +D W+LG +L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
Query: 611 AELWTG-------------------EVLFPNDAVVMILAR 631
E+ G EV FP V AR
Sbjct: 223 YEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSAR 262
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 455 DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG 513
+L+EI +L L+ + I+ Y++F L I E LY K ++ G
Sbjct: 44 RDALNEIVILSLLQHPN------IIAYYNHFMDDNTLLIEMEYANGGTLY--DKIVRQKG 95
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
F + Q + A+ Y+H GI+H D+K NI + + IK+ D G S
Sbjct: 96 --QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--KAGLIKLGDFGISKIL 151
Query: 574 TDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF----PNDAVV 626
+ V + Y +PE+ G+ Y+ K D+W+LGC+L EL T + F P + VV
Sbjct: 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 627 MILARIIGM-LGPIDLEMLM 645
I+ + E++
Sbjct: 212 KIVQGNYTPVVSVYSSELIS 231
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYR 587
A+ +H +G +H D+KPEN+LI IK+ D GS+ T N L V + Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 588 APEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APEV+ + Y + D WSLG I E+ G F I+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G F V Q + +TG V +K IK D + F +++ + KL +KN
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEET---AVMTKLHHKN------ 60
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++RL H L+IV EL+ + NL F + + G A ++ +L + E +E
Sbjct: 61 -LVRLLGVILH-NGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGME 114
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVI 592
YL S ++H DL NIL+ + K+ D G + + DN L V+ + APE +
Sbjct: 115 YLESKKLVHRDLAARNILVS--EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEAL 169
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E+++ G +P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL-R 480
+G +++KV + T +K+IK + D+ +D ++ K V + A H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET--ASNHPFLVG 60
Query: 481 LYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
L+ F LF V E + ++ Q+ + A F + + AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNFLH 113
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT----DNLCLYVQSRSYRAPEVIIG 594
GII+ DLK +N+L+ + IK+ D G C + D + + +Y APE++ G
Sbjct: 114 ERGIIYRDLKLDNVLLDA--EGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 595 LPYDQKIDLWSLGCILAELWTGEVLF 620
Y +D W+LG ++ E+ G F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F V+ A + HT V +K + K + + + E+K L+ + + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE--- 85
Query: 478 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 86 ----YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 136
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 595
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASKSSPANS-FVGTPYWMAPEVILAMD 193
Query: 596 --PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 194 EGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV A+ TG +K +K +D + + E ++ + N E H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-----ERH 61
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVITR 528
++ L+ F +H+ V E +GG F+ R
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYA-------------AGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L+YLH I++ DLK +N+L+ + +KI D G LC + R+
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFG--------LCKEGMGFGDRT 158
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ APEV+ Y + +D W LG ++ E+ GE FP D
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ----SLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + + Q +L+E +L LV+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP---F 58
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE----- 532
I+ + F+ + L + +L+ +GG+ ++ L + V + + +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLM-------------NGGDLHYHLSQHGVFSEKEMRFYATE 105
Query: 533 ---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRA 588
LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y A
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMA 163
Query: 589 PEVI-IGLPYDQKIDLWSLGCILAELWTGEVLF 620
PEV+ G YD D +SLGC+L +L G F
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + T +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-ASNHPFLVGL 61
Query: 482 YDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
+ F LF V E + ++ Q+ + A F + + AL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNYLHE 114
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLP 596
GII+ DLK +N+L+ S IK+ D G D + + +Y APE++ G
Sbjct: 115 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 597 YDQKIDLWSLGCILAELWTGEVLF 620
Y +D W+LG ++ E+ G F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 18/142 (12%)
Query: 513 GGEAYFTL----GRLQVITRQCLE-------ALEYLHSLGIIHCDLKPENILIKSYQRCE 561
GG+ Y L G+L + Q +E AL+YLH I+H DLK +N+ +
Sbjct: 84 GGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-- 140
Query: 562 IKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
IK+ DLG + Q D + + Y +PE+ PY+ K D+W+LGC + E+ T +
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200
Query: 619 LFPNDAVVMILARII-GMLGPI 639
F + ++ RII G L P+
Sbjct: 201 AFNAKDMNSLVYRIIEGKLPPM 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 11/100 (11%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 583
T+Q L+ + YLH+ ++H D+K N+++ IK+ID G + + +
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+S APEVI Y +K D+WS+GC + E+ TG+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 21/125 (16%)
Query: 512 SGGEA--------YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE F+ ++ + + + ALE+LH LGI++ D+K ENIL+ S +
Sbjct: 88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVV 145
Query: 564 IIDLG-SSCF------QTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 615
+ D G S F +T + C ++ Y APE+I G + + +D WSLG ++ EL T
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIE---YMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 616 GEVLF 620
G F
Sbjct: 203 GASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+ E +G + KVF+ + G +KI+ D ++ E +LK + +D +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL-----SDHPN 76
Query: 478 ILRLYDYFYHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++ Y +Y + L++V EL ++ + K + G + + I + L
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEAL 134
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 588
L++LH IH D+K NIL+ + +K++D G S T V + + A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 589 PEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
PEVI + YD + D+WSLG EL G+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ--NSRHP----- 55
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ-------ESGGEAYFTLGRLQVITR-- 528
L A Y FQ ++ +GGE +F L R +V +
Sbjct: 56 -------------------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 96
Query: 529 ------QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLC 578
+ + AL+YLHS +++ DLK EN+++ + IKI D G +
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 154
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ + Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+Q I RQ L AL+ LHS GI+H D+KP+NI+ KIIDLG++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLL-KLVNKNDPADEH 476
+G +F V+ A+D+ V +K + K + + + E++ L KL + N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 477 HILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
LR + + +E+ L +LL + Q+ + +T L+ L
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------------EIAAVTHGALQGLA 129
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL 595
YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APEVI+ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANX-FVGTPYWMAPEVILAM 186
Query: 596 ---PYDQKIDLWSLGCILAEL 613
YD K+D+WSLG EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 12/116 (10%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G+IH D+KP+N+L+ + +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFG-TCMKMDETGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 16/141 (11%)
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 581
T + + AL+ +HS+G IH D+KP+N+L+ +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAV 204
Query: 582 QSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII---- 633
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264
Query: 634 GMLGPIDLEMLMQGQEIYKYF 654
+ P D+E+ Q +++ F
Sbjct: 265 SLTFPDDIEISKQAKDLICAF 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL----CL- 579
I R+ LEAL YLH GIIH D+K ENI + + + D G++C + C
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYG 246
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+ + +PE++ PY K D+WS G +L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 474
LG AF KVF A+ C ++ D+ L +K LK +++ D
Sbjct: 13 LGEGAFGKVFLAE--------CHNLLPEQ----DKMLVAVKALKEASESARQDFQREAEL 60
Query: 475 -----EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAY------------ 517
HI+R Y L +V E +R + +F + G +A
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TLG++ I Q + YL SL +H DL N L+ Q +KI D G S + TD
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG--QGLVVKIGDFGMSRDIYSTD 176
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V R+ + PE I+ + + D+WS G +L E++T
Sbjct: 177 Y--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 31/255 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K L+E L+K + + ++RL
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD------KLVRL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++I+ E + + +L +F K + GG+ L +L + Q E + Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGK--VLLPKLIDFSAQIAEGMAYIERK 122
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ N+L+ C KI D G + DN + + APE I
Sbjct: 123 NYIHRDLRAANVLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 597 YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655
+ K D+WS G +L E+ T G++ +P GM + L +G + +
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYP------------GMSNSDVMSALQRGYRMPRMEN 228
Query: 656 KEYDLYYINEVCFAN 670
+LY I + C+
Sbjct: 229 CPDELYDIMKTCWKE 243
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 79/261 (30%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPA 473
++ + +G AF +V Q TG +K + + F L +K + L + P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR- 528
++ LY F ++L+++ E L GG+ L + +TR
Sbjct: 62 ---WVVSLYYSFQDAQYLYLIMEFL-------------PGGDLMTMLIKYDTFSEDVTRF 105
Query: 529 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------------- 571
+C+ A+E +H LG IH D+KP+NILI + IK+ D G S
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 572 FQ---------------TDNLCLYVQSRS---------------------YRAPEVIIGL 595
Q D++ L + S+ Y APE+ +
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 596 PYDQKIDLWSLGCILAELWTG 616
Y Q+ D WSLG I+ E G
Sbjct: 224 GYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLL-KLVNKNDPADEHHI 478
+G F V + G V +K +K+D L E ++ L + N +
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPN-------L 62
Query: 479 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
++L L+IV E + + +L ++ + S G A TL + E +EYL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 594
+H DL N+L+ + K+ D G + D+ L V+ + APE +
Sbjct: 119 EEKNFVHRDLAARNVLVS--EDLVAKVSDFGLAKEASQGQDSGKLPVK---WTAPEALRE 173
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L E+++ G V +P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 474
+ + + +GS + V++A++++TG +K+IK + + F EI ++K
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK------DCK 64
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 532
+I+ + + + L+I E Q +G L Q+ ++R+ L+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGG--SLQDIYHVTG-----PLSESQIAYVSRETLQ 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 589
L YLHS G +H D+K NIL+ +K+ D G S T + ++ + + AP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 590 EVII---GLPYDQKIDLWSLGCILAEL 613
EV Y+Q D+W++G EL
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ L V V +K++K+D KD D + E++++K++ K+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 81
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR-------- 522
+I+ L L+++ E + NL E+ + + G E + + R
Sbjct: 82 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 523 --LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L T Q +EYL S IH DL N+L+ + +KI D G + +N+ Y
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVMKIADFGLA-RDVNNIDYY 193
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + R APE + Y + D+WS G ++ E++T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 23/151 (15%)
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE---- 532
+++ L+ Y + +F+V + GG+ + + + I +C++
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQ-------------HAEGGKLWSHISKFLNIPEECVKRWAA 92
Query: 533 ----ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
AL+ LH GI+ DL P NIL+ R I++ D+ Y A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLD--DRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
PEV + D WSLG IL EL TG+ L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
+ + E +G + KV++ + G +KI+ D ++ E +L+ + N P
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-PNHP 79
Query: 473 ADEHHILRLYDYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
++++ Y FY + L++V EL ++ E K G + I
Sbjct: 80 ----NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYI 133
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQS 583
L L++LH+ IIH D+K NIL+ + +K++D G S T V +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 584 RSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
+ APEVI YD + D+WSLG EL G+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADE 475
V + LG + V++ TGV + +K I+ D+ F+Q + E+ +L A
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH------KAVS 58
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I+ Y F+ +++ E + A K L+ IT ++ L+
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAG--SLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 536 YL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRA 588
+L IIH D+KP N+L+ ++K+ D G +S +T+ C +SY A
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAKTNIGC-----QSYMA 169
Query: 589 PEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
PE I Y + D+WSLG + E+ G +P + I A++
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G +++KV + +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-LVGL 61
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ F LF+V E + F Q E + ++ C+ AL +LH G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI----CI-ALNFLHERG 116
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYD 598
II+ DLK +N+L+ IK+ D G D + + +Y APE++ G Y
Sbjct: 117 IIYRDLKLDNVLLD--ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 599 QKIDLWSLGCILAELWTGEVLF 620
+D W+LG ++ E+ G F
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 422 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG + C K+ K + ++ ++ E ++L V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRF 54
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFN--QESGGEAYFTLGRLQVITRQCLEALE 535
I+ L F L +V ++ + +N +E+ G F R T Q + LE
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLE 111
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVI 592
+LH II+ DLKPEN+L+ + ++I DLG + D Y + + APE++
Sbjct: 112 HLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 593 IGLPYDQKIDLWSLGCILAEL 613
G YD +D ++LG L E+
Sbjct: 170 QGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPA 473
LG F KV +A V +K++K + + D L E LLK VN
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQVN----- 61
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKF---------NQESG-----G 514
H+++LY L ++ E LR+ L E +K N+ S
Sbjct: 62 -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E T+G L Q ++YL + ++H DL N+L+ ++ +I L ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 575 DNLCLYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
D+ + R + A E + Y + D+WS G +L E+ T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 17/185 (9%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
K +K Q +EI L +N + ILR Y + + +LY
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY------DFDLYS 251
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
F +++ + L + + I +Q L A+EY+H +IH D+K ENI + C+ KI
Sbjct: 252 FM-YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN----CDGKI 306
Query: 565 I--DLGSSC-FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
+ D G++ F+ + +V + + +PE++ G Y + D+WS G IL ++ + +
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 619 LFPND 623
D
Sbjct: 367 CPIGD 371
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 63/199 (31%)
Query: 473 ADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
AD +++LY F ++L+ V + + + L F ++ L R +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--------LARFYIAE 109
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------- 568
C A+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 110 LTC--AIESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 569 ---------------SSC---------FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKI 601
C + CL V + +Y APEV++ Y Q
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 602 DLWSLGCILAELWTGEVLF 620
D WS+G IL E+ G+ F
Sbjct: 226 DWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFDQSLDEIKLLKLVNKND 471
+Y + +G +F K + G +K I K ++S E+ +L N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS--NMKH 58
Query: 472 PADEHHILRLYDYFYHLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR-LQVIT 527
P +I++ + F +L+IV CE +LY +K N + G F + L
Sbjct: 59 P----NIVQYQESFEENGNLYIVMDYCE--GGDLY--KKINAQRG--VLFPEDQILDWFV 108
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQ 582
+ CL AL+++H I+H D+K +NI + + IK+ D G +S + C +
Sbjct: 109 QICL-ALKHVHDRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC--IG 163
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ Y +PE+ PY+ K D+W+LGC+L E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 4e-07
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 50/242 (20%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
Y V + +G+ F +VF + T C K I + ++ +L+ VN
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKH 71
Query: 476 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV-----ITR 528
+I+R D F + + L+I+ E A + + Q+ Y G+++ ITR
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAG--DLSRNIQK----CYKMFGKIEEHAIVDITR 125
Query: 529 QCLEALEYLHSLG-------IIHCDLKPENILIKS---------------YQRCEIKIID 566
Q L AL Y H+L ++H DLKP+NI + + R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 567 LGSSCFQTDNLCLYVQSRS------YRAPEVII--GLPYDQKIDLWSLGCILAELWTGEV 618
G S N+ + + S Y +PE+++ YD K D+W+LGCI+ EL +G+
Sbjct: 186 FGLS----KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 619 LF 620
F
Sbjct: 242 PF 243
|
Length = 1021 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 34/256 (13%)
Query: 422 LGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480
LG+ F +V+ A + HT V V K +K + L E ++K +H L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV--KTMKPGSMSVEAFLAEANVMK-------TLQHDKLV 64
Query: 481 LYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
E ++I+ E + + +L +F K + G + L +L + Q E + ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQ--PLPKLIDFSAQIAEGMAFIEQ 120
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGL 595
IH DL+ NIL+ + C KI D G + DN + + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 596 PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654
+ K D+WS G +L E+ T G + +P GM P + L +G + +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYP------------GMSNPEVIRALERGYRMPRPE 226
Query: 655 TKEYDLYYINEVCFAN 670
+LY I C+ N
Sbjct: 227 NCPEELYNIMMRCWKN 242
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ LG +F V + + V +K +K+DK +D+ LK D
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDD--FLKEAAIMHSLDHE 56
Query: 477 HILRLYDYFYHLEH-LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++RLY L H L +V EL +L + + + +F + L Q +
Sbjct: 57 NLIRLYGVV--LTHPLMMVTELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGM 110
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
YL S IH DL NIL+ S ++KI D G N YV + A
Sbjct: 111 RYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + + D+W G L E++T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 512 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563
SGGE + F+ R + + + ALE+LH I++ DLKPENIL+ + I
Sbjct: 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIA 136
Query: 564 IIDLG-SSCFQTDNLC--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 616
+ D G S TDN + + Y APEV++ Y + +D WSLG ++ E+ G
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 71/255 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A + T +K ++ + +K + + AD +++L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE--ADNEWVVKL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R++V A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMEVFPEVLARFYIAELTLA 113
Query: 534 LEYLHSLGIIHCDLKPENILI-----------------------KSYQ------------ 558
+E +H +G IH D+KP+NILI K YQ
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 559 ----------RCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWS 605
RC ++ L + CL V + +Y APEV++ Y Q D WS
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 606 LGCILAELWTGEVLF 620
+G IL E+ G+ F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K G Y L +L + Q + + Y+ + IH DL
Sbjct: 73 EPIYIVTEFMGKGSLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGDNLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP 621
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 420 EYLGSAAFSKVF----QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
E +G F +VF +A + V C + + D + L E ++LK + +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPN---- 54
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
I+RL + ++IV EL++ +F F + G + L + +E
Sbjct: 55 --IVRLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEG--PRLKVKELIQMVENAAAGME 108
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-------A 588
YL S IH DL N L+ ++ +KI D G S + D + Y + + A
Sbjct: 109 YLESKHCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTA 164
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PE + Y + D+WS G +L E ++ G V + N
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 75/257 (29%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG AF +V A+ + T +K ++ + +K + + AD ++RL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE--ADNEWVVRL 66
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 533
Y F ++L+ V + + GG+ L R+ + A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------------- 568
+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 114 VESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 569 ---------SSCFQTDNL-------------CL---YVQSRSYRAPEVIIGLPYDQKIDL 603
++C D L CL V + +Y APEV++ Y Q D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 604 WSLGCILAELWTGEVLF 620
WS+G IL E+ G+ F
Sbjct: 232 WSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 445 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE-LLRANLY 503
KIIK + D E K+L +N + LY F +L++V E ++ +
Sbjct: 68 KIIKQKQ--VDHVFSERKILNYIN------HPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 504 EFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562
F + N+ + F ++ +I EYL SL I++ DLKPEN+L+ + I
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSLNIVYRDLKPENLLLD--KDGFI 170
Query: 563 KIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619
K+ D G + +T LC + Y APE+++ + + + D W+LG + E+ G
Sbjct: 171 KMTDFGFAKVVDTRTYTLC---GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 620 FPNDAVVMILARII 633
F + ++I +I+
Sbjct: 228 FYANEPLLIYQKIL 241
|
Length = 340 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADE 475
LGS AF V++ + G + V +K+++ + + LDE ++ V D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DH 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVIT--RQCLE 532
H++RL + ++ +L+ L ++ + +++ +G ++ Q +
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-------NIGSQYLLNWCVQIAK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR----- 587
+ YL ++H DL N+L+K+ Q +KI D G + L V + Y
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL------LDVDEKEYHAEGGK 172
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E I+ Y K D+WS G + EL T
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRAPEV 591
LE L I++ DLKPENIL+ R I+I DLG + + + + V + Y APEV
Sbjct: 115 LEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 592 IIGLPYDQKIDLWSLGCILAELWTGEVLF 620
I Y D W LGC++ E+ G+ F
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/238 (23%), Positives = 106/238 (44%), Gaps = 36/238 (15%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------KNDKDFFDQSLDEIKLLK 465
A Y V + +G AF +V + T +K++ ++D FF + D +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-- 99
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
A+ +++L+ F +L++V E + +L A F
Sbjct: 100 -------ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------ 146
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---- 580
T + + AL+ +HS+G IH D+KP+N+L+ + +K+ D G +C + + +
Sbjct: 147 -YTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFG-TCMKMNKEGMVRCDT 202
Query: 581 -VQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
V + Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 23/103 (22%)
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQSRS---- 585
+EY+HS G++H DLKP+NIL+ + E+ I+D G++ F + D L + V R+
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 586 -------------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE ++G+P + D+++LG IL ++ T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ + V +K +K + L+E +++K + ++D +++L
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHD-----KLVQL 66
Query: 482 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
Y E ++IV E + + +L +F K G L L + Q + Y+ +
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 596
IH DL+ NIL+ C KI D G + DN Q + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 597 YDQKIDLWSLGCILAELWT-GEVLFP 621
+ K D+WS G +L EL T G V +P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR---- 584
Q + AL+ +HS ++H DLK NI + IK+ D G S +D++ L V S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 585 -SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE+ Y +K D+WSLG IL EL T
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
QCL AL LH L + L+K GS F+T +
Sbjct: 24 LQCLGALRELHRQAKSGNILLTWDGLLKLD----------GSVAFKTPEQSR--PDPYFM 71
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEV 618
APEVI G Y +K D++SLG L E E+
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 49/275 (17%)
Query: 422 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 471
LG F +V A+ + + V V +K++K+D KD D + E++++K++ K+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMIGKHK 78
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF----------TL 520
+I+ L L+++ E + NL E+ + + G + F T
Sbjct: 79 -----NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
L Q +EYL S IH DL N+L+ + +KI D G + N+ Y
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVMKIADFGLA-RDVHNIDYY 190
Query: 581 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633
++ + R APE + Y + D+WS G +L E++T G +P V +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----- 245
Query: 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCF 668
++L +G + K ++LY I C+
Sbjct: 246 -------FKLLKEGHRMDKPANCTHELYMIMRECW 273
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVC----LKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
LG AF +V +A+ D LK +KD D + E++++K++ K+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK-- 76
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYF----------TLGR 522
+I+ L L++V E NL +F + + G A T
Sbjct: 77 ---NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L Q +E+L S IH DL N+L+ + +KI D G + + + Y +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--EDHVMKIADFGLA--RDIHHIDYYR 189
Query: 583 SRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + APE + Y + D+WS G +L E++T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 43/129 (33%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY------- 580
+ + A++ +H LG IH D+KP+N+L+ + + IK+ D G + + + +
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 581 ---------------------------------VQSRSYRAPEVIIGLPYDQKIDLWSLG 607
V + Y APEV + Y+++ D WSLG
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 608 CILAELWTG 616
I+ E+ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LGS F V + + + V +KI+KND + D +L + +LL+ N D +I+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKD-ELLREANVMQQLDNPYIV 59
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 539
R+ E +V EL A L KF Q++ + T + + Q ++YL
Sbjct: 60 RMIG-ICEAESWMLVMEL--AELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE 113
Query: 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------YRAPEVI 592
+H DL N+L+ + +I L + +N Y ++++ + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECM 170
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+WS G ++ E ++
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V++ +T V +K +K + KDF L E +++K + H
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDF----LAEAQIMKKL--------RH 60
Query: 478 --ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV EL++ +L E+ Q G A L +L + Q +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRA-LKLPQLIDMAAQVASGM 116
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPE 590
YL + IH DL N+L+ C K+ D G + + D ++ + APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNIC--KVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
+ + K D+WS G +L E+ T G + +P GM L+ + QG
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP------------GMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 441 DVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
DV +K+IK D+ ++E K ++KL ++ +++LY ++IV E +
Sbjct: 30 DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK-------LVQLYGVCTKQRPIYIVTEYMS 82
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559
N F +L + + E + YL S IH DL N L+ Q
Sbjct: 83 NGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QG 137
Query: 560 CEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
C +K+ D G S + D+ Y S + PEV++ + K D+W+ G ++ E+
Sbjct: 138 C-VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
Query: 614 WT 615
++
Sbjct: 195 YS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++IV E + + +L +F K E G Y L +L + Q + Y+ + +H DL
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--GEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C K+ D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP 621
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS---LDEIKLLKLVNKNDPADEH 476
E +G F V++ L +V +K ++ D L E ++LK + P
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILK--QYDHP---- 52
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA--- 533
+I++L + ++IV EL+ F ++ T+ +L + L+A
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNR--LTVKKL---LQMSLDAAAG 105
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------ 587
+EYL S IH DL N L+ + +KI D G S + + +Y S +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMS--REEEGGIYTVSDGLKQIPIKW 161
Query: 588 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + Y + D+WS G +L E ++ G+ +P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKN---DKDFFDQSLDEIKLLKLVNK 469
LG F +V +A+ G+D V +K++K+ DKD D + E++L+KL+ K
Sbjct: 20 LGEGCFGQVVRAEAY--GIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLIGK 76
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR------ 522
+ +I+ L L+++ E + NL EF + + G + F + +
Sbjct: 77 HK-----NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 523 ----LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
L Q +EYL S IH DL N+L+ +I L D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G ++ E++T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + I+ E + K+ ++ GE F+ +L + R ++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENG--ALDKYLRDHDGE--FSSYQLVGMLRGIAAGMK 121
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-----YRAP 589
YL + +H DL NIL+ S C K+ D G S + D Y S + AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLEC--KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GE 617
E I + D+WS G ++ E+ + GE
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKND---KDFFDQSLDEIKLLKLVNK 469
LG F +V A+ + G+D V +K++K+D KD D + E++++K++ K
Sbjct: 26 LGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEMMKMIGK 82
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQK----------FNQESGGEAYF 518
+ +I+ L L+++ E + NL E+ + +N E
Sbjct: 83 HK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+ L Q +EYL S IH DL N+L+ +I L D
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 579 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
R + APE + Y + D+WS G +L E++T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 21/99 (21%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q L A+ ++HS +IH D+K NIL+ C ++ LG F +Y + S
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL-----CSNGLVKLGDFGFSK----MYAATVSDDV 201
Query: 586 ---------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
Y APE+ PY +K D++SLG +L EL T
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 20/48 (41%), Positives = 32/48 (66%), Gaps = 2/48 (4%)
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
++ + RQ L L LH +GI+H D+KPEN+L+ ++KIID G++
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG AF KVF A+ +L D L +K KD D + + + N HI+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN--LQHEHIV 70
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF----------TLGRLQVITRQ 529
+ Y + L +V E ++ + KF + G +A T ++ I +Q
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSR--- 584
+ YL S +H DL N L+ + +KI D G S + TD + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVG--ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ PE I+ + + D+WSLG +L E++T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 474 DEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
D +I+RL + I+ E + +L +F + N + FT+G+L + R
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIAS 117
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------Y 586
++YL + +H DL NIL+ S C K+ D G S D+ Y ++ +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVC--KVSDFGLSRRLEDSEATY-TTKGGKIPIRW 174
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617
APE I + D+WS G ++ E+ + GE
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADE 475
LG F KV +TG V +K + + + +S EI++L+ + D
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DH 65
Query: 476 HHILRL--YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++ L ++ E L +L ++ + +++ L RL + + Q +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICK 120
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRS-----Y 586
++YL S IH DL NIL++S +KI D G + D YV+ +
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + D+WS G L EL+T
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 23/128 (17%)
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------S 585
E +EYL IH DL N L+ S +K+ D G + + D+ Y S
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVK 166
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644
+ PEV Y K D+WS G ++ E++T G++ F + + +EM+
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------------VEMI 214
Query: 645 MQGQEIYK 652
+G +Y+
Sbjct: 215 SRGFRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 489 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547
E ++I+ E + +L +F K G + T+ +L + Q E + ++ IH DL
Sbjct: 73 EPIYIITEYMENGSLVDFLK--TPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 603
+ NIL+ C KI D G + DN + + APE I + K D+
Sbjct: 129 RAANILVSETLCC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 604 WSLGCILAELWT-GEVLFP---NDAVVMILARIIGMLGP 638
WS G +L E+ T G + +P N V+ L R M P
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLC---LYVQSRSYR 587
A++ +H LG +H D+KP+N+L+ + I++ D G SC + D + V + Y
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A++ +H L +H D+KP+NIL+ I++ D G SC + T + V + Y
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 67/243 (27%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE----ADSLWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE------- 532
+++ F +L+++ E L GG+ L + +T + +
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-------------PGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 533 -ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SS 570
A++ +H LG IH D+KP+N+L+ S + +K+ D G S
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 571 CFQTDNLCLYVQSRSYR-----------------APEVIIGLPYDQKIDLWSLGCILAEL 613
F N+ ++ +++ APEV + Y++ D WSLG I+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 614 WTG 616
G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 21/38 (55%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
AL+YLH GIIH DLKP+N+LI + IK+ D G S
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID--LGSSCFQTDNLCLY-VQSRS 585
Q + YLH G+IH D+ N +I + +KI D L F D CL ++R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 586 YR--APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ A E ++ Y D+WS G +L EL T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDF--------FDQS---LDEIK----- 462
E LG AF K+++ G+D L IK KD F Q + E+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 463 -LLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEFQKFNQESGG-EAYFT 519
LL +V + P + L++Y + H F++ +R+ + + E G ++
Sbjct: 71 CLLGVVTQEQP-----VCMLFEYLNQGDLHEFLI---MRSPHSDVGCSSDEDGTVKSSLD 122
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579
G I Q +EYL S +H DL NILI ++ +KI DLG S
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--EQLHVKISDLGLSREIYSADYY 180
Query: 580 YVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
VQ +S + PE I+ + D+WS G +L E+++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 587
A+ +H L +H D+KP+N+L+ I++ D G SC + T + V + Y
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170
Query: 588 APEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 479
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE----ADGAWVV 64
Query: 480 RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+++ F +L+++ E L + K + S F + + + A++ +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-------ETVLAIDAI 117
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SSCFQTDN 576
H LG IH D+KP+N+L+ + + +K+ D G S F N
Sbjct: 118 HQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 577 L---------------CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y V + Y APEV + Y++ D WSLG I+ E+ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 422 LGSAAFSKVFQ--AQDL---HTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPAD 474
LG +F V++ A+ + V +K + + + + L+E ++K N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC----- 68
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + +V EL L++ L + + + G TL + + +
Sbjct: 69 -HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL + +H DL N ++ KI D G + ++TD Y YR
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTV--KIGDFGMTRDIYETD----Y-----YR 176
Query: 588 ------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE + + K D+WS G +L E+ T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 8/105 (7%)
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ 573
+ FT+ +L + R ++YL +G +H DL NIL+ S C K+ D G S +
Sbjct: 100 DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC--KVSDFGLSRVLE 157
Query: 574 TDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAEL 613
D Y + APE I + D+WS G ++ E+
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 26/155 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
L ++V+ D LKI + + D+ E+ +L+L+ + + ++
Sbjct: 6 LKGGLTNRVYLLGT--KDEDYVLKINPSREKGADR-EREVAILQLLARKGL----PVPKV 58
Query: 482 YDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+++ E + L E + +E I Q E L LH L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLHQL 105
Query: 541 ---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ H DL P NIL+ + + IID + +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 530 CL---EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
CL E + YL S +IH DL N L+ Q +K+ D G + F D+ Y S
Sbjct: 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQ--YTSSTGT 161
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ +PEV Y K D+WS G ++ E+++
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
I + L LEY+H GI H D+KPENI++ R IID G
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYG 171
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/110 (29%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ TL L + Q +E+L S IH DL NIL+ +KI D G
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDI 223
Query: 572 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 224 YKDPD---YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLY-VQ 582
I Q +EYL S +H DL N L+ + +KI D G S + D Y VQ
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSAD---YYRVQ 183
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL----FPNDAVV-MILARI 632
S+S + PE I+ + + D+WS G +L E+++ + F N V+ MI +R
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 633 I 633
+
Sbjct: 244 L 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 49/225 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 474
LG AF KVF + C + + D+ L +K LK ND
Sbjct: 13 LGEGAFGKVFLGE--------CYHLEPEN----DKELVAVKTLKETASNDARKDFEREAE 60
Query: 475 -----EH-HILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFT 519
+H +I++ Y + +V E LR++ + T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNL 577
L +L I Q + YL S +H DL N L+ +KI D G S + TD
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY--DLVVKIGDFGMSRDVYTTD-- 176
Query: 578 CLYVQSRSYR-------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y + + PE I+ + + D+WS G +L E++T
Sbjct: 177 --YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 414 GRYYVTEYLGSAAFS-KVFQAQDLHTGVD-VCLKIIKND------KDFFDQSLDEIKLLK 465
G ++ E G FS K F D V +K+++ D +DF L E+K+L
Sbjct: 19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF----LKEVKILS 74
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
++ DP +I RL L ++ E + + +F Q+ E +
Sbjct: 75 RLS--DP----NIARLLGVCTVDPPLCMIMEYM--ENGDLNQFLQKHVAETSGLACNSKS 126
Query: 526 ITRQCL--------EALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQTDN 576
++ L + YL SL +H DL N L+ K+Y IKI D G S N
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS----RN 179
Query: 577 L--CLYVQSRSYRAP--------EVIIGLPYDQKIDLWSLGCILAELWT 615
L Y + + RAP E ++ + K D+W+ G L E+ T
Sbjct: 180 LYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 421 YLGSAAFSKVFQAQ---DLHTG---VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+LGS AF +V++ L G + V +K ++ K DQ ++ + LK + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQ--EKKEFLKEAHLMSNFN 57
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
+I++L E +I+ EL+ L + E G TL L I +
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 533 ALEYLHSLGIIHCDLKPENILI--KSYQRCEI-KIIDLG--SSCFQTDNLCLYVQSRSYR 587
YL + IH DL N L+ K Y + KI D G +++D Y +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEG 173
Query: 588 -------APEVIIGLPYDQKIDLWSLGCILAELWT 615
APE ++ + + D+WS G ++ E+ T
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 491 LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549
L+IV E + + +L ++ + S G + L + EA+EYL + +H DL
Sbjct: 75 LYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 550 ENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLW 604
N+L+ K+ D G SS T L + + APE + + K D+W
Sbjct: 131 RNVLVSEDNVA--KVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDVW 183
Query: 605 SLGCILAELWT-GEVLFPNDAVVMILARI 632
S G +L E+++ G V +P + ++ R+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+L + Q + +EYL S +H DL NIL++S R +KI D G + + Y
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYK 166
Query: 582 QSRS------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ APE + + D+WS G +L EL+T
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 13/121 (10%)
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
Q + ++YL S +H DL N+L++S + +KI D G + +TD V+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ APE +I + D+WS G L EL T D+ + + M+GP +
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQ 229
Query: 643 M 643
M
Sbjct: 230 M 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 25/203 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH--IL 479
LG + +V++ + V +K +K D ++ L E ++K + H ++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--------EIKHPNLV 65
Query: 480 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+L +I+ E + NL ++ + A L + Q A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL----YMATQISSAMEYLE 121
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRAPEVI 592
IH DL N L+ +K+ D G S T + Y + APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL 177
Query: 593 IGLPYDQKIDLWSLGCILAELWT 615
+ K D+W+ G +L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 19/124 (15%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------FQTDNLC 578
I + L AL+Y+HS G IH +K +IL+ + + + L S Q
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 579 LYVQSRS---YRAPEV----IIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILA 630
S + +PEV + G Y++K D++S+G EL G V F + A M+L
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 631 RIIG 634
++ G
Sbjct: 222 KVRG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 11/115 (9%)
Query: 531 LEALEYLHSLGIIHCDLKPENILIK-------SYQRCEIKIIDLGSSCFQTDNLCLY-VQ 582
L+AL+Y+H +G +H +K +ILI S R + +I+ G + Y V+
Sbjct: 111 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 583 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIG 634
+ +PEV+ YD K D++S+G EL G V F + A M+L ++ G
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNLCLYVQS 583
I Q +E+L S ++H DL N+L+ + + +KI DLG + D L S
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 584 R---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ +PE I+ + D+WS G +L E+++
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 477
E LG F +VF+ L V +K K D ++ + L E ++LK D +
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILK------QYDHPN 53
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA---L 534
I++L + ++IV EL+ +F F ++ E + + + + L+A +
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDEL-----KTKQLVKFALDAAAGM 106
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRA 588
YL S IH DL N L+ + +KI D G S + D + Y S + A
Sbjct: 107 AYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMSRQEDDGI--YSSSGLKQIPIKWTA 162
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + Y + D+WS G +L E ++
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| cd08677 | 118 | C2A_Synaptotagmin-13 C2 domain. Synaptotagmin is a | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd08692 | 135 | C2B_Tac2-N C2 domain second repeat found in Tac2-N | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| cd08680 | 124 | C2_Kibra C2 domain found in Human protein Kibra. K | 99.78 | |
| cd08407 | 138 | C2B_Synaptotagmin-13 C2 domain second repeat prese | 99.77 | |
| cd08406 | 136 | C2B_Synaptotagmin-12 C2 domain second repeat prese | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd04028 | 146 | C2B_RIM1alpha C2 domain second repeat contained in | 99.74 | |
| cd08392 | 128 | C2A_SLP-3 C2 domain first repeat present in Synapt | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| cd08381 | 122 | C2B_PI3K_class_II C2 domain second repeat present | 99.72 | |
| cd08685 | 119 | C2_RGS-like C2 domain of the Regulator Of G-Protei | 99.71 | |
| cd08393 | 125 | C2A_SLP-1_2 C2 domain first repeat present in Syna | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.68 | |
| cd08408 | 138 | C2B_Synaptotagmin-14_16 C2 domain second repeat pr | 99.68 | |
| cd04029 | 125 | C2A_SLP-4_5 C2 domain first repeat present in Syna | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| cd08395 | 120 | C2C_Munc13 C2 domain third repeat in Munc13 (mamma | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.62 | |
| cd04020 | 162 | C2B_SLP_1-2-3-4 C2 domain second repeat present in | 99.6 | |
| cd08409 | 137 | C2B_Synaptotagmin-15 C2 domain second repeat prese | 99.6 | |
| cd08410 | 135 | C2B_Synaptotagmin-17 C2 domain second repeat prese | 99.6 | |
| cd08404 | 136 | C2B_Synaptotagmin-4 C2 domain second repeat presen | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| cd08389 | 124 | C2A_Synaptotagmin-14_16 C2A domain first repeat pr | 99.58 | |
| cd08384 | 133 | C2B_Rabphilin_Doc2 C2 domain second repeat present | 99.57 | |
| cd08388 | 128 | C2A_Synaptotagmin-4-11 C2A domain first repeat pre | 99.57 | |
| cd08387 | 124 | C2A_Synaptotagmin-8 C2A domain first repeat presen | 99.57 | |
| cd08521 | 123 | C2A_SLP C2 domain first repeat present in Synaptot | 99.56 | |
| cd04010 | 148 | C2B_RasA3 C2 domain second repeat present in RAS p | 99.56 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.55 | |
| cd04031 | 125 | C2A_RIM1alpha C2 domain first repeat contained in | 99.55 | |
| cd08403 | 134 | C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repe | 99.55 | |
| cd08385 | 124 | C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repe | 99.54 | |
| cd04030 | 127 | C2C_KIAA1228 C2 domain third repeat present in unc | 99.54 | |
| cd08402 | 136 | C2B_Synaptotagmin-1 C2 domain second repeat presen | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.52 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| cd04041 | 111 | C2A_fungal C2 domain first repeat; fungal group. C | 99.51 | |
| cd08405 | 136 | C2B_Synaptotagmin-7 C2 domain second repeat presen | 99.51 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.49 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.49 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| cd08386 | 125 | C2A_Synaptotagmin-7 C2A domain first repeat presen | 99.48 | |
| cd04009 | 133 | C2B_Munc13-like C2 domain second repeat in Munc13 | 99.47 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| cd08682 | 126 | C2_Rab11-FIP_classI C2 domain found in Rab11-famil | 99.46 | |
| cd04039 | 108 | C2_PSD C2 domain present in Phosphatidylserine dec | 99.45 | |
| cd08688 | 110 | C2_KIAA0528-like C2 domain found in the Human KIAA | 99.44 | |
| cd08390 | 123 | C2A_Synaptotagmin-15-17 C2A domain first repeat pr | 99.43 | |
| cd08401 | 121 | C2A_RasA2_RasA3 C2 domain first repeat present in | 99.43 | |
| cd04032 | 127 | C2_Perforin C2 domain of Perforin. Perforin contai | 99.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.39 | |
| cd08690 | 155 | C2_Freud-1 C2 domain found in 5' repressor element | 99.38 | |
| cd04036 | 119 | C2_cPLA2 C2 domain present in cytosolic PhosphoLip | 99.38 | |
| cd08376 | 116 | C2B_MCTP_PRT C2 domain second repeat found in Mult | 99.37 | |
| cd04022 | 127 | C2A_MCTP_PRT_plant C2 domain first repeat found in | 99.37 | |
| cd04018 | 151 | C2C_Ferlin C2 domain third repeat in Ferlin. Ferli | 99.36 | |
| cd04025 | 123 | C2B_RasA1_RasA4 C2 domain second repeat present in | 99.36 | |
| cd04035 | 123 | C2A_Rabphilin_Doc2 C2 domain first repeat present | 99.35 | |
| cd00276 | 134 | C2B_Synaptotagmin C2 domain second repeat present | 99.35 | |
| cd08374 | 133 | C2F_Ferlin C2 domain sixth repeat in Ferlin. Ferli | 99.35 | |
| cd08686 | 118 | C2_ABR C2 domain in the Active BCR (Breakpoint clu | 99.35 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.35 | |
| KOG1030 | 168 | consensus Predicted Ca2+-dependent phospholipid-bi | 99.35 | |
| cd04042 | 121 | C2A_MCTP_PRT C2 domain first repeat found in Multi | 99.33 | |
| cd08379 | 126 | C2D_MCTP_PRT_plant C2 domain fourth repeat found i | 99.33 | |
| cd04033 | 133 | C2_NEDD4_NEDD4L C2 domain present in the Human neu | 99.32 | |
| cd04019 | 150 | C2C_MCTP_PRT_plant C2 domain third repeat found in | 99.32 | |
| cd04016 | 121 | C2_Tollip C2 domain present in Toll-interacting pr | 99.32 | |
| cd08676 | 153 | C2A_Munc13-like C2 domain first repeat in Munc13 ( | 99.31 | |
| cd04043 | 126 | C2_Munc13_fungal C2 domain in Munc13 (mammalian un | 99.31 | |
| cd08375 | 136 | C2_Intersectin C2 domain present in Intersectin. A | 99.3 | |
| cd04026 | 131 | C2_PKC_alpha_gamma C2 domain in Protein Kinase C ( | 99.3 | |
| cd04037 | 124 | C2E_Ferlin C2 domain fifth repeat in Ferlin. Ferli | 99.29 | |
| cd04054 | 121 | C2A_Rasal1_RasA4 C2 domain first repeat present in | 99.27 | |
| cd08681 | 118 | C2_fungal_Inn1p-like C2 domain found in fungal Ing | 99.27 | |
| cd04011 | 111 | C2B_Ferlin C2 domain second repeat in Ferlin. Ferl | 99.27 | |
| cd04017 | 135 | C2D_Ferlin C2 domain fourth repeat in Ferlin. Ferl | 99.27 | |
| cd04024 | 128 | C2A_Synaptotagmin-like C2 domain first repeat pres | 99.26 | |
| cd08678 | 126 | C2_C21orf25-like C2 domain found in the Human chro | 99.25 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-65 Score=536.68 Aligned_cols=394 Identities=22% Similarity=0.298 Sum_probs=322.4
Q ss_pred CCCccccccccCCCCCcccccceeeccccCCCccCCccccccccccccCCCCCccccCCCCccccceeEEEEecc-Cccc
Q 005415 201 LDKPCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEA-DLID 279 (697)
Q Consensus 201 ~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~s~~~l~v~l~e~-~L~~ 279 (697)
++++|+.|++|+|+.++|++++... +++.. ..+.|+|.|++| ||.|
T Consensus 148 VH~rCv~nVPslCG~DhtE~RGrl~-----------l~~~~----------------------~~~~l~v~i~ea~NLiP 194 (683)
T KOG0696|consen 148 VHHRCVENVPSLCGTDHTERRGRLY-----------LEAHI----------------------KRDVLTVTIKEAKNLIP 194 (683)
T ss_pred HHHHHhhcCCcccCCcchhhcceEE-----------EEEEe----------------------cCceEEEEehhhccccc
Confidence 4589999999999998888776555 23222 348899999999 9999
Q ss_pred ccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCCCCCCcccccccCc
Q 005415 280 LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 280 ~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~ 359 (697)
||.||.||||||+.|.||.+.++|+||++.|+||||+|||+|+|+ +...+.++.|.++|||||+.+||||+|.++++.
T Consensus 195 MDpNGlSDPYvk~kliPD~~~~sKqKTkTik~~LNP~wNEtftf~--Lkp~DkdrRlsiEvWDWDrTsRNDFMGslSFgi 272 (683)
T KOG0696|consen 195 MDPNGLSDPYVKLKLIPDPKNESKQKTKTIKATLNPVWNETFTFK--LKPSDKDRRLSIEVWDWDRTSRNDFMGSLSFGI 272 (683)
T ss_pred cCCCCCCCcceeEEeccCCcchhhhhhhhhhhhcCccccceeEEe--cccccccceeEEEEecccccccccccceecccH
Confidence 999999999999999999999999999999999999999999999 999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccchhhHhHhhhhhhhhhh-------------cccCCCcCC-----------CCCcceee-CceecC
Q 005415 360 ADAEEHGVATPDLLMFDNLEEECEIFHLRIIH-------------RKNRTGFEE-----------NKDLPIIL-NTVIAG 414 (697)
Q Consensus 360 ~~~d~e~~~~~~~l~~~~l~ee~e~~~lrii~-------------~~~~~~~~~-----------~~~~pv~~-~~~i~~ 414 (697)
.++.++++.+|..++ .++|-|.+++.+.. ++.+.+... .+.++..- ..+-..
T Consensus 273 sEl~K~p~~GWyKlL---sqeEGEyyNvp~~~~~~e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~~~d~i~~t 349 (683)
T KOG0696|consen 273 SELQKAPVDGWYKLL---SQEEGEYYNVPVPDEDSEDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSSKRDRIKAT 349 (683)
T ss_pred HHHhhcchhhHHHHh---hhhcCceeccCCCCchhhHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCCcccceeec
Confidence 999999999987765 34444544433211 111111100 01111111 122245
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|..+.+||+|+||+|.+|..+.+.+.+|||+++++- ...+--+.|.++|....+ -|.+++++.+|+..+.
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k-----ppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLVQLHSCFQTMDR 424 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCC-----CchHHHHHHHhhhhhh
Confidence 7899999999999999999999999999999998753 223444566666655443 4799999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+|+||||+.|+-+-+..+.-.. +.++.+..++.+|+-||-+||++||+.||||.+|||++. .|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc--CCceEeeecccc
Confidence 9999999987655444332222 788889999999999999999999999999999999996 999999999998
Q ss_pred ccc---ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 571 CFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 571 ~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
... +....+++|||.|+|||++..++|+..+|.||+||+||||+.|++||.+.+..++++.|++---..|..+.
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS 574 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS 574 (683)
T ss_pred cccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc
Confidence 653 34456789999999999999999999999999999999999999999999999999999887666665443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=430.52 Aligned_cols=256 Identities=52% Similarity=0.832 Sum_probs=245.7
Q ss_pred CcCCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCC
Q 005415 397 GFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 397 ~~~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
.....+.+.++.++.+..||.|++.||+|+||.|.+|.|..+++.||||++++.+.+..+...|++||..|+...+.+.-
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 45567788999999999999999999999999999999999999999999999999999999999999999987777888
Q ss_pred ceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 477 nIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
|||+++++|...+|+|||+|.+..+|+++++.++..+ +++..++.++.||+.||.+||+.+|||+||||+|||+..
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 9999999999999999999999999999999888766 999999999999999999999999999999999999998
Q ss_pred cCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
.....|||+|||+|+........+++++.|+|||+++|.+|+.++||||||||++||++|.+.|+|.+..++++.|++.+
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 78889999999999999999889999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcccccccccC
Q 005415 637 GPIDLEMLMQGQEIYKYFTK 656 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~ 656 (697)
|.||..++..+.+..+||++
T Consensus 405 G~Pp~~mL~~~~~~~kff~~ 424 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTS 424 (586)
T ss_pred CCCCHHHHHhccccceehhc
Confidence 99999999999998998888
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=369.44 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=218.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..+|...+.||+|+|+.||.+++..+|+.||+|++.+ .....+...+||+|.+.|+ |||||+++++|++.
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~------HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK------HPNIVQFYHFFEDS 90 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC------CCcEEeeeeEeecC
Confidence 3789999999999999999999999999999999986 4556678889999999886 88999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+|||+|+|. ++|.++++..+ .+++.+++.+++||+.||.|||+++|+|||||..|++++. +.+|||+||
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~--~~~VKIgDF 162 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE--NMNVKIGDF 162 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC--cCcEEeccc
Confidence 99999999998 55666665322 2999999999999999999999999999999999999995 889999999
Q ss_pred CCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|+|.... ....+.+|||.|.|||++...+++..+||||+||+||.||.|++||...+..+.+.+|...--
T Consensus 163 GLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------- 235 (592)
T KOG0575|consen 163 GLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------- 235 (592)
T ss_pred ceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-------
Confidence 9998765 456778999999999999999999999999999999999999999999999999999854322
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..+..+.....+...+++...|..|+++++++ .|+
T Consensus 236 ----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 ----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 22235667778889999999999999999999 887
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=360.17 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=209.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+...|.+.+.||+|+||.|-+|..+.+|+.||||++++... ......+|++||+.|+ |||||++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~------HP~IV~~~d 243 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS------HPNIVRIKD 243 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC------CCCEEEEee
Confidence 55679999999999999999999999999999999985321 2234578999999986 889999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-Ccce
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCE 561 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~ 561 (697)
+|...+..||||||++ |.|.+.+..+.. +.+...+.+++||+.||.|||++||+||||||+|||+..+ .+..
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceE
Confidence 9999999999999998 567777765554 6777889999999999999999999999999999999864 5689
Q ss_pred EEEeeCCCccccc--cccccccccCCCCCchhhcCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHh
Q 005415 562 IKIIDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGLPY---DQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGM 635 (697)
Q Consensus 562 vKL~DFGla~~~~--~~~~~~~gt~~Y~APE~l~~~~~---s~ksDIWSLGviL~ELltG~~PF~~~~~~e-~l~~I~~~ 635 (697)
+||+|||+|+..+ .-..+.+|||.|.|||++.++++ ..++|||||||+||-+++|.+||.+..... ...+|.+.
T Consensus 318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G 397 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG 397 (475)
T ss_pred EEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC
Confidence 9999999998874 34567899999999999987763 347899999999999999999998765544 44444332
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.-.+-+.. | .....-..+...++++--|.+|.++++|+ ||+...+
T Consensus 398 ~y~f~p~~----------w---~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 RYAFGPLQ----------W---DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccccChh----------h---hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 21111111 1 13444556777888888899999999999 9998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.21 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=220.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|+.+.++|+|+||.||+++++.+|+.||||.+..++ ....-.++||++|++++ |+|+|.++.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk------H~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK------HENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc------cchHHHHHHHHHhcce
Confidence 57889999999999999999999999999999997543 34456789999999996 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+++|+|||+.++++.+...... ++...+..++.|++.|+.|+|+++++||||||+||||+. .+.+||||||+|
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G-----~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~--~gvvKLCDFGFA 148 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNG-----VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ--NGVVKLCDFGFA 148 (396)
T ss_pred eEEEeeecchHHHHHHHhccCC-----CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec--CCcEEeccchhh
Confidence 9999999999988888766543 889999999999999999999999999999999999995 899999999999
Q ss_pred cccc---cccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQT---DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~---~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+... +..+.++.|++|+|||.+.| ..|+..+||||+||++.||++|++.|++.++.+++..|+..+|+.+++-..-
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 8765 34566888999999999998 5799999999999999999999999999999999999999999988865441
Q ss_pred cc--------ccccc------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 647 GQ--------EIYKY------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 647 ~~--------~~~~~------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
-. .++.. -.+-+.+.....+-.+.-+..-|..|++.++++
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11 11111 011123344555556666667789999999988
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=335.88 Aligned_cols=265 Identities=30% Similarity=0.422 Sum_probs=226.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.||...++||+|.||.||+|+|..+|+.||||.++..+. .....++||+.|++++ |+||+.++++|.+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~------h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK------HPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc------CcchhhhhhhccCCCc
Confidence 478899999999999999999999999999999986432 2457789999999986 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+.||+||++.+|...++.... .++...+..++.++++||+|||++.|+||||||.|+||++ +|.+||+|||++
T Consensus 76 l~lVfEfm~tdLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLA 148 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLA 148 (318)
T ss_pred eEEEEEeccccHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccch
Confidence 999999999999988875443 4999999999999999999999999999999999999996 999999999999
Q ss_pred ccccccc---ccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+...... ...+-|++|+|||.+.|.. |+..+||||+|||+.||+.|.+.|+|.++.+++..|.+.+|.|..+.|+.
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 8876543 2346799999999999865 99999999999999999999999999999999999999999999998887
Q ss_pred ccccccccc----CCchhh-------hhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFT----KEYDLY-------YINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~----~~~~l~-------~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
...++.|-. ..+.+. +-..+...+++.--|..|+++.|++ +|++.
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 666555422 111111 2224555666666688899999999 77764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=352.49 Aligned_cols=295 Identities=34% Similarity=0.553 Sum_probs=261.0
Q ss_pred cccCCCcCCCCCcceeeCceec-CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhccc
Q 005415 392 RKNRTGFEENKDLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470 (697)
Q Consensus 392 ~~~~~~~~~~~~~pv~~~~~i~-~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~ 470 (697)
.+....|..+++|||.+|+.+. +||.+.++||.|-|++||+|.|..+.+.||+|+++....+.+..++||++|+.++..
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3455678889999999999998 999999999999999999999999999999999999888889999999999999987
Q ss_pred C--CCCCCceeEEEEEEEe----cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCcc
Q 005415 471 D--PADEHHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGII 543 (697)
Q Consensus 471 ~--~~~hpnIv~l~~~f~~----~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIv 543 (697)
. ..+..+||+|++.|.. +.|+++|+|+++.+|+.+++.....+ +++..++.|++||+.||.|||. +|||
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~ecgII 210 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHRECGII 210 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 6 4455689999999985 47899999999999999999887766 9999999999999999999996 6999
Q ss_pred ccCCCCcccccccc------------------------------------------------------------------
Q 005415 544 HCDLKPENILIKSY------------------------------------------------------------------ 557 (697)
Q Consensus 544 HrDLKP~NILl~~~------------------------------------------------------------------ 557 (697)
|-||||+|||+...
T Consensus 211 HTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~ 290 (590)
T KOG1290|consen 211 HTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAG 290 (590)
T ss_pred ccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcc
Confidence 99999999997300
Q ss_pred ----------------------------------------------C---------------------------------
Q 005415 558 ----------------------------------------------Q--------------------------------- 558 (697)
Q Consensus 558 ----------------------------------------------~--------------------------------- 558 (697)
.
T Consensus 291 ~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s 370 (590)
T KOG1290|consen 291 LEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSS 370 (590)
T ss_pred cccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCC
Confidence 0
Q ss_pred -------------------cceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005415 559 -------------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619 (697)
Q Consensus 559 -------------------~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~P 619 (697)
+.++||+|||.|++.....+.-++|+.|+|||++.|.+|++.+||||++|++|||+||...
T Consensus 371 ~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL 450 (590)
T KOG1290|consen 371 PGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL 450 (590)
T ss_pred ccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence 0147999999999999988888999999999999999999999999999999999999999
Q ss_pred CCCC------cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHh------------------
Q 005415 620 FPND------AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISL------------------ 675 (697)
Q Consensus 620 F~~~------~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~------------------ 675 (697)
|... .++++++.|++++|.+|..+...++..+.||++.++|++|-+.....++.-+
T Consensus 451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 9543 4689999999999999999999999999999999988887654433332222
Q ss_pred -------hhhccCHHHHH--Hhhc
Q 005415 676 -------VVIRLTLEYAA--LWLF 690 (697)
Q Consensus 676 -------~~~r~t~e~~~--~wl~ 690 (697)
|.+|.|+.+.+ |||+
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred HHHHhcCccccccHHHHhcCcccc
Confidence 66799999999 9998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.95 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=211.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..+|++++.||+|+||+||+++.+.+++.+|+|++++.. ...++..+|..||..++ ||+||.++..|++.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~------hPFiv~l~ysFQt~ 97 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK------HPFIVKLIYSFQTE 97 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC------CCcEeeeEEecccC
Confidence 468999999999999999999999999999999998643 34567888999998864 89999999999999
Q ss_pred CeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+|+|+||+.|+ |.-.++.... +++..++-++.+|+.||.|||++|||||||||+|||++. .|+++|+||
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~--~GHi~LtDF 169 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE--QGHIKLTDF 169 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC--CCcEEEecc
Confidence 9999999999864 5544443322 999999999999999999999999999999999999995 999999999
Q ss_pred CCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|+|+..- ....+++||+.|||||++.+.+|+..+|.||||+++|||++|.+||.+.+......+|.....+.++.
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~-- 247 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG-- 247 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc--
Confidence 9997532 34556899999999999999999999999999999999999999999999999999997655322221
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc----CHHHHH--HhhcccCCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL----TLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~----t~e~~~--~wl~~~~~n~ 696 (697)
-+..-+++....++..-+..|+ ..+.+. ++...++|++
T Consensus 248 --------------~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 248 --------------YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred --------------cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 2334555666667777777775 344444 7777776653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=349.65 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=211.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEe--cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~--~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (697)
..+.+.++.||+|+.|+||+++++.+++.+|+|++. .+.....++.+|++|++.++ ||+||.+|+.|.+..
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~------spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ------SPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC------CCCeeeEeEEEEeCCc
Confidence 356777889999999999999999999999999994 45667789999999999884 789999999999998
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.+.|+||||++ +|..+++..+. +++..+..|+.++++||.|||+ ++||||||||+|||+++ .|.||||||
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicDF 223 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICDF 223 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEeccc
Confidence 59999999985 56666554322 8999999999999999999995 89999999999999996 999999999
Q ss_pred CCcccccccc-ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHHHhhCCCCH
Q 005415 568 GSSCFQTDNL-CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-----AVVMILARIIGMLGPIDL 641 (697)
Q Consensus 568 Gla~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~-----~~~e~l~~I~~~lg~~p~ 641 (697)
|.+....... .+++||..|||||.+.+..|+.++||||||++++|+++|+.||+.. +..+++..|+. .+|+
T Consensus 224 GVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP 300 (364)
T KOG0581|consen 224 GVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP 300 (364)
T ss_pred cccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC
Confidence 9997765554 6789999999999999999999999999999999999999999874 44555555533 2332
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..-.. ...+++..+...|.++. +.+|.++++++ +||...+
T Consensus 301 ~lP~~--------~fS~ef~~FV~~CL~Kd----p~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 RLPEG--------EFSPEFRSFVSCCLRKD----PSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCcc--------cCCHHHHHHHHHHhcCC----cccCCCHHHHhcCHHHhhcc
Confidence 22110 13347788888887765 89999999999 9998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.75 Aligned_cols=211 Identities=31% Similarity=0.497 Sum_probs=188.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.++|.+.+.||+|+||+||+|+++.++..||||.+.+. +...+....|++||+.++ |||||++++++...+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~------H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK------HPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC------CcceeeEEEEEecCC
Confidence 47899999999999999999999999999999998754 445677789999999996 889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-Cc---ceEEE
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR---CEIKI 564 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~---~~vKL 564 (697)
.+|+|||||. |+|..++..... +++..++.++.||+.||++||+++||||||||.||||... .. -.+||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999998 567777765543 8999999999999999999999999999999999999863 22 57899
Q ss_pred eeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 565 ~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
+|||+|+..... ..+.+|++.|||||++....|+.|+|+||+|+|||+|++|++||...+..+.+..+.+.
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 999999887644 45689999999999999999999999999999999999999999999999988877543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.32 Aligned_cols=263 Identities=30% Similarity=0.446 Sum_probs=221.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhH--hHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~--~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.+||+++++||.|.||.||+|+.+.++..||||.+++.-...+ .-++|++.|++++. ||||++|..++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~-----hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNP-----HPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCC-----CCcchhhHHHhhccC
Confidence 45799999999999999999999999999999999986432222 34678888888763 899999999999887
Q ss_pred -eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 -HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 -~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+|||||..+|+++++.+.+ +|++..++.|+.||++||+|+|.+|+.||||||+|||+.. ...+||+|||
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDFG 155 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADFG 155 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEecccc
Confidence 9999999999999999986533 3999999999999999999999999999999999999995 7789999999
Q ss_pred Ccccccc--ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+|+.... ..+.++.|++|+|||+++.. .|+.++||||+|||++|+.+-++.|+|.++.+++.+|.+.+|.|..+.+.
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 9987654 45668999999999998765 58999999999999999999999999999999999999999999998877
Q ss_pred hcccccc------cccCCchhhhhH-------HHHHHHHHHHhhhhccCHHHHH
Q 005415 646 QGQEIYK------YFTKEYDLYYIN-------EVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 646 ~~~~~~~------~~~~~~~l~~i~-------~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.+..... .......+..++ .....++..+-|.+|.|+++++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 6533221 112223333333 3445566667789999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.65 Aligned_cols=264 Identities=28% Similarity=0.431 Sum_probs=223.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
-...|+.+++||+|.||.||+|++..+|+.||+|.++.+ ..+.....+||+||+.|. ||||++|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~------HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD------HPNIIKLEEIVTSK 188 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC------CCcccceeeEEEec
Confidence 346799999999999999999999999999999999854 455667889999999986 88999999999987
Q ss_pred --CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 489 --~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..+|||+|||+.+|.-++.... ..|++.++..+++||+.||.|+|++||+|||||.+||||+. +|.+||+|
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn--~G~LKiaD 261 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN--NGVLKIAD 261 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC--CCCEEecc
Confidence 6899999999999887775432 33999999999999999999999999999999999999995 99999999
Q ss_pred CCCccccccc----cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 567 FGla~~~~~~----~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|++.... .+..+-|.+|+|||+++|.. |+.++|+||+||||.||++|++.|++.++.+++.+|.+.+|.|..
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 9999865432 45567899999999999874 999999999999999999999999999999999999999999999
Q ss_pred HHHhhccccc--ccccCC-----------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 642 EMLMQGQEIY--KYFTKE-----------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 642 e~~~~~~~~~--~~~~~~-----------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+.|. ..+++ ..|... ..+..-..+....++..-|..|.|+++++ .|+
T Consensus 342 ~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 342 DYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred hccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 9887 22222 111111 12223445566667777788899999998 666
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=354.67 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=220.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+|...+.||.|+|++|++|.++.+++.||||++.+. .....-...|..+|..|. +||.|++||-.|+++.
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDEE 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeeccc
Confidence 6799999999999999999999999999999998753 223355667888888886 5899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+|+||++ |.|+++++.... |++...+.++.||+.||+|||++|||||||||+|||++. ++++||+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~--dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK--DGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC--CCcEEEeecc
Confidence 9999999997 678888876543 899999999999999999999999999999999999995 9999999999
Q ss_pred Cccccccc----------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 005415 569 SSCFQTDN----------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (697)
Q Consensus 569 la~~~~~~----------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I 632 (697)
.|..+... ...++||..|.+||++..+..++.+|||+||||||+|+.|.+||.+.++.-++++|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 98764321 14489999999999999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
+...-.+|. ...+..++..+.+++.-|..|+|.+++. ++..+.+|+
T Consensus 300 ~~l~y~fp~-----------------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 300 QALDYEFPE-----------------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHhcccCCC-----------------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 886554443 4447888999999999999999999999 666665554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.48 Aligned_cols=270 Identities=26% Similarity=0.356 Sum_probs=228.1
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+..-...|+.+..|+.|+||.||+|+|+.+++.||+|.++.+. .+.-..++||.+|..++ |||||.+-.+.
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~------H~NIV~vkEVV 144 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR------HPNIVEVKEVV 144 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC------CCCeeeeEEEE
Confidence 3444567999999999999999999999999999999998653 23446789999998875 88999999888
Q ss_pred Eec--CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 486 YHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 486 ~~~--~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
... +.+|||||||+.+|..++..... +|...+++.++.|+++||.|||.+.|+||||||+|+|++. .|.+|
T Consensus 145 vG~~~d~iy~VMe~~EhDLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~--~G~lK 217 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEHDLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH--KGILK 217 (419)
T ss_pred eccccceeeeeHHHHHhhHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc--CCcEE
Confidence 744 67999999999999999886652 3899999999999999999999999999999999999995 89999
Q ss_pred EeeCCCccccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 564 L~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|+|||+|+..+.. .+..+-|.+|+|||.+++.. |+.++|+||+|||+.||+++++.|+|.+..+++.+|...+|.|
T Consensus 218 iaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 9999999988776 55567799999999999875 9999999999999999999999999999999999999999999
Q ss_pred CHHHHhhccccc----------------ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 640 DLEMLMQGQEIY----------------KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 640 p~e~~~~~~~~~----------------~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
....|+.-.... +-|.. ..+..---+....++.-.|..|+|+++++ .|....
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~-~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA-LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccc-cccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 988776432221 00111 11334445667778888899999999999 787653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.78 Aligned_cols=215 Identities=27% Similarity=0.462 Sum_probs=195.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+|++++.||.|+||.|.+++.+.+|..+|+|++.+.. ...++..+|..+|+.+. ||+++++++.|.+.+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~------~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS------HPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc------CceeEEEEEeeccCC
Confidence 57999999999999999999999999999999998643 45567788999998875 899999999999999
Q ss_pred eEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||++|+ |..+++..++ ++++.++-++.||+.||+|||+++|++|||||+|||++. +|.+||+|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~--~G~iKitDFG 189 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ--NGHIKITDFG 189 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc--CCcEEEEecc
Confidence 999999999864 6666654433 999999999999999999999999999999999999995 9999999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+|+.......+.+|||.|+|||++..++|..++|.|||||++|||+.|.+||.+.++..++.+|++..-.+|..
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~ 263 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY 263 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence 99998888888999999999999999999999999999999999999999999999999999998877666653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.22 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=205.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|.+++.||+|+||.||+|+.+.+|..+|+|+++++. ........|..||... +.|+||+||..|++.
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~------ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV------DSPWVVKLYYSFQDK 213 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc------CCCcEEEEEEEecCC
Confidence 468999999999999999999999999999999998753 4456777788888774 367999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+||||||++| ++..++..... +++..++.++.+++.|+..||+.|+|||||||+|+||+. .|++||+||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~--~GHiKLSDF 285 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA--KGHIKLSDF 285 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC--CCCEeeccc
Confidence 999999999985 45555553332 899999999999999999999999999999999999995 999999999
Q ss_pred CCcccccc------------------------cc--------------------------ccccccCCCCCchhhcCCCC
Q 005415 568 GSSCFQTD------------------------NL--------------------------CLYVQSRSYRAPEVIIGLPY 597 (697)
Q Consensus 568 Gla~~~~~------------------------~~--------------------------~~~~gt~~Y~APE~l~~~~~ 597 (697)
|+|.-... .. ...+|||.|+|||++.+++|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 98732100 00 01488999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh--CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHh
Q 005415 598 DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML--GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISL 675 (697)
Q Consensus 598 s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l--g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~ 675 (697)
+..+|.||||||+||||.|-+||.+.++.+.+.+|+... -+.|.+. .+..-..+....++. -
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~---------------~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV---------------DLSDEAKDLITRLLC-D 429 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC---------------cccHHHHHHHHHHhc-C
Confidence 999999999999999999999999999999999997533 2222211 111222233333333 3
Q ss_pred hhhccC---HHHHH--HhhcccCCCCC
Q 005415 676 VVIRLT---LEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 676 ~~~r~t---~e~~~--~wl~~~~~n~~ 697 (697)
+..|+- .+++. ||..+++|++|
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcchh
Confidence 455554 67777 99999999976
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=333.13 Aligned_cols=266 Identities=33% Similarity=0.515 Sum_probs=224.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
+..+|..++.||.|+||.|+.|.++.+|+.||||.+.. ......+..+|+++|+.++ |+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~------HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR------HENIIGLLDIFRPP 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc------CCCcceEEeecccc
Confidence 34667778999999999999999999999999999873 4455678889999999986 7799999999986
Q ss_pred ----cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 488 ----~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
-+.+|+|+|+|+.+|...++..+. ++...++.++.||+.||.|+|+.+|+||||||.|+|++. ++.+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~--~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA--DCDLK 165 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc--CCCEE
Confidence 256999999999999998886554 889999999999999999999999999999999999996 89999
Q ss_pred EeeCCCccccc-----cccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 564 IIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 564 L~DFGla~~~~-----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|+|||+|+... ...+.++.|.+|+|||++.. ..|+.++||||+|||+.||++|++.|+|.+..+++..|++.+|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999998874 33466788999999999865 4699999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcc--cccccccCC------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 638 PIDLEMLMQGQ--EIYKYFTKE------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 638 ~~p~e~~~~~~--~~~~~~~~~------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.|+.+.+..-. ....|.... +...+...+....++.--|..|.|+++|+ |++..
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 99998776532 222232221 12234445666666777788899999999 77764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.65 Aligned_cols=287 Identities=34% Similarity=0.541 Sum_probs=247.6
Q ss_pred CCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005415 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (697)
Q Consensus 400 ~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv 479 (697)
..+.+-...++.+.+||+|+.+||+|.||.|-.+.|..++..||||+++.-....+..+-|+++|++++...+.+---++
T Consensus 75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 34445678899999999999999999999999999999999999999999888889999999999999988777777899
Q ss_pred EEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc--
Q 005415 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-- 557 (697)
Q Consensus 480 ~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-- 557 (697)
++.++|...++.+||+|.++-++.+++..+.... ++...++.|++|+++++++||+.+++|-||||+|||+.+.
T Consensus 155 ~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~----fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELLGLSTFDFLKENNYIP----FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred eeehhhhccCceEEEEeccChhHHHHhccCCccc----cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccce
Confidence 9999999999999999999999999998766543 9999999999999999999999999999999999998531
Q ss_pred ----------------CcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 558 ----------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 558 ----------------~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
....|+|+|||.|.......+..+.|..|+|||++++.+|+.++||||+||||+|+.||...|+
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 1346899999999998888888999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccc--------------------cCCchhhhhH----------HHHHHHH
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF--------------------TKEYDLYYIN----------EVCFANI 671 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~--------------------~~~~~l~~i~----------~~cw~~l 671 (697)
+.++.++++.|...+||+|..++.+.. ..+|| +.+-.+...| -+....+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 999999999999999999999987662 11222 2222233232 2344445
Q ss_pred HHHhhhhccCHHHHH--Hhhcc
Q 005415 672 FISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 672 ~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+.=.|..|.|+.+|+ +|.+.
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HccCccccccHHHHhcCHHhhc
Confidence 555588899999999 88764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=347.77 Aligned_cols=274 Identities=27% Similarity=0.444 Sum_probs=224.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-CeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-~~l 491 (697)
.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+++....+|++|++++++|... .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5789999999999999999999999999999999986555555677899999999888777888999999999865 579
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccC------------
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQ------------ 558 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~------------ 558 (697)
++|||+++++|.+++.... .+++..+..++.||+.||.|||+ .|||||||||+|||++..+
T Consensus 208 ~iv~~~~g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9999999998888776432 28899999999999999999998 5999999999999998522
Q ss_pred --cceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 559 --RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 559 --~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
.+.+||+|||.+..........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++..|.+.+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 135999999998766555666789999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcc--cccccccCCch------------------h-----hhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 637 GPIDLEMLMQGQ--EIYKYFTKEYD------------------L-----YYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 637 g~~p~e~~~~~~--~~~~~~~~~~~------------------l-----~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
|++|.++...+. ....++..... + .....+....++...|..|+|+++++ +|+
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 999988765321 11111111100 0 11223455556666688899999999 999
Q ss_pred ccc
Q 005415 690 FGI 692 (697)
Q Consensus 690 ~~~ 692 (697)
..+
T Consensus 442 ~~~ 444 (467)
T PTZ00284 442 LKY 444 (467)
T ss_pred ccc
Confidence 864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.46 Aligned_cols=260 Identities=32% Similarity=0.469 Sum_probs=210.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--C---
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E--- 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~--- 489 (697)
.|.-.+++|+|+||.||+|....+++.||||.+-.++... .+|+.||+.+ +|||||++.-+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l------~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKL------DHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhc------CCcCeeeEEEEEEecCCCchh
Confidence 5888999999999999999999999999999988766533 3688888855 589999999999854 2
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+.+||||++.+|.+.++..... ...++...++.++.||++||.|||+.||+||||||.|+|++. +.+.+||+|||+
T Consensus 96 ~lnlVleymP~tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMPETLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhchHHHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCCc
Confidence 35789999999999998753222 222788889999999999999999999999999999999997 679999999999
Q ss_pred cccccc--ccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~--~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|+.... ....+..|+.|+|||.+.|.. |+.++||||.||++.||+-|++.|+|++..+++..|++++|.|+.+.+..
T Consensus 173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 987543 345578899999999999864 99999999999999999999999999999999999999999999998875
Q ss_pred cccccc----------cccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 647 GQEIYK----------YFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 647 ~~~~~~----------~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
....+. .|.+ ...+..-..+...+++.=-|..|.++-+++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 433211 1111 011112223333444445577899888877
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=322.35 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=215.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.++||.|+||.||+|.+..+++.||+|+++... .......+|+.+++.++ ||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK------HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC------CCCEeeEEEEEcCCCeE
Confidence 57999999999999999999999999999999987432 22346678999888874 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~ 151 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLAR 151 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCccee
Confidence 99999999988887754322 2788899999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++.+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 54322 233567899999999876 46899999999999999999999999999999999999999999998887653
Q ss_pred ccccccc---cC----------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYF---TK----------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~---~~----------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+. .. ...+.....+...+++...|.+|.|+++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 3221111 10 112334445666677777788899999999 875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.57 Aligned_cols=269 Identities=30% Similarity=0.435 Sum_probs=221.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCc-eeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHH-ILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpn-Iv~l~~~f~~~~ 489 (697)
..|..+++||.|+||+||+|+++.+|+.||+|.++.... ......+|+.+|+.|++ +| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~------~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSH------ANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCC------CcceEEEEeeeeecc
Confidence 457778889999999999999999999999999986533 45667899999999985 45 999999999877
Q ss_pred ------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 490 ------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 490 ------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
.+++|+||+..+|..++....... ..++...++.+++||+.||+|||+++|+||||||.||||++ .|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLK 160 (323)
T ss_pred cccccceEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEe
Confidence 799999999999999988765431 22667889999999999999999999999999999999996 89999
Q ss_pred EeeCCCcccccc---ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 564 IIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 564 L~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|+|||+|+...- ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|++.++.+++.+|.+.+|.|
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 999999976542 24556789999999999988 69999999999999999999999999999999999999999999
Q ss_pred CHHHHhhccccccc---ccCCc---hhhh-------hHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 640 DLEMLMQGQEIYKY---FTKEY---DLYY-------INEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 640 p~e~~~~~~~~~~~---~~~~~---~l~~-------i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..+.|+......+| |.... .+.. -..+...+++.-.+..|.+++.++ +++...
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 99888865433332 11111 1111 223444555556677899999888 666543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=334.87 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=209.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----h--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
...++|.+.+.||.|+||+|++|.+..+++.||+|++... . .....+.+|+.+++.+.+ ||||++++.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-----HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-----HPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-----CCCEeEEEEE
Confidence 4567999999999999999999999999999999987653 1 234466689999998863 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+.....+|+||||+.+ .|++.+..... +.+..++.+++||+.|++|||++||+||||||+|||++... +.+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~K 161 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLK 161 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEE
Confidence 9999999999999985 78888875222 88899999999999999999999999999999999999622 8999
Q ss_pred EeeCCCcccc---ccccccccccCCCCCchhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 564 IIDLGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLP-YD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 564 L~DFGla~~~---~~~~~~~~gt~~Y~APE~l~~~~-~s-~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|+|||++... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+....+..|...--.
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK 241 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc
Confidence 9999999876 34567789999999999999987 76 7899999999999999999999998888877776543333
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+|. ++. ..-.......++..-|..|.++++++ +|+..
T Consensus 242 ~p~-----------~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 IPS-----------YLL-----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCC-----------CcC-----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 332 111 22334445556666678899999999 99986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=323.40 Aligned_cols=214 Identities=29% Similarity=0.382 Sum_probs=186.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE-EEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD-YFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~-~f~~~~ 489 (697)
..|+|+++||+|+||+||+++++.+|..||.|.++- +....+....|+.+|++|+ |||||++++ .|...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~------HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN------HPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC------CchHHHHHHHhhhccc
Confidence 569999999999999999999999999999999874 4455677889999999986 789999999 555555
Q ss_pred e-EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh--cC--ccccCCCCccccccccCcceEE
Q 005415 490 H-LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LG--IIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 490 ~-l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs--~g--IvHrDLKP~NILl~~~~~~~vK 563 (697)
. ++|||||++ |+|...++..+.. ...+++..++.++.|++.||.++|+ .+ |+||||||.||+++. +|.+|
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~--~gvvK 168 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA--NGVVK 168 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC--CCcee
Confidence 5 899999998 5676766655433 3449999999999999999999999 45 999999999999995 89999
Q ss_pred EeeCCCcccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 564 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 564 L~DFGla~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|+|||+++...... ...+|||+||+||.+...+|+.++|||||||++|||+.-++||.+.+-.++..+|.+.--
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 99999998876553 458999999999999999999999999999999999999999999988888888876533
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.42 Aligned_cols=289 Identities=34% Similarity=0.570 Sum_probs=254.9
Q ss_pred CCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCce
Q 005415 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478 (697)
Q Consensus 399 ~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnI 478 (697)
...++|.+.+|+++..+|.+....|+|-||+|..|.|...|..||||||++.......-+.|+.||++|+...+.+-.|+
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 34578899999999999999999999999999999999999999999999988888889999999999999988888899
Q ss_pred eEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 479 v~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++|+..|.+.+|+|||+|.+.-+|.++++.....-+ +.+..++.++.||+.||..|-.+||+|+||||+|||++. .
T Consensus 497 lrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvG---L~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVG---LHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-S 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccc---eeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-C
Confidence 999999999999999999999999999986554333 888899999999999999999999999999999999996 5
Q ss_pred cceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 559 RCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
...+||||||.|.....+ .+.+.-+..|+|||+++|.+|+...|+||+||+||||.||+..|+|....++|..++++.|
T Consensus 573 k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 778999999999776654 5556778899999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcccccccccC-------------------------------------------CchhhhhHHHHHHHHHHH
Q 005415 638 PIDLEMLMQGQEIYKYFTK-------------------------------------------EYDLYYINEVCFANIFIS 674 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~-------------------------------------------~~~l~~i~~~cw~~l~~~ 674 (697)
++|..|+..++=..+.|+. +....+-..+...++|+.
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 9999999866544444433 223334446667777888
Q ss_pred hhhhccCHHHHH--Hhhcc
Q 005415 675 LVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 675 ~~~~r~t~e~~~--~wl~~ 691 (697)
-|..|.|..+|+ |++.+
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 899999999999 66643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.66 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=208.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
..+++++.||+|.||.||+|.+. ....||+|.++......+.+.+|+++++.|+ |++||++++++..+..++|
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~------H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLR------HEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCc------ccCeEEEEEEEecCCceEE
Confidence 34666788999999999999974 3448999999987666688899999999997 7799999999999889999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
|||||. |+|+++++.... ..+...+...++.||++||+||+++++|||||..+||||+. +..+||+|||+|+.
T Consensus 279 VtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLARL 352 (468)
T ss_pred EEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEcccccccc
Confidence 999998 789999986222 23889999999999999999999999999999999999995 88999999999996
Q ss_pred ccccccc-ccc---cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~~~-~~g---t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..+.... ..+ +..|.|||.+....++.|+|||||||+||||+| |+.||++.+..+.+..| .++
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l------------e~G 420 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL------------ERG 420 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH------------hcc
Confidence 6554332 222 566999999999999999999999999999999 99999999999988887 456
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.++++.-.++..++.+|..||+.. |..|.|-+.+.
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~----P~~RPtF~~L~ 455 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHED----PEDRPTFETLR 455 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCC----cccCCCHHHHH
Confidence 667777778899999999999987 55555555444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.43 Aligned_cols=212 Identities=27% Similarity=0.453 Sum_probs=189.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+-..+|.++++||+|.||+|+++..+.+++.+|||+++++ ....+..+.|.+|+..++ +||.+++++.+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSCFQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeecccccc
Confidence 3346899999999999999999999999999999999975 345677888999998886 5999999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..+++|+||||+.|+..-.+... ..+++..++.++..|+.||.|||++|||+||||.+|||++. .|.+||+|
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~--eGh~kiAD 511 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT--EGHVKIAD 511 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc--cCcEEecc
Confidence 99999999999998762222111 12999999999999999999999999999999999999996 99999999
Q ss_pred CCCccc---cccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 567 LGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 567 FGla~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
||+++. .+....+++|||.|+|||++.+..|+..+|.|||||+|||||.|+.||++++.+++...|+..
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d 583 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND 583 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 999975 345677899999999999999999999999999999999999999999999999999998653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.98 Aligned_cols=265 Identities=32% Similarity=0.483 Sum_probs=208.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
+|++.++||+|+||.||+|.+..+++.||||++... .....++.+|+.+++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR------HPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC------CCCEeeecceEeccCCC
Confidence 699999999999999999999999999999998742 223346778888888775 88999999988643
Q ss_pred --CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 489 --~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..+|+||||++++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kL~D 146 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICD 146 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEcc
Confidence 3589999999998888776432 2889999999999999999999999999999999999985 88999999
Q ss_pred CCCccccccc------cccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~------~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998653221 123568999999999876 57899999999999999999999999999988888888899998
Q ss_pred CCHHHHhhcccc--ccccc------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 639 IDLEMLMQGQEI--YKYFT------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 639 ~p~e~~~~~~~~--~~~~~------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
++.......... ..++. ........+.+...+.+...|..|.++++++ +|+.+..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 887765432110 00000 0001112223344444455688999999999 9997644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.18 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=212.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK------QENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC------CccccchhhhEecCCE
Confidence 47999999999999999999999999999999987532 23456678888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+.++++..+..... .+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~ 147 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH--NDVLKLCDFGFA 147 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccCc
Confidence 999999999887776643321 2888999999999999999999999999999999999985 788999999998
Q ss_pred cccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||++.+..+.+..+....++.|.+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 765332 2235688999999999998899999999999999999999999999988888888888888888766542
Q ss_pred ccccccc----ccC-----------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQEIYKY----FTK-----------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~~~~~----~~~-----------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+ +.. ...+.....+...+++...|..|.|+++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1111100 000 001223345566666677799999999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=316.04 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=209.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|+||.||+|.+..+++.||||+++... .......+|+.+++.++ ||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK------HANIVLLHDIIHTKETL 78 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC------CCCcCeEEEEEecCCeE
Confidence 68999999999999999999999999999999987532 22345677888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.+++.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 151 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLAR 151 (303)
T ss_pred EEEEECCCcCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcce
Confidence 99999999998887764322 2788899999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~-~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...++.+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred eccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 54322 2335678999999998764 5888999999999999999999999875 44577777877777776655443
Q ss_pred cccccccccC------Cch---------hhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 647 GQEIYKYFTK------EYD---------LYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 647 ~~~~~~~~~~------~~~---------l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
......+... ... ......+....++...|.+|+|+++++ +|+...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 2211111000 000 112234455556666788999999999 9998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=324.33 Aligned_cols=274 Identities=30% Similarity=0.477 Sum_probs=216.7
Q ss_pred CCcceeeCc---eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 005415 402 KDLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 402 ~~~pv~~~~---~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
+.+++..++ .+.++|++.+.||+|+||.||++.+..+++.||||++... ........+|+.+++.++ |
T Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h 79 (359)
T cd07876 6 QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN------H 79 (359)
T ss_pred CcceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC------C
Confidence 345555555 4568999999999999999999999999999999998643 233456667888887764 8
Q ss_pred CceeEEEEEEEecC------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 476 HHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 476 pnIv~l~~~f~~~~------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
|||+++++++.... ..++||||+++++...+.. .++...+..++.||+.||.|||++||+||||||
T Consensus 80 ~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 151 (359)
T cd07876 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 151 (359)
T ss_pred CCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 89999999987543 5799999999988776531 177888999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
+|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 152 ~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~ 229 (359)
T cd07876 152 SNIVVKS--DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229 (359)
T ss_pred HHEEECC--CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999985 789999999998754332 234577899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHhhCCCCHHHHhhcccc-cccccC------------------------CchhhhhHHHHHHHHHHHhhhhccCH
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEI-YKYFTK------------------------EYDLYYINEVCFANIFISLVVIRLTL 682 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~-~~~~~~------------------------~~~l~~i~~~cw~~l~~~~~~~r~t~ 682 (697)
.+..+.+.++.++.++....... ..++.. .........+...+++...|..|.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 309 (359)
T cd07876 230 QWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309 (359)
T ss_pred HHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence 99999999998887665432111 000000 00011223455556666778899999
Q ss_pred HHHH--Hhhcc
Q 005415 683 EYAA--LWLFG 691 (697)
Q Consensus 683 e~~~--~wl~~ 691 (697)
++++ +|+..
T Consensus 310 ~e~l~hp~~~~ 320 (359)
T cd07876 310 DEALRHPYITV 320 (359)
T ss_pred HHHhcCchhhh
Confidence 9999 89864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.67 Aligned_cols=214 Identities=28% Similarity=0.477 Sum_probs=191.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .....+.+|++|++.++ ||||+.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk------Hpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK------HPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC------CcchhhHHHhhcccce
Confidence 57889999999999999999999999999999997533 34466889999999986 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+|+|+||+.|+|..++..... ++++.++.++.|++.||.|||+++|.|||+||.|||+.. .+.+|++|||+|
T Consensus 76 ~~vVte~a~g~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~--~~~~KlcdFg~A 147 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK--GGTLKLCDFGLA 147 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC--CCceeechhhhh
Confidence 999999999999999887655 899999999999999999999999999999999999994 899999999999
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+....+ .+...|||.|||||++.+.+|+..+|+||||||+|||++|++||-..+..+.+..|..---++|.
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS 221 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc
Confidence 877654 34468999999999999999999999999999999999999999988888887777654444444
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.83 Aligned_cols=267 Identities=27% Similarity=0.404 Sum_probs=210.9
Q ss_pred CceEEEEEeccCCCCceEEEEECC-CCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~-~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
.+|++++.||+|+||.||+|++.. +++.||+|+++... .......+|+.+++.+.. ..||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET---FEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc---cCCCCcceEEEEEeccc
Confidence 479999999999999999999854 47889999987432 223456678888877754 359999999999862
Q ss_pred ---cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 ---~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
...+++||||+.++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl 151 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKL 151 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEE
Confidence 356899999999998888764332 22788999999999999999999999999999999999985 788999
Q ss_pred eeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 565 ~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..|+...+.+..+
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 152 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred ccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999998754432 234567999999999998899999999999999999999999999999999999999988877665
Q ss_pred HHhhccccc-ccccC---------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 643 MLMQGQEIY-KYFTK---------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 643 ~~~~~~~~~-~~~~~---------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.+....... ..+.. .+.+.....+.+.+.+...|..|.|+.+++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 543321111 11110 012334445666667777799999999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.10 Aligned_cols=259 Identities=25% Similarity=0.313 Sum_probs=207.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||+|.+..+++.||||+++... .....+..|+.++..++ ||||+++++++....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK------SEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC------CCCCccEEEEEEcCC
Confidence 47999999999999999999999999999999997542 23345667777777664 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg 146 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFG 146 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCc
Confidence 9999999997 46767665332 2788999999999999999999999999999999999985 7899999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
++...........|++.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+............
T Consensus 147 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 222 (333)
T cd05600 147 LSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY---- 222 (333)
T ss_pred CCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC----
Confidence 9987665555678999999999999999999999999999999999999999998888777766542211110000
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
..........+..++..||. .-+..|.++++++ +|+....++
T Consensus 223 -~~~~~~~s~~~~~li~~~l~----~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLIN----DPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred -CccccccCHHHHHHHHHHhh----ChhhhcCCHHHHHhCcccCCCCHH
Confidence 00001223456667777775 4577788999999 898866543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.87 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=203.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC------CCcHhhhHhhhccCC
Confidence 36999999999999999999999999999999997532 23345677888888774 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecC
Confidence 9999999997 46777665432 2788999999999999999999999999999999999985 7889999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....-.+|..
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 220 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH------ 220 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc------
Confidence 99876655555678999999999999999999999999999999999999999988888777775532222210
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n 695 (697)
....+..++..||. ..|..|. ++++++ +|+...+++
T Consensus 221 -------~~~~~~~li~~~l~----~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 221 -------LDLYAKDLIKKLLV----VDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred -------CCHHHHHHHHHHcC----CCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 12234444444444 4566677 588888 999866543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.46 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=205.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS------HPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEcC
Confidence 367999999999999999999999999999999997532 23456778888888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+..++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Df 162 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDF 162 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeec
Confidence 999999999975 6666665332 2788899999999999999999999999999999999985 788999999
Q ss_pred CCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
|++...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.+...+.|.
T Consensus 163 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~------ 236 (329)
T PTZ00263 163 GFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN------ 236 (329)
T ss_pred cCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC------
Confidence 99987766555678999999999999999999999999999999999999999988887777766543222111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
. ....+..++..||... |..|++ +++++ +|+.+.+++
T Consensus 237 -----~--~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 237 -----W--FDGRARDLVKGLLQTD----HTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred -----C--CCHHHHHHHHHHhhcC----HHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 1 1234555666665544 666664 78888 998775543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.90 Aligned_cols=269 Identities=29% Similarity=0.415 Sum_probs=209.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
...+|++.++||+|+||.||+|.+..+++.||||.+..... ...+|+.+++.++ ||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~------h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLN------HINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcC------CCCCcceeeeEeecccc
Confidence 34689999999999999999999999999999999875433 2346888888874 88999999987542
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
..+++||||+++++..++....... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ..+.+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~--~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vk 211 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNN--HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLK 211 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCcee
Confidence 2477999999999887775432222 23889999999999999999999999999999999999985 345799
Q ss_pred EeeCCCcccccc--ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++..... ......+++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+.++++.++.++
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999999976432 23345789999999998765 689999999999999999999999999999999999999999888
Q ss_pred HHHHhhccccccc--cc--CCch--------hhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 641 LEMLMQGQEIYKY--FT--KEYD--------LYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 641 ~e~~~~~~~~~~~--~~--~~~~--------l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.+.+........- |. .... ...-..+...+++...|..|+|+.+++ +|+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 8766532111000 00 0001 111233444445556688999999999 998643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.13 Aligned_cols=208 Identities=23% Similarity=0.387 Sum_probs=177.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.++..++ ||||+++++.+....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~------~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD------SLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC------CCCcceEEEEEecCC
Confidence 36999999999999999999999999999999997532 23345667888877764 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+.+ +|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFG 146 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFG 146 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeecc
Confidence 99999999975 6666665332 2889999999999999999999999999999999999985 7899999999
Q ss_pred Cccccccc--------------------------------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHH
Q 005415 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (697)
Q Consensus 569 la~~~~~~--------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL 610 (697)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98643211 1134789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 611 AELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 611 ~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
|||++|..||.+.+..+.+.+|...
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~ 251 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNW 251 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999998888888877653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.12 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=214.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+-|++.+.||.|+.|.|-+|++..||+.+|||++.+. ......+.+||-|++.+. |||++++|++++...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~------HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE------HPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc------CCCeeeeeeeeccCc
Confidence 6799999999999999999999999999999999754 234567889999999986 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
++|+|+||+. |.|.+++..... +++.++.++++||+.|+.|+|..+|+||||||+|+|++. .+.|||+|||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~--~~nIKIADFG 157 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV--KNNIKIADFG 157 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc--ccCEeeeccc
Confidence 9999999997 567777765443 899999999999999999999999999999999999996 5569999999
Q ss_pred Ccccccc--ccccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~--~~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+|..... -..+.+|+|+|.|||++.|.+| +.++||||.|||||.||||++||.+++...++.++.+..-..|
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----- 232 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----- 232 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-----
Confidence 9976543 3567899999999999999987 4689999999999999999999999999999988866444333
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..+..-.++....++.--+..|.|++++. +||.++.
T Consensus 233 ------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 233 ------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 23344455666677777788899999999 9998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.64 Aligned_cols=240 Identities=28% Similarity=0.331 Sum_probs=194.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcE-EEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~-VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
....+.+.||+|+||+||+|.+. |.. ||+|++.... .....+.+|+.+|..++ |||||+++|++....
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~------HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR------HPNIVQFYGACTSPP 112 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCC
Confidence 34555666999999999999874 555 9999998532 22568899999999875 899999999999887
Q ss_pred -eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC-ccccCCCCccccccccCcc-eEEEe
Q 005415 490 -HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLKPENILIKSYQRC-EIKII 565 (697)
Q Consensus 490 -~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g-IvHrDLKP~NILl~~~~~~-~vKL~ 565 (697)
.++|||||++ |+|..++... ....+++..+..|+.||+.||.|||+++ ||||||||+|||++. .. ++||+
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI~ 186 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKIA 186 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEEC
Confidence 7999999998 5566666542 1223999999999999999999999999 999999999999995 65 99999
Q ss_pred eCCCcccccc---ccccccccCCCCCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 566 DLGSSCFQTD---NLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 566 DFGla~~~~~---~~~~~~gt~~Y~APE~l~--~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|||+++.... ..+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+....+....++.....++
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9999977653 334468999999999999 56899999999999999999999999999988666666654433333
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVI 678 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~ 678 (697)
.. ..++..+..+|+.||......+|..
T Consensus 267 ~p-----------~~~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 267 IP-----------KECPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred CC-----------ccCCHHHHHHHHHhCCCCCCcCCCH
Confidence 21 1266788999999999885554444
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.14 Aligned_cols=267 Identities=26% Similarity=0.367 Sum_probs=214.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.++||+|+||.||+|.+..+++.||+|.++... .......+|+.+++.++ ||||+++++++...+..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC------CCCcceEEEEEeeCCeE
Confidence 57999999999999999999999999999999987432 22335667888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.+++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 152 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccce
Confidence 99999999988877654322 2788899999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 54322 223467889999999875 45889999999999999999999999999999999999999998888776543
Q ss_pred cccccccc-------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYFT-------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~-------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.....+.. ....+..-..+...+++...|..|.|+++++ +|+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 22111110 0112233334555666666788999999999 9998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.52 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=204.5
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCC-cEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g-~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
..+..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.++ ||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN------HPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCCcceEE
Confidence 3444578999999999999999999876554 789999987532 23455677888888774 889999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++......++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~i 170 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK--DGFI 170 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCE
Confidence 9999999999999996 56777665432 2889999999999999999999999999999999999984 8899
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+......+|.
T Consensus 171 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~- 249 (340)
T PTZ00426 171 KMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK- 249 (340)
T ss_pred EEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC-
Confidence 9999999987665555678999999999999988999999999999999999999999998887777777553322221
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhc-----cCHHHHH--HhhcccCC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIR-----LTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r-----~t~e~~~--~wl~~~~~ 694 (697)
. ....+..++..|+... |..| .++++++ +|+...++
T Consensus 250 ----------~--~~~~~~~li~~~l~~d----p~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 250 ----------F--LDNNCKHLMKKLLSHD----LTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred ----------C--CCHHHHHHHHHHcccC----HHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 1 1223445555555544 5555 4899988 99887654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.99 Aligned_cols=273 Identities=28% Similarity=0.457 Sum_probs=216.3
Q ss_pred CcceeeCc---eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005415 403 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 403 ~~pv~~~~---~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
.+++.+++ .+.++|++.+.||+|+||.||+|.+..+++.||||.+... ........+|+.+++.++ ||
T Consensus 3 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ 76 (355)
T cd07874 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HK 76 (355)
T ss_pred ceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC------CC
Confidence 34555554 3468999999999999999999999999999999998753 233456667888888774 78
Q ss_pred ceeEEEEEEEec------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 477 HILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 477 nIv~l~~~f~~~------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
||+++++++... ...++||||+.+++...+.. .++...+..++.|++.||.|||++||+||||||+
T Consensus 77 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~ 148 (355)
T cd07874 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_pred chhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChH
Confidence 999999998754 35799999999988776642 1778889999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 149 Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 226 (355)
T cd07874 149 NIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_pred HEEECC--CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999985 788999999999765443 2345789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhCCCCHHHHhhcccc-ccccc--------------------CC----chhhhhHHHHHHHHHHHhhhhccCHH
Q 005415 629 LARIIGMLGPIDLEMLMQGQEI-YKYFT--------------------KE----YDLYYINEVCFANIFISLVVIRLTLE 683 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~-~~~~~--------------------~~----~~l~~i~~~cw~~l~~~~~~~r~t~e 683 (697)
+..+++.++.+..+++...... ..+.. .. ......+.+...+.+...|..|.|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ 306 (355)
T cd07874 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306 (355)
T ss_pred HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence 8988888888777665432211 01100 00 01112334555556666689999999
Q ss_pred HHH--Hhhcc
Q 005415 684 YAA--LWLFG 691 (697)
Q Consensus 684 ~~~--~wl~~ 691 (697)
+++ +|+..
T Consensus 307 ell~hp~~~~ 316 (355)
T cd07874 307 EALQHPYINV 316 (355)
T ss_pred HHhcCcchhc
Confidence 999 88864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.46 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=197.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------NPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCC
Confidence 36999999999999999999999999999999997532 23345667888888774 889999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 146 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFG 146 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEeecc
Confidence 99999999975 5666665322 2899999999999999999999999999999999999985 8899999999
Q ss_pred Cccccccc-----------------------------------------cccccccCCCCCchhhcCCCCCchhhHHHHH
Q 005415 569 SSCFQTDN-----------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLG 607 (697)
Q Consensus 569 la~~~~~~-----------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLG 607 (697)
++...... ....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 87543211 0123689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC---HHH
Q 005415 608 CILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT---LEY 684 (697)
Q Consensus 608 viL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t---~e~ 684 (697)
|++|+|++|..||.+.+..+.+..++......+. ............++ ..++ ..+..|.+ +++
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~s~~~~~li----~~ll-~~p~~R~~~~~~~~ 292 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF---------PDEVPLSPEAKDLI----KRLC-CEAERRLGNNGVNE 292 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCC---------CCCCCCCHHHHHHH----HHHc-cCHhhcCCCCCHHH
Confidence 9999999999999998887777776543221110 00001112233333 3333 25667776 888
Q ss_pred HH--HhhcccCC
Q 005415 685 AA--LWLFGIDQ 694 (697)
Q Consensus 685 ~~--~wl~~~~~ 694 (697)
++ +|+.+.++
T Consensus 293 ll~h~~~~~~~~ 304 (364)
T cd05599 293 IKSHPFFKGVDW 304 (364)
T ss_pred HhcCCCcCCCCH
Confidence 88 89877653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.62 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=211.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+..||++.+.||+|.||+|-+|.+...|+.||||.++++. ...-++.+||+|+..|+ ||||+.+|.+|+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN------HPhII~IyEVFEN 124 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN------HPHIIQIYEVFEN 124 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC------CCceeehhhhhcC
Confidence 4579999999999999999999999999999999998643 44456788999998886 8999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+.+.|||||.. |.|++++...+. +++.+++.+++||.+|+.|+|+++++|||||.+|||++. ++.+||+|
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~--N~NiKIAD 196 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ--NNNIKIAD 196 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC--CCCeeeec
Confidence 999999999997 679999876654 899999999999999999999999999999999999995 89999999
Q ss_pred CCCcccccc--ccccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||++....+ -..+++|+|-|.+||++.|.+| ++.+|.|||||+||.|+.|..||.+.+-..++.+|...
T Consensus 197 FGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-------- 268 (668)
T KOG0611|consen 197 FGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-------- 268 (668)
T ss_pred cchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--------
Confidence 999977554 3567999999999999999987 46799999999999999999999999888877777432
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH-HhhcccCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA-LWLFGIDQNK 696 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~-~wl~~~~~n~ 696 (697)
.|+.....-..-+. ...++---|..|.|+|.+. -||..|.-|+
T Consensus 269 --------aYrEP~~PSdA~gL--IRwmLmVNP~RRATieDiAsHWWvNwgy~~ 312 (668)
T KOG0611|consen 269 --------AYREPETPSDASGL--IRWMLMVNPERRATIEDIASHWWVNWGYNM 312 (668)
T ss_pred --------cccCCCCCchHHHH--HHHHHhcCcccchhHHHHhhhheeeccccc
Confidence 12222111111122 2223444577799999999 9999887764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.89 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=194.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||++.+..+++.||||++.... .....+.+|+++++.+ +||||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES------DSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcCC
Confidence 46999999999999999999999999999999987532 2334566788887765 4889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~--~~~~kl~DfG 146 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR--GGHIKLSDFG 146 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEEeecc
Confidence 9999999996 56766665332 2788999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc--------------------------------------------------cccccccCCCCCchhhcCCCCC
Q 005415 569 SSCFQTDN--------------------------------------------------LCLYVQSRSYRAPEVIIGLPYD 598 (697)
Q Consensus 569 la~~~~~~--------------------------------------------------~~~~~gt~~Y~APE~l~~~~~s 598 (697)
++...... ....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 88532110 0024689999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhh
Q 005415 599 QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVI 678 (697)
Q Consensus 599 ~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~ 678 (697)
.++|||||||++|||++|.+||.+.+..+.+..+......+.. .....+.....+...+++. .+..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF-------------PDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC-------------CCCCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999999999999999999988887777776542211110 0001112222333333332 3444
Q ss_pred ---ccCHHHHH--HhhcccCC
Q 005415 679 ---RLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 679 ---r~t~e~~~--~wl~~~~~ 694 (697)
|.++++++ +|+.+.++
T Consensus 293 r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 293 RLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred cCCCCCHHHHhcCCCcCCCCH
Confidence 45999988 99987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=304.69 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=211.3
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~---- 487 (697)
+|++++.||+|+||+||+|.++.+++.||+|.++... .......+|+.+++.+.. .+||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---FDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---cCCCCeeeeeeeeccccCC
Confidence 5899999999999999999999999999999987432 222355678888887754 359999999999864
Q ss_pred -cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 -LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 -~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+++..++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLAD 151 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECc
Confidence 245899999999988887764322 22889999999999999999999999999999999999985 78899999
Q ss_pred CCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 567 FGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
||++...... .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9998765432 23356788999999999989999999999999999999999999999999999999988887666554
Q ss_pred hhccccc-cccc---------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIY-KYFT---------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~-~~~~---------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
....... ..+. ..+.+.....+...+++...|..|+|+++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 3221111 0110 0112333445666677777789999999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=322.89 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=206.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.++|++++.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++ ||||++++++|......+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAIN------HPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCC------CCCCCCEeEEEEECCeeE
Confidence 4679999999999999999999999999999997542 34678999998885 889999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+|||++.++|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..
T Consensus 160 lv~e~~~~~L~~~l~~~~~------l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~~ 231 (391)
T PHA03212 160 LILPRYKTDLYCYLAAKRN------IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAACF 231 (391)
T ss_pred EEEecCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCcccc
Confidence 9999999988887754322 788999999999999999999999999999999999985 78899999999865
Q ss_pred ccc----ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------cHHHHHHHHHHhhCCCCH
Q 005415 573 QTD----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-------AVVMILARIIGMLGPIDL 641 (697)
Q Consensus 573 ~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~-------~~~e~l~~I~~~lg~~p~ 641 (697)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||... ....++..|+..+|.+|.
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 322 223357899999999999999999999999999999999999887543 245677888888887765
Q ss_pred HHHhhcc-ccc------------c-----cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQ-EIY------------K-----YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~-~~~------------~-----~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
++..... ... . .|.....+..-+.+...+++...|..|.|+++++ +|+...
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 4321110 000 0 0000011112234445556666688899999999 999764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=317.17 Aligned_cols=263 Identities=30% Similarity=0.491 Sum_probs=211.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ........+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC------CCCccccceeeccc
Confidence 458999999999999999999999999999999998753 233455677888887764 78999999988643
Q ss_pred ------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
...|+||||+++++...+.. .++...+..++.|++.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 165 (364)
T cd07875 96 KSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 165 (364)
T ss_pred ccccccCeEEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcE
Confidence 35799999999988876642 1778889999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 563 KL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++++.++.+.
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999999765443 2345789999999999999999999999999999999999999999999999999999999888
Q ss_pred HHHHhhccccc-ccccC--------------------Cc----hhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 641 LEMLMQGQEIY-KYFTK--------------------EY----DLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 641 ~e~~~~~~~~~-~~~~~--------------------~~----~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
++++....... .+... .. ......++...+++...|..|.|+++++ +|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 77655422110 00000 00 0012234555666666688899999999 8986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.60 Aligned_cols=259 Identities=30% Similarity=0.424 Sum_probs=220.5
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
..-+...|++.+.||+|.||.||+++.+.+|+.+|+|++.+... ......+|+.||+.+.. |||||.+++.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEEE
Confidence 34556789999999999999999999999999999999976432 34678899999999974 8999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc--ce
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CE 561 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~--~~ 561 (697)
|++...+++|||++. |.|.+.+... .+++..+..+++|++.|+.|||+.||+||||||+|+|+..... +.
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCc
Confidence 999999999999998 4566666544 2899999999999999999999999999999999999986443 58
Q ss_pred EEEeeCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+|++|||++..... .....+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+......+|...--.+
T Consensus 178 ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred EEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 99999999988766 4566899999999999999999999999999999999999999999999888888776543333
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+.+. | ........+-...++..-+..|+|+++++ ||+.+.
T Consensus 258 ~~~~----------w---~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 258 TSEP----------W---DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCC----------c---cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 3222 2 24455666666777777788899999999 999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.83 Aligned_cols=256 Identities=23% Similarity=0.242 Sum_probs=196.6
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++...+..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN------SRFVVSLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC------CCcEEEEEEEEccCCeE
Confidence 788999999999999999999999999999987532 22234567888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|...+..... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ++.++|+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeCCCc
Confidence 999999985 45444432211 23889999999999999999999999999999999999985 788999999998
Q ss_pred cccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..........
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 223 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE------ 223 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc------
Confidence 764332 234578999999999999999999999999999999999999998765433333332222111110
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQNK 696 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n~ 696 (697)
... .-...+..++..||... |.+|++ +++++ +|+.+.++++
T Consensus 224 -~~~--~~s~~~~~li~~~l~~~----P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 224 -YSE--KFSEDAKSICRMLLTKN----PKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred -CCc--cCCHHHHHHHHHHhhcC----HHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 000 11235556666666655 566654 78888 9999887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.76 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=209.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---------------hhHhHHHHHHHHHHhcccCCCCCC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------------FFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---------------~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
..++|++++.||+|.||.|-+|++..+++.||||++.+.+. ..+...+||.||+++. ||
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~------H~ 168 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH------HP 168 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC------Cc
Confidence 34789999999999999999999999999999999975321 2357788999999986 78
Q ss_pred ceeEEEEEEEec--CeEEEEEEccccchHHHHHhhhccCCCcc-cCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 477 HILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAY-FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 477 nIv~l~~~f~~~--~~l~LVmEyl~gsL~~~l~~~~~~~~~~~-ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
|||+|+.+..+. +.+|||+|||..+-... ...+.+ +++.+++.++++++.||.|||.+|||||||||+|+|
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w------~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKW------CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLL 242 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCcccc------CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 999999999865 67999999998543221 222333 889999999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCccccc--------cccccccccCCCCCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 554 IKSYQRCEIKIIDLGSSCFQT--------DNLCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~--------~~~~~~~gt~~Y~APE~l~~~~----~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
++. +|++||+|||.+.... ......+|||.|+|||...+.. .+.+.|||||||+||.|+.|+.||-
T Consensus 243 l~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 243 LSS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred EcC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 996 7999999999987541 1233468999999999997732 4568999999999999999999999
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
++...+...+|+..--.+| ..+++.+..++....++.+-|..|.++.++. +|...
T Consensus 321 ~~~~~~l~~KIvn~pL~fP---------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFP---------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred cchHHHHHHHHhcCcccCC---------------CcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 9999999999976332222 2346778888899999999999999999888 99874
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=320.81 Aligned_cols=206 Identities=25% Similarity=0.381 Sum_probs=175.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|+++++||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++.+.....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~------h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC------CCcCCeEEEEEEeCCE
Confidence 6899999999999999999999999999999997532 23456677888888764 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFGl 147 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFGL 147 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECCC
Confidence 9999999975 5666664322 2788899999999999999999999999999999999985 88999999998
Q ss_pred cccccc--------------------------------------------------ccccccccCCCCCchhhcCCCCCc
Q 005415 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (697)
Q Consensus 570 a~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ 599 (697)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 642110 011246899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 600 ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
++|||||||++|||++|++||.+.+..+...++..
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99999999999999999999999888777766654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.60 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=205.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.++..++ ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD------SPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC------CCCccchhhheecCC
Confidence 47999999999999999999999999999999997532 33345677888887775 889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg 146 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFG 146 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCC
Confidence 9999999996 56777665431 2889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc--------------------------------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 005415 569 SSCFQTDNL--------------------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (697)
Q Consensus 569 la~~~~~~~--------------------------------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG 616 (697)
++....... ....|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 987544322 235689999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-HHHHH--HhhcccC
Q 005415 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-LEYAA--LWLFGID 693 (697)
Q Consensus 617 ~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-~e~~~--~wl~~~~ 693 (697)
+.||.+.+..+...++......... .........+..++..|+. .+..|.+ +++++ +|+...+
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~~---------p~~~~~~~~~~~li~~ll~-----dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLRF---------PPDPPVSPEAIDLICRLLC-----DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcccC---------CCCCCCCHHHHHHHHHHcc-----ChhhcCCCHHHHhcCCCcCCCC
Confidence 9999998887777777652221111 0111123455566666653 5888999 99999 9998776
Q ss_pred CC
Q 005415 694 QN 695 (697)
Q Consensus 694 ~n 695 (697)
++
T Consensus 293 ~~ 294 (350)
T cd05573 293 WE 294 (350)
T ss_pred HH
Confidence 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=318.48 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=210.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (697)
.|++.+.||+|+||.||++.+..+++.||||.+... .....++.+|+.+++.++ |+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK------HDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC------CCCcCCHhheecCCCcc
Confidence 378899999999999999999999999999998642 223456778888888775 789999999998776
Q ss_pred ---eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 490 ---~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..++||||+.++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~D 146 (372)
T cd07853 75 PFEEIYVVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICD 146 (372)
T ss_pred ccceEEEEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEecc
Confidence 799999999988887765332 2889999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc----cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 567 FGla~~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||++...... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..|.+.+|.++.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9998754322 2234678899999999875 4789999999999999999999999999999999999999998888
Q ss_pred HHHhhccc-ccc--------------cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 642 EMLMQGQE-IYK--------------YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 642 e~~~~~~~-~~~--------------~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+.+..... ... .+...........+...+++...|..|.|+++++ +|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 76543211 000 0011111122333444555556688999999999 99876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=320.45 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=196.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD------NEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC------CCCcceEEEEEEcCC
Confidence 36999999999999999999999999999999997532 23345677888888774 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG 146 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCC
Confidence 9999999997 56777765332 2788899999999999999999999999999999999985 7889999999
Q ss_pred Ccccccc----------------------------------------------ccccccccCCCCCchhhcCCCCCchhh
Q 005415 569 SSCFQTD----------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQKID 602 (697)
Q Consensus 569 la~~~~~----------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksD 602 (697)
++..... .....+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 8742110 001246899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc--
Q 005415 603 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-- 680 (697)
Q Consensus 603 IWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-- 680 (697)
||||||++|+|++|+.||.+.+..+...++.......+. .....+.....+....+ ...|..|.
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------~~~~~~s~~~~~li~~l-~~~p~~R~~~ 292 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI-------------PSQAKLSREASDLILRL-CCGAEDRLGK 292 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccC-------------CCCCCCCHHHHHHHHHH-hcCHhhcCCC
Confidence 999999999999999999988877766665432211110 00011111122222222 24688898
Q ss_pred -CHHHHH--HhhcccCC
Q 005415 681 -TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 681 -t~e~~~--~wl~~~~~ 694 (697)
++++++ +|+.+++.
T Consensus 293 ~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 293 NGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCHHHHhCCCCcCCCCH
Confidence 889988 99987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=309.18 Aligned_cols=261 Identities=27% Similarity=0.364 Sum_probs=207.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..+.|++.+.||.|..++||+|+.+.+++.||||++..++ ...+.+.+|+..+..+ +||||++++-.|..+.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~------~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI------DHPNIVTYHCSFVVDS 97 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc------CCCCcceEEEEEEecc
Confidence 3568999999999999999999999999999999998543 2356777777777766 4899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||+||. |+++++++..-..+ +.+..+..|++++++||.|||.+|.||||||+.||||+. +|.|||+|||
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~--dG~VkLadFg 171 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS--DGTVKLADFG 171 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC--CCcEEEcCce
Confidence 9999999997 67888877655444 999999999999999999999999999999999999995 9999999999
Q ss_pred Cccccccc-------cccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 569 SSCFQTDN-------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 569 la~~~~~~-------~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
.+...... ..+++|++.|||||++.. .+|+.|+||||||++..||.+|..||....+..++..- .-+.|
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~p 249 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDP 249 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCC
Confidence 76432211 145789999999999654 36999999999999999999999999988887766443 34444
Q ss_pred CHHH-HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 640 DLEM-LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 640 p~e~-~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
|... ........+-|.+ .+++....|..+ -|..|.|++.++ +|++..
T Consensus 250 p~~~t~~~~~d~~k~~~k--sf~e~i~~CL~k----DP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSK--SFREMIALCLVK----DPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CCcccccCChHHhhhhcH--HHHHHHHHHhhc----CcccCCCHHHHhccHHHhhc
Confidence 4222 1111122222222 555666666554 489999999999 887743
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.49 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=193.8
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..+++.||||+++... .......+|+.+++.++ ||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR------HPFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC------CCCCCCEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999998532 23345667888877764 889999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccc
Confidence 99985 5555554322 2889999999999999999999999999999999999985 7889999999986532
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|.
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 216 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---------- 216 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 2233467899999999999999999999999999999999999999988777766665432222221
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n 695 (697)
.....+..++..||. ..|..|+ ++++++ +|+...++.
T Consensus 217 ---~~~~~~~~li~~~L~----~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 217 ---TLSPEAKSLLAGLLK----KDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ---CCCHHHHHHHHHHcc----CCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 112344455555554 4577777 788888 898776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.77 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=194.5
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.+...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD------NEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC------CCCeeeeEEEEecCCE
Confidence 5899999999999999999999999999999997532 33456677888888764 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl 147 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGL 147 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcC
Confidence 9999999975 6666665332 2788899999999999999999999999999999999985 78999999998
Q ss_pred cccccc--------------------------------------------------ccccccccCCCCCchhhcCCCCCc
Q 005415 570 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 599 (697)
Q Consensus 570 a~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ 599 (697)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 743210 011346899999999999989999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhc
Q 005415 600 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIR 679 (697)
Q Consensus 600 ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r 679 (697)
++|||||||++|||++|..||...+..+....++.....+.. ............++..... ....+..|
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~s~~~~dli~~ll~--~~~~~~~R 296 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI---------PPQVKLSPEAVDLITKLCC--SAEERLGR 296 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC---------CCCCCCCHHHHHHHHHHcc--CcccccCC
Confidence 999999999999999999999988777666666532221110 0000111223333322110 12234458
Q ss_pred cCHHHHH--HhhcccCC
Q 005415 680 LTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 680 ~t~e~~~--~wl~~~~~ 694 (697)
.++++++ +|+.+.++
T Consensus 297 ~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 297 NGADDIKAHPFFSEVDF 313 (381)
T ss_pred CCHHHHhcCcccCCCCh
Confidence 8999998 88876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.31 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=196.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|++++.||+|+||.||+|++..+++.||||+++... ........|+.++..+.+ |++|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC-----CCceeeeEEEEEcCCE
Confidence 4899999999999999999999999999999997532 234556677777777653 4579999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+|+||||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCc
Confidence 9999999975 5655554322 2788999999999999999999999999999999999985 78899999999
Q ss_pred cccc---ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......|.
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----- 222 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----- 222 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 8642 22233457899999999999999999999999999999999999999998888888777654332221
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCH-----HHHH--HhhcccCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL-----EYAA--LWLFGIDQ 694 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~-----e~~~--~wl~~~~~ 694 (697)
.-...+..++..||... |..|.+. ++++ +|+...++
T Consensus 223 --------~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 223 --------SLSKEAVSICKGLLTKH----PAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred --------CCCHHHHHHHHHHhhcC----HHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11224445555555544 5666543 5555 77766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.27 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=196.6
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|++++..++. .+||||+++++++......
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~---l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS---ERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc---cCCCChhceeeEEEcCCEE
Confidence 788999999999999999999999999999997532 233456677777766543 4699999999999999999
Q ss_pred EEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
|+||||+.++ |...+. . ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~lv~E~~~~~~L~~~~~-~------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~ 148 (324)
T cd05589 78 CFVMEYAAGGDLMMHIH-T------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLC 148 (324)
T ss_pred EEEEcCCCCCcHHHHhh-c------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCC
Confidence 9999999865 433332 1 12899999999999999999999999999999999999985 789999999988
Q ss_pred cccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......|.
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~------ 222 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR------ 222 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 6432 2233467899999999999999999999999999999999999999998888777776553322221
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
.....+..++..||... |..|+ ++++++ +|+...+
T Consensus 223 -------~~~~~~~~li~~~L~~d----P~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 223 -------FLSREAISIMRRLLRRN----PERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -------CCCHHHHHHHHHHhhcC----HhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 11234555666665544 66665 577777 7776543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.92 Aligned_cols=266 Identities=29% Similarity=0.492 Sum_probs=213.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
.++|++++.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK------HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC------CCchhhhhhhhcccc
Confidence 478999999999999999999999999999999987532 22345667888888774 78999999988643
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...+++|++++++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~k 158 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELR 158 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCEE
Confidence 457999999988887766421 2889999999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 564 L~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
|+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.++.+..+.++.+
T Consensus 159 l~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 159 ILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred EcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999877666666788999999999977 468899999999999999999999999999999999999988888877
Q ss_pred HHhhccc--ccccccCC------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQE--IYKYFTKE------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~--~~~~~~~~------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
....... ..++.... ........+...+.+...|..|.|+++++ +|+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 6543211 11111100 01122334555566666788899999999 9998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.25 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=195.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~~ 115 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFCAFQDD 115 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEcC
Confidence 468999999999999999999999999999999997422 2233456777777765 488999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+. ++|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~--~~~~kL~DF 186 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK--HGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEEec
Confidence 99999999997 5676666422 1788899999999999999999999999999999999985 789999999
Q ss_pred CCccccccc----cccccccCCCCCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 568 Gla~~~~~~----~~~~~gt~~Y~APE~l~~~~----~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+.+|+.....+
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 998765432 12457899999999997643 7889999999999999999999999988888877776533322
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
... ....-......++..+.. -......|.++++++ +|+....
T Consensus 267 ~~p---------~~~~~s~~~~~li~~~L~--~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 267 NFP---------EDVEISKHAKNLICAFLT--DREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCC---------CcccCCHHHHHHHHHHcc--CchhccCCCCHHHHhcCcccCCCC
Confidence 110 000011122233322221 012223488999998 9987643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.47 Aligned_cols=209 Identities=26% Similarity=0.381 Sum_probs=175.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|++.+.||+|+||.||+|++..+++.||||++++.. ........|..++..+. .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEecCCE
Confidence 4889999999999999999999999999999998542 22234455666665543 47899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCC
Confidence 9999999974 5665554322 2888999999999999999999999999999999999985 78899999999
Q ss_pred ccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 570 a~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
+.... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 86532 22334578999999999999999999999999999999999999999988888888776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=300.28 Aligned_cols=266 Identities=25% Similarity=0.361 Sum_probs=212.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|+||.||+|.+..+++.||+|.++... .......+|+.+++.++ ||||+++++++......
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC------CCCcceEEEEEecCCeE
Confidence 57999999999999999999999999999999987432 22345677888888874 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++|.+++..... .+++..++.++.||+.||.|||+++|+|+||||+||+++. ++.++|+|||++.
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 152 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (301)
T ss_pred EEEEeccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchh
Confidence 99999999988887754322 2788999999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 54322 2234568899999998764 4788999999999999999999999999999999999888888777665432
Q ss_pred cccccccc-------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 648 QEIYKYFT-------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~-------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....+.. ....+.....+...+++...|.+|.|+++++ +|+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111100 0112333445566666667788899999999 888643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=312.12 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=200.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||+||+|.+..+++.||||+++.... ....+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS------NSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceeeEEecCC
Confidence 369999999999999999999999999999999985432 334556677777655 4889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~--~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC--CCCEEeccCC
Confidence 9999999996 567666654322 2889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~------~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
++....... ....+++.|+|||++. +..++.++|||||||++|+|++|..||...+....+.++......
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc
Confidence 987654321 2246899999999987 456788999999999999999999999988887777776543211
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
.. ......-...+..++..++ . .+..|.+.++++ +|+...+++.
T Consensus 228 ~~---------~~~~~~~~~~~~~li~~ll----~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 228 LK---------FPEDPKVSSDFLDLIQSLL----C-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred cC---------CCCCCCCCHHHHHHHHHHc----c-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 10 0000111223444444443 3 588999999999 9998766543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.42 Aligned_cols=273 Identities=30% Similarity=0.489 Sum_probs=219.2
Q ss_pred CcceeeCc---eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005415 403 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 403 ~~pv~~~~---~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
++|+.+++ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ........+|+.+++.++ ||
T Consensus 2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ 75 (353)
T cd07850 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN------HK 75 (353)
T ss_pred ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC------CC
Confidence 56777777 4578999999999999999999999999999999998642 223345667888888774 78
Q ss_pred ceeEEEEEEEec------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 477 HILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 477 nIv~l~~~f~~~------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
||++++++|... ...++||||+.++|.+.+... ++...+..++.||+.||.|||++||+||||||+
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 147 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 999999998644 357999999999888776421 778889999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCcccccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
||+++. ++.+||+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....
T Consensus 148 Nil~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 148 NIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred HEEECC--CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999985 7889999999997654432 234578899999999999999999999999999999999999999998899
Q ss_pred HHHHHHhhCCCCHHHHhhcccccc-cccC-------------------------CchhhhhHHHHHHHHHHHhhhhccCH
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYK-YFTK-------------------------EYDLYYINEVCFANIFISLVVIRLTL 682 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~-~~~~-------------------------~~~l~~i~~~cw~~l~~~~~~~r~t~ 682 (697)
+..++..++.++.++......... +... .........++....+...|..|.|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 305 (353)
T cd07850 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305 (353)
T ss_pred HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH
Confidence 999999999988876554221111 0000 00112234566677777779999999
Q ss_pred HHHH--Hhhcc
Q 005415 683 EYAA--LWLFG 691 (697)
Q Consensus 683 e~~~--~wl~~ 691 (697)
++++ +|+..
T Consensus 306 ~eiL~~~~~~~ 316 (353)
T cd07850 306 DDALQHPYINV 316 (353)
T ss_pred HHHhcChhHhh
Confidence 9999 87764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=289.31 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=211.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.-.++|.+.+.||+|.||.||+|+.+.++..||+|++-++.- ...++.+|++|.. ..+||||+++|++|.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs------~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQS------HLRHPNILRLYGYFH 92 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeec------ccCCccHHhhhhhee
Confidence 334789999999999999999999999999999999976431 2234444554444 446899999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
+...+|+++||.. |.++..+...+.. .+++.....+++|++.||.|+|.++|+||||||+|+|++. .+.+||+
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiA 166 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIA 166 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeecc
Confidence 9999999999997 6777777633322 2888899999999999999999999999999999999996 8899999
Q ss_pred eCCCcccc-ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 566 DLGSSCFQ-TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 566 DFGla~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|||-+... .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+++|.+.--.+|.
T Consensus 167 dfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--- 243 (281)
T KOG0580|consen 167 DFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--- 243 (281)
T ss_pred CCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc---
Confidence 99988765 34466789999999999999999999999999999999999999999999999999999776554442
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+..-..+....++...+..|++..+.+ +|+..
T Consensus 244 --------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 244 --------------TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 2333445566777888899999999999 89864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=298.72 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=216.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.+.|++.+.||+|.|+.|+++.+..+|+.+|+|++.. .....+.+.+|++|-+.|+ ||||++|.+.+.+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq------HP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC------CCcEeehhhhhcc
Confidence 456789999999999999999999999999999999863 2335678889999999886 8899999999999
Q ss_pred cCeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc-ceEEEe
Q 005415 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKII 565 (697)
Q Consensus 488 ~~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~-~~vKL~ 565 (697)
....|||+|++.|+ |..-+-.. ..+++..+...++||++||.|+|.+||||||+||.|+|+.+..+ .-+||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cceeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeec
Confidence 99999999999875 33333322 22888899999999999999999999999999999999976433 368999
Q ss_pred eCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 566 DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|||++...... ...++|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...++.+|++..-..|...
T Consensus 156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred ccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 99999776643 3457899999999999999999999999999999999999999999999999999987655444422
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
| ....+-.++....++..-|.+|.|+.+++ +||...++
T Consensus 236 w-------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 236 W-------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred c-------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 2 13444556666777777899999999999 99986553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=319.10 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=203.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.+|...++||+|+.|.||.|....+++.||||.+...... .+-+++|+.+++..+ |+|||++++.|...+.+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~------H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH------HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc------chHHHHHHHHhcccceeE
Confidence 5688899999999999999999999999999999865433 356779999999886 789999999999999999
Q ss_pred EEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+|||||+|+ |.+.+.... +++.++..|+++++.||.|||.+||+|||||.+|||++. ++.+||+|||+|.
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFca 417 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCA 417 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeee
Confidence 999999865 445444222 889999999999999999999999999999999999996 7889999999987
Q ss_pred cccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
.... ...+.+|||+|||||++..+.|++++||||||++++||+-|++||-..++...+..|... |+|.......
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~k-- 494 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEK-- 494 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccc--
Confidence 6543 356689999999999999999999999999999999999999999999888888887543 3333322111
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
--..++.++..| +...+..|.++.+++ +.|+.
T Consensus 495 -------lS~~~kdFL~~c----L~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 495 -------LSPELKDFLDRC----LVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -------cCHHHHHHHHHH----hhcchhcCCCHHHHhcChhhhh
Confidence 112333343344 344477788888888 66643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.46 Aligned_cols=207 Identities=23% Similarity=0.398 Sum_probs=176.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.|++++.||+|+||.||+|.+..+++.||||+++.. ......+..|+.++..+ +||+|+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA------DGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 3689999999999999999999999999999999753 22344566788777766 3789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+.+ +|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG 146 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFG 146 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999975 6666665332 2889999999999999999999999999999999999985 7899999999
Q ss_pred Cccccccc--------------------------------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHH
Q 005415 569 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610 (697)
Q Consensus 569 la~~~~~~--------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL 610 (697)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 87543211 1124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 611 AELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 611 ~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
|||++|.+||.+.+....+.++..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~ 250 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMN 250 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHc
Confidence 999999999999888877777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.49 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=224.0
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..-|.+-|.+.+.||+|-|+.|-+|++.-+|+.||||++.+.+ ....++.+|++.++.++ |||||+||.+.
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ------HpNiVRLYEVi 86 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ------HPNIVRLYEVI 86 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc------CcCeeeeeehh
Confidence 4456788999999999999999999999999999999998643 34467788898888876 88999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
..+..+|||+|+-. |+|.+++...... +.+..++.++.||+.|+.|+|+..+|||||||+||.+-. +-|.+||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKL 160 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKL 160 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEe
Confidence 99999999999987 5899998765432 899999999999999999999999999999999999875 6789999
Q ss_pred eeCCCcccc--ccccccccccCCCCCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 565 IDLGSSCFQ--TDNLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 565 ~DFGla~~~--~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|||++... +....+.+|+..|-|||+++|..|+ +++||||||||||.|++|++||+..++.+.+.+|+.+.-..|.
T Consensus 161 TDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred eeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch
Confidence 999998654 4557788999999999999999887 4799999999999999999999999999999999888777776
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
.....+ ++..+.++...|-.|.+.|++. +||+..++.
T Consensus 241 hvS~eC-----------------rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 241 HVSKEC-----------------RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhHHH-----------------HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 554322 3455677888899999999999 999988764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.38 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=196.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------h~~iv~~~~~~~~~ 115 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN------SEWIVQLHYAFQDD 115 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCcceEEEEEecC
Confidence 468999999999999999999999999999999997532 22234567888877764 88999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC--CCCEEEEec
Confidence 999999999975 566655421 1788889999999999999999999999999999999985 889999999
Q ss_pred CCccccccc----cccccccCCCCCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 568 Gla~~~~~~----~~~~~gt~~Y~APE~l~~~----~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|++...... .....|++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+.+|+.....+
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 998765432 2235789999999999754 37889999999999999999999999988877777775432211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhh--ccCHHHHH--HhhcccCCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVI--RLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~--r~t~e~~~--~wl~~~~~n 695 (697)
.. +........+..++..+. ...+.. |.++++++ +|+...+++
T Consensus 267 ~~---------~~~~~~s~~~~~li~~~L----~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 267 TF---------PDDIEISKQAKDLICAFL----TDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CC---------CCcCCCCHHHHHHHHHHc----cChhhccCCCCHHHHhcCcccCCCChh
Confidence 10 000011223333333333 323433 88999998 998876544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.48 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=212.0
Q ss_pred CceecCceEEEEEeccCCCCceEEEEEC--CCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..++..+|++++.||.|+||.||+|... .+++.||+|.+.... ...+|+.+++.++ ||||+++++++.
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~------h~~iv~~~~~~~ 156 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTIS------HRAIINLIHAYR 156 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcC------CCCccceeeeEe
Confidence 3445678999999999999999999754 456889999887542 3457999998875 789999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.....++|||++.++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. .+.++|+|
T Consensus 157 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~--~~~~~l~D 228 (392)
T PHA03207 157 WKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE--PENAVLGD 228 (392)
T ss_pred eCCEEEEEehhcCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcc
Confidence 999999999999999888774222 2889999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---~~e~l~~I~~~lg~ 638 (697)
||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..|++.++.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 99986544321 23568999999999999999999999999999999999999997653 45677778887776
Q ss_pred CCHHHHhhcc--------ccccc----ccC-----CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCCC
Q 005415 639 IDLEMLMQGQ--------EIYKY----FTK-----EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 639 ~p~e~~~~~~--------~~~~~----~~~-----~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~~ 697 (697)
.+.++..... ..... +.. ...+..-..+.+.+.+...|..|.++++++ +|+...++|++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 6654322110 00000 000 011112234445666677788999999999 99998888764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.55 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=193.8
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|++..+++.||||+++... ........|.+++..+. +||||+++++++.....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEE
Confidence 36899999999999999999999999997532 23345566777776653 4899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceecc
Confidence 99985 5555554322 2788999999999999999999999999999999999985 7899999999986532
Q ss_pred c---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~---------- 217 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV---------- 217 (321)
T ss_pred cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 1 233456899999999999989999999999999999999999999999888888777543222111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhcc-------CHHHHH--HhhcccCCC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRL-------TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-------t~e~~~--~wl~~~~~n 695 (697)
.....+..++..|+. ..|..|+ ++++++ +|+...+++
T Consensus 218 ---~~~~~~~~ll~~~L~----~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 218 ---WLSKEAVSILKAFMT----KNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred ---CCCHHHHHHHHHHhc----cCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 012234444444444 4577777 888888 898776554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.99 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=192.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|+++.+++.||||+++... ........|+.++..+. +||||+++++++.....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999997532 23345566777776553 4899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecC
Confidence 99985 5655554322 2889999999999999999999999999999999999985 7889999999986532
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 217 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT---------- 217 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----------
Confidence 2233457899999999999989999999999999999999999999998888877777543222211
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCH------HHHH--HhhcccCC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTL------EYAA--LWLFGIDQ 694 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~------e~~~--~wl~~~~~ 694 (697)
.....+..++..|+. ..|..|++. ++++ +|+...++
T Consensus 218 ---~~~~~~~~li~~~L~----~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 218 ---WLSQDAVDILKAFMT----KNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ---CCCHHHHHHHHHHcc----cCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 012234445555544 457778876 7777 89876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=303.93 Aligned_cols=240 Identities=26% Similarity=0.368 Sum_probs=189.9
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||+|+||.||+|.+..+++.||+|+++.. ........+|+.+++.++ ||||+++++++...+..++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN------CPFIVPLKFSFQSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCcEeceeeEEecCCeEEEEEcC
Confidence 79999999999999999999999999753 233455667888887764 88999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc-
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~- 575 (697)
+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 75 INGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccC
Confidence 975 5666665322 2889999999999999999999999999999999999985 78899999999875322
Q ss_pred --ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccc
Q 005415 576 --NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (697)
Q Consensus 576 --~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~ 653 (697)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+|
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------------- 213 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP------------- 213 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC-------------
Confidence 22345789999999999999999999999999999999999999998888777766644221111
Q ss_pred ccCCchhhhhHHHHHHHHHHHhhhhcc---CHHHHH--Hhhccc
Q 005415 654 FTKEYDLYYINEVCFANIFISLVVIRL---TLEYAA--LWLFGI 692 (697)
Q Consensus 654 ~~~~~~l~~i~~~cw~~l~~~~~~~r~---t~e~~~--~wl~~~ 692 (697)
..+...+.+...+.+...|..|+ ++++++ +|+...
T Consensus 214 ----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 214 ----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 11222333444444555678886 466766 888754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.95 Aligned_cols=203 Identities=29% Similarity=0.399 Sum_probs=174.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..++|++++.||+|+||.||++++..++..||+|++... ......+.+|+++++.++ ||||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 357899999999999999999999999999999998753 234467888999888874 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.+++||||+.+ +|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Df 148 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDF 148 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccC
Confidence 99999999985 6666665332 278899999999999999999986 6999999999999985 788999999
Q ss_pred CCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 568 Gla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 149 g~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998654332 3345789999999999998999999999999999999999999987766543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.35 Aligned_cols=243 Identities=25% Similarity=0.334 Sum_probs=189.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||++.+..+++.||+|++.... .......+|+.+++.+ +||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT------RHPFLTSLKYSFQTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997532 2334566777777766 4889999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 Ey~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 75 EYVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (328)
T ss_pred eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCC
Confidence 99985 4544443222 2889999999999999999999999999999999999985 7889999999986532
Q ss_pred c---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|.
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 216 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR---------- 216 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----------
Confidence 2 223457899999999999989999999999999999999999999888777666655332212211
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
.....+..++..| +...|..|+ ++++++ +|+...+
T Consensus 217 ---~~~~~~~~li~~~----L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 217 ---TLSADAKSLLSGL----LIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred ---CCCHHHHHHHHHH----cCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1122344444444 445567776 788888 8876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.33 Aligned_cols=264 Identities=25% Similarity=0.363 Sum_probs=200.9
Q ss_pred EEEeccCCCCceEEEEEC--CCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cCeEEEE
Q 005415 419 TEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIV 494 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--~~~l~LV 494 (697)
.++||+|+||.||+|+++ .+++.||+|.+..... .....+|+.+++.++ ||||+++++++.. ....++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcC------CCCCcceeeeEecCCCcEEEEE
Confidence 357999999999999965 4678999999875432 245678999998875 8899999999864 4578999
Q ss_pred EEccccchHHHHHhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc--cCcceEEEeeCCC
Q 005415 495 CELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGS 569 (697)
Q Consensus 495 mEyl~gsL~~~l~~~~~~~---~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~vKL~DFGl 569 (697)
|||+++++..++....... ....+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9999999888776433211 1224889999999999999999999999999999999999953 2367899999999
Q ss_pred ccccccc------cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---------HHHHHHHH
Q 005415 570 SCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARII 633 (697)
Q Consensus 570 a~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~---------~e~l~~I~ 633 (697)
+...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+... ...+.++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 9765432 2235678999999999874 589999999999999999999999975432 46778888
Q ss_pred HhhCCCCHHHHhhcccccccc-----------cCCc----------hhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 634 GMLGPIDLEMLMQGQEIYKYF-----------TKEY----------DLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~-----------~~~~----------~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..+|.++...+.......... .... ....-..+...+++...|..|.|+++++ +|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 888887776655432221110 0000 0011234556677777899999999999 885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.02 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=190.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||++++..+|+.||+|+++... .......+|+.+++.++ ||||++++++|.....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC------CCCCcceeeEEecCCEEEEEE
Confidence 36899999999999999999999999997532 23345567777777764 789999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 75 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 75 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhcccc
Confidence 99985 4544443222 2889999999999999999999999999999999999985 7889999999886532
Q ss_pred c---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+|.
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 216 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------- 216 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----------
Confidence 2 223356899999999999999999999999999999999999999988877776666432222221
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
.....+..++..||.. .|..|+ ++++++ +|+...+
T Consensus 217 ---~~~~~~~~li~~~L~~----dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 217 ---TLSPEAKSLLAGLLKK----DPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred ---CCCHHHHHHHHHHccC----CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1123455555555554 466665 777777 8877654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.76 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=174.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|++.+.||+|+||.||+|+++.+++.||||+++... ........|..++..+. +|++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCchhheeeEEecCCE
Confidence 3788999999999999999999999999999998532 22345566777776654 35789999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+|+||||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEecccc
Confidence 9999999975 5655554322 2889999999999999999999999999999999999995 78899999999
Q ss_pred cccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 570 SCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 570 a~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
+..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 865322 223356899999999999989999999999999999999999999998888777777653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=310.52 Aligned_cols=209 Identities=23% Similarity=0.376 Sum_probs=175.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +||||+++++.+...
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~~ 115 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQDD 115 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEcC
Confidence 478999999999999999999999999999999987422 2223455677777765 488999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+++ +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEeC
Confidence 999999999974 566665421 1788889999999999999999999999999999999985 789999999
Q ss_pred CCccccccc----cccccccCCCCCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 568 Gla~~~~~~----~~~~~gt~~Y~APE~l~~~~----~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
|++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+.+|+...
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 998765432 22457899999999997643 7889999999999999999999999988888887776543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=305.77 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=193.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.+++.+ +|+||+++++++....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG------DRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCceEEEEecCC
Confidence 47999999999999999999999999999999997522 2234456677777665 4789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
++++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK--NGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC--CCCEEEEECC
Confidence 9999999996 567777653221 2888999999999999999999999999999999999985 7889999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
++....... ....|++.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 986543321 22468999999999973 357889999999999999999999999888877777765432211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+... ........+..+++.+.. ....+..|.++++++ +|+.+.+
T Consensus 228 ~~~~--------~~~~~~~~~~~li~~ll~--~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 228 QFPP--------DVTDVSEEAKDLIRRLIC--SPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred cCCC--------ccCCCCHHHHHHHHHHcc--CcccccCCCCHHHHhcCCCCCCCC
Confidence 1000 000112233333333221 123334477899998 9987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.93 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=205.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++++.||.|++|.||+|.+..++..||||+++... .......+|+.+++.+. ||||+++++++..+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ------HPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC------CCCEeeeEEEEeeCCeE
Confidence 4899999999999999999999999999999986432 22356678888888875 88999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.+++.+++..... ...+++..++.++.||+.||.|||+++|+|+||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~ 149 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLAR 149 (285)
T ss_pred EEEEecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECccccee
Confidence 99999999888877754322 123889999999999999999999999999999999999985 7889999999986
Q ss_pred cccccc---ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~~---~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.+.++.+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 543321 223567889999998764 4788999999999999999999999999888888888887777665554432
Q ss_pred ccccccc----------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYF----------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~----------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+. .....+..++..||. ..|..|+|+++++ +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLI----YDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhc----CChhhCCCHHHHhcCCCC
Confidence 2211110 012233345555554 4588899999998 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=303.07 Aligned_cols=244 Identities=26% Similarity=0.358 Sum_probs=187.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..+++.||||+++... ........|..++..+ .+||||+++++++......++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999998542 2223344555555433 35899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECC
Confidence 99975 5655554322 2889999999999999999999999999999999999985 7889999999986532
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......|.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 217 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR---------- 217 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 2233457899999999999989999999999999999999999999998887777766443222111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHH-HHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLE-YAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e-~~~--~wl~~~~ 693 (697)
.....+..++..| +...|..|.++. +++ +|+...+
T Consensus 218 ---~~~~~~~~ll~~~----l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 218 ---WISKEAKDCLSKL----FERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred ---CCCHHHHHHHHHH----ccCCHHHcCCChHHHHcCcccCCCC
Confidence 0112333444444 445688888764 444 7776554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=303.77 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=190.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|+++.+++.||+|+++... ........|..++..+ .+||||+++++++...+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-----WENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCCccCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999998542 2233455566666543 25899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc-
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~- 573 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++...
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecc
Confidence 99985 5655554321 2788999999999999999999999999999999999985 788999999998642
Q ss_pred --ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 574 --~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......|
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------- 216 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----------- 216 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 2223446789999999999999999999999999999999999999998887776666543221111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCH-HHHH--HhhcccCC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTL-EYAA--LWLFGIDQ 694 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~-e~~~--~wl~~~~~ 694 (697)
.. ....+..++..|| ...|..|.++ +++. +|+...++
T Consensus 217 ~~--~~~~~~~li~~~l----~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 217 RW--ITKESKDILEKLF----ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred CC--CCHHHHHHHHHHc----cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 10 1224445555554 4558888887 4555 88876654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.80 Aligned_cols=253 Identities=26% Similarity=0.322 Sum_probs=194.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--e
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--H 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~--~ 490 (697)
.+|...+.||+|+||.||++.+..+|...|||.+.... ...+.+.+|+++|..++ |||||++++...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~------~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN------HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC------CCCEEeeCCccccccCee
Confidence 45888899999999999999999999999999987542 22466889999999986 789999999855444 6
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++|.|||+. |+|.+++..... .+++..++.+++||++||.|||++|||||||||+|||++. .++.+||+|||+
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~-~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP-SNGDVKLADFGL 164 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC-CCCeEEeccCcc
Confidence 999999998 577777765442 2899999999999999999999999999999999999995 257999999999
Q ss_pred cccccc------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCCCH
Q 005415 570 SCFQTD------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 570 a~~~~~------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~p~ 641 (697)
+..... ......||+.|||||++... ....++|||||||++.||+||.+||.. ....+.+.+|.... ..|
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P- 242 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP- 242 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-
Confidence 876552 13347899999999999953 334599999999999999999999987 34444343432211 111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.++.. -......++..| |...+..|.|+++++ +|+...+
T Consensus 243 -------~ip~~--ls~~a~~Fl~~C----~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 243 -------EIPDS--LSDEAKDFLRKC----FKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -------CCCcc--cCHHHHHHHHHH----hhcCcccCcCHHHHhhChhhhccc
Confidence 11111 112333444444 445588899999998 8886544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.18 Aligned_cols=250 Identities=33% Similarity=0.479 Sum_probs=197.0
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhH---hHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD---QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~---~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
|++++.||+|+||+||++.+..+++.||+|++........ ...+|+.+++.++ ||||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR------HPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT------BTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc------cccccccccccccccccc
Confidence 8999999999999999999999999999999987643322 2345888888884 789999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+|||++.+ +|.+++..... +++..+..++.||+.||.+||+++|+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~--~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKP------LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE--NGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSS------BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST--TSEEEESSGTTTE
T ss_pred cccccccccccccccccccc------ccccccccccccccccccccccccccccccccccccccc--ccccccccccccc
Confidence 99999997 78777762222 889999999999999999999999999999999999994 8889999999986
Q ss_pred cc---ccccccccccCCCCCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQ---TDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~---~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.. ........++..|+|||++. +..++.++||||||+++|+|++|..||......+....+.+.+...........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 42 23344467788999999998 788999999999999999999999999987544444444333322221111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+.. ...+++...|..|++++++. ||+
T Consensus 227 ------~~~~~~l~~----li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 ------REKSEELRD----LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------TTSHHHHHH----HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------chhHHHHHH----HHHHHccCChhHCcCHHHHhcCCCC
Confidence 000123334 44444556699999999999 886
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.81 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=192.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+. +||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999999999999999998542 23445667777777664 4899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecC
Confidence 99975 5555443321 2889999999999999999999999999999999999985 7889999999886422
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.......|.
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~---------- 217 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR---------- 217 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 2223356899999999999999999999999999999999999999988877777666442221111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCH-----HHHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTL-----EYAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~-----e~~~--~wl~~~~ 693 (697)
.....+..++..||. ..|..|.+. ++++ +|+...+
T Consensus 218 ---~~~~~~~~li~~~l~----~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 218 ---WLSKEAKSILKSFLT----KNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred ---cCCHHHHHHHHHHcc----CCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 112345555555554 457788887 7777 8887654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.90 Aligned_cols=262 Identities=29% Similarity=0.403 Sum_probs=205.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||.|+||.||+|.+..+|+.||+|.++... .....+.+|+.+++.++ ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC------CCCeeeHHHHhccCCce
Confidence 5899999999999999999999999999999987432 22345667888888874 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++|+||++++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~ 147 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLAR 147 (284)
T ss_pred EEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhh
Confidence 99999999988887654321 2889999999999999999999999999999999999995 7889999999987
Q ss_pred ccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~P-F~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....+++.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 54332 22345688899999987754 78999999999999999998777 577777888888888888777665543
Q ss_pred cccccccc-----cC-------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQEIYKYF-----TK-------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~~~~~~-----~~-------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+- .. ...+..-+.+...+.+...|.+|+|+++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 22211110 00 011222233444444445689999999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=303.96 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=191.3
Q ss_pred EEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 420 EYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+.||+|+||.||++++. .+++.||||+++... ........|+.+++.++ ||||+++++++......
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK------HPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC------CCchhceeeEEecCCeE
Confidence 67999999999999864 478999999997532 22345567888888774 88999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
|+||||+.+ +|.+.+.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCC
Confidence 999999985 5666554322 2778889999999999999999999999999999999985 789999999998
Q ss_pred ccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+.......|.
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~------ 221 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP------ 221 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence 64322 223356899999999999988999999999999999999999999988887777776543222221
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~ 694 (697)
.....+..++..||.. .|..|. ++++++ +|+....+
T Consensus 222 -------~~~~~~~~li~~~l~~----~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 222 -------YLTPEARDLLKKLLKR----NPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred -------CCCHHHHHHHHHHccc----CHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1123455565555554 466776 788887 88765443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=273.36 Aligned_cols=264 Identities=28% Similarity=0.397 Sum_probs=221.5
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|.-.++||+|.||+||+|++..+++.||+|.++.+. ......++||.+|++++ |.|||++++...+.+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk------hknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh------hcceeehhhhhccCcee
Confidence 4666789999999999999999999999999998543 33457889999999997 67999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
-+|+|||...|..+...... .+..+.++.++.|+++||.|+|++++.||||||.|+||+. +|.+||+|||+++
T Consensus 77 tlvfe~cdqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--NGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--CCcEEecccchhh
Confidence 99999999988887765432 2889999999999999999999999999999999999995 9999999999998
Q ss_pred ccccccc---cccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDNLC---LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~~~---~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..+.... ..+-|.+|++|.++.|.. |+...|+||.|||+.|+.. |++.|++.+..+++.+|...+|.|..+.|+.
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 8776543 346689999999998865 8999999999999999998 9999999999999999999999999988877
Q ss_pred ccccccc-----ccCCchhh-------hhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKY-----FTKEYDLY-------YINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~-----~~~~~~l~-------~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
....+.| +.....|. ..-++..++++.-.|..|.++|.++ ++...
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 6555544 11112222 2235666666666788899999988 65543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=303.86 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=188.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||++.+..+++.||+|++.... ........|+++++.+ +||||+++++++.....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~------~hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997532 2234455666666655 4889999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
||+.+ +|...+.... .+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 75 E~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~--~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEG 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC--CCCEEEecCCCCeec
Confidence 99985 4544443222 28899999999999999999997 79999999999999985 788999999998643
Q ss_pred c---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 574 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
. .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......+|.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--------- 217 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--------- 217 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC---------
Confidence 2 2223457899999999999999999999999999999999999999988777666665432222211
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
.-...+..++..||. ..|..|+ ++++++ +|+.+..
T Consensus 218 ----~~~~~~~~li~~~L~----~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 218 ----TLSPEAKSLLSGLLK----KDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred ----CCCHHHHHHHHHHhh----cCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 112344455555544 4577776 788887 8887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.20 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=188.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~i-L~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|+||+||+|.+..+++.||||++..... ....+..|..+ ++. .+||||+++++.+...+..++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~------l~hp~iv~~~~~~~~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN------VKHPFLVGLHYSFQTADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhh------CCCCCCCCeeEEEEeCCEEEEE
Confidence 369999999999999999999999999975321 12233333332 232 3589999999999999999999
Q ss_pred EEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 75 LDYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (323)
T ss_pred EcCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCccc
Confidence 999985 5555554322 2888999999999999999999999999999999999985 789999999998643
Q ss_pred c---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 574 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
. .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 217 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP--------- 217 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence 2 2223456899999999999999999999999999999999999999988887777776542111110
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.....+..++..|+......++..+...++++ +|+....+
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 218 ----NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred ----CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 11334555666666655555555555556777 88765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.53 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=188.4
Q ss_pred ceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+|++++.||+|+||.||++++. .+++.||+|++.... ........|+.+++.++ +||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-----QSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCcccEEEEEe
Confidence 4899999999999999999864 478999999997532 22345667888888775 3789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
....+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEe
Confidence 99999999999975 6666664322 2889999999999999999999999999999999999985 7899999
Q ss_pred eCCCcccccc----ccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHhh
Q 005415 566 DLGSSCFQTD----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARIIGML 636 (697)
Q Consensus 566 DFGla~~~~~----~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~----~e~l~~I~~~l 636 (697)
|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+....
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 227 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999865322 122357899999999998754 78899999999999999999999965322 22222222211
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
.+.+. .....+..++..||. ..|..|. ++++++ +|+...+
T Consensus 228 ~~~~~-------------~~~~~~~~li~~~l~----~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 228 PPFPS-------------FIGPEAQDLLHKLLR----KDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCCC-------------CCCHHHHHHHHHHcC----CCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 11110 012234445554544 4477777 778888 8987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.35 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=193.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
-.++|++.++||.|+||.||+|.+. .+++.||||+++... .....+.+|+.++..+. +||||++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~ 79 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLGA 79 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEeE
Confidence 3578999999999999999999752 345789999997532 33456788999998884 38999999998
Q ss_pred EEec-CeEEEEEEccc-cchHHHHHhhhccC-------------------------------------------------
Q 005415 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQESG------------------------------------------------- 513 (697)
Q Consensus 485 f~~~-~~l~LVmEyl~-gsL~~~l~~~~~~~------------------------------------------------- 513 (697)
+... ..+++||||+. ++|.+++.......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 46899999997 56777765422100
Q ss_pred -------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccc-----cccc
Q 005415 514 -------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYV 581 (697)
Q Consensus 514 -------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~ 581 (697)
....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCCC
Confidence 0123778889999999999999999999999999999999985 7889999999987543221 1233
Q ss_pred ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchh
Q 005415 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDL 660 (697)
Q Consensus 582 gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l 660 (697)
+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+.....+. ..-.....+
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l 306 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-----------APENATPEI 306 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-----------CCCCCCHHH
Confidence 4678999999999999999999999999999997 9999987654433333222111110 001233467
Q ss_pred hhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 661 YYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 661 ~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..++..||... |..|+++.++...|.
T Consensus 307 ~~li~~cl~~d----p~~RPs~~el~~~l~ 332 (338)
T cd05102 307 YRIMLACWQGD----PKERPTFSALVEILG 332 (338)
T ss_pred HHHHHHHccCC----hhhCcCHHHHHHHHH
Confidence 78888888765 777888888875544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=325.95 Aligned_cols=262 Identities=22% Similarity=0.267 Sum_probs=215.9
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..+-+..+.||+|+||+||+|+-. .....||||.++... ....++.+|+.++..++ |||||+|+|++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~------H~nIVrLlGVC 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ------HPNIVRLLGVC 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEE
Confidence 345677889999999999999753 245679999998643 35678999999999986 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCC--------CcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGG--------EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~--------~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
..++.+++|+|||. |+|.+++........ ..+++..+.+.|+.||+.||.||-++.+|||||..+|+||..
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 99999999999997 789999876443211 223888999999999999999999999999999999999995
Q ss_pred cCcceEEEeeCCCcccccccccccc-----ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNLCLYV-----QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~~~~~-----gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~ 630 (697)
...|||+|||+++..-......+ -+.+|||||.|....|+.++||||+||+|||+++ |..||.+.+.++++.
T Consensus 639 --~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 639 --NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred --ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 88999999999976443332222 2678999999999999999999999999999999 999999999999998
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcccCC
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGIDQ 694 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~~~ 694 (697)
.|.+ ++.....-+++..+|.+|..||......+|.......++..|....+.
T Consensus 717 ~i~~------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 717 CIRA------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHc------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 8854 233333346788999999999999866666666666666688776554
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.74 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=188.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|++..+++.||||+++... ........|..++..+ .+||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 2233445566666543 35899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECC
Confidence 99974 6666654322 2788899999999999999999999999999999999985 7889999999986432
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......|
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----------- 216 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----------- 216 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 223345789999999999998999999999999999999999999998887776666532211111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHH-HHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLE-YAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e-~~~--~wl~~~~ 693 (697)
.. ....+..++..|| ...|..|+++. ++. +|+...+
T Consensus 217 ~~--~~~~~~~li~~~l----~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 217 RW--LTREAKDILVKLF----VREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred cc--CCHHHHHHHHHHh----ccCHhhcCCChHHHHcCcccCCCC
Confidence 11 1223445555554 44578888885 555 7876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.86 Aligned_cols=209 Identities=22% Similarity=0.320 Sum_probs=173.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++..+ .|++|+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG------DCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 47999999999999999999999999999999997532 1223355666666554 4889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..|+||||+. ++|..++..... .+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM--NGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC--CCCEEEEecc
Confidence 9999999997 567776654222 2788999999999999999999999999999999999985 7889999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
++....... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 986554321 23468999999999876 45788999999999999999999999988887777776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.81 Aligned_cols=258 Identities=19% Similarity=0.256 Sum_probs=194.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|+++++||+|+||.||+++++.+++.||+|++.+.. .....+.+|+.++..+ +|++|+++++++....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG------DNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC------CCCCEeeEEEEEecCC
Confidence 36999999999999999999999999999999997422 1223345566666554 4889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~--~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEeecc
Confidence 9999999996 567777654322 2788899999999999999999999999999999999984 7889999999
Q ss_pred Cccccccc----cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 569 SSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 569 la~~~~~~----~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
++...... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+.+.++......+
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc
Confidence 98653221 12356899999999986 3457889999999999999999999999988888887775432221
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
+... ........+..++..+... ......|.++++++ +|+.+.++
T Consensus 228 ~~p~--------~~~~~s~~~~~li~~ll~~--~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 228 QFPA--------QVTDVSEDAKDLIRRLICS--REHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred cCCC--------ccccCCHHHHHHHHHHccC--hhhhcCCCCHHHHhCCCCcCCCCH
Confidence 1000 0001122333344333321 22334467888888 99887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.32 Aligned_cols=256 Identities=22% Similarity=0.214 Sum_probs=189.4
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||+|+||+||++.+..+++.||+|.+.... .....+..|+.+++.++ |+||+++++++......++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC------CCcEeeeeEEEcCCCeEEEEEeC
Confidence 799999999999999999999999987532 22345567888888774 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+.+ +|...+..... ....+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCC
Confidence 985 45444432211 1233889999999999999999999999999999999999985 788999999998654332
Q ss_pred ---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccc
Q 005415 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (697)
Q Consensus 577 ---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~ 653 (697)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+... .
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~-- 221 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY-------P-- 221 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC-------c--
Confidence 2235688999999999999999999999999999999999999986543222222221111111100 0
Q ss_pred ccCCchhhhhHHHHHHHHHHHhhhhcc-CHHHHH--HhhcccCCCC
Q 005415 654 FTKEYDLYYINEVCFANIFISLVVIRL-TLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 654 ~~~~~~l~~i~~~cw~~l~~~~~~~r~-t~e~~~--~wl~~~~~n~ 696 (697)
-.....+..++..||......++..+. ++++++ +|+++.++.+
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 012235566666666554333333222 888888 9998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=293.75 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=198.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPA 473 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~----------------~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~ 473 (697)
..++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.++..++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----- 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK----- 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-----
Confidence 35789999999999999999997532 3457999998763 333456778888888774
Q ss_pred CCCceeEEEEEEEecCeEEEEEEccc-cchHHHHHhhhccC-------------CCcccCHHHHHHHHHHHHHHHHHHHh
Q 005415 474 DEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-------------GEAYFTLGRLQVITRQCLEALEYLHS 539 (697)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-------------~~~~ls~~~i~~i~~qIa~aL~yLHs 539 (697)
||||+++++++...+..++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+
T Consensus 78 -h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 78 -DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred -CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999997 46777665432111 11236788899999999999999999
Q ss_pred cCccccCCCCccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHH
Q 005415 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (697)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELl 614 (697)
.||+||||||+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|+
T Consensus 157 ~~ivH~dlkp~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 157 LNFVHRDLATRNCLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CCccccCcchhheEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999995 7889999999987543221 1233467899999999888999999999999999998
Q ss_pred h--CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 615 T--GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 615 t--G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+ +..||.+.+..+.+..+............ ..........+..++..||... |..|++++++..+|.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~----p~~RPs~~~i~~~l~ 303 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRD----CRERPSFSDIHAFLT 303 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCC----chhCcCHHHHHHHHh
Confidence 7 67899887776666555433211111000 0111123456788888888865 888999999887764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=290.81 Aligned_cols=254 Identities=23% Similarity=0.238 Sum_probs=195.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|++.++||+|+||+||++.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++.+..++.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC------CCCEeeeeeeecCCCe
Confidence 4889999999999999999999999999999987532 12234567888888774 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+.+ +|...+.... ...+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999975 5555543221 123889999999999999999999999999999999999985 78899999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...... .....+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 223 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE----- 223 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc-----
Confidence 8765332 223578899999999998889999999999999999999999998876654444433322111110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
... .-...+..++..||... |..|. ++++++ +|+...+
T Consensus 224 --~~~--~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 224 --YSE--KFSEAARSICRQLLTKD----PGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred --cCc--ccCHHHHHHHHHHccCC----HHHhcCCCCCCHHHHhcCcCccCCC
Confidence 000 11234566666666654 67777 788887 8887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=293.63 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=199.0
Q ss_pred EEEeccCCCCceEEEEECC--CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cCeEEEE
Q 005415 419 TEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIV 494 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~--~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--~~~l~LV 494 (697)
..+||+|+||.||+|.+.. ++..||+|.+..... .....+|+.+++.++ ||||+++++++.. ....++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELK------HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCC------CCCeeeEEEEEeccCCCeEEEE
Confidence 3579999999999998653 668999999875432 245678999988875 7899999999864 4678999
Q ss_pred EEccccchHHHHHhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc--cCcceEEEeeCCC
Q 005415 495 CELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGS 569 (697)
Q Consensus 495 mEyl~gsL~~~l~~~~~~~---~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~vKL~DFGl 569 (697)
|||+++++.+++....... ....+++..++.++.||+.||.|||+.+|+||||||+|||+.. ..++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9999999888876433211 1224788899999999999999999999999999999999943 1367899999999
Q ss_pred ccccccc------cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---------HHHHHHHH
Q 005415 570 SCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARII 633 (697)
Q Consensus 570 a~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~---------~e~l~~I~ 633 (697)
++..... .....+++.|+|||++.+. .++.++|||||||++|||+||++||..... ...+.++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9765432 2234678999999999774 588999999999999999999999975432 35677788
Q ss_pred HhhCCCCHHHHhhcccccccccCC----------ch-----------hhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKE----------YD-----------LYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~----------~~-----------l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..++.+..+.+........+.... .. ......+....++...|..|.|+++++ +|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888877766655433222211110 00 111233455666777789999999998 885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.99 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=188.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~i-L~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|+||+||+|.+..+|+.||+|++.... .....+..|..+ ++. .+||||+++++++...+..++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~hp~iv~~~~~~~~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN------VKHPFLVGLHYSFQTTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHh------CCCCCCccEEEEEecCCEEEEE
Confidence 36899999999999999999999999997532 122233344332 232 3589999999999999999999
Q ss_pred EEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~ 146 (325)
T cd05604 75 LDFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (325)
T ss_pred EcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccC
Confidence 999986 4544443221 2889999999999999999999999999999999999985 789999999998643
Q ss_pred c---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 574 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
. .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+....-..+.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~--------- 217 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP--------- 217 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC---------
Confidence 2 2233457899999999999999999999999999999999999999988877777666542111110
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.....+..++..++......++..+.+.++++ +|+...+
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 11234455666666666555566666667777 7876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=310.86 Aligned_cols=251 Identities=22% Similarity=0.228 Sum_probs=197.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-CcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+.... .....+..|+.+++.++ ||||+++++++...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD------HFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeEEEEEEEECCE
Confidence 34599999999999999999998877 7889999775433 33345567888887764 8899999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.||||||+. ++|.+.+..... ...++++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgl 215 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGF 215 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcC
Confidence 999999997 567666543221 1234888999999999999999999999999999999999995 78899999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....++.+
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~--- 292 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP--- 292 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 9765432 23356899999999999999999999999999999999999999988887777776543221111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+..++..||. ..|..|.+.++++ +|+
T Consensus 293 ---------~~~s~~~~~li~~~L~----~dP~~Rps~~~~l~~~~~ 326 (478)
T PTZ00267 293 ---------CPVSSGMKALLDPLLS----KNPALRPTTQQLLHTEFL 326 (478)
T ss_pred ---------ccCCHHHHHHHHHHhc----cChhhCcCHHHHHhCHHH
Confidence 0112345566666654 4477788887776 554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.65 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=203.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|++|.||+|.++.+++.||||.+..... ......+|+.+++.++ |+||+++++++......
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK------HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC------CcceeeEEEEEecCCeE
Confidence 679999999999999999999998999999999875321 2234567999998875 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++|.+++..... .+++..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~ 151 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLAR 151 (291)
T ss_pred EEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECcccccc
Confidence 99999999888877654322 3789999999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.. ..+.+..+...++.+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 54321 122345788999999876 458899999999999999999999998765 5677777888888777766544
Q ss_pred cccccccccCC-------------chhh--hhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQEIYKYFTKE-------------YDLY--YINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~~~~~~~~~-------------~~l~--~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+.... ..+. ....+...+.+...|..|.++++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 33222111110 0111 1112333444455688899999887 774
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.34 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=210.4
Q ss_pred CceEEE--EEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVT--EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~--e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.-|+|. +.||+|.||+||-|++.++|+.||||++.+- .....++.+|+.||+.+. ||.||.+--.|+..
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~------HPGiV~le~M~ET~ 635 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH------HPGIVNLECMFETP 635 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC------CCCeeEEEEeecCC
Confidence 446664 7899999999999999999999999999752 344578889999999986 78999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc-ceEEEeeC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~-~~vKL~DF 567 (697)
+.+++|||-+.|+.++.+....... +++...+.++.||+.||.|||-++|+|+||||+|||+.+.+. ..+|||||
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgR----L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGR----LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhccc----chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence 9999999999999999887665433 888888999999999999999999999999999999986433 47999999
Q ss_pred CCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~~lg~~p~e~~ 644 (697)
|+|+..+.. ....+|||.|+|||++..++|....|+||+|||+|--++|..||..+. ..++++.-.=+ -||..|
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM--yPp~PW- 788 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM--YPPNPW- 788 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc--cCCCch-
Confidence 999988764 456799999999999999999999999999999999999999996543 33444432111 122111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.++....-+...+++.-+...|.+.+..+ +||.++
T Consensus 789 -------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 789 -------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 23444556777888889999999999998 999865
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.65 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=164.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~-iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|+||+||+|++..+++.||+|++..... ....+..|.. +++. .+||||+++++++...+.+++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~h~~Iv~~~~~~~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN------VKHPFLVGLHFSFQTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHh------CCCCCCCceeEEEEcCCeEEEE
Confidence 369999999999999999999999999975321 1122233332 2222 3589999999999999999999
Q ss_pred EEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~ 146 (325)
T cd05602 75 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKEN 146 (325)
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCccc
Confidence 999986 5555554322 2778889999999999999999999999999999999985 788999999998643
Q ss_pred c---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 574 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 574 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
. .......|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 2 123345789999999999999999999999999999999999999998888877777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.71 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=190.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||+|+||+||+|++..+++.||||++..... .......|..++..+. ..+||||+++++++......++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL---LDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc---cCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999999999999999975321 1223344555555443 22589999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc-
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 575 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~- 575 (697)
+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 78 MSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCC
Confidence 975 5665554322 2889999999999999999999999999999999999985 78899999999865322
Q ss_pred --ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccc
Q 005415 576 --NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652 (697)
Q Consensus 576 --~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~ 652 (697)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 219 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---------- 219 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc----------
Confidence 22345789999999999765 48899999999999999999999999888777776664332222211
Q ss_pred cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 653 YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 653 ~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.-...+..++..||......++..+.++++++ +|+...+
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 11234556666666666555555556888888 8987554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.65 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=183.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~-iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|+||.||+|++..+++.||+|++..... ....+..|.. +++. .+||||+++++++...+..++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN------LKHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHh------CCCCCccceeeEEEcCCEEEEE
Confidence 369999999999999999999999999975321 1223333433 2333 3589999999999999999999
Q ss_pred EEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+.+ +|...+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 75 LDYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (321)
T ss_pred EcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccC
Confidence 999986 4544443221 2788899999999999999999999999999999999985 789999999998653
Q ss_pred cc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 574 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 574 ~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....-..|.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------- 217 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--------- 217 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC---------
Confidence 21 223457899999999999988999999999999999999999999988877776666432211111
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.....+..++..|+......++..+.+..++. +|+..
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 218 ----GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ----CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 11234555555665555444444444455555 66543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=286.07 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=209.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
++|.-.+.||.|..+.|.++.++.+|..+|+|++.-. ....+.-..|+.||+++. +||+|+.+.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeee
Confidence 4566678899999999999999999999999998631 123345567999999986 69999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
|++...+++|+|.|+ |.|.+++...-. +++...++|++|++.|+.|||.++||||||||+|||++. +..+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~Vt------lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd--n~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKVT------LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD--NMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhee------ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc--ccceE
Confidence 999999999999997 678888865433 899999999999999999999999999999999999994 88999
Q ss_pred EeeCCCcccccc--ccccccccCCCCCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 564 L~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~------~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
|+|||+++.... .....+|||+|+|||.+.- .+|+..+|+|++|||+|.|+.|.+||.......++..|++.
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 999999987654 3556899999999999852 35899999999999999999999999988888888888775
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.-.+..+.|. +...-..+...+++.--|.+|.|.++++ +|+.+
T Consensus 244 kyqF~speWa-------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 244 KYQFRSPEWA-------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccccCCcchh-------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 5544443332 2223345566677777799999999999 88854
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.63 Aligned_cols=189 Identities=24% Similarity=0.396 Sum_probs=161.3
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.+. +||||+++++++.....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998532 23345667888887764 4899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc-
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 573 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~- 573 (697)
||+++ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccc
Confidence 99985 5555544322 2899999999999999999999999999999999999985 788999999998642
Q ss_pred --ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 574 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 574 --~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
........|++.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 222334678999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=285.10 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=210.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||.|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ------HPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC------CCCCcceeeEEecCCee
Confidence 5899999999999999999999999999999987532 23456778888888775 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||++++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~ 147 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLAR 147 (286)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecc
Confidence 9999999778888775433 22889999999999999999999999999999999999995 7889999999987
Q ss_pred ccccc----cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+......+.++++.++.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 65433 2335678899999998754 468999999999999999999999999998899999999888877755543
Q ss_pred ccccccc----ccCC---------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 647 GQEIYKY----FTKE---------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 647 ~~~~~~~----~~~~---------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
......+ +... ......+.+-...++...|.+|.++++++ +|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 2221111 0000 11223444555555566799999999998 8874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.88 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=193.1
Q ss_pred EEeccCCCCceEEEEEC---CCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 420 EYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
+.||+|+||.||++++. .+++.||+|++.... ........|+.+++.++ ||||+++++++.....+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------HPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC------CCCcccEEEEEEcCCEEEE
Confidence 57999999999999863 578999999998533 12334566888877764 8899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. ++|.+.+.... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcc
Confidence 999997 56666654322 2889999999999999999999999999999999999985 78899999999865
Q ss_pred cccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......|.
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~-------- 219 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ-------- 219 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 4332 23357899999999999988999999999999999999999999988888777776543332221
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
.....+..++..||.. .|..|.+ +++++ +|+...+++
T Consensus 220 -----~~~~~~~~li~~~l~~----~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 220 -----FLSPEAQSLLRALFKR----NPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred -----CCCHHHHHHHHHHhhc----CHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 1123455555555554 4777777 66676 888765543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.24 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=194.3
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ........|+.+++.++ |++|+++++.+...+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC------CCCeeeeeEEEecCCE
Confidence 3788899999999999999999999999999987532 22234567888888774 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.+ +|..++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccc
Confidence 9999999975 56665543222 22888999999999999999999999999999999999985 77899999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV---MILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~---e~l~~I~~~lg~~p~e~~ 644 (697)
+...... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +....+... .+..
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~-- 223 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEE-- 223 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhh--
Confidence 8654332 22346899999999999989999999999999999999999999865432 222222111 1110
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
... .....+..++..||.. .|..|.+ +++++ +|+...++.
T Consensus 224 -----~~~--~~~~~~~~li~~~l~~----~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 224 -----YSE--KFSPDARSLCKMLLCK----DPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred -----cCc--cCCHHHHHHHHHHhhc----CHHHccCCCCCchHHHHcChhhhccCHH
Confidence 000 1123456666666665 4777887 78888 899875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.94 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=203.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR------HPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCccceeeEEEcCC
Confidence 46999999999999999999999999999999987532 23456777888888774 789999999999999
Q ss_pred eEEEEEEcc-ccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl-~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+ +++|.+++.... .++...+..++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCC
Confidence 999999999 467777765442 2889999999999999999999999999999999999985 7889999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
++...........+++.|+|||.+.+..++.++||||||+++|+|++|..||...+......++.....+.|.
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 219 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS------- 219 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc-------
Confidence 9987665555567889999999998888899999999999999999999999888876666666532222221
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhh-hccCHHHHH--Hhhccc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVV-IRLTLEYAA--LWLFGI 692 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~-~r~t~e~~~--~wl~~~ 692 (697)
. ....+..++..||......++. .+.+++++. +|+...
T Consensus 220 ----~--~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 220 ----F--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred ----c--CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 1 1456777888887765443331 123777777 776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.45 Aligned_cols=189 Identities=25% Similarity=0.402 Sum_probs=159.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..+++.||+|+++.. ......+..|+.++..+. +||||+++++++......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEE
Confidence 3699999999999999999999999999853 223345566777766553 4899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCcccccc
Confidence 99985 4544443221 2889999999999999999999999999999999999985 7899999999986532
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 22334678999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.54 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=205.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
-..|++++.||+|.-|+||+++...++..+|+|++.+. .....+...|.+||+.+. ||.++.||..|+..
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD------HPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD------HPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC------CCccchhhheeecc
Confidence 46789999999999999999999999999999999864 234456677888888874 89999999999999
Q ss_pred CeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...|+|||||.|+ |..+++... ...+++..++.++.+++.||+|||-.|||.|||||+||||.. +|+|.|+||
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvre--dGHIMLsDF 223 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRE--DGHIMLSDF 223 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEec--CCcEEeeec
Confidence 9999999999865 444444322 234999999999999999999999999999999999999995 999999999
Q ss_pred CCccccc----------------------------------c-c------------------------cccccccCCCCC
Q 005415 568 GSSCFQT----------------------------------D-N------------------------LCLYVQSRSYRA 588 (697)
Q Consensus 568 Gla~~~~----------------------------------~-~------------------------~~~~~gt~~Y~A 588 (697)
.++.... . . ...++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9753200 0 0 012577888999
Q ss_pred chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHH
Q 005415 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCF 668 (697)
Q Consensus 589 PE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw 668 (697)
||++.|.+.+.++|.|+|||+||||+.|..||.|.+..+.+.+|+..--.+|. .+....-.++..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------~~~vs~~akDLI 368 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------EPEVSSAAKDLI 368 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------------CCcchhHHHHHH
Confidence 99999999999999999999999999999999999999999998654333332 223445567788
Q ss_pred HHHHHHhhhhccC----HHHHH--HhhcccCC
Q 005415 669 ANIFISLVVIRLT----LEYAA--LWLFGIDQ 694 (697)
Q Consensus 669 ~~l~~~~~~~r~t----~e~~~--~wl~~~~~ 694 (697)
..++.+.|..|+- +.++. +...+.+|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 8888888999888 44444 44444433
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=286.22 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=208.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.+.||+|+||.||+|.+..+++.||||.++... .....+.+|+.+++.+.+ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE-----SIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC-----CCCccceeeeEeecCC
Confidence 46999999999999999999999999999999987532 223467789999988853 6899999999987665
Q ss_pred -----EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 491 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 491 -----l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.|+||||+.+++.+++...... ....+++..++.++.||+.||.|||+++|+||||+|+||+++. +++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~ 153 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIA 153 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEe
Confidence 8999999999888887654322 1234899999999999999999999999999999999999984 36789999
Q ss_pred eCCCccccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 566 DFGla~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|||.+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||.+.+....+.++...++.++.
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998754322 122356788999999865 45789999999999999999999999999888888888888777766
Q ss_pred HHHhhcccccccc---------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 642 EMLMQGQEIYKYF---------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 642 e~~~~~~~~~~~~---------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
..+........+. .....+..++..||. ..|..|+++++++ +|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~----~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLR----YDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHcc----CChhhcCCHHHHhcCCCcC
Confidence 5543321111110 112334445555554 4588899999998 8873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=290.89 Aligned_cols=266 Identities=27% Similarity=0.414 Sum_probs=214.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCC----cEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g----~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..|++++.||+|.||.||+|..+.+. +.+|||.++..+ .......+|+.++++++ ||||+.|..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~------h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK------HPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc------CCcchhHHHHHh
Confidence 36899999999999999999655443 378999998542 22346678999999997 789999999998
Q ss_pred e-cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc--CcceEE
Q 005415 487 H-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIK 563 (697)
Q Consensus 487 ~-~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~vK 563 (697)
. +..+++++||.+.+|++.++....... ..++...++.|+.||+.|+.|||++-|+||||||.|||+..+ ..|.||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 788999999999999999998776655 458889999999999999999999999999999999999742 358999
Q ss_pred EeeCCCccccccccc------cccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcH---------HH
Q 005415 564 IIDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAV---------VM 627 (697)
Q Consensus 564 L~DFGla~~~~~~~~------~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~---------~e 627 (697)
|+|||+++....... ..+-|.+|+|||.++|.. |+.++||||+|||+.||+|-++.|.+... .+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999988765533 246689999999999875 99999999999999999999999987542 57
Q ss_pred HHHHHHHhhCCCCHHHHhhccccccc-----------ccCC--chhhhh-------HHHHHHHHHHHhhhhccCHHHHH
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIYKY-----------FTKE--YDLYYI-------NEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~~~-----------~~~~--~~l~~i-------~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
++.+|.+.+|.|....|+.-++.+++ ++.. ..+++. .-+....++.-.|..|.|+++|+
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 99999999999998877765444433 2221 011111 23344455555688899999999
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.09 Aligned_cols=203 Identities=28% Similarity=0.404 Sum_probs=173.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..++|++.++||.|+||.||++.+..++..+|+|++... ......+.+|+++++.++ ||||++++++|...+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSDG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCcccceeEEEEECC
Confidence 457899999999999999999999999999999998753 233456788999998874 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.+++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+|||++. ++.+||+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~Df 148 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDF 148 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEeeC
Confidence 9999999997 47777765432 278889999999999999999985 7999999999999985 788999999
Q ss_pred CCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 568 Gla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
|++...... .....++..|+|||++.+..++.++|+|||||++|+|++|+.||......+.
T Consensus 149 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred CcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 998654332 2345688999999999998899999999999999999999999987665443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.51 Aligned_cols=263 Identities=30% Similarity=0.401 Sum_probs=208.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+|++.+.||.|++|.||+|.+..+++.||||.++.... ....+..|+.+++.++ |+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------HPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC------CCCChhhhheeecC
Confidence 58899999999999999999999999999999975432 2234556777777664 78999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+++||||+.++|.+++.... ..+++..+..++.||++||.|||++||+|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFG 147 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccce
Confidence 9999999999778887775432 13889999999999999999999999999999999999995 7889999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.++...++.+....+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 98765432 223355778999999865 45789999999999999999999999988888888888888877777665
Q ss_pred hhccccccccc---------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 645 MQGQEIYKYFT---------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 645 ~~~~~~~~~~~---------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
........+.. ....+..++..||. ..|..|.++++++ +|+....+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLT----LNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhc----CCcccCcCHHHHhhCccccCCCC
Confidence 54322222211 12234445555555 4588899999999 88886443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=285.00 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=202.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||+|+||.||+|.+..++..||+|++.... .......+|+.+++.++ |+||+++++++......
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK------HANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC------CCCEeEEEEEEecCCeE
Confidence 67999999999999999999999999999999987532 22235667888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.+++...+..... .+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY--LGELKLADFGLAR 151 (291)
T ss_pred EEEEecccCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--CCcEEEecccccc
Confidence 99999999888877653321 2678888999999999999999999999999999999985 7889999999886
Q ss_pred ccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+ ..+.+.++....+.++..++..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 54322 2234568899999998764 47889999999999999999999997654 4577777778788776665443
Q ss_pred cccccccccCC---------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQEIYKYFTKE---------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~~~~~~~~~---------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+.... .....-..+...+++...|..|.|+++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 32222111110 00011223334445555688899999998 775
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=312.04 Aligned_cols=253 Identities=21% Similarity=0.223 Sum_probs=196.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..++|++.+.||+|+||+||+|.+..+++.||||++... ........+|+.++..+ .|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~------~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC------DFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC------CCCcEEEeecceecc
Confidence 357999999999999999999999999999999998753 23334556677666654 488999998877643
Q ss_pred C--------eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 489 E--------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 489 ~--------~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
. .+++||||+. ++|.+.+...... ...+++..+..++.|++.||.|||+++|+||||||+|||++. +
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~--~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS--N 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--C
Confidence 2 3789999997 5777776543322 234889999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 88999999998654322 2345789999999999999999999999999999999999999999888777776654
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
....+.+ -.....+..++..||.. .|..|+++++++ +|..
T Consensus 260 ~~~~~~~------------~~~~~~l~~li~~~L~~----dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 260 GRYDPLP------------PSISPEMQEIVTALLSS----DPKRRPSSSKLLNMPICK 301 (496)
T ss_pred CCCCCCC------------CCCCHHHHHHHHHHccc----ChhhCcCHHHHHhCHHHH
Confidence 3221100 01233555666666653 477888888876 5543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=285.44 Aligned_cols=268 Identities=26% Similarity=0.379 Sum_probs=208.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.+.||.|++|.||+|.++.+++.||+|.+.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc------CCCEeeEEEEEecCCe
Confidence 57999999999999999999999999999999986432 22345677888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+++++.+.+..... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++. .++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLA 150 (294)
T ss_pred EEEEEecccccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccc
Confidence 999999999888877654322 12678888899999999999999999999999999999984 3567999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..+.+.++....+.+....+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 654322 2234567889999998764 578999999999999999999999999888888888888888777666543
Q ss_pred cccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 647 GQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 647 ~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
......+... .+.....+.+...+.+...|..|.++++++ +|+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 2222221100 011122233344444445688899999998 888654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.29 Aligned_cols=190 Identities=23% Similarity=0.385 Sum_probs=161.8
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..+++.||+|+++... .....+..|+.++..+. .||+|+++++++.....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----CCCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998542 23345667888777764 3789999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceecc
Confidence 99975 5555554322 2889999999999999999999999999999999999985 7889999999986532
Q ss_pred ---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 575 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 575 ---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 223446789999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=282.58 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.+.||+|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK------HPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC------CCCEeeeeeEEeeCCE
Confidence 47999999999999999999999999999999986432 22345678888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||++++++..+..... .+++..++.++.||+.||.|||+++|+|+||||+||+++. ++.++|+|||++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~ 147 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFA 147 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccc
Confidence 999999999877665543221 2889999999999999999999999999999999999985 788999999998
Q ss_pred ccccccc---ccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.+.+..+.+..+...++.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654332 23456788999999876 4578899999999999999999999999888887777776665544322111
Q ss_pred ccc--------cc---------ccc-cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQE--------IY---------KYF-TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~--------~~---------~~~-~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... .. ..+ .-...+..++..||. ..|..|.++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQ----MDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhc----CCccccCCHHHHhcCCCC
Confidence 000 00 000 112344455556654 4488899999988 764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=308.64 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=200.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..|+.++.||+|+||.||+|.+..+++.||+|++..+ ......+.+|+.+|..++ ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~------~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD------SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC------cchHHhhhhheeecccH
Confidence 4688889999999999999999999999999999854 344567888999998886 57999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+++||||.| ++.++++.... +.+..+..++++++.||.|||..+.+|||||+.|||+.. .|.+||+|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEeccee
Confidence 999999984 56666654332 477788889999999999999999999999999999996 699999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+||....+..++..|-+ ..||.
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--~~PP~------ 230 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--SAPPR------ 230 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--CCCCc------
Confidence 765433 3568999999999999988999999999999999999999999998887544444422 11111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
....|. ..+.+++..|...- |..|.++.+++ +.|+....
T Consensus 231 --L~~~~S--~~~kEFV~~CL~k~----P~~RpsA~~LLKh~FIk~a~k 271 (467)
T KOG0201|consen 231 --LDGDFS--PPFKEFVEACLDKN----PEFRPSAKELLKHKFIKRAKK 271 (467)
T ss_pred --cccccC--HHHHHHHHHHhhcC----cccCcCHHHHhhhHHHHhcCC
Confidence 111222 24555666665543 77777777777 55554443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.25 Aligned_cols=263 Identities=31% Similarity=0.518 Sum_probs=208.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
+.++|++.+.||+|+||.||+|.+..+++.||||.+... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK------HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC------CCCcCchhheeeccc
Confidence 357899999999999999999999999999999998642 233456677888888875 78999999887644
Q ss_pred ----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 489 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 489 ----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.+.++||||+.+++...+... .+++..++.++.|++.||.|||+.||+||||||+||+++. ++.++|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl 147 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKI 147 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEE
Confidence 358999999998877666421 2889999999999999999999999999999999999985 788999
Q ss_pred eeCCCcccccccc------ccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 565 ~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|||++....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999986543221 22467889999998765 4689999999999999999999999999888888888888888
Q ss_pred CCCHHHHhhccc--ccccc----------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 638 PIDLEMLMQGQE--IYKYF----------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 638 ~~p~e~~~~~~~--~~~~~----------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.++.+.+..... ...++ .-...+..++..||. ..|.+|+|+++++ +|+..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT----FNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC----CChhhCcCHHHHhcCccccccC
Confidence 877765532110 00000 112345566666665 4588999999999 9998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=302.97 Aligned_cols=249 Identities=23% Similarity=0.258 Sum_probs=189.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+|+++++||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |+||+++++++.....+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN------HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC------CCCcceeeeEeccCCeE
Confidence 4678889999999999999999999999999998643 233456778998888774 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++.+... ....+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 148 ~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~~ 216 (353)
T PLN00034 148 QVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSR 216 (353)
T ss_pred EEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccce
Confidence 999999986533211 11566778889999999999999999999999999999985 7889999999987
Q ss_pred ccccc---cccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
..... .....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+....+.......+.
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 294 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP-- 294 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC--
Confidence 65432 234578999999998743 23456899999999999999999999754332222222111110000
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.........+..++..||.. .+..|.++++++ +|+...
T Consensus 295 -------~~~~~~~~~l~~li~~~l~~----~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 295 -------EAPATASREFRHFISCCLQR----EPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -------CCCCccCHHHHHHHHHHccC----ChhhCcCHHHHhcCcccccC
Confidence 00112234667777777764 488899999999 998854
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=284.06 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=209.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.+.||+|++|.||+|.+..+++.||+|.++.. ......+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR------HENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC------CCCeeehhheEEECCE
Confidence 4799999999999999999999999999999998743 334467788999998875 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||++++++..+..... .+++..+..++.||+.||.|||+.+|+|+||+|+||+++. ++.+||+|||.+
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~ 147 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFA 147 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecc
Confidence 999999999887766543322 2788999999999999999999999999999999999995 889999999998
Q ss_pred ccccccc----ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~----~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
....... ....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+.+..+...++..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 7654332 235678889999999888 78999999999999999999999999988888888888888877765443
Q ss_pred hcccccc-----------------cccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 646 QGQEIYK-----------------YFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 646 ~~~~~~~-----------------~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
....... .+.. ...+..+++.||... |..|.++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD----PKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccC----chhcccHHHHhcCCCC
Confidence 2211000 0001 344556666666544 78899998887 664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=284.25 Aligned_cols=246 Identities=17% Similarity=0.178 Sum_probs=193.7
Q ss_pred cCceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..+|++.+.||+|+||.||+|.+. ..+..||+|+++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF------DHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEec
Confidence 457999999999999999999764 456789999988642 2334566777777765 48999999999999
Q ss_pred cCeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||++++ |.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~d 150 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISG 150 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECC
Confidence 99999999999865 555554322 12889999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccccc--c--cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 567 LGSSCFQTDNL--C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 567 FGla~~~~~~~--~--~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||.+....... . ...++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+..+.+..+.+....+.+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 99875532221 1 1233567999999999999999999999999999876 99999988887777766443322211
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
-..+..+..++..||... |..|++++++..
T Consensus 231 ------------~~~~~~~~~li~~c~~~~----p~~RP~~~~i~~ 260 (266)
T cd05064 231 ------------RNCPNLLHQLMLDCWQKE----RGERPRFSQIHS 260 (266)
T ss_pred ------------CCCCHHHHHHHHHHcCCC----chhCCCHHHHHH
Confidence 123457888999999765 778888887763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=287.99 Aligned_cols=267 Identities=26% Similarity=0.353 Sum_probs=210.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
..+|++.+.||.|+||.||+|.+..+++.||+|.++... .......+|+.+++.++ |+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR------HPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC------CCCCcceEEEEecCC
Confidence 367999999999999999999999999999999987432 12234567888888875 78999999999765
Q ss_pred -CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 -EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 -~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+++||||+.++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.+||+||
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~df 152 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADF 152 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcc
Confidence 5689999999998888776433 23889999999999999999999999999999999999985 788999999
Q ss_pred CCccccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 568 Gla~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|.+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++..+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998765432 222345778999999876 4578999999999999999999999999999999999999998877766
Q ss_pred Hhhcccccc---c------cc---C-CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 644 LMQGQEIYK---Y------FT---K-EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 644 ~~~~~~~~~---~------~~---~-~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+........ + +. . .........+...+.+...|..|.|+++++ +|+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 543211110 0 00 0 001122334455555566688999999999 998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.78 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=195.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++ ||||+++++++......++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVN------HPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCC------CCCCcChhheEEeCCeeEE
Confidence 4699999999999999999999999999999986543 2346888888774 8899999999999999999
Q ss_pred EEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 494 VmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||++.++|..++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||++...
T Consensus 135 v~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCcccccc
Confidence 999999998888764322 2889999999999999999999999999999999999985 788999999998754
Q ss_pred cc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCc---------HHHHHHHHHHhhCCCCH
Q 005415 574 TD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDA---------VVMILARIIGMLGPIDL 641 (697)
Q Consensus 574 ~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG-~~PF~~~~---------~~e~l~~I~~~lg~~p~ 641 (697)
.. ......|++.|+|||++.+..++.++|||||||++|||+++ .++|.... ....+..++..++..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 32 22345689999999999999999999999999999999985 44444321 23455566666665544
Q ss_pred HHHhh--ccccccc----------c---------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 642 EMLMQ--GQEIYKY----------F---------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 642 e~~~~--~~~~~~~----------~---------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
++... ......+ + ........++ .+.+...|..|+|+++++ +|+..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li----~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLV----HKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHH----HHHHcCCcccCcCHHHHhcCchhcc
Confidence 33210 0000000 0 0111222233 344456688999999999 99864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.30 Aligned_cols=245 Identities=24% Similarity=0.285 Sum_probs=206.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|..++.+|+|+||.+++++++.++..+++|.+.... ........|+.++.+++ |||||.+++.|...+.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~------hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL------HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc------CCCeeeeccchhcCCc
Confidence 57999999999999999999999999999999997533 33456788999998875 8999999999999887
Q ss_pred -EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 491 -LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 491 -l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
++|||+|++| ++.+.+...+ ...+++..+..|+.||+.|+.|||+++|+|||||+.||+++. ++.|+|.|||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDfG 151 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDFG 151 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecchh
Confidence 9999999985 5656665444 234999999999999999999999999999999999999996 7778999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+|+..... ..+.+||+.|++||++.+.+|..|+|||||||++|||++-+++|.+.+....+.+|......|.+.+..
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys 231 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYS 231 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcccc
Confidence 99887654 355799999999999999999999999999999999999999999999999999998877544443322
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.-++...++.+...|..|+++.+++
T Consensus 232 ----------------~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 232 ----------------SELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred ----------------HHHHHHHHHHhhcCCccCCCHHHHh
Confidence 2223334455556677777777766
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.87 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=201.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+.|++++.||+|+||.||+|.+..+++.|++|++.... .....+.+|+.+++.++ ||||+++++.+......
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN------HPYIVKLLGAFYWDGKL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCcEeeeEEEEEeCCeE
Confidence 467999999999999999999999999999999987543 33456677888887764 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++.+..+...... .+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||.+.
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~~ 158 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL--DGDIKLADFGVSA 158 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC--CCCEEEccCccce
Confidence 999999987654433222111 2889999999999999999999999999999999999985 7889999999886
Q ss_pred ccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
..... .....+++.|+|||++. ...++.++|+|||||++|+|++|.+||...+....+.++.....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 236 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS-- 236 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC--
Confidence 53322 22346788999999985 344788999999999999999999999887766555554332111000
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~~ 697 (697)
..-.....+..++..||. ..|..|++.++++ +|+....+||.
T Consensus 237 --------~~~~~~~~~~~li~~~l~----~~p~~Rp~~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 237 --------QPSKWSMEFRDFLKTALD----KHPETRPSAAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred --------CCcccCHHHHHHHHHHhc----CCcccCcCHHHHhcCccccccccchh
Confidence 000112356667777775 4588999999998 99998888873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=281.21 Aligned_cols=264 Identities=26% Similarity=0.402 Sum_probs=208.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+|++.++||.|++|.||+|.+..+++.||||.++... .....+.+|+.+++.++ |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK------HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc------CCCEeeeeeeEeeCCcEE
Confidence 5899999999999999999999999999999987542 22356678888888874 789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+||||+.++|.+++..... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++..
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~ 149 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARA 149 (284)
T ss_pred EEEecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhh
Confidence 9999999988887754332 223899999999999999999999999999999999999985 78899999999865
Q ss_pred cccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 573 QTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+.++.+....+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 4332 1234567889999998664 47889999999999999999999999998888888888888877776655433
Q ss_pred cccccccCC------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIYKYFTKE------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~~~~~~~------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
....+...- +.......+.....+...|..|.+.++++ +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 222211100 01112223344444445688899999988 774
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=287.39 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=205.0
Q ss_pred ceEEEEEeccCCCCceEEEEECC--CCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~--~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+|++.++||+|++|.||+|.+.. +++.||||.+.... .......+|+.+++.++ ||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------HENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC------CCCccceEEEEeCC
Confidence 58999999999999999999988 89999999998632 33456678888888775 78999999999988
Q ss_pred --CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc--CcceEEE
Q 005415 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKI 564 (697)
Q Consensus 489 --~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~vKL 564 (697)
..+++||||+++++.+++....... ...+++..++.++.||+.||.|||+++|+||||||+||+++.+ .++.+||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8899999999998888776443322 2248899999999999999999999999999999999999831 2688999
Q ss_pred eeCCCcccccccc------ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---------HHH
Q 005415 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMI 628 (697)
Q Consensus 565 ~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~---------~e~ 628 (697)
+|||++....... ....+++.|+|||++.+. .++.++|||||||++++|++|++||.+... ...
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 9999987643322 224567889999998764 578999999999999999999999976543 346
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccC-------C---c----------hhhhhHHHHHHHHHHHhhhhccCHHHHH--
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTK-------E---Y----------DLYYINEVCFANIFISLVVIRLTLEYAA-- 686 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~-------~---~----------~l~~i~~~cw~~l~~~~~~~r~t~e~~~-- 686 (697)
+.++++.++.++...+........+... . . .......+...+.+...|..|.|+++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 7777888887777655432222222110 0 0 0111223344445556688999999998
Q ss_pred Hhh
Q 005415 687 LWL 689 (697)
Q Consensus 687 ~wl 689 (697)
+|+
T Consensus 314 ~~f 316 (316)
T cd07842 314 PYF 316 (316)
T ss_pred CCC
Confidence 774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=285.62 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=194.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|++.+.||.|+||+||+|.+..+++.||+|++.... .......+|+.+++.++ |+||+++++.+..++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC------CcCceeEEEEEecCCE
Confidence 3788899999999999999999999999999987532 22234667888888775 7899999999999999
Q ss_pred EEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.++ |...+..... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~ 148 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCc
Confidence 99999999864 5544432221 23899999999999999999999999999999999999985 67899999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+...........
T Consensus 149 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 224 (285)
T cd05632 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY---- 224 (285)
T ss_pred ceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc----
Confidence 8654322 2335689999999999988899999999999999999999999988766554444433222221110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~ 693 (697)
.. .....+..++..||... |..|.+ ++++. +|+....
T Consensus 225 ---~~--~~~~~~~~li~~~l~~~----P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 225 ---SA--KFSEEAKSICKMLLTKD----PKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ---Cc--cCCHHHHHHHHHHccCC----HhHcCCCcccChHHHHcChhhhcCC
Confidence 00 11234566666666554 566666 55666 8887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=292.59 Aligned_cols=268 Identities=27% Similarity=0.359 Sum_probs=210.1
Q ss_pred ecCceEE-EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhh---------------HhHHHHHHHHHHhcccCCCCC
Q 005415 412 IAGRYYV-TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF---------------DQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 412 i~~rY~i-~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~---------------~~~~~Ei~iL~~L~~~~~~~h 475 (697)
+.+||.. .+.||.|+||+||+|.+..+++.||||+++...... ..+.+|+.+++.++ |
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h 79 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK------H 79 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC------C
Confidence 4678875 477999999999999999999999999987532211 13567888888774 7
Q ss_pred CceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc
Q 005415 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (697)
Q Consensus 476 pnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~ 555 (697)
+||+++++++......++||||+.++|.+.+.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~ 153 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN 153 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC
Confidence 89999999999999999999999998888875432 288999999999999999999999999999999999998
Q ss_pred ccCcceEEEeeCCCcccccc-----------------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCC
Q 005415 556 SYQRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGE 617 (697)
Q Consensus 556 ~~~~~~vKL~DFGla~~~~~-----------------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~ 617 (697)
. ++.++|+|||.+..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|.
T Consensus 154 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 154 S--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred C--CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 5 78899999998865441 11123457789999998764 4689999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccC-----------CchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK-----------EYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 618 ~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~-----------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+||.+.+..+.+..+.+.++.++...+........+... ......-+.+...+.+...|..|.++++++
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 999999999999999998888877655443322211100 011112234455555556699999999999
Q ss_pred --HhhcccC
Q 005415 687 --LWLFGID 693 (697)
Q Consensus 687 --~wl~~~~ 693 (697)
+|+...+
T Consensus 312 ~~~~~~~~~ 320 (335)
T PTZ00024 312 KHEYFKSDP 320 (335)
T ss_pred cCcccCCCC
Confidence 9987553
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=285.83 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=203.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (697)
++|++.++||+|+||.||+|.+..+++.||||.+.... .......+|+.+++.++ ||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC------CCCccceEEEEecccc
Confidence 57999999999999999999999999999999986432 22234567888888775 789999999987543
Q ss_pred -------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 490 -------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 490 -------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
..++||||+++++...+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~ 158 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK--DGIL 158 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC--CCcE
Confidence 459999999988877765332 12889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCcccccccc-------ccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 563 KIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 563 KL~DFGla~~~~~~~-------~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
||+|||++....... ....++..|+|||.+.+.. ++.++||||||+++|+|++|.+||.+.+....+..+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999986543221 2245678899999987654 78899999999999999999999999988888888888
Q ss_pred hhCCCCHHHHhhcccccc-------------------cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 635 MLGPIDLEMLMQGQEIYK-------------------YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~-------------------~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..+.++.+++........ .+.....+..++..||. ..|..|.++++++ +|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~----~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV----LDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhc----CChhhccCHHHHhcCCCC
Confidence 888888776554321110 00011233345555553 4588899999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=284.70 Aligned_cols=259 Identities=30% Similarity=0.433 Sum_probs=204.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.|++++.||.|++|.||+|.+..+++.||||.+.... .....+..|+.+++.++ ||||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC------CCCCcchhhhcccCCcE
Confidence 4889999999999999999999999999999987432 22346778888888874 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++|..++..... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++. ++.+||+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~ 148 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLAR 148 (284)
T ss_pred EEEeeccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchh
Confidence 99999998888777754322 22889999999999999999999999999999999999995 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+.+.++.+.++.++...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 54332 22234678899999887654 688999999999999999999999999988888888888887776554322
Q ss_pred cccccc---c-------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKY---F-------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~---~-------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+ + .-...++.++..||. ..|..|+|+++++ +|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLH----YDPNKRISAKAALAHPFF 284 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcC----CCcccCCCHHHHhcCCCC
Confidence 111100 0 011233334444444 4688999999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=280.40 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=201.5
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--CeE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EHL 491 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~~l 491 (697)
|++++.||+|+||.||+|.+..+++.||+|+++.... .......|+.++..+. +|+||+++++++... +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcE
Confidence 6889999999999999999999999999999875321 1123345666666653 488999999999987 889
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.+++++.+.... ..+++..++.++.|++.||.|||+.+|+||||+|+||+++. +.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~ 147 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCR 147 (282)
T ss_pred EEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccc
Confidence 9999999999888776432 12889999999999999999999999999999999999994 899999999987
Q ss_pred ccccc--cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++.++.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 65332 223457889999998754 457889999999999999999999999999999999999989988876643221
Q ss_pred ccc-cccc---------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIY-KYFT---------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~-~~~~---------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... ..+. ....+..++..||. ..|.+|.++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA----YDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhc----cCcccccCHHHHhhCCCC
Confidence 110 0000 01233444444444 4488899999998 775
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=276.65 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=200.5
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.|.+.+.||+|++|.||+|.+..+++.|++|.+... ......+.+|+.+++.++ ||||+++++++......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD------SSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC------CCCeehheeeeccCCEE
Confidence 488999999999999999999999999999998743 334456677888777764 88999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+. ++|.+++..... ..++...+..++.|++.||.|||++||+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~ 148 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVA 148 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccc
Confidence 99999996 577777654321 23888999999999999999999999999999999999995 788999999988
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.....++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 223 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ----- 223 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-----
Confidence 7654332 23467889999999999889999999999999999999999999888777666664432221111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+..+++.||... |..|.+++++. +||
T Consensus 224 -------~~~~~~~~~i~~~l~~~----p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 224 -------MYSQQLAQLIDQCLTKD----YRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------ccCHHHHHHHHHHccCC----cccCcCHHHHhhCCCC
Confidence 12346778888888654 88899998887 775
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.25 Aligned_cols=231 Identities=27% Similarity=0.361 Sum_probs=187.0
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl 498 (697)
++-||+|+.|.||+|+. .++.||||.++.-+ ..+|+-|++|+ ||||+.+.++|.....++||||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk------ETdIKHLRkLk------H~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK------ETDIKHLRKLK------HPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh------hhhHHHHHhcc------CcceeeEeeeecCCceeEEeeecc
Confidence 56699999999999974 57899999886332 24577677664 889999999999999999999999
Q ss_pred c-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccc
Q 005415 499 R-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577 (697)
Q Consensus 499 ~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~ 577 (697)
. |-|++.++..+. ++...+..|.++|+.||.|||.+.|||||||.-||||.. +..|||+|||.++...+..
T Consensus 195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELSDKS 266 (904)
T ss_pred ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhhhhh
Confidence 8 678888875543 788889999999999999999999999999999999996 6789999999998766543
Q ss_pred --ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccccc
Q 005415 578 --CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655 (697)
Q Consensus 578 --~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~ 655 (697)
-.+.||..|||||+|...+.+.|+|||||||+|||||||+.||.+.+...++.-+ |.-...+ .-.=.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----GsNsL~L-------pvPst 335 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GSNSLHL-------PVPST 335 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----cCCcccc-------cCccc
Confidence 3478999999999999999999999999999999999999999876655444332 2221111 11124
Q ss_pred CCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 656 KEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 656 ~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
++..+.-++++||.+. +.+|.+-.+++
T Consensus 336 cP~GfklL~Kqcw~sK----pRNRPSFrqil 362 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSK----PRNRPSFRQIL 362 (904)
T ss_pred CchHHHHHHHHHHhcC----CCCCccHHHHH
Confidence 5667888999999987 55555555555
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=320.38 Aligned_cols=260 Identities=25% Similarity=0.311 Sum_probs=200.0
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
++...++|++++.||.|+||+||+|.+..++..||+|++... ......+..|+.+++.|+ ||||++++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~------HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK------HKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEE
Confidence 556678999999999999999999999999999999998743 334466788999999885 78999999998
Q ss_pred Eec--CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-------CccccCCCCcccccc
Q 005415 486 YHL--EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-------GIIHCDLKPENILIK 555 (697)
Q Consensus 486 ~~~--~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-------gIvHrDLKP~NILl~ 555 (697)
... ..+||||||+. ++|..++...... ...+++..++.|+.||+.||.|||+. +||||||||+||||.
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 654 56999999998 5777776543221 12389999999999999999999984 499999999999996
Q ss_pred cc---------------CcceEEEeeCCCccccccc--cccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhC
Q 005415 556 SY---------------QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTG 616 (697)
Q Consensus 556 ~~---------------~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG 616 (697)
.. ....+||+|||++...... .....||+.|+|||++.+ ..++.++||||||||||+|++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 41 2345899999998765432 233578999999999965 3588999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 617 ~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..||...+....+..++.....++. ......+..++..||. ..|..|+++.+++ +|+...
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi------------~~~S~eL~dLI~~~L~----~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPI------------KGKSKELNILIKNLLN----LSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCc------------CCCCHHHHHHHHHHhc----CChhHCcCHHHHhccHHHhhc
Confidence 9999876554444433322211111 1123456666666664 4588899999998 888644
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=305.67 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=196.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++ |+||+++++++......
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~------HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLS------HPAVLALLDVRVVGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCC------CCCCCcEEEEEEECCEE
Confidence 35689999999999999999999999999999996432 34568999999875 78999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++|||++.++|..++..... .+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||+++
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~ 308 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAAC 308 (461)
T ss_pred EEEEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCce
Confidence 99999999998887754322 3899999999999999999999999999999999999985 7889999999987
Q ss_pred ccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHHHhhCCC
Q 005415 572 FQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-------VVMILARIIGMLGPI 639 (697)
Q Consensus 572 ~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-------~~e~l~~I~~~lg~~ 639 (697)
..... .....||+.|+|||++.+..++.++|||||||+||||++|..|+-... ....+.+++...+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 54322 123468999999999999999999999999999999999876553221 134455555443322
Q ss_pred CHHH--------Hhhc-----cc-----ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 640 DLEM--------LMQG-----QE-----IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 640 p~e~--------~~~~-----~~-----~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
..++ .... .. ....|.....+.....+.....+...+..|.|+++++ +|+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 1111 0000 00 0001111111222333444444566688999999999 9985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=287.72 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=200.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+|++.+.||+|++|.||+|.+..+++.||||.+.... .....+..|+++++.+. |+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD------HPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC------CCCchhheeeeecCC
Confidence 37999999999999999999999899999999997543 23345677888887774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg 148 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFD 148 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecc
Confidence 99999999975 67776653221 23888999999999999999999999999999999999995 7889999999
Q ss_pred Cccccccc--------------------------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 005415 569 SSCFQTDN--------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (697)
Q Consensus 569 la~~~~~~--------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG 616 (697)
++...... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 87543211 1123578889999999998899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC----HHHHH--Hhhc
Q 005415 617 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT----LEYAA--LWLF 690 (697)
Q Consensus 617 ~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t----~e~~~--~wl~ 690 (697)
..||.+.+....+..+...-...+. ...-...+..++..||... +..|.+ +++++ +|+.
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~----p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEVTFPG-----------SPPVSSSARDLIRKLLVKD----PSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCccCCC-----------ccccCHHHHHHHHHHccCC----HhHCCCchhhHHHHHcCchhh
Confidence 9999988877766665432111111 1112345666666666644 666777 99998 8998
Q ss_pred ccCCC
Q 005415 691 GIDQN 695 (697)
Q Consensus 691 ~~~~n 695 (697)
+.++-
T Consensus 294 ~~~~~ 298 (316)
T cd05574 294 GVNWA 298 (316)
T ss_pred cCChh
Confidence 77654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=285.85 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=195.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----cCeE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----LEHL 491 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~----~~~l 491 (697)
..||+|+++.||+|.. +|+.||||.++.... ..+.+.+|+.+++.++ ||||+++++++.+ ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID------SNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC------CCCEEEEeeeEEecccCCCce
Confidence 4689999999999986 789999999975432 2356678999998875 7899999999977 3578
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCC
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++||||+.+ +|.+++.... .+++.....++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||+
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~ 169 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGL 169 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccch
Confidence 999999985 5766665332 27888999999999999999998 49999999999999995 78999999999
Q ss_pred ccccccccccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....++..
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 244 (283)
T PHA02988 170 EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP----- 244 (283)
T ss_pred HhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-----
Confidence 8766555555678899999999976 678999999999999999999999999888777777665433332211
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
......+..++..||... |..|+|+++++.-|.+.
T Consensus 245 ------~~~~~~l~~li~~cl~~d----p~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 ------LDCPLEIKCIVEACTSHD----SIKRPNIKEILYNLSLY 279 (283)
T ss_pred ------CcCcHHHHHHHHHHhcCC----cccCcCHHHHHHHHHHH
Confidence 123457888899998866 78889999888655544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=291.32 Aligned_cols=262 Identities=29% Similarity=0.451 Sum_probs=206.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+..+|++.+.||.|+||+||+|.+..+++.||||.+... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD------HENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC------CCCccchHHheecc
Confidence 356899999999999999999999999999999998742 223345667888888774 78999999988754
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...++||||+.++|.+.+.... .+++..+..++.|++.||.|||+++++|+||||+||+++. ++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~k 148 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLK 148 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEE
Confidence 3589999999988887775432 2889999999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 564 L~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..+.+..+.+
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765432 223467888999999875 458899999999999999999999999998888888888888887
Q ss_pred CHHHHhhcc--cccc----------------cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 640 DLEMLMQGQ--EIYK----------------YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 640 p~e~~~~~~--~~~~----------------~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+.+.+.... ...+ +......+..+++.||. ..|..|.++++++ +|+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLV----FDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhc----CChhhccCHHHHHcCcchhh
Confidence 776542100 0000 01112233344444444 4588899999999 99874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.05 Aligned_cols=261 Identities=34% Similarity=0.480 Sum_probs=212.2
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (697)
+|++.+.||.|++|.||+|.+..+++.||||.+... ......+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR------HENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC------CcchhhhhhhhcccCcc
Confidence 689999999999999999999889999999998753 233456778888888775 789999999998775
Q ss_pred ---eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 490 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 490 ---~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+|+||||++++|...+.... .+++..++.++.||+.||.|||+.||+||||||.|||++. ++.++|+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~d 146 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICD 146 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 799999999988777765332 3889999999999999999999999999999999999995 68999999
Q ss_pred CCCccccccc------cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||.+...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..++..++.+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9998765433 2234678889999999888 78999999999999999999999999999999999999999988
Q ss_pred CHHHHhhc--cccccccc----------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQG--QEIYKYFT----------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~--~~~~~~~~----------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+.+.+... .....+.. -...+..++..||. ..|..|.+.++++ +|+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLV----FDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHcc----CChhhCCCHHHHHhCccHHhhc
Confidence 87765411 11111111 12334445555554 4588899999999 8997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=283.79 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=202.4
Q ss_pred cCceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 413 AGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 413 ~~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
.++|+|. ++||-|-.|.|..+.++.+++++|+|++.-. ....+|+++.-..+ .|||||.++++|...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS-----GHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc-----CCCceEEeehhhhhhccC
Confidence 4567765 5799999999999999999999999998754 34556777665544 589999999998743
Q ss_pred -CeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEe
Q 005415 489 -EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (697)
Q Consensus 489 -~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~ 565 (697)
..+.+|||.|+|+ |...+... ++..+++.++..|++||..|+.|||+.+|.||||||+|+|.... .+..+||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 5689999999864 55555533 34459999999999999999999999999999999999999742 45689999
Q ss_pred eCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~----~e~l~~I~~~lg~~ 639 (697)
|||+|+.... ...+.+-||+|.|||++....|+..+|+||+||++|-|++|.+||....- ...-.+|....-.+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9999987763 35567889999999999988999999999999999999999999976542 12333333322233
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
|.+.|. ...+-..+....++...|.+|+|+++.+ +|+++.+
T Consensus 287 P~pEWs-------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 287 PEPEWS-------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CChhHh-------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 322221 2334557788899999999999999999 9999865
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=277.51 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=200.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
-.++|+++++||+|++|.||+|.+ .++..||+|.+.........+.+|+.+++.++ |+||+++++.+......
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ------HDKLVRLYAVVTKEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCCCc
Confidence 346899999999999999999986 45678999998765555567888999988874 78999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~ 150 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLA 150 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccc
Confidence 99999996 577777654322 22788899999999999999999999999999999999985 788999999999
Q ss_pred ccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+......+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 226 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM---- 226 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence 7654322 12234567999999988889999999999999999998 99999988777766666443221110
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
......+..++..||... |..|++++++..+|.
T Consensus 227 --------~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 227 --------ENCPDELYDIMKTCWKEK----AEERPTFDYLQSVLD 259 (261)
T ss_pred --------CCCCHHHHHHHHHHccCC----cccCcCHHHHHHHHh
Confidence 112345677777787544 889999999987775
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=287.94 Aligned_cols=261 Identities=32% Similarity=0.492 Sum_probs=210.5
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
+.++|++++.||.|+||.||+|.+..+++.||||++... ......+..|+.+++.++ ||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR------HENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC------CCCeeeEeeeEecC
Confidence 467899999999999999999999999999999987642 223356678888888774 7899999999876
Q ss_pred cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 488 ~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
....++||||++++|..++... .++...+..++.||+.||.|||+++|+||||+|+||+++. ++.++|+||
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~df 152 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDF 152 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCcc
Confidence 4678999999988877666421 2778888899999999999999999999999999999985 788999999
Q ss_pred CCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.+.++.++.++...
T Consensus 153 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 998766555455667889999999866 5689999999999999999999999999988888888889999888776543
Q ss_pred cccc--ccc----------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEI--YKY----------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~--~~~----------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.... .++ -.....+..+++.||. ..|..|.++++++ +|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV----FDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcC----CChhhCCCHHHHhcCCcccc
Confidence 2110 000 0112345566666654 4588899999999 88853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=281.16 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=194.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++...+..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD------SPYIIGFYGAFFVENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC------CCCeeeEEEEEEECCEEE
Confidence 688999999999999999999999999999998754 233356777888887764 789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+||||++++.+.... .+++..+..++.|++.||.|||+.||+|+||||+|||++. ++.++|+|||++..
T Consensus 76 lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~~ 144 (279)
T cd06619 76 ICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCccee
Confidence 999999976554321 1678889999999999999999999999999999999985 78999999999875
Q ss_pred cccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHhhCCCCHHHHhhcc
Q 005415 573 QTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM---ILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 573 ~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e---~l~~I~~~lg~~p~e~~~~~~ 648 (697)
.... .....++..|+|||++.+..++.++|+|||||++|+|++|..||......+ ....+...........
T Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 219 (279)
T cd06619 145 LVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV----- 219 (279)
T ss_pred cccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----
Confidence 4433 334578899999999999899999999999999999999999996532111 0011111111000000
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
. ........+..++..||. ..|..|++++++. +|+...+.+
T Consensus 220 -~-~~~~~~~~~~~li~~~l~----~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 220 -L-PVGQFSEKFVHFITQCMR----KQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred -C-CCCcCCHHHHHHHHHHhh----CChhhCCCHHHHhcCcccccccCc
Confidence 0 000122356667777666 4488999999988 999876654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=280.44 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=205.2
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--Ce
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 490 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~~ 490 (697)
|++.+.||.|++|.||+|.+..+++.+|+|++... ......+.+|+.+++.+. |+|++++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR------HPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCeeeheeeEecCCCCc
Confidence 68899999999999999999999999999999865 233456778888888875 78999999999988 88
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||++++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~ 147 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLA 147 (287)
T ss_pred EEEEeccccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccce
Confidence 99999999988887775432 23889999999999999999999999999999999999995 889999999998
Q ss_pred cccccc----cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+....+..+.+..+.++...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 765443 2234567889999987654 57899999999999999999999999998888888888888877665544
Q ss_pred hcccc----------------cccccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 646 QGQEI----------------YKYFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 646 ~~~~~----------------~~~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..... ...+.. ...+..+++.||. ..|..|+++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~----~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT----LDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcC----CChhhCcCHHHHhhCcCC
Confidence 32211 001111 2334444455543 4488899999988 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=281.78 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=206.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (697)
+.|++.+.||.|+||.||+|.+..+++.+|+|.++... .......+|+.+++.++ ||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ------HPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC------CCCEEEEEEEEEecCC
Confidence 47999999999999999999999999999999997532 22234567888888774 78999999999877
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
...++||||+.++|.+++..... .+++..++.++.||+.||.|||+++|+|+||||+||+++. ++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g 151 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFG 151 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecC
Confidence 88999999999888887764332 3899999999999999999999999999999999999995 7889999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
++...... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+..+.+.++...++.+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 98765443 22345678899999987654 688999999999999999999999999999999999888887777655
Q ss_pred hhccccccc----------------cc---CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIYKY----------------FT---KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~----------------~~---~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......... +. -...+..++..|| ...|..|+++++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l----~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLL----TYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHh----ccCccccCCHHHHhcCCCC
Confidence 432111110 11 0223334444444 45588999999998 774
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=280.20 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=206.6
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
|++.+.||.|++|.||+|.++.+|..||+|++.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC------CCCccCHhheeccCCeEE
Confidence 678899999999999999999999999999987542 22345678888888875 789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+||||++++|.+++..... ..+++..+..++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 iv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~ 148 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARA 148 (283)
T ss_pred EEEeccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccc
Confidence 9999999888887764432 23889999999999999999999999999999999999996 78899999999875
Q ss_pred ccccc---ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... ....++..|+|||++.+. .++.++||||||+++|+|++|++||...+....+.++.+..+.+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 43221 223557889999988764 47889999999999999999999999998888888888888877776654322
Q ss_pred cccccc----------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIYKYF----------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~~~~----------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
....+. .-...+..++..||.. .|..|.|+++++ +|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~----~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVY----DPAKRISAKAALQHPYF 283 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcC----ChhhCcCHHHHhcCCCC
Confidence 221110 0112344555555554 488899999998 774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=276.61 Aligned_cols=247 Identities=27% Similarity=0.320 Sum_probs=194.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+.|++.+.||.|++|.||+|.+..+++.||+|.+..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ------HERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC------CCCeeeeEEEEcc
Confidence 468999999999999999999999999999999874321 2245667777777664 8899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...+++||||+.+ +|.+.+.... .++...+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~--~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEee
Confidence 9999999999974 6666665332 2788899999999999999999999999999999999985 78899999
Q ss_pred CCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 567 FGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
||++....... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......+.
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ 227 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC
Confidence 99986543211 234567889999999998899999999999999999999999987766555544432211111
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
. . -.....+..++..||... |..|.|+++++ +|+
T Consensus 228 ~---------~--~~~~~~~~~li~~~l~~~----p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 228 L---------P--SHVSPDARNFLRRTFVEN----AKKRPSAEELLRHFFV 263 (263)
T ss_pred C---------C--ccCCHHHHHHHHHHhhcC----cccCCCHHHHhhCCCC
Confidence 0 0 012345667777777655 78888999888 664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=279.88 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=195.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~---- 488 (697)
.++|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++.+. +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeecCCCC
Confidence 46799999999999999999999999999999999866555567788888888764 378999999999753
Q ss_pred --CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 489 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 489 --~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
...++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEc
Confidence 468999999985 67666654221 23788999999999999999999999999999999999995 7789999
Q ss_pred eCCCccccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||++...... .....+++.|+|||++. +..++.++|||||||++|+|++|..||...........+.....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC
Confidence 99998754322 23356788999999986 33588899999999999999999999976655444433322110
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+. .........+..++..||... |..|+++++++ +|+
T Consensus 234 ~~-----------~~~~~~~~~~~~li~~~l~~~----p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PR-----------LKSKKWSKKFQSFIESCLVKN----HSQRPTTEQLMKHPFI 272 (272)
T ss_pred CC-----------CCCCCcCHHHHHHHHHHcCCC----hhhCCCHHHHhhCCCC
Confidence 00 000112345667777777643 88899999888 774
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.35 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=198.5
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
..+++..+...+.+.||+|.||+||+|+|.. .||||+++. .....+.+..|+.++++-+ |-||+-+.|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR------H~NIlLFMG 455 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR------HENILLFMG 455 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc------hhhheeeeh
Confidence 4567777888999999999999999999754 599999974 3456778889999999876 669999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++..... .||+-+|+| +|+.++...... |.....+.|++||++||.|||.++|||||||..||++.. +++|
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~kV 527 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLKV 527 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCcE
Confidence 9988776 899999987 577776544432 889999999999999999999999999999999999995 6999
Q ss_pred EEeeCCCcccccc-----ccccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 563 KIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 563 KL~DFGla~~~~~-----~~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
||+|||++..... ......|..-|||||++.. .+|+..+|||||||++|||++|..||......+++..+-+
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr 607 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR 607 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc
Confidence 9999999854322 2333566788999999964 4699999999999999999999999997777777766655
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhc
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIR 679 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r 679 (697)
..+.++.... .-++...+..++.+||+-....+|+-.
T Consensus 608 G~l~pd~s~~--------~s~~pk~mk~Ll~~C~~~~~~eRP~F~ 644 (678)
T KOG0193|consen 608 GYLMPDLSKI--------RSNCPKAMKRLLSDCWKFDREERPLFP 644 (678)
T ss_pred cccCccchhh--------hccCHHHHHHHHHHHHhcCcccCccHH
Confidence 4444433221 113344899999999997755554443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=277.15 Aligned_cols=250 Identities=19% Similarity=0.245 Sum_probs=200.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
....|.+.+.||.|++|.||+|.+..+++.||+|++..+......+.+|+.+++.++ ||||+++++++......
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC------CCChhheEEEEcCCCCc
Confidence 345799999999999999999999999999999999876555567788999888874 78999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+++++||||||+||+++. ++.+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~df~~~ 151 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLS 151 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCcEEeCCCccc
Confidence 99999997 567776654322 22788899999999999999999999999999999999985 788999999998
Q ss_pred ccccccccc----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~~~----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
......... ...+..|+|||.+.+..++.++|||||||++|+|++ |..||++.+..+....+.....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----- 226 (263)
T cd05052 152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER----- 226 (263)
T ss_pred cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-----
Confidence 765433211 123567999999999899999999999999999998 9999998877766666543221110
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.......+..++..||.. .|..|+++.++..-|
T Consensus 227 -------~~~~~~~~~~li~~cl~~----~p~~Rp~~~~l~~~l 259 (263)
T cd05052 227 -------PEGCPPKVYELMRACWQW----NPSDRPSFAEIHQAF 259 (263)
T ss_pred -------CCCCCHHHHHHHHHHccC----CcccCCCHHHHHHHH
Confidence 012245677788888875 488899998887433
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=281.79 Aligned_cols=256 Identities=28% Similarity=0.366 Sum_probs=200.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
++|++++.||.|++|.||++.+..++..||+|++.... .....+..|+.+++.++ ||||+++++.+......+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK------HPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC------CCceeEEEEEEecCCeEE
Confidence 57999999999999999999998899999999987543 34456778888888775 789999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+++ +|..++..... .+++..++.++.|++.||.|||+++|+|+||+|+||+++. ++.++|+|||.+.
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~~ 151 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVSA 151 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccch
Confidence 99999986 55555443221 2889999999999999999999999999999999999985 7889999999876
Q ss_pred ccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
..... .....+++.|+|||.+. +..++.++|+|||||++|+|++|++||...+....+..+..... +...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~- 229 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-PTLD- 229 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-CCcC-
Confidence 54322 23356788999999985 34577899999999999999999999988776665555532211 1000
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
. .. .....+..++..||.. .|..|.++++++ +|+.....|+
T Consensus 230 --~----~~--~~~~~~~~li~~~l~~----~p~~Rps~~~il~~~~~~~~~~~~ 272 (280)
T cd06611 230 --Q----PS--KWSSSFNDFLKSCLVK----DPDDRPTAAELLKHPFVSDQSDNK 272 (280)
T ss_pred --C----cc--cCCHHHHHHHHHHhcc----ChhhCcCHHHHhcChhhcccchhH
Confidence 0 00 1123566677777764 488999999999 9998776553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=290.56 Aligned_cols=264 Identities=30% Similarity=0.478 Sum_probs=209.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
..+|++.+.||.|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK------HDNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC------CCCccCHHHhccccC
Confidence 468999999999999999999999999999999987532 23455667888888775 7899999998863
Q ss_pred --cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 488 --LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 488 --~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
...+++||||+.++|..++.... .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+||+
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~ 149 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRIG 149 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEec
Confidence 35689999999988877765322 2889999999999999999999999999999999999995 8899999
Q ss_pred eCCCcccccccc-------ccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDNL-------CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~~-------~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+....+..+...+|
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 999986543221 23467889999999866 4588999999999999999999999999998899999999999
Q ss_pred CCCHHHHhhcc--ccccccc----------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 638 PIDLEMLMQGQ--EIYKYFT----------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 638 ~~p~e~~~~~~--~~~~~~~----------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.++.+.+.... ...+++. ....+..++..|| ...|..|.++++++ +|+.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l----~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML----QFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHc----cCChhhCcCHHHHHhChhhhhccC
Confidence 88887654211 1111111 1223334444444 45588899999988 99976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=289.75 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=207.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
..+|.+.+.||.|+||.||+|.+..+++.||||.+... ......+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ------HENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC------CCCccchhheecccc
Confidence 46899999999999999999999999999999998743 222345677888888764 78999999998754
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...++||||+..++..... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~k 157 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCELK 157 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEE
Confidence 3469999999876654431 12788999999999999999999999999999999999995 78999
Q ss_pred EeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 564 L~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
|+|||++...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..++...+.++++
T Consensus 158 L~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 158 ILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred EeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999998776555555677889999999876 458899999999999999999999999998888889999888888777
Q ss_pred HHhhccccc--c-------cc---------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQEIY--K-------YF---------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~~~--~-------~~---------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+........ . +. .....+..++..||. ..|..|.++++++ +|+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLE----LDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcC----CChhhCcCHHHHhcCcchhhcc
Confidence 655432110 0 00 112234445555544 4488899999999 8987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=281.16 Aligned_cols=191 Identities=26% Similarity=0.373 Sum_probs=159.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||+|+||.||++.+..+|+.||+|.+.... ........|+.+++.++ ||||+++++++....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC------CCcEEEEEEEEecCCeEEEEEec
Confidence 799999999999999999999999986432 12234456888887764 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+.+ +|...+..... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 75 MNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCC
Confidence 975 55555543222 22788889999999999999999999999999999999985 788999999998665432
Q ss_pred --cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 577 --~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 223567899999999999889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=281.75 Aligned_cols=255 Identities=29% Similarity=0.386 Sum_probs=199.9
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
|++.+.||.|+||.||++.+..++..+++|.+... ......+.+|+.+++.+. ||||+++++++......++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC------CCCeeeEEEEEeeCCEEEEE
Confidence 67889999999999999999999999999998753 334456777888888764 78999999999999999999
Q ss_pred EEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 495 mEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
|||+.++.+........ ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 81 IEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNT 154 (282)
T ss_pred EEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEcccccccccc
Confidence 99998655443322211 23889999999999999999999999999999999999985 7889999999986543
Q ss_pred cc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 575 DN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 575 ~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
.. .....+++.|+|||++. +..++.++|+|||||++|+|++|.+||...+..+.+..+.....+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 229 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA----- 229 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-----
Confidence 32 22346788999999984 345788999999999999999999999888776666665433221110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
........+..++..||... |..|.++++++ +|+.....++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~~~ 272 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKN----VDARWTTTQLLQHPFVTVNSNKP 272 (282)
T ss_pred -----CccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCCCEeccCCCC
Confidence 00112346777888887755 88899999998 9988766654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=291.65 Aligned_cols=263 Identities=32% Similarity=0.526 Sum_probs=211.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++.+.||.|++|.||+|.+..+++.||+|++... ........+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD------HENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc------CCCHHHHHHHhhcc
Confidence 457899999999999999999999999999999998642 223355667888887774 78999999988765
Q ss_pred Ce------EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~~------l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
.. .++|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCEL 157 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCE
Confidence 54 899999999888887753 12889999999999999999999999999999999999995 7889
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|+|||++...........++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++.
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 158 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred EEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 999999998766555556788899999998653 6788999999999999999999999999988899999998888887
Q ss_pred HHHhhcccc--ccc----------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 642 EMLMQGQEI--YKY----------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 642 e~~~~~~~~--~~~----------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.++.+.... ..+ ......+..++..|+ ...|..|+|+++++ +|+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l----~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML----VLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhC----CCChhhCCCHHHHhcCCCccccC
Confidence 665432110 000 011233444444444 45588899999998 8987553
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=296.07 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=195.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
...++|++.+.||+|+||.||+|++... +..||||+++.. ......+.+|+.+++.+. +|+||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~ 109 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLG 109 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEee
Confidence 3356899999999999999999986543 357999999753 233456778999998873 3889999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhcc--------------------------------------------------
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-------------------------------------------------- 512 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~-------------------------------------------------- 512 (697)
++......++||||+. ++|.+++......
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999997 5677766432110
Q ss_pred --------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccccc
Q 005415 513 --------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578 (697)
Q Consensus 513 --------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~ 578 (697)
.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~--~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD--GRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC--CCeEEEeeceeeeeccCCcc
Confidence 01123788889999999999999999999999999999999984 78899999999865432211
Q ss_pred -----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccc
Q 005415 579 -----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 652 (697)
Q Consensus 579 -----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~ 652 (697)
...++..|+|||++.+..++.++|||||||++|+|++ |..||........+..++.....++. ..
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~ 338 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR---------PD 338 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC---------CC
Confidence 1223567999999998899999999999999999997 99999876655444444332111110 00
Q ss_pred cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 653 YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 653 ~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.....+..++..||... |..|++++++...|
T Consensus 339 --~~~~~l~~li~~cl~~d----p~~RPs~~~l~~~l 369 (374)
T cd05106 339 --FAPPEIYSIMKMCWNLE----PTERPTFSQISQLI 369 (374)
T ss_pred --CCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence 12356778888888755 77888888887544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=275.16 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=199.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+..++|+++++||+|+||.||+|.+ .+++.||+|.+.........+.+|+.+++.++ |+||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~~ 74 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ------HPRLVRLYAVVT-QEP 74 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcC------CcCeeeEEEEEc-cCC
Confidence 4567899999999999999999985 46788999999876655567888998888874 789999999874 467
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+. ++|.+.+..... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~ 148 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFGL 148 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCcc
Confidence 899999996 567776654322 23888999999999999999999999999999999999995 78899999999
Q ss_pred cccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
+....... ....++..|+|||++.+..++.++||||||+++|+|++ |++||.+.+..+....+......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 225 (260)
T cd05067 149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP--- 225 (260)
T ss_pred eeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC---
Confidence 86654221 12234568999999998889999999999999999999 99999988877766665433221110
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
......+..++..||.. .|..|++++++..+|..
T Consensus 226 ---------~~~~~~~~~li~~~l~~----~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 ---------DNCPEELYELMRLCWKE----KPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------CCCCHHHHHHHHHHccC----ChhhCCCHHHHHHHhhc
Confidence 11234566777777664 48889999999887754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=276.77 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=195.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..++|++.++||+|+||.||+|.+..+ ..||+|+++........+.+|+.+++.++ ||||+++++.+. ....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEPI 75 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCC------CCCcceEEEEEC-CCCc
Confidence 457899999999999999999987655 46999999865544567788999888874 789999999874 4568
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|+|||.+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~~ 149 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 149 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCce
Confidence 999999974 77777753221 23788999999999999999999999999999999999985 788999999998
Q ss_pred cccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
........ ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+...... +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~---- 224 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC---- 224 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CC----
Confidence 75543221 1234567999999998889999999999999999999 99999888777766665432211 10
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.......+..++..||+.. |..|.+++++..+|.
T Consensus 225 -------~~~~~~~l~~li~~~l~~~----p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 225 -------PPECPESLHDLMCQCWRKE----PEERPTFEYLQAFLE 258 (262)
T ss_pred -------ccccCHHHHHHHHHHccCC----cccCCCHHHHHHHHH
Confidence 0122345667777777544 888999998886654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=285.01 Aligned_cols=266 Identities=32% Similarity=0.456 Sum_probs=207.6
Q ss_pred ceEEEEEeccCCCCceEEEEECCC--CcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~--g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
+|++.+.||+|+||.||++.+..+ +..||+|.+... ........+|+.+++.+. +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeeecc
Confidence 589999999999999999999887 899999998742 223456678888888874 378999999875432
Q ss_pred ---CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 489 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 489 ---~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
...+++||+++++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~ 147 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKIC 147 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeC
Confidence 4589999999988888775332 2889999999999999999999999999999999999985 7889999
Q ss_pred eCCCccccccc-------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~-------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||.+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+..++..+|
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998654321 123467889999998876 4689999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccccc-------------ccccC-CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 638 PIDLEMLMQGQEIY-------------KYFTK-EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 638 ~~p~e~~~~~~~~~-------------~~~~~-~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.++.+.+....... ..+.. .......+.+...+.+...|..|.|++++. +|+..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 88876654321100 00000 011122334444444456688899999999 9997664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=287.09 Aligned_cols=267 Identities=29% Similarity=0.488 Sum_probs=210.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++++.||+|+||.||++.+..++..||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK------HENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCccceeeeecCC
Confidence 467899999999999999999999999999999998642 223345678888888775 78999999998765
Q ss_pred C------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
. ..++||||++++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCEL 157 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCE
Confidence 3 45899999987777665421 2889999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|+|||.+...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..++...+.++.
T Consensus 158 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 158 KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred EEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999876655555677899999999876 35889999999999999999999999998888888888888777776
Q ss_pred HHHhhcccc--ccccc------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 642 EMLMQGQEI--YKYFT------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 642 e~~~~~~~~--~~~~~------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
++....... ..+.. ..........+...+.+...|..|.|+.+++ +|+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 655432110 01100 0011222234455555666688899999998 9987653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=281.33 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=207.0
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
....++|++.+.||.|+||.||+|.++.+++.||+|+++... .......+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~------h~~i~~~~~~~~ 76 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN------HRNIVNLKEIVT 76 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC------CCCeeeeeheec
Confidence 445678999999999999999999999999999999997532 22345567888887774 789999999987
Q ss_pred ecC----------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 487 HLE----------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 487 ~~~----------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
... .+++||||+++++...+.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~ 151 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN 151 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 654 799999999998877765432 12889999999999999999999999999999999999985
Q ss_pred cCcceEEEeeCCCcccccccc----ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
++.+||+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+..
T Consensus 152 --~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 152 --KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred --CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 7889999999987654322 123457789999998654 478899999999999999999999999888888888
Q ss_pred HHHhhCCCCHHHHhhccccccc-----------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKY-----------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~-----------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+.+..+.++...+........+ -.-+..+..++..||. ..|..|.++++++ +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLT----LDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHcc----CChhhCCCHHHHhcCCCC
Confidence 8888877766554332111110 0113445555666654 4588899999988 775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=283.19 Aligned_cols=200 Identities=30% Similarity=0.397 Sum_probs=170.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||+|+||.||++.+..++..+|+|.+... .....++.+|+++++.++ ||||+++++++...+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN------SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCEE
Confidence 3699999999999999999999999999999998753 233456778888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCC
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+|||++. ++.++|+|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCC
Confidence 999999975 6766665332 27889999999999999999997 58999999999999985 78899999998
Q ss_pred ccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 570 a~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 147 SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred cccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 8654332 334567899999999988889999999999999999999999998765433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=277.43 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=204.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR------SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC------CCCeeeeeEEEEECCeE
Confidence 47899999999999999999999999999999987542 33456678888888775 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|+||+.+ +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999975 666665432 3889999999999999999999999999999999999995 788999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.....+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 220 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG----- 220 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc-----
Confidence 765433 234567888999999999889999999999999999999999998777665555544332211110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
..-...+..++..||.. .|..|+|+++++ +|+....++
T Consensus 221 ------~~~~~~~~~~l~~~l~~----~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 221 ------NKFSKPFKDFVSLCLNK----DPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred ------cccCHHHHHHHHHHhhC----ChhhCcCHHHHhhChhhcCCCcc
Confidence 00233566777777764 488899999998 999877765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=273.65 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=195.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+|++.+.||.|+||.||++.+..+++.+|+|.++.. ....+....|+.+++.++ |+||+++++.+.....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK------HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC------CCCcceEEEEEEECCEEE
Confidence 589999999999999999999999999999998643 233456677888877764 789999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||++ +++.+++..... ..+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 148 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSAR 148 (255)
T ss_pred EEEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcce
Confidence 9999997 467666653221 22788999999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+......+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 221 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP------- 221 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC-------
Confidence 55432 22356788999999999888999999999999999999999999988776666665432211111
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
. .....+..++..||... |..|+++++++
T Consensus 222 ---~--~~~~~~~~li~~~l~~~----P~~Rp~~~~il 250 (255)
T cd08219 222 ---S--HYSYELRSLIKQMFKRN----PRSRPSATTIL 250 (255)
T ss_pred ---c--ccCHHHHHHHHHHHhCC----cccCCCHHHHh
Confidence 0 11234666777776654 88888888775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=275.16 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=198.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+..++|++.++||+|+||.||+|.+. .+..||+|.+.........+.+|+.+++.++ |+||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR------HDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC------CCceEEEEeEEC-CCC
Confidence 44578999999999999999999864 5677999999875555567888999988875 789999999875 456
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~ 148 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGL 148 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCcee
Confidence 899999997 46777665322 123789999999999999999999999999999999999985 78899999999
Q ss_pred ccccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
+........ ...++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+.+..+..... ++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--- 224 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MPC--- 224 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC---
Confidence 876543221 1234567999999988889999999999999999999 9999998877776666543211 110
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.......+..++..||... |..|+|++++..+|..
T Consensus 225 --------~~~~~~~~~~li~~~l~~~----p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 --------PQDCPISLHELMLQCWKKD----PEERPTFEYLQSFLED 259 (260)
T ss_pred --------CCcCCHHHHHHHHHHcccC----cccCcCHHHHHHHHhc
Confidence 1122346777888888754 8889999999888765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=274.06 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=195.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|++.+.||+|+||.||++.+. .+..+|+|.+.........+..|+.+++.++ ||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLS------HPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCC------CCCceeEEEEEccCCCEEE
Confidence 46899999999999999999864 4568999998765544567788999998874 7899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. ++|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC--CCeEEECCCCCccc
Confidence 999997 567666653221 2788999999999999999999999999999999999984 78899999998875
Q ss_pred cccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..+........+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----- 224 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK----- 224 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC-----
Confidence 432211 1234567999999998889999999999999999999 999999888877777775532211110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.....+..++..||... |..|++++++.
T Consensus 225 -------~~~~~~~~li~~c~~~~----p~~Rps~~~l~ 252 (256)
T cd05114 225 -------LASMTVYEVMYSCWHEK----PEGRPTFAELL 252 (256)
T ss_pred -------CCCHHHHHHHHHHccCC----cccCcCHHHHH
Confidence 12346788889999766 77888888876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=279.94 Aligned_cols=253 Identities=22% Similarity=0.237 Sum_probs=200.1
Q ss_pred CceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
++|.+.+.||+|+||.||+|.+.. +++.||||+++.... ....+.+|+++++.+. |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ------HENIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC------CCCchheeeEEe
Confidence 568999999999999999998643 468899999875432 3467788999988874 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhc--------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQE--------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~--------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
.....++||||+. ++|.+++..... ......+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~- 157 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY- 157 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC-
Confidence 9999999999997 567777654321 112233788899999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~ 631 (697)
++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 789999999998653221 122334678999999999999999999999999999999 9999988877777666
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+.....+++. ......+..++..||... |..|+++++++.+|.
T Consensus 237 ~~~~~~~~~~------------~~~~~~~~~li~~~l~~~----p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQRP------------RTCPSEVYDIMLGCWKRD----PQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCCC------------CCCCHHHHHHHHHHcCCC----cccCCCHHHHHHHhh
Confidence 6532222211 123456778888888754 888999999887663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=278.99 Aligned_cols=257 Identities=32% Similarity=0.469 Sum_probs=208.8
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
|++.+.||.|++|.||+|.+..+++.+++|.+..... ......+|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCcchHHHhhccCCCEE
Confidence 6778999999999999999988999999999875432 3456777888888775 789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+||||+++++.+.+.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~ 147 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARS 147 (283)
T ss_pred EEEeccCCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEe
Confidence 999999998888776532 12889999999999999999999999999999999999985 78899999998866
Q ss_pred ccccc---ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+.++.+.++.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 54432 234567889999999876 78999999999999999999999999999988888988888877666554432
Q ss_pred ccccc-----------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIYKY-----------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~~~-----------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..... -.....+..++..||.. .|..|++++++. +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~----~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY----DPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhcc----CcccCcCHHHHhhCCCC
Confidence 20000 01134555666666654 488899999988 775
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=275.56 Aligned_cols=261 Identities=28% Similarity=0.380 Sum_probs=203.1
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe--
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 490 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~-- 490 (697)
|++.+.||+|+||.||+|++..+++.||+|+++... .......+|+.+++.+.. ..||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES---FEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc---cCCCCcceEEEEEeeccCCC
Confidence 688999999999999999998889999999997432 222345678888887753 358999999999998776
Q ss_pred ---EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 491 ---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 491 ---l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.+++|||+.+++.+++...... .+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+||
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADF 151 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEecc
Confidence 9999999998888777643321 3889999999999999999999999999999999999996 689999999
Q ss_pred CCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 568 Gla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
|.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+....+.+.++.+..+.+....+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 998665432 223456788999999999889999999999999999999999999999999998888766544332222
Q ss_pred hccc-cccccc-------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 646 QGQE-IYKYFT-------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 646 ~~~~-~~~~~~-------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.... ....+. -...+..++..||. ..|..|.++++++ +|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~----~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLT----FNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhc----cCCccCCCHHHHhcCcCC
Confidence 1110 000000 01233445555554 3488899999988 775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=271.36 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=200.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++++.||.|+||.||.+++..+++.+++|.+... ......+.+|+.+++.++ |+||+++++++.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ------HPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC------CCCeeEEEeEEecCCeE
Confidence 699999999999999999999999999999987643 334456778888888774 78999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+. ++|.+.+.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~ 148 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGIS 148 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcce
Confidence 99999997 57777765432 123789999999999999999999999999999999999985 778999999998
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+.....++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV------ 222 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc------
Confidence 7654332 3356789999999999888899999999999999999999999988887777776542211111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
......+..++..||.. .|..|.++++++
T Consensus 223 ------~~~~~~~~~~i~~~l~~----~p~~R~s~~~ll 251 (256)
T cd08221 223 ------SVYSSELISLVHSLLQQ----DPEKRPTADEVL 251 (256)
T ss_pred ------cccCHHHHHHHHHHccc----CcccCCCHHHHh
Confidence 12234577777888764 488899999888
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=280.72 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=199.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.|++++.||+|+||.||++.+..+++.|++|.+.... .....+.+|+.+++.++ ||||+++++.+....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE------NPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC------CCCeeeeEEEEecCC
Confidence 36899999999999999999999999999999987542 22345567777777654 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
++++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++. .+.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~--~~~~~l~dfg 146 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--MGHIKLTDFG 146 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC--CCCEEEeeCC
Confidence 99999999985 5666664322 2788999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc------------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 005415 569 SSCFQTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (697)
Q Consensus 569 la~~~~~~------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~ 630 (697)
++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 87531110 011346778999999998889999999999999999999999999888777776
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC---HHHHH--HhhcccCCCC
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT---LEYAA--LWLFGIDQNK 696 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t---~e~~~--~wl~~~~~n~ 696 (697)
.+.......|... ......+..++..||... |..|.+ +++++ +|+...++++
T Consensus 227 ~~~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~----P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 227 QVISDDIEWPEGD----------EALPADAQDLISRLLRQN----PLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HHHhcccCCCCcc----------ccCCHHHHHHHHHHhccC----hhhccCccCHHHHHhCccccCCCHHH
Confidence 6644322222110 012345677888888765 666665 55555 8988777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=278.11 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=199.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCC-----cEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g-----~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
++|++.+.||+|+||.||+|.+...+ ..||+|.++... .....+.+|+.++..++ ||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ------HPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC------CcccceEEEEEc
Confidence 57899999999999999999876554 689999987432 33456778888887764 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~ 555 (697)
.....+++|||+. ++|.+++....... ....+++..+..++.||+.||.|||+++|+|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 9899999999997 57777776432211 113478889999999999999999999999999999999998
Q ss_pred ccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 005415 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (697)
Q Consensus 556 ~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l 629 (697)
. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 ~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 E--GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 788999999998654322 122345778999999998889999999999999999998 99999988877766
Q ss_pred HHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 630 ~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..|.....++. .-.....+..++..||... |..|++++++...|.
T Consensus 237 ~~i~~~~~~~~------------~~~~~~~~~~l~~~c~~~~----p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 237 EMIRSRQLLPC------------PEDCPARVYALMIECWNEI----PARRPRFKDIHTRLR 281 (283)
T ss_pred HHHHcCCcCCC------------cccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHHh
Confidence 66543221111 0123467888999999875 777888888775554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=272.94 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=198.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..++|++.+.||+|++|.||+|.+. .++.||+|.++........+.+|+.+++.++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR------HPKLIQLYAVCTLEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCC------CCCccceeEEEecCCCe
Confidence 3467999999999999999999864 4578999999876555567788999888875 78999999999999999
Q ss_pred EEEEEcc-ccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl-~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+ .++|.+++.... ...+++..+..++.|++.||.+||++||+||||||+||+++. ++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~~ 150 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGLA 150 (261)
T ss_pred eeeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcceE
Confidence 9999999 467887775432 123789999999999999999999999999999999999995 788999999998
Q ss_pred cccccccc-cccc---cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNLC-LYVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~~-~~~g---t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
........ ...+ +..|+|||.+.+..++.++||||||+++|+|++ |+.||.+......+..+......+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 226 (261)
T cd05068 151 RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP---- 226 (261)
T ss_pred EEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence 76543211 1122 357999999998889999999999999999999 99999988877767666443221111
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
......+..++..||... |..|++++++..-|
T Consensus 227 --------~~~~~~~~~li~~~l~~~----P~~Rp~~~~l~~~l 258 (261)
T cd05068 227 --------PGCPKELYDIMLDCWKED----PDDRPTFETLQWKL 258 (261)
T ss_pred --------CcCCHHHHHHHHHHhhcC----cccCCCHHHHHHHH
Confidence 123356777888888654 88889988877443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=276.81 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=190.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++......
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC------KHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc------CCCCeeeeeEEEEeCCEE
Confidence 357999999999999999999999999999999987532 3334566788888776 488999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++.... .+++..+..++.|++.||.|||+.+|+||||+|+||+++. ++.++|+|||++
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~~ 153 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD--NGDVKLADFGVA 153 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEECcCccc
Confidence 999999985 5666654322 2789999999999999999999999999999999999985 778999999998
Q ss_pred cccccc---cccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
...... .....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||......+....+......++. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~- 231 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK-L- 231 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC-C-
Confidence 765332 22346788999999985 344788999999999999999999999765544333332221111110 0
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.........+..++..||. ..|..|+++++++
T Consensus 232 ------~~~~~~~~~~~~li~~~l~----~~P~~Rp~~~~il 263 (267)
T cd06646 232 ------KDKTKWSSTFHNFVKISLT----KNPKKRPTAERLL 263 (267)
T ss_pred ------ccccccCHHHHHHHHHHhh----CChhhCcCHHHHh
Confidence 0001123456677777775 4488899998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=279.12 Aligned_cols=262 Identities=19% Similarity=0.152 Sum_probs=186.2
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecchhhhH-h-----HHHHHHHHHHhcccCCCCCCc
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDFFD-Q-----SLDEIKLLKLVNKNDPADEHH 477 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~~~~~~-~-----~~~Ei~iL~~L~~~~~~~hpn 477 (697)
.+.++..++|++.++||+|+||.||+|.+..+ +..+|+|+......... . ...+......+.......|++
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567788999999999999999999998777 67788887543221110 0 011111222222233457999
Q ss_pred eeEEEEEEEecC----eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 478 ILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 478 Iv~l~~~f~~~~----~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
|+++++++.... ..+++|+++..++.+.+..... .++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999998776543 4578899887777666543221 567788999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCcccccc----------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005415 554 IKSYQRCEIKIIDLGSSCFQTD----------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~~----------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~ 623 (697)
++. ++.++|+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 159 l~~--~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 159 VDG--NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EcC--CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 985 77899999999865421 112346899999999999999999999999999999999999999877
Q ss_pred cHHHHHHHHH--HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 624 AVVMILARII--GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 624 ~~~e~l~~I~--~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
.....+.... +....+... ...+...+..+..++..||.-- +.+|++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~----~~~rp~~~~l~~ 291 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEG-------KIKIKNANKFIYDFIECVTKLS----YEEKPDYDALIK 291 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhh-------hhccCCCCHHHHHHHHHHHhCC----CCCCCCHHHHHH
Confidence 4322222111 111111110 0112234566888888898854 777888887753
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=278.82 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=196.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~----- 487 (697)
.++|++.+.||.|+||.||+|.+..+++.||+|++.........+..|+.+++.+. +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhcccccC
Confidence 47899999999999999999999999999999999876555567778888888874 48899999999863
Q ss_pred -cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 488 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 488 -~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
....+++|||+++ +|.+++..... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l~ 163 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKLV 163 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEe
Confidence 4678999999985 67676654322 12778889999999999999999999999999999999995 7789999
Q ss_pred eCCCccccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||++...... .....+++.|+|||.+. +..++.++|+|||||++|+|++|..||........+..+...
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-- 241 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-- 241 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC--
Confidence 99998654322 23356788999999986 345788999999999999999999999776654444333221
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.+.... .-.....+..++..||..- +..|.+.++++ +|+
T Consensus 242 -~~~~~~--------~~~~~~~~~~li~~cl~~~----p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 242 -PPPKLK--------SKKWSKKFIDFIEGCLVKN----YLSRPSTEQLLKHPFI 282 (282)
T ss_pred -CCCCCc--------ccccCHHHHHHHHHHhCCC----hhhCcCHHHHhcCCCC
Confidence 111100 0012346777888887654 88899999988 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=274.35 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=194.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||.||+|.+..+++.||||.++. .......+.+|+.+++.++ ||||+++++++....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN------HPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC------CcceeeeeeeEEECC
Confidence 579999999999999999999999999999998764 2233345677888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+.+ +|..++...... ...+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g 151 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccc
Confidence 99999999985 666666533221 123788899999999999999999999999999999999985 7789999999
Q ss_pred Ccccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~--~e~l~~I~~~lg~~p~e~ 643 (697)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+ ...+.++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPPLPT 230 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCCCCh
Confidence 887654322 234678889999999988899999999999999999999999965432 3333332 2222222110
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
......+..++..||... |..|+++++.+.
T Consensus 231 ----------~~~~~~~~~li~~cl~~~----p~~Rp~~~~vl~ 260 (267)
T cd08228 231 ----------EHYSEKLRELVSMCIYPD----PDQRPDIGYVHQ 260 (267)
T ss_pred ----------hhcCHHHHHHHHHHCCCC----cccCcCHHHHHH
Confidence 012345677777787654 888999888873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=295.71 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=198.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEe---cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~---~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+..|+++++||+||.+.||++.. .+.+.||+|.+. .+......+..|+.+|.+|+. |.+||+||+|-..++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg-----~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG-----HDKIIQLYDYEVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC-----CceEEEEeeeeccCc
Confidence 46799999999999999999984 444566666554 355667889999999999985 569999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+|+||||-+.+|-..+...... .+.-.++.+..||+.|+.++|+.||||.||||.|+|+. .|.+||+|||.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecccccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 99999999999998888755433 33337888999999999999999999999999999998 79999999999
Q ss_pred ccccccccc-----cccccCCCCCchhhcCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 570 SCFQTDNLC-----LYVQSRSYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 570 a~~~~~~~~-----~~~gt~~Y~APE~l~~~~-----------~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
|.......+ ..+||+.||+||.+.... .+.++||||||||||+|+.|++||.... ..++++.
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~ 583 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH 583 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH
Confidence 977654433 368999999999995432 5678999999999999999999997432 2334443
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
....|-. +-........+.+..+|..|.+.- |-+|+++-+++ ++|.++
T Consensus 584 aI~~P~~-------~Iefp~~~~~~~li~~mK~CL~rd----PkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 584 AITDPNH-------EIEFPDIPENDELIDVMKCCLARD----PKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred hhcCCCc-------cccccCCCCchHHHHHHHHHHhcC----cccCCCcHHHhcCcccccc
Confidence 3332211 111122333444888999887754 88899998888 887763
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=273.73 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=195.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|++.+.||+|+||.||++.+. ++..+|+|++.........+.+|+.+++.++ ||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS------HPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEEEEEEEEcCCCceEE
Confidence 46889999999999999999875 5678999998765444456778888888764 7899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||++ ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCccccee
Confidence 999996 467777654322 3889999999999999999999999999999999999985 78899999999875
Q ss_pred cccccc-c---ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNLC-L---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~~-~---~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... . ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 221 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-------- 221 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC--------
Confidence 543221 1 122357999999998899999999999999999999 899998887777666654332211
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..-.....+..++..||... |..|+++++++.+|
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~----p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 ----RPKLAPTEVYTIMYSCWHEK----PEDRPAFKKLLSQL 255 (256)
T ss_pred ----CCCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHHh
Confidence 00123456778888888654 88899999988665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=273.51 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=196.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (697)
.++|++.+.||.|++|.||+|.+..+++.+++|++.........+.+|+.+++.+. .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEecCCCC
Confidence 47899999999999999999999889999999999876655677888999998874 3789999999997644
Q ss_pred ---eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 490 ---HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 490 ---~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
..++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~ 155 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLV 155 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEEC
Confidence 48999999985 666665543211 123889999999999999999999999999999999999985 7889999
Q ss_pred eCCCccccccc---cccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|..||........+..+....
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 234 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP- 234 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-
Confidence 99988654332 223567889999999854 346788999999999999999999998766655555543221
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+.... ........+..++..||. ..|..|.|+++++ +||
T Consensus 235 --~~~~~-------~~~~~~~~~~~li~~~l~----~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 --PPTLK-------SPENWSKKFNDFISECLI----KNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --CCCCC-------chhhcCHHHHHHHHHHhh----cChhhCcCHHHHhcCCCC
Confidence 11100 000112345566666655 4589999999998 886
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-31 Score=278.01 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=197.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.+|++.+.||.|++|.||+|.+..+++.|++|.+.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK------NPNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC------CCceeeeeeeEecCceEE
Confidence 57999999999999999999999999999999986432 23456677888887764 789999999999999999
Q ss_pred EEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+.++ |..++. .. .+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~-~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~~ 163 (296)
T cd06655 93 VVMEYLAGGSLTDVVT-ET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFCA 163 (296)
T ss_pred EEEEecCCCcHHHHHH-hc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccch
Confidence 999999764 544443 21 2789999999999999999999999999999999999985 7889999999886
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+... +.++..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~------ 236 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQ------ 236 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccC------
Confidence 54332 22346788999999999888999999999999999999999999888766555444221 111110
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
........+..++..||... |..|.+++++. +|+..
T Consensus 237 ---~~~~~~~~~~~li~~~l~~d----p~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMD----VEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcC----hhhCCCHHHHhhChHhhh
Confidence 11122345666777777654 78899999988 99874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=305.81 Aligned_cols=275 Identities=20% Similarity=0.228 Sum_probs=195.5
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCC-CcEEEE------------------EEEecchhhhHhHHHHHHHHHHhc
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCL------------------KIIKNDKDFFDQSLDEIKLLKLVN 468 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-g~~VAV------------------Kii~~~~~~~~~~~~Ei~iL~~L~ 468 (697)
.++.+.++|++++.||+|+||+||+|..+.. +..+++ |.+.........+.+|+.+++.++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 3445568999999999999999999875432 222222 222222333456778888888874
Q ss_pred ccCCCCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 469 ~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
||||+++++++...+..|+|++++.+++.+++....... ........++.++.||+.||.|||++||+|||||
T Consensus 222 ------HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 222 ------HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred ------CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 889999999999999999999999988888765332211 1113466788899999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCcccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCC-
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN- 622 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~P-F~~- 622 (697)
|+|||++. ++.+||+|||++....... ....|++.|+|||++.+..++.++|||||||++|||++|..+ |..
T Consensus 295 P~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 295 LENIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred HHHEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 99999985 7889999999997654322 235789999999999999999999999999999999998754 432
Q ss_pred -CcHHHHHHHHHHhhCCCCHHHHhhccccccccc------CCchhhh---------hHHHHHHHHHHHhhhhccCHHHHH
Q 005415 623 -DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT------KEYDLYY---------INEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 623 -~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~------~~~~l~~---------i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
......+.+++..++..+.++.........++. ....+.. -..+.+.+++...|..|.++++++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 345566666666655443332211111111110 1111111 122335566667788899999999
Q ss_pred --Hhhcc
Q 005415 687 --LWLFG 691 (697)
Q Consensus 687 --~wl~~ 691 (697)
+|+..
T Consensus 453 ~hp~f~~ 459 (501)
T PHA03210 453 ALPLFSA 459 (501)
T ss_pred hChhhhc
Confidence 99864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-31 Score=271.12 Aligned_cols=252 Identities=24% Similarity=0.305 Sum_probs=201.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+..++|++.+.||+|+||.||+|.+. .++.||||.+.........+.+|+.+++.++ |+||+++++++.....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR------HDKLVQLYAVCSEEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC------CCCEeeeeeeeecCCc
Confidence 44578999999999999999999865 5678999999876555677888999888874 7899999999998889
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.+ +|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++. ++.++|+|||.
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~ 149 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGL 149 (261)
T ss_pred eEEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECcccc
Confidence 9999999974 67777654321 23889999999999999999999999999999999999985 78999999999
Q ss_pred ccccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
+........ ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+......+..+......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 226 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP--- 226 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 876543211 1223567999999998889999999999999999999 99999988887777776543322111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
......+..++..||.. .|..|++++++..+|..
T Consensus 227 ---------~~~~~~~~~~i~~~l~~----~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ---------PNCPEELYDLMLQCWDK----DPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------CCCCHHHHHHHHHHccc----CcccCCCHHHHHHHHhc
Confidence 11234566677777654 47789999988766643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=279.54 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=203.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..++|++.++||.|++|.||+|.+..+++.||||++.... .......+|+++++.++ ||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 79 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK------HPNVVPLIDMAVER 79 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC------CCCccchhhheecc
Confidence 3578999999999999999999999999999999986432 12235567888888774 78999999987643
Q ss_pred --------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc
Q 005415 489 --------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 489 --------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (697)
..+++||||+.+++...+.... ..+++..+..++.||++||.|||++||+|+||||+||+++. ++
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~ 152 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QG 152 (311)
T ss_pred cccccccCceEEEEEecCCcCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CC
Confidence 3479999999988877665322 23899999999999999999999999999999999999995 78
Q ss_pred eEEEeeCCCcccccccc--------------ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 561 EIKIIDLGSSCFQTDNL--------------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~~--------------~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
.++|+|||++....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999886543211 123457789999998754 478999999999999999999999999999
Q ss_pred HHHHHHHHHhhCCCCHHHHhhccccccccc------CC-------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFT------KE-------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~------~~-------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
...+..+....+.++...+.........-. .. ..+...+.+.....+...|..|.|+++++ +|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 888888888888776655443322221110 00 01112233444444455588899999988 774
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=302.40 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=210.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEe-cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~-~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.-|.|+..||.|+||+||+|..+.++-..|-|++. +.....+.++.||.||..+. ||+||+|++.|...+.+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd------HP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD------HPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC------ChHHHHHHHHHhccCceE
Confidence 45888899999999999999999899888999886 34566788899999998774 899999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
|+.|+|+|+..+.+...-... +++.+++.+++|++.||.|||+++|||||||..|||++- +|.|+|+|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL~r~----LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRV----LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHhccc----cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeeccccccc
Confidence 999999998777665543332 999999999999999999999999999999999999995 89999999998855
Q ss_pred ccc---ccccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 573 QTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 573 ~~~---~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
... ....++|||+|||||+.. ..+|++++||||||++|.||..+.+|....++.-++-+|.+. -|+.++
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLl 256 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLL 256 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCccc
Confidence 433 345689999999999974 567999999999999999999999999999998888887542 222222
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
.... |. .....++..| +..-|..|+++.+++ +|....+-||
T Consensus 257 qPS~-----Ws--~~F~DfLk~c----L~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 257 QPSH-----WS--RSFSDFLKRC----LVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred Ccch-----hh--hHHHHHHHHH----HhcCCccCCCHHHHhhCcccccCCcch
Confidence 1111 11 2334455445 445588899999988 9999888776
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-31 Score=284.19 Aligned_cols=266 Identities=30% Similarity=0.504 Sum_probs=208.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC------CCcccceeeeeeec
Confidence 3578999999999999999999999999999999987532 22345667888887764 78999999988643
Q ss_pred ------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
...++++++++++|.+.+... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 159 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCE
Confidence 347899999988887665421 2788999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||++...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..++...+.++.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 160 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred EEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998876655555678899999999876 46888999999999999999999999988888888888888887777
Q ss_pred HHHhhcccc--ccccc-----------C-CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQEI--YKYFT-----------K-EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~~--~~~~~-----------~-~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
......... ..++. . .......+.+.....+...+..|.+..+++ +|+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 665432110 00000 0 001122233444445555688899999988 998744
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=275.48 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=193.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++++.||+|+||.||++.+..+|+.||||.++... ........|+.++.+. .+||||+++++++......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-----VDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----cCCCCeeeeeEEEecCCcE
Confidence 36899999999999999999999999999999987542 2223444555543332 3589999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||++++|.+++...... ...+++..+..++.||+.||.|||++ +++||||||+||+++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhcccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccc
Confidence 999999999888777543222 23489999999999999999999997 9999999999999985 788999999998
Q ss_pred ccccccc--ccccccCCCCCchhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHHhhCC-CCHH
Q 005415 571 CFQTDNL--CLYVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGP-IDLE 642 (697)
Q Consensus 571 ~~~~~~~--~~~~gt~~Y~APE~l~~----~~~s~ksDIWSLGviL~ELltG~~PF~~~-~~~e~l~~I~~~lg~-~p~e 642 (697)
....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.....+ .+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcc
Confidence 7654322 23467888999999865 45788999999999999999999999653 223333333221111 0000
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.-...+..++..||... |..|++.++++ +|+....+
T Consensus 232 ------------~~~~~l~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 232 ------------KFSPEFQDFVNKCLKKN----YKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred ------------ccCHHHHHHHHHHccCC----hhhCcCHHHHhcCchhhhccc
Confidence 01234566666666544 88899999998 89876543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=286.86 Aligned_cols=204 Identities=25% Similarity=0.436 Sum_probs=179.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
-|.|+++||.|+||.||+|.++.+|..+|||.+.-+.. ...+..|+.|++++. .|++|++|+.|.....+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~------S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCK------SKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcC------CchhhhhhhhhccCCceEee
Confidence 46778899999999999999999999999999876544 467888999999886 46999999999999999999
Q ss_pred EEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
||||+ |+..+.+..++.. +++.++..+++..++||+|||...-+|||||..|||++. +|..||+|||.+...
T Consensus 107 MEYCGAGSiSDI~R~R~K~-----L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT--~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKP-----LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT--DGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHHhcCC-----ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc--cchhhhhhccccchh
Confidence 99998 5666666655443 999999999999999999999999999999999999995 899999999999876
Q ss_pred ccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 005415 574 TDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (697)
Q Consensus 574 ~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I 632 (697)
.+. ..+..|||.|||||++..-+|..++||||||++..||..|++||.+..+...+..|
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 654 45679999999999999999999999999999999999999999988776544443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=275.49 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=201.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..+|++.++||.|+||.||+|.+.. +..+|+|++..... ....+..|+.+++.++ |+||+++++++......
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC------CcchhheeeeEecCCCe
Confidence 3569999999999999999999877 89999999986543 4556778888887764 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++..... ..+++..+..++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccch
Confidence 999999975 77777754321 23789999999999999999999999999999999999985 788999999998
Q ss_pred cccccccc---cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.+..+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 225 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC------ 225 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC------
Confidence 76543221 2234567999999998889999999999999999998 8999998887777777654322111
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.......+..++..||... |..|.|+.++..+|..
T Consensus 226 ------~~~~~~~~~~~i~~~l~~~----p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 ------PAKCPQEIYKIMLECWAAE----PEDRPSFKALREELDN 260 (261)
T ss_pred ------CCCCCHHHHHHHHHHcCCC----chhCcCHHHHHHHHhc
Confidence 1123456778888888654 7789999998877753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=272.65 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=196.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..++|++.+.||.|++|.||+|.+..+ ..+|+|.+.........+.+|+.+++.+. ||||+++++++. ....
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR------HDKLVPLYAVVS-EEPI 75 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCC------CCCeeeEEEEEc-CCCc
Confidence 457899999999999999999987554 46999998765555567788999888874 789999999875 4668
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||.+
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~--~~~~~l~dfg~~ 149 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKIADFGLA 149 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCeEEECCCccc
Confidence 999999985 78777754321 23788999999999999999999999999999999999985 788999999998
Q ss_pred cccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 225 (260)
T cd05069 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP---- 225 (260)
T ss_pred eEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence 75433221 1234567999999998889999999999999999999 99999988777766665443211100
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
-.....+..++..||.. .|..|++++++..+|..
T Consensus 226 --------~~~~~~~~~li~~~l~~----~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 --------QGCPESLHELMKLCWKK----DPDERPTFEYIQSFLED 259 (260)
T ss_pred --------cccCHHHHHHHHHHccC----CcccCcCHHHHHHHHhc
Confidence 01234567777777774 48889999998877753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=273.82 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=194.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
++|++.+.||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.+ +||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL------SHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC------CCCCeeeEEEEEccCCCcEE
Confidence 57999999999999999999864 345699999886544456678888888776 47899999999998889999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+.+ +|.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCcccee
Confidence 9999974 57666653322 2889999999999999999999999999999999999985 78899999998865
Q ss_pred cccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 224 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH----- 224 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC-----
Confidence 433211 1234567999999998889999999999999999999 999998877777666665443322111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
.....+..++..||... |..|.+++++..
T Consensus 225 -------~~~~~~~~li~~cl~~~----p~~Rp~~~~ll~ 253 (256)
T cd05113 225 -------LASEKVYAIMYSCWHEK----AEERPTFQQLLS 253 (256)
T ss_pred -------CCCHHHHHHHHHHcCCC----cccCCCHHHHHH
Confidence 12357788888898655 778888887763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.93 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=197.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+|++++.||+|+||.||++.+..+++.||+|.++.. ......+.+|+.+++.++ ||||+++++.+......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV------SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC------CCcHHhhhhheecCCeE
Confidence 3689999999999999999999989999999988753 233456778888888764 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCC
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++||||+.+ +|..++.... ....+++..+..++.||+.||.|||+ .+|+|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 149 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGV 149 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCC
Confidence 999999986 4555544321 11238999999999999999999997 59999999999999995 78899999999
Q ss_pred ccccccc-cccccccCCCCCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 570 SCFQTDN-LCLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 570 a~~~~~~-~~~~~gt~~Y~APE~l~~~------~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+...... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 150 SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred cccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 8654332 3335678899999998654 35789999999999999999999998766555444443332222211
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.. -.....+..++..||.. .|..|.+++++. +|+....
T Consensus 230 ~~---------~~~~~~~~~li~~~l~~----~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 230 LP---------SGYSDDAQDFVAKCLNK----IPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CC---------cccCHHHHHHHHHHccc----CcccCCCHHHHhcChhhhhcc
Confidence 10 01234666777777754 588899999988 8886543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.67 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=193.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-Ce
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-~~ 490 (697)
+|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++ |+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK------HPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeecCCCCE
Confidence 4899999999999999999999999999999987532 23345667777777764 78999999988643 46
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+++ +|.+.+..... ..+++..+..++.|++.||.+||++||+|+||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~--~~~~~l~df~~ 148 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGI 148 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec--CCcEEEecccc
Confidence 8999999974 66666653221 23789999999999999999999999999999999999984 78899999999
Q ss_pred ccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+...... .....+++.|+|||++.+..++.++|+|||||++++|++|+.||...+.......+.....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---- 224 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPK---- 224 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCcc----
Confidence 8654322 233467889999999999889999999999999999999999998877766665554432211110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+..++..||.. .|..|.+++++. +|+
T Consensus 225 --------~~~~~~~~li~~~l~~----~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 225 --------DYSPELGELIATMLSK----RPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------ccCHHHHHHHHHHhcc----CcccCCCHHHHhcCCCC
Confidence 1123455566666554 488999999988 765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=299.08 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=205.9
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCC----cEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g----~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
+++...+-.+.++||+|+||.||+|..+..+ ..||+|..+. .......++.|.++++.++ |||||+
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~------H~NVVr 225 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN------HPNVVR 225 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC------CCCEEE
Confidence 4555666777799999999999999865432 2389999884 2455678889999999875 889999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+||+......++||||+|. |+|.++++..... ++..+...++.+.+.||+|||+++++||||-.+|+|+.. +
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~-----v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~--~ 298 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS-----LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK--K 298 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC-----CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC--C
Confidence 9999999999999999997 4788888766542 889999999999999999999999999999999999995 6
Q ss_pred ceEEEeeCCCccccccccc---cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHH-
Q 005415 560 CEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG- 634 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~- 634 (697)
+.+||+|||+++....... ...-+..|+|||.+....|+.++|||||||++||+.+ |..||++....++.++|+.
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN 378 (474)
T ss_pred CeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence 7789999999876542111 1124578999999999999999999999999999999 8999999999999999844
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
....+.+ ...+..+..++..||... +..|.++.++..|+.
T Consensus 379 ~~r~~~~------------~~~p~~~~~~~~~c~~~~----p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 379 GYRMPIP------------SKTPKELAKVMKQCWKKD----PEDRPTMSTIKKKLE 418 (474)
T ss_pred CccCCCC------------CCCHHHHHHHHHHhccCC----hhhccCHHHHHHHHH
Confidence 3222222 144567888999999876 777888877775554
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=278.83 Aligned_cols=257 Identities=26% Similarity=0.360 Sum_probs=205.3
Q ss_pred CceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+-|++. +.||+|+++.|--+....+|..+|||++.+.. ..+.+..+|++++..++ +|+||++|+++|++++..
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceE
Confidence 345554 68999999999999999999999999997643 44578899999999986 589999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeCCC
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DFGl 569 (697)
|||||-|.| .|+..+..... |++.++.+++++|+.||.|||.+||.||||||+|||... +.-.-+||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999975 56666654443 999999999999999999999999999999999999864 2234689999987
Q ss_pred cccc----------ccccccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----------
Q 005415 570 SCFQ----------TDNLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDA---------- 624 (697)
Q Consensus 570 a~~~----------~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---------- 624 (697)
..-. +....+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.|.=
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 6432 12334568888999999873 2358999999999999999999999997641
Q ss_pred -----HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 625 -----VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 625 -----~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
...++..|.+..-.+|...| ..+.....+...+++...+..|+++.+.. ||.....+
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdW-------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDW-------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhh-------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 23455556555555555333 24445667777888888888899998888 89886554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=320.46 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=206.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..+|.|+++||+|+||.|.+++.+.+++.||+|++++- ......+..|..||...+ .+.|++++-.|++.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n------s~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN------SEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC------cHHHHHHHHHhcCc
Confidence 46899999999999999999999999999999999761 233456777888876654 35899999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.++|+||||++ |+|..++.... .+++.-++.++..|+.||.-||+.|+|||||||+||||+. .|+|||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~--~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK--SGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc--cCcEeeccc
Confidence 99999999997 56777765443 2889999999999999999999999999999999999995 999999999
Q ss_pred CCccccccc----cccccccCCCCCchhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh--
Q 005415 568 GSSCFQTDN----LCLYVQSRSYRAPEVII----G-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML-- 636 (697)
Q Consensus 568 Gla~~~~~~----~~~~~gt~~Y~APE~l~----~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l-- 636 (697)
|.+..+... ....+|||.|++||++. + +.|+..+|.|||||++|||+.|..||..++..+.+.+|+.-.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 998776533 23468999999999995 3 458999999999999999999999999999999999998652
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC---HHHHH--HhhcccCCCCC
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT---LEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t---~e~~~--~wl~~~~~n~~ 697 (697)
-.+|.+. +...-.+ .....|..-+..|+. +|+.. ||..+++|+.|
T Consensus 300 l~FP~~~---------------~VSeeak-dLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 300 LSFPDET---------------DVSEEAK-DLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred cCCCccc---------------ccCHHHH-HHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 2233111 1111112 223334444566777 89988 99999999765
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=269.58 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=200.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+++.++ ||||+++++++....+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK------HPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC------CCCeeeeEeeecCCCeE
Confidence 699999999999999999999999999999998743 233456778888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~ 148 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIA 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccce
Confidence 999999974 67666653222 12788899999999999999999999999999999999985 778999999998
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....+++.|+|||++.+..++.++|+|||||++++|++|..||...+..+.+..++....++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~------- 221 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV------- 221 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC-------
Confidence 6654322 224578889999999988899999999999999999999999988877777766643221111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.......+..++..||.. .|..|+++.+++ +|+
T Consensus 222 -----~~~~~~~~~~li~~~l~~----~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 222 -----SSHYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----cccCCHHHHHHHHHHhhC----ChhhCcCHHHHhhCcCC
Confidence 112244677888888764 588999999988 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.47 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=200.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++.++||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC------CcchhhHHHhcccCCe
Confidence 47999999999999999999998899999999876432 22345677888888764 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+.++++..+..... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~ 147 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFA 147 (286)
T ss_pred EEEEEecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeee
Confidence 999999999876654432221 2789999999999999999999999999999999999985 788999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|.+||......+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 654322 2234578889999998764 478899999999999999999999998888888888877766654432211
Q ss_pred ccc--------ccc----------cccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 647 GQE--------IYK----------YFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 647 ~~~--------~~~----------~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... ... .-.-...+..++..||.. .|..|.++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~----~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRI----DPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcC----CcccchhHHHHhcCCCC
Confidence 000 000 001123455666666643 488899998887 663
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.36 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=196.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..+|++.+.||+|++|.||+|.+..+++.|++|.+.... .....+.+|+.+++.+. |+||+++++.+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~------h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC------CCCEeeEEEEEEeCCEE
Confidence 368999999999999999999999999999999987533 23356677888887664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~--~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCEEECccccc
Confidence 999999975 566665321 2788899999999999999999999999999999999985 778999999988
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+.. .+.++...
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~---- 238 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQN---- 238 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCCCC----
Confidence 654322 2234678899999999988899999999999999999999999988776554433322 11111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
...-...+..++..||. ..|..|.++++++ +|+...
T Consensus 239 -----~~~~~~~l~~li~~~l~----~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 239 -----PEKLSAIFRDFLNRCLD----MDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----ccccCHHHHHHHHHHCc----CCcccCcCHHHHhhChhhhcc
Confidence 00112345566666664 4488899999998 888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=303.87 Aligned_cols=206 Identities=27% Similarity=0.363 Sum_probs=174.4
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+...-.+-|...+.||+|+||.||+++++.+|+.||||.+++. ....+...+|++++++++ |+|||+++++-
T Consensus 7 l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn------h~NIVk~f~ie 80 (732)
T KOG4250|consen 7 LTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN------HPNIVKLFDIE 80 (732)
T ss_pred cccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC------chhhhhhcccC
Confidence 3333446788889999999999999999999999999999863 345678889999999996 78999999987
Q ss_pred EecC------eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 486 YHLE------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 486 ~~~~------~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
.... ...+|||||. |+|+..+.......+ +++.+++.++.++..||.|||++|||||||||.||++-...
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~G---LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYG---LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE 157 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcCcccccC---CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC
Confidence 6543 5789999997 567766655443333 99999999999999999999999999999999999987543
Q ss_pred cc--eEEEeeCCCccccccc--cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 559 RC--EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 559 ~~--~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
+| ..||+|||.|+...+. ....+||+.|.+||++.. +.|+..+|.|||||++|+++||..||..
T Consensus 158 dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 33 5699999999887654 456899999999999984 7899999999999999999999999954
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.92 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=205.5
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
|++.+.||.|++|+||+|.+..+++.|+||.+...... .....+|+..++.+. +|+||+++++++......++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-----CCCCchhHHHHhhcCCcEEE
Confidence 67899999999999999999888999999998754221 123345666665553 38899999999999999999
Q ss_pred EEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 494 VmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
||||+++++.+.+..... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 v~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~ 149 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREI 149 (283)
T ss_pred EEecCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceec
Confidence 999998888887765431 22789999999999999999999999999999999999995 889999999998765
Q ss_pred ccc--cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 574 TDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 574 ~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
... .....++..|+|||++.+ ..++.++|+||||+++++|++|++||+..+..+.+.++...++.++...+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 432 233567888999998854 45789999999999999999999999999999999999999988877655433221
Q ss_pred cccc-----------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 651 YKYF-----------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 651 ~~~~-----------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
...+ .....+..+++.||. ..|..|.|+++++ +|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~----~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR----WDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcc----cCcccCCCHHHHhhCCCC
Confidence 1111 112445566666665 3488899999988 764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=270.04 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=194.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
++|++.+.||.|+||.||+|.+..+++.+++|++.... .....+.+|+.+++.++ ||||+++++++.....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR------HPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC------CCChhceEEEEEeCCEEE
Confidence 67999999999999999999998899999999988543 33466778888887764 889999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++|||+++ +|.+++..... .+++..+..++.|++.||.|||+++|+|+||+|+||+++. ++.++|+|||.+.
T Consensus 77 l~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~ 149 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSA 149 (262)
T ss_pred EEEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC--CCCEEECccccch
Confidence 99999986 55555543311 2889999999999999999999999999999999999995 7889999999987
Q ss_pred ccccc---cccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......+...--+++. ..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~- 227 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK-LK- 227 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc-cc-
Confidence 64432 2334678889999999877 7889999999999999999999999887766555444322111111 00
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
. .......+..+++.||... |..|.+++++.
T Consensus 228 ~------~~~~~~~~~~li~~~l~~~----p~~Rpt~~~il 258 (262)
T cd06613 228 D------KEKWSPVFHDFIKKCLTKD----PKKRPTATKLL 258 (262)
T ss_pred c------hhhhhHHHHHHHHHHcCCC----hhhCCCHHHHh
Confidence 0 0011235667777777643 77889988876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.35 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=192.5
Q ss_pred cCceEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d-----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... .....+.+|+.+++.+. +||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 46899999999999999999974 3457789999987532 23456778999998874 389999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc----------------------------------------------------
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~---------------------------------------------------- 512 (697)
......++||||+. |+|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999997 5677776542210
Q ss_pred -----------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 513 -----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 513 -----------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
.....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccC
Confidence 01124778889999999999999999999999999999999984 77899999999875443
Q ss_pred ccc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 576 NLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 576 ~~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
... ...++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+++.....+..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 338 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS-------- 338 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--------
Confidence 221 1233567999999999999999999999999999998 99999876544433333221111100
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
. -.....+..++..||... |..|+++.+++.
T Consensus 339 -~--~~~~~~l~~li~~cl~~d----P~~RPs~~eil~ 369 (375)
T cd05104 339 -P--ECAPSEMYDIMKSCWDAD----PLKRPTFKQIVQ 369 (375)
T ss_pred -C--CCCCHHHHHHHHHHccCC----hhHCcCHHHHHH
Confidence 0 012346778888888755 778888888773
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=293.38 Aligned_cols=197 Identities=23% Similarity=0.362 Sum_probs=167.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-eE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~-~l 491 (697)
+.|.-...||+|+||.||+|. ..++..||||.+...... ..++..|+.++..++ |||+|+|+|||.+.+ +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~-l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~------H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGV-LSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR------HPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEE-ECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC------CcCcccEEEEEecCCceE
Confidence 456666789999999999998 456699999988765543 456999999998885 789999999999988 59
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC---ccccCCCCccccccccCcceEEEeeC
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g---IvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+||+||+. |+|.+.+...... .++|..+..|+.++|+||+|||+.. ||||||||+|||++. +..+||+||
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~--~~~aKlsDF 221 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE--DFNAKLSDF 221 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC--CCCEEccCc
Confidence 99999998 5777766543321 4899999999999999999999853 999999999999995 899999999
Q ss_pred CCcccccc-cccc--c-cccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005415 568 GSSCFQTD-NLCL--Y-VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (697)
Q Consensus 568 Gla~~~~~-~~~~--~-~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~ 623 (697)
|+|+.... .... . .||.+|+|||++..+..+.|+|||||||+|+||+||+.|....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99976654 3222 2 7999999999999888999999999999999999999888653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=272.44 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=191.8
Q ss_pred eEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
|++.+.||+|+||.||+|.+..+ +..||+|+++... .....+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD------HPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC------CCCeeeEEeeeccCC
Confidence 57889999999999999987543 4789999987542 23456777888887764 789999999887654
Q ss_pred e------EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 490 H------LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 490 ~------l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
. .++||||+. ++|..++...........+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeE
Confidence 4 799999997 466666644332222334889999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccccc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
||+|||++........ ....+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876433221 1234567999999988889999999999999999999 999999888777666654321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
... ........+..++..||... |..|+++.++...|.
T Consensus 233 ~~~------------~~~~~~~~~~~li~~~l~~~----p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 233 RLK------------QPEDCLDELYDLMYSCWRAD----PKDRPTFTKLREVLE 270 (273)
T ss_pred CCC------------CCcCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHHH
Confidence 110 01123346667777776644 778889988886654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=280.06 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=199.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
....+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~~~~~~~ 85 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR------HPNTIEYKGCYL 85 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEE
Confidence 34567999999999999999999998899999999986422 23345677888887764 789999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.....++||||+.+++.+++..... .+++..+..++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~d 158 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLAD 158 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEee
Confidence 9999999999999988877754332 2889999999999999999999999999999999999985 78899999
Q ss_pred CCCccccccccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|.+||.+.+....+..+.... ++...
T Consensus 159 fg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~- 235 (307)
T cd06607 159 FGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLS- 235 (307)
T ss_pred cCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-CCCCC-
Confidence 9998655433 3356788999999874 3458889999999999999999999998877666555443211 11100
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. ......+..++..||... |..|.+++++. +|+..
T Consensus 236 -------~--~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 236 -------S--NDWSDYFRNFVDSCLQKI----PQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -------c--hhhCHHHHHHHHHHhcCC----hhhCcCHHHHhcChhhcc
Confidence 0 012235677777777655 77888998887 88764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=274.42 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=189.7
Q ss_pred EEEEEeccCCCCceEEEEEC----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 417 YVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 417 ~i~e~LG~G~fG~Vy~a~d~----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.+.+.||.|+||.||+|.+. ..+..|+||+++.. ......+.+|+++++.++ ||||+++++++.....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR------HPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS------BTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc------cccccccccccccccc
Confidence 56889999999999999987 45688999999653 233577888888888874 7899999999998888
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+. ++|.+++..... ..+++..+..|+.||+.||.|||+++|+|++|+++||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTT
T ss_pred cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence 999999997 678888876511 22889999999999999999999999999999999999995 78999999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+...... .........|+|||.+.+..++.++||||||+++|||++ |+.||...+..+.+..+.+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---- 225 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---- 225 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce----
Confidence 8765221 122345677999999998889999999999999999999 789999888888777763322211
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..-.....++.++..||... |..|++++++.
T Consensus 226 --------~~~~~~~~~~~li~~C~~~~----p~~RPs~~~i~ 256 (259)
T PF07714_consen 226 --------IPDNCPKDIYSLIQQCWSHD----PEKRPSFQEIL 256 (259)
T ss_dssp --------SBTTSBHHHHHHHHHHT-SS----GGGS--HHHHH
T ss_pred --------eccchhHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 11124567889999999977 77888887765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=268.44 Aligned_cols=248 Identities=26% Similarity=0.293 Sum_probs=199.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||+|++|.||+|.+..+++.+|||.+... ......+.+|+.+++.++ ||||+++++.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS------HPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC------CCchhheeeeEecCCEE
Confidence 589999999999999999999999999999998753 233456777888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++..... ..+++..+..++.|++.||.|||++||+|+||+|+||+++. +++.++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCc
Confidence 999999975 67777654321 22788999999999999999999999999999999999975 3557899999998
Q ss_pred ccccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 571 CFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 571 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+......++......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 222 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS------- 222 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC-------
Confidence 7654332 2346788999999999888899999999999999999999999887776666555432211100
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
......+..++..||... |..|.|+++++ +|+
T Consensus 223 -----~~~~~~l~~li~~~l~~~----p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 223 -----DRYSPDLRQLILSMLNLD----PSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----CCcCHHHHHHHHHHccCC----hhhCCCHHHHhhCCCC
Confidence 012346778888888644 88899999988 664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=268.73 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=197.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
++|++.+.||.|+||.||+|.+..+++.|++|.+..... ...+.+|+.+++.+ +||||+++++++......++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCCcEEE
Confidence 579999999999999999999988899999999986544 56788899988887 48899999999999999999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
++||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchh
Confidence 9999985 5666654322 22889999999999999999999999999999999999995 77899999999876
Q ss_pred ccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 573 QTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
..... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...........+.... +..+ .
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~---- 220 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP---PPTL-S---- 220 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC---CCCC-C----
Confidence 54332 23457889999999999899999999999999999999999998766554333321110 0000 0
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... .....+..++..||.. .|..|.++++++ +|+
T Consensus 221 ~~~--~~~~~~~~~i~~~l~~----~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 221 DPE--KWSPEFNDFVKKCLVK----DPEERPSAIQLLQHPFI 256 (256)
T ss_pred chh--hcCHHHHHHHHHHHhc----ChhhCcCHHHHhcCCCC
Confidence 000 1123566777777765 488899999998 775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.13 Aligned_cols=253 Identities=28% Similarity=0.343 Sum_probs=199.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|++|.||++.+..+++.||+|.+.... ....++.+|+++++.+. ||||+++++.+......
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN------SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC------CCchhhhheeeecCCEE
Confidence 36788899999999999999999999999999987642 33456677888877764 78999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCC
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 99999998 67777765432 238889999999999999999999 99999999999999995 78899999998
Q ss_pred ccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHhhCCCCHHH
Q 005415 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-----VVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 570 a~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-----~~e~l~~I~~~lg~~p~e~ 643 (697)
+...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+... .+...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 224 (265)
T cd06605 148 SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPPRL 224 (265)
T ss_pred chhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCCCC
Confidence 8654322 122567889999999999899999999999999999999999997542 22333333221 11100
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
. ... ....+..++..||... |..|+|+++++ +|++.+++
T Consensus 225 ~------~~~--~~~~~~~li~~~l~~~----p~~Rpt~~~ll~~~~~~~~~~ 265 (265)
T cd06605 225 P------SGK--FSPDFQDFVNLCLIKD----PRERPSYKELLEHPFIKKYES 265 (265)
T ss_pred C------hhh--cCHHHHHHHHHHcCCC----chhCcCHHHHhhCchhhcccC
Confidence 0 000 2335666777776644 89999999999 99998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=274.66 Aligned_cols=257 Identities=30% Similarity=0.432 Sum_probs=209.5
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
|++.+.||+|++|.||+|.+..+++.||+|++... .........|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC------CCCHHHHHhhhhcCCceE
Confidence 67788999999999999999999999999999864 333456677888888774 789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+||||++++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~ 147 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARA 147 (282)
T ss_pred EEecCcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccc
Confidence 999999999888887543 12889999999999999999999999999999999999995 78899999999876
Q ss_pred ccccc---ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 573 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 573 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+....+.+.++.+.++.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 54322 223456789999999776 78999999999999999999999999999999999999999988887765443
Q ss_pred ccc-------ccc---------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 649 EIY-------KYF---------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 649 ~~~-------~~~---------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... .+. .-...+..++..||. .-|..|+++++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~----~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQ----YNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhc----cCcccCCCHHHHhhCcCC
Confidence 332 000 012234445555554 4588999999998 885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=269.44 Aligned_cols=247 Identities=20% Similarity=0.274 Sum_probs=195.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-~~~~l~ 492 (697)
.+|++.+.||+|+||.||++.. .+..||+|.++.... ...+.+|+.+++.++ |+|++++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLR------HSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-HHHHHHHHHHHHhCC------CCCeeeEEEEEEcCCCceE
Confidence 5799999999999999999975 478899999875543 356778888888774 789999999765 446789
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||++ ++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--DNVAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--CCcEEecCCccce
Confidence 9999997 577777654322 23788999999999999999999999999999999999985 7899999999987
Q ss_pred ccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
...........+..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.+...+..
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 220 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---------- 220 (256)
T ss_pred eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC----------
Confidence 65544444455678999999998889999999999999999998 9999988777666655533211100
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
. -.....+..++..||.. .|..|.|++++..+|..
T Consensus 221 ~--~~~~~~~~~li~~~l~~----~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 P--DGCPPVVYDVMKQCWHL----DAATRPSFLQLREQLEH 255 (256)
T ss_pred C--CCCCHHHHHHHHHHhcC----ChhhCcCHHHHHHHHhc
Confidence 0 01235677777888774 48889999999877653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=273.09 Aligned_cols=253 Identities=17% Similarity=0.213 Sum_probs=192.4
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+|+.+++.++ ||||++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~iv~~~ 75 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN------CHHVVRLL 75 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCeeeEE
Confidence 3456789999999999999999998642 45789999986432 22345667887777664 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccC----CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~----~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+++......++||||+. ++|.+++....... ....+++..+..++.|++.||.|||+.+++|+||||+||+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~- 154 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 154 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-
Confidence 99999999999999997 46766664322110 1123677888999999999999999999999999999999995
Q ss_pred CcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~ 631 (697)
++.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..
T Consensus 155 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred -CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 7889999999986543221 11234678999999998889999999999999999999 7999998877766665
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.....+... -.....+..++..||.. .|..|+++.+++
T Consensus 234 ~~~~~~~~~~------------~~~~~~~~~li~~~l~~----~p~~Rps~~e~l 272 (277)
T cd05062 234 VMEGGLLDKP------------DNCPDMLFELMRMCWQY----NPKMRPSFLEII 272 (277)
T ss_pred HHcCCcCCCC------------CCCCHHHHHHHHHHcCC----ChhhCcCHHHHH
Confidence 5432211110 01234566777777775 477888888876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=277.52 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=194.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..+|++++.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.+ +|+||+++++++......
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCCEE
Confidence 378999999999999999999999999999999987533 2334566788777765 488999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++.. . .+++..+..++.|++.||.|||+.+|+||||||+|||++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~--~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEECcCccc
Confidence 999999975 55555432 1 2788899999999999999999999999999999999985 788999999988
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~---- 237 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN---- 237 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCCCC----
Confidence 654332 2234678899999999998899999999999999999999999987665443332211 12111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.......+..++..||. ..|..|.+++++. +|+..-.
T Consensus 238 -----~~~~~~~~~~li~~~l~----~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 238 -----PERLSAVFRDFLNRCLE----MDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -----ccccCHHHHHHHHHHcc----CChhhCcCHHHHhcCchhcccc
Confidence 00112234445555544 4578899999999 8987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=272.84 Aligned_cols=256 Identities=20% Similarity=0.257 Sum_probs=197.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||.|+||.||+|.+... +..||+|.+.... .....+.+|+.+++.+ +||||+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~ 76 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF------NCHHVVRLLG 76 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC------CCCceeEEEE
Confidence 3457899999999999999999987643 4889999987543 2234566777777665 3789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||+.+|+||||||+||+++.
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-- 154 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-- 154 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--
Confidence 9999999999999997 5777776543211 11223678899999999999999999999999999999999995
Q ss_pred cceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 005415 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I 632 (697)
++.+||+|||+++..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 788999999998654322 122345678999999988889999999999999999998 99999988877766655
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
... ..++. .......+..++..||... |..|.|++++..+|.
T Consensus 235 ~~~-~~~~~-----------~~~~~~~~~~li~~~l~~~----p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDG-GHLDL-----------PENCPDKLLELMRMCWQYN----PKMRPTFLEIVSSLK 276 (277)
T ss_pred hcC-CCCCC-----------CCCCCHHHHHHHHHHcCCC----hhhCCCHHHHHHHhc
Confidence 421 11110 0112456777778887655 888999999987664
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.19 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=196.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~---- 488 (697)
.++|.+.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+. +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEeccccC
Confidence 57899999999999999999999999999999999765444566778888888774 389999999998754
Q ss_pred -CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 489 -EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 489 -~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.+|+|+||||+||+++. ++.++|+|
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~d 171 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVD 171 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEee
Confidence 358999999975 666666532211 123789999999999999999999999999999999999985 77899999
Q ss_pred CCCccccccc---cccccccCCCCCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~---~~~~~gt~~Y~APE~l~~~-----~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||++...... .....++..|+|||.+... .++.++|||||||++|+|++|++||........+..+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-- 249 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-- 249 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--
Confidence 9998754322 2234678889999998643 36889999999999999999999998877665555543221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+.... ..-.....+..++..||.. .|..|.++++++ +|+
T Consensus 250 -~~~~~-------~~~~~~~~l~~li~~~l~~----~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 250 -PPTLL-------HPEKWCRSFNHFISQCLIK----DFEARPSVTHLLEHPFI 290 (291)
T ss_pred -CCCCC-------cccccCHHHHHHHHHHhhc----ChhhCcCHHHHhcCccc
Confidence 11110 0001123566777777765 488899999988 786
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=272.10 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=190.4
Q ss_pred EEEEEeccCCCCceEEEEECCCCc--EEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 417 YVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 417 ~i~e~LG~G~fG~Vy~a~d~~~g~--~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
.+.+.||+|+||.||+|++..++. .||+|.++.. ......+..|+.+++.++ ||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEccCCcc
Confidence 467889999999999999877665 6999988753 333456777888887764 78999999987532
Q ss_pred ---CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 489 ---EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 489 ---~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
...+++|||+. ++|..++...........+++..+..++.||+.||.|||+++|+||||||+|||++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE--NMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC--CCCEEE
Confidence 35789999997 567666644332222334889999999999999999999999999999999999985 788999
Q ss_pred eeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+....+....+...-..
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987654321 12234678999999999889999999999999999999 89999987776666555432111
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+ ........+..++..||... |..|++++++..-|
T Consensus 234 ~------------~~~~~~~~~~~li~~~l~~~----p~~Rps~~~l~~~l 268 (272)
T cd05075 234 K------------QPPDCLDGLYSLMSSCWLLN----PKDRPSFETLRCEL 268 (272)
T ss_pred C------------CCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence 1 11123346778888888755 77888888887433
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=270.23 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=196.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||.|++|.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++.+......++||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN------HPFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC------CCCEeeeeeeEEcCCccEEEEec
Confidence 799999999999999999999999987532 23456777888887764 78999999999999999999999
Q ss_pred cc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+. ++|.+++..... ++...+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~~------l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 75 CLGGELWTILRDRGL------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcc
Confidence 87 567776654321 788999999999999999999999999999999999985 788999999998765443
Q ss_pred --cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHhhCCCCHHHHhhcccccc
Q 005415 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEMLMQGQEIYK 652 (697)
Q Consensus 577 --~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~--~~e~l~~I~~~lg~~p~e~~~~~~~~~~ 652 (697)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.+..+......+.. +.
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 217 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF---------PN 217 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC---------Cc
Confidence 233467889999999988889999999999999999999999998766 55555555421111110 00
Q ss_pred cccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 653 YFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 653 ~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
.....+..++..||... |..|.+ ++++. +|++..+|+
T Consensus 218 --~~~~~~~~~i~~~l~~~----p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 218 --YIDKAAKDLIKQLLRRN----PEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred --ccCHHHHHHHHHHccCC----hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 11457788888888755 777877 78888 999988776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=267.76 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=199.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.++|++.+.||.|++|.||+|.+ .++.||+|.+........++.+|+.+++.++ |+||+++++++......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLR------HPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcC------CcceeeeEEEEcCCCCeE
Confidence 46799999999999999999986 4889999999876555567888998888874 789999999999889999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||++ ++|.+++..... ..+++..+..++.|++.||.|||+++++|+||||+||+++. ++.++|+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~--~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC--CCCEEEccccccc
Confidence 9999998 577777654332 13889999999999999999999999999999999999985 7889999999997
Q ss_pred ccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
...........+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..... +.
T Consensus 151 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~---------- 219 (256)
T cd05039 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-ME---------- 219 (256)
T ss_pred ccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CC----------
Confidence 76544443445667999999988889999999999999999998 9999988877665555433211 00
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
........+..++..||... |..|+++++++.-|.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELD----PAKRPTFKQLREQLA 254 (256)
T ss_pred -CccCCCHHHHHHHHHHhccC----hhhCcCHHHHHHHHh
Confidence 00122456777777777654 888999998886553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=272.20 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=191.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+|.+.+.||.|++|.||+|.+..+++.||+|.+..... ....+.+|+.+++.++ ||||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ------HENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC------CCCeeeEEEE
Confidence 57888999999999999999988999999998864321 2245667888888774 7899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+......++||||+++ +|..++.... .+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~--~~~~~ 146 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIK 146 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC--CCCEE
Confidence 9999999999999975 5666664322 2788899999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccc---------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 564 IIDLGSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 564 L~DFGla~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 9999988655421 1123567889999999988899999999999999999999999987766554444433
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
...+..+ ......+..++..||... |..|.++++++ +|+
T Consensus 227 ~~~~~~~------------~~~~~~~~~li~~~l~~~----p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 NASPEIP------------SNISSEAIDFLEKTFEID----HNKRPTAAELLKHPFL 267 (267)
T ss_pred cCCCcCC------------cccCHHHHHHHHHHccCC----chhCcCHHHHhhCCCC
Confidence 2111100 112345556666666544 78889998887 664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.81 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=196.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.+.||+|++|.||+|.+.. ++..||+|.+.... .....+..|+.+++.++ |+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~ 78 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN------HQNIVRLIGVS 78 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 4679999999999999999999877 77899999886432 22345677887777764 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES-GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~-~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~v 562 (697)
......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||+++++||||||+||+++... ...+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 99889999999996 5777777554321 1122488999999999999999999999999999999999998532 3468
Q ss_pred EEeeCCCccccccccc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876532211 1223467999999998889999999999999999997 999999887766655543321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
. ++. .......+..++..||... |..|+++++++..|.
T Consensus 239 ~-~~~-----------~~~~~~~~~~~i~~cl~~~----p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 R-LDP-----------PKGCPGPVYRIMTDCWQHT----PEDRPNFATILERIQ 276 (277)
T ss_pred c-CCC-----------CCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHhh
Confidence 1 110 0112346667777777754 888999998886654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=278.96 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=190.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcE--EEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~--VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||.||+|.+..++.. +++|.++.. ......+.+|+.++..+. +|+||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECCCC
Confidence 5799999999999999999998777754 577766532 233456778998888873 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
..++||||+. ++|.+++....... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~-- 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC--
Confidence 9999999997 57777775433211 1124789999999999999999999999999999999999985
Q ss_pred cceEEEeeCCCcccccccccc--ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHh
Q 005415 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~~~--~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~ 635 (697)
++.+||+|||++......... ...+..|+|||.+.+..++.++|||||||++|+|+| |..||.+.+..+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 788999999998643222111 223567999999988889999999999999999998 99999887776655554221
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
... .........+..++..||... |..|.++++++
T Consensus 240 ~~~------------~~~~~~~~~~~~li~~~l~~~----p~~Rp~~~~il 274 (303)
T cd05088 240 YRL------------EKPLNCDDEVYDLMRQCWREK----PYERPSFAQIL 274 (303)
T ss_pred CcC------------CCCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 110 001122345667777777655 66777777766
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.42 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=194.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECC-------CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+..++|.+.+.||+|+||.||+|.+.. ....+|+|+++.. ......+..|+.+++.+. +||||+++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~ 89 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINL 89 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEeeE
Confidence 445789999999999999999998643 2357999999754 233456777888888774 37899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
++++......++||||+. ++|.+++...... .....+++..+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999997 5787777653321 11224788999999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~ 624 (697)
||+++. ++.+||+|||.+....... ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus 170 Nill~~--~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 170 NVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred heEEcC--CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999985 7889999999986543211 11223467999999998889999999999999999998 999998877
Q ss_pred HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 625 ~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..+....+..... ++ ........+..++..||... |..|++++++.
T Consensus 248 ~~~~~~~~~~~~~-~~-----------~~~~~~~~~~~li~~~l~~~----p~~Rps~~evl 293 (307)
T cd05098 248 VEELFKLLKEGHR-MD-----------KPSNCTNELYMMMRDCWHAV----PSQRPTFKQLV 293 (307)
T ss_pred HHHHHHHHHcCCC-CC-----------CCCcCCHHHHHHHHHHcccC----hhhCcCHHHHH
Confidence 7665555432211 00 01122346667777787754 77888888877
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=279.84 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=190.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|++.+.||+|+||.||+|.+..++. .||+|+++.. ......+.+|+.+++.+. ||||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEc
Confidence 3679999999999999999999866655 4899998743 233456777888887764 889999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.. ..++|+||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~ 151 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKIT 151 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEc
Confidence 64 5678999987 567777664332 2788889999999999999999999999999999999985 7789999
Q ss_pred eCCCccccccccc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++........ ....+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.. .+......+
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~ 230 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL 230 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC
Confidence 9999976543221 1223567999999999999999999999999999998 99999887665543 333322222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
+. .......+..++..||... |..|.++.++...
T Consensus 231 ~~-----------~~~~~~~~~~li~~cl~~~----p~~Rps~~~l~~~ 264 (316)
T cd05108 231 PQ-----------PPICTIDVYMIMVKCWMID----ADSRPKFRELIIE 264 (316)
T ss_pred CC-----------CCCCCHHHHHHHHHHccCC----hhhCcCHHHHHHH
Confidence 11 1123456788999999854 7778888877733
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.93 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=201.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCC----------------cEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----------------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 474 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g----------------~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~ 474 (697)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .....+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS------ 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC------
Confidence 468999999999999999999876543 568999987543 34456778899888875
Q ss_pred CCceeEEEEEEEecCeEEEEEEccc-cchHHHHHhhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 475 EHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 475 hpnIv~l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~-----~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
||||+++++++......++|||++. ++|..++...... .....+++..++.++.|++.||.|||+++|+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 7899999999999999999999997 4676666543310 011248899999999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 621 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt--G~~PF~ 621 (697)
|+||+++. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC--CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999995 689999999998654322 122345678999999998889999999999999999998 788998
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..+..+.+..+............ ..........+..++..||... |..|.+++++..||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~----p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRD----EEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHHHHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccC----hhcCCCHHHHHHHhc
Confidence 87777777666544222111100 0011112346788888888655 889999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=313.40 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=204.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
...-++.+.||+|+||.||.|.-... ...||||.+++. ......++.|..++..+ +|||||+++|++
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f------~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF------DHPNIVSLIGVC 764 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCcceeeEEEee
Confidence 45678889999999999999976432 235899998864 44456677777777766 489999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
.+....+|++|||. |+|+.+++..+... ....++..++..++.||++|+.||+++++|||||..+|+|++. ...+|
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~VK 842 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRVVK 842 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCcEE
Confidence 99999999999997 67888887653221 2334889999999999999999999999999999999999996 68999
Q ss_pred EeeCCCccccccccccc-----cccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhC
Q 005415 564 IIDLGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 564 L~DFGla~~~~~~~~~~-----~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg 637 (697)
|+|||+|+..-+..... .-+..|||||.+....++.|+|||||||+|||++| |..||++.+..+++..+++..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 99999998433322211 22467999999999999999999999999999999 999999999988887654432
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
++...-.++..++.+|.+||+.....+|.-+...+|..
T Consensus 922 -----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 922 -----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred -----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 33334467889999999999998777776665555544
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=274.35 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=190.9
Q ss_pred CceEEEEEeccCCCCceEEEEE----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..|++.+.||+|+||+||+|.+ ...+..|++|.+.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH------HPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC------CCCeeeEEEEEec
Confidence 4689999999999999999985 3456889999987432 23356777888888774 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQES-----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~-----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~ 555 (697)
....++||||+. ++|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 999999999997 4677776432210 0112377888999999999999999999999999999999999
Q ss_pred ccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 005415 556 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (697)
Q Consensus 556 ~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l 629 (697)
. ++.+||+|||++...... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+...+.
T Consensus 159 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 E--QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 778999999998654322 122344667999999998889999999999999999999 99999887766655
Q ss_pred HHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 630 ~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
..+.... .++. .......+..++..||... |..|+++.++..
T Consensus 237 ~~~~~~~-~~~~-----------~~~~~~~~~~li~~cl~~~----p~~Rp~~~~i~~ 278 (283)
T cd05090 237 EMVRKRQ-LLPC-----------SEDCPPRMYSLMTECWQEG----PSRRPRFKDIHT 278 (283)
T ss_pred HHHHcCC-cCCC-----------CCCCCHHHHHHHHHHcccC----cccCcCHHHHHH
Confidence 5543311 1110 0122456777777787655 677777777663
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=276.20 Aligned_cols=250 Identities=18% Similarity=0.241 Sum_probs=193.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCc--EEEEEEEec--chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~--~VAVKii~~--~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||.|+||.||+|.+..++. .+++|.++. .......+.+|+.++..+. +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-----CCCchhheEEEEccCC
Confidence 479999999999999999999877664 478888874 2233456778888888774 3889999999999989
Q ss_pred eEEEEEEccc-cchHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
..++||||++ ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--
Confidence 9999999997 57777775432111 1124888999999999999999999999999999999999985
Q ss_pred cceEEEeeCCCcccccccccc--ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHh
Q 005415 559 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~~~--~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~ 635 (697)
++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 788999999998643322221 122456999999998889999999999999999998 99999988877776665443
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
...... ......+..++..||... |..|.+++++.
T Consensus 235 ~~~~~~------------~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~ 269 (297)
T cd05089 235 YRMEKP------------RNCDDEVYELMRQCWRDR----PYERPPFAQIS 269 (297)
T ss_pred CCCCCC------------CCCCHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 221111 112346777888888755 67777777775
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.30 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=194.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+... ......+..|+++++.++ ||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS------HHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC------CCCeeEEEEEEcc
Confidence 4578999999999999999999876554 7999998754 233456677777777664 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+..++||||+++ +|..++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++. ++.+||+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 150 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSD 150 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECC
Confidence 9999999999985 5555554322 12788999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccccccc------ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~~~~------~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 9998654332111 112356999999998889999999999999999998 999998887777666665432211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
. ..+....+..++..||... |..|++++++...|.
T Consensus 231 ~------------~~~~~~~~~~li~~c~~~~----p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 231 A------------PMDCPSAVYQLMLQCWQQD----RARRPRFVDIVNLLD 265 (268)
T ss_pred C------------CCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHHH
Confidence 1 1123456778888888655 788889988886553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=268.21 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=189.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..|++.+.||+|+||.||++.+..+++.||||.+.... .....+.+|+.+++.+. ||||+++++++..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL------HERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC------CCCeeeEEeEecc
Confidence 46999999999999999999999999999999886321 22346677888888774 7899999999876
Q ss_pred c--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 ~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
. ..+++||||+++ +|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC--CCCEEE
Confidence 4 568899999975 6766665322 1778889999999999999999999999999999999985 788999
Q ss_pred eeCCCcccccc------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||........+.++......
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC
Confidence 99998865432 122345788999999999888999999999999999999999999877655554443321111
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+. .+. .....+..++..||. .+..|++.++.. +|+
T Consensus 228 ~~---------~~~--~~~~~~~~~i~~~l~-----~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 228 PV---------LPP--HVSDHCRDFLKRIFV-----EAKLRPSADELLRHTFV 264 (265)
T ss_pred CC---------Cch--hhCHHHHHHHHHHhc-----ChhhCCCHHHHhcCccc
Confidence 10 000 111234456666662 478899999888 775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=273.66 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=192.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-----
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY----- 486 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~----- 486 (697)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.........+..|+.+++.+. +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeeecccC
Confidence 357899999999999999999999999999999998764444456778888888874 3889999999885
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.....++||||+++ +|.+++...... ...+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEc
Confidence 34568999999975 566655422211 123788899999999999999999999999999999999995 7789999
Q ss_pred eCCCccccccc---cccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||++...... .....+++.|+|||++.. ..++.++|||||||++|+|++|+.||........+..+...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-- 244 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-- 244 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--
Confidence 99998754332 223468899999999853 45788999999999999999999999877655444333221
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.++. .. ... .....+..++..||... |..|.+++++. +|+
T Consensus 245 ~~~~-~~-----~~~--~~~~~~~~li~~~l~~~----p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPT-LH-----QPE--LWSNEFNDFIRKCLTKD----YEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCc-cc-----CCC--CcCHHHHHHHHHHccCC----cccCCCHHHHhhcccC
Confidence 1110 00 000 11235666777776544 88899999987 553
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=276.42 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=196.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .....+..|+.++..+. +|+||+++++++......+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecCCcEE
Confidence 4667788999999999999999999999999987532 33456677887777664 3789999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++|||+..++..+....... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGISG 156 (288)
T ss_pred EEEecccCCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchhH
Confidence 99999988766654332111 112388999999999999999999974 9999999999999985 7789999999986
Q ss_pred ccccc--cccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN--LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~--~~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||..... ....+.+.....++....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~- 233 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSN- 233 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCC-
Confidence 54332 2234678889999999876 689999999999999999999999976542 222222222211111100
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
.........+..++..||... |..|.+++++. +|+..+.+.+
T Consensus 234 ----~~~~~~~~~l~~li~~~l~~~----p~~Rpt~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 234 ----SEEREFSPSFVNFINLCLIKD----ESKRPKYKELLEHPFIKDYEERN 277 (288)
T ss_pred ----cCCCccCHHHHHHHHHHccCC----hhhCcCHHHHhcChhhhchhhcc
Confidence 000122345667777777654 88899999998 9997665543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.20 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=197.9
Q ss_pred CceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..|.+.+.||.|+||+||++.+. .++..+|+|.+... ......+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ------HEHIVKFYGVCVE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEec
Confidence 57999999999999999999852 34567999998753 333456788888888774 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhc-------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~-------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
....++||||+. ++|.+++..... ......+++..+..++.||+.||.|||++|++||||||+|||++. +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~--~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE--N 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--C
Confidence 999999999997 567666653321 011123889999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~ 633 (697)
+.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 889999999987543221 12234678999999998889999999999999999998 999998888777776665
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
....... . -.....+..++..||... |..|++++++...|..
T Consensus 237 ~~~~~~~----------~--~~~~~~l~~li~~~l~~~----p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 237 QGRVLQR----------P--RTCPKEVYDLMLGCWQRE----PHMRLNIKEIHSLLQN 278 (288)
T ss_pred cCCcCCC----------C--CCCCHHHHHHHHHHccCC----hhhCCCHHHHHHHHHH
Confidence 4221110 0 012346777777777655 8889999998866653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=273.21 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=190.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.++ ||||+++++.+......+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~------h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK------HSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC------CCCeeeEEEEEEeCCEEE
Confidence 57899999999999999999999999999999987543 22345667887777764 889999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+++ +|.+++.... .+++..++.++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~~ 154 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSA 154 (267)
T ss_pred EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECcceeee
Confidence 99999985 6766665332 2889999999999999999999999999999999999985 7889999999986
Q ss_pred ccccc---cccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
..... .....++..|+|||++. ...++.++|+|||||++|+|++|..||........+..+......++ .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~-~ 232 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-KL-K 232 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC-cc-c
Confidence 54332 23356889999999984 44588899999999999999999999976655444433322111111 00 0
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
........+..++..||.. .|..|.++++++
T Consensus 233 ------~~~~~~~~~~~li~~~l~~----~P~~R~~~~~ll 263 (267)
T cd06645 233 ------DKMKWSNSFHHFVKMALTK----NPKKRPTAEKLL 263 (267)
T ss_pred ------ccCCCCHHHHHHHHHHccC----CchhCcCHHHHh
Confidence 0001123456666666653 588899998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.03 Aligned_cols=202 Identities=22% Similarity=0.297 Sum_probs=162.9
Q ss_pred EEEEeccC--CCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 418 VTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 418 i~e~LG~G--~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
++++||+| +|++||++.+..+|+.||+|++... ......+.+|+.+++.++ ||||+++++++...+..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN------HPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEEECCEEE
Confidence 56789999 6789999999999999999999753 233345667888887764 889999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+. ++|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.++++||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhh
Confidence 9999998 4666666543221 2788999999999999999999999999999999999985 7789999998643
Q ss_pred cccc----------ccccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 572 FQTD----------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 572 ~~~~----------~~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 221 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence 3211 1112345677999999976 3589999999999999999999999987665544433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=267.89 Aligned_cols=239 Identities=23% Similarity=0.319 Sum_probs=184.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++ ||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS------HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEcCCCCeEEEEee
Confidence 3689999999999999999999999988643 334466788888888764 88999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+.+ +|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||.+......
T Consensus 75 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 75 VQGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE--KNVLKISDFGMSREEEDG 147 (252)
T ss_pred ccCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC--CCcEEECccccCcccccc
Confidence 975 5666654321 12788999999999999999999999999999999999985 778999999998654332
Q ss_pred ccc-----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 577 LCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 577 ~~~-----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
... ...+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..... ++..
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~-------- 218 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-LPCP-------- 218 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-CCCc--------
Confidence 111 122456999999998889999999999999999998 9999987766554444432211 1100
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
-.....+..++..||. ..|..|++++++..
T Consensus 219 ---~~~~~~~~~li~~~l~----~~p~~Rps~~~~~~ 248 (252)
T cd05084 219 ---ELCPDAVYRLMERCWE----YDPGQRPSFSTVHQ 248 (252)
T ss_pred ---ccCCHHHHHHHHHHcC----CChhhCcCHHHHHH
Confidence 0112345555555555 45888999988873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=308.24 Aligned_cols=206 Identities=25% Similarity=0.361 Sum_probs=170.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.++||+|+||.||+|.+..+++.||||+++.. .....++.+|+++++.++ ||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~------HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI------HPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC------CcCcCeEEEEEeeCC
Confidence 6899999999999999999999999999999998753 223456778888888774 889999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccC-----CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~-----~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
..++||||+++ +|.+++....... ....++...+..++.||+.||.|||++||+||||||+|||++. ++.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEE
Confidence 99999999975 6666665321110 1122566778899999999999999999999999999999985 78899
Q ss_pred EeeCCCcccccc---------------------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 564 IIDLGSSCFQTD---------------------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 564 L~DFGla~~~~~---------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||+||..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999865411 01124689999999999999999999999999999999999999987
Q ss_pred CcHHH
Q 005415 623 DAVVM 627 (697)
Q Consensus 623 ~~~~e 627 (697)
.....
T Consensus 234 ~~~~k 238 (932)
T PRK13184 234 KKGRK 238 (932)
T ss_pred cchhh
Confidence 65443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=282.69 Aligned_cols=265 Identities=30% Similarity=0.471 Sum_probs=207.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ........+|+.+++.+. +||||+++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~ni~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc-----CCCCccceeeeecc
Confidence 4567899999999999999999999889999999988532 223345667888888872 37899999999875
Q ss_pred c--CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 488 L--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 488 ~--~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
. ...++||||+.++|..++... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~--~~~~kl~ 149 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLA 149 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEe
Confidence 4 468999999998887776532 2788888999999999999999999999999999999985 8899999
Q ss_pred eCCCccccccc--------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 566 DLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 566 DFGla~~~~~~--------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||.+....+.+.++....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99988654322 223567889999998865 457889999999999999999999999998888899988888
Q ss_pred CCCCHHHHhhccc-----------------cccccc-CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 637 GPIDLEMLMQGQE-----------------IYKYFT-KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 637 g~~p~e~~~~~~~-----------------~~~~~~-~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+.++.+.+..... ....+. ....+..++..||. ..|..|.++++++ +|+...+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~----~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV----FNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhcc----CCcccccCHHHHhhChhhhhhc
Confidence 8776544332100 000011 12345556666664 3488899999999 8987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.41 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=196.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
++|++.+.||+|+||.||+|.+... ...||||+++.. ......+.+|+.+++.++ ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD------HPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCcceEeEEEecC
Confidence 5799999999999999999988644 468999998753 233456677888887774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ++.++|+||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~df 150 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECcc
Confidence 999999999975 67776654322 3889999999999999999999999999999999999985 788999999
Q ss_pred CCcccccccc---c--cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 568 GSSCFQTDNL---C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 568 Gla~~~~~~~---~--~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|++....... . ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.+....+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP 230 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9987654211 1 1223567999999998889999999999999999998 99999887777766666543222211
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
......+..++..||... |..|++++++...|.
T Consensus 231 ------------~~~~~~l~~li~~cl~~~----p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 231 ------------MDCPSALYQLMLDCWQKD----RNERPTFSQIVSTLD 263 (266)
T ss_pred ------------CCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHHH
Confidence 123456778888888755 778889988886553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=266.32 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=188.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||.|++|.||+|.+..+++.||+|+++.... .......|..++.. ..+|+||+++++++...+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~-----~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-----QGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh-----cCCCCCeeeeeeeEEcCCeEEEEE
Confidence 568999999999999999999999999875421 11122233333222 235899999999999999999999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+.+ +|..++.... .+++..+..++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|||++....
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceecc
Confidence 99975 6666654322 2788999999999999999999999999999999999985 7889999999886543
Q ss_pred cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccc
Q 005415 575 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (697)
Q Consensus 575 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~ 654 (697)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.......+.... .
T Consensus 149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 218 (260)
T cd05611 149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK---------E 218 (260)
T ss_pred c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccc---------c
Confidence 3 23346788999999999888899999999999999999999999888777666665432211111100 0
Q ss_pred cCCchhhhhHHHHHHHHHHHhhhhcc---CHHHHH--HhhcccCC
Q 005415 655 TKEYDLYYINEVCFANIFISLVVIRL---TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 655 ~~~~~l~~i~~~cw~~l~~~~~~~r~---t~e~~~--~wl~~~~~ 694 (697)
.....+..++..||. ..|..|. +.++++ +|+..++|
T Consensus 219 ~~~~~~~~~i~~~l~----~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 219 FCSPEAVDLINRLLC----MDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHHHHHHHHcc----CCHHHccCCCcHHHHHcChHhhcCCC
Confidence 123455566666665 4477777 457777 99988765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.61 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
.++|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+|+.+++.++ ||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC------CCcchhhHhhhcccccc
Confidence 579999999999999999999999999999999986533 33456778888888774 78999999776543
Q ss_pred -----------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 489 -----------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 489 -----------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
...++||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~- 149 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT- 149 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-
Confidence 357999999998877666421 2788999999999999999999999999999999999975
Q ss_pred CcceEEEeeCCCccccccc------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~ 630 (697)
.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3567899999998654321 122356788999998754 458889999999999999999999999888877777
Q ss_pred HHHHhhCCCCHHHHhhccc-ccccc-----cC-------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 631 RIIGMLGPIDLEMLMQGQE-IYKYF-----TK-------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~-~~~~~-----~~-------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+.........+....... ..... .. ...+..-..+...+.+...|..|.++++++ +|+.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 7766554433322211100 00000 00 001112222333444445588899999999 99973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=272.27 Aligned_cols=252 Identities=18% Similarity=0.231 Sum_probs=190.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||+|+||.||+|.++ ..+..||+|.+..... ....+.+|+.+++.++ ||||+++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~ 76 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT------CHHVVRLLG 76 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC------CCCeeeEEE
Confidence 44578999999999999999999754 2356899998875432 2234556777776654 789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++......++||||+. ++|.+++...... .+...++...+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~-- 154 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH-- 154 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC--
Confidence 9999999999999997 6777777543211 11233567788999999999999999999999999999999995
Q ss_pred cceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 005415 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I 632 (697)
++.++|+|||+++...... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+.+..+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7889999999986543221 11234567999999998889999999999999999999 89999888777766655
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..... ++. .-.....+..++..||... |..|++++++.
T Consensus 235 ~~~~~-~~~-----------~~~~~~~~~~li~~~l~~~----p~~Rps~~~ll 272 (288)
T cd05061 235 MDGGY-LDQ-----------PDNCPERVTDLMRMCWQFN----PKMRPTFLEIV 272 (288)
T ss_pred HcCCC-CCC-----------CCCCCHHHHHHHHHHcCCC----hhHCcCHHHHH
Confidence 43211 110 0112346777888887765 66777887776
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.67 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=197.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.+.||+|+||.||++.+... ...+|+|++.... .....+.+|+.+++.+. +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~~~ 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLGVC 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEE
Confidence 46899999999999999999987643 3789999987532 23345778888888773 378999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~----------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
......+++|||+. ++|..++..... ......+++..+..++.|++.||.|||+.+|+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 99999999999997 567777653210 0122348899999999999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~ 628 (697)
+. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 166 ~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 166 TE--DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred cC--CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 85 7899999999987644321 11223567999999998889999999999999999998 9999998877766
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
...+...... .........+..++..||... |..|.|++++...|.
T Consensus 244 ~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~----p~~Rps~~eil~~l~ 289 (293)
T cd05053 244 FKLLKEGYRM------------EKPQNCTQELYHLMRDCWHEV----PSQRPTFKQLVEDLD 289 (293)
T ss_pred HHHHHcCCcC------------CCCCCCCHHHHHHHHHHcccC----cccCcCHHHHHHHHH
Confidence 6655332111 111233456778888888755 778899988885553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.46 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=193.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+|+..+.||+|++|+||+|.+..+++.|++|.+.... .....+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ------HPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC------CCCchheeeeEecC
Confidence 5788899999999999999998899999999986532 23456777888877764 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||+++ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~ 146 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADF 146 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccC
Confidence 999999999975 6666664322 2788899999999999999999999999999999999985 788999999
Q ss_pred CCccccccc--cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~~--~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|.+...... .....++..|+|||.+.... ++.++|+|||||++|+|++|+.||........+..+......+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 222 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP---- 222 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC----
Confidence 988654332 23456788899999998776 89999999999999999999999987765555544432111110
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... .....+..++..||.. .|..|.+++++. +||
T Consensus 223 -----~~~--~~~~~~~~li~~~l~~----~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 223 -----IPD--HLSDEAKDFILKCLQR----DPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----cCC--CcCHHHHHHHHHHhhc----CcccCcCHHHHhcCCCC
Confidence 000 1234566667777664 588899999988 775
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.48 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=184.7
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||+|.+..+++.||+|++..... .......|..+++.++. ..||+|+++++++......++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEEEEEe
Confidence 38999999999999999999999999875321 11223445555555543 358999999999999999999999
Q ss_pred ccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+.++ |...+... ..+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||++.....
T Consensus 78 ~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 78 LMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (278)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCc
Confidence 99854 54444322 13899999999999999999999999999999999999985 77899999999865432
Q ss_pred -ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 576 -NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 576 -~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~---~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
......++..|+|||++.+. .++.++||||+||++|+|++|+.||..... ......+... .+. .
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~---------~ 218 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVE---------L 218 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--CCC---------C
Confidence 22345788999999999754 588999999999999999999999976532 2221111110 000 0
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCCCC
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n~~ 697 (697)
.. .....+..++..|+.. .+..|. +++++. +|+...++|.+
T Consensus 219 ~~--~~s~~~~~li~~~l~~----~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 219 PD--SFSPELRSLLEGLLQR----DVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred CC--cCCHHHHHHHHHHhhc----CHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 00 1123445555555544 466666 898888 99998888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=274.82 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=199.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~-------~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+...+|++.+.||+|+||.||+|++. ..+..||+|.+... ......+.+|+.+++.+. +||||+++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~ 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchhe
Confidence 44678999999999999999999753 23457999998753 233456788988888773 37899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
++++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 999999999999999997 47777776432211 1123788889999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~ 624 (697)
||+++. ++.+||+|||.+....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 167 Nili~~--~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTE--NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcC--CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999985 7889999999987653221 11234567999999998889999999999999999998 899998888
Q ss_pred HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 625 ~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..+....+...... .........+..++..||... |..|.+++++...|
T Consensus 245 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~cl~~~----p~~Rps~~e~l~~l 293 (304)
T cd05101 245 VEELFKLLKEGHRM------------DKPANCTNELYMMMRDCWHAI----PSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHHHHHcCCcC------------CCCCCCCHHHHHHHHHHcccC----hhhCCCHHHHHHHH
Confidence 77766665332111 111234567888889999754 78888888887433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=288.22 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=192.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.++||.|+||.||+|.+... +..||||+++... .....+.+|+.+++.+. .||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 46899999999999999999987433 3579999997532 33456788999988874 389999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc----------------------------------------------------
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~---------------------------------------------------- 512 (697)
.....++|||||+. ++|.+++......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999997 5677666543210
Q ss_pred --------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 513 --------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 513 --------------------------------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
.....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 001237788889999999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~ 628 (697)
+. ++.+||+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 271 ~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 271 AQ--GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred eC--CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 85 7789999999987543221 12345678999999999899999999999999999997 9999987654433
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+...+.....++. .-.....+..++..||... |..|+++.++...|
T Consensus 349 ~~~~~~~~~~~~~-----------~~~~~~~l~~li~~cl~~d----P~~RPt~~~l~~~l 394 (400)
T cd05105 349 FYNKIKSGYRMAK-----------PDHATQEVYDIMVKCWNSE----PEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHHhcCCCCCC-----------CccCCHHHHHHHHHHCccC----HhHCcCHHHHHHHH
Confidence 3332222111110 1123346778888888765 77788887776444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=283.96 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=193.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
-..+|++.+.||.|+||.||+|.+.. +++.||+|+++... .....+..|+.+++.+. +|+||++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~~ 79 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLGA 79 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheeee
Confidence 34689999999999999999997533 45789999987432 23356677888888773 37899999998
Q ss_pred EEec-CeEEEEEEcccc-chHHHHHhhhccC-------------------------------------------------
Q 005415 485 FYHL-EHLFIVCELLRA-NLYEFQKFNQESG------------------------------------------------- 513 (697)
Q Consensus 485 f~~~-~~l~LVmEyl~g-sL~~~l~~~~~~~------------------------------------------------- 513 (697)
+... ..++++|||+.+ +|.+++.......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8754 678999999985 6666664322100
Q ss_pred ------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccc-----ccccc
Q 005415 514 ------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQ 582 (697)
Q Consensus 514 ------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~g 582 (697)
....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.++|+|||++....... ....+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCCC
Confidence 0124788999999999999999999999999999999999985 7889999999987643221 12344
Q ss_pred cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhh
Q 005415 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLY 661 (697)
Q Consensus 583 t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~ 661 (697)
+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+...-.+. .. -.....+.
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~~ 306 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---------AP--EYATPEIY 306 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC---------CC--ccCCHHHH
Confidence 678999999999999999999999999999998 9999987654444433322111110 00 11234677
Q ss_pred hhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 662 YINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 662 ~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.++..||+.. |..|+++++++..|.
T Consensus 307 ~l~~~cl~~~----p~~RPs~~ell~~l~ 331 (337)
T cd05054 307 SIMLDCWHNN----PEDRPTFSELVEILG 331 (337)
T ss_pred HHHHHHccCC----hhhCcCHHHHHHHHH
Confidence 8888888755 778999999886654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=265.48 Aligned_cols=246 Identities=20% Similarity=0.307 Sum_probs=195.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|++.+.||.|+||.||++.+. .+..+|+|++.........+.+|+++++.++ ||||+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS------HPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC------CCCeeeEEEEEccCCceEE
Confidence 47899999999999999999875 4678999998865544567888999998874 7899999999999999999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+.+ +|.+++..... .+++..+..++.|++.||.+||+.+++|+||||+||+++. ++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC--CCeEEECCCcceee
Confidence 9999985 55555543221 2788899999999999999999999999999999999984 77899999998865
Q ss_pred cccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||........+..+.+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 223 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP------ 223 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC------
Confidence 433211 1234567999999998889999999999999999998 99999888777766665432221111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
. .....+..++..||... |..|+++++++.+|
T Consensus 224 ----~--~~~~~~~~l~~~~l~~~----p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 ----R--LASQSVYELMQHCWKER----PEDRPSFSLLLHQL 255 (256)
T ss_pred ----C--CCCHHHHHHHHHHcccC----hhhCCCHHHHHHhh
Confidence 0 02346778888888654 88899999888665
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=271.16 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=197.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..|++++.||.|+||.||+|.+..++..||+|++.... .....+.+|+.+++.+. ||||+++++++......
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEECCEE
Confidence 46888999999999999999999999999999987532 33456677888777764 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccc
Confidence 999999975 566655421 2788889999999999999999999999999999999985 778999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.... ++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~------ 221 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTL------ 221 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCC------
Confidence 654432 222456788999999998889999999999999999999999998776655544432211 1110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
. ......+..++..||.. .|..|++++++. +|+.....
T Consensus 222 ---~--~~~~~~~~~li~~~l~~----~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 222 ---T--GEFSKPFKEFIDACLNK----DPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ---c--hhhhHHHHHHHHHHccc----CcccCcCHHHHHhChHhhhcch
Confidence 0 01234566777778764 488899999998 88875544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=292.81 Aligned_cols=207 Identities=24% Similarity=0.379 Sum_probs=181.2
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|.-++.||.|+||.||-|+|..+.+.||||.+..+ ......++.|+++|+.++ |||++.+-++|.....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~------HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR------HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc------CCCcccccceeeccch
Confidence 355567799999999999999999999999998743 334467788999998886 8999999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.|||||||-|+-.+++.-.+.. +.+.++..|..+.+.||+|||+.+.||||||..|||++. .|.|||+|||++
T Consensus 101 aWLVMEYClGSAsDlleVhkKp-----lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse--~g~VKLaDFGSA 173 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE--PGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhcc-----chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC--CCeeeeccccch
Confidence 9999999998877777655543 888999999999999999999999999999999999994 999999999998
Q ss_pred cccccccccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 571 CFQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 571 ~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
.... +...++|||+|||||+|+. +.|+-++||||||++..||.-.++|+-+-+....+..|.+.
T Consensus 174 si~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN 240 (948)
T KOG0577|consen 174 SIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 240 (948)
T ss_pred hhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc
Confidence 7554 3456899999999999974 46999999999999999999999999888888888887653
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=272.30 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=195.4
Q ss_pred ceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN------HPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC------CCCEeeEEEEEec
Confidence 47889999999999999998743 23578999887543 23456778888888774 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhcc------------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQES------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~------------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
....++||||+. ++|.+++...... .....+++..+..++.|++.||.|||+++|+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999998 5676666532211 112347888999999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~ 622 (697)
|+|||++. ++.+||+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999985 7889999999986543221 12234678999999988889999999999999999999 9999998
Q ss_pred CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 623 ~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.........+......+.+ ......+..++..||+.. |..|.++.++..+|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~i~~cl~~~----P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 233 IAPERLFNLLKTGYRMERP------------ENCSEEMYNLMLTCWKQE----PDKRPTFADISKELE 284 (290)
T ss_pred CCHHHHHHHHhCCCCCCCC------------CCCCHHHHHHHHHHccCC----cccCCCHHHHHHHHH
Confidence 8777665554332211111 122357788888888754 888999999986664
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=266.34 Aligned_cols=249 Identities=28% Similarity=0.358 Sum_probs=199.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.|++.+.||.|++|.||+|.+..+++.|+||++.... .....+..|+.++..++ |+||+++++++......+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE------SPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC------CCCeeeEEEEEccCCeEE
Confidence 6899999999999999999999999999999987653 34566778888888775 789999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~~ 147 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGIS 147 (264)
T ss_pred EEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCccc
Confidence 9999998 6677776543 228899999999999999999999 99999999999999985 788999999988
Q ss_pred cccccccc---cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHhhCCCCHHHH
Q 005415 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 571 ~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---~~e~l~~I~~~lg~~p~e~~ 644 (697)
........ ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+... .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~- 223 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---PPPSL- 223 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---CCCCC-
Confidence 76543222 3467888999999998889999999999999999999999997763 33334333311 11000
Q ss_pred hhccccccccc-CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 645 MQGQEIYKYFT-KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 645 ~~~~~~~~~~~-~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
. .. ....+..++..||. ..+..|+++++++ +|+..++
T Consensus 224 ------~--~~~~~~~l~~li~~~l~----~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 224 ------P--AEEFSPEFRDFISACLQ----KDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ------C--cccCCHHHHHHHHHHcc----CChhhCCCHHHHHhCHHHHhcc
Confidence 0 01 22456666666665 3588999999999 9987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.52 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=196.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++..++|++.++||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++ |+||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC------CCCcceEEEEEcC-C
Confidence 355689999999999999999999854 5567999998876555567888999988775 7899999999887 7
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. .+.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~ 147 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 147 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCCc
Confidence 7899999997 577777754321 23788889999999999999999999999999999999985 7899999999
Q ss_pred Cccccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
.+........ ...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+......+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~--- 224 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--- 224 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC---
Confidence 8865433211 1234567999999998889999999999999999999 9999998877666665543221110
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.-.....+..++..||... |..|.++.++..-|.
T Consensus 225 ---------~~~~~~~~~~~i~~~l~~~----p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 225 ---------PENCPEELYNIMMRCWKNR----PEERPTFEYIQSVLD 258 (260)
T ss_pred ---------cccCCHHHHHHHHHHcccC----cccCcCHHHHHHHHh
Confidence 0112335666777776544 788889888876554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=276.26 Aligned_cols=250 Identities=18% Similarity=0.201 Sum_probs=192.3
Q ss_pred CceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.+|++.+.||.|+||.||+|.+.. .+..||||+++.... ....+..|+.++..++ ||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ------HPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC------CCCcCeEEEEEc
Confidence 457888999999999999998754 357899999975432 2345667777776654 889999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~----------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~ 555 (697)
.....++++||+. ++|.+++..... ......+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 9999999999997 456666642211 01122378888999999999999999999999999999999998
Q ss_pred ccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 005415 556 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 629 (697)
Q Consensus 556 ~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l 629 (697)
. ++.+||+|||+++...... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus 159 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D--KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C--CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 4 7789999999986543221 12344678999999988889999999999999999998 99999988887777
Q ss_pred HHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 630 ~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
..+......+.. -.....+..++..||+.. |..|++++++..
T Consensus 237 ~~i~~~~~~~~~------------~~~~~~~~~li~~cl~~~----p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQVLPCP------------DDCPAWVYTLMLECWNEF----PSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCCcCCCC------------CCCCHHHHHHHHHHhCCC----cccCCCHHHHHH
Confidence 776543221110 123446778889999877 666777777663
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=270.29 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=200.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.|++.+.||.|+||.||+|.+..+++.||+|.++.. ......+.+|+.+++.+.. ..|||++++++++......+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---SQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---CCCCCeeeEeeeeeeCCEEE
Confidence 478899999999999999999999999999998753 3334567789999998865 35899999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+.+ +|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++. .+.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCcee
Confidence 99999975 565555321 2889999999999999999999999999999999999995 7889999999987
Q ss_pred ccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+... . +.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~-- 224 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-K--PPRLED-- 224 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-C--CCCCCc--
Confidence 65432 223467888999999865 44788999999999999999999999877654433322111 1 111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
......+..++..||... |..|.++++++ +|+.....++
T Consensus 225 ------~~~~~~~~~~i~~~l~~~----p~~R~~~~~il~~~~~~~~~~~~ 265 (277)
T cd06917 225 ------NGYSKLLREFVAACLDEE----PKERLSAEELLKSKWIKAHSKTP 265 (277)
T ss_pred ------ccCCHHHHHHHHHHcCCC----cccCcCHHHHhhChHhhccccCc
Confidence 012346677777777654 88899999998 9997766553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=299.56 Aligned_cols=201 Identities=29% Similarity=0.457 Sum_probs=171.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEe-cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-e---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H--- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~-~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-~--- 487 (697)
..+++|.+.|.+|||+.||+|++...|..||+|++- .++...+...+||.+++.|. +|+|||.+++... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccC
Confidence 468999999999999999999998888999999764 56777788999999999997 4899999999432 1
Q ss_pred ---cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcce
Q 005415 488 ---LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ---~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~ 561 (697)
.-.++|+||||. ++|.+++..+.... |++.++++|+.|+++|+++||.++ |||||||-+||||.. ++.
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~--~g~ 184 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA--DGN 184 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC--CCC
Confidence 135789999999 69999997654433 999999999999999999999997 999999999999995 889
Q ss_pred EEEeeCCCccccccccc------------cccccCCCCCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 562 IKIIDLGSSCFQTDNLC------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 562 vKL~DFGla~~~~~~~~------------~~~gt~~Y~APE~l---~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
.||||||.+.-...... ....|+.|+|||++ .+.+.+.|+|||+|||+||.||....||....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 99999999864332221 12458999999987 57789999999999999999999999997653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.05 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=197.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|.+.+.||+|++|.||+|.+..+++.||+|++... ......+..|..+++.++ +||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhcCCc
Confidence 4799999999999999999999999999999998753 222345667777777764 4889999999999999
Q ss_pred eEEEEEEcc-ccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl-~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++|||++ .++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCc
Confidence 999999999 567777775432 2899999999999999999999999999999999999985 7889999999
Q ss_pred Ccccccccc-----------------------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 569 SSCFQTDNL-----------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 569 la~~~~~~~-----------------------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
++....... ....++..|+|||.+.+..++.++|+||||++++++++|+.||...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 886543321 123567889999999888899999999999999999999999998876
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH----HHHH--Hhh
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL----EYAA--LWL 689 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~----e~~~--~wl 689 (697)
...+..+......++.. ....+..++..||.. .|..|.+. ++++ +|+
T Consensus 228 ~~~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~----~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 228 YLTFQKILKLEYSFPPN-------------FPPDAKDLIEKLLVL----DPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHhcCCCCCCc-------------cCHHHHHHHHHHhcC----CHhhCCCcccCHHHHhcCCCC
Confidence 66666655333222221 134566677777754 47778888 8887 664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=277.50 Aligned_cols=215 Identities=26% Similarity=0.358 Sum_probs=182.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
-++|..+++||+|.||+|-+++.+.+++.+|||++++. +.....-+.|-++|+..+ ||.+..|--.|+..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~------HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR------HPFLTSLKYSFQTQ 240 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc------CcHHHHhhhhhccC
Confidence 45688899999999999999999999999999999864 344556667778887764 88999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
+++|+||||..|+-+-+..... ..+++...+.+...|+.||.|||+++||.||||.+|+|++. +|++||+|||
T Consensus 241 drlCFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk--DGHIKitDFG 313 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK--DGHIKITDFG 313 (516)
T ss_pred ceEEEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc--CCceEeeecc
Confidence 9999999999865332222222 22899999999999999999999999999999999999995 9999999999
Q ss_pred Cccc---cccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 569 SSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 569 la~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
+++. .+....+++|||.|+|||++....|+.++|.|.+||++|||++|+.||.+.+...++..|+-.--.+|
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP 388 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence 9965 34456779999999999999999999999999999999999999999999888777777654333333
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=267.47 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=194.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCC---cEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g---~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+..|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEec
Confidence 368999999999999999999876544 379999886532 23456677888887763 8899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++||||||+|||++. ++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~d 149 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSD 149 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCC
Confidence 9999999999975 6666665332 12788999999999999999999999999999999999985 78899999
Q ss_pred CCCccccccccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||++........ ...++..|+|||.+.+..++.++|+|||||++|++++ |..||......+.+..+.+....+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC
Confidence 999876543221 1122457999999998889999999999999999887 999998887777666665432211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
. .......+..++..||... +..|++++++..-|
T Consensus 230 ~------------~~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~~~l 263 (267)
T cd05066 230 A------------PMDCPAALHQLMLDCWQKD----RNERPKFEQIVSIL 263 (267)
T ss_pred C------------CCCCCHHHHHHHHHHcccC----chhCCCHHHHHHHH
Confidence 1 1123456778888888765 77888888877433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=266.58 Aligned_cols=246 Identities=21% Similarity=0.269 Sum_probs=190.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK------HVNIVQYLGTCLD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC------CCCEeeEeeEeec
Confidence 588899999999999999986 578899999987432 12345667777777764 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~d 145 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLID 145 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC--CCeEEecc
Confidence 9999999999975 6666664322 2788999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccc---------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 567 LGSSCFQTD---------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 567 FGla~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 998865321 11234578899999999988899999999999999999999999987665544444433222
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..+. ... .....+..+++.||... |..|.++++++ +|+
T Consensus 226 ~~~~--------~~~--~~~~~~~~~i~~~l~~~----p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 LMPR--------LPD--SFSAAAIDFVTSCLTRD----QHERPSALQLLRHDFL 265 (265)
T ss_pred CCCC--------CCC--CCCHHHHHHHHHHhcCC----cccCCCHHHHhcCCCC
Confidence 2111 000 12335566666666544 78889999988 775
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=265.22 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=191.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
||++.+.||+|+||.||++.+..+++.|++|.++.... ....+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK------HPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC------CCChhheeeeEecCCEE
Confidence 69999999999999999999988999999999986433 4567788888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|+||+.+ +|.+.+.... .+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~ 146 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCA 146 (264)
T ss_pred EEEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999974 5666554321 2778889999999999999999999999999999999995 788999999998
Q ss_pred cccccccc-------cccccCCCCCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHhhCCC
Q 005415 571 CFQTDNLC-------LYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPI 639 (697)
Q Consensus 571 ~~~~~~~~-------~~~gt~~Y~APE~l~~~~---~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I~~~lg~~ 639 (697)
........ ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .....+.. +..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~ 224 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHK 224 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCC
Confidence 76543211 235678899999998766 889999999999999999999999765333 33322222 111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+. ..........+..++..||.. .|..|.++++++ +||
T Consensus 225 ~~--------~~~~~~~~~~~~~li~~~l~~----~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 PP--------IPDSLQLSPEGKDFLDRCLES----DPKKRPTASELLQHPFV 264 (264)
T ss_pred CC--------CCcccccCHHHHHHHHHHccC----CcccCCCHHHHhcCCCC
Confidence 10 111111234455666666654 488899999988 876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=265.50 Aligned_cols=246 Identities=24% Similarity=0.293 Sum_probs=194.0
Q ss_pred EEeccCCCCceEEEEECCC---CcEEEEEEEecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|+||.||+|.+... +..|++|+++..... ...+.+|+.+++.++ |+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------HPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC------CCChheeeeeecCCCceEEE
Confidence 4689999999999998766 899999999865432 467778888888774 78999999999999999999
Q ss_pred EEccc-cchHHHHHhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 495 CELLR-ANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~---~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
|||+. ++|.+++...... .....+++..+..++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEcccccc
Confidence 99994 6777776643210 00123899999999999999999999999999999999999995 689999999998
Q ss_pred cccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 571 CFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 571 ~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----- 227 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP----- 227 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 765543 223456788999999998889999999999999999999 699999988777777665411100
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
........+..++..||... +..|++++++...|
T Consensus 228 -------~~~~~~~~~~~li~~~l~~~----p~~Rps~~~l~~~l 261 (262)
T cd00192 228 -------KPEYCPDELYELMLSCWQLD----PEDRPTFSELVERL 261 (262)
T ss_pred -------CCccCChHHHHHHHHHccCC----cccCcCHHHHHHhh
Confidence 00112345666777766544 77899999887554
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=268.29 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=191.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.|++.+.||+|+||.||+|.+..+++ .||||++... ......+..|+.+++.+. ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CcCcceEEEEECCC
Confidence 568999999999999999999877664 6999998753 334457778888888764 88999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~--~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC--CCcEEECCC
Confidence 999999999985 5656654332 12788999999999999999999999999999999999984 788999999
Q ss_pred CCcccccccccc-----cc---ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 568 GSSCFQTDNLCL-----YV---QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 568 Gla~~~~~~~~~-----~~---gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|++......... .. .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~ 230 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL 230 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 988654332111 11 1346999999998899999999999999999987 99999888777766666433221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.. ......+..++..||... |..|++++++.
T Consensus 231 ~~~------------~~~~~~~~~li~~~l~~~----p~~Rp~~~~i~ 262 (269)
T cd05065 231 PPP------------MDCPTALHQLMLDCWQKD----RNARPKFGQIV 262 (269)
T ss_pred CCc------------ccCCHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 111 123456677778888654 77788888877
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=265.59 Aligned_cols=243 Identities=23% Similarity=0.248 Sum_probs=189.8
Q ss_pred EEeccCCCCceEEEEECCCC---cEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g---~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
++||+|+||.||+|.+...+ ..+|+|.+..... ....+.+|+.+++.+ +|+||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------DHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999876554 7899999886543 445677788888776 4789999999876 4568999
Q ss_pred EEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+|||++. ++.+||+|||.+...
T Consensus 74 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEecccccccee
Confidence 99987 56777776433 2789999999999999999999999999999999999985 788999999998765
Q ss_pred cccccc------ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 574 TDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 574 ~~~~~~------~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... ..++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.... +.+
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~------ 218 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-RLP------ 218 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCC------
Confidence 433221 112357999999998889999999999999999998 999998877766555553321 111
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcccC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGID 693 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~~ 693 (697)
........+..++..||... |..|+++.++..+|..+.
T Consensus 219 -----~~~~~~~~l~~li~~cl~~~----p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -----RPEECPQEIYSIMLSCWKYR----PEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhcCC----hhhCcCHHHHHHHHHhcc
Confidence 11123356777888888754 888999999987776543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=267.08 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=193.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
++|++.+.||+|+||.||++. .+++.||+|.++.... ...+.+|+.+++.++ ||||+++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-AQAFLEETAVMTKLH------HKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-HHHHHHHHHHHHhCC------CCCcCeEEEEEcCC-CcEE
Confidence 579999999999999999986 4788999999875432 356778888887764 78999999998764 5799
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. ++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCcccee
Confidence 999997 577777754322 23788899999999999999999999999999999999985 78899999999876
Q ss_pred cccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 573 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
..........+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+.+.....+.
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 219 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP---------- 219 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC----------
Confidence 5443333444677999999988889999999999999999998 99999988776665555332211111
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..++..||... |..|++++++..+|.
T Consensus 220 --~~~~~~~~~li~~~l~~~----p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 --EGCPADVYVLMTSCWETE----PKKRPSFHKLREKLE 252 (254)
T ss_pred --CcCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHHc
Confidence 112346677888888765 667888888876654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=277.06 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=195.9
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC-------CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-------GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-------g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+...+|++.+.||+|+||.||+|++... ...||+|+++.. ......+.+|+.+++.+. +||||+++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~ 83 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-----KHKNIINL 83 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-----CCCCeeee
Confidence 4456899999999999999999986432 346899988753 233467788999888874 37899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
++++.....++++|||+. ++|.+++...... .....+++..+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999997 4777777543211 11233778889999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~ 624 (697)
|||++. ++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 164 Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVTE--DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEcC--CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999985 7889999999987543321 11223467999999999899999999999999999999 999999888
Q ss_pred HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 625 ~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..+....+....... ........+..++..||... |..|.++++++..|
T Consensus 242 ~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~----p~~Rps~~ell~~l 290 (334)
T cd05100 242 VEELFKLLKEGHRMD------------KPANCTHELYMIMRECWHAV----PSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHHHHHcCCCCC------------CCCCCCHHHHHHHHHHcccC----hhhCcCHHHHHHHH
Confidence 777666654321111 01122346777788888755 77788888777333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=273.91 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=194.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC-------CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
...+|.+.+.||+|+||.||+|.+.. ....||+|+++... .....+..|+.+++.+. +||||++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 84 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINLL 84 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeEE
Confidence 34789999999999999999998632 34579999987532 33456778888887763 388999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
+++......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999899999999997 5677777543210 112348889999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcH
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~ 625 (697)
||++. ++.+||+|||.++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE--DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC--CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99985 7889999999987543221 11223457999999998889999999999999999999 9999998887
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.+.+..+...... .........+..++..||... |..|++++++...|
T Consensus 243 ~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~----p~~Rps~~~ll~~l 290 (314)
T cd05099 243 EELFKLLREGHRM------------DKPSNCTHELYMLMRECWHAV----PTQRPTFKQLVEAL 290 (314)
T ss_pred HHHHHHHHcCCCC------------CCCCCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence 7766665432110 011122346667777777655 67788877777444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=287.94 Aligned_cols=233 Identities=21% Similarity=0.325 Sum_probs=204.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+..+..+||-|.||.||.|.|++-.-.||||.++.+....+.++.|..+++.++ |||+|+|+++|..+..+||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik------HpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc------CccHHHHhhhhccCCCeEE
Confidence 4566788999999999999999999999999999999888899999999999986 7899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
|+|||. |+|++++....+.. ++.-.+..++.||..||.||..+++|||||..+|+|+.. +..+|++|||++++
T Consensus 341 iTEfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE--nhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHIVKVADFGLSRL 414 (1157)
T ss_pred EEecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc--cceEEeeccchhhh
Confidence 999996 89999998765543 677788899999999999999999999999999999995 88899999999998
Q ss_pred ccccc-ccccc---cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDNL-CLYVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~~-~~~~g---t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+.... +...| +.-|.|||.+..+.++.|+|||+|||+||||.| |..||++.+..+++..+ .++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL------------Ekg 482 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL------------EKG 482 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH------------hcc
Confidence 76543 33344 566999999999999999999999999999999 99999999877766554 445
Q ss_pred ccccccccCCchhhhhHHHHHHH
Q 005415 648 QEIYKYFTKEYDLYYINEVCFAN 670 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~ 670 (697)
.++...--|++..|.+|+.||+=
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~W 505 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNW 505 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcC
Confidence 55556667889999999999973
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=268.88 Aligned_cols=244 Identities=21% Similarity=0.261 Sum_probs=186.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|++.++||.|+||+||+|.+..++. .||+|+++.. ......+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV------GSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc------CCCCCceEEEEEc
Confidence 4689999999999999999999877765 4899998743 22334566677776655 4789999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
. ...+++|||++ ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL~ 151 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKIT 151 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEEC
Confidence 5 45778999997 577776653321 2889999999999999999999999999999999999984 7789999
Q ss_pred eCCCcccccccccc-----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++......... ..+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ...+
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~ 230 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL 230 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC
Confidence 99998765432211 223567999999998889999999999999999998 9999987766555444332 2222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.. -.....+..++..||... |..|.++.++.
T Consensus 231 ~~~-----------~~~~~~~~~li~~~l~~d----p~~Rp~~~~l~ 262 (279)
T cd05109 231 PQP-----------PICTIDVYMIMVKCWMID----SECRPRFRELV 262 (279)
T ss_pred CCC-----------ccCCHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 211 112346677888888755 66777777766
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=264.17 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=194.6
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cC
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--~~ 489 (697)
+|++.+.||.|+||.||++.+..+++.||+|++... .....++..|+.+++.++ ||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK------HPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC------CCccceeeeeeecCCCC
Confidence 589999999999999999999999999999998743 233456677888888774 7899999998864 45
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-----hcCccccCCCCccccccccCcceEE
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-----SLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH-----s~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
..+++|||++ ++|.+++..... ....+++..++.++.||+.||.||| +.+|+|+||+|+||+++. ++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEE
Confidence 6899999997 467777654322 1233889999999999999999999 889999999999999995 78999
Q ss_pred EeeCCCcccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....+..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC
Confidence 99999987654432 235678899999999988899999999999999999999999988876555555433211110
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
. . .....+..++..||. ..|..|+++++++ +||
T Consensus 231 ~----------~--~~~~~~~~l~~~~l~----~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 P----------Y--RYSSELNEVIKSMLN----VDPDKRPSTEELLQLPLI 265 (265)
T ss_pred c----------c--ccCHHHHHHHHHHcc----CCcccCCCHHHHhhCCCC
Confidence 0 0 112355566666665 3488899999988 664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=269.80 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=196.4
Q ss_pred CceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ....+.+|+.+++.++ |+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ------HEHIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC------CCCcceEEEEEcc
Confidence 57999999999999999999853 3456789999875432 2345677888777764 7899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
....++||||+. ++|.+++...... .....+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999996 5777776543210 11123788999999999999999999999999999999999995
Q ss_pred cCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~ 630 (697)
++.++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 159 --~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 --NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred --CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7899999999986543321 22345678999999999899999999999999999999 999998877766665
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+........ .-.....+..++..||... |..|++++++..+|.
T Consensus 237 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~----P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 237 CITQGRVLER------------PRVCPKEVYDIMLGCWQRE----PQQRLNIKEIYKILH 280 (291)
T ss_pred HHhCCCCCCC------------CccCCHHHHHHHHHHcccC----hhhCcCHHHHHHHHH
Confidence 5433211110 0112346778888888755 888899998886664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=265.16 Aligned_cols=238 Identities=23% Similarity=0.273 Sum_probs=184.0
Q ss_pred EeccCCCCceEEEEE--CCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 421 YLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d--~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
.||+|+||.||+|.+ ..++..+|+|+++... ...+.+..|+.+++.+. ||||+++++++. ....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD------NPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC------CCCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 4578899999987432 33456777888887764 789999999875 45678999
Q ss_pred Ecccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
||+++ .|.+++.... .+++..+..++.|++.||.|||++||+||||||.||+++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALG 146 (257)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccC
Confidence 99985 5766664322 2889999999999999999999999999999999999985 7789999999987654
Q ss_pred cccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 575 DNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 575 ~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.... ...++..|+|||.+....++.++|+|||||++|||++ |..||......+....+.+...++.+
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 220 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP------ 220 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC------
Confidence 3221 1223568999999988889999999999999999998 99999988777766665432211110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
-.....+..++..||... |..|++++.+..-|
T Consensus 221 ------~~~~~~l~~li~~~~~~~----p~~Rp~~~~i~~~l 252 (257)
T cd05116 221 ------QRCPPEMYDLMKLCWTYG----VDERPGFAVVELRL 252 (257)
T ss_pred ------CCCCHHHHHHHHHHhccC----chhCcCHHHHHHHH
Confidence 123456778888888766 66777777766433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=263.58 Aligned_cols=249 Identities=27% Similarity=0.326 Sum_probs=192.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||.|++|.||+|.+..+++.||+|.++.. ......+.+|+++++.++ |+||+++++++....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~------~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD------HPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCeeeeeeeeecCC
Confidence 5799999999999999999999989999999988632 223456778888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+.+ +|..++..... ....+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccc
Confidence 99999999985 67766653322 1223788999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~--~~e~l~~I~~~lg~~p~e~ 643 (697)
.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.....++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA- 230 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCCh-
Confidence 98654432 223467888999999998889999999999999999999999996543 223333332211111000
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
-.....+..++..||... |..|+++.++..
T Consensus 231 ----------~~~~~~~~~~i~~cl~~~----p~~Rp~~~~il~ 260 (267)
T cd08224 231 ----------DHYSEELRDLVSRCINPD----PEKRPDISYVLQ 260 (267)
T ss_pred ----------hhcCHHHHHHHHHHcCCC----cccCCCHHHHHH
Confidence 012335667777776544 788888887763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=273.75 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=197.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..|...+.||+|+||.||++.+..++..||+|.+.... .....+..|+.+++.++ |||++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK------HPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC------CCCEEEEEEEEeeCC
Confidence 45888899999999999999999999999999987432 22345667777777664 789999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
..++||||+.+++.+.+..... .+++..+..++.|++.||.|||+++|+||||+|+||+++. ++.++|+|||+
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg~ 171 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 171 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCCC
Confidence 9999999999988877654322 2788999999999999999999999999999999999985 78899999998
Q ss_pred ccccccccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+...... ....+++.|+|||.+. ...++.++|+|||||++|+|++|..||........+..+.....++...
T Consensus 172 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 246 (317)
T cd06635 172 ASIASPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---- 246 (317)
T ss_pred ccccCCc-ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCC----
Confidence 8654432 3356788999999984 3468889999999999999999999998877666666654432221110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
......+..++..||... |..|.+++++. +|+....
T Consensus 247 -------~~~~~~l~~li~~~l~~~----p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 247 -------NEWSDYFRNFVDSCLQKI----PQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -------ccccHHHHHHHHHHccCC----cccCcCHHHHHhChhhhccC
Confidence 012234667777777644 78888998888 7765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.11 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=195.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC--------------CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT--------------GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~--------------g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
.++|++.+.||+|+||.||++.+..+ ...||+|.++.. ......+.+|+++++.++ |+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~------h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK------NP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CC
Confidence 36899999999999999999986543 235899998753 233456778988888775 78
Q ss_pred ceeEEEEEEEecCeEEEEEEcccc-chHHHHHhhhcc------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 477 nIv~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
||+++++++......++||||+.+ +|.+++...... .....+++..+..++.|++.||.|||+++++|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999999999999999999974 666666432210 0112267888999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPN 622 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt--G~~PF~~ 622 (697)
+||+++. ++.+||+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN--HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC--CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999985 7789999999986543221 11234668999999998889999999999999999998 7789988
Q ss_pred CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 623 ~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+..+.+..+.+.......... ..........+..++..||... |..|++++++..+|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~----p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIY-----LSQTPLCPSPVFKLMMRCWSRD----IKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhcccccc-----CCCCCCCCHHHHHHHHHHcCCC----chhCcCHHHHHHHHh
Confidence 7777666655442211110000 0001112356778888888755 788888888876654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=269.10 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=191.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|++|.||++.+..+++.+|||.+... ......+.+|+.+++.++ |+||+++++++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN------HPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc------CCchhhhhheeEeCC
Confidence 4688999999999999999999999999999987642 223456677888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+++|||+.+ +|.+++...... ...+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcch
Confidence 99999999985 676666533221 223889999999999999999999999999999999999985 7889999999
Q ss_pred Ccccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~--~e~l~~I~~~lg~~p~e~ 643 (697)
++....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ......+... ..++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLPS 230 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCCCCc
Confidence 886554322 234678899999999988899999999999999999999999976543 2333333221 1111100
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
. .....+..++..||... |..|+|++++.
T Consensus 231 --------~--~~~~~~~~li~~~l~~~----p~~Rpt~~~i~ 259 (267)
T cd08229 231 --------D--HYSEELRQLVNMCINPD----PEKRPDITYVY 259 (267)
T ss_pred --------c--cccHHHHHHHHHhcCCC----cccCCCHHHHH
Confidence 0 12335667777777654 88888888654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=268.67 Aligned_cols=260 Identities=26% Similarity=0.317 Sum_probs=195.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--C
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~ 489 (697)
++|.+.+.||.|++|.||++.+..+++.+|+|++.... .....+.+|+++++.++ ||||+++++++... .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK------SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC------CCCeeeeeeEEEccCCC
Confidence 46899999999999999999999999999999987542 34466778888887764 78999999998754 4
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+++ +|.+++..... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeecc
Confidence 78999999974 66666543222 1223788899999999999999999999999999999999985 7789999999
Q ss_pred Cccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHhhCCCCHH
Q 005415 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-----VVMILARIIGMLGPIDLE 642 (697)
Q Consensus 569 la~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-----~~e~l~~I~~~lg~~p~e 642 (697)
++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~- 226 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP- 226 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch-
Confidence 98654332 223456788999999998889999999999999999999999997652 22333222211 111
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.+........ .....+..++..||.. .|..|.|+++++ +|+....
T Consensus 227 ~~~~~~~~~~--~~~~~~~~li~~~l~~----~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 227 ELKDEPGNGI--KWSEEFKDFIKQCLEK----DPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hhccCCCCCC--chHHHHHHHHHHHcCC----CcccCCCHHHHHhCccccccc
Confidence 1111100000 1123556666777654 488999999999 8986543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=269.83 Aligned_cols=246 Identities=20% Similarity=0.241 Sum_probs=184.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++|++.+.||.|+||+||+|.+..++. .+++|.+.... .....+..|+.++.. .+||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~------l~h~~iv~~~~~~~~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS------LDHAYIVRLLGICPG 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhc------CCCCCcceEEEEECC
Confidence 578999999999999999999877776 47777775332 222344445555543 358999999998754
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...++++||+. ++|.+++..... .+++..+..++.||+.||.|||+++++||||||+|||++. ++.+||+|
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~--~~~~kl~D 152 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS--DSIVQIAD 152 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEEcC
Confidence 55788999987 677777754322 2889999999999999999999999999999999999985 78899999
Q ss_pred CCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 567 FGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
||++...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ +....++
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~ 231 (279)
T cd05111 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA 231 (279)
T ss_pred CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC
Confidence 9998754322 122345678999999998889999999999999999998 99999887765543333 2222221
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.. -.....+..++..||... |..|.++++++.-|
T Consensus 232 ~~-----------~~~~~~~~~li~~c~~~~----p~~Rps~~el~~~l 265 (279)
T cd05111 232 QP-----------QICTIDVYMVMVKCWMID----ENVRPTFKELANEF 265 (279)
T ss_pred CC-----------CCCCHHHHHHHHHHcCCC----cccCcCHHHHHHHH
Confidence 10 012345677888888865 77788888877433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=266.39 Aligned_cols=247 Identities=20% Similarity=0.232 Sum_probs=183.4
Q ss_pred EeccCCCCceEEEEECC--CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~--~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||+|.... ....+|+|.+.... .....+.+|+.+++.+ +||||+++++.+......++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL------NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC------CCCCcceEEEEECCCCceEEEEE
Confidence 58999999999996432 44678888876432 2234566787777765 48899999999999999999999
Q ss_pred ccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+. ++|.+++...... .....++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEecccccccccc
Confidence 997 4677776543321 1122567788899999999999999999999999999999985 78899999999864322
Q ss_pred c-----cccccccCCCCCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC-CCH
Q 005415 576 N-----LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP-IDL 641 (697)
Q Consensus 576 ~-----~~~~~gt~~Y~APE~l~~-------~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~-~p~ 641 (697)
. .....++..|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..++..... ++.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence 1 112334667999999743 356889999999999999999 89999988877777666543321 111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
... . -.....+..++..||. .|..|++++++...|
T Consensus 233 ~~~------~--~~~~~~~~~~~~~~~~-----dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQL------D--LKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267 (269)
T ss_pred Ccc------c--ccCCHHHHHHHHHHhc-----CcccccCHHHHHHHh
Confidence 110 0 1123456678888983 688999999887544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=265.67 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=189.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ------HERIVQYYGCLRD 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC------CCCeeeEEEEEEc
Confidence 36899999999999999999999999999999986431 22345677888888774 7899999999875
Q ss_pred c--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 ~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
. ..++++|||+.+ +|.+.+.... .+++..++.++.|++.||.|||+++|+||||+|+||+++. ++.++|
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l 147 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEE
Confidence 3 678999999974 6766664322 2788889999999999999999999999999999999985 778999
Q ss_pred eeCCCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||........+..+......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC
Confidence 999998654321 12245788899999999988999999999999999999999999876555444443221111
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
+. ... .....+..++ .||.. .|..|.+++++. +|++
T Consensus 228 ~~---------~~~--~~~~~~~~li-~~~~~----~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 PQ---------LPS--HISEHARDFL-GCIFV----EARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CC---------Cch--hcCHHHHHHH-HHhcC----ChhhCcCHHHHhcCcccc
Confidence 10 000 1122334444 46553 588999999998 8764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=262.46 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=194.1
Q ss_pred eEEEEEeccCCCCceEEEEECCCC----cEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g----~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+++.+.||.|+||.||++.+...+ ..||+|+++.... ....+..|+.+++.++ |+||+++++++...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD------HPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC------CCchheEEEEEcCCC
Confidence 357789999999999999988766 8999999976543 4567788888888773 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+++|||+.+ +|.+++....... +++..+..++.|++.||.+||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg 148 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFG 148 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhcc----CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccC
Confidence 99999999974 6777765433211 788999999999999999999999999999999999995 7789999999
Q ss_pred Cccccccccc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
++........ ...+++.|+|||.+.+..++.++||||||+++++|++ |.+||...+..+.+..+......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 227 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPE- 227 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC-
Confidence 9866543311 1225678999999988889999999999999999998 899998887777777664432211110
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.....+..++..||... |..|+|++++..+|
T Consensus 228 -----------~~~~~~~~~i~~~l~~~----p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 -----------NCPPEIYKLMLQCWAED----PEDRPTFSELVEIL 258 (258)
T ss_pred -----------cCCHHHHHHHHHHCcCC----hhhCcCHHHHHhhC
Confidence 12335556666665544 88899999887554
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=268.32 Aligned_cols=244 Identities=24% Similarity=0.304 Sum_probs=191.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++ ||||+++++++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN------HPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC------CCChHHHHHhhcCCCe
Confidence 4899999999999999999999999999999997532 33456777888877764 8899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.+ +|...+... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeeccc
Confidence 9999999975 566555433 12888999999999999999999999999999999999985 78899999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~---~e~l~~I~~~lg~~p~e~~ 644 (697)
+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ......+.......|.
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA--- 223 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcc---
Confidence 8765433 2335678889999999988899999999999999999999999987663 2222222111111111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH--HHHH--Hhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL--EYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~--e~~~--~wl 689 (697)
.....+..++..||... |..|.+. ++++ +|+
T Consensus 224 ----------~~~~~~~~~i~~~l~~~----p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 224 ----------TWSTEAIDAINKLLERD----PQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cCcHHHHHHHHHHccCC----hhHcCCccHHHHhcCCCC
Confidence 11246667777777655 6666766 6666 664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=268.86 Aligned_cols=252 Identities=23% Similarity=0.248 Sum_probs=190.5
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||+|+||+||+|.+..+++.||+|++.... .....+..|+++++.++ ||||+++++.+...+..++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS------SRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC------CCCEeeeeeEEecCCeEEEEEec
Confidence 699999999999999999999999987432 22334567888888774 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+++ +|.+++..... ..+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccC
Confidence 984 66666653332 23889999999999999999999999999999999999985 788999999988654322
Q ss_pred --cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccc
Q 005415 577 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 654 (697)
Q Consensus 577 --~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~ 654 (697)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.......+. ....
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~-- 219 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------EYPD-- 219 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc-------cCCc--
Confidence 22345678899999998888999999999999999999999999765432222222111110000 0011
Q ss_pred cCCchhhhhHHHHHHHHHHHhhhhcc-CHHHHH--HhhcccCC
Q 005415 655 TKEYDLYYINEVCFANIFISLVVIRL-TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 655 ~~~~~l~~i~~~cw~~l~~~~~~~r~-t~e~~~--~wl~~~~~ 694 (697)
.....+..++..||......++..+. +.++++ +|+...++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 12456777888888766555555555 888888 99975544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.38 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=191.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+|++++.||+|+||+||++.+..+++.||+|++... ......+.+|+++++.++ ||||+++++++......
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR------SPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC------CCCcceEeeeEecCCEE
Confidence 5789999999999999999999999999999988753 334467778888888764 78999999999999999
Q ss_pred EEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCC
Q 005415 492 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++||||++++ |..++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC--CCcEEEccCCc
Confidence 9999999864 544443221 27899999999999999999997 58999999999999985 78899999998
Q ss_pred ccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHHHHhhCCCC
Q 005415 570 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV--------MILARIIGMLGPID 640 (697)
Q Consensus 570 a~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~--------e~l~~I~~~lg~~p 640 (697)
+...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...... .+...+.......+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 151 SGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred ccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 8654322 23356889999999998888999999999999999999999999865442 11111111111100
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
... . .......+..++..||. ..|..|.+++++. +|+.
T Consensus 231 ~~~-------~-~~~~~~~~~~li~~~l~----~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 231 PRL-------P-SSDFPEDLRDFVDACLL----KDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CCC-------C-chhcCHHHHHHHHHHhc----CCcccCcCHHHHhcCcccc
Confidence 000 0 00112345556666654 4589999999988 5553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=269.69 Aligned_cols=257 Identities=23% Similarity=0.253 Sum_probs=188.0
Q ss_pred Cce-EEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY-~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+|| ++++.||+|+||+||++. ...++..||+|+++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~ 76 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY------HENIVKYKGCCS 76 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC------CCCEeeEEEEEe
Confidence 566 999999999999998864 34578899999997542 23456678888888774 789999999887
Q ss_pred ec--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 487 HL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 487 ~~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
.. ...++||||+.+ +|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++. ++.++
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~ 147 (283)
T cd05080 77 EQGGKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLVK 147 (283)
T ss_pred cCCCceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcEE
Confidence 54 468999999985 555555421 1889999999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH-Hhh
Q 005415 564 IIDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GML 636 (697)
Q Consensus 564 L~DFGla~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~-~~l 636 (697)
|+|||++........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||...... +..+. ...
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~ 225 (283)
T cd05080 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQ 225 (283)
T ss_pred EeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccc
Confidence 999999876543211 123456699999998888999999999999999999999999654321 11111 111
Q ss_pred CCCCH----HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 637 GPIDL----EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 637 g~~p~----e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
+.... +.................+..++..||... |..|++++++...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE----AKFRPTFRSLIPILKE 280 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC----hhhCCCHHHHHHHHHH
Confidence 11111 111111111111123356778888888865 8889999988866543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=262.97 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=194.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++.+.||.|+||+||+|.+..++..+|+|++.... .....+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN------HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC------CCCEEEEEEEEeeCCEE
Confidence 46999999999999999999998899999999987432 24466778888887764 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|||++.+ +|.+++..... ...+++..+..++.|++.||.|||++||+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchH
Confidence 999999975 56666543221 123789999999999999999999999999999999999995 778999999988
Q ss_pred ccccccc-------ccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 571 CFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 571 ~~~~~~~-------~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
....... ....++..|+|||++... .++.++|+|||||++|+|++|+.||...+....+.++... .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~ 226 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS 226 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC
Confidence 6544321 234678899999999876 7899999999999999999999999877766655554432 1110
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
. .. ...+-.-...+..++..||.. .|..|.+++++. +|+
T Consensus 227 ~-~~---~~~~~~~~~~~~~li~~~l~~----~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 L-ET---GADYKKYSKSFRKMISLCLQK----DPSKRPTAEELLKHKFF 267 (267)
T ss_pred c-CC---ccccccccHHHHHHHHHHcCC----ChhhCcCHHHHhhCCCC
Confidence 0 00 000001123445566666554 488899999988 764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=258.00 Aligned_cols=247 Identities=31% Similarity=0.462 Sum_probs=197.1
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++ |++|+++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCCeEEE
Confidence 48889999999999999999988999999999986543 4567788888888775 7899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
++||++ ++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~ 147 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQ 147 (253)
T ss_pred EEecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeecccccc
Confidence 999998 56666655432 23899999999999999999999999999999999999995 78899999999876
Q ss_pred ccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 573 QTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 573 ~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....+..+... ..+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--------- 217 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPGL--------- 217 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCc---------
Confidence 65443 4567788999999999888899999999999999999999999877655544443321 11110
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hh
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LW 688 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~w 688 (697)
.........+..++..||... |..|.|+++++ +|
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~----p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKN----PEKRPTAEQLLKHPF 253 (253)
T ss_pred CcccccCHHHHHHHHHHccCC----hhhCCCHHHHhcCCC
Confidence 000011345666777776654 78899999887 55
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=265.26 Aligned_cols=244 Identities=30% Similarity=0.379 Sum_probs=194.3
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||.|+||.||++.+..+++.+++|++.... .....+.+|+.+++.++ ||||+++++.+......++||||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ------SPYVVKLYYSFQGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC------CcchhHHHHheecCcEEEEEEec
Confidence 689999999999998899999999987543 23456667777777664 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+.+ +|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 75 LPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccC
Confidence 975 6777665332 2889999999999999999999999999999999999995 788999999987653322
Q ss_pred -----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 577 -----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 577 -----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
.....++..|+|||.+....++.++|+||||+++|+|++|..||......+....+.....+++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 222 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE---- 222 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc----
Confidence 12345678899999998888899999999999999999999999988877777666442211111
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH---HHHH--HhhcccCC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL---EYAA--LWLFGIDQ 694 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~---e~~~--~wl~~~~~ 694 (697)
...-...+..++..||.. .+..|+|+ ++++ +|++.++|
T Consensus 223 -------~~~~~~~~~~~i~~~l~~----~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 223 -------DVEVSDEAIDLISKLLVP----DPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred -------cccCCHHHHHHHHHHhcC----CHhhcCCCccHHHHhcCccccCCCC
Confidence 011244666777777764 47788888 7777 99987765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=266.40 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=193.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|++.+.||+|+||.||+|.++.++. .||+|.+.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD------HPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEe
Confidence 4689999999999999999999876654 58999887543 23456677888887764 789999999998
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
. ...++||||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.+||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kL~ 151 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT--PQHVKIT 151 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC--CCeEEEC
Confidence 7 78999999997 567776653322 2889999999999999999999999999999999999985 7789999
Q ss_pred eCCCcccccccccc-----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||.+......... ..++..|+|||.+....++.++|+|||||++||+++ |..||.+....+....+... ..+
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~ 230 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERL 230 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCC
Confidence 99998765432211 112457999999988889999999999999999999 99999988777766555432 111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+. .......+..++..||... +..|+++.++...+.
T Consensus 231 ~~-----------~~~~~~~~~~~~~~~l~~~----p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 231 PQ-----------PPICTIDVYMVLVKCWMID----AESRPTFKELINEFS 266 (279)
T ss_pred CC-----------CCCCCHHHHHHHHHHcCCC----hhhCCCHHHHHHHHH
Confidence 11 1123346778888888865 677888887774444
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=266.05 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=188.9
Q ss_pred EEeccCCCCceEEEEECCCCc--EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~--~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+.||+|+||.||+|.+..++. .+++|.++.. ......+..|+.+++.+. +||||+++++++......++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEEE
Confidence 358999999999999887775 4688887742 334456778999888875 3889999999999999999999
Q ss_pred Eccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 496 ELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 496 Eyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
||+. ++|.+++...... .....+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~--~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC--CCeEEE
Confidence 9997 5777777543311 11123788999999999999999999999999999999999985 788999
Q ss_pred eeCCCcccccccccc--ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 565 IDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 565 ~DFGla~~~~~~~~~--~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|||++......... ...+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--- 230 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---
Confidence 999998533222111 223567999999988889999999999999999997 99999887776666555322110
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
.........+..++..||... |..|.++++++.-
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~----p~~Rps~~~il~~ 264 (270)
T cd05047 231 ---------EKPLNCDDEVYDLMRQCWREK----PYERPSFAQILVS 264 (270)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccC----hhhCCCHHHHHHH
Confidence 011123346778888888654 7778888888733
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=261.25 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=195.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||+|+||.||++.+..++..||+|.+... ....+.+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK------HPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC------CCChhhhhheeccCCeE
Confidence 589999999999999999999999999999998753 223456678888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|+||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++. +...++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIA 149 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccc
Confidence 999999974 67666653322 12788999999999999999999999999999999999985 2346799999988
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.....++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 222 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI------- 222 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC-------
Confidence 7654332 224578889999999888899999999999999999999999987776655554432111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
. ......+..++..||.. .|..|.++++++ +|+
T Consensus 223 ---~--~~~~~~~~~~i~~~l~~----~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 223 ---S--PNFSRDLRSLISQLFKV----SPRDRPSITSILKRPFL 257 (257)
T ss_pred ---C--CCCCHHHHHHHHHHhcc----ChhhCcCHHHHhhCCCC
Confidence 0 01123566677777654 589999999998 664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=271.99 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=194.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
...++|.+.+.||+|+||.||++.+. .++..||+|+++.. ......+.+|+.+++.+. +||||+++++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 106 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLLG 106 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEEE
Confidence 44568999999999999999999752 34568999998753 233456778999998873 3789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++......++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+++|+|+||||+|||++. ++.+
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~ 180 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH--GKIV 180 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC--CCeE
Confidence 9999999999999997 567777653221 22789999999999999999999999999999999999984 7789
Q ss_pred EEeeCCCccccccccc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
+|+|||++........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+.+++...
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 9999999875433211 1234677999999999889999999999999999998 999998876655444443321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.+++. .......+..++..||.. .|..|+++.+++.-|
T Consensus 261 ~~~~~-----------~~~~~~~~~~li~~cl~~----~p~~Rpt~~ell~~l 298 (302)
T cd05055 261 YRMAQ-----------PEHAPAEIYDIMKTCWDA----DPLKRPTFKQIVQLI 298 (302)
T ss_pred CcCCC-----------CCCCCHHHHHHHHHHcCC----CchhCcCHHHHHHHH
Confidence 11110 011234566777777753 488899998887443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=269.91 Aligned_cols=259 Identities=21% Similarity=0.253 Sum_probs=193.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPAD 474 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~----------------~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~ 474 (697)
.++|++.++||+|+||.||++.+.. ++..||+|+++.. ......+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~------ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK------ 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------
Confidence 4689999999999999999986432 3457999999753 233457788999888875
Q ss_pred CCceeEEEEEEEecCeEEEEEEccc-cchHHHHHhhhccC-----CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 475 EHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 475 hpnIv~l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-----~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
|+||+++++++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 7899999999999999999999997 57777765432111 11237788899999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 621 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt--G~~PF~ 621 (697)
|+|||++. ++.++|+|||++....... .....+..|+|||...+..++.++|||||||++|||++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGK--NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcC--CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999985 7889999999986543221 11233567999999988889999999999999999998 889998
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
..+..+.+............ .......-.....+..++..||... |..|++++++..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rp~~~~i~~~ 293 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGR-----QVYLPKPALCPDSLYKLMLSCWRRN----AKERPSFQEIHAT 293 (296)
T ss_pred ccChHHHHHHHHHHHhhccc-----cccCCCCCCCCHHHHHHHHHHcCCC----cccCCCHHHHHHH
Confidence 77766655443221100000 0000111123356778888888654 7888888887643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=263.72 Aligned_cols=240 Identities=20% Similarity=0.263 Sum_probs=185.4
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+|+.+++.++ ||||+++++++. ....++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD------NPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC------CCCeEEEEEEEc-CCCeEEEEE
Confidence 3899999999999764 445679999987543 23456778889888874 789999999875 457899999
Q ss_pred cccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+++ +|.+++..... .+++..+..++.||+.||.|||++|++||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 75 MASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGA 147 (257)
T ss_pred eCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC--CCcEEeccCCccccccC
Confidence 9974 56666543221 2889999999999999999999999999999999999985 78899999999875433
Q ss_pred ccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 576 NLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 576 ~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.+... ++.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~------- 219 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LDC------- 219 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCC-------
Confidence 211 1122467999999998889999999999999999996 9999998877776655543221 110
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.-.....+..++..||... +..|++++++...|.
T Consensus 220 ----~~~~~~~l~~li~~c~~~~----~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 220 ----PAECPPEMYALMKDCWIYK----WEDRPNFAKVEERMR 253 (257)
T ss_pred ----CCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHHh
Confidence 0123457788899999865 677888888875554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=260.25 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=199.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||.|++|.||++.+..++..|++|++.... .....+.+|+++++.++ |||++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN------HPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC------CCChhheEEEEecCCEE
Confidence 5899999999999999999999899999999987542 34456778888888775 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|+|++++ +|.+.+..... ....+++..+..++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccce
Confidence 999999985 67776665431 1133899999999999999999999999999999999999995 788999999998
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.....++.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 225 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS----- 225 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCC-----
Confidence 6654432 23467888999999998889999999999999999999999998887766666654332111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.....+..++..||.. .|..|.++++++ +|+
T Consensus 226 -------~~~~~~~~~i~~~l~~----~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 226 -------QYSSELRNLVSSLLQK----DPEERPSIAQILQSPFI 258 (258)
T ss_pred -------CCCHHHHHHHHHHcCC----ChhhCcCHHHHhcCCCC
Confidence 2234555566666554 488999999988 775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=265.15 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=187.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+|++.+.||+|++|.||++.+..+++.||+|++.... .....+..|+++++.++ |+||+++++++..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN------HPHIIRMLGATCE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC------CCceehhhceecc
Confidence 4788899999999999999999999999999987432 13456778888888774 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++. ....++|+|
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~d 147 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIAD 147 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcc
Confidence 9999999999985 5666654322 2788999999999999999999999999999999999975 234699999
Q ss_pred CCCcccccccc-------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH---hh
Q 005415 567 LGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG---ML 636 (697)
Q Consensus 567 FGla~~~~~~~-------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~---~l 636 (697)
||.+....... ....++..|+|||.+.+..++.++|+||||+++++|++|..||...........+.. ..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence 99986654321 124567889999999988899999999999999999999999976543322222221 11
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..++. .. .-...+..++. +.+...|..|.++.+++ +|+
T Consensus 228 ~~~~~---------~~--~~~~~~~~~i~----~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 228 TAPSI---------PE--HLSPGLRDVTL----RCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred CCCCC---------ch--hhCHHHHHHHH----HHcCCCcccCcCHHHHhcCccc
Confidence 11110 00 01123334444 44445588899999888 775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=289.48 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=204.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+.|.+.+.||+|.|+.|.+|.+..++..||||++.++. .......+|+++++.|+ |||||+++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~------HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN------HPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC------Ccceeeeeeeeeecc
Confidence 367999999999999999999999999999999998643 33445778999998885 899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+. +.+.+++..+.. +.+..++.++.|++.|++|||+++|||||||++|||++. +..+||+|||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~--~mnikIaDfg 200 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE--NMNIKIADFG 200 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc--ccceeeeccc
Confidence 9999999986 567777765544 666889999999999999999999999999999999995 7779999999
Q ss_pred Cccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
++...... ..+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|.+||.+.+..+.-.+.+...-.+|..+..
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSC 280 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeec
Confidence 99776543 456899999999999999876 568999999999999999999999988777777766666666665555
Q ss_pred hcccccc-cc----cCCchhhhhHHHHHHHHHHHh
Q 005415 646 QGQEIYK-YF----TKEYDLYYINEVCFANIFISL 675 (697)
Q Consensus 646 ~~~~~~~-~~----~~~~~l~~i~~~cw~~l~~~~ 675 (697)
.++...+ ++ .+.+.+..+|..+|.+..-..
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 5443222 21 223456677777777665444
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=273.36 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=191.7
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
|.....||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++......++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC------CCCchhhhhhheeeCCeEEEE
Confidence 334557999999999999999899999999986432 2334566777777765 488999999999999999999
Q ss_pred EEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 495 mEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
|||+.++.+..+.... .+++..++.++.|++.||.|||+++|+|+||+|+||+++. ++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~--~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 97 MEFLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EecCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc--CCcEEEeechhHhhcc
Confidence 9999865443332221 2788999999999999999999999999999999999985 7899999999886543
Q ss_pred cc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 575 DN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 575 ~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.. .....++..|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.... +. ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~------ 238 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PP-KLK------ 238 (297)
T ss_pred cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CC-Ccc------
Confidence 22 223567899999999998889999999999999999999999998877766665543211 10 000
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
........+..++..||. ..|..|.+++++. +|+....
T Consensus 239 ~~~~~~~~l~~~i~~~l~----~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 239 NAHKISPVLRDFLERMLT----REPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ccCCCCHHHHHHHHHHhc----CCcccCcCHHHHhhChhhccCC
Confidence 001112345556666654 4588899999988 8887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.50 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=193.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
..|.....||.|+||.||++.+..++..||||.+.... .....+.+|+.+++.++ |+||+++++.+...+..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH------HENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC------CCcHHHHHHheecCCeEE
Confidence 34555678999999999999998899999999986533 33445677888777664 889999999999999999
Q ss_pred EEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+.++ |.+++. .. .+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 96 lv~e~~~~~~L~~~~~-~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~ 166 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCA 166 (292)
T ss_pred EEEeCCCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchh
Confidence 999999865 444432 21 2788999999999999999999999999999999999985 7889999999886
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....++..|+|||.+.+..++.++|+||||+++|||++|..||...+....+..+.....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 241 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS----- 241 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccc-----
Confidence 54322 2235678899999999988899999999999999999999999988777666655543332211100
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
......+..++..|| ...|..|.|+++++ +|+..
T Consensus 242 -----~~~~~~~~~li~~~l----~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 242 -----HKVSSVLRGFLDLML----VREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred -----cccCHHHHHHHHHHc----cCChhHCcCHHHHhhChhhhc
Confidence 011223444444444 45689999999999 88873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=266.18 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=183.0
Q ss_pred CceEEEEEe--ccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~L--G~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|.+.+.+ |+|+||.||++.++.++..+|+|++...... ..|+.+...+. +||||+++++.+...+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AIEPMVHQLMK-----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hhhHHHHHHhh-----cCCCEEEEEEEEecCCee
Confidence 456666665 9999999999999999999999998754221 11333332222 489999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc-eEEEeeCCC
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~vKL~DFGl 569 (697)
++||||++ ++|.+++.... .+++..+..++.||++||.|||+.|++||||||+||+++. ++ .++|+|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~~l~dfg~ 156 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR--AKDRIYLCDYGL 156 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC--CCCeEEEecCcc
Confidence 99999997 57877775432 2899999999999999999999999999999999999986 45 899999999
Q ss_pred ccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHhhCCCCHHHHhhcc
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI-LARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~-l~~I~~~lg~~p~e~~~~~~ 648 (697)
+....... ...++..|+|||++.+..++.++|+||||+++|+|++|..||........ ...+..... .+....
T Consensus 157 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~---- 230 (267)
T PHA03390 157 CKIIGTPS-CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-KKLPFI---- 230 (267)
T ss_pred ceecCCCc-cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-ccCCcc----
Confidence 87654332 34678899999999998899999999999999999999999986543321 111111111 000000
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccC-HHHHH--Hhhc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-LEYAA--LWLF 690 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-~e~~~--~wl~ 690 (697)
+ .....+..++. +++...|..|.+ .++++ +|+.
T Consensus 231 ---~--~~~~~~~~li~----~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 231 ---K--NVSKNANDFVQ----SMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---c--ccCHHHHHHHH----HHhccChhhCCchHHHHhcCCccc
Confidence 0 12234444444 444455888986 58888 9986
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=265.64 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=189.8
Q ss_pred CceEEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.+|++++.||+|+||.||++. +..+++.||+|.+.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ------HDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCeeEEEEEEccC
Confidence 579999999999999999997 45678899999987543 33456778888888774 78999999987543
Q ss_pred --CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 489 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 489 --~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
..+++||||+. ++|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~ 150 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIG 150 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEEC
Confidence 46899999996 577777653321 2788999999999999999999999999999999999985 7889999
Q ss_pred eCCCcccccccccc------ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC-C
Q 005415 566 DLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-P 638 (697)
Q Consensus 566 DFGla~~~~~~~~~------~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg-~ 638 (697)
|||++......... ..++..|+|||++.+..++.++|||||||++|||++|..|+..... .....+..... +
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQ 229 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccc
Confidence 99998765432211 1223459999999988899999999999999999999887754322 11111100000 0
Q ss_pred CC-H---HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 639 ID-L---EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 639 ~p-~---e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.. . +.+...............+..++..||... |..|+|++++...|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND----PSQRPSFSELALQVEA 282 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCC----hhhCCCHHHHHHHHHh
Confidence 00 0 111111111112233456778888888865 8889999998866543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=284.83 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=212.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++-..+..++++||+|.||.|.+++ ...+..||+|+++... .....+..|+++|.+|+ ||||++++++|..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk------hPNIveLvGVC~~ 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLK------HPNIVELLGVCVQ 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccC------CCCeeEEEeeeec
Confidence 4445678999999999999999998 4557999999998643 34578899999999885 8999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
++.+++||||++ |+|.+++..+.... .......+|+.||+.||+||.+.++|||||.++|+|++ +++++||+|
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~--~e~~iKiad 680 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD--GEFTIKIAD 680 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec--CcccEEecC
Confidence 999999999998 77888887654322 34455667999999999999999999999999999999 499999999
Q ss_pred CCCcccccccccc-----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt--G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+++..-..... .+-+..|||+|.+.-+.++.++|+|+||+++||+++ .+.||....+++.+.+.-+.+...
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence 9999754333222 344688999999999999999999999999999887 899999988888888877776655
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+.... ..+.--++..++++|..||... -.+|.+-|++-..|.
T Consensus 761 ~~~~~-----l~~P~~cp~~lyelml~Cw~~e----s~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 761 GRQVV-----LSRPPACPQGLYELMLRCWRRE----SEQRPSFEQLHLFLQ 802 (807)
T ss_pred Cccee-----ccCCCcCcHHHHHHHHHHhchh----hhcCCCHHHHHHHHH
Confidence 55433 2233457789999999999966 566778887764443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=291.14 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=206.6
Q ss_pred cCceE-EEEEeccCCCCceEEEEECCCCcEEEEEEEe-----cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~-i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~-----~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.+||. ..+.||+|+|-+||+|.|..+|..||--.++ ......+++..|+.+|+.|+ ||||+++|++|.
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~------H~NIirfy~SW~ 111 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK------HPNIIRFYDSWV 111 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC------CCceeeeeehee
Confidence 45654 4578999999999999999999999855443 34455678899999999886 789999999999
Q ss_pred ecCe--EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcce
Q 005415 487 HLEH--LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 487 ~~~~--l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~ 561 (697)
+... +.+|+|++. |+|..+++..+. +....++.|++||++||.|||++. |+|||||.+||+|+. ..|.
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~ 184 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGE 184 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCc
Confidence 8754 889999996 788888876665 788899999999999999999985 999999999999985 6789
Q ss_pred EEEeeCCCccccccccc-cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~~~~-~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~ 639 (697)
|||+|+|+|........ ..+|||.|||||++. ..|...+||||||+.++||+|+..||.. .++.+++.++++.. .
T Consensus 185 VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi--K 261 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI--K 261 (632)
T ss_pred eeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC--C
Confidence 99999999987766543 469999999999998 5789999999999999999999999965 67888999987643 4
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
|..+.. -+++..+.++..|... ...|+++.+++ +++..
T Consensus 262 P~sl~k---------V~dPevr~fIekCl~~-----~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 262 PAALSK---------VKDPEVREFIEKCLAT-----KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHhhc---------cCCHHHHHHHHHHhcC-----chhccCHHHHhhChhhcc
Confidence 443321 2467888899999875 57789998888 66553
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.55 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=194.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..|++.+.||.|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.+ +||||+++++++......
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC------CCCccHhhhcccccCCce
Confidence 3577778899999999999999989999999998743 23345667788877766 488999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|.+++.. ..+++..++.++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~ 148 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEcccccc
Confidence 999999985 55555431 12788999999999999999999999999999999999985 788999999998
Q ss_pred ccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
....... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.... ++ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~-~~---- 221 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--PP-TL---- 221 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--CC-CC----
Confidence 6644322 22457888999999999889999999999999999999999998665554443332111 11 00
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.......+..++..||.. .|..|++++++. +|+....+
T Consensus 222 -----~~~~~~~~~~li~~~l~~----~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 222 -----EGQYSKPFKEFVEACLNK----DPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred -----CcccCHHHHHHHHHHccC----CcccCcCHHHHHHhHHHHHHhh
Confidence 011233566677777764 488899999988 78765443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=264.07 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=188.6
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-----------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+|.+.+.||.|++|.||+|.+..+++.||+|.++.... ..+.+..|+.+++.++ ||||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD------HLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC------CCCcceEEE
Confidence 58899999999999999999988999999998863211 1234556777777664 789999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++......++||||+.+ +|.+++... ..++...+..++.||+.||.|||+++++|+||+|+||+++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~--~~~~ 147 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA--DGIC 147 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC--CCeE
Confidence 99999999999999975 566665433 12788899999999999999999999999999999999985 7899
Q ss_pred EEeeCCCccccccc-----cccccccCCCCCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 563 KIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 563 KL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~--~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
+|+|||++...... .....++..|+|||.+.... ++.++|+||||+++|+|++|..||......+.+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999998654322 12245788899999987654 789999999999999999999999766555444443221
Q ss_pred hCC--CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 636 LGP--IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 636 lg~--~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
... .+.+.. -.-...+..++..||.. .|..|+++++++ +|+
T Consensus 228 ~~~~~~~~~~~---------~~~~~~~~~li~~~l~~----~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 228 RSAPPIPPDVS---------MNLSPVALDFLNACFTI----NPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCcCCcccc---------ccCCHHHHHHHHHHhcC----ChhhCCCHHHHhhCCCC
Confidence 111 111000 01123455566666654 588899999987 774
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=273.11 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=198.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+|...+.||.|++|.||+|+++.++..+|+|.+... .....++.+|+.+++.++ |+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCcccEEEEEEcCC
Confidence 4588889999999999999999999999999998642 223345667888888774 789999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
..++||||+.+++...+..... .+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||+
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~ 161 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCccc
Confidence 9999999999888776653322 2788999999999999999999999999999999999985 78899999999
Q ss_pred ccccccccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+.+..+.....+...
T Consensus 162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 235 (308)
T cd06634 162 ASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235 (308)
T ss_pred ceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC-----
Confidence 8665432 3356788999999985 345788999999999999999999999876655555444332111100
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
.......+..++..||... |.+|.+.++++ +|+....++
T Consensus 236 ------~~~~~~~~~~li~~cl~~~----P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 236 ------SGHWSEYFRNFVDSCLQKI----PQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred ------cccccHHHHHHHHHHhhCC----cccCCCHHHHhhCccccccCCh
Confidence 0122345677788888644 88899999998 888765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=269.84 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=193.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+.|++.+.||+|++|.||+|.+..+++.||||.++... ........|+.++..+. +||||+++++++......
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-----CCCchHhhheeeecCCeE
Confidence 67999999999999999999998889999999997532 22334455665554432 589999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++.+..++..... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++. ++.++|+|||++
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~--~~~~kL~dfg~~ 162 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA--SGNVKLCDFGIS 162 (296)
T ss_pred EEEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC--CCCEEECccccc
Confidence 99999998877776654322 38889999999999999999997 59999999999999984 789999999998
Q ss_pred ccccccc--ccccccCCCCCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHhhCCCCHHH
Q 005415 571 CFQTDNL--CLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEM 643 (697)
Q Consensus 571 ~~~~~~~--~~~~gt~~Y~APE~l~~~~----~s~ksDIWSLGviL~ELltG~~PF~~~~~-~e~l~~I~~~lg~~p~e~ 643 (697)
....... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+.....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL--- 239 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC---
Confidence 6543322 2234678899999987653 78899999999999999999999976433 344444432211100
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.........+..++..||... |..|+++++++ +|+..++
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~~----p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 240 -------PPNEGFSPDFCSFVDLCLTKD----HRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -------CCCCCCCHHHHHHHHHHccCC----hhhCCCHHHHhcChhhhccc
Confidence 000012345667777777644 88899999998 8887544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=266.81 Aligned_cols=253 Identities=19% Similarity=0.235 Sum_probs=195.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++.+. ||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~------h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------HPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC------CCchheEEEEE
Confidence 3679999999999999999998743 67899999987532 33456777888888774 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhc----------------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQE----------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~----------------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
......++||||++ ++|.+++..... ......+++..++.++.||+.||.|||+++++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 99999999999998 477777753221 0111237788899999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~ 622 (697)
|+||+++. ++.++|+|||++...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE--NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC--CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999985 788999999998653322 112234567999999998899999999999999999998 8899988
Q ss_pred CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 623 ~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
....+.+..+......+. .-.....+..++..||... |..|++++++..-|
T Consensus 236 ~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~----p~~Rpt~~el~~~l 286 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSC------------PDNCPLELYNLMRLCWSKL----PSDRPSFASINRIL 286 (288)
T ss_pred CCHHHHHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcccC----cccCCCHHHHHHHh
Confidence 777776665533211100 0012346777888887655 88899999887443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=265.23 Aligned_cols=255 Identities=20% Similarity=0.233 Sum_probs=197.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECC----CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~----~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|++.+.||+|+||.||+|.+.. ++..|++|++... ......+.+|+.+++.+. ||||+++++++.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~ 78 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS------HQNILPILHVCI 78 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEe
Confidence 4689999999999999999999865 3688999988753 233455677888777763 889999999877
Q ss_pred e-cCeEEEEEEccc-cchHHHHHhhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 487 H-LEHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 487 ~-~~~l~LVmEyl~-gsL~~~l~~~~~~~--~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
. ....++++||+. ++|.+++....... ....+++..+..++.|++.||.|||+++++|+||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCcE
Confidence 6 467899999997 57777765432211 1134889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
||+|||+++...... ....++..|+|||++.+..++.++|||||||++|++++ |++||...+..+....+....
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 999999987543221 11234667999999998889999999999999999999 999998877766555443321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.++ ..-.....+..++..||... |..|++++++..+|..
T Consensus 237 -~~~-----------~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 237 -RLA-----------QPINCPDELFAVMACCWALD----PEERPSFSQLVQCLTD 275 (280)
T ss_pred -CCC-----------CCCcCCHHHHHHHHHHcCCC----hhhCCCHHHHHHHHHH
Confidence 111 11122456788999999764 7889999999877654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=264.46 Aligned_cols=248 Identities=22% Similarity=0.258 Sum_probs=190.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..+|.+.+.||+|+||.||+|.+... ...||||..... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD------HPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC------CCchhceeEEEcC
Confidence 46799999999999999999987543 457899988754 334456778888888774 7899999998875
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...++||||+. ++|.+++..... .+++..++.++.|++.||.|||+.+++|+||||+||+++. .+.++|+|
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d 150 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLGD 150 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEcc
Confidence 55789999997 567777754321 2789999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 567 LGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 567 FGla~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.+..+......+.
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~- 229 (270)
T cd05056 151 FGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM- 229 (270)
T ss_pred CceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC-
Confidence 99986543321 11223467999999988889999999999999999997 9999988877766665533221111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.-.....+..++..||. ..|..|+|+.++...|.
T Consensus 230 -----------~~~~~~~~~~li~~~l~----~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 230 -----------PPNCPPTLYSLMTKCWA----YDPSKRPRFTELKAQLS 263 (270)
T ss_pred -----------CCCCCHHHHHHHHHHcC----CChhhCcCHHHHHHHHH
Confidence 11223456666666664 44778889888775443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=265.99 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=202.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.+.|++.+.||+|++|.||++.+..++..|++|++.........+.+|+.+++.++ |+||+++++.+......+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK------HPNIVDYYDSYLVGDELW 91 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC------CCCeeEEEEEEEECCEEE
Confidence 45688999999999999999999888999999999865544566778888887774 789999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~~ 164 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFAA 164 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchhh
Confidence 9999998 67877776543 12889999999999999999999999999999999999985 7889999999876
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... +.++...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~----- 238 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLKN----- 238 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCcc-----
Confidence 54332 12345678899999999888999999999999999999999999887766555544321 1111100
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.-..+..+..++..||.. .+..|.++++++ +|+...
T Consensus 239 ----~~~~~~~l~~li~~~l~~----~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVK----DPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----hhhCCHHHHHHHHHHhcc----ChhhCcCHHHHhhChHhhcc
Confidence 001234566677777764 488899999998 888763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=264.70 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=180.3
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||++.+..+++.+|+|.+..... ......+|..+++.+.. .+||||+.+++++...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh---CCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999999999875321 11233445555555433 358999999999999999999999
Q ss_pred cccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+.+ +|..++.... .+++..+..++.|++.||.|||+++|+|+||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 78 LMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (279)
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccc
Confidence 9985 4555544221 2899999999999999999999999999999999999985 78899999999865433
Q ss_pred c-cccccccCCCCCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 576 N-LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 576 ~-~~~~~gt~~Y~APE~l~-~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~--~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
. .....++..|+|||.+. +..++.++|||||||++|+|++|..||..... ...+..+... .+.. ..
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~-------~~ 219 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---VNVE-------LP 219 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---CCcC-------Cc
Confidence 2 23346889999999986 45689999999999999999999999975432 1222222110 0000 00
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
. .....+..++..||... |..|. ++++++ +|..+++
T Consensus 220 ~--~~~~~~~~li~~~l~~~----p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 220 D--SFSPELKSLLEGLLQRD----VSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred c--ccCHHHHHHHHHHhcCC----HHHhcCCCCCCHHHHHhCccccCCC
Confidence 0 11235556666666544 56665 688888 8887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=277.50 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=190.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d-----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
-.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.++..+. +||||++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~ 79 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGA 79 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-----CCccHhhhcce
Confidence 357899999999999999999985 3467899999997532 33456778999998885 37899999998
Q ss_pred EEec-CeEEEEEEccc-cchHHHHHhhhccC-------------------------------------------------
Q 005415 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQESG------------------------------------------------- 513 (697)
Q Consensus 485 f~~~-~~l~LVmEyl~-gsL~~~l~~~~~~~------------------------------------------------- 513 (697)
+... ..+++||||+. ++|.+++.......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 56899999997 56766665321100
Q ss_pred ------------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccc----
Q 005415 514 ------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---- 577 (697)
Q Consensus 514 ------------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~---- 577 (697)
....+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhh
Confidence 0123677888899999999999999999999999999999985 7889999999987543221
Q ss_pred -ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccccc
Q 005415 578 -CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655 (697)
Q Consensus 578 -~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~ 655 (697)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+......+...+.....++. .. .
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~--~ 306 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---------PD--Y 306 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---------CC--C
Confidence 11234567999999998889999999999999999997 99999876543333222211111110 11 1
Q ss_pred CCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 656 KEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 656 ~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
....+..++..||+.. |..|++++++..-|
T Consensus 307 ~~~~~~~~~~~cl~~~----p~~Rps~~eil~~l 336 (343)
T cd05103 307 TTPEMYQTMLDCWHGE----PSQRPTFSELVEHL 336 (343)
T ss_pred CCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence 2346788888888764 77788888877433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=281.56 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=194.0
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|.+.++||+|+||.||+|.+. ..++.||||+++... .....+..|++++..+. .||||+++++++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----~H~niv~~~~~~ 110 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-----PHLNIVNLLGAC 110 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-----CCCCeEEEEEEE
Confidence 457889999999999999999853 345789999997542 22346778999888874 378999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc----------------------------------------------------
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 512 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~---------------------------------------------------- 512 (697)
......++||||+. ++|.+++......
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999997 5777777543210
Q ss_pred ----------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 513 ----------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 513 ----------------------------------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
.....+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 0112367778899999999999999999999999999999
Q ss_pred cccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHH
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVV 626 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~ 626 (697)
|++. .+.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 271 Ll~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 271 LICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEeC--CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9985 788999999998754221 112345778999999998889999999999999999998 99999876655
Q ss_pred HHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
+.+...+.....++ ........+..++..||... |..|+++++++.
T Consensus 349 ~~~~~~~~~~~~~~-----------~p~~~~~~l~~li~~cl~~~----P~~RPs~~ell~ 394 (401)
T cd05107 349 EQFYNAIKRGYRMA-----------KPAHASDEIYEIMQKCWEEK----FEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHHcCCCCC-----------CCCCCCHHHHHHHHHHcCCC----hhHCcCHHHHHH
Confidence 55444332211111 01123457888999999865 677777777763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=264.94 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=193.4
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|.+.++||+|+||.||++... .++..+|+|.+... ......+.+|+.+++.++ |+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ------HQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC------CCCCceEEEEEe
Confidence 357889999999999999999742 35678999988743 233456778888887764 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhc---------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQE---------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~---------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
.....++||||+. ++|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 9999999999997 567666653321 001123788999999999999999999999999999999999985
Q ss_pred cCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~ 630 (697)
++.++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+.+.
T Consensus 158 --~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 --GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred --CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 7889999999986543221 12234678999999999999999999999999999998 999998877766665
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
.+........ .......+..++..||... |..|.+++++..
T Consensus 236 ~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~----P~~Rp~~~~l~~ 276 (280)
T cd05092 236 CITQGRELER------------PRTCPPEVYAIMQGCWQRE----PQQRMVIKDIHS 276 (280)
T ss_pred HHHcCccCCC------------CCCCCHHHHHHHHHHccCC----hhhCCCHHHHHH
Confidence 5543221110 0123456778888888755 788888887763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=260.64 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=189.1
Q ss_pred EEeccCCCCceEEEEECC-CC--cEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~-~g--~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
+.||+|++|.||+|.+.. .+ ..||||.+..... ....+..|+.+++.++ ||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD------HENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC------CCCccceeEEEcC-CeEEEE
Confidence 368999999999999865 33 3699999986543 4456777888888774 7899999999988 889999
Q ss_pred EEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+. ++|.+.+..... ..+++..++.++.|++.||.|||+++++|+||+|+||+++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~ 147 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRAL 147 (257)
T ss_pred EEecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccc
Confidence 99996 577777654331 23889999999999999999999999999999999999996 689999999998765
Q ss_pred cccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 574 TDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 574 ~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
.... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..+......++
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------ 221 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE------ 221 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC------
Confidence 4321 12345678999999998899999999999999999999 9999988877776666543211111
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
........+..++..||... |..|++++++..+|.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~----p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -----RPEACPQDIYNVMLQCWAHN----PADRPTFAALREFLP 256 (257)
T ss_pred -----CCccCCHHHHHHHHHHCCCC----cccCCCHHHHHHHhc
Confidence 00112345666777776654 788999988876653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=262.76 Aligned_cols=246 Identities=19% Similarity=0.195 Sum_probs=182.5
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||+|.+. .++..+|+|.++... .....+.+|+.+++.++ ||||+++++++......++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ------HSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC------CCCEeeEEEEEcCCCCcEEEEE
Confidence 5899999999999764 355789999887543 22345677888887764 8899999999999899999999
Q ss_pred ccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+. ++|.+++...... .....++..++.++.|++.||.|||+++++|+||||+||+++. .+.++|+|||.+.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccC
Confidence 998 5676666543321 1223567788899999999999999999999999999999985 78899999999865332
Q ss_pred cc-----ccccccCCCCCchhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh-CCCCH
Q 005415 576 NL-----CLYVQSRSYRAPEVIIGL-------PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML-GPIDL 641 (697)
Q Consensus 576 ~~-----~~~~gt~~Y~APE~l~~~-------~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l-g~~p~ 641 (697)
.. ....++..|+|||++.+. .++.++|||||||++|||++ |..||......+.....+... .+.+.
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 21 123457789999998642 35789999999999999996 999998776665544433211 11111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
... .......+..+|..||. .|..|+|++++..-
T Consensus 233 ~~~--------~~~~~~~~~~l~~~c~~-----~P~~Rpt~~~l~~~ 266 (269)
T cd05087 233 PRL--------KLPLSDRWYEVMQFCWL-----QPEQRPSAEEVHLL 266 (269)
T ss_pred Ccc--------CCCCChHHHHHHHHHhc-----CcccCCCHHHHHHH
Confidence 110 01123457789999983 38899999988743
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=255.96 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=195.3
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|++++..++ |||++++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK------HPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC------CCCccEEEEEEEeCCEE
Confidence 5899999999999999999999899999999997654 34566778888888774 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++.... .+++..+..++.|++.||.+||+.||+|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~ 146 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVA 146 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccc
Confidence 999999975 6666665331 2889999999999999999999999999999999999995 788999999998
Q ss_pred cccccccc---cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
........ ...++..|+|||.+.+..++.++|+||||+++|+|++|..||........+..+.....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 219 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL------- 219 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC-------
Confidence 76554332 34678889999999888889999999999999999999999987765555544432111000
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.. .-...+..++..||. ..|..|.++++++ +|+
T Consensus 220 ---~~--~~~~~~~~~i~~~l~----~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 220 ---PE--GISPELKDFLMQCFQ----KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---CC--CCCHHHHHHHHHHHh----CChhhCcCHHHHhcCCCC
Confidence 00 112355666666665 4588899999887 664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=258.92 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=187.8
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
++||.|++|.||++.+.. ++.||+|.+..... ....+..|+.+++.+. |+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD------HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCeEEEEEEEecCCCeEEEEEc
Confidence 369999999999999877 99999999875432 3456777888888764 78999999999999999999999
Q ss_pred cc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+. ++|.+++..... .++...+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||.+......
T Consensus 74 ~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 74 VPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC--CCcEEEeeccccccccCC
Confidence 96 456666543221 2788899999999999999999999999999999999985 788999999998755422
Q ss_pred cc-----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc
Q 005415 577 LC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 577 ~~-----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
.. ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+......+.+
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~--------- 217 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP--------- 217 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC---------
Confidence 11 1222456999999998889999999999999999999 89999887766555554332111110
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
......+..++..||. ..|..|+++++++.+|.
T Consensus 218 ---~~~~~~~~~li~~~l~----~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 ---QLCPEEIYRLMLQCWA----YDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---ccCCHHHHHHHHHHhc----cChhhCcCHHHHHHHhh
Confidence 1123456677777775 45888999999987764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.95 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=193.0
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
-|++.+.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC------CCCEeEEEEEEEeCCeEE
Confidence 3778899999999999999998899999999986432 23345667777777664 789999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+++ +|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccce
Confidence 99999985 45555431 12789999999999999999999999999999999999985 7889999999886
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+... ..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~------- 221 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NPPTL------- 221 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CCCCC-------
Confidence 54332 12245788899999998888899999999999999999999999877665555544221 11100
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. ......+..++..||.. -|..|.+++++. +|+..
T Consensus 222 --~--~~~~~~~~~~i~~~l~~----~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 222 --E--GNYSKPLKEFVEACLNK----EPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred --C--cccCHHHHHHHHHHccC----ChhhCcCHHHHHhCHHHhh
Confidence 0 01234566777777753 378899999888 78763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=293.60 Aligned_cols=236 Identities=22% Similarity=0.293 Sum_probs=201.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCC---cEEEEEEEec--chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g---~~VAVKii~~--~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
...+|.++||.|-||.|++|+.+..| ..||||.++. .......++.|..|+-+. +||||++|.|+....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF------dHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF------DHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC------CCCcEEEEEEEEecC
Confidence 45788999999999999999977655 5799999985 345556777777777655 599999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..++||+|||+ |.|..++..+... |+..++..+++.|+.||.||-+.+.|||||..+|||+++ +...|++||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsDF 775 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSDF 775 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEeccc
Confidence 99999999998 6777777755432 888999999999999999999999999999999999996 888999999
Q ss_pred CCcccccccccc----ccc--cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 568 GSSCFQTDNLCL----YVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 568 Gla~~~~~~~~~----~~g--t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+++...+.... ..| +..|.|||.|....++.++||||+|+++||.++ |+.||.+-++++++..|.+..+-||
T Consensus 776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 999887554322 122 467999999999999999999999999999998 9999999999999999977666444
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFIS 674 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~ 674 (697)
+ .+++..|+++|.+||++....
T Consensus 856 P------------mDCP~aL~qLMldCWqkdR~~ 877 (996)
T KOG0196|consen 856 P------------MDCPAALYQLMLDCWQKDRNR 877 (996)
T ss_pred C------------CCCcHHHHHHHHHHHHHHhhc
Confidence 3 588899999999999987443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=268.05 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=194.9
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.|...+.||+|+||+||+|.+..+++.|++|++.... .....+..|+.+++.++ |||++++++++.....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK------HPNTIEYKGCYLKEHT 95 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC------CCCCccEEEEEEeCCE
Confidence 4777888999999999999999999999999987432 22345667777777764 7899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+.+++.+++..... .+++..+..++.||+.||.|||++||+|+||+|+||+++. ++.++|+|||++
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~~ 168 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGSA 168 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCCC
Confidence 999999999988877754322 2788999999999999999999999999999999999985 788999999988
Q ss_pred cccccccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....++..|+|||++. ...++.++|||||||++|+|++|..||...+....+..+..... +...
T Consensus 169 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~---- 241 (313)
T cd06633 169 SKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQ---- 241 (313)
T ss_pred cccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC----
Confidence 65432 23456788999999984 35588899999999999999999999988776666655533211 1100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.. .....+..++..||... |..|.++++++ +|+.-
T Consensus 242 ---~~--~~~~~l~~li~~~l~~~----P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 242 ---SN--EWTDSFRGFVDYCLQKI----PQERPASAELLRHDFVRR 278 (313)
T ss_pred ---cc--ccCHHHHHHHHHHccCC----hhhCcCHHHHhcCcccCC
Confidence 00 11234566667676654 78899999888 88764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-29 Score=258.29 Aligned_cols=243 Identities=26% Similarity=0.323 Sum_probs=186.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++ |+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR------HDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC------CCCcceEEEEEEc
Confidence 4699999999999999999999999999999987532 223356677888888875 7899999999876
Q ss_pred c--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 ~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
. ..+++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+++++|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEE
Confidence 4 568899999975 5666654322 2778889999999999999999999999999999999985 778999
Q ss_pred eeCCCcccccc------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........+.++. ..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQ 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cC
Confidence 99999875432 1123457889999999998889999999999999999999999998776555444432 21
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+..... .. .-...+..++..||.. +..|.+.++..
T Consensus 225 ~~~~~~------p~--~~~~~~~~~i~~~l~~-----~~~r~~~~~~~ 259 (264)
T cd06653 225 PTKPML------PD--GVSDACRDFLKQIFVE-----EKRRPTAEFLL 259 (264)
T ss_pred CCCCCC------Cc--ccCHHHHHHHHHHhcC-----cccCccHHHHh
Confidence 111111 00 1112455555666653 57788887665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=260.00 Aligned_cols=237 Identities=20% Similarity=0.235 Sum_probs=178.3
Q ss_pred EEeccCCCCceEEEEECCCC----------cEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 420 EYLGSAAFSKVFQAQDLHTG----------VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g----------~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.||+|+||.||+|.+..++ ..|++|++.........+.+|+.+++.++ ||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS------HKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC------CcchhheeeEEec-C
Confidence 46899999999999987766 45888887765443566777888777664 7899999999988 7
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc-----ceEE
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CEIK 563 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~-----~~vK 563 (697)
..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++.... ..+|
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 78999999985 55555554332 2888999999999999999999999999999999999985221 1799
Q ss_pred EeeCCCccccccccccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+......... .....+
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~ 226 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLP 226 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCC
Confidence 999999876544 2234567789999999876 78999999999999999999 688887665333222221 100000
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
......+..++..||... |..|+++.+++.
T Consensus 227 -------------~~~~~~~~~li~~~l~~~----p~~Rpt~~~il~ 256 (259)
T cd05037 227 -------------MPDCAELANLINQCWTYD----PTKRPSFRAILR 256 (259)
T ss_pred -------------CCCchHHHHHHHHHhccC----hhhCCCHHHHHH
Confidence 011146677788888644 777888887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=256.83 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=185.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
++||+|+||.||+|.. .++..||+|+++... .....+.+|+.+++.+ +||||+++++++......++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY------DHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCCcCeEEEEEecCCccEEEEEC
Confidence 3689999999999985 468899999987542 2234567788887776 488999999999999999999999
Q ss_pred cc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+. ++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++......
T Consensus 74 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 74 VPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC--CCeEEECCCccceecccc
Confidence 97 45666554322 12788999999999999999999999999999999999985 788999999998654332
Q ss_pred cc----cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 577 LC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 577 ~~----~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.. ...++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+...... .
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------~ 214 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM------------S 214 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC------------C
Confidence 21 1233567999999988889999999999999999998 99999888776655554322110 0
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
........+..++..||.. .|..|++++++..-|
T Consensus 215 ~~~~~~~~~~~li~~~l~~----~p~~Rp~~~~l~~~l 248 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDY----KPENRPKFSELQKEL 248 (250)
T ss_pred CCCCCCHHHHHHHHHHccc----CcccCCCHHHHHHHh
Confidence 0112235677777777764 488899998887433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=266.10 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=194.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.++|.+.+.||+|+||.||++.+..++..||+|.+... ......+.+|+.+++.+ +||||+++++++...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN------KHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc------CCCCeeehhheeeeCCcE
Confidence 37899999999999999999999889999999998643 23335567777777765 388999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++|+||+.+ +|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcce
Confidence 999999974 666655421 2778899999999999999999999999999999999985 778999999987
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....+..+.. .+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~----- 236 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQ----- 236 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCCCC-----
Confidence 654332 2234678889999999888899999999999999999999999987766544333211 1111100
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
....-...+..+++.||... +..|.+.+++. +|+..
T Consensus 237 ----~~~~~~~~l~~li~~~l~~~----p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 237 ----NPEKLSAIFRDFLNRCLEMD----VEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ----CccccCHHHHHHHHHHccCC----hhhCcCHHHHhcCHHHhc
Confidence 00011235667777777654 77788999988 88863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=289.18 Aligned_cols=233 Identities=26% Similarity=0.377 Sum_probs=196.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
++.++.++||+|.||.|++|.|... ...||||+++.+.. ..+.+++|+.++..|+ |+|+++|||+..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~------H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ------HPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc------CcceeEEeeeecc-
Confidence 4567789999999999999998653 35689999986542 4678889999888875 8899999999987
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+.+|||++. |+|++.+.... ...|....+..++.||+.||.||.++++|||||..+|+|+.+ ...|||+||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~DF 256 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICDF 256 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeecc
Confidence 78899999998 67888776522 233888899999999999999999999999999999999996 778999999
Q ss_pred CCcccccccccccc------ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 568 GSSCFQTDNLCLYV------QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 568 Gla~~~~~~~~~~~------gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+.+........++ -...|+|||.+....++.++|+|++||+||||+| |+.||.|....++|.+|-
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------- 329 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------- 329 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------
Confidence 99987765543332 2456999999999999999999999999999999 999999999999998872
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANI 671 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l 671 (697)
.+.++.+.-.+..++|.+|.+||+-.
T Consensus 330 -----~~erLpRPk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 330 -----AGERLPRPKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred -----ccccCCCCCCChHHHHHHHHHhccCC
Confidence 33444455567889999999999855
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=280.51 Aligned_cols=209 Identities=31% Similarity=0.440 Sum_probs=171.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhh--------HhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF--------DQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~--------~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.+..||.++.+||+|+|+.||+|.|....++||+|+-...+.+. ....+|..|.+.| +||.||++|
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL------DHpRIVKlY 533 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL------DHPRIVKLY 533 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc------Ccceeeeee
Confidence 56789999999999999999999999999999999987554443 3445666666665 588999999
Q ss_pred EEEEec-CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCcccccccc-C
Q 005415 483 DYFYHL-EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSY-Q 558 (697)
Q Consensus 483 ~~f~~~-~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~-~ 558 (697)
++|.-. +.+|-|+|||+|+.+++....... +++.+++.|+.||+.||.||.+.. |||-||||.|||+... .
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence 999855 668999999999877766544433 899999999999999999999864 9999999999999642 2
Q ss_pred cceEEEeeCCCcccccccc----------ccccccCCCCCchhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 559 RCEIKIIDLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~----------~~~~gt~~Y~APE~l~~~----~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
-|.+||+|||++..+.+.. ....||.+|++||.+.-. ..+.++||||+|||+|.++.|+.||..+-
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 4689999999998865432 235789999999998533 37889999999999999999999997653
Q ss_pred -HHHHHH
Q 005415 625 -VVMILA 630 (697)
Q Consensus 625 -~~e~l~ 630 (697)
..+++.
T Consensus 689 sQQdILq 695 (775)
T KOG1151|consen 689 SQQDILQ 695 (775)
T ss_pred hHHHHHh
Confidence 344444
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=263.45 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=196.6
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
+|...+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.+. ||||+++++++...+..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~------h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC------CCChheEEEEEEcCCeEEE
Confidence 4555679999999999999998999999999886432 23345677888877764 7899999999999999999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
|+||+.+ +|.+++.. . .++...+..++.|++.||.|||++||+||||+|+||+++. ++.++|+|||.+..
T Consensus 94 v~e~~~~~~L~~~~~~-~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~d~g~~~~ 164 (285)
T cd06648 94 VMEFLEGGALTDIVTH-T------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS--DGRVKLSDFGFCAQ 164 (285)
T ss_pred EEeccCCCCHHHHHHh-C------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC--CCcEEEcccccchh
Confidence 9999975 66665543 1 2788899999999999999999999999999999999985 78999999998764
Q ss_pred cccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
.... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+.....+..
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 235 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--------- 235 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC---------
Confidence 4322 2234678899999999988899999999999999999999999988777766666544311111
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.........+..++..||. ..|..|.+.++++ +|+...
T Consensus 236 -~~~~~~~~~l~~li~~~l~----~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLV----RDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred -cccccCCHHHHHHHHHHcc----cChhhCcCHHHHccCcccccC
Confidence 0111123467778888875 4488899999998 887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=256.79 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=192.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--- 488 (697)
++||+|.+.||.|||+.||+++...++..+|+|.+.... ...+..++|+...++++ |||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~------s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN------SPNVLRLVDHQLREEKD 93 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC------CcchHHHHHHHHHhhcc
Confidence 589999999999999999999999999999999887544 56677888888888876 68999999887644
Q ss_pred --CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcceEE
Q 005415 489 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 --~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~vK 563 (697)
...||+++|.. |+|.+.+......+ ..+++.++..|+.+|++||.+||+.. .+||||||.|||+.. .+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg--~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKG--NFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceE
Confidence 34899999986 67888887665443 34999999999999999999999998 999999999999995 78999
Q ss_pred EeeCCCccccccccc------------cccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 564 IIDLGSSCFQTDNLC------------LYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 564 L~DFGla~~~~~~~~------------~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
|.|||++........ ....|..|+|||.+. +...+.++|||||||+||.|+.|.-||..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------ 243 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------ 243 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------
Confidence 999999866432211 123478899999985 44578899999999999999999999952
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.+..|......... .--|-......+.+.+..+..+..-|.+|+++.++.
T Consensus 244 ---~~~~GgSlaLAv~n~----q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll 294 (302)
T KOG2345|consen 244 ---IYQQGGSLALAVQNA----QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELL 294 (302)
T ss_pred ---HhhcCCeEEEeeecc----ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 222222222211110 001112222345556666666667788899888776
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=266.71 Aligned_cols=244 Identities=20% Similarity=0.245 Sum_probs=184.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+|+.+++.+. ||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------h~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD------HPHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCcccEEEEEc
Confidence 3578999999999999999999877776 57888887542 22235567777777654 889999999987
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.. ..++++||+. ++|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~ 151 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKIT 151 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEc
Confidence 54 4678999997 567776654321 2788899999999999999999999999999999999984 6789999
Q ss_pred eCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+ .....+
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~ 230 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL 230 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC
Confidence 999987643221 11234668999999998889999999999999999998 99999877655443333 222222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.. -....++..++..||... |..|++++++.
T Consensus 231 ~~~-----------~~~~~~~~~li~~c~~~~----p~~Rp~~~~l~ 262 (303)
T cd05110 231 PQP-----------PICTIDVYMVMVKCWMID----ADSRPKFKELA 262 (303)
T ss_pred CCC-----------CCCCHHHHHHHHHHcCCC----hhhCcCHHHHH
Confidence 110 112346778888888865 66777777765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=269.90 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=204.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-----CeE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-----EHL 491 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-----~~l 491 (697)
+.||.|+||.||.+.|..+|+.||+|.+.+- -....+..+|+++|...+ |.|++..++..+.. ..+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk------HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR------HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc------cccHHHHHHhcCCCCchHHHHH
Confidence 4699999999999999999999999998742 223467788999998876 56888888777643 347
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
|+++|+|..+|...+-..+ .++...+..+++||+.||.|||+.+|.||||||.|+|+++ ++.+||+|||+++
T Consensus 133 YV~TELmQSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccc
Confidence 8899998887776665333 3888899999999999999999999999999999999996 9999999999997
Q ss_pred ccccc----cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN----LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .+..+-|.+|+|||++.|.. |+.++||||+|||+.|++..+..|+..++.+++..|++.+|.|..|.+..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 65432 33356688999999999875 99999999999999999999999999999999999999999999987652
Q ss_pred c-c--------------cccccccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 647 G-Q--------------EIYKYFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 647 ~-~--------------~~~~~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
. + .....+.- ...--+....|..+++.-.+.+|.+.+++.+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 1 1 11111111 1122344567888888888888888888874
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=261.83 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=185.6
Q ss_pred EeccCCCCceEEEEECCCC------cEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 421 YLGSAAFSKVFQAQDLHTG------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g------~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.||+|+||.||+|.+.... +.+|+|.+.... .....+.+|+.+++.++ ||||+++++++......+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN------HPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC------CCCeeeEeeeecCCCCeE
Confidence 6899999999999876443 789999886543 33456777888887764 889999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC---cceEEEeeC
Q 005415 493 IVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---RCEIKIIDL 567 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~-~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~---~~~vKL~DF 567 (697)
+||||+. ++|.+++....... ....+++..+..++.|++.||.|||+++++|+||||+||+++... ...++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999997 57777775432211 223478899999999999999999999999999999999998522 127999999
Q ss_pred CCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 568 GSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 568 Gla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|++....... .....+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..... +.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~- 233 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-LQ- 233 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-cC-
Confidence 9986543211 12234678999999998889999999999999999998 9999988777666655532111 10
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
........+..++..||.. .|..|++++++..
T Consensus 234 ----------~~~~~~~~~~~li~~~l~~----~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 ----------KPENCPDKIYQLMTNCWAQ----DPSERPTFDRIQE 265 (269)
T ss_pred ----------CcccchHHHHHHHHHHcCC----CcccCCCHHHHHH
Confidence 0111234566777777764 4888999988763
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=256.18 Aligned_cols=277 Identities=24% Similarity=0.390 Sum_probs=210.8
Q ss_pred CCcCCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCC
Q 005415 396 TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 396 ~~~~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
..+.....+.+..|. ..+|+|++++|+|.++.||.|....+.++++||++++-+. ..+.+|++||+.|. +|
T Consensus 22 ~eYWdYE~~~i~wg~--~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~-----gg 92 (338)
T KOG0668|consen 22 REYWDYESLVIDWGN--QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLR-----GG 92 (338)
T ss_pred hhhcchhheeeeccc--cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhcc-----CC
Confidence 344444455555553 4789999999999999999999999999999999987654 67889999999986 57
Q ss_pred CceeEEEEEEEec--CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 476 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 476 pnIv~l~~~f~~~--~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
|||+++++...+. ....+|+||+...-. ....+. ++...++.++.|+++||.|+|+.||+|||+||.|+|
T Consensus 93 ~NIi~L~DiV~Dp~SktpaLiFE~v~n~Df--k~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 93 PNIIKLLDIVKDPESKTPSLIFEYVNNTDF--KQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred CCeeehhhhhcCccccCchhHhhhhccccH--HHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 9999999999876 457899999975422 222222 777889999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCcHHHHH
Q 005415 554 IKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF-PNDAVVMIL 629 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF-~~~~~~e~l 629 (697)
|+. ..-.++|+|+|+|.+.... ....+.+..|.-||.+...+ |+...|+|||||+|..|+..+.|| .|.+..+++
T Consensus 165 Idh-~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 165 IDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred ech-hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 997 5668999999999876544 34456788999999997654 899999999999999999977776 788889999
Q ss_pred HHHHHhhCCCCHHHHhh--------------cccccccc----cCC-chhh-hhHHHHHHHHHHHhhhhccCHHHHH--H
Q 005415 630 ARIIGMLGPIDLEMLMQ--------------GQEIYKYF----TKE-YDLY-YINEVCFANIFISLVVIRLTLEYAA--L 687 (697)
Q Consensus 630 ~~I~~~lg~~p~e~~~~--------------~~~~~~~~----~~~-~~l~-~i~~~cw~~l~~~~~~~r~t~e~~~--~ 687 (697)
.+|.+.+|.-...-.-+ ++..++.| ... ..+. +-..+...+++.---.+|+|+.++| |
T Consensus 244 VkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 244 VKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 99999988654422111 11111111 111 1222 2234444555555566799999999 7
Q ss_pred hhc
Q 005415 688 WLF 690 (697)
Q Consensus 688 wl~ 690 (697)
|..
T Consensus 324 yF~ 326 (338)
T KOG0668|consen 324 YFA 326 (338)
T ss_pred hHH
Confidence 654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=262.28 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=187.2
Q ss_pred ceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.|++.+.||.|+||.||+|.+. .+|+.||+|+++... .......+|+.+++.+. +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-----cCCChhceeeEee
Confidence 4889999999999999999874 478999999997532 22355677888888875 3789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.....++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+.|++||||+|+|||++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEe
Confidence 99999999999984 6666665332 2788899999999999999999999999999999999985 7899999
Q ss_pred eCCCccccccc----cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence 99998654332 1234578899999998753 46789999999999999999999997543322222222211100
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
... ... .....+..+++.||... |..|. +.++++ +|+....
T Consensus 228 ~~~-------~~~--~~~~~~~~ll~~~l~~~----p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 EPP-------YPQ--EMSALAKDIIQRLLMKD----PKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCC-------CCc--cCCHHHHHHHHHHhcCC----HHHhcCCCCCCHHHHHcCcccccCC
Confidence 000 000 11234455555555544 66665 677777 7876554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-29 Score=252.29 Aligned_cols=246 Identities=28% Similarity=0.338 Sum_probs=194.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--C
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~ 489 (697)
+|++.+.||+|++|.||+|.+..+++.|++|++.... .....+.+|+.+++.++ ||||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ------HPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC------CCCEeeEEEEEecCCCC
Confidence 5888999999999999999999899999999987654 34567778888888875 78999999999988 8
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~ 146 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFG 146 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccc
Confidence 9999999995 56777665432 2889999999999999999999999999999999999995 7899999999
Q ss_pred Ccccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHhhCCCCHH
Q 005415 569 SSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLE 642 (697)
Q Consensus 569 la~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~~lg~~p~e 642 (697)
.+....... ....++..|+|||.+.+...+.++||||||+++++|++|..||.... ....+..+... ...+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-- 223 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS-GEPP-- 223 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc-CCCc--
Confidence 987655432 33567888999999988889999999999999999999999998765 22222222110 0000
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
..... ....+..++..||. ..+..|.++++++ +|+
T Consensus 224 ------~~~~~--~~~~l~~~i~~~l~----~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 224 ------EIPEH--LSEEAKDFLRKCLR----RDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CCCcc--cCHHHHHHHHHhCc----CChhhCCCHHHHhhCCCC
Confidence 01111 13455666666654 4588899999988 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=259.57 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=192.0
Q ss_pred ceEEEEEeccCCCCceEEEEECC-CCcEEEEEEEecch-----------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK-----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~-~g~~VAVKii~~~~-----------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... .....+..|+.++... .+||||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-----LRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-----CCCCCeeeEE
Confidence 37889999999999999999877 68899999876321 1223344555555432 3589999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcc
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~ 560 (697)
+++......++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+ .+|+|+||+|+||+++. ++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~ 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DD 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CC
Confidence 999999999999999975 666665432221 1238889999999999999999996 78999999999999985 78
Q ss_pred eEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
.++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+......
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 8999999998765433 23356788899999999888999999999999999999999999887776666666543332
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
+..+ -.....+..++..||... |..|+++.++.+
T Consensus 232 ~~~~-----------~~~~~~l~~li~~cl~~~----p~~Rp~~~e~~~ 265 (269)
T cd08528 232 PLPE-----------GMYSEDVTDVITSCLTPD----AEARPDIIQVSA 265 (269)
T ss_pred cCCc-----------ccCCHHHHHHHHHHCCCC----CccCCCHHHHHH
Confidence 2211 012346777778777654 778888888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=269.50 Aligned_cols=203 Identities=21% Similarity=0.288 Sum_probs=159.6
Q ss_pred EEeccC--CCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G--~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
..||.| +||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ +||||++++++|..+...++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF------RHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcceEeeeEecCCceEEE
Confidence 356666 99999999999999999999987532 2235566777776655 488999999999999999999
Q ss_pred EEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+.+ ++.+++...... .+++..++.++.||+.||.|||++||+||||||+|||+.. ++.++++||+.+...
T Consensus 78 ~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhh
Confidence 999985 666666543221 2788999999999999999999999999999999999985 788999999754322
Q ss_pred ccc----------cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 574 TDN----------LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 574 ~~~----------~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
... .....++..|+|||++.+. .++.++|||||||++|+|++|..||.+......+..++.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 224 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence 110 0112335669999999764 478999999999999999999999988766555544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=260.73 Aligned_cols=252 Identities=20% Similarity=0.245 Sum_probs=195.0
Q ss_pred CceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.+|++++.||.|+||.||+|+.+. ..+.|++|.+..... ....+.+|+.+++.++ |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS------HKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC------CcceeeeEEEEC
Confidence 579999999999999999999653 356799998875432 3467788999988875 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~---~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
.....++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+++|+||||||+||+++. ++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~ 156 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREV 156 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcE
Confidence 8899999999998 57777776443111 0123889999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhC
Q 005415 563 KIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 563 KL~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........+..+.....
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99999987643221 122345677999999988888999999999999999999 8999987776666665532211
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
..+. ....+..+..++..||... |..|+++++++.-
T Consensus 237 ~~~~-----------~~~~~~~l~~~i~~~l~~~----p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ELPV-----------PEGCPSRLYKLMTRCWAVN----PKDRPSFSELVSA 272 (275)
T ss_pred CCCC-----------CCCCCHHHHHHHHHHcCCC----cccCCCHHHHHHH
Confidence 1110 0122346677777777744 7888999887743
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.67 Aligned_cols=237 Identities=19% Similarity=0.267 Sum_probs=177.3
Q ss_pred EEeccCCCCceEEEEECCCCc-------EEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGV-------DVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~-------~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+.||+|+||.||+|.+...+. .||+|.+.... ...+.+.+|+.+++.+ .||||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL------SHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC------CCCChhheeeEEEeCCCc
Confidence 369999999999998765443 48888876543 3335566777777765 488999999999998999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc------ceEEE
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR------CEIKI 564 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~------~~vKL 564 (697)
++||||+.+ +|..++..... .+++..+..++.||+.||.|||+++|+||||||+||+++.+.. +.++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 999999985 56666653322 2788889999999999999999999999999999999985322 24799
Q ss_pred eeCCCccccccccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 565 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 565 ~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG-~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+|||.+..... .....++..|+|||++.+. .++.++|||||||++|+|++| .+||...+........ ......|.
T Consensus 150 ~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~- 226 (258)
T cd05078 150 SDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQLPA- 226 (258)
T ss_pred cccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-HccccCCC-
Confidence 99998865433 2235678889999999864 578999999999999999998 5777665554433222 11111111
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
....++..++..||... |..|+|++++.
T Consensus 227 ------------~~~~~~~~li~~~l~~~----p~~Rps~~~il 254 (258)
T cd05078 227 ------------PKWTELANLINQCMDYE----PDFRPSFRAII 254 (258)
T ss_pred ------------CCcHHHHHHHHHHhccC----hhhCCCHHHHH
Confidence 11245777888888766 77888888876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-31 Score=265.69 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=211.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
.+.|.-+.+||+|.||.||+|+.+.+++.||+|++-. ...+....++|+++|+.|. |+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk------Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc------chhHHHHHHHHhhcc
Confidence 4678888999999999999999999999999997643 3345567889999999987 5677777666542
Q ss_pred ------cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ------~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
...+|+||.+|+.+|.-++.... ..+++.++..++.+++.||.|+|...|+|||+|+.|+||+. ++.
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~--dgi 162 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK--DGI 162 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC--Cce
Confidence 23489999999998887765332 23999999999999999999999999999999999999994 899
Q ss_pred EEEeeCCCcccccc-------ccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 562 vKL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+||+|||+++.... ..+..+-|.+|++||.++|.. |+++.|||..|||+.||+||.+.|++++...++..|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999999965332 233356699999999999864 9999999999999999999999999999999999999
Q ss_pred HhhCCCCHHHHhhcccccccccC------------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTK------------------EYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~------------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..+|.+.++.|++..+..-+-.- .+-...-..+...+++.-.|..|.+..+++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 99999999988875543322111 011112334566777777788999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=283.83 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=201.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+...|.+...+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++.... +||||+++.+.+.+..++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR-----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc-----CCCcceeecceecCCcee
Confidence 3467999999999999999999999999999999998662 34556777777765 489999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
|+|||.+.++..-....... .....+..|+.+|+.|+.|||++|||||||||+|||+. ++.+.++|+|||.++
T Consensus 392 ~~v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhh
Confidence 99999998764433222222 22267778999999999999999999999999999995 258899999999998
Q ss_pred ccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccc
Q 005415 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 651 (697)
Q Consensus 572 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~ 651 (697)
.......+.+-|..|.|||++....|+.++||||||++||+||+|+.||...+.. ..|...++.++..
T Consensus 465 ~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 465 ELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------- 532 (612)
T ss_pred hCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc---------
Confidence 8877755667788999999999999999999999999999999999999876655 2333333444332
Q ss_pred ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 652 KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 652 ~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
.......++...+++.--|..|+++.++. +|+.
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 24556677788888888899999999999 9993
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=256.85 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=183.6
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
...||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++ |+||+++++++......++||||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK------HRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC------CCCeeeeeeeeccCCEEEEEEec
Confidence 357999999999999999999999999887543 33456778888888774 78999999999999999999999
Q ss_pred ccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+.+ +|..++...... ...+...+..++.||+.||.|||++||+||||||+||+++. ..+.++|+|||.+......
T Consensus 87 ~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccC
Confidence 974 666666532211 11277888899999999999999999999999999999974 3568999999988654321
Q ss_pred ---cccccccCCCCCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHhhCCCCHHHHhhcccc
Q 005415 577 ---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDLEMLMQGQEI 650 (697)
Q Consensus 577 ---~~~~~gt~~Y~APE~l~~~~--~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I~~~lg~~p~e~~~~~~~~ 650 (697)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .....+ ...... ...
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~--------~~~ 233 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIH--------PEI 233 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccC--------CCC
Confidence 22345788999999987643 788999999999999999999999754322 111111 111100 001
Q ss_pred cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 651 ~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.. .....+..++..||. ..|..|.+++++. +|+
T Consensus 234 ~~--~~~~~~~~li~~~l~----~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 234 PE--SLSAEAKNFILRCFE----PDPDKRASAHDLLQDPFL 268 (268)
T ss_pred Cc--ccCHHHHHHHHHHcC----CCchhCCCHHHHHhCCCC
Confidence 11 112356666777765 4588899999988 885
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=263.31 Aligned_cols=243 Identities=22% Similarity=0.312 Sum_probs=190.0
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
..+||+|+||.||++.+..+++.||||.+.... .....+.+|+.+++.++ |+||+++++.+...+..++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC------CcchhheeeEEEeCCEEEEEEec
Confidence 457999999999999999999999999986432 23456777888887764 78999999999999999999999
Q ss_pred cccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 LRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
++++ |.+++. .. .+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~-~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 99 LEGGALTDIVT-HT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceecccc
Confidence 9864 444432 21 2788899999999999999999999999999999999985 678999999987654332
Q ss_pred ---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccc
Q 005415 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (697)
Q Consensus 577 ---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~ 653 (697)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.+..+...+.+.. ...
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~ 239 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL----------KNL 239 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc----------CCc
Confidence 2234678899999999888899999999999999999999999988777666555433221110 011
Q ss_pred ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 654 FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 654 ~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
-.....+..++..||.. .|..|.++++++ +|+.
T Consensus 240 ~~~~~~l~~li~~~l~~----~P~~R~~~~~ll~~~~~~ 274 (292)
T cd06657 240 HKVSPSLKGFLDRLLVR----DPAQRATAAELLKHPFLA 274 (292)
T ss_pred ccCCHHHHHHHHHHHhC----CcccCcCHHHHhcChHHh
Confidence 11233455666666654 588999999999 8876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=256.41 Aligned_cols=237 Identities=29% Similarity=0.396 Sum_probs=190.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
||.|+||.||++.+..+++.+|+|++..... ....+..|+.+++.++ |+||+++++.+......++||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN------HPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC------CCcHHHHHHHeecCCeeEEEEec
Confidence 6999999999999988899999999875432 3456778888888775 78999999999999999999999
Q ss_pred c-ccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc
Q 005415 498 L-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576 (697)
Q Consensus 498 l-~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~ 576 (697)
+ .++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 75 APGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccC
Confidence 9 567777776443 2789999999999999999999999999999999999985 778999999998765432
Q ss_pred ---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccc
Q 005415 577 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (697)
Q Consensus 577 ---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~ 653 (697)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.+...+.+.
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 214 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE------------ 214 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC------------
Confidence 33456788899999999888899999999999999999999999888776666665441111111
Q ss_pred ccCCchhhhhHHHHHHHHHHHhhhhccCH---HHHH--Hhh
Q 005415 654 FTKEYDLYYINEVCFANIFISLVVIRLTL---EYAA--LWL 689 (697)
Q Consensus 654 ~~~~~~l~~i~~~cw~~l~~~~~~~r~t~---e~~~--~wl 689 (697)
.....+..++..||.. .|..|.+. ++++ +|+
T Consensus 215 -~~~~~l~~~i~~~l~~----~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 215 -FLSPEARDLISGLLQK----DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -CCCHHHHHHHHHHhcC----CHhhCCCcccHHHHHhCCCC
Confidence 1134566777777664 47778887 6666 664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=289.80 Aligned_cols=144 Identities=27% Similarity=0.431 Sum_probs=124.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|+++++||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.++ ||||+++++++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK------SPFIVHLYYSLQSAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC------CCCcCeEEEEEEECC
Confidence 67999999999999999999999999999999997532 23356667777777654 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
++||||||+. ++|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DFG 149 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFG 149 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeCC
Confidence 9999999996 56777665332 2788899999999999999999999999999999999985 7889999999
Q ss_pred Ccc
Q 005415 569 SSC 571 (697)
Q Consensus 569 la~ 571 (697)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=257.69 Aligned_cols=240 Identities=20% Similarity=0.242 Sum_probs=178.7
Q ss_pred EEeccCCCCceEEEEECC---CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEEE
Q 005415 420 EYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFI 493 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~---~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-~~~~l~L 493 (697)
+.||+|+||.||+|.+.. ....||+|.+... ......+.+|+.+++.+ +||||+++++++. .....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF------SHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC------CCCCcceEEEEeecCCCCcEE
Confidence 368999999999998643 3467999988542 23345666777777655 4899999999776 4556899
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. ++|.+++..... ..++..+..++.|++.||.|||+.+++||||||+|||++. ++.+||+|||++..
T Consensus 75 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~ 147 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARD 147 (262)
T ss_pred EEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCcccccc
Confidence 999997 567676653221 1567778889999999999999999999999999999985 77899999999865
Q ss_pred cccc-------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 573 QTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 573 ~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+......+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 224 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP--- 224 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC---
Confidence 4321 112234667999999988889999999999999999999 67788877766655554322111110
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
. .....+..++..||... |..|+++.+++.-
T Consensus 225 -------~--~~~~~~~~li~~cl~~~----p~~Rp~~~~il~~ 255 (262)
T cd05058 225 -------E--YCPDPLYEVMLSCWHPK----PEMRPTFSELVSR 255 (262)
T ss_pred -------C--cCCHHHHHHHHHHcCCC----hhhCCCHHHHHHH
Confidence 0 12346778888888655 7778888887733
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=260.22 Aligned_cols=238 Identities=17% Similarity=0.185 Sum_probs=173.1
Q ss_pred EeccCCCCceEEEEECC------------------------CCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCC
Q 005415 421 YLGSAAFSKVFQAQDLH------------------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~------------------------~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
+||+|+||.||+|.... ....|++|++..... ....+.+|+.+++.+ .|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l------~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV------SH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC------CC
Confidence 59999999999997422 124688998865432 223455666666555 48
Q ss_pred CceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc
Q 005415 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 555 (697)
Q Consensus 476 pnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~ 555 (697)
|||+++++++......++||||++++.+..+..... ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 999999999999999999999998664443332211 1278889999999999999999999999999999999997
Q ss_pred ccC-----cceEEEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHHH
Q 005415 556 SYQ-----RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVMI 628 (697)
Q Consensus 556 ~~~-----~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELl-tG~~PF~~~~~~e~ 628 (697)
... ...++|+|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+.
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 421 235899999987543322 22356788999998875 56899999999999999995 69999987665543
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
...+ ......|. .....+..++..||... |..|.+++++..
T Consensus 231 ~~~~-~~~~~~~~-------------~~~~~~~~li~~cl~~~----p~~Rps~~~il~ 271 (274)
T cd05076 231 ERFY-EKKHRLPE-------------PSCKELATLISQCLTYE----PTQRPSFRTILR 271 (274)
T ss_pred HHHH-HhccCCCC-------------CCChHHHHHHHHHcccC----hhhCcCHHHHHH
Confidence 3222 11111111 11235778888888754 777888887764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.38 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=189.6
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
||.+.+.||+|+||.||++.+...+..+++|+++.. .....+...|+.+++.++ ||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD------HPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC------CCcHHHHHHHHhcC
Confidence 699999999999999999999888777878877632 112234556777776654 88999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||+.+ +|..++...... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ .+.++|+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~---~~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK---NNLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee---cCCEeeccc
Confidence 999999999985 555555432221 12388999999999999999999999999999999999997 456999999
Q ss_pred CCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|.+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+... .++. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~-~- 225 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTPS-L- 225 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCC-C-
Confidence 988654332 22345788899999998888899999999999999999999999877666655554332 1111 0
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
. ......+..++..||. ..|..|.+.++++ +|+
T Consensus 226 ------~--~~~~~~~~~li~~~l~----~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 226 ------P--ETYSRQLNSIMQSMLN----KDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------c--chhcHHHHHHHHHHhc----CChhhCcCHHHHhhCCCC
Confidence 0 0112355566666665 4588999999998 875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=259.78 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=191.3
Q ss_pred CceEEEEEeccCCCCceEEEEEC----CCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~----~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..|++.+.||+|+||.||+|... .++..||||+++.... ....+.+|+++++.+. |+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~------~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD------HENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC------CCChheEEeeeec
Confidence 46888999999999999999854 3478999999986544 3567788888888764 7899999999887
Q ss_pred --cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 --LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 --~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
....++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l 150 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKI 150 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEE
Confidence 567999999996 577777754332 2888999999999999999999999999999999999985 789999
Q ss_pred eeCCCccccccccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-----------
Q 005415 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM----------- 627 (697)
Q Consensus 565 ~DFGla~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e----------- 627 (697)
+|||.+........ ...++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence 99999876553211 1233556999999988889999999999999999999999986543211
Q ss_pred HHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
....+...+ ...............+..++..||..- |..|++++++..+|.
T Consensus 231 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~----p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 231 IVTRLLELL--------KEGERLPRPPSCPDEVYDLMKLCWEAE----PQDRPSFADLILIVD 281 (284)
T ss_pred cHHHHHHHH--------HcCCcCCCCccCCHHHHHHHHHHhccC----hhhCCCHHHHHHHHh
Confidence 011111111 111111111223356777888888764 788999999886654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=258.01 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=186.1
Q ss_pred eEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
|++.+.||+|+||.||+|.+. .+++.||||++... ....+++.+|+++++.++ ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD------HPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC------CCCcceEEEEEccCC
Confidence 677889999999999999864 35789999998753 233456777888887764 789999999887542
Q ss_pred ------eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 490 ------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 490 ------~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
..++++||+. ++|..++...........++...++.++.|++.||+|||+++|+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~--~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE--NMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC--CCCE
Confidence 2478899987 455555543222112223788899999999999999999999999999999999985 7889
Q ss_pred EEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
||+|||++....... ....+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987653221 12234567999999998889999999999999999999 999998877766655554321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
. +. ........+..++..||... |..|.++.++..
T Consensus 233 ~-~~-----------~~~~~~~~~~~l~~~~l~~~----p~~Rps~~~~~~ 267 (273)
T cd05074 233 R-LK-----------QPPDCLEDVYELMCQCWSPE----PKCRPSFQHLRD 267 (273)
T ss_pred c-CC-----------CCCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHH
Confidence 1 10 00122346777888888765 677778877763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=258.79 Aligned_cols=239 Identities=18% Similarity=0.177 Sum_probs=174.1
Q ss_pred EEeccCCCCceEEEEECC------------CCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLH------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~------------~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+.||.|+||.||+|.... ....|++|++..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~------hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS------HKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC------CCCEeeEEEEEe
Confidence 368999999999997432 234689998765432 2335566677776664 899999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc-----ce
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CE 561 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~-----~~ 561 (697)
.....++||||++++.+........ ..+++..+..++.||+.||.|||+++|+||||||+|||++.... ..
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 9889999999998655444332211 23888999999999999999999999999999999999975221 23
Q ss_pred EEEeeCCCccccccccccccccCCCCCchhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIWSLGviL~ELl-tG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... +......
T Consensus 151 ~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~- 227 (262)
T cd05077 151 IKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM- 227 (262)
T ss_pred eEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc-
Confidence 899999988654332 2345778899999987 456899999999999999998 5999998765443322 1111000
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
........+..++..||... |..|++.++++.
T Consensus 228 ------------~~~~~~~~~~~li~~cl~~d----p~~Rp~~~~il~ 259 (262)
T cd05077 228 ------------LVTPSCKELADLMTHCMNYD----PNQRPFFRAIMR 259 (262)
T ss_pred ------------CCCCChHHHHHHHHHHcCCC----hhhCcCHHHHHH
Confidence 00112346778888888754 778888877763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=261.67 Aligned_cols=254 Identities=22% Similarity=0.257 Sum_probs=184.9
Q ss_pred ceEEEEEeccCCCCceEEEEE----CCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d----~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
-|++++.||+|+||.||++.. ..++..||+|.++.. ......+.+|+.+++.++ ||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEecC
Confidence 368999999999999999974 457889999998743 233456778888888774 78999999998875
Q ss_pred --CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 489 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 489 --~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
...++||||++ ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEEC
Confidence 56899999996 566666643221 2788999999999999999999999999999999999985 7889999
Q ss_pred eCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++....... ....++..|+|||.+.+..++.++|||||||++|+|+++..|+.... ... .+..++.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~---~~~~~~~ 226 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM--TLF---LKMIGPT 226 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc--chh---hhhcccc
Confidence 999987543321 12345667999999998889999999999999999999887653321 111 1111111
Q ss_pred CHH----H----HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLE----M----LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e----~----~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..+ . ................+..++..||.. .|..|++++++...+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~----~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEF----QPSKRTTFQNLIEGFE 281 (284)
T ss_pred cccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccC----CcccCcCHHHHHHHHH
Confidence 100 0 001111111112234566666766664 4888999998886554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.70 Aligned_cols=247 Identities=17% Similarity=0.179 Sum_probs=181.1
Q ss_pred EeccCCCCceEEEEECCC--CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEE
Q 005415 421 YLGSAAFSKVFQAQDLHT--GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~--g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmE 496 (697)
.||+|+||.||++..... ...+++|.+.... .....+.+|+.+++.+ +||||+++++.+......++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL------QHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc------CCcchhheEEEecCCCccEEEEe
Confidence 589999999999975332 3456677766432 2345667777777655 48999999999999999999999
Q ss_pred ccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc
Q 005415 497 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 497 yl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+. ++|.+++...... ...++...++.++.||+.||.|||+.+|+||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCc
Confidence 998 5777777543221 122667778899999999999999999999999999999985 78899999998754221
Q ss_pred -----ccccccccCCCCCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 576 -----NLCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 576 -----~~~~~~gt~~Y~APE~l~~-------~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~- 230 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF- 230 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC-
Confidence 1223457788999999743 245788999999999999997 68899887777766665432211100
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+ ..... .-...+..++..||. .|..|.+++++..-|
T Consensus 231 ---~-~~~~~--~~~~~~~~l~~~c~~-----~P~~Rp~~~~i~~~l 266 (268)
T cd05086 231 ---K-PQLEL--PYSERWYEVLQFCWL-----SPEKRATAEEVHRLL 266 (268)
T ss_pred ---C-CccCC--CCcHHHHHHHHHHhh-----CcccCCCHHHHHHHh
Confidence 0 00111 123467788999993 389999999987554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=260.63 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=189.5
Q ss_pred ceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+|++.+.||.|++|.||++.+. .+++.||||+++... .....+..|+.+++.+. +||||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-----CCcchhhhheeee
Confidence 4889999999999999999864 467899999987532 22345667888888775 3789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.....++||||+.+ +|...+.... .+++..+..++.|++.||.|||+.+++||||+|+||+++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEE
Confidence 99999999999975 5666554321 2788899999999999999999999999999999999985 7789999
Q ss_pred eCCCcccccccc----ccccccCCCCCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHh
Q 005415 566 DLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARIIGM 635 (697)
Q Consensus 566 DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~~--~s~ksDIWSLGviL~ELltG~~PF~~~~~----~e~l~~I~~~ 635 (697)
|||++....... ....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||..... .+....+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 999886543221 1245788999999987654 78899999999999999999999965432 2222222221
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH---HHHH--HhhcccCCCC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL---EYAA--LWLFGIDQNK 696 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~---e~~~--~wl~~~~~n~ 696 (697)
..+.+ . .....+..++..||... +..|.|+ ++++ +|+..++++.
T Consensus 228 ~~~~~-----------~--~~~~~l~~li~~~l~~~----p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 228 KPPFP-----------K--TMSAEARDFIQKLLEKD----PKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred CCCCC-----------c--ccCHHHHHHHHHHhcCC----HhhccCcchHHHHhcCcccccCCHHH
Confidence 11111 1 12345667777777655 6666664 3344 9998888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=285.31 Aligned_cols=229 Identities=25% Similarity=0.353 Sum_probs=177.8
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEEec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 005415 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g~~VAVKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~ 499 (697)
+||+|.||+||.|+|..+...+|||-+.. +.....-..+||.+.+.|+ |.|||+++|.+...+++-|.||-++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr------HkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR------HKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh------hHhHHHHhhccCCCCeEEEEeecCC
Confidence 59999999999999999999999999874 4445566778999988886 6799999999999999999999998
Q ss_pred cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc---cc
Q 005415 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DN 576 (697)
Q Consensus 500 gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~---~~ 576 (697)
|+.+..+...... ...-.+..+..+.+||++||.|||++.|||||||-+||||+. -.|.+||+|||.++... .-
T Consensus 656 GGSLSsLLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCcHHHHHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCcc
Confidence 6544444333321 111267888889999999999999999999999999999986 46899999999987643 23
Q ss_pred cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHH--HHHhhCCCCHHHHhhccc-c
Q 005415 577 LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILAR--IIGMLGPIDLEMLMQGQE-I 650 (697)
Q Consensus 577 ~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~-~~~e~l~~--I~~~lg~~p~e~~~~~~~-~ 650 (697)
..++.||..|||||++..+ +|+.++|||||||++.||.||++||..- ++...+.+ +.+.-.++|.++....+. +
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 4458899999999999765 4899999999999999999999999653 33333333 223344566665554443 2
Q ss_pred cccccCCc
Q 005415 651 YKYFTKEY 658 (697)
Q Consensus 651 ~~~~~~~~ 658 (697)
.++|..++
T Consensus 813 lrcFepd~ 820 (1226)
T KOG4279|consen 813 LRCFEPDP 820 (1226)
T ss_pred HHHcCCCc
Confidence 34444443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=252.63 Aligned_cols=246 Identities=26% Similarity=0.295 Sum_probs=191.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+|++.+.||.|++|.||++.+..+++.+|+|.+.... .....+.+|+.+++.++ |+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN------HPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC------CCCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999987532 22345567777777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+++ +|..++...... ...+++..+..++.|++.||.|||+.|++|+||+|.||+++. ++.+||+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccch
Confidence 999999964 676666543221 123788999999999999999999999999999999999995 778999999998
Q ss_pred cccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 571 CFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 571 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 223 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP------- 223 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch-------
Confidence 665443 222457889999999999889999999999999999999999998887766555543322111110
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.....+..++..||. ..+..|.++++++
T Consensus 224 -----~~~~~~~~li~~~l~----~~p~~Rp~~~~~l 251 (256)
T cd08530 224 -----IYSQDLQNFIRSMLQ----VKPKLRPNCDKIL 251 (256)
T ss_pred -----hhCHHHHHHHHHHcC----CCcccCCCHHHHh
Confidence 112345555555554 4478899988876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.02 Aligned_cols=201 Identities=28% Similarity=0.386 Sum_probs=175.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.+.|+.-++||+|+||.||-++-..+|+-+|+|.+.+. +......+.|..||+.++. +.||.+--.|++.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s------~FiVslaYAfeTk 257 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS------PFIVSLAYAFETK 257 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc------CcEEEEeeeecCC
Confidence 35688889999999999999999999999999988643 2334566789999999874 5899999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
+.+++||..|+|+.+.+..++... .-++++.++.++.+|+.||.+||+.+||.|||||+|||++. .|+++|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd--~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD--HGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc--CCCeEeeccc
Confidence 999999999998776666555432 34999999999999999999999999999999999999994 9999999999
Q ss_pred Cccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 569 la~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
+|...... ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||....
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 99876543 445699999999999999999999999999999999999999997543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=260.64 Aligned_cols=208 Identities=27% Similarity=0.372 Sum_probs=171.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
..+++..||+|+.|+||++..+.+|..+|||.+.... ....+++..+.+....+ +.|+||+.+|+|......+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchHH
Confidence 4567888999999999999999999999999998643 23344445555444332 4689999999999999999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
|.||.|..-+..+++..... +++..+-.+...+++||.||-++ +|+|||+||+|||++. .|.+||||||.+.
T Consensus 168 IcMelMs~C~ekLlkrik~p-----iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe--~GniKlCDFGIsG 240 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGP-----IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCC-----chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc--CCCEEeecccccc
Confidence 99999987666666554432 88888889999999999999965 8999999999999995 8999999999997
Q ss_pred ccccc--cccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHH
Q 005415 572 FQTDN--LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIG 634 (697)
Q Consensus 572 ~~~~~--~~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~ 634 (697)
+..+. .+...|++.|||||.+.-. .|+.++||||||++++||.||+.||.+.+ +-+.+.+|..
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 76554 3456889999999998643 58999999999999999999999999854 5577777766
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=278.96 Aligned_cols=210 Identities=26% Similarity=0.392 Sum_probs=183.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+++++..||-|+||.|=++........+|+|++++ +....++...|..|+..++ .|+||++|..|.+..
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~------s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR------SDFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC------chHHHHHHHHhccch
Confidence 467788899999999999998766555689999875 3345677888999998886 469999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|++||-|= |.+...+.-... |.....+.++..+++|+.|||++|||.|||||+|+|++. +|-+||.|||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~--~Gy~KLVDFG 565 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN--RGYLKLVDFG 565 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc--CCceEEeehh
Confidence 9999999974 567766653332 888899999999999999999999999999999999995 8899999999
Q ss_pred Ccccccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 569 SSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 569 la~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|+...... -+++|||.|.|||++++++.+.++|.||||+++|||++|.+||.+.++...+..|++.+.
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID 636 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence 998876553 458999999999999999999999999999999999999999999999999999987654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=277.97 Aligned_cols=235 Identities=24% Similarity=0.343 Sum_probs=195.3
Q ss_pred ceEEEEEeccCCCCceEEEEECC----CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~----~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..++.++||.|.||.||+|.... ..-.||||..+.+ ....+.++.|.-+++.+ +||||++++|++..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf------dHphIikLIGv~~e- 462 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF------DHPHIIKLIGVCVE- 462 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC------CCcchhheeeeeec-
Confidence 34456789999999999997532 2346899999863 34567888898888876 48999999999976
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...|||||++. |.|..+++.+... ++...+..++.||..||+|||+.++|||||..+|||+.+ ..-+||+||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS--p~CVKLaDF 535 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS--PQCVKLADF 535 (974)
T ss_pred cceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC--cceeeeccc
Confidence 68999999998 7899999877765 888999999999999999999999999999999999996 556899999
Q ss_pred CCccccccccccc----cccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 568 GSSCFQTDNLCLY----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 568 Gla~~~~~~~~~~----~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
|+++...+..... .-+.-|||||.+.-..++.++|||.|||.+||++. |..||.+-...+++-.|
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---------- 605 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---------- 605 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----------
Confidence 9999887654321 22556999999999999999999999999999998 99999998887777665
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHh
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISL 675 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~ 675 (697)
.++.+.+..-.+++.||.+|..||+=....+
T Consensus 606 --EnGeRlP~P~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 606 --ENGERLPCPPNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred --cCCCCCCCCCCCChHHHHHHHHHhccCcccC
Confidence 3455555556788999999999998654333
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=258.62 Aligned_cols=191 Identities=24% Similarity=0.296 Sum_probs=154.4
Q ss_pred CCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-c
Q 005415 426 AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-N 501 (697)
Q Consensus 426 ~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-s 501 (697)
+++.||++++..+++.||||+++.. ......+..|+.+++.++ |+||+++++++......+++|||+.+ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ------HPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC------CcchhhhhheeecCCeEEEEEeccCCCC
Confidence 4566777777779999999998754 344567788888888774 78999999999999999999999985 5
Q ss_pred hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc-----
Q 005415 502 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----- 576 (697)
Q Consensus 502 L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~----- 576 (697)
+.+++...... .+++..+..++.|++.||.|||+++|+||||||+||+++. ++.++|+|||.+......
T Consensus 86 l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeecccccccc
Confidence 65665533221 2788899999999999999999999999999999999985 788999999987543221
Q ss_pred -----cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 577 -----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 577 -----~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
.....++..|+|||++... .++.++|+|||||++|+|++|..||........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1223456789999999763 588999999999999999999999987665443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=257.69 Aligned_cols=263 Identities=31% Similarity=0.509 Sum_probs=217.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++..||.-+..+|.|+- .|..|.|.-.++.||+|.+... .....+..+|.+++..++ |+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~------~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN------HKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc------ccceeeeeeccCc
Confidence 45678999999999998 8999999999999999987542 223356678888888886 7799999999985
Q ss_pred c------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 488 L------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ~------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
. ...|+|||+|..+|.+.+... +.-.++..|+.|++.|++|||+.||+||||||+||++.. ++.
T Consensus 87 ~~~l~~~~e~y~v~e~m~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~ 156 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDANLCQVILME--------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCT 156 (369)
T ss_pred cccHHHHHhHHHHHHhhhhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhh
Confidence 5 357999999999999888732 566789999999999999999999999999999999995 899
Q ss_pred EEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+||.|||+++..... .+.++.++.|+|||++.+..+...+||||+|||+.||++|...|+|.+..++..+|++.+|.|
T Consensus 157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999999765443 556788999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhhcccccccccC-------------------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 640 DLEMLMQGQEIYKYFTK-------------------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~-------------------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
+++++.+-+..-+-+-. ...-....++...+++.-.|..|.+.+.++ |+++
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 99988753322111110 011223446666666777788899999999 6654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=274.59 Aligned_cols=206 Identities=25% Similarity=0.372 Sum_probs=171.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
...|..++.||-|+||.|.++....+...+|+|.+++.. ........|..||.+.. .+.||+||-.|++.
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD------n~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDK 701 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC------CcceEEEEEEeccC
Confidence 356889999999999999999988899999999998642 33455667888887765 45899999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+|+||+|++| ++-.++..... |.+..++.++.++..|+.+.|..|+|||||||+||||+. +|+|||+||
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr--dGHIKLTDF 773 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDF 773 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc--CCceeeeec
Confidence 999999999985 56666654433 888899999999999999999999999999999999996 999999999
Q ss_pred CCccccc---c------------------------------------------ccccccccCCCCCchhhcCCCCCchhh
Q 005415 568 GSSCFQT---D------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQKID 602 (697)
Q Consensus 568 Gla~~~~---~------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksD 602 (697)
|++.-.. + .....+||+.|+|||++...+|+..+|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9873200 0 001247899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 005415 603 LWSLGCILAELWTGEVLFPNDAVVMILARI 632 (697)
Q Consensus 603 IWSLGviL~ELltG~~PF~~~~~~e~l~~I 632 (697)
.||.|||||||+.|++||..+.+.+.-.+|
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence 999999999999999999877655443333
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=242.99 Aligned_cols=213 Identities=26% Similarity=0.393 Sum_probs=175.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+...-+..||+|++|.|=+.++..+|...|+|.++..- ....+.++|+.+... ..+.|++|++|+.......+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r-----~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMR-----TVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhcc-----CCCCCeEEEeehhhhccccE
Confidence 34455677999999999999999999999999987532 223344444444332 35689999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+|.||.|..+|..+...--..++ .+++..+-+|+..++.||.|||++ .|+|||+||+||||+. .|++|+||||.+
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~--~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~--~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGG--TIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY--DGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCC--cCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc--CCcEEEcccccc
Confidence 99999999998887765444333 388999999999999999999976 8999999999999995 899999999999
Q ss_pred ccccccccc--ccccCCCCCchhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHh
Q 005415 571 CFQTDNLCL--YVQSRSYRAPEVII----GLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGM 635 (697)
Q Consensus 571 ~~~~~~~~~--~~gt~~Y~APE~l~----~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~ 635 (697)
....+.... ..|+..|+|||.+. ...|+.++||||||++++||.+++.||+. .++-+++.++++.
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 877665432 57888999999985 34699999999999999999999999976 5677888888663
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=300.00 Aligned_cols=214 Identities=30% Similarity=0.425 Sum_probs=180.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.-||+-...||.|.||.||.|.+..+|+..|+|-++. .......+.+|++++..++ |||+|++|++-.+.+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln------HpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN------HPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc------CccccccCceeecHH
Confidence 4578888999999999999999999999999997763 3445677889999999886 889999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+|.||||.+ +|.+++...+. .++...+.+..|++.|+.|||+.|||||||||.||+++. +|.+|+.|||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeeccc
Confidence 99999999985 55555543322 667778889999999999999999999999999999995 8899999999
Q ss_pred Ccccccccc-------ccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 569 SSCFQTDNL-------CLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 569 la~~~~~~~-------~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
.|.....+. ....||+.|||||++.+. +...+.|||||||++.||+||+.||..-+.+-++.-.+.+.-.
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK 1459 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC
Confidence 997765442 346899999999999754 4667899999999999999999999987777666666655544
Q ss_pred CC
Q 005415 639 ID 640 (697)
Q Consensus 639 ~p 640 (697)
|+
T Consensus 1460 Pq 1461 (1509)
T KOG4645|consen 1460 PQ 1461 (1509)
T ss_pred CC
Confidence 43
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=262.41 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=197.2
Q ss_pred CCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 401 ~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
+...|......+..+.++++.||+|.||.||+|.+ -|+.||||++....+ ..+.+|.+|++.+- .+|+||+.
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE--~SWfrEtEIYqTvm----LRHENILg 269 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE--RSWFRETEIYQTVM----LRHENILG 269 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccch--hhhhhHHHHHHHHH----hccchhhh
Confidence 45677777888899999999999999999999987 489999999986544 46678888888764 35899999
Q ss_pred EEEEEEec----CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-----c---CccccCC
Q 005415 481 LYDYFYHL----EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-----L---GIIHCDL 547 (697)
Q Consensus 481 l~~~f~~~----~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-----~---gIvHrDL 547 (697)
+++.-... ..+|||++|.+ |+|.+++.... ++.....+++..++.||+|||- + .|.||||
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 98876543 46999999998 88999997632 8888999999999999999994 2 3999999
Q ss_pred CCccccccccCcceEEEeeCCCcccccc-------ccccccccCCCCCchhhcCCC----C-C-chhhHHHHHHHHHHHH
Q 005415 548 KPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGLP----Y-D-QKIDLWSLGCILAELW 614 (697)
Q Consensus 548 KP~NILl~~~~~~~vKL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~~~----~-s-~ksDIWSLGviL~ELl 614 (697)
|..|||+.. ++...|+|+|+|..... .....+||..|||||++...- + + ..+||||||.++||++
T Consensus 343 KSKNILVKk--n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 343 KSKNILVKK--NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccccEEEcc--CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 999999995 88999999999865432 345579999999999995431 1 2 3599999999999998
Q ss_pred hC----------CCCCCC----CcHHHHHHHHH--HhhCCCCHHHHhhcccccccccCCc---hhhhhHHHHHHHHHHHh
Q 005415 615 TG----------EVLFPN----DAVVMILARII--GMLGPIDLEMLMQGQEIYKYFTKEY---DLYYINEVCFANIFISL 675 (697)
Q Consensus 615 tG----------~~PF~~----~~~~e~l~~I~--~~lg~~p~e~~~~~~~~~~~~~~~~---~l~~i~~~cw~~l~~~~ 675 (697)
.+ ++||.+ ++..+.+.+++ +.++|.++. .|..++ .+-.+|++||..-
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn----------rW~s~~~l~~m~klMkeCW~~N---- 486 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN----------RWKSDPALRVMAKLMKECWYAN---- 486 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc----------ccccCHHHHHHHHHHHHhhcCC----
Confidence 63 678854 33344555543 333443333 334443 4557899999976
Q ss_pred hhhccCHHHHH
Q 005415 676 VVIRLTLEYAA 686 (697)
Q Consensus 676 ~~~r~t~e~~~ 686 (697)
|..|+|+=++.
T Consensus 487 p~aRltALriK 497 (513)
T KOG2052|consen 487 PAARLTALRIK 497 (513)
T ss_pred chhhhHHHHHH
Confidence 66667665555
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.26 Aligned_cols=219 Identities=22% Similarity=0.347 Sum_probs=181.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
-++|.++++||+|+|++|.+++.+.+.+.+|+|++++. .+..+-...|..+..... +||.+|-++.+|+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhhccc
Confidence 36799999999999999999999999999999999853 333445556666666553 589999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..+++|.||++|+-+-+....++. ++++.++.+..+|..||.|||++||+.||||.+|||++. .|++||+|+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda--eghikltdyg 396 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYG 396 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc--CCceeecccc
Confidence 999999999997655444443333 899999999999999999999999999999999999996 8999999999
Q ss_pred Cccc---cccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCcHHHHHHHH-HHhhC
Q 005415 569 SSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP-------NDAVVMILARI-IGMLG 637 (697)
Q Consensus 569 la~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~-------~~~~~e~l~~I-~~~lg 637 (697)
+++. .++..++++|||.|.|||++.+..|+..+|.|+|||+++||+.|+.||. ..+.++.+.++ ++..-
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 9865 3455677999999999999999999999999999999999999999993 23445555544 34444
Q ss_pred CCCHHH
Q 005415 638 PIDLEM 643 (697)
Q Consensus 638 ~~p~e~ 643 (697)
.+|..+
T Consensus 477 riprsl 482 (593)
T KOG0695|consen 477 RIPRSL 482 (593)
T ss_pred ccccee
Confidence 445443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-30 Score=258.21 Aligned_cols=217 Identities=26% Similarity=0.349 Sum_probs=175.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++-....+-+..||.|+||+|++..++.+|+..|||.++... ....+++.|.....+-. +.||||++||....
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhhhc
Confidence 344455666778999999999999999999999999998543 33455666666554433 47899999999999
Q ss_pred cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
+...||.||+|.-++..+.+.-.... ...+++..+-.|....+.||.||-. ..|+|||+||+|||++. .|.+||||
T Consensus 135 EGdcWiCMELMd~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr--~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELMDISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR--HGDVKLCD 211 (361)
T ss_pred CCceeeeHHHHhhhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec--CCCEeeec
Confidence 99999999999988877765433221 1238888888999999999999986 58999999999999996 89999999
Q ss_pred CCCccccccc--cccccccCCCCCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHHH
Q 005415 567 LGSSCFQTDN--LCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIG 634 (697)
Q Consensus 567 FGla~~~~~~--~~~~~gt~~Y~APE~l~--~~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I~~ 634 (697)
||.+...... .+.-.|+..|||||.+. +.+|+.++|+||||++|||+.||..||..-+ ..+++..++.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 9999776554 33457899999999995 4468999999999999999999999998754 4566666643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=270.17 Aligned_cols=197 Identities=29% Similarity=0.520 Sum_probs=174.2
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhH---------HHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS---------LDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~---------~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.|..++.||.|+||.|++|.++.+...|+||.+.+.+-..+.. -.||.||..|+.+. |+||++++++|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~s---H~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHS---HENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcC---ccchhhhhhee
Confidence 5999999999999999999999999999999998765443333 35999999998764 99999999999
Q ss_pred EecCeEEEEEEcccc--chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 486 YHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 486 ~~~~~l~LVmEyl~g--sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
++++..||+||..+. +|.+++.+.+. +++.++..|++|++.|+++||+.||||||||-+||.++. +|-+|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~--~g~~k 710 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS--NGFVK 710 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhccccccccCceecccccccEEEec--CCeEE
Confidence 999999999999874 57777776554 899999999999999999999999999999999999995 89999
Q ss_pred EeeCCCcccccc-ccccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 564 IIDLGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 564 L~DFGla~~~~~-~~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
|+|||.+.+... +...++||..|.|||++.|..| +..-|||+||++||.++..+-||.+
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999877654 4566899999999999999886 4568999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.92 Aligned_cols=180 Identities=24% Similarity=0.271 Sum_probs=150.3
Q ss_pred CCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-chH
Q 005415 425 AAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLY 503 (697)
Q Consensus 425 G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-sL~ 503 (697)
|.+|.||+++++.+++.||+|.++..... ..|...+.. ..||||+++++++......++||||+.+ +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~------~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIP------HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHh------cCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 88999999999999999999999765321 223222221 2389999999999999999999999985 676
Q ss_pred HHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccccccccc
Q 005415 504 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583 (697)
Q Consensus 504 ~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt 583 (697)
+.+.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||.+...........++
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcC
Confidence 7665332 2889999999999999999999999999999999999995 7789999999876655544445567
Q ss_pred CCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 584 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 584 ~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 789999999888899999999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=275.20 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=202.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEEC----C---CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL----H---TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~----~---~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
++...+..+.+.||.|+||.|++|.-. . ....||||.++... .....+..|+++++.+.+ |+||+.
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~-----H~niv~ 366 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGK-----HPNIVN 366 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcC-----Ccchhh
Confidence 333455567779999999999999742 1 25679999988533 446788899999999864 899999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhh---ccCCC-------cccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQ---ESGGE-------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~---~~~~~-------~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
+++++.....+++|+||+. |+|+.++...+ ..... ..++...+..++.||+.|++||++.++|||||..
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999997 78999888766 11111 1388899999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccccccc-c-----ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-V-----QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~~~~-~-----gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~ 622 (697)
+|||+.. +..+||+|||+++......... . -+..|||||.+....|+.++||||+|++||||+| |..||++
T Consensus 447 RNVLi~~--~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITK--NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecC--CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999995 6789999999998644332221 1 2445999999999999999999999999999999 9999998
Q ss_pred Cc-HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHH
Q 005415 623 DA-VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYA 685 (697)
Q Consensus 623 ~~-~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~ 685 (697)
-. ..+.+.. +..+.+..+...+..++|.+|+.||......+|.-....+..
T Consensus 525 ~~~~~~l~~~------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 525 IPPTEELLEF------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred CCcHHHHHHH------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 54 4444333 345666677777888999999999977655554443333333
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=281.24 Aligned_cols=250 Identities=27% Similarity=0.344 Sum_probs=182.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--- 487 (697)
..+|+.++.||+||||.||+++++-+|+.||||.+... ......+.+|+++|..|+ |||||++|..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn------HpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN------HPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC------CcceeeeehhhhccCC
Confidence 35678889999999999999999999999999998765 445567888999998886 7899998855400
Q ss_pred --------------------------------------------------------------------------------
Q 005415 488 -------------------------------------------------------------------------------- 487 (697)
Q Consensus 488 -------------------------------------------------------------------------------- 487 (697)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------c--------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHH
Q 005415 488 ----------------------------L--------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531 (697)
Q Consensus 488 ----------------------------~--------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa 531 (697)
. ..+||-||||+..++..+....... -.....+++++||+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREIL 707 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHH
Confidence 0 1368899999977666554433321 13567899999999
Q ss_pred HHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc---------------------cccccccccCCCCCch
Q 005415 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---------------------DNLCLYVQSRSYRAPE 590 (697)
Q Consensus 532 ~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~---------------------~~~~~~~gt~~Y~APE 590 (697)
.||.|+|++|||||||||.||++++ ++.|||+|||++.... ...+..+||.-|+|||
T Consensus 708 EGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 708 EGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 9999999999999999999999995 8899999999986511 1234468899999999
Q ss_pred hhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHH
Q 005415 591 VIIGLP---YDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEV 666 (697)
Q Consensus 591 ~l~~~~---~s~ksDIWSLGviL~ELltG~~PF~~~-~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~ 666 (697)
++.+.. |+.|+||||||+||+||+ .||... ....++..+. .|.+|.. ..+|... ...-..
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~--------~~f~~~~---~~~e~s 849 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEP--------ADFFDPE---HPEEAS 849 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCC--------ccccccc---chHHHH
Confidence 997654 999999999999999999 567543 3334555543 3333332 1112211 111122
Q ss_pred HHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 667 CFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 667 cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
...-++..-|.+|+|+.+++ .|+.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCC
Confidence 22334444577899998888 5654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=268.52 Aligned_cols=209 Identities=25% Similarity=0.402 Sum_probs=181.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~----- 487 (697)
.+.|.|.+.||.|.+|.||++..+.+++.+|+||+..+....+.+..|.+||+.+. +|||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~-----~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS-----HHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc-----CCCCcceEEEEEEEecCCC
Confidence 35699999999999999999999999999999999988777778888888998875 48999999999984
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
++.+|||||||++ +.-++++... ...+.+..+..|++.++.||.+||.+.++|||||-.|||++. ++.|||+|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~--e~~VKLvD 166 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE--NAEVKLVD 166 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec--cCcEEEee
Confidence 3679999999985 5556665443 223889999999999999999999999999999999999995 89999999
Q ss_pred CCCccccccc---cccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 005415 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (697)
Q Consensus 567 FGla~~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I 632 (697)
||.+...+.. ..+.+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..+.-.|..|
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9998776543 456799999999999953 34788899999999999999999999988877666665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=269.75 Aligned_cols=270 Identities=19% Similarity=0.126 Sum_probs=172.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC----CcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY---- 484 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~----g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~---- 484 (697)
.++|.+.+.||+|+||.||+|.+..+ +..||||.+..... .|+.+...+.+.. +.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~---~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRAC---PNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhc---hhhHHHHHHhhhcc
Confidence 36799999999999999999999888 99999998864322 1222222222111 1111111111
Q ss_pred --EEecCeEEEEEEcccc-chHHHHHhhhcc--------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCC
Q 005415 485 --FYHLEHLFIVCELLRA-NLYEFQKFNQES--------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (697)
Q Consensus 485 --f~~~~~l~LVmEyl~g-sL~~~l~~~~~~--------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDL 547 (697)
.......++||||+++ +|.+++...... ..........+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345679999999985 566666432110 00001223456779999999999999999999999
Q ss_pred CCccccccccCcceEEEeeCCCccccccc----cccccccCCCCCchhhcCC----------------------CCCchh
Q 005415 548 KPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL----------------------PYDQKI 601 (697)
Q Consensus 548 KP~NILl~~~~~~~vKL~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~----------------------~~s~ks 601 (697)
||+|||++. +.+.+||+|||++...... .....+++.|+|||.+... .+..++
T Consensus 282 KP~NILl~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999984 3578999999999754322 2346788999999976432 233456
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccc-----cccccCCchhhhhHHHHHHHHHHHhh
Q 005415 602 DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI-----YKYFTKEYDLYYINEVCFANIFISLV 676 (697)
Q Consensus 602 DIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~-----~~~~~~~~~l~~i~~~cw~~l~~~~~ 676 (697)
|||||||+||||+++..|+ .+....+.+++...+.....+....... .+.|...........+...+++...|
T Consensus 361 DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999999976554 4444555555554444333332211110 00010000000011134555666678
Q ss_pred hhccCHHHHH--HhhcccCC
Q 005415 677 VIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 677 ~~r~t~e~~~--~wl~~~~~ 694 (697)
.+|+|+++++ +|+.+...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 8899999999 99986554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=256.26 Aligned_cols=256 Identities=23% Similarity=0.229 Sum_probs=186.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC----
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~---- 489 (697)
...++.+.||+|.||.||+|+. +++.||||++.... ...+..|..|..... ..|+||+++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~----m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE--KQSFQNEKNIYSLPG----MKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH--HHHHHhHHHHHhccC----ccchhHHHhhchhccCCcccc
Confidence 3467788999999999999974 56999999998543 357778888887763 46999999999887665
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh---------cCccccCCCCccccccccCc
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---------LGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs---------~gIvHrDLKP~NILl~~~~~ 559 (697)
.++||++|.+ |+|.++++.+. +++....+|+..|++||+|||+ ..|+|||||..||||.. +
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~--D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN--D 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--C
Confidence 7899999987 88999998654 8999999999999999999996 24999999999999995 8
Q ss_pred ceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCCC-CCcHHH
Q 005415 560 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP-YD-----QKIDLWSLGCILAELWTGEVLFP-NDAVVM 627 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~-~s-----~ksDIWSLGviL~ELltG~~PF~-~~~~~e 627 (697)
++..|+|||+|...... ....+||.+|||||++.+.. +. .+.||||+|.+||||+++-.-+. +..+.-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 89999999999765432 22368999999999997642 22 36999999999999998644432 111111
Q ss_pred HHHHHHHhhCCCCHHHHh-------hcccccccccCC---chhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 628 ILARIIGMLGPIDLEMLM-------QGQEIYKYFTKE---YDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~-------~~~~~~~~~~~~---~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
++.--.+....|..+.+. ..+.++..|.+. ..+...+++||......+.+.-...||..
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 111111111222222221 122334444443 35668899999988655555555555555
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=269.81 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=193.0
Q ss_pred eEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+..++||+|+||+||+|.+...|+ +||||++.... +....+++|.-++..| +|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl------dHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL------DHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC------CCchHHHHhhhcccch
Confidence 4456789999999999999876554 68888887543 2345666776666655 5899999999998765
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
+.||++|++ |.|+++++.++.. +-.+..+.|..||++||.|||++++|||||-.+|||+.. ...+||+|||
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks--P~hvkitdfg 843 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS--PNHVKITDFG 843 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC--CCeEEEEecc
Confidence 889999998 7899999876654 777889999999999999999999999999999999996 7889999999
Q ss_pred Ccccccccccc---ccc--cCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 569 SSCFQTDNLCL---YVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 569 la~~~~~~~~~---~~g--t~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+++........ ..| .+-|||-|.+....|+.++|||||||++||++| |..||.+.+..++-..+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll---------- 913 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL---------- 913 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------
Confidence 99876544222 222 456999999999999999999999999999999 99999998887655443
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHH
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLE 683 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e 683 (697)
..+.++...-.+.-+++.+|..||.-.-..+|.-+.+.+
T Consensus 914 --e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 914 --EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 334445555567789999999999866544444444333
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=229.25 Aligned_cols=236 Identities=35% Similarity=0.525 Sum_probs=185.7
Q ss_pred CCCceEEEEECCCCcEEEEEEEecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-ch
Q 005415 426 AFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NL 502 (697)
Q Consensus 426 ~fG~Vy~a~d~~~g~~VAVKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-sL 502 (697)
+||.||+|.+..+++.+|+|++...... ...+.+|+++++.+ +|+||+++++++......+++||++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 5899999999888999999999754322 46778888888877 478999999999999999999999987 77
Q ss_pred HHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc--cccc
Q 005415 503 YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLY 580 (697)
Q Consensus 503 ~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~--~~~~ 580 (697)
.+++..... ++...+..++.+++.+|.+||+.+|+|+||+|+||+++. ++.++|+|||.+...... ....
T Consensus 75 ~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 75 FDLLKKRGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred HHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccc
Confidence 777654322 788899999999999999999999999999999999995 689999999998766543 3445
Q ss_pred cccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCch
Q 005415 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 659 (697)
Q Consensus 581 ~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~ 659 (697)
.++..|+|||.+.+..++.++||||||+++++|++|..||.. ......+..+......+.... ......
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~ 216 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE----------WKISPE 216 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc----------ccCCHH
Confidence 678899999999988889999999999999999999999987 444444443322211111100 002345
Q ss_pred hhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 660 LYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 660 l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
+..++..||... |..|+++++++ +|+
T Consensus 217 ~~~~i~~~l~~~----p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 217 AKDLIRKLLVKD----PEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHccCC----chhccCHHHHhhCCCC
Confidence 667777776644 77889998887 654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=222.46 Aligned_cols=206 Identities=36% Similarity=0.555 Sum_probs=172.1
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|+..++.+ +|+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL------KHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC------CCCChhhheeeeecCCceEE
Confidence 5678999999999999999988899999999986543 356777788888777 37899999999998899999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
++|++.+ +|.+++...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++. .+.++|+|||.+..
T Consensus 75 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~ 147 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARF 147 (225)
T ss_pred EEeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeE
Confidence 9999987 777776543221 678889999999999999999999999999999999995 68999999999876
Q ss_pred ccccc----ccccccCCCCCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHH-HHHHHHHH
Q 005415 573 QTDNL----CLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVV-MILARIIG 634 (697)
Q Consensus 573 ~~~~~----~~~~gt~~Y~APE~l-~~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~-e~l~~I~~ 634 (697)
..... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+.. .+...|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 65432 445677889999998 666788899999999999999999999987 4444 55555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=278.09 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=176.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
..+...+.||+|+||.||+|++..++..||||.+..... ....|+++++.+ +||||+++++++......++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l------~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL------QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC------CCCCcceEEEEEEcCCCCEE
Confidence 356677899999999999999989999999999875432 123456666655 58999999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH---hcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH---SLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH---s~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
||||++ ++|.+++. . +++..+..++.|++.||+||| +.+|+||||||+||+++. ++..++. |+.
T Consensus 761 v~Ey~~~g~L~~~l~---~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~ 828 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---N------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSL 828 (968)
T ss_pred EEeCCCCCcHHHHHh---c------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecc
Confidence 999997 56766663 1 788899999999999999999 669999999999999985 4444443 444
Q ss_pred ccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHHH-hhCCCCHHHHhhc
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIG-MLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~-~e~l~~I~~-~lg~~p~e~~~~~ 647 (697)
...... .....+++.|+|||++.+..++.++|||||||++|||+||+.||..... ...+.+... .........+...
T Consensus 829 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 829 PGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred cccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 432221 1223678999999999999999999999999999999999999953211 011111111 1111111111000
Q ss_pred cc---ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 648 QE---IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 648 ~~---~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.. ..........+..++..||... |..|++++++...|..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~----P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATD----PTARPCANDVLKTLES 950 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCC----chhCcCHHHHHHHHHH
Confidence 00 0000011124556777888765 7888899888855543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=248.38 Aligned_cols=207 Identities=22% Similarity=0.355 Sum_probs=149.0
Q ss_pred cCceEEEEEeccCCCCceEEEEEC----------------CCCcEEEEEEEecchhh---------------hHhHHHHH
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL----------------HTGVDVCLKIIKNDKDF---------------FDQSLDEI 461 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~----------------~~g~~VAVKii~~~~~~---------------~~~~~~Ei 461 (697)
.++|.+.++||+|+||+||+|.+. ..++.||||.+...... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 467999999999999999999752 24568999998753221 11223456
Q ss_pred HHHHHhcccCCCCCCceeEEEEEEEe--------cCeEEEEEEccc-cchHHHHHhhhcc------------------CC
Q 005415 462 KLLKLVNKNDPADEHHILRLYDYFYH--------LEHLFIVCELLR-ANLYEFQKFNQES------------------GG 514 (697)
Q Consensus 462 ~iL~~L~~~~~~~hpnIv~l~~~f~~--------~~~l~LVmEyl~-gsL~~~l~~~~~~------------------~~ 514 (697)
.++..+++. ...+.++++++++|.. ....++||||++ ++|.+++...... ..
T Consensus 224 ~~l~~l~~~-~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRN-PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhcc-cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666543 2335567788888763 356899999998 4666665432100 01
Q ss_pred CcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccc--c--cccccCCCCCch
Q 005415 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--C--LYVQSRSYRAPE 590 (697)
Q Consensus 515 ~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~--~--~~~gt~~Y~APE 590 (697)
...+++..++.++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||++....... . ...+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 112466788899999999999999999999999999999985 6789999999986543221 1 123478999999
Q ss_pred hhcCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCC
Q 005415 591 VIIGLP--------------------Y--DQKIDLWSLGCILAELWTGEV-LFPN 622 (697)
Q Consensus 591 ~l~~~~--------------------~--s~ksDIWSLGviL~ELltG~~-PF~~ 622 (697)
.+.... + ..+.||||+||++++|++|.. ||.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 985432 1 124799999999999999886 7754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=235.34 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=200.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..|+++..++-+|.||.||.|.+... .+.|.+|.++... -....++.|-.++..+ .|||++.+.++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~------sH~nll~V~~V~ 356 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA------SHPNLLSVLGVS 356 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC------cCCCccceeEEE
Confidence 46788888999999999999987643 3456677766433 2344555565555444 489999999988
Q ss_pred Eec-CeEEEEEEccc-cchHHHHHhhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 486 YHL-EHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 486 ~~~-~~l~LVmEyl~-gsL~~~l~~~~~~~--~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
... ...++++.+++ ++|..++...+... ....++..++..++.|++.|+.|||+.||||.||..+|++|+. ..+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd--~Lq 434 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD--QLQ 434 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh--hee
Confidence 754 66889999998 88988887544322 2334667778889999999999999999999999999999994 789
Q ss_pred EEEeeCCCcccccccccccc-----ccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHh
Q 005415 562 IKIIDLGSSCFQTDNLCLYV-----QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 562 vKL~DFGla~~~~~~~~~~~-----gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~ 635 (697)
+||+|=.+++..-.....-. .+..||+||.+....|+.++|+|||||++|||+| |+.||...++.++...+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--- 511 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--- 511 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH---
Confidence 99999998876544332222 2566999999999999999999999999999999 99999998888776554
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..+.++.+.|+++.+|+.+|..||+-+ |.+|.+-+|+.
T Consensus 512 ---------kdGyRlaQP~NCPDeLf~vMacCWall----peeRPsf~Qlv 549 (563)
T KOG1024|consen 512 ---------KDGYRLAQPFNCPDELFTVMACCWALL----PEERPSFSQLV 549 (563)
T ss_pred ---------hccceecCCCCCcHHHHHHHHHHHhcC----cccCCCHHHHH
Confidence 567888999999999999999999966 88888888876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=257.79 Aligned_cols=192 Identities=29% Similarity=0.379 Sum_probs=159.2
Q ss_pred EEeccCCCCc-eEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 005415 420 EYLGSAAFSK-VFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (697)
Q Consensus 420 e~LG~G~fG~-Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl 498 (697)
+.+|.|+.|+ ||+|. ..|+.||||.+-.. ..+-..+|+..|+.-. .|||||++|+.-.+..++||..|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehHh
Confidence 5689999987 78997 57899999988643 4456788999998764 5899999999999999999999999
Q ss_pred ccchHHHHHhh-hccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc---cCcceEEEeeCCCccccc
Q 005415 499 RANLYEFQKFN-QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 499 ~gsL~~~l~~~-~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~---~~~~~vKL~DFGla~~~~ 574 (697)
..+|.+++... ..... ......+.++.|+++||++||+.+||||||||.||||.. .....++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~---~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEM---QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhh---cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999864 11110 111345778999999999999999999999999999985 345689999999998765
Q ss_pred cc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005415 575 DN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (697)
Q Consensus 575 ~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~ 623 (697)
.. .....||-+|+|||++....-+.++||+||||++|..++ |.+||...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 43 234578999999999998888889999999999999999 59999754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=236.61 Aligned_cols=212 Identities=27% Similarity=0.438 Sum_probs=173.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC---CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~---~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.+.|.++++||.|.|++||++.+.. ..+.||+|.+..... ..++..|+++|..+.. +.||+.+.+++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG-----~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGG-----SDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhcc-----chhhhcchhhhccC
Confidence 34679999999999999999999877 789999999875433 4678999999999975 46999999999999
Q ss_pred CeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+...+||||++.. ..+++. . ++...++.+++.++.||.++|.+|||||||||.|+|.+. ..++-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---S------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHh---c------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEec
Confidence 9999999999864 333332 1 778899999999999999999999999999999999986 5677899999
Q ss_pred CCcccc-----------------cc------------------------------ccccccccCCCCCchhhcCCC-CCc
Q 005415 568 GSSCFQ-----------------TD------------------------------NLCLYVQSRSYRAPEVIIGLP-YDQ 599 (697)
Q Consensus 568 Gla~~~-----------------~~------------------------------~~~~~~gt~~Y~APE~l~~~~-~s~ 599 (697)
|++... .. ......||++|+|||++...+ .+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 987510 00 001147899999999998765 688
Q ss_pred hhhHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHHHhhCCC
Q 005415 600 KIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 600 ksDIWSLGviL~ELltG~~PF-~~~~~~e~l~~I~~~lg~~ 639 (697)
++||||.|||++-+++++.|| ...++.+.+.+|+...|.-
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~ 298 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSA 298 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChH
Confidence 999999999999999999998 4455566777776666543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=224.56 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=163.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE-EEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-FYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~-f~~~~~l 491 (697)
.+.|.|.+.||.|.||.+-+++++.+...+++|.+.........+.+|..---.|. .|.||+.-|+. |+..+..
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls-----~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS-----PHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec-----cchhhhHHHHHHhhcCceE
Confidence 46799999999999999999999999999999999877666667777765444443 47788877654 5666888
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+++|||++ |+|.+.+... -+-+.....++.|+++||.|||++++||||||.+||||-..+..++||||||.+
T Consensus 98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 89999998 6665544321 167788899999999999999999999999999999998767779999999999
Q ss_pred cccccccccccccCCCCCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005415 571 CFQTDNLCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPND 623 (697)
Q Consensus 571 ~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDIWSLGviL~ELltG~~PF~~~ 623 (697)
+..+........+..|.+||+.... ...+.+|||.||+++|.++||.+||+..
T Consensus 171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 8777665555567779999987533 2566799999999999999999999744
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=211.13 Aligned_cols=225 Identities=21% Similarity=0.336 Sum_probs=188.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++.++|+++++||+|+||.+|+|....+|+.||||+-+.... ..+...|.++.+.|+.. ..|..+..++.+..+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g-----~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGG-----VGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccC-----CCCchhhhhcccccc
Confidence 456899999999999999999999999999999999875443 36788999999999864 467777778888899
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceEEEeeCCC
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~vKL~DFGl 569 (697)
-.+||++++.+|.++.....+. ++..+++.++-|++.-+.|+|.++++||||||+|+|+.-.. ..++.|+|||+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 9999999999999998877654 99999999999999999999999999999999999987422 34789999999
Q ss_pred ccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHhh
Q 005415 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGML 636 (697)
Q Consensus 570 a~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~---~e~l~~I~~~l 636 (697)
|+...+. .....||..|.+--...+...+...|+-|+|.+|..+..|..||++... .+-..+|.+..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9764432 2235789999998888888888999999999999999999999998654 45566677666
Q ss_pred CCCCHHHHhh
Q 005415 637 GPIDLEMLMQ 646 (697)
Q Consensus 637 g~~p~e~~~~ 646 (697)
-..|.+.+..
T Consensus 241 ~s~~ie~LC~ 250 (341)
T KOG1163|consen 241 MSTPIEVLCK 250 (341)
T ss_pred cCCCHHHHhC
Confidence 6666665544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=198.76 Aligned_cols=180 Identities=43% Similarity=0.678 Sum_probs=154.2
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 005415 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (697)
Q Consensus 422 LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~ 499 (697)
||.|++|.||++.+..+++.+++|++..... ....+.+|+.+++.+. |++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN------HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC------CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999888899999999986644 2467888888888885 5799999999999899999999998
Q ss_pred -cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc--
Q 005415 500 -ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-- 576 (697)
Q Consensus 500 -gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~-- 576 (697)
++|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ..+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~-~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 75 GGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS-DNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC-CCCcEEEecCCceEEccCCcc
Confidence 67777765432 12788999999999999999999999999999999999984 1578999999998766544
Q ss_pred -cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHH
Q 005415 577 -LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAEL 613 (697)
Q Consensus 577 -~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~EL 613 (697)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3445678889999999877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=240.29 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=194.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.+|.++..+|.|.+|.||+|+|+.+++..|+|+++... ....-+.+|+-+++..+ ||||+.+++.+.....+|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~------h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR------HPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC------CcChHHHHhhhhhhcCcE
Confidence 57999999999999999999999999999999998643 33455667887777764 889999999999999999
Q ss_pred EEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
|+||||+++ |.+..... .++++.++....+..+++|.|||+.|-+|||||-.|||++. .+.+||+|||.+.
T Consensus 89 icMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd--~gDvklaDfgvsa 160 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD--EGDVKLADFGVSA 160 (829)
T ss_pred EEEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc--cCceeecccCchh
Confidence 999999864 54443322 23888899999999999999999999999999999999995 8999999999987
Q ss_pred ccccc---cccccccCCCCCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l---~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
..+.. ...+.||++|||||+. ....|...+|||++|++..|+---++|--...+...+..+.+..-+||. .
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-l-- 237 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-L-- 237 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-c--
Confidence 65543 4458999999999987 3556899999999999999999999998888888888777665555443 1
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.....|++..-+-.+.-+.+-+-.|.+.|.++
T Consensus 238 ---------kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 ---------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ---------cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11122333333333444445555666666554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=216.30 Aligned_cols=205 Identities=28% Similarity=0.343 Sum_probs=170.4
Q ss_pred ceEEEEEeccCCCCceEEEEECCCC-cEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE-EecCeE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF-YHLEHL 491 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g-~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f-~~~~~l 491 (697)
+|++.++||+|+||.||++.+..++ ..+|+|+...... ....+..|+.++..+.. ...-+++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987764 6899998876432 22267889999999875 11235899999999 477889
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-c--ceEEEeeCC
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R--CEIKIIDLG 568 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~--~~vKL~DFG 568 (697)
|+||+.++.+|.++..... ...++..++..|+.|++.+|.+||+.|++||||||.|+++.... . ..+.|.|||
T Consensus 97 ~iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999999999999886554 22399999999999999999999999999999999999998532 1 579999999
Q ss_pred Ccc--ccc-c---------c-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 569 SSC--FQT-D---------N-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 569 la~--~~~-~---------~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
+++ ... . . ...+.||..|+++.+..+...+.+.|+||++.++.+++.|..||.+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 311 1 1 1234589999999999999999999999999999999999999977653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=208.18 Aligned_cols=224 Identities=21% Similarity=0.292 Sum_probs=190.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+++-.|++.++||.|+||.++.|.+..++++||||.-... ....++..|.+..+.|.. .+.|...|-+...+.+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g-----~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGG-----TEGIPQVYYFGQEGKY 98 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcC-----CCCCCceeeeccccch
Confidence 4566899999999999999999999999999999986533 234688899999999975 4689999988888899
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc---CcceEEEeeC
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIIDL 567 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~vKL~DF 567 (697)
-.||||+++.+|.++.....+. |+..++..++.||+.-++++|++.+|.|||||+|+||... +...|.|+||
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999999999999999877665 9999999999999999999999999999999999999752 3457899999
Q ss_pred CCcccccccc----------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHHH
Q 005415 568 GSSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARIIG 634 (697)
Q Consensus 568 Gla~~~~~~~----------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~---~~~e~l~~I~~ 634 (697)
|+|+...+.. ....||..||+--..+|...+.+.|+-|||-+++..|.|.+||++. +..+-+.+|=+
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9998755432 2357899999999999999999999999999999999999999874 45667777765
Q ss_pred hhCCCCHHHHh
Q 005415 635 MLGPIDLEMLM 645 (697)
Q Consensus 635 ~lg~~p~e~~~ 645 (697)
....-|.+.+.
T Consensus 254 ~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 254 TKRSTPIEVLC 264 (449)
T ss_pred ccccCCHHHHH
Confidence 55555554444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=240.92 Aligned_cols=142 Identities=19% Similarity=0.184 Sum_probs=113.8
Q ss_pred CceeEEEEEEE-------ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 476 HHILRLYDYFY-------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 476 pnIv~l~~~f~-------~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
+||++++++|. ....++++||+++++|.+++.... ..+++..++.+++||+.||.|||++||+|||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 36777778772 234678899999999998886322 228899999999999999999999999999999
Q ss_pred Cccccccc-----------------cCcceEEEeeCCCcccccc-------------------ccccccccCCCCCchhh
Q 005415 549 PENILIKS-----------------YQRCEIKIIDLGSSCFQTD-------------------NLCLYVQSRSYRAPEVI 592 (697)
Q Consensus 549 P~NILl~~-----------------~~~~~vKL~DFGla~~~~~-------------------~~~~~~gt~~Y~APE~l 592 (697)
|+||||+. +.++.+||+|||+++.... .....++|+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999963 2345677888887754211 01123578889999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 593 ~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
.+..++.++|||||||+||||++|.+|+..
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999988763
|
|
| >cd08677 C2A_Synaptotagmin-13 C2 domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=179.18 Aligned_cols=93 Identities=14% Similarity=0.045 Sum_probs=83.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
+.+.|+|+|++| +|+ + .|.+|||||++|+|+.++ +|+||+++|+|+||+|||+|.|+ ++.+++ +++|.++||
T Consensus 12 ~~~~L~V~vikA~~L~-~--~g~sDPYVKv~L~~~~k~-~k~kT~v~rktlnPvfnE~f~F~--v~~~~l~~~tL~~~V~ 85 (118)
T cd08677 12 QKAELHVNILEAENIS-V--DAGCECYISGCVSVSEGQ-KEAQTALKKLALHTQWEEELVFP--LPEEESLDGTLTLTLR 85 (118)
T ss_pred cCCEEEEEEEEecCCC-C--CCCCCeEEEEEEcCCcCc-cEEEcceecCCCCCccccEEEEe--CCHHHhCCcEEEEEEE
Confidence 568999999999 998 3 477999999999987653 57799999999999999999999 998888 666999999
Q ss_pred cCCCCCCCCcccccccCcccc
Q 005415 342 DNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|+|++++|++||++.++..+.
T Consensus 86 d~Drfs~~d~IG~v~l~l~~~ 106 (118)
T cd08677 86 CCDRFSRHSTLGELRLKLADV 106 (118)
T ss_pred eCCCCCCCceEEEEEEccccc
Confidence 999999999999999987665
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domain |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=204.30 Aligned_cols=162 Identities=21% Similarity=0.208 Sum_probs=124.0
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECC-CCcEEEEEEEecc------hhhhHhHHHHHHHHHHhcccCCCCCCcee-
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHIL- 479 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~-~g~~VAVKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv- 479 (697)
....+.++|.+.+.||+|+||+||+|++.. +++.||||++... ......+.+|+++|+.++ |+||+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~------h~~iv~ 85 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR------GIGVVP 85 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc------CCCCCc
Confidence 345667899999999999999999998876 6788899986532 223456789999999986 56777
Q ss_pred EEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCC-CCccccccccC
Q 005415 480 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIKSYQ 558 (697)
Q Consensus 480 ~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDL-KP~NILl~~~~ 558 (697)
.+++. ...++||||+.+..+.... . .. ...++.|+++||.|||++||+|||| ||+|||++.
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~~~----~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~-- 147 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHLAR----P-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP-- 147 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHHhC----c-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC--
Confidence 45442 4589999999876543221 0 11 1467889999999999999999999 999999974
Q ss_pred cceEEEeeCCCccccccc-----------cccccccCCCCCchhhc
Q 005415 559 RCEIKIIDLGSSCFQTDN-----------LCLYVQSRSYRAPEVII 593 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-----------~~~~~gt~~Y~APE~l~ 593 (697)
++.+||+|||+++..... .....+++.|.|||.+.
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 678999999998754332 12346678899999984
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-19 Score=182.45 Aligned_cols=197 Identities=35% Similarity=0.526 Sum_probs=161.6
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ....+.+|+.++..+.+. ++|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-----PNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-----cceeeEEEEEecCCEE
Confidence 788999999999999999976 7889999875432 356778888888887642 2799999999877778
Q ss_pred EEEEEccccchHH-HHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc-eEEEeeCCC
Q 005415 492 FIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 569 (697)
Q Consensus 492 ~LVmEyl~gsL~~-~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~vKL~DFGl 569 (697)
+++++++.+.... ++...... ..+.......++.|++.++.|+|+.+++|||+||+||+++. .. .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCc
Confidence 9999999865443 33322210 23888999999999999999999999999999999999995 44 799999999
Q ss_pred ccccccc---------cccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 570 SCFQTDN---------LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 570 a~~~~~~---------~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
+...... .....++..|+|||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8644332 355688999999999988 5788899999999999999999999987764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=178.47 Aligned_cols=166 Identities=23% Similarity=0.256 Sum_probs=120.2
Q ss_pred cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccccccc
Q 005415 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (697)
Q Consensus 500 gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~ 579 (697)
|+|.+++..... .+++..++.++.||+.||.|||+++ ||+|||++. ++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--DGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC--ccceee--ccceEeecccc--
Confidence 466677654322 2899999999999999999999998 999999985 778888 99987655433
Q ss_pred ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHhhCCCCHHHHhhcccccccccCCc
Q 005415 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY 658 (697)
Q Consensus 580 ~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~-~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~ 658 (697)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+.....+....... ....+....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 139 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRS----NLESVSAAR 139 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccc----cHHHHHhhh
Confidence 2678999999999999999999999999999999999999976543 23344443332222111000 001111112
Q ss_pred hhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 659 DLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 659 ~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
.+..++..||... |..|.+..++. +|+.
T Consensus 140 ~~~~~i~~cl~~~----p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 140 SFADFMRVCASRL----PQRREAANHYLAHCRAL 169 (176)
T ss_pred hHHHHHHHHHhcc----cccccCHHHHHHHHHHH
Confidence 5778888888765 78899998887 5543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=185.39 Aligned_cols=177 Identities=15% Similarity=0.197 Sum_probs=130.3
Q ss_pred cceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHh------HHHHHHHHHHhcccCCC
Q 005415 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQ------SLDEIKLLKLVNKNDPA 473 (697)
Q Consensus 404 ~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~------~~~Ei~iL~~L~~~~~~ 473 (697)
+.-...+++.++|+++++||.|+||.||++.+ ++..+|||+++.... .... +.+|+..+..+.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~----- 93 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR----- 93 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-----
Confidence 44556788899999999999999999999765 467899999974322 1112 467888888885
Q ss_pred CCCceeEEEEEEEec--------CeEEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccc
Q 005415 474 DEHHILRLYDYFYHL--------EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIH 544 (697)
Q Consensus 474 ~hpnIv~l~~~f~~~--------~~l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvH 544 (697)
|++|..+.+++... ...+|||||++|. |.+... ++. ....+++.+|..||+.|++|
T Consensus 94 -~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 94 -SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred -HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 56788887776643 3589999999974 444311 222 24569999999999999999
Q ss_pred cCCCCccccccccCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHH
Q 005415 545 CDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 614 (697)
Q Consensus 545 rDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELl 614 (697)
||+||+||++++ ++ ++|+|||........... ..+.....|..++|+||||+++.-+.
T Consensus 159 ~Dikp~Nili~~--~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSK--NG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeC--CC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999985 55 999999987544322111 11334445667899999999987654
|
|
| >cd08692 C2B_Tac2-N C2 domain second repeat found in Tac2-N (Tandem C2 protein in Nucleus) | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-20 Score=173.51 Aligned_cols=107 Identities=12% Similarity=0.031 Sum_probs=93.3
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCC-CcceecccccCcccccccccccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGS-SIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tl-nP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
.++++|+|+|++| ||++|+..+..|||||+.|++++++.+|+||+++|+|+ ||+|||+|.|+ ++.+..+.+|.++|
T Consensus 11 p~~~rLtV~VikarnL~~~~~~~~~dpYVKV~L~~~~k~~~KkKT~v~k~t~~~P~fNEsF~Fd--v~~~~~~v~l~v~v 88 (135)
T cd08692 11 AVNSRIQLQILEAQNLPSSSTPLTLSFFVKVGMFSTGGLLYKKKTRLVKSSNGQVKWGETMIFP--VTQQEHGIQFLIKL 88 (135)
T ss_pred CcCCeEEEEEEEccCCCcccCCCCCCcEEEEEEEECCCcceeecCccEECCCCCceecceEEEe--CCchhheeEEEEEE
Confidence 4678999999999 99999878888999999999999999999999999996 59999999999 78766666699999
Q ss_pred ccCCCCCCCCcccccccCcccccccCCCCcc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEHGVATPD 371 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e~~~~~~ 371 (697)
||+|++++|++||.+.++..+...++...|.
T Consensus 89 ~d~~~~~~n~~IG~v~lG~~~~~~~~~~hW~ 119 (135)
T cd08692 89 YSRSSVRRKHFLGQVWISSDSSSSEAVEQWK 119 (135)
T ss_pred EeCCCCcCCceEEEEEECCccCCchhhhhHH
Confidence 9999999999999999987655444444443
|
Tac2-N contains two C2 domains and a short C-terminus including a WHXL motif, which are key in stabilizing transport vesicles to the plasma membrane by binding to a plasma membrane. However unlike the usual carboxyl-terminal-type (C-type) tandem C2 proteins, it lacks a transmembrane domain, a Slp-homology domain, and a Munc13-1-interacting domain. Homology search analysis indicate that no known protein motifs are located in its N-terminus, making Tac2-N a novel class of Ca2+-independent, C-type tandem C2 proteins. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polypho |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-20 Score=212.62 Aligned_cols=260 Identities=22% Similarity=0.227 Sum_probs=185.2
Q ss_pred Cce-EEEEEeccCCCCceEEEEECCCCcEEEEEEEe----cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY-~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~----~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..| .-.+.+|.|++|.|+.+......+..+.|..+ ..... ... ...+..++-......|||++..+..+.+.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~--~~~-~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESE--RKY-NYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccH--HHH-hhhhhhheeecccccCCchhhhHHHHhhc
Confidence 344 35678999999999998877666666666544 11111 111 11155555555567799998887777766
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
....-+|||++.+|..++..... ++..++..+++|++.||.|||+.||.||||||+|+++.. ++.+||+|||
T Consensus 394 ~~~~~~mE~~~~Dlf~~~~~~~~------~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~--~g~lki~Dfg 465 (601)
T KOG0590|consen 394 DGILQSMEYCPYDLFSLVMSNGK------LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE--NGILKIIDFG 465 (601)
T ss_pred ccchhhhhcccHHHHHHHhcccc------cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec--CCceEEeecC
Confidence 65556699999877777765422 788889999999999999999999999999999999996 7899999999
Q ss_pred Ccccccc-------ccccccccCCCCCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH-HHHHhhCCC
Q 005415 569 SSCFQTD-------NLCLYVQSRSYRAPEVIIGLPYDQ-KIDLWSLGCILAELWTGEVLFPNDAVVMILA-RIIGMLGPI 639 (697)
Q Consensus 569 la~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~-ksDIWSLGviL~ELltG~~PF~~~~~~e~l~-~I~~~lg~~ 639 (697)
.+..... .....+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||.-....+... .+..
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----- 540 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----- 540 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----
Confidence 8754322 123468899999999999999886 4999999999999999999996543332211 1000
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.........++.-...|..-.+...-.++..-|..|.|+++++ .|+..++
T Consensus 541 ----~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 541 ----SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ----ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0000111111122224445556667777778899999999999 9998664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-19 Score=175.78 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=103.3
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~---------------------------~~~~~~Ei~iL~~L~~~~ 471 (697)
.+.||+|++|.||+|.+. +|+.||||+++..... ......|++++..+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999754210 012234889999987532
Q ss_pred CCCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHH-HhcCccccCCCCc
Q 005415 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL-HSLGIIHCDLKPE 550 (697)
Q Consensus 472 ~~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yL-Hs~gIvHrDLKP~ 550 (697)
..+|+++. . ...+|||||++++.+....... ..++...+..++.|++.+|.+| |+.||+||||||+
T Consensus 81 -v~~p~~~~------~-~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 81 -IPCPEPIL------L-KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred -CCCCcEEE------e-cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 23344431 1 1238999999976433221111 1278899999999999999999 7999999999999
Q ss_pred cccccccCcceEEEeeCCCccccc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
|||++ ++.++|+|||+|....
T Consensus 148 NIli~---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE---CCcEEEEEccccccCC
Confidence 99998 4679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08680 C2_Kibra C2 domain found in Human protein Kibra | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=168.88 Aligned_cols=100 Identities=14% Similarity=0.053 Sum_probs=90.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCc-cccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE-KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~-~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|+|++| ||+++|.+|.+|||||++|+|++++. .++||+++++|+||+|||+|.|. ++.+++ +++|.++|
T Consensus 12 ~~~~L~V~V~~arnL~~~~~~~~~dpyVKv~Llp~~~~~~~~~kT~v~~~t~nPvfnE~F~f~--v~~~~L~~~~L~~~V 89 (124)
T cd08680 12 GDSSLVISVEQLRNLSALSIPENSKVYVRVALLPCSSSTSCLFRTKALEDQDKPVFNEVFRVP--ISSTKLYQKTLQVDV 89 (124)
T ss_pred CCCEEEEEEeEecCCcccccCCCCCeEEEEEEccCCCCCCceEEcCccCCCCCCccccEEEEE--CCHHHhhcCEEEEEE
Confidence 567899999999 99999999999999999999999763 68999999999999999999999 888888 56799999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
||++++++++++|+++++-.+.+..
T Consensus 90 ~~~~~~~~~~~lG~~~i~L~~~~~~ 114 (124)
T cd08680 90 CSVGPDQQEECLGGAQISLADFESS 114 (124)
T ss_pred EeCCCCCceeEEEEEEEEhhhccCC
Confidence 9999999999999999877666443
|
Kibra is thought to be a regulator of the Salvador (Sav)/Warts (Wts)/Hippo (Hpo) (SWH) signaling network, which limits tissue growth by inhibiting cell proliferation and promoting apoptosis. The core of the pathway consists of a MST and LATS family kinase cascade that ultimately phosphorylates and inactivates the YAP/Yorkie (Yki) transcription coactivator. The FERM domain proteins Merlin (Mer) and Expanded (Ex) are part of the upstream regulation controlling pathway mechanism. Kibra colocalizes and associates with Mer and Ex and is thought to transduce an extracellular signal via the SWH network. The apical scaffold machinery that contains Hpo, Wts, and Ex recruits Yki to the apical membrane facilitating its inhibitory phosphorlyation by Wts. Since Kibra associates with Ex and is apically located it is hypothesized that KIBRA is part of the scaffold, helps in the Hpo/Wts complex, and helps recruit Yki for inactivation that prom |
| >cd08407 C2B_Synaptotagmin-13 C2 domain second repeat present in Synaptotagmin 13 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-19 Score=170.02 Aligned_cols=95 Identities=14% Similarity=0.008 Sum_probs=87.3
Q ss_pred ccceeEEEEecc-CcccccCC--CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHN--VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~--g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~ 339 (697)
++++|+|+|++| ||.++|.+ +.+|||||++|+|+.++.+|+||+++++|+||+|||+|.|+ ++.+.+ +.+|.++
T Consensus 13 ~~~~L~V~V~karnL~~~d~~~~~~~DpYVKv~l~~~~~k~~kkkT~v~k~t~nPvfNE~f~F~--v~~~~L~~~~L~~~ 90 (138)
T cd08407 13 AANRLLVVVIKAKNLHSDQLKLLLGIDVSVKVTLKHQNAKLKKKQTKRAKHKINPVWNEMIMFE--LPSELLAASSVELE 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCCCeEEEEEEEcCCcccceeccceeeCCCCCccccEEEEE--CCHHHhCccEEEEE
Confidence 668899999999 99999954 55899999999999988899999999999999999999999 998888 5559999
Q ss_pred cccCCCCCCCCcccccccCcc
Q 005415 340 EIDNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~~~~ 360 (697)
|||+|++++++++|++.++..
T Consensus 91 V~d~d~~~~~d~iG~v~lg~~ 111 (138)
T cd08407 91 VLNQDSPGQSLPLGRCSLGLH 111 (138)
T ss_pred EEeCCCCcCcceeceEEecCc
Confidence 999999999999999999874
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recy |
| >cd08406 C2B_Synaptotagmin-12 C2 domain second repeat present in Synaptotagmin 12 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=168.25 Aligned_cols=95 Identities=12% Similarity=-0.003 Sum_probs=88.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..++|+|.|++| ||.++|.+|.+|||||++|+|++++.+|+||+++|+|+||+|||+|.|. ++.+.+ +.+|.++||
T Consensus 13 ~~~~L~V~Vi~A~nL~~~~~~g~~DpyVkv~l~~~~~~~~k~kT~v~k~t~nP~~nE~f~F~--v~~~~l~~~~l~~~V~ 90 (136)
T cd08406 13 TAERLTVVVVKARNLVWDNGKTTADPFVKVYLLQDGRKISKKKTSVKRDDTNPIFNEAMIFS--VPAIVLQDLSLRVTVA 90 (136)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCccccccCCccccCCCCCeeceeEEEE--CCHHHhCCcEEEEEEE
Confidence 567899999999 9999999999999999999999988889999999999999999999999 888777 555999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|++++++++|.+.++..
T Consensus 91 ~~d~~~~~~~iG~v~lg~~ 109 (136)
T cd08406 91 ESTEDGKTPNVGHVIIGPA 109 (136)
T ss_pred eCCCCCCCCeeEEEEECCC
Confidence 9999999999999988764
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 12, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 13, do not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycl |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-18 Score=201.28 Aligned_cols=201 Identities=19% Similarity=0.283 Sum_probs=157.3
Q ss_pred eeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 406 v~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.....+-+..|.|.+.||.|+||+||+|.+.. |+.||||+-+....+. +---.+++.+|+- .--+-|..+...+
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~---~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKP---QMLPSIMHISSAH 763 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhch---hhhcchHHHHHHH
Confidence 33344456789999999999999999999765 9999999988765432 1112223333330 0123567777777
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-----cCc
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-----YQR 559 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-----~~~ 559 (697)
...+.-+||+||.+ |+|++++.. ...+++..++.++.||+..+.+||..+||||||||+|+||.. .+.
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred ccCCcceeeeeccccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcc
Confidence 77788899999998 788888872 233889999999999999999999999999999999999963 234
Q ss_pred ceEEEeeCCCccccc---c--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 005415 560 CEIKIIDLGSSCFQT---D--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 618 (697)
Q Consensus 560 ~~vKL~DFGla~~~~---~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~ 618 (697)
..++|+|||.+..+. + ......+|-.+-.+|+..|.+|++.+|.|.|+.+++-||.|+.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 568999999885432 1 2344677888999999999999999999999999999999963
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.9e-18 Score=167.22 Aligned_cols=140 Identities=18% Similarity=0.211 Sum_probs=102.3
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 471 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~---------------------------~~~~~~Ei~iL~~L~~~~ 471 (697)
.+.||+|++|.||+|.+. +|+.||||+++..... ......|...+..+.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA- 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 468999999999999976 8999999999864210 11224677778777643
Q ss_pred CCCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCc
Q 005415 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPE 550 (697)
Q Consensus 472 ~~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~ 550 (697)
++.....+... ..++||||+++.......... ..++...+..++.|++.+|.+||+ .||+||||||+
T Consensus 80 -----~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 80 -----GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred -----CCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 33222222222 248999999876222111111 126778899999999999999999 99999999999
Q ss_pred cccccccCcceEEEeeCCCcccccc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE---CCCEEEEEcccceecCC
Confidence 99998 57899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=175.02 Aligned_cols=206 Identities=22% Similarity=0.333 Sum_probs=131.5
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhccc-CC---CCCCceeEEEEEEE-
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKN-DP---ADEHHILRLYDYFY- 486 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~-~~---~~hpnIv~l~~~f~- 486 (697)
+...+.||.|+++.||.+.|..+++.+|||++.... ...+++.+|.-....+... ++ ..|-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 556788999999999999999999999999986432 1223333333222221110 00 00112222222222
Q ss_pred --------ec---C-----eEEEEEEccccchHHHHHhhhccCC-CcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 487 --------HL---E-----HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 487 --------~~---~-----~l~LVmEyl~gsL~~~l~~~~~~~~-~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
.. . ..+++|+-+.++|..++........ ...+.......+..|+++.+++||..||||+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 11 1 2478899999998888664332221 11233344456779999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccccccccccCCCCCchhhcCC--------CCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~--------~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
+|++++. +|.++|+||+.....+........+..|.+||..... .++.+.|.|+||++||.|++|..||.
T Consensus 174 ~nfll~~--~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQ--DGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-T--TS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcC--CCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999996 8999999999877666554444556789999987432 47889999999999999999999997
Q ss_pred CC
Q 005415 622 ND 623 (697)
Q Consensus 622 ~~ 623 (697)
..
T Consensus 252 ~~ 253 (288)
T PF14531_consen 252 LS 253 (288)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
|
| >cd04028 C2B_RIM1alpha C2 domain second repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=166.37 Aligned_cols=97 Identities=9% Similarity=-0.043 Sum_probs=86.3
Q ss_pred ccceeEEEEecc-Cccccc-CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
..+.|+|.|++| ||.++| .+|.+|||||++|+|++++..|+||+++|+|+||+|||+|.|. +. ..+++|.++||
T Consensus 27 ~~~~L~V~Vi~ArnL~~~~~~~g~sDPYVKv~Llp~~~~~~k~KT~v~kktlnPvfNE~F~f~--v~--l~~~~L~v~V~ 102 (146)
T cd04028 27 KKGQLEVEVIRARGLVQKPGSKVLPAPYVKVYLLEGKKCIAKKKTKIARKTLDPLYQQQLVFD--VS--PTGKTLQVIVW 102 (146)
T ss_pred CCCEEEEEEEEeeCCCcccCCCCCcCCeEEEEEECCCccccceeceecCCCCCCccCCeEEEE--Ec--CCCCEEEEEEE
Confidence 357899999999 999985 6889999999999999998889999999999999999999999 66 34667999999
Q ss_pred -cCCCCCCCCcccccccCcccccc
Q 005415 342 -DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 -D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|++++++++++|++.+.-...+-
T Consensus 103 ~d~~~~~~~~~iG~~~i~L~~l~~ 126 (146)
T cd04028 103 GDYGRMDKKVFMGVAQILLDDLDL 126 (146)
T ss_pred eCCCCCCCCceEEEEEEEcccccC
Confidence 79999999999999887766643
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08392 C2A_SLP-3 C2 domain first repeat present in Synaptotagmin-like protein 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=162.44 Aligned_cols=100 Identities=11% Similarity=-0.011 Sum_probs=90.8
Q ss_pred ccceeEEEEecc-CcccccCC-CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|++| ||.++|.+ |.+|||||++|+|++++..|+||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~V~~a~nL~~~d~~~g~~dpYVkv~llp~~~~~~k~kT~v~~~t~nPvfNE~F~f~--v~~~~l~~~~L~v~V 90 (128)
T cd08392 13 RTSCLEITIKACRNLAYGDEKKKKCHPYVKVCLLPDKSHNSKRKTAVKKGTVNPVFNETLKYV--VEADLLSSRQLQVSV 90 (128)
T ss_pred CCCEEEEEEEecCCCCccCCCCCCCCeEEEEEEEeCCcccceeecccccCCCCCccceEEEEE--cCHHHhCCcEEEEEE
Confidence 467999999999 99999986 99999999999999988889999999999999999999999 888777 56799999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
||++.+++++++|+++++..+.+-.
T Consensus 91 ~~~~~~~~~~~lG~~~i~L~~~~~~ 115 (128)
T cd08392 91 WHSRTLKRRVFLGEVLIPLADWDFE 115 (128)
T ss_pred EeCCCCcCcceEEEEEEEcCCcccC
Confidence 9999999999999999987666544
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. Little is known about the expression or localization of Slp3. The C2A domain of Slp3 is Ca2+ dependent. It has been demonstrated that Slp3 promotes dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=164.06 Aligned_cols=183 Identities=17% Similarity=0.122 Sum_probs=137.6
Q ss_pred EEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhH-----hHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 417 ~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~-----~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+...|++|+||+|+++.. .+.+++.+.+.....+.. .+.+|+++|+.|.+ +++|++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-----~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-----LPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-----CCCCCEEEEE----cCE
Confidence 3567899999999998864 788888888876654333 56789999999964 4678888775 456
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCC-CCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDL-KP~NILl~~~~~~~vKL~DFGla 570 (697)
+++|||+.|..+.... ... ...++.|++.+|.++|++||+|||| ||.|||++. ++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~~-----------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP-----------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhhh-----------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCc
Confidence 9999999876442111 011 1347789999999999999999999 799999985 778999999999
Q ss_pred cccccccc----------------cccccCCCCCchhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 571 CFQTDNLC----------------LYVQSRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 571 ~~~~~~~~----------------~~~gt~~Y~APE~l~~~-~~s-~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
........ ....++.|++|+...-. ..+ ...+.++.|+-+|.++|+..|+.++.
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 75443221 02347788888765432 233 56788999999999999999986553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=192.76 Aligned_cols=204 Identities=26% Similarity=0.345 Sum_probs=161.9
Q ss_pred eccCCCCceEEEEE---CCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEE
Q 005415 422 LGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 495 (697)
Q Consensus 422 LG~G~fG~Vy~a~d---~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVm 495 (697)
+|.|+||.|+++.- ...+..+|+|+.++... .......|..++..++ .||.++++.-.|+....+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-----~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-----NTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-----CCCceeeeeeeeccccchhHhh
Confidence 79999999998853 23567789998875321 1114445666777665 3789999999999999999999
Q ss_pred Eccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc
Q 005415 496 ELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574 (697)
Q Consensus 496 Eyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~ 574 (697)
++..++ +...+... ..+.+.....+...++-|++++|+.+|+|||+|++||+++. +|++++.|||+++..-
T Consensus 77 d~~rgg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~--~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL--EGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhcccchhhhccccC------CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc--cCccccCCchhhhHhH
Confidence 999864 33332222 22777788888999999999999999999999999999996 9999999999997765
Q ss_pred cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 575 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 575 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
..... +|+..|||||++. +....+|.||||++++||+||..||.+ +...+|.+..-..|.+++.
T Consensus 149 ~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 149 KEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSA 212 (612)
T ss_pred hhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhH
Confidence 44433 8999999999998 567889999999999999999999987 6777777655566665544
|
|
| >cd08381 C2B_PI3K_class_II C2 domain second repeat present in class II phosphatidylinositol 3-kinases (PI3Ks) | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-18 Score=158.57 Aligned_cols=98 Identities=12% Similarity=0.053 Sum_probs=87.9
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccc-ccccc-ccccccccc
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDL-HFKGA-EKDLMPAEI 341 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v-~~~~~-~~~L~~~V~ 341 (697)
.+.|+|.|++| ||+++| +|.+|||||++|+|+.++..++||+++++++||+|||+|.|. + +.+.+ +.+|.++||
T Consensus 12 ~~~L~V~Vi~A~~L~~~~-~~~~DpyVkv~l~~~~~~~~~~kT~v~~~~~nP~wnE~F~f~--~~~~~~l~~~~L~~~V~ 88 (122)
T cd08381 12 NGTLFVMVMHAKNLPLLD-GSDPDPYVKTYLLPDPQKTTKRKTKVVRKTRNPTFNEMLVYD--GLPVEDLQQRVLQVSVW 88 (122)
T ss_pred CCEEEEEEEEeeCCCCCC-CCCCCCEEEEEEeeCCccCCceeCCccCCCCCCCcccEEEEe--cCChHHhCCCEEEEEEE
Confidence 57899999999 999999 999999999999999888889999999999999999999998 5 55555 566999999
Q ss_pred cCCCCCCCCcccccccCccccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
|+|++++++++|++.++..++...
T Consensus 89 d~d~~~~~~~lG~~~i~l~~l~~~ 112 (122)
T cd08381 89 SHDSLVENEFLGGVCIPLKKLDLS 112 (122)
T ss_pred eCCCCcCCcEEEEEEEeccccccC
Confidence 999999999999999887666543
|
There are 3 classes of PI3Ks based on structure, regulation, and specificity. All classes contain a N-terminal C2 domain, a PIK domain, and a kinase catalytic domain. Unlike class I and class III, class II PI3Ks have additionally a PX domain and a C-terminal C2 domain containing a nuclear localization signal both of which bind phospholipids though in a slightly different fashion. PI3Ks (AKA phosphatidylinositol (PtdIns) 3-kinases) regulate cell processes such as cell growth, differentiation, proliferation, and motility. PI3Ks work on phosphorylation of phosphatidylinositol, phosphatidylinositide (4)P (PtdIns (4)P),2 or PtdIns(4,5)P2. Specifically they phosphorylate the D3 hydroxyl group of phosphoinositol lipids on the inositol ring. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permut |
| >cd08685 C2_RGS-like C2 domain of the Regulator Of G-Protein Signaling (RGS) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-18 Score=157.68 Aligned_cols=98 Identities=16% Similarity=0.113 Sum_probs=88.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
..++|+|.|++| ||.++| +|.+|||||++|+|++++..++||+++++|+||+|||+|.|. ++.+..++.|.++|||
T Consensus 10 ~~~~L~V~Vi~ar~L~~~~-~g~~dpYVkv~l~p~~~~~~~~kT~v~~~t~~P~~nE~F~f~--v~~~~~~~~l~v~V~~ 86 (119)
T cd08685 10 QNRKLTLHVLEAKGLRSTN-SGTCNSYVKISLSPDKEVRFRQKTSTVPDSANPLFHETFSFD--VNERDYQKRLLVTVWN 86 (119)
T ss_pred cCCEEEEEEEEEECCCCCC-CCCCCeeEEEEEEeCCCCcceEeCccccCCCCCccccEEEEE--cChHHhCCEEEEEEEC
Confidence 457899999999 999999 899999999999999988889999999999999999999998 7777776678999999
Q ss_pred CCCCC-CCCcccccccCcccccc
Q 005415 343 NSDTR-DGEVNGALHEGKADAEE 364 (697)
Q Consensus 343 ~d~~~-~~d~~G~v~~~~~~~d~ 364 (697)
.+... +++++|+++++..+...
T Consensus 87 ~~~~~~~~~~lG~~~i~l~~~~~ 109 (119)
T cd08685 87 KLSKSRDSGLLGCMSFGVKSIVN 109 (119)
T ss_pred CCCCcCCCEEEEEEEecHHHhcc
Confidence 99987 47999999998877753
|
This CD contains members of the regulator of G-protein signaling (RGS) family. RGS is a GTPase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. There are multiple alternatively spliced transcript variants in this family with some members having additional domains (ex. PDZ and RGS) downstream of the C2 domain. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind pho |
| >cd08393 C2A_SLP-1_2 C2 domain first repeat present in Synaptotagmin-like proteins 1 and 2 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-18 Score=157.80 Aligned_cols=100 Identities=10% Similarity=-0.006 Sum_probs=89.8
Q ss_pred ccceeEEEEecc-CcccccCC-CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|++| ||+++|.+ |.+|||||++|+|++++..++||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~~g~~dpyVkv~l~p~~~~~~~~kT~v~~~t~nP~~nE~f~f~--v~~~~l~~~~L~~~V 90 (125)
T cd08393 13 KLRELHVHVIQCQDLAAADPKKQRSDPYVKTYLLPDKSNRGKRKTSVKKKTLNPVFNETLRYK--VEREELPTRVLNLSV 90 (125)
T ss_pred CCCEEEEEEEEeCCCCCcCCCCCCCCcEEEEEEEcCCCccccccCccCcCCCCCccCceEEEE--CCHHHhCCCEEEEEE
Confidence 457899999999 99999986 89999999999999988788999999999999999999999 887766 46699999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
||+|++++++++|++.++..+.+..
T Consensus 91 ~d~~~~~~~~~iG~~~i~L~~~~~~ 115 (125)
T cd08393 91 WHRDSLGRNSFLGEVEVDLGSWDWS 115 (125)
T ss_pred EeCCCCCCCcEeEEEEEecCccccC
Confidence 9999999999999999887666543
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike Slp3 and Slp4/granuphilin which are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=160.37 Aligned_cols=139 Identities=21% Similarity=0.232 Sum_probs=106.8
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---e-EEE
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---H-LFI 493 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~---~-l~L 493 (697)
.+.||+|+||.||. ++.++.. +||++... ....+...+|+++++.+.+ ...+||||+++++++.+.. . ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~-~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSR-RLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhc-cCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46799999999996 6777666 69988753 2344678999999999976 3467999999999999863 3 347
Q ss_pred EEEccc---cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHH-HHHHhcCccccCCCCcccccccc--CcceEEEeeC
Q 005415 494 VCELLR---ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL-EYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDL 567 (697)
Q Consensus 494 VmEyl~---gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL-~yLHs~gIvHrDLKP~NILl~~~--~~~~vKL~DF 567 (697)
||||.+ ++|.+++.... +++. ..++.|++.++ .|||+++|+||||||+|||++.. ....++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 899954 58888875321 4444 35678888777 89999999999999999999742 2347999995
Q ss_pred CCc
Q 005415 568 GSS 570 (697)
Q Consensus 568 Gla 570 (697)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.4e-17 Score=187.33 Aligned_cols=180 Identities=27% Similarity=0.375 Sum_probs=134.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
...|..+++|-.|++|.||+++++.+.+.+|+|+-+..- |++. +....+.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----------hhhc--cccccCCccee-------------
Confidence 467999999999999999999999999999996543221 1111 00011122222
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
|+-..+++.... ++. +++.+++|||+.||+|||+||+|.+|+. -|++|++|||++..
T Consensus 136 -------gDc~tllk~~g~------lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGP------LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKK 192 (1205)
T ss_pred -------chhhhhcccCCC------Ccc--------hhhHHhHhhccCCeecCCCCCCcceeee--cccccccchhhhhh
Confidence 222222221111 222 2277999999999999999999999996 89999999998754
Q ss_pred cccc------------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 573 QTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 573 ~~~~------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
.... ....+||+.|+|||++..++|+..+|.|++|+|+||.+.|..||-++.+++++..++.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 2111 1225889999999999999999999999999999999999999999999999999887
Q ss_pred hhCCCCH
Q 005415 635 MLGPIDL 641 (697)
Q Consensus 635 ~lg~~p~ 641 (697)
.....|.
T Consensus 273 d~i~wpE 279 (1205)
T KOG0606|consen 273 DDIEWPE 279 (1205)
T ss_pred hhccccc
Confidence 6554443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-17 Score=190.71 Aligned_cols=190 Identities=32% Similarity=0.467 Sum_probs=146.2
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.|...+.||++.|=+|.+|++ ..|. |+||++-+.. ....+.+.|++ .. ...+||++.+.-+.....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik---~~----l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK---FA----LMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH---HH----hhcCCcccchHHHHHhhH
Confidence 678899999999999999986 3455 8999986532 12233334444 11 124789999888877778
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
..|||-+|+..+|++.+..++. +...+.+.|+-||+.||.-+|..||+|||||.+||||++ .+-+.|+||..
T Consensus 95 AAylvRqyvkhnLyDRlSTRPF------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS--WNW~~LtDFAs 166 (1431)
T KOG1240|consen 95 AAYLVRQYVKHNLYDRLSTRPF------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS--WNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHHHhhhhhhhhccchH------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee--echhhhhcccc
Confidence 8899999999999998875544 778889999999999999999999999999999999997 66789999986
Q ss_pred ccc---ccccc---cccccc----CCCCCchhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCC
Q 005415 570 SCF---QTDNL---CLYVQS----RSYRAPEVIIGL----------P-YDQKIDLWSLGCILAELWT-GEVLFP 621 (697)
Q Consensus 570 a~~---~~~~~---~~~~gt----~~Y~APE~l~~~----------~-~s~ksDIWSLGviL~ELlt-G~~PF~ 621 (697)
-+. ..++. ..+..| ..|.|||.+... . .+++.||||+||+++||++ |++||.
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 422 11221 112222 349999988531 2 5778999999999999999 899994
|
|
| >cd08408 C2B_Synaptotagmin-14_16 C2 domain second repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.68 E-value=9e-18 Score=159.02 Aligned_cols=95 Identities=16% Similarity=0.098 Sum_probs=85.9
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCC-CccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~-~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..++|.|+|++| ||.++|.+|..|||||++|+|+.+ +..|+||+++++++||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~VikarnL~~~~~~~~~dpyVkv~llp~~~~~~~~~kT~v~~~t~nPvfnEtF~f~--i~~~~l~~~~L~~~V 90 (138)
T cd08408 13 LTGRLSVEVIKGSNFKNLAMNKAPDTYVKLTLLNSDGQEISKSKTSIRRGQPDPEFKETFVFQ--VALFQLSEVTLMFSV 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCeeEEEEEEeCCCcceeeccceeecCCCCCcEeeeEEEE--CCHHHhCccEEEEEE
Confidence 568999999999 999999999999999999999654 4568899999999999999999999 888877 56699999
Q ss_pred ccCCCCCCCCcccccccCcc
Q 005415 341 IDNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~ 360 (697)
||++++++++++|++.++..
T Consensus 91 ~~~~~~~~~~~iG~v~l~~~ 110 (138)
T cd08408 91 YNKRKMKRKEMIGWFSLGLN 110 (138)
T ss_pred EECCCCCCCcEEEEEEECCc
Confidence 99999999999999988654
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd04029 C2A_SLP-4_5 C2 domain first repeat present in Synaptotagmin-like proteins 4 and 5 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-17 Score=152.94 Aligned_cols=101 Identities=11% Similarity=0.019 Sum_probs=89.7
Q ss_pred ccceeEEEEecc-CcccccC-CCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~-~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|++| ||.++|. +|.+|||||++++|++.+..++||+++++|+||+|||+|.|. ++.+.+ ++.|.++|
T Consensus 13 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyVkv~l~p~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~l~~~~L~~~V 90 (125)
T cd04029 13 KTQSLNVHVKECRNLAYGDEAKKRSNPYVKTYLLPDKSRQSKRKTSIKRNTTNPVYNETLKYS--ISHSQLETRTLQLSV 90 (125)
T ss_pred CCCeEEEEEEEecCCCccCCCCCCCCcEEEEEEEcCCccccceEeeeeeCCCCCcccceEEEE--CCHHHhCCCEEEEEE
Confidence 567899999999 9999986 589999999999999987788999999999999999999999 887766 55699999
Q ss_pred ccCCCCCCCCcccccccCcccccccC
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEHG 366 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e~ 366 (697)
||+|.+++++++|++.++....+-..
T Consensus 91 ~d~~~~~~~~~lG~~~i~l~~~~~~~ 116 (125)
T cd04029 91 WHYDRFGRNTFLGEVEIPLDSWNFDS 116 (125)
T ss_pred EECCCCCCCcEEEEEEEeCCcccccC
Confidence 99999999999999998876665543
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp4/granuphilin promotes dense-core vesicle exocytosis. The C2A domain of Slp4 is Ca2+ dependent. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2 |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=162.97 Aligned_cols=144 Identities=16% Similarity=0.158 Sum_probs=107.9
Q ss_pred eEEEEEeccCCCCceEEEE-ECCCCcEEEEEEEecchh-------------------------hhHhHHHHHHHHHHhcc
Q 005415 416 YYVTEYLGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKD-------------------------FFDQSLDEIKLLKLVNK 469 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~-d~~~g~~VAVKii~~~~~-------------------------~~~~~~~Ei~iL~~L~~ 469 (697)
|.+.+.||.|++|.||+|. +..+|+.||||+++.... .......|+.+++.+..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7889999999999999998 678999999999875321 01224579999999864
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC-ccccCCC
Q 005415 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLK 548 (697)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g-IvHrDLK 548 (697)
. ...+.+++.. ...++||||+++..+....... ..+....+..++.||+.+|.+||+.| |+|||||
T Consensus 110 ~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 110 A----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred c----CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 2 2234444443 2348999999985433221111 12556667889999999999999999 9999999
Q ss_pred CccccccccCcceEEEeeCCCcccccc
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~ 575 (697)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~---~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH---DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE---CCCEEEEEChhhhccCC
Confidence 9999998 57899999998865443
|
|
| >cd08395 C2C_Munc13 C2 domain third repeat in Munc13 (mammalian uncoordinated) proteins | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=147.45 Aligned_cols=97 Identities=16% Similarity=0.045 Sum_probs=80.7
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccC--CCCCccccceeecccCCCcceecccccCcccccc-cc-ccccccccc
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP--HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-GA-EKDLMPAEI 341 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~p--d~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~-~~-~~~L~~~V~ 341 (697)
+|+|+|.+| +|+++| .|.+|||||++|.- ...+++|++|+++++|+||+|||+|.|. ++.+ .. ..+|.+.||
T Consensus 1 kL~V~Vi~A~~L~~~d-~g~~DPYVkV~l~g~~~~~k~~k~kTkv~~~tlnPvwNE~f~F~--v~~~~~~~~~~L~~~V~ 77 (120)
T cd08395 1 KVTVKVVAANDLKWQT-TGMFRPFVEVNLIGPHLSDKKRKFATKSKNNNWSPKYNETFQFI--LGNEDDPESYELHICVK 77 (120)
T ss_pred CEEEEEEECcCCCccc-CCCCCCEEEEEEecCCCcccccEeeeEEecCCCCCccCcEEEEE--eeCcCCCceeEEEEEEE
Confidence 589999999 999998 49999999999962 2334447899999999999999999999 7654 34 455999999
Q ss_pred cCCCCCCCCcccccccCcccccccC
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e~ 366 (697)
|+|.+++++++|.+.++.......+
T Consensus 78 D~d~~~~dd~IG~~~l~l~~~~~~~ 102 (120)
T cd08395 78 DYCFARDDRLVGVTVLQLRDIAQAG 102 (120)
T ss_pred EecccCCCCEEEEEEEEHHHCcCCC
Confidence 9998888999999988876666544
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synaptobrevi |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=161.73 Aligned_cols=144 Identities=26% Similarity=0.374 Sum_probs=113.7
Q ss_pred CCCCceeEEEEEEEe---------------------------cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHH
Q 005415 473 ADEHHILRLYDYFYH---------------------------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525 (697)
Q Consensus 473 ~~hpnIv~l~~~f~~---------------------------~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~ 525 (697)
..|||||+++.+|.+ ...+|+||.....+|.+++-.+. .+......
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHH
Confidence 579999999988853 23589999999999999987554 45567778
Q ss_pred HHHHHHHHHHHHHhcCccccCCCCccccccccCc--ceEEEeeCCCcccccc---------ccccccccCCCCCchhhcC
Q 005415 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--CEIKIIDLGSSCFQTD---------NLCLYVQSRSYRAPEVIIG 594 (697)
Q Consensus 526 i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~--~~vKL~DFGla~~~~~---------~~~~~~gt~~Y~APE~l~~ 594 (697)
++.|+++|+.|||++||.|||+|.+|||+.-+++ ..++|+|||++--... ......|.-..||||+...
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999999999999999999964333 4678999998743221 1122345666899999864
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005415 595 LP------YDQKIDLWSLGCILAELWTGEVLFPND 623 (697)
Q Consensus 595 ~~------~s~ksDIWSLGviL~ELltG~~PF~~~ 623 (697)
.+ --.|+|.|+.|.+.||+++..-||.+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 32 124799999999999999999999763
|
|
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=174.93 Aligned_cols=97 Identities=11% Similarity=0.047 Sum_probs=87.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|++| +|+++|..|.+|||||++|+||++. |.||+++|+|+||+|||+|.|. |+.+++ .++|.++||
T Consensus 165 ~~~~L~V~V~qa~~Lp~~d~~g~sdpyVK~~llPdk~~--k~kT~v~r~tlnP~fnEtf~f~--v~~~~l~~~~L~l~V~ 240 (421)
T KOG1028|consen 165 ELNLLTVRVIQAHDLPAKDRGGTSDPYVKVYLLPDKKG--KFKTRVHRKTLNPVFNETFRFE--VPYEELSNRVLHLSVY 240 (421)
T ss_pred cCCEEEEEEEEecCCCcccCCCCCCCeeEEEEcCCCCC--cceeeeeecCcCCccccceEee--cCHHHhccCEEEEEEE
Confidence 557899999999 9999998889999999999999944 9999999999999999999999 777766 778999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|+|++++++|++.++-...+.
T Consensus 241 ~~drfsr~~~iGev~~~l~~~~~ 263 (421)
T KOG1028|consen 241 DFDRFSRHDFIGEVILPLGEVDL 263 (421)
T ss_pred ecCCcccccEEEEEEecCccccc
Confidence 99999999999999887434433
|
|
| >cd04020 C2B_SLP_1-2-3-4 C2 domain second repeat present in Synaptotagmin-like proteins 1-4 | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.5e-16 Score=149.83 Aligned_cols=119 Identities=18% Similarity=0.201 Sum_probs=99.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
+.+.|+|.|.+| ||+++|..|.+|||||++++++..+..++||+++++|+||.|||+|.|.. ++.+.+ +..|.++||
T Consensus 25 ~~g~L~V~Vi~A~nL~~~d~~g~~DPYVkv~l~~~~~~~~~~kT~vi~~t~nP~WnE~f~f~~-~~~~~l~~~~L~i~V~ 103 (162)
T cd04020 25 STGELHVWVKEAKNLPALKSGGTSDSFVKCYLLPDKSKKSKQKTPVVKKSVNPVWNHTFVYDG-VSPEDLSQACLELTVW 103 (162)
T ss_pred CCceEEEEEEeeeCCCCCCCCCCCCCEEEEEEEcCCCCCcceeCCccCCCCCCCCCCEEEEec-CCHHHhCCCEEEEEEE
Confidence 668899999999 99999999999999999999998777899999999999999999999983 333444 556999999
Q ss_pred cCCCCCCCCcccccccCcccccccCCCCcccccchhhHhHhhhhh
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFH 386 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e~~~~~~~l~~~~l~ee~e~~~ 386 (697)
|+|.+++++++|++.++..+....+.. ..|++...+|..+++
T Consensus 104 d~d~~~~d~~lG~v~i~l~~~~~~~~~---~~w~~~~~~~~~~w~ 145 (162)
T cd04020 104 DHDKLSSNDFLGGVRLGLGTGKSYGQA---VDWMDSTGEEILLWQ 145 (162)
T ss_pred eCCCCCCCceEEEEEEeCCccccCCCc---cccccCChHHHHHHH
Confidence 999999999999999988777665532 336666666666653
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involvin |
| >cd08409 C2B_Synaptotagmin-15 C2 domain second repeat present in Synaptotagmin 15 | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-16 Score=148.02 Aligned_cols=93 Identities=14% Similarity=0.107 Sum_probs=85.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
..++|+|.|.+| ||.++| .|.+|||||+.|.|+.++..++||+++++++||+|||+|.|. ++.+.++ .+|.++||
T Consensus 13 ~~~~L~V~V~~a~nL~~~~-~~~~d~yVkv~l~~~~~~~~~~kT~v~~~~~nP~fnE~F~f~--i~~~~l~~~~L~~~V~ 89 (137)
T cd08409 13 TLNRLTVVVLRARGLRQLD-HAHTSVYVKVSLMIHNKVVKTKKTEVVDGAASPSFNESFSFK--VTSRQLDTASLSLSVM 89 (137)
T ss_pred CCCeEEEEEEEecCCCccc-CCCCCeEEEEEEEECCEEeeeeecccEeCCCCCcccceEEEE--CCHHHhCccEEEEEEE
Confidence 468899999999 999999 888999999999999777778899999999999999999999 8888784 56999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|.+.+++++++|++.++.
T Consensus 90 ~~~~~~~~~~lG~v~ig~ 107 (137)
T cd08409 90 QSGGVRKSKLLGRVVLGP 107 (137)
T ss_pred eCCCCCCcceEEEEEECC
Confidence 999999999999998874
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 id |
| >cd08410 C2B_Synaptotagmin-17 C2 domain second repeat present in Synaptotagmin 17 | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-16 Score=147.66 Aligned_cols=94 Identities=13% Similarity=0.037 Sum_probs=84.7
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
+.+.|+|.|++| +|.++|.+|.+|||||+.+.++.+...++||+++++|+||+|||+|.|. ++.+.++ ..|.++||
T Consensus 12 ~~~~L~V~vi~a~~L~~~d~~g~~DPyV~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~F~f~--i~~~~l~~~~l~~~V~ 89 (135)
T cd08410 12 SAGRLNVDIIRAKQLLQTDMSQGSDPFVKIQLVHGLKLIKTKKTSCMRGTIDPFYNESFSFK--VPQEELENVSLVFTVY 89 (135)
T ss_pred CCCeEEEEEEEecCCCcccCCCCCCeEEEEEEEcCCcccceEcCccccCCCCCccceeEEEe--CCHHHhCCCEEEEEEE
Confidence 567899999999 9999999999999999999888776678899999999999999999999 8777774 45999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|..++++++|++.++.
T Consensus 90 d~d~~~~~~~iG~~~l~~ 107 (135)
T cd08410 90 GHNVKSSNDFIGRIVIGQ 107 (135)
T ss_pred eCCCCCCCcEEEEEEEcC
Confidence 999999999999997654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta- |
| >cd08404 C2B_Synaptotagmin-4 C2 domain second repeat present in Synaptotagmin 4 | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.9e-16 Score=147.25 Aligned_cols=96 Identities=14% Similarity=0.041 Sum_probs=86.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|++| +|+++|..|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.... ..+|.++||
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~k~t~nP~w~e~F~f~--v~~~~~~~~~l~~~v~ 90 (136)
T cd08404 13 TTNRLTVVVLKARHLPKMDVSGLADPYVKVNLYYGKKRISKKKTHVKKCTLNPVFNESFVFD--IPSEELEDISVEFLVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCeEEEEEEEcCCceeeeEcCccccCCCCCccCceEEEE--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999998777778999999999999999999999 776666 455999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|+|.+++++++|++.++...
T Consensus 91 d~d~~~~~~~iG~~~~~~~~ 110 (136)
T cd08404 91 DSDRVTKNEVIGRLVLGPKA 110 (136)
T ss_pred ECCCCCCCccEEEEEECCcC
Confidence 99999999999999987755
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling s |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=145.90 Aligned_cols=132 Identities=21% Similarity=0.301 Sum_probs=102.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchh---------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+.||+|++|.||+|.+ .+..|++|+...... ......+|+.++..+.+ ++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK------AGVNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH------CCCCCCeEEEEeCCC
Confidence 5799999999999986 678899998653211 12346678888888863 455555555666677
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||++| +|.+.+.. ... ....++.+++.+|.+||+.+++|+|++|.|||++ .+.++|+|||.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~---------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~ 140 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINS---------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGL 140 (211)
T ss_pred CEEEEEEeCCcCHHHHHHh---------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCc
Confidence 8999999976 55555431 111 6788999999999999999999999999999998 57799999998
Q ss_pred ccc
Q 005415 570 SCF 572 (697)
Q Consensus 570 a~~ 572 (697)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 865
|
|
| >cd08389 C2A_Synaptotagmin-14_16 C2A domain first repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-15 Score=141.98 Aligned_cols=98 Identities=10% Similarity=-0.031 Sum_probs=85.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|+|++| ||.++|.+|.+|||||+.++|+++. ++||+++++ +||+|||+|.|.. ++.+.+ +++|.+.||
T Consensus 14 ~~~~L~V~Vi~a~nL~~~~~~~~~d~yVk~~llp~~~~--~~kTkv~~~-~nP~fnE~F~f~~-i~~~~l~~~~L~~~V~ 89 (124)
T cd08389 14 SARKLTVTVIRAQDIPTKDRGGASSWQVHLVLLPSKKQ--RAKTKVQRG-PNPVFNETFTFSR-VEPEELNNMALRFRLY 89 (124)
T ss_pred CCCEEEEEEEEecCCCchhcCCCCCcEEEEEEccCCcc--eeecccccC-CCCcccCEEEECC-CCHHHhccCEEEEEEE
Confidence 557899999999 9999999999999999999999764 788999888 9999999999973 555555 677999999
Q ss_pred cCCCCCCCCcccccccCccccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
|++++++++++|++.++-......
T Consensus 90 ~~~~~~~~~~lG~~~i~L~~l~~~ 113 (124)
T cd08389 90 GVERMRKERLIGEKVVPLSQLNLE 113 (124)
T ss_pred ECCCcccCceEEEEEEeccccCCC
Confidence 999999999999999887766443
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd08384 C2B_Rabphilin_Doc2 C2 domain second repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-15 Score=142.78 Aligned_cols=95 Identities=16% Similarity=0.150 Sum_probs=86.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|..|.+|||||+.+.++..+..++||+++++|+||+|||+|.|. ++...+ ++.|.++||
T Consensus 11 ~~~~L~V~Vi~a~~L~~~d~~~~~DpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--~~~~~l~~~~l~~~V~ 88 (133)
T cd08384 11 QRRGLIVGIIRCVNLAAMDANGYSDPFVKLYLKPDAGKKSKHKTQVKKKTLNPEFNEEFFYD--IKHSDLAKKTLEITVW 88 (133)
T ss_pred CCCEEEEEEEEEcCCCCcCCCCCCCcEEEEEEEcCCCccCCceeeeEeccCCCCcccEEEEE--CCHHHhCCCEEEEEEE
Confidence 467899999999 9999999999999999999998877788999999999999999999999 776666 466999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|.+++++++|++.++..
T Consensus 89 d~d~~~~~~~lG~~~i~l~ 107 (133)
T cd08384 89 DKDIGKSNDYIGGLQLGIN 107 (133)
T ss_pred eCCCCCCccEEEEEEEecC
Confidence 9999999999999988764
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domai |
| >cd08388 C2A_Synaptotagmin-4-11 C2A domain first repeat present in Synaptotagmins 4 and 11 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-15 Score=142.00 Aligned_cols=98 Identities=14% Similarity=0.094 Sum_probs=83.5
Q ss_pred ccceeEEEEecc-CcccccCC-CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
....|+|.|.+| ||+++|.. |.+||||++.|+|++++ ++||+++++|+||+|||+|.|.. ++.+.+ +..|.+.|
T Consensus 14 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyV~v~l~~~~~~--~~kT~v~~~t~nP~wnE~F~f~~-~~~~~~~~~~L~~~V 90 (128)
T cd08388 14 EKKALLVNIIECRDLPAMDEQSGTSDPYVKLQLLPEKEH--KVKTRVLRKTRNPVYDETFTFYG-IPYNQLQDLSLHFAV 90 (128)
T ss_pred CCCEEEEEEEEeECCCCCCCCCCCcCCEEEEEEeCCcCc--eeeccEEcCCCCCceeeEEEEcc-cCHHHhCCCEEEEEE
Confidence 457899999999 99999987 99999999999987654 77899999999999999999931 565555 45699999
Q ss_pred ccCCCCCCCCcccccccCcccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
||+|++++++++|++.++..+++-
T Consensus 91 ~d~d~~~~d~~lG~~~i~L~~l~~ 114 (128)
T cd08388 91 LSFDRYSRDDVIGEVVCPLAGADL 114 (128)
T ss_pred EEcCCCCCCceeEEEEEeccccCC
Confidence 999999999999999887655543
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmins 4 and 11, class 4 synaptotagmins, are located in the brain. Their functions are unknown. They are distinguished from the other synaptotagmins by having and Asp to Ser substitution in their C2A domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence |
| >cd08387 C2A_Synaptotagmin-8 C2A domain first repeat present in Synaptotagmin 8 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-15 Score=140.78 Aligned_cols=99 Identities=13% Similarity=0.065 Sum_probs=87.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||++++.|++.. ++||+++++|+||+|||+|.|. ++...+ +.+|.++||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~i~V~ 89 (124)
T cd08387 14 DMGILNVKLIQARNLQPRDFSGTADPYCKVRLLPDRSN--TKQSKIHKKTLNPEFDESFVFE--VPPQELPKRTLEVLLY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCeEEEEEecCCCC--cEeCceEcCCCCCCcccEEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999987654 6789999999999999999998 887766 456999999
Q ss_pred cCCCCCCCCcccccccCcccccccC
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e~ 366 (697)
|++.+++++++|+++++..+....+
T Consensus 90 d~~~~~~~~~iG~~~i~l~~~~~~~ 114 (124)
T cd08387 90 DFDQFSRDECIGVVELPLAEVDLSE 114 (124)
T ss_pred ECCCCCCCceeEEEEEecccccCCC
Confidence 9999999999999999887776443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involv |
| >cd08521 C2A_SLP C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-15 Score=139.07 Aligned_cols=98 Identities=11% Similarity=0.033 Sum_probs=87.7
Q ss_pred ccceeEEEEecc-Cccccc-CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|.+| ||+++| ..|.+|||||++++|+.....++||+++++++||+|||+|.|. ++...+ .+.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--i~~~~l~~~~l~i~v 89 (123)
T cd08521 12 KTGSLEVHIKECRNLAYADEKKKRSNPYVKVYLLPDKSKQSKRKTSVKKNTTNPVFNETLKYH--ISKSQLETRTLQLSV 89 (123)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCcEEEEEEecCCCcCceeeccccCCCCCCcccceEEEe--CCHHHhCCCEEEEEE
Confidence 567899999999 999999 8899999999999998876678999999999999999999999 877666 45699999
Q ss_pred ccCCCCCCCCcccccccCccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d 363 (697)
||++.+++++++|++.++..+..
T Consensus 90 ~d~~~~~~~~~iG~~~i~l~~l~ 112 (123)
T cd08521 90 WHHDRFGRNTFLGEVEIPLDSWD 112 (123)
T ss_pred EeCCCCcCCceeeEEEEeccccc
Confidence 99999999999999988776664
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into |
| >cd04010 C2B_RasA3 C2 domain second repeat present in RAS p21 protein activator 3 (RasA3) | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-15 Score=143.78 Aligned_cols=97 Identities=13% Similarity=0.009 Sum_probs=82.9
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcc-----------cccccc-c
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-----------LHFKGA-E 333 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~-----------v~~~~~-~ 333 (697)
+|+|.|.+| ||.+ .+|.+||||++++.+++++..+++|+++++|+||+|||+|.|+.. ++.+.. .
T Consensus 1 kL~V~Vi~ArnL~~--~~g~sDPYV~V~l~~~~~k~~~~kT~v~~~t~nP~wNE~F~F~v~~~~~~~~~~~~~~~~~~~~ 78 (148)
T cd04010 1 KLSVRVIECSDLAL--KNGTCDPYASVTLIYSNKKQDTKRTKVKKKTNNPQFDEAFYFDVTIDSSPEKKQFEMPEEDAEK 78 (148)
T ss_pred CEEEEEEeCcCCCC--CCCCCCceEEEEEeCCcccCcccCCccEeCCCCCccceEEEEEEecccccccccccCCcccccE
Confidence 589999999 9998 789999999999999887777899999999999999999999932 134444 3
Q ss_pred cccccccccCCCCCCCCcccccccCccccccc
Q 005415 334 KDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 334 ~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
..|.+.|||.+.+++++++|++.+....+...
T Consensus 79 ~~L~i~V~d~~~~~~ddfLG~v~i~l~~l~~~ 110 (148)
T cd04010 79 LELRVDLWHASMGGGDVFLGEVRIPLRGLDLQ 110 (148)
T ss_pred EEEEEEEEcCCCCCCCceeEEEEEeccccccc
Confidence 45999999999999999999999887666654
|
RasA3 are members of GTPase activating protein 1 (GAP1), a Ras-specific GAP, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA3 contains an N-terminal C2 domain, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.1e-14 Score=143.59 Aligned_cols=138 Identities=22% Similarity=0.216 Sum_probs=102.4
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh-----------------------hHhHHHHHHHHHHhcccCC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----------------------FDQSLDEIKLLKLVNKNDP 472 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~-----------------------~~~~~~Ei~iL~~L~~~~~ 472 (697)
|.+.+.||.|+||.||++.+ .+|+.||||+++.+... ......|+.++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 77889999999999999986 47999999997653210 112456788888775431
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
..++..++. ...++||||+++..+..+.. ......++.+++.++.++|+.||+||||+|+||
T Consensus 95 ---i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 ---FPVPKPIDW----NRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred ---CCCCceeec----CCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 134444432 34589999998754332211 123567889999999999999999999999999
Q ss_pred cccccCcceEEEeeCCCcccccc
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~ 575 (697)
+++. ++.++|+|||.+.....
T Consensus 157 ll~~--~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDD--DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcC--CCcEEEEECCccccCCC
Confidence 9985 78999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd04031 C2A_RIM1alpha C2 domain first repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-15 Score=137.82 Aligned_cols=97 Identities=15% Similarity=0.167 Sum_probs=84.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||.++|.+|.+||||++++.++.....++||+++++|+||+|||+|.|.. ++.+.+ +..|.++||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~l~~~V~ 92 (125)
T cd04031 14 VTSQLIVTVLQARDLPPRDDGSLRNPYVKVYLLPDRSEKSKRRTKTVKKTLNPEWNQTFEYSN-VRRETLKERTLEVTVW 92 (125)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCEEEEEEccCCCccccccccccCCCCCCccccEEEEcc-cCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999987766788999999999999999999982 233444 556999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|++.+++++++|.+.++..+
T Consensus 93 d~~~~~~~~~iG~~~i~l~~ 112 (125)
T cd04031 93 DYDRDGENDFLGEVVIDLAD 112 (125)
T ss_pred eCCCCCCCcEeeEEEEeccc
Confidence 99999999999999887665
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08403 C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repeat present in Synaptotagmins 3, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-15 Score=142.16 Aligned_cols=95 Identities=16% Similarity=0.099 Sum_probs=85.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccc-ccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEK-DLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~-~L~~~V~ 341 (697)
..+.|+|.|.+| +|.++|..|.+|||||++|.+++++..++||+++++++||.|||+|.|. ++.+.++. .|.++||
T Consensus 12 ~~~~L~V~v~~A~~L~~~d~~g~~dpyvkv~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~~~~~~l~~~v~ 89 (134)
T cd08403 12 TAGRLTLTIIKARNLKAMDITGFSDPYVKVSLMCEGRRLKKKKTSVKKNTLNPTYNEALVFD--VPPENVDNVSLIIAVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCccccCCCCCceEEEEEEeCCcccceecCCcccCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 467899999999 9999999999999999999988777778899999999999999999998 77766644 4999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|++++++++++|++.++..
T Consensus 90 d~~~~~~~~~IG~~~l~~~ 108 (134)
T cd08403 90 DYDRVGHNELIGVCRVGPN 108 (134)
T ss_pred ECCCCCCCceeEEEEECCC
Confidence 9999999999999988754
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 3, a member of class 3 synaptotagmins, is located in the brain and localized to the active zone and plasma membrane. It functions as a Ca2+ sensor for fast exocytosis. It, along with synaptotagmins 5,6, and 10, has disulfide bonds at its N-terminus. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and localized to the synaptic vesicles. It is thought to be a Ca2+-sensor for dense-core vesicle exocytosis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind |
| >cd08385 C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repeat present in Synaptotagmins 1, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.3e-15 Score=137.61 Aligned_cols=97 Identities=12% Similarity=0.078 Sum_probs=85.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||.++|.+|.+||||++++.|++++ +++|+++++++||+|||+|.|. ++...+ ...|.+.||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~~~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~V~ 89 (124)
T cd08385 14 QSNQLTVGIIQAADLPAMDMGGTSDPYVKVYLLPDKKK--KFETKVHRKTLNPVFNETFTFK--VPYSELGNKTLVFSVY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCCEEEEEEEcCCCC--ceecccCcCCCCCceeeeEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999987754 7899999999999999999999 776555 456999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|.+++++++|++.++..+...
T Consensus 90 d~d~~~~~~~lG~~~i~l~~~~~ 112 (124)
T cd08385 90 DFDRFSKHDLIGEVRVPLLTVDL 112 (124)
T ss_pred eCCCCCCCceeEEEEEecCcccC
Confidence 99999999999999988766544
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis as do synaptotagmins 5, 6, and 10. It is distinguished from the other synaptotagmins by having an N-glycosylated N-terminus. Synaptotagmins 5, 6, and 10, members of class 3 synaptotagmins, are located primarily in the brain and localized to the active zone and plasma membrane. They is distinguished from the other synaptotagmins by having disulfide bonds at its N-terminus. Synaptotagmin 6 also regulates the acrosome reaction, a unique Ca2+-regulated exocytosis, in sperm. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and |
| >cd04030 C2C_KIAA1228 C2 domain third repeat present in uncharacterized human KIAA1228-like proteins | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-15 Score=138.21 Aligned_cols=99 Identities=13% Similarity=0.101 Sum_probs=87.9
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|++| ||+++|.+|.+|||||++++++++...++||+++++++||+|||+|.|. ++...+ ...|.+.||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~~~nP~wne~f~f~--i~~~~l~~~~l~i~v~ 91 (127)
T cd04030 14 QRQKLIVTVHKCRNLPPCDSSDIPDPYVRLYLLPDKSKSTRRKTSVKKDNLNPVFDETFEFP--VSLEELKRRTLDVAVK 91 (127)
T ss_pred CCCEEEEEEEEEECCCCccCCCCCCceEEEEEEcCCCCCceEecccccCCCCCEECeEEEEe--cCHHHhcCCEEEEEEE
Confidence 457899999999 9999999999999999999998877789999999999999999999999 877666 456999999
Q ss_pred cCCCC--CCCCcccccccCcccccc
Q 005415 342 DNSDT--RDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~--~~~d~~G~v~~~~~~~d~ 364 (697)
|.+.+ ++++++|++..+..++..
T Consensus 92 ~~~~~~~~~~~~iG~~~i~l~~l~~ 116 (127)
T cd04030 92 NSKSFLSREKKLLGQVLIDLSDLDL 116 (127)
T ss_pred ECCcccCCCCceEEEEEEecccccc
Confidence 99986 679999999888766644
|
KIAA proteins are uncharacterized human proteins. They were compiled by the Kazusa mammalian cDNA project which identified more than 2000 human genes. They are identified by 4 digit codes that precede the KIAA designation. Many KIAA genes are still functionally uncharacterized including KIAA1228. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1 |
| >cd08402 C2B_Synaptotagmin-1 C2 domain second repeat present in Synaptotagmin 1 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-15 Score=140.26 Aligned_cols=95 Identities=16% Similarity=0.116 Sum_probs=85.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
+.+.|+|.|.+| +|+++|.+|.+||||++++.+++++..+++|+++++|+||+|||+|.|. ++.+.++ ..|.++||
T Consensus 13 ~~~~l~V~Vi~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~v~ 90 (136)
T cd08402 13 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKRTLNPYYNESFSFE--VPFEQIQKVHLIVTVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCcccCCCCCCCeEEEEEEECCcccceeeccceeCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 667899999999 9999999999999999999987777678899999999999999999999 7766664 45999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|++.+++++++|++.++..
T Consensus 91 d~~~~~~~~~iG~~~i~~~ 109 (136)
T cd08402 91 DYDRIGKNDPIGKVVLGCN 109 (136)
T ss_pred eCCCCCCCceeEEEEECCc
Confidence 9999999999999988764
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of the class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis. It, like synaptotagmin-2, has an N-glycosylated N-terminus. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.2e-14 Score=139.16 Aligned_cols=129 Identities=19% Similarity=0.257 Sum_probs=95.6
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.||+|++|.||++.+ ++..|++|...... ....+..+|+++++.+.+. ++.....++......
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA------GVNTPVVYDVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC------CCCCCEEEEEECCCC
Confidence 389999999999984 67889999865321 1124566799999988753 232222233455667
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||++| +|.+.+.... ..++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||++
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~-------------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a 136 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN-------------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEEECCccHHHHHhhcH-------------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCC
Confidence 899999976 4444432110 07899999999999999999999999999998 678999999988
Q ss_pred ccc
Q 005415 571 CFQ 573 (697)
Q Consensus 571 ~~~ 573 (697)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.1e-15 Score=164.29 Aligned_cols=97 Identities=12% Similarity=0.009 Sum_probs=90.8
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccc-ccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKD-LMPAE 340 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~-L~~~V 340 (697)
..+++|+|.|++| ||.+||.+|.+|||||++|+++.++.+|+||.++|+++||+|||+|.|. ++.+.++++ |.++|
T Consensus 295 p~~g~ltv~v~kar~L~~~~~~~~~d~~Vk~~l~~~~~~~~kkkT~~~~~~~npv~nesf~F~--vp~~~l~~~~l~l~V 372 (421)
T KOG1028|consen 295 PTAGRLTVVVIKARNLKSMDVGGLSDPYVKVTLLDGDKRLSKKKTSVKKKTLNPVFNETFVFD--VPPEQLAEVSLELTV 372 (421)
T ss_pred cCCCeEEEEEEEecCCCcccCCCCCCccEEEEEecCCceeeeeeeecccCCCCCcccccEEEe--CCHHHhheeEEEEEE
Confidence 3679999999999 9999999999999999999999999999999999999999999999998 999999665 99999
Q ss_pred ccCCCCCCCCcccccccCccc
Q 005415 341 IDNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~ 361 (697)
||+|++++++++|.+.++...
T Consensus 373 ~d~d~~~~~~~iG~~~lG~~~ 393 (421)
T KOG1028|consen 373 WDHDTLGSNDLIGRCILGSDS 393 (421)
T ss_pred EEcccccccceeeEEEecCCC
Confidence 999999999999999887644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.7e-14 Score=138.38 Aligned_cols=139 Identities=22% Similarity=0.291 Sum_probs=95.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHh-------------------------HHHHHHHHHHhcccCCC
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-------------------------SLDEIKLLKLVNKNDPA 473 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~-------------------------~~~Ei~iL~~L~~~~~~ 473 (697)
.+.||+|+||+||+|.+. +++.||||+++........ ...|...+..+...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--- 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA--- 77 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc---
Confidence 467999999999999976 8999999998754221111 12455555555432
Q ss_pred CCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccc
Q 005415 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENI 552 (697)
Q Consensus 474 ~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NI 552 (697)
+..+.++++. ...++||||++++........... . ...+..++.+++.++.++|. .+|+|+||||+||
T Consensus 78 -~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 78 -GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred -CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 1124444433 246899999987321100000000 1 15678899999999999999 9999999999999
Q ss_pred cccccCcceEEEeeCCCcccccc
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTD 575 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~ 575 (697)
+++ ++.++|+|||.+.....
T Consensus 147 li~---~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD---DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE---CCcEEEEECcccccccC
Confidence 998 67899999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd04041 C2A_fungal C2 domain first repeat; fungal group | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=132.67 Aligned_cols=94 Identities=12% Similarity=0.005 Sum_probs=80.4
Q ss_pred ceeEEEEecc-CcccccCC-CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc--ccccccccc
Q 005415 266 DYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA--EKDLMPAEI 341 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~-g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~--~~~L~~~V~ 341 (697)
+.|+|.|.+| +|+++|.. |.+||||++++.++++ .+++|+++++|+||+|||+|.|. +...+. +..|.++||
T Consensus 1 G~L~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~~~~--~~~kT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~ 76 (111)
T cd04041 1 GVLVVTIHRATDLPKADFGTGSSDPYVTASFAKFGK--PLYSTRIIRKDLNPVWEETWFVL--VTPDEVKAGERLSCRLW 76 (111)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCCccEEEEEccCCC--ccEeeeeECCCCCCccceeEEEE--eCchhccCCCEEEEEEE
Confidence 4689999999 99999998 9999999999987654 36789999999999999999997 544433 455999999
Q ss_pred cCCCCCCCCcccccccCccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|+|+++.++++|++.++..++.
T Consensus 77 d~d~~~~dd~lG~~~i~l~~l~ 98 (111)
T cd04041 77 DSDRFTADDRLGRVEIDLKELI 98 (111)
T ss_pred eCCCCCCCCcceEEEEEHHHHh
Confidence 9999999999999988765555
|
C2 domains were first identified in Protein Kinase C (PKC). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 domains with a calcium binding region have negatively charged residues, primarily aspartates, that serve as ligan |
| >cd08405 C2B_Synaptotagmin-7 C2 domain second repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=137.43 Aligned_cols=96 Identities=15% Similarity=0.090 Sum_probs=85.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||.++|..|.+|||||+.+.+..++..++||++.++++||+|||+|.|. ++.+.+ +..|.++||
T Consensus 13 ~~~~L~v~vi~a~~L~~~~~~g~~dpyV~v~l~~~~~~~~~~kT~v~~~t~~P~wne~F~f~--i~~~~~~~~~l~~~v~ 90 (136)
T cd08405 13 TANRITVNIIKARNLKAMDINGTSDPYVKVWLMYKDKRVEKKKTVIKKRTLNPVFNESFIFN--IPLERLRETTLIITVM 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCceEEEEEEeCCCccccccCcceeCCCCCcccceEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999987766668899999999999999999999 777666 456999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|++.+++++++|++.++..+
T Consensus 91 d~~~~~~~~~lG~~~i~~~~ 110 (136)
T cd08405 91 DKDRLSRNDLIGKIYLGWKS 110 (136)
T ss_pred ECCCCCCCcEeEEEEECCcc
Confidence 99999999999999887644
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-14 Score=147.50 Aligned_cols=204 Identities=19% Similarity=0.254 Sum_probs=151.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+...++.+|...-.|..|+|++. |..++.|++.-. ......+..|.-.|+.. .||||+.+++.+.+..+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif------shpnilpvlgacnsppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF------SHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee------cCCchhhhhhhccCCCC
Confidence 34556778899999999999985 456677877532 22223455555555444 58999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcceEEEeeC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.++..||+ ++|+..+.... .......++.+++.+++.|++|||+.. |.---|....++|+.+-..++-.+|-
T Consensus 262 lv~isq~mp~gslynvlhe~t----~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 999999998 78888876432 233677788999999999999999975 44456888899998633334444453
Q ss_pred CCccccccccccccccCCCCCchhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~~~~s---~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
-++.... ...-.|.|++||.+..++-+ .++|+|||+++||||.|.+.||..-++.+.-.+|.
T Consensus 338 kfsfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia 402 (448)
T KOG0195|consen 338 KFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA 402 (448)
T ss_pred eeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh
Confidence 3332211 12347889999999877643 46999999999999999999999999888777764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=158.37 Aligned_cols=135 Identities=21% Similarity=0.244 Sum_probs=102.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----h-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
..|...+.||+|+||+||++.+.. ..+++|+.... . .....+.+|+++++.++ |++++....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~p~~~ 404 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR------RAGVPTPVIY 404 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc------ccCCCeeEEE
Confidence 445667899999999999998643 34444443211 1 12345678899998886 4577777767
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+......++||||+++ +|.+++. ....++.|++.+|.+||+.||+||||||+|||++ ++.++
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~---~~~~~ 467 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR---DDRLY 467 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---CCcEE
Confidence 7777778999999976 4544432 2467899999999999999999999999999994 67899
Q ss_pred EeeCCCcccc
Q 005415 564 IIDLGSSCFQ 573 (697)
Q Consensus 564 L~DFGla~~~ 573 (697)
|+|||+++..
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999998653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.8e-14 Score=155.88 Aligned_cols=197 Identities=19% Similarity=0.210 Sum_probs=145.7
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCc-cccCCCCc
Q 005415 473 ADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI-IHCDLKPE 550 (697)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gI-vHrDLKP~ 550 (697)
..|.|+.++++.+..+...++|.+|+. |+|.+.+.... ..++..-...++++|+.||.|||.-.| .|+.++..
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 458899999999999999999999997 67777776422 227777788899999999999998765 99999999
Q ss_pred cccccccCcceEEEeeCCCcccccc-----ccccccccCCCCCchhhcCCC-------CCchhhHHHHHHHHHHHHhCCC
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-------YDQKIDLWSLGCILAELWTGEV 618 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~-----~~~~~~gt~~Y~APE~l~~~~-------~s~ksDIWSLGviL~ELltG~~ 618 (697)
|++++. ...+||+|||+...... .........-|.|||.+.+.. .+.+.||||+|++++|+++...
T Consensus 79 nClvd~--~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 79 NCLVDS--RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cceeee--eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999995 89999999999876642 111112234599999997641 4667999999999999999999
Q ss_pred CCCCC----cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 619 LFPND----AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 619 PF~~~----~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
||... ++.+++.++.+...++......... ...+.+..++++||... |..|.+++++.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~----P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN------ELPPELLLLVARCWEEI----PEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhh------hcchHHHHHHHHhcccC----hhhCccHHHHH
Confidence 99763 2334555544412222222211111 23347889999999987 66777776665
|
|
| >cd08386 C2A_Synaptotagmin-7 C2A domain first repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=131.68 Aligned_cols=98 Identities=12% Similarity=0.097 Sum_probs=84.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| ||+++|.+|.+||||+++++++... +.+|+++++|+||+|||+|.|.. ++.+.+ ++.|.++||
T Consensus 14 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~kT~v~~~t~~P~Wne~f~f~~-~~~~~l~~~~l~~~v~ 90 (125)
T cd08386 14 QESTLTLKILKAVELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEG-FPYEKLQQRVLYLQVL 90 (125)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCceEEEEECCCCCc--ceeeeeecCCCCCccceeEEEcc-cCHHHhCCCEEEEEEE
Confidence 346899999999 9999999999999999999987654 68999999999999999999973 344444 556999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|++++++++|+++++..+.+.
T Consensus 91 d~d~~~~~~~iG~~~i~l~~l~~ 113 (125)
T cd08386 91 DYDRFSRNDPIGEVSLPLNKVDL 113 (125)
T ss_pred eCCCCcCCcEeeEEEEecccccC
Confidence 99999999999999998776664
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd04009 C2B_Munc13-like C2 domain second repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-14 Score=133.99 Aligned_cols=99 Identities=14% Similarity=0.045 Sum_probs=84.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCC--CccccceeecccCCCcceecccccCccccccc---cccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG--TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG---AEKDLM 337 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~--~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~---~~~~L~ 337 (697)
....|+|.|.+| +|+++|..|.+||||++++.++.+ ...++||+++++|+||+|||+|.|. +.... .+..|.
T Consensus 14 ~~~~L~V~Vi~A~~L~~~~~~g~~dPyv~v~l~~~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~~~~~~~~l~ 91 (133)
T cd04009 14 SEQSLRVEILNARNLLPLDSNGSSDPFVKVELLPRHLFPDVPTPKTQVKKKTLFPLFDESFEFN--VPPEQCSVEGALLL 91 (133)
T ss_pred CCCEEEEEEEEeeCCCCcCCCCCCCCEEEEEEECCCcCccccccccccCcCCCCCccCCEEEEE--echhhcccCCCEEE
Confidence 346899999999 999999999999999999998764 3568999999999999999999999 65432 245699
Q ss_pred cccccCCCCCCCCcccccccCcccccc
Q 005415 338 PAEIDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 338 ~~V~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
++|||++++++++++|+++++..++.+
T Consensus 92 ~~V~d~d~~~~d~~iG~~~i~l~~l~~ 118 (133)
T cd04009 92 FTVKDYDLLGSNDFEGEAFLPLNDIPG 118 (133)
T ss_pred EEEEecCCCCCCcEeEEEEEeHHHCCc
Confidence 999999999999999999887655554
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, s |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.4e-13 Score=124.86 Aligned_cols=134 Identities=20% Similarity=0.233 Sum_probs=108.1
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEc
Q 005415 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 497 (697)
Q Consensus 418 i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEy 497 (697)
+++.||.|.++.||++.+. +..+++|....... ...+..|+.+++.+++. ..++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999864 37899999876543 45788899999999764 24678888888777889999999
Q ss_pred cccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc---CccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 498 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 498 l~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~---gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
+.+..... ++......++.+++.+|.+||.. +++|+|++|.||+++. .+.++++||+.+..
T Consensus 75 ~~g~~~~~------------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~--~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDE------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeeccc------------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC--CcEEEEEecccccC
Confidence 97653221 13455677889999999999985 6999999999999985 68899999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd08682 C2_Rab11-FIP_classI C2 domain found in Rab11-family interacting proteins (FIP) class I | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.3e-14 Score=132.25 Aligned_cols=89 Identities=15% Similarity=0.047 Sum_probs=76.5
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccc---ccc-cccccccccc
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF---KGA-EKDLMPAEID 342 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~---~~~-~~~L~~~V~D 342 (697)
++|.|.+| ||.++|.+|.+||||++.+. ..++||+++++|+||+|||+|.|. ++. +.. ...|.++|||
T Consensus 1 ~~V~V~~A~~L~~~d~~g~~dpYv~v~l~-----~~~~kT~v~~~t~nP~Wne~f~F~--v~~~~~~~~~~~~l~~~v~d 73 (126)
T cd08682 1 VQVTVLQARGLLCKGKSGTNDAYVIIQLG-----KEKYSTSVKEKTTSPVWKEECSFE--LPGLLSGNGNRATLQLTVMH 73 (126)
T ss_pred CEEEEEECcCCcCCCCCcCCCceEEEEEC-----CeeeeeeeecCCCCCEeCceEEEE--ecCcccCCCcCCEEEEEEEE
Confidence 47899999 99999999999999999985 246789999999999999999998 665 223 4559999999
Q ss_pred CCCCCCCCcccccccCccccc
Q 005415 343 NSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d 363 (697)
++.+++++++|.+.+...++.
T Consensus 74 ~~~~~~d~~iG~~~i~l~~l~ 94 (126)
T cd08682 74 RNLLGLDKFLGQVSIPLNDLD 94 (126)
T ss_pred ccccCCCceeEEEEEEHHHhh
Confidence 999999999999988766554
|
Rab GTPases recruit various effector proteins to organelles and vesicles. Rab11-family interacting proteins (FIPs) are involved in mediating the role of Rab11. FIPs can be divided into three classes: class I FIPs (Rip11a, Rip11b, RCP, and FIP2) which contain a C2 domain after N-terminus of the protein, class II FIPs (FIP3 and FIP4) which contain two EF-hands and a proline rich region, and class III FIPs (FIP1) which exhibits no homology to known protein domains. All FIP proteins contain a highly conserved, 20-amino acid motif at the C-terminus of the protein, known as Rab11/25 binding domain (RBD). Class I FIPs are thought to bind to endocytic membranes via their C2 domain, which interacts directly with phospholipids. Class II FIPs do not have any membrane binding domains leaving much to speculate about the mechanism involving FIP3 and FIP4 interactions with endocytic membranes. The member |
| >cd04039 C2_PSD C2 domain present in Phosphatidylserine decarboxylase (PSD) | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.6e-14 Score=128.09 Aligned_cols=92 Identities=10% Similarity=-0.044 Sum_probs=76.0
Q ss_pred ceeEEEEecc-CcccccCC----CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccc
Q 005415 266 DYGYLSSKEA-DLIDLQHN----VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~----g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
+.|.|.|++| +|+++|.. +.+||||++.+- .+++||+++++|+||+|||.|.|. +........|.+.|
T Consensus 1 g~l~v~v~~A~~L~~~~~~~~~~~~~DPYv~v~~~-----~~~~kT~v~~~t~nPvWne~f~f~--v~~~~~~~~L~~~V 73 (108)
T cd04039 1 GVVFMEIKSITDLPPLKNMTRTGFDMDPFVIISFG-----RRVFRTSWRRHTLNPVFNERLAFE--VYPHEKNFDIQFKV 73 (108)
T ss_pred CEEEEEEEeeeCCCCccccCCCCCccCceEEEEEC-----CEeEeeeeecCCCCCcccceEEEE--EeCccCCCEEEEEE
Confidence 4688999999 99999842 347999999982 246789999999999999999998 65544455699999
Q ss_pred ccCCCCCCCCcccccccCcccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
||+|++++++++|.+++...++..
T Consensus 74 ~D~d~~~~dd~IG~~~l~L~~l~~ 97 (108)
T cd04039 74 LDKDKFSFNDYVATGSLSVQELLN 97 (108)
T ss_pred EECCCCCCCcceEEEEEEHHHHHh
Confidence 999999999999999887655444
|
PSD is involved in the biosynthesis of aminophospholipid by converting phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn). There is a single C2 domain present and it is thought to confer PtdSer binding motif that is common to PKC and synaptotagmin. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM |
| >cd08688 C2_KIAA0528-like C2 domain found in the Human KIAA0528 cDNA clone | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.1e-14 Score=127.46 Aligned_cols=91 Identities=12% Similarity=0.081 Sum_probs=79.6
Q ss_pred eEEEEecc-CcccccC-CCCCCcceEeeccCCCCCccccceeecccCCCcce-ecccccCcccccccc-ccccccccccC
Q 005415 268 GYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDW-IEGFKGSSDLHFKGA-EKDLMPAEIDN 343 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~-~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~f-nE~f~f~~~v~~~~~-~~~L~~~V~D~ 343 (697)
|+|.|.+| +|++||. +|.+||||++++.. .++||+++++++||.| ||+|.|. ++...+ +..|.++|||+
T Consensus 1 l~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~-----~~~kT~v~~~~~nP~W~ne~f~f~--i~~~~l~~~~l~i~V~d~ 73 (110)
T cd08688 1 LKVRVVAARDLPVMDRSSDLTDAFVEVKFGS-----TTYKTDVVKKSLNPVWNSEWFRFE--VDDEELQDEPLQIRVMDH 73 (110)
T ss_pred CEEEEEEEECCCccccCCCCCCceEEEEECC-----eeEecceecCCCCCcccCcEEEEE--cChHHcCCCeEEEEEEeC
Confidence 67999999 9999994 78999999999953 5788999999999999 9999999 776665 45699999999
Q ss_pred CCCCCCCcccccccCccccccc
Q 005415 344 SDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~~~~d~e 365 (697)
+.+++++++|++.+...++...
T Consensus 74 d~~~~~~~iG~~~~~l~~l~~~ 95 (110)
T cd08688 74 DTYSANDAIGKVYIDLNPLLLK 95 (110)
T ss_pred CCCCCCCceEEEEEeHHHhccc
Confidence 9999999999999887766653
|
The members of this CD are named after the Human KIAA0528 cDNA clone. All members here contain a single C2 repeat. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/a |
| >cd08390 C2A_Synaptotagmin-15-17 C2A domain first repeat present in Synaptotagmins 15 and 17 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.9e-14 Score=128.80 Aligned_cols=98 Identities=15% Similarity=0.058 Sum_probs=84.9
Q ss_pred ccceeEEEEecc-Cccccc-CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-ccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V 340 (697)
.++.|+|.|.+| ||+++| ..|.+||||+++++|+.++ +++|+++++++||+|||+|.|. ++...++ +.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyV~v~l~~~~~~--~~~T~v~~~~~~P~wne~f~f~--i~~~~l~~~~l~i~v 87 (123)
T cd08390 12 EEEQLTVSLIKARNLPPRTKDVAHCDPFVKVCLLPDERR--SLQSKVKRKTQNPNFDETFVFQ--VSFKELQRRTLRLSV 87 (123)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCCcEEEEEEeeCCCC--ceEeeeEcCCCCCccceEEEEE--cCHHHhcccEEEEEE
Confidence 457899999999 999999 6889999999999988754 6789999999999999999999 8777664 5699999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
||++..++++++|++.++..+....
T Consensus 88 ~d~~~~~~~~~iG~~~i~L~~l~~~ 112 (123)
T cd08390 88 YDVDRFSRHCIIGHVLFPLKDLDLV 112 (123)
T ss_pred EECCcCCCCcEEEEEEEeccceecC
Confidence 9999999999999998876555443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulat |
| >cd08401 C2A_RasA2_RasA3 C2 domain first repeat present in RasA2 and RasA3 | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.9e-14 Score=129.12 Aligned_cols=89 Identities=18% Similarity=0.065 Sum_probs=74.5
Q ss_pred eEEEEecc-Cccccc-CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCC
Q 005415 268 GYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (697)
Q Consensus 268 l~v~l~e~-~L~~~d-~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~ 345 (697)
|+|.|.+| ||++++ .+|.+||||++++. + +.+.||+++++|+||+|||+|.|. ++.. .++|.+.|||+|+
T Consensus 2 l~v~v~~a~~L~~~~~~~g~sDpYv~v~l~--~--~~~~kT~v~~kt~~P~WnE~F~f~--v~~~--~~~l~~~v~d~~~ 73 (121)
T cd08401 2 LKIKIGEAKNLPPRSGPNKMRDCYCTVNLD--Q--EEVFRTKTVEKSLCPFFGEDFYFE--IPRT--FRHLSFYIYDRDV 73 (121)
T ss_pred eEEEEEEccCCCCCCCCCCCcCcEEEEEEC--C--ccEEEeeEEECCCCCccCCeEEEE--cCCC--CCEEEEEEEECCC
Confidence 67899999 999985 57899999999993 2 236789999999999999999999 7643 3569999999999
Q ss_pred CCCCCcccccccCcccccc
Q 005415 346 TRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 346 ~~~~d~~G~v~~~~~~~d~ 364 (697)
+++++++|.+.+...++..
T Consensus 74 ~~~~~~iG~~~i~l~~l~~ 92 (121)
T cd08401 74 LRRDSVIGKVAIKKEDLHK 92 (121)
T ss_pred CCCCceEEEEEEEHHHccC
Confidence 9999999999876555443
|
RasA2 and RasA3 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA2 and RasA3 are both inositol 1,3,4,5-tetrakisphosphate-binding proteins and contain an N-terminal C2 domain, a Ras-GAP domain, a pleckstrin-homology (PH) domain which localizes it to the plasma membrane, and Bruton's Tyrosine Kinase (BTK) a zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular p |
| >cd04032 C2_Perforin C2 domain of Perforin | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-13 Score=127.23 Aligned_cols=90 Identities=10% Similarity=-0.060 Sum_probs=74.5
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
...+.|+|.|.+| +|+ +|..|.+|||||+++. ..++||++.++++||+|||+|.|. .........|.++||
T Consensus 25 ~~~~~L~V~V~~A~~L~-~d~~g~~DPYVkV~~~-----~~~~kT~vi~~t~nPvWNE~F~f~--~~~~~~~~~L~v~V~ 96 (127)
T cd04032 25 RGLATLTVTVLRATGLW-GDYFTSTDGYVKVFFG-----GQEKRTEVIWNNNNPRWNATFDFG--SVELSPGGKLRFEVW 96 (127)
T ss_pred CCcEEEEEEEEECCCCC-cCcCCCCCeEEEEEEC-----CccccCceecCCCCCcCCCEEEEe--cccCCCCCEEEEEEE
Confidence 3557899999999 997 5888899999999983 228899999999999999999997 222123445999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|.+++++++|.+.++..
T Consensus 97 D~d~~s~dd~IG~~~i~l~ 115 (127)
T cd04032 97 DRDNGWDDDLLGTCSVVPE 115 (127)
T ss_pred eCCCCCCCCeeEEEEEEec
Confidence 9999999999999987654
|
Perforin contains a single copy of a C2 domain in its C-terminus and plays a role in lymphocyte-mediated cytotoxicity. Mutations in perforin leads to familial hemophagocytic lymphohistiocytosis type 2. The function of perforin is calcium dependent and the C2 domain is thought to confer this binding to target cell membranes. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.3e-12 Score=131.29 Aligned_cols=133 Identities=17% Similarity=0.189 Sum_probs=95.9
Q ss_pred Eec-cCCCCceEEEEECCCCcEEEEEEEecch--------------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 421 YLG-SAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 421 ~LG-~G~fG~Vy~a~d~~~g~~VAVKii~~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.|| .|+.|+||.+.. .+..++||.+.... .......+|+.++..+.+.. ..+++.+++.
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCceeEeee
Confidence 466 788889999875 47889999885311 12245678999999997542 2346666654
Q ss_pred Eec-C---eEEEEEEcccc--chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 486 YHL-E---HLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 486 ~~~-~---~l~LVmEyl~g--sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
... . ..++|||++++ +|.+++... .++.. .+.||+.+|.+||++||+|+||||.|||++. +
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~--~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP--D 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC--C
Confidence 432 2 23599999985 555554321 13433 3578999999999999999999999999985 5
Q ss_pred ceEEEeeCCCccc
Q 005415 560 CEIKIIDLGSSCF 572 (697)
Q Consensus 560 ~~vKL~DFGla~~ 572 (697)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 6899999998764
|
|
| >cd08690 C2_Freud-1 C2 domain found in 5' repressor element under dual repression binding protein-1 (Freud-1) | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.4e-13 Score=129.75 Aligned_cols=92 Identities=14% Similarity=0.014 Sum_probs=73.8
Q ss_pred EEEEecc---CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccc------cc-cccccc
Q 005415 269 YLSSKEA---DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK------GA-EKDLMP 338 (697)
Q Consensus 269 ~v~l~e~---~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~------~~-~~~L~~ 338 (697)
.|+|+.| +|++.+.+|.+|||||++|+....+..+.||+++|+|+||+|||+|.|. ++.. .+ ++.|.+
T Consensus 5 el~i~~~~~~~l~~~~~~~~~DpYVk~~l~~p~~~~~k~KT~v~k~TlnPvfNE~f~f~--I~~~~~~~~R~l~~~~L~~ 82 (155)
T cd08690 5 ELTIVRCIGIPLPSGWNPKDLDTYVKFEFPYPNEEPQSGKTSTIKDTNSPEYNESFKLN--INRKHRSFQRVFKRHGLKF 82 (155)
T ss_pred EEEEEEeeccccCCCcCCCCCCeEEEEEEecCCCCCceeecCcccCCCCCcccceEEEE--eccccchhhhhccCCcEEE
Confidence 3445555 5889999999999999998544556779999999999999999999999 6655 23 445999
Q ss_pred ccccCCCCC-CCCcccccccCcccc
Q 005415 339 AEIDNSDTR-DGEVNGALHEGKADA 362 (697)
Q Consensus 339 ~V~D~d~~~-~~d~~G~v~~~~~~~ 362 (697)
+|||.+.+. +++++|.+.+.....
T Consensus 83 ~V~d~~~f~~~D~~iG~~~i~L~~l 107 (155)
T cd08690 83 EVYHKGGFLRSDKLLGTAQVKLEPL 107 (155)
T ss_pred EEEeCCCcccCCCeeEEEEEEcccc
Confidence 999999974 699999997754443
|
Freud-1 is a novel calcium-regulated repressor that negatively regulates basal 5-HT1A receptor expression in neurons. It may also play a role in the altered regulation of 5-HT1A receptors associated with anxiety or major depression. Freud-1 contains two DM-14 basic repeats, a helix-loop-helix DNA binding domain, and a C2 domain. The Freud-1 C2 domain is thought to be calcium insensitive and it lacks several acidic residues that mediate calcium binding of the PKC C2 domain. In addition, it contains a poly-basic insert that is not present in calcium-dependent C2 domains and may function as a nuclear localization signal. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules tha |
| >cd04036 C2_cPLA2 C2 domain present in cytosolic PhosphoLipase A2 (cPLA2) | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-13 Score=124.43 Aligned_cols=89 Identities=11% Similarity=0.033 Sum_probs=75.7
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
|+|.|.+| +|++.|..|.+||||++.+...+. .+++|++.++|+||+|||+|.|. +... ....|.++|||+|.+
T Consensus 2 L~V~vi~a~~L~~~~~~~~~Dpyv~v~~~~~~~--~~~kT~vv~~t~nP~Wne~f~f~--i~~~-~~~~l~v~v~d~d~~ 76 (119)
T cd04036 2 LTVRVLRATNITKGDLLSTPDCYVELWLPTASD--EKKRTKTIKNSINPVWNETFEFR--IQSQ-VKNVLELTVMDEDYV 76 (119)
T ss_pred eEEEEEEeeCCCccCCCCCCCcEEEEEEcCCCC--ccCccceecCCCCCccceEEEEE--eCcc-cCCEEEEEEEECCCC
Confidence 78999999 999999999999999999965543 47889999999999999999998 6554 334599999999999
Q ss_pred CCCCcccccccCcccc
Q 005415 347 RDGEVNGALHEGKADA 362 (697)
Q Consensus 347 ~~~d~~G~v~~~~~~~ 362 (697)
+++++|++.+....+
T Consensus 77 -~~~~iG~~~~~l~~l 91 (119)
T cd04036 77 -MDDHLGTVLFDVSKL 91 (119)
T ss_pred -CCcccEEEEEEHHHC
Confidence 899999997765443
|
A single copy of the C2 domain is present in cPLA2 which releases arachidonic acid from membranes initiating the biosynthesis of potent inflammatory mediators such as prostaglandins, leukotrienes, and platelet-activating factor. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants o |
| >cd08376 C2B_MCTP_PRT C2 domain second repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.6e-13 Score=123.21 Aligned_cols=88 Identities=15% Similarity=0.132 Sum_probs=75.1
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
++|.|.+| ||+++|.+|.+||||++++. ..+.||++.++|+||.|||+|.|. +... .+..|.++|||++.+
T Consensus 2 ~~V~v~~a~~L~~~~~~~~~dPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~-~~~~l~v~v~d~~~~ 73 (116)
T cd08376 2 VTIVLVEGKNLPPMDDNGLSDPYVKFRLG-----NEKYKSKVCSKTLNPQWLEQFDLH--LFDD-QSQILEIEVWDKDTG 73 (116)
T ss_pred EEEEEEEEECCCCCCCCCCCCcEEEEEEC-----CEeEecccccCCCCCceeEEEEEE--ecCC-CCCEEEEEEEECCCC
Confidence 68999999 99999999999999999983 246889999999999999999998 5533 245699999999999
Q ss_pred CCCCcccccccCccccc
Q 005415 347 RDGEVNGALHEGKADAE 363 (697)
Q Consensus 347 ~~~d~~G~v~~~~~~~d 363 (697)
++++++|.+..+..+..
T Consensus 74 ~~~~~iG~~~~~l~~l~ 90 (116)
T cd08376 74 KKDEFIGRCEIDLSALP 90 (116)
T ss_pred CCCCeEEEEEEeHHHCC
Confidence 99999999987654433
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protei |
| >cd04022 C2A_MCTP_PRT_plant C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.7e-13 Score=125.36 Aligned_cols=90 Identities=9% Similarity=0.011 Sum_probs=76.9
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccc-ccc-ccccccccccC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF-KGA-EKDLMPAEIDN 343 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~-~~~-~~~L~~~V~D~ 343 (697)
+|+|.|.+| +|.++|.+|.+||||++++.. .+++|+++++++||+|||+|.|. +.. ... +..|.++|||.
T Consensus 1 ~L~V~vi~A~~L~~~d~~g~~dpyv~v~~~~-----~~~rT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~d~ 73 (127)
T cd04022 1 KLVVEVVDAQDLMPKDGQGSSSAYVELDFDG-----QKKRTRTKPKDLNPVWNEKLVFN--VSDPSRLSNLVLEVYVYND 73 (127)
T ss_pred CeEEEEEEeeCCCCCCCCCCcCcEEEEEECC-----EEecceeEcCCCCCccceEEEEE--ccCHHHccCCeEEEEEeeC
Confidence 589999999 999999999999999999874 36789999999999999999999 553 222 45599999999
Q ss_pred CCCC-CCCcccccccCccccc
Q 005415 344 SDTR-DGEVNGALHEGKADAE 363 (697)
Q Consensus 344 d~~~-~~d~~G~v~~~~~~~d 363 (697)
+.+. +++++|++.++..++.
T Consensus 74 ~~~~~~d~~lG~v~i~l~~l~ 94 (127)
T cd04022 74 RRSGRRRSFLGRVRISGTSFV 94 (127)
T ss_pred CCCcCCCCeeeEEEEcHHHcC
Confidence 9997 7999999988765554
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd04018 C2C_Ferlin C2 domain third repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-13 Score=129.94 Aligned_cols=94 Identities=15% Similarity=0.106 Sum_probs=77.6
Q ss_pred eeEEEEecc-CcccccCCC--------------CCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccc
Q 005415 267 YGYLSSKEA-DLIDLQHNV--------------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG 331 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g--------------~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~ 331 (697)
.|+|.|.+| +|++||..+ .+||||++.+.. ++.||+++++++||+|||+|.|. +....
T Consensus 1 ~~~V~V~~A~dLp~~d~~~~~~~~~~~~~~~~~~~DPYV~V~~~g-----~~~kT~v~~~t~nPvWNE~f~f~--v~~p~ 73 (151)
T cd04018 1 RFIFKIYRAEDLPQMDSGIMANVKKAFLGEKKELVDPYVEVSFAG-----QKVKTSVKKNSYNPEWNEQIVFP--EMFPP 73 (151)
T ss_pred CeEEEEEEeCCCCccChhhhccceeccccCCCCCcCcEEEEEECC-----EeeecceEcCCCCCCcceEEEEE--eeCCC
Confidence 478999999 999999665 689999999853 25689999999999999999998 54444
Q ss_pred cccccccccccCCCCCCCCcccccccCcccccccCC
Q 005415 332 AEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 367 (697)
Q Consensus 332 ~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~e~~ 367 (697)
.+..|.++|||+|.+++++++|.+.+....+...+.
T Consensus 74 ~~~~l~~~v~D~d~~~~dd~iG~~~l~l~~l~~~~~ 109 (151)
T cd04018 74 LCERIKIQIRDWDRVGNDDVIGTHFIDLSKISNSGD 109 (151)
T ss_pred cCCEEEEEEEECCCCCCCCEEEEEEEeHHHhccCCc
Confidence 555699999999999999999999887655555443
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04025 C2B_RasA1_RasA4 C2 domain second repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.1e-13 Score=123.62 Aligned_cols=90 Identities=17% Similarity=0.043 Sum_probs=76.9
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~ 345 (697)
+|+|.|.+| +|.++|.+|.+||||++++. ..+.+|++.++|+||.|||+|.|. +.... ...|.++|||++.
T Consensus 1 ~L~v~vi~a~~L~~~d~~~~~DPyv~v~~~-----~~~~kT~v~~~t~nP~Wne~f~f~--~~~~~-~~~l~~~v~d~~~ 72 (123)
T cd04025 1 RLRCHVLEARDLAPKDRNGTSDPFVRVFYN-----GQTLETSVVKKSCYPRWNEVFEFE--LMEGA-DSPLSVEVWDWDL 72 (123)
T ss_pred CEEEEEEEeeCCCCCCCCCCcCceEEEEEC-----CEEEeceeecCCCCCccCcEEEEE--cCCCC-CCEEEEEEEECCC
Confidence 589999999 99999999999999999983 235789999999999999999998 65433 4459999999999
Q ss_pred CCCCCcccccccCcccccc
Q 005415 346 TRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 346 ~~~~d~~G~v~~~~~~~d~ 364 (697)
+++++++|.+.++..++..
T Consensus 73 ~~~~~~iG~~~~~l~~l~~ 91 (123)
T cd04025 73 VSKNDFLGKVVFSIQTLQQ 91 (123)
T ss_pred CCCCcEeEEEEEEHHHccc
Confidence 9999999999887665543
|
RasA1 and RasA4 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both proteins contain two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such a |
| >cd04035 C2A_Rabphilin_Doc2 C2 domain first repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.2e-13 Score=123.07 Aligned_cols=98 Identities=12% Similarity=0.074 Sum_probs=82.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
.+.+|+|.|.+| +|.++|..|.+|||||+++.++.....+++|+++++++||+|||+|.|.. ++.... ...|.++||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~Wne~f~f~~-~~~~~~~~~~l~~~v~ 91 (123)
T cd04035 13 ANSALHCTIIRAKGLKAMDANGLSDPYVKLNLLPGASKATKLRTKTVHKTRNPEFNETLTYYG-ITEEDIQRKTLRLLVL 91 (123)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCceEEEEEecCCCCCCceeeeeecCCCCCCccceEEEcC-CCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999887666789999999999999999999963 333333 456999999
Q ss_pred cCCCCCCCCcccccccCccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|++.+ +++++|.++++..++.
T Consensus 92 d~~~~-~~~~iG~~~i~l~~l~ 112 (123)
T cd04035 92 DEDRF-GNDFLGETRIPLKKLK 112 (123)
T ss_pred EcCCc-CCeeEEEEEEEcccCC
Confidence 99998 8899999988665544
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd00276 C2B_Synaptotagmin C2 domain second repeat present in Synaptotagmin | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-13 Score=126.68 Aligned_cols=96 Identities=17% Similarity=0.088 Sum_probs=86.0
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
+.+.|+|.|.+| ||+++|..|..||||++.+.++..+..+++|++.+++.||.|||+|.|. ++...+ +..|.++||
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~~T~~~~~~~~P~wne~f~f~--i~~~~l~~~~l~~~v~ 89 (134)
T cd00276 12 TAERLTVVVLKARNLPPSDGKGLSDPYVKVSLLQGGKKLKKKKTSVKKGTLNPVFNEAFSFD--VPAEQLEEVSLVITVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCcEEEEEEEcCCeEeeeecCcceecCCCCeeeeeEEEE--CCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999998776678899999999999999999999 777665 455999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|.+.+++++++|.+.++..+
T Consensus 90 d~~~~~~~~~lG~~~i~l~~ 109 (134)
T cd00276 90 DKDSVGRNEVIGQVVLGPDS 109 (134)
T ss_pred ecCCCCCCceeEEEEECCCC
Confidence 99999999999999888766
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. There are several classes of Synaptotagmins. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distin |
| >cd08374 C2F_Ferlin C2 domain sixth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.1e-13 Score=125.10 Aligned_cols=89 Identities=13% Similarity=0.020 Sum_probs=75.7
Q ss_pred eEEEEecc-Ccc--cccCCCC--CCcceEeeccCCCCCccccceeecccCCC--cceecccccCccccc-----------
Q 005415 268 GYLSSKEA-DLI--DLQHNVV--GDSSTDCDLAPHPGTEKSSSYSSSKRGSS--IDWIEGFKGSSDLHF----------- 329 (697)
Q Consensus 268 l~v~l~e~-~L~--~~d~~g~--sDpyVk~~l~pd~~~~~k~kt~v~k~tln--P~fnE~f~f~~~v~~----------- 329 (697)
|||+|-+| ++. .++.+|. +|||||++|.+. +..|+||.||.+++| |.||+.|.|+ ++.
T Consensus 2 LRViIw~~~~v~~~~~~~~g~~~sD~yVK~~L~~~--~~~kqkTDVHyrslnG~~~FNwRfvF~--~~~~~~~~~~~~~~ 77 (133)
T cd08374 2 LRVIVWNTRDVLNDDTNITGEKMSDIYVKGWLDGL--EEDKQKTDVHYRSLDGEGNFNWRFVFP--FDYLPAEKKIVVIK 77 (133)
T ss_pred EEEEEEECcCCcccccccCCccccCeEEEEEEccC--cccccccceEEecCCCCcEEeEEEEEe--eecCCccceeEEEe
Confidence 78999999 844 4455784 999999999998 445999999999999 9999999998 555
Q ss_pred ----------ccc-ccccccccccCCCCCCCCcccccccCcc
Q 005415 330 ----------KGA-EKDLMPAEIDNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 330 ----------~~~-~~~L~~~V~D~d~~~~~d~~G~v~~~~~ 360 (697)
+.+ ..+|.++|||.|++++++++|+++++..
T Consensus 78 ~~~~~~~~~~e~~~~~~L~lqvwD~D~~s~dd~iG~~~l~l~ 119 (133)
T cd08374 78 KEHFWSLDETEYKIPPKLTLQVWDNDKFSPDDFLGSLELDLS 119 (133)
T ss_pred eccccccCcceEecCcEEEEEEEECcccCCCCcceEEEEEhh
Confidence 555 4559999999999999999999987654
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd08686 C2_ABR C2 domain in the Active BCR (Breakpoint cluster region) Related protein | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.4e-13 Score=121.98 Aligned_cols=79 Identities=10% Similarity=0.070 Sum_probs=67.1
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC---
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN--- 343 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~--- 343 (697)
|+|+|++| ||+ |.+||||++.+.+.++...+.||++.++|+||+|||+|.|. ++ ..++|.+.|||+
T Consensus 1 L~V~V~~A~~L~-----~~sDPYV~l~v~~~~~~~~~~KTk~i~~TlnPvWnE~F~i~--l~---~s~~L~~~v~d~~~~ 70 (118)
T cd08686 1 LNVIVHSAQGFK-----QSANLYCTLEVDSFGYFVKKAKTRVCRDTTEPNWNEEFEIE--LE---GSQTLRILCYEKCYS 70 (118)
T ss_pred CEEEEEeCCCCC-----CCCCCEEEEEEcCccccceeeeeeeecCCCCCccceEEEEE--eC---CCCEEEEEEEEcccc
Confidence 67999999 995 67999999999998766679999999999999999999998 64 244699999998
Q ss_pred ----CCCCCCCcccccc
Q 005415 344 ----SDTRDGEVNGALH 356 (697)
Q Consensus 344 ----d~~~~~d~~G~v~ 356 (697)
|.++.++.+|...
T Consensus 71 ~~~~d~~~~d~~~G~g~ 87 (118)
T cd08686 71 KVKLDGEGTDAIMGKGQ 87 (118)
T ss_pred cccccccCcccEEEEEE
Confidence 5677788886543
|
The ABR protein is similar to the breakpoint cluster region protein. It has homology to guanine nucleotide exchange proteins and GTPase-activating proteins (GAPs). ABR is expressed primarily in the brain, but also includes non-neuronal tissues such as the heart. It has been associated with human diseases such as Miller-Dieker syndrome in which mental retardation and malformations of the heart are present. ABR contains a RhoGEF domain and a PH-like domain upstream of its C2 domain and a RhoGAP domain downstream of this domain. A few members also contain a Bcr-Abl oncoprotein oligomerization domain at the very N-terminal end. Splice variants of ABR have been identified. ABR is found in a wide variety of organisms including chimpanzee, dog, mouse, rat, fruit fly, and mosquito. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arr |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.8e-13 Score=147.02 Aligned_cols=119 Identities=35% Similarity=0.510 Sum_probs=98.2
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.++||.|++|.. +|.+.+.... .... .++.....++.|++.|+.| ++.+|+|+||.||++.. +..+||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~--d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD--DDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccc--cchhHHHHHHHhhccchhh---ccchhhhcccccccccc--chhhhhhhh
Confidence 468999999984 5555554332 2222 6677889999999999999 99999999999999984 668999999
Q ss_pred CCccccccc---------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh
Q 005415 568 GSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615 (697)
Q Consensus 568 Gla~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt 615 (697)
|+....... .+..+||..||+||.+.+..|+.++||||||+||+|++.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987554332 344688999999999999999999999999999999997
|
|
| >KOG1030 consensus Predicted Ca2+-dependent phospholipid-binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.5e-13 Score=126.28 Aligned_cols=84 Identities=12% Similarity=0.067 Sum_probs=74.4
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
.+-|+|.|+.+ ||...|+.|.|||||-+.+- ..|.||++.++++||+|||.|+|. + .+....|.++|||+
T Consensus 5 vGLL~v~v~~g~~L~~rD~~~sSDPyVVl~lg-----~q~lkT~~v~~n~NPeWNe~ltf~--v--~d~~~~lkv~VyD~ 75 (168)
T KOG1030|consen 5 VGLLRVRVKRGKNLAIRDFLGSSDPYVVLELG-----NQKLKTRVVYKNLNPEWNEELTFT--V--KDPNTPLKVTVYDK 75 (168)
T ss_pred ceEEEEEEEeecCeeeeccccCCCCeEEEEEC-----CeeeeeeeecCCCCCcccceEEEE--e--cCCCceEEEEEEeC
Confidence 36789999999 99999999999999999996 568889999999999999999987 3 34445589999999
Q ss_pred CCCCCCCccccccc
Q 005415 344 SDTRDGEVNGALHE 357 (697)
Q Consensus 344 d~~~~~d~~G~v~~ 357 (697)
|.+++.|++|+..+
T Consensus 76 D~fs~dD~mG~A~I 89 (168)
T KOG1030|consen 76 DTFSSDDFMGEATI 89 (168)
T ss_pred CCCCcccccceeee
Confidence 99999999999855
|
|
| >cd04042 C2A_MCTP_PRT C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-13 Score=122.00 Aligned_cols=89 Identities=12% Similarity=0.063 Sum_probs=75.5
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~ 345 (697)
.|+|.|++| +|+++|.+|.+||||++.+.. +..++|++.++|+||+|||+|.|. +.. ....|.++|||+|.
T Consensus 1 ~L~v~v~~a~~L~~~d~~g~~Dpyv~v~~~~----~~~~kT~~~~~t~nP~Wne~f~f~--v~~--~~~~l~~~v~D~d~ 72 (121)
T cd04042 1 QLDIHLKEGRNLAARDRGGTSDPYVKFKYGG----KTVYKSKTIYKNLNPVWDEKFTLP--IED--VTQPLYIKVFDYDR 72 (121)
T ss_pred CeEEEEEEeeCCCCcCCCCCCCCeEEEEECC----EEEEEeeeccCCCCCccceeEEEE--ecC--CCCeEEEEEEeCCC
Confidence 378999999 999999999999999999842 246788888999999999999998 542 34559999999999
Q ss_pred CCCCCcccccccCccccc
Q 005415 346 TRDGEVNGALHEGKADAE 363 (697)
Q Consensus 346 ~~~~d~~G~v~~~~~~~d 363 (697)
+++++++|.++++..+..
T Consensus 73 ~~~~~~iG~~~~~l~~l~ 90 (121)
T cd04042 73 GLTDDFMGSAFVDLSTLE 90 (121)
T ss_pred CCCCcceEEEEEEHHHcC
Confidence 999999999988654444
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protein |
| >cd08379 C2D_MCTP_PRT_plant C2 domain fourth repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.9e-13 Score=123.57 Aligned_cols=87 Identities=15% Similarity=0.039 Sum_probs=72.7
Q ss_pred eEEEEecc-C---cccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 268 GYLSSKEA-D---LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 268 l~v~l~e~-~---L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
|+|.|.+| | |.++|..|.+||||++.+- ..+.+|++.++++||+|||+|.|. +.. ....|.++|||.
T Consensus 2 L~v~v~~A~~~~~l~~~d~~g~sDPYv~i~~g-----~~~~rTk~~~~~~nP~WnE~f~f~--v~~--~~~~l~v~V~d~ 72 (126)
T cd08379 2 LEVGILGAQGLDVLRAKDGRGSTDAYCVAKYG-----PKWVRTRTVEDSSNPRWNEQYTWP--VYD--PCTVLTVGVFDN 72 (126)
T ss_pred eEEEEEEeECCccccccccCCCCCeeEEEEEC-----CEEeEcCcccCCCCCcceeEEEEE--ecC--CCCEEEEEEEEC
Confidence 78999999 9 9999999999999999973 236689999999999999999998 532 223699999999
Q ss_pred CCCC------CCCcccccccCccccc
Q 005415 344 SDTR------DGEVNGALHEGKADAE 363 (697)
Q Consensus 344 d~~~------~~d~~G~v~~~~~~~d 363 (697)
+.++ .++++|++.+...++.
T Consensus 73 d~~~~~~~~~~dd~lG~~~i~l~~l~ 98 (126)
T cd08379 73 SQSHWKEAVQPDVLIGKVRIRLSTLE 98 (126)
T ss_pred CCccccccCCCCceEEEEEEEHHHcc
Confidence 9884 7999999987644443
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphate |
| >cd04033 C2_NEDD4_NEDD4L C2 domain present in the Human neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) and NEDD4-like (NEDD4L/NEDD42) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=122.69 Aligned_cols=95 Identities=15% Similarity=0.097 Sum_probs=79.1
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCC--CCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPH--PGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd--~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
.|+|.|.+| +|.++|..|.+||||++.+... .+...+.+|++.++|+||.|||+|.|. +... ...|.++|||+
T Consensus 1 ~L~v~Vi~a~~L~~~d~~~~~Dpyv~v~~~~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~ 76 (133)
T cd04033 1 ILRVKVLAGIDLAKKDIFGASDPYVKISLYDPDGNGEIDSVQTKTIKKTLNPKWNEEFFFR--VNPR--EHRLLFEVFDE 76 (133)
T ss_pred CEEEEEEEeECCCcccCCCCcCcEEEEEEECCCCCCcccceeeeEEcCCCCCcEeeEEEEE--EcCC--CCEEEEEEEEC
Confidence 378999999 9999999999999999999865 223346789999999999999999998 5543 34589999999
Q ss_pred CCCCCCCcccccccCccccccc
Q 005415 344 SDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~~~~d~e 365 (697)
+.+++++++|.+.+...+....
T Consensus 77 ~~~~~~~~iG~~~i~l~~l~~~ 98 (133)
T cd04033 77 NRLTRDDFLGQVEVPLNNLPTE 98 (133)
T ss_pred CCCCCCCeeEEEEEEHHHCCCc
Confidence 9999999999998876555543
|
Nedd4 and Nedd4-2 are two of the nine members of the Human Nedd4 family. All vertebrates appear to have both Nedd4 and Nedd4-2 genes. They are thought to participate in the regulation of epithelial Na+ channel (ENaC) activity. They also have identical specificity for ubiquitin conjugating enzymes (E2). Nedd4 and Nedd4-2 are composed of a C2 domain, 2-4 WW domains, and a ubiquitin ligase Hect domain. Their WW domains can bind PPxY (PY) or LPSY motifs, and in vitro studies suggest that WW3 and WW4 of both proteins bind PY motifs in the key substrates, with WW3 generally exhibiting higher affinity. Most Nedd4 family members, especially Nedd4-2, also have multiple splice variants, which might play different roles in regulating their substrates. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04019 C2C_MCTP_PRT_plant C2 domain third repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.5e-13 Score=126.49 Aligned_cols=90 Identities=20% Similarity=0.146 Sum_probs=75.6
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeeccc-CCCcceecccccCccccccccccccccccccCC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~-tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d 344 (697)
+|+|.|.+| +|+++|.+|.+||||++.+.. .+.+|++.++ |+||+|||+|.|. ++.. ....|.+.|||++
T Consensus 1 ~L~V~Vi~A~~L~~~d~~g~sDPYV~v~l~~-----~~~kTk~~~~~t~nP~WNE~F~f~--v~~~-~~~~l~v~V~d~~ 72 (150)
T cd04019 1 YLRVTVIEAQDLVPSDKNRVPEVFVKAQLGN-----QVLRTRPSQTRNGNPSWNEELMFV--AAEP-FEDHLILSVEDRV 72 (150)
T ss_pred CEEEEEEEeECCCCCCCCCCCCeEEEEEECC-----EEeeeEeccCCCCCCcccCcEEEE--ecCc-cCCeEEEEEEEec
Confidence 689999999 999999999999999999963 4667777655 7999999999998 6432 2345899999999
Q ss_pred CCCCCCcccccccCcccccc
Q 005415 345 DTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 345 ~~~~~d~~G~v~~~~~~~d~ 364 (697)
..++++++|.+.++..++..
T Consensus 73 ~~~~dd~lG~v~i~L~~l~~ 92 (150)
T cd04019 73 GPNKDEPLGRAVIPLNDIER 92 (150)
T ss_pred CCCCCCeEEEEEEEHHHCcc
Confidence 99999999999888766543
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd04016 C2_Tollip C2 domain present in Toll-interacting protein (Tollip) | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=120.68 Aligned_cols=85 Identities=8% Similarity=-0.044 Sum_probs=71.3
Q ss_pred ceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeeccc-CCCcceecccccCccccccccccccccccccC
Q 005415 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~-tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
+.|+|.|.+| +|+.++ -|.+||||++.+- .++.+|++.++ ++||+|||+|.|. +... ...|.++|||.
T Consensus 2 g~L~v~v~~Ak~l~~~~-~g~sDPYv~i~lg-----~~~~kT~v~~~~~~nP~WNe~F~f~--v~~~--~~~l~~~V~d~ 71 (121)
T cd04016 2 GRLSITVVQAKLVKNYG-LTRMDPYCRIRVG-----HAVYETPTAYNGAKNPRWNKTIQCT--LPEG--VDSIYIEIFDE 71 (121)
T ss_pred cEEEEEEEEccCCCcCC-CCCCCceEEEEEC-----CEEEEeEEccCCCCCCccCeEEEEE--ecCC--CcEEEEEEEeC
Confidence 5789999999 888777 6899999999993 24678988655 8999999999998 6543 23499999999
Q ss_pred CCCCCCCcccccccCcc
Q 005415 344 SDTRDGEVNGALHEGKA 360 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~~ 360 (697)
|.+++++++|++.....
T Consensus 72 d~~~~dd~iG~~~i~l~ 88 (121)
T cd04016 72 RAFTMDERIAWTHITIP 88 (121)
T ss_pred CCCcCCceEEEEEEECc
Confidence 99999999999877653
|
Tollip is a part of the Interleukin-1 receptor (IL-1R) signaling pathway. Tollip is proposed to link serine/threonine kinase IRAK to IL-1Rs as well as inhibiting phosphorylation of IRAK. There is a single C2 domain present in Tollip. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice varian |
| >cd08676 C2A_Munc13-like C2 domain first repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-12 Score=126.03 Aligned_cols=99 Identities=14% Similarity=0.087 Sum_probs=79.7
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCc------------------------cccceeecccCCCccee
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE------------------------KSSSYSSSKRGSSIDWI 318 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~------------------------~k~kt~v~k~tlnP~fn 318 (697)
+...|+|.|.+| +|.++|.+|.+||||++.+.+..++. ..++|.++++|+||.||
T Consensus 26 ~~~~L~V~vi~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kT~v~~~tlnP~Wn 105 (153)
T cd08676 26 PIFVLKVTVIEAKGLLAKDVNGFSDPYCMLGIVPASRERNSEKSKKRKSHRKKAVLKDTVPAKSIKVTEVKPQTLNPVWN 105 (153)
T ss_pred CeEEEEEEEEeccCCcccCCCCCCCceEEEEEcccccccccccccccccccccccccccccccccEecceecCCCCCccc
Confidence 557899999999 99999999999999999998754321 23678899999999999
Q ss_pred cccccCccccccccccccccccccCCCCCCCCcccccccCcccccccCCCC
Q 005415 319 EGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVAT 369 (697)
Q Consensus 319 E~f~f~~~v~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~e~~~~ 369 (697)
|+|.|. +... ....|.++|||++ ++++|++.++..++...+...
T Consensus 106 E~F~f~--v~~~-~~~~L~i~V~D~d----d~~IG~v~i~l~~l~~~~~d~ 149 (153)
T cd08676 106 ETFRFE--VEDV-SNDQLHLDIWDHD----DDFLGCVNIPLKDLPSCGLDS 149 (153)
T ss_pred cEEEEE--eccC-CCCEEEEEEEecC----CCeEEEEEEEHHHhCCCCCCC
Confidence 999998 5432 2445999999998 889999988776666444433
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, sy |
| >cd04043 C2_Munc13_fungal C2 domain in Munc13 (mammalian uncoordinated) proteins; fungal group | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=120.21 Aligned_cols=90 Identities=11% Similarity=-0.039 Sum_probs=76.0
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 345 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~ 345 (697)
.++|.|.+| +|+++|.+|.+||||++++...+ ..+.||++.++++||.|||+|.|. ++.. ....|.++|||++.
T Consensus 2 ~~~V~v~~a~~L~~~~~~~~~Dpyv~v~~~~~~--~~~~kT~~~~~t~~P~Wne~f~f~--i~~~-~~~~L~i~v~d~d~ 76 (126)
T cd04043 2 LFTIRIVRAENLKADSSNGLSDPYVTLVDTNGK--RRIAKTRTIYDTLNPRWDEEFELE--VPAG-EPLWISATVWDRSF 76 (126)
T ss_pred EEEEEEEEeECCCCCCCCCCCCceEEEEECCCC--eeeecccEecCCCCCcccceEEEE--cCCC-CCCEEEEEEEECCC
Confidence 578999999 99999999999999999875443 236789999999999999999998 6654 34459999999999
Q ss_pred CCCCCcccccccCccc
Q 005415 346 TRDGEVNGALHEGKAD 361 (697)
Q Consensus 346 ~~~~d~~G~v~~~~~~ 361 (697)
+++++++|++.+....
T Consensus 77 ~~~~~~iG~~~i~l~~ 92 (126)
T cd04043 77 VGKHDLCGRASLKLDP 92 (126)
T ss_pred CCCCceEEEEEEecCH
Confidence 9999999999876543
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synap |
| >cd08375 C2_Intersectin C2 domain present in Intersectin | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-12 Score=122.91 Aligned_cols=94 Identities=12% Similarity=0.010 Sum_probs=78.7
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
...+.|+|.|.+| +|.++|..|.+||||++.+. ..+++|+++++|+||.|||+|.|. +... ....|.++||
T Consensus 12 ~~~G~L~V~Vi~A~~L~~~d~~g~~DPYv~v~~~-----~~~~kT~vi~~t~nP~Wne~f~f~--v~~~-~~~~l~i~V~ 83 (136)
T cd08375 12 SGIGRLMVVIVEGRDLKPCNSNGKSDPYCEVSMG-----SQEHKTKVVSDTLNPKWNSSMQFF--VKDL-EQDVLCITVF 83 (136)
T ss_pred CCcEEEEEEEEEeeCCCCCCCCCCcCcEEEEEEC-----CEeeeccccCCCCCCccCceEEEE--ecCc-cCCEEEEEEE
Confidence 3557899999999 99999999999999999983 346889999999999999999998 5432 2345999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|.|.+++++++|.+.....+...
T Consensus 84 D~d~~~~d~~lG~~~i~l~~l~~ 106 (136)
T cd08375 84 DRDFFSPDDFLGRTEIRVADILK 106 (136)
T ss_pred ECCCCCCCCeeEEEEEEHHHhcc
Confidence 99999999999999776544443
|
A single instance of the C2 domain is located C terminally in the intersectin protein. Intersectin functions as a scaffolding protein, providing a link between the actin cytoskeleton and the components of endocytosis and plays a role in signal transduction. In addition to C2, intersectin contains several additional domains including: Eps15 homology domains, SH3 domains, a RhoGEF domain, and a PH domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking pro |
| >cd04026 C2_PKC_alpha_gamma C2 domain in Protein Kinase C (PKC) alpha and gamma | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.2e-12 Score=120.75 Aligned_cols=104 Identities=21% Similarity=0.249 Sum_probs=88.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
..+.++|.|.+| +|++.|..|..||||++.+.+...+..+++|++.++++||.|||+|.|. +........|.++|||
T Consensus 11 ~~~~l~v~i~~a~nL~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~wne~f~~~--~~~~~~~~~l~v~v~d 88 (131)
T cd04026 11 KDNKLTVEVREAKNLIPMDPNGLSDPYVKLKLIPDPKNETKQKTKTIKKTLNPVWNETFTFD--LKPADKDRRLSIEVWD 88 (131)
T ss_pred CCCEEEEEEEEeeCCCCcCCCCCCCCcEEEEEEcCCCCCceecceeecCCCCCCccceEEEe--CCchhcCCEEEEEEEE
Confidence 337899999999 9999999999999999999987766678899999999999999999998 6654455669999999
Q ss_pred CCCCCCCCcccccccCcccccccCCCC
Q 005415 343 NSDTRDGEVNGALHEGKADAEEHGVAT 369 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d~e~~~~ 369 (697)
++.+++++++|.++.+..+........
T Consensus 89 ~~~~~~~~~iG~~~~~l~~l~~~~~~~ 115 (131)
T cd04026 89 WDRTTRNDFMGSLSFGVSELIKMPVDG 115 (131)
T ss_pred CCCCCCcceeEEEEEeHHHhCcCccCc
Confidence 999999999999988766665443333
|
A single C2 domain is found in PKC alpha and gamma. The PKC family of serine/threonine kinases regulates apoptosis, proliferation, migration, motility, chemo-resistance, and differentiation. There are 3 groups: group 1(alpha, betaI, beta II, gamma) which require phospholipids and calcium, group 2 (delta, epsilon, theta, eta) which do not require calcium for activation, and group 3 (xi, iota/lambda) which are atypical and can be activated in the absence of diacylglycerol and calcium. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transd |
| >cd04037 C2E_Ferlin C2 domain fifth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.4e-12 Score=119.60 Aligned_cols=87 Identities=11% Similarity=-0.031 Sum_probs=72.1
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
++|.|.+| +|.++|..|.+||||++.+...+ .+.||.+.++|+||+|||+|.|. +.... ...|.++|||+|.+
T Consensus 2 lrV~Vi~a~~L~~~d~~g~~DPYv~v~~~~~~---~~~kT~~v~~t~nP~Wne~f~f~--~~~~~-~~~L~~~V~d~d~~ 75 (124)
T cd04037 2 VRVYVVRARNLQPKDPNGKSDPYLKIKLGKKK---INDRDNYIPNTLNPVFGKMFELE--ATLPG-NSILKISVMDYDLL 75 (124)
T ss_pred EEEEEEECcCCCCCCCCCCCCcEEEEEECCee---ccceeeEEECCCCCccceEEEEE--ecCCC-CCEEEEEEEECCCC
Confidence 78999999 99999999999999999995432 34667777889999999999997 43221 34599999999999
Q ss_pred CCCCcccccccCcc
Q 005415 347 RDGEVNGALHEGKA 360 (697)
Q Consensus 347 ~~~d~~G~v~~~~~ 360 (697)
++++++|++.....
T Consensus 76 ~~dd~iG~~~i~l~ 89 (124)
T cd04037 76 GSDDLIGETVIDLE 89 (124)
T ss_pred CCCceeEEEEEeec
Confidence 99999999977553
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04054 C2A_Rasal1_RasA4 C2 domain first repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.1e-12 Score=118.30 Aligned_cols=87 Identities=13% Similarity=0.024 Sum_probs=73.5
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
|+|.|.+| +|.++|.+|.+||||++.+. + ....||+++++|+||+|||.|.|. ++.. .+.|.+.|||.+.+
T Consensus 2 l~v~vi~a~~L~~~d~~g~~DPYv~v~~~--~--~~~~kT~v~~~t~nP~Wne~f~~~--~~~~--~~~l~v~v~d~~~~ 73 (121)
T cd04054 2 LYIRIVEGKNLPAKDITGSSDPYCIVKVD--N--EVIIRTATVWKTLNPFWGEEYTVH--LPPG--FHTVSFYVLDEDTL 73 (121)
T ss_pred EEEEEEEeeCCcCCCCCCCCCceEEEEEC--C--EeeeeeeeEcCCCCCcccceEEEe--eCCC--CCEEEEEEEECCCC
Confidence 78999999 99999999999999999983 2 224689999999999999999998 5432 34599999999999
Q ss_pred CCCCcccccccCcccc
Q 005415 347 RDGEVNGALHEGKADA 362 (697)
Q Consensus 347 ~~~d~~G~v~~~~~~~ 362 (697)
++++++|.+.++....
T Consensus 74 ~~d~~iG~~~~~~~~~ 89 (121)
T cd04054 74 SRDDVIGKVSLTREVI 89 (121)
T ss_pred CCCCEEEEEEEcHHHh
Confidence 9999999998875433
|
Rasal1 and RasA4 are both members of GAP1 (GTPase activating protein 1). Rasal1 responds to repetitive Ca2+ signals by associating with the plasma membrane and deactivating Ras. RasA4 suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both of these proteins contains two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. |
| >cd08681 C2_fungal_Inn1p-like C2 domain found in fungal Ingression 1 (Inn1) proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.8e-12 Score=117.60 Aligned_cols=88 Identities=13% Similarity=0.097 Sum_probs=72.6
Q ss_pred ceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeec-ccCCCcceecccccCccccccccccccccccccC
Q 005415 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
+.|+|.|.+| +|+++|..|.+||||++.+.. .+++|++. +.++||+|||+|.|. ++.. ....|.++|||+
T Consensus 1 g~L~V~v~~A~~L~~~~~~~~~dpyv~v~~~~-----~~~kT~~~~~~~~nP~Wne~f~f~--v~~~-~~~~l~i~v~d~ 72 (118)
T cd08681 1 GTLVVVVLKARNLPNKRKLDKQDPYCVLRIGG-----VTKKTKTDFRGGQHPEWDEELRFE--ITED-KKPILKVAVFDD 72 (118)
T ss_pred CEEEEEEEEccCCCCCCcCCCCCceEEEEECC-----CccccccccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeC
Confidence 4689999999 999999999999999999864 35567664 568999999999998 6654 234599999999
Q ss_pred CCCCCCCcccccccCcccc
Q 005415 344 SDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~~~~ 362 (697)
+..+ ++++|++.++..++
T Consensus 73 ~~~~-~~~iG~~~~~l~~~ 90 (118)
T cd08681 73 DKRK-PDLIGDTEVDLSPA 90 (118)
T ss_pred CCCC-CcceEEEEEecHHH
Confidence 9877 89999998865544
|
Saccharomyces cerevisiae Inn1 associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. The C2 domain of Inn1, located at the N-terminus, is required for ingression of the plasma membrane. The C-terminus is relatively unstructured and contains eight PXXP motifs that are thought to mediate interaction of Inn1 with other proteins with SH3 domains in the cytokinesis proteins Hof1 (an F-BAR protein) and Cyk3 (whose overexpression can restore primary septum formation in Inn1Delta cells) as well as recruiting Inn1 to the bud-neck by binding to Cyk3. Inn1 and Cyk3 appear to cooperate in activating chitin synthase Chs2 for primary septum formation, which allows coordination of actomyosin ring contraction with ingression of the cleavage furrow. It is thought that the C2 domain of Inn1 helps to preserve the link between the actomyosin ring and the plasma membrane, contr |
| >cd04011 C2B_Ferlin C2 domain second repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-12 Score=116.12 Aligned_cols=90 Identities=13% Similarity=0.017 Sum_probs=74.5
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccccCC
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEIDNS 344 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~D~d 344 (697)
.++|.|.+| +|. +|..||||++.+.. .++||+++++|+||.|||+|.|....+...+ +..|.++|||.+
T Consensus 5 ~l~V~v~~a~~L~----~~~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~~~~~~~~l~~~~l~i~V~d~~ 75 (111)
T cd04011 5 QVRVRVIEARQLV----GGNIDPVVKVEVGG-----QKKYTSVKKGTNCPFYNEYFFFNFHESPDELFDKIIKISVYDSR 75 (111)
T ss_pred EEEEEEEEcccCC----CCCCCCEEEEEECC-----EeeeeeEEeccCCCccccEEEEecCCCHHHHhcCeEEEEEEcCc
Confidence 578999999 998 78899999999972 3568999999999999999999843444444 455999999999
Q ss_pred CCCCCCcccccccCccccccc
Q 005415 345 DTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 345 ~~~~~d~~G~v~~~~~~~d~e 365 (697)
.+++++++|++.+...+....
T Consensus 76 ~~~~~~~iG~~~i~l~~v~~~ 96 (111)
T cd04011 76 SLRSDTLIGSFKLDVGTVYDQ 96 (111)
T ss_pred ccccCCccEEEEECCccccCC
Confidence 999999999999887665443
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd04017 C2D_Ferlin C2 domain fourth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.5e-12 Score=119.54 Aligned_cols=86 Identities=14% Similarity=0.038 Sum_probs=71.4
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcc-cc--cccc---ccccccc
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-LH--FKGA---EKDLMPA 339 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~-v~--~~~~---~~~L~~~ 339 (697)
+|+|.|.+| +|.++|.+|.+|||||+.+. ..++||+++++|+||+|||+|.|... +. .+.. ...|.++
T Consensus 2 ~l~v~V~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~v~~~t~nP~Wne~~~f~~~~~~~~~~~~~~~~~~l~v~ 76 (135)
T cd04017 2 QLRAYIYQARDLLAADKSGLSDPFARVSFL-----NQSQETEVIKETLSPTWDQTLIFDEVELYGSPEEIAQNPPLVVVE 76 (135)
T ss_pred EEEEEEEEeecCcCCCCCCCCCCEEEEEEC-----CeeeEeeeEcCCCCCccCcEEEEeeeeccCChHHhhcCCCEEEEE
Confidence 578999999 99999999999999999985 24778999999999999999999721 11 1111 2348899
Q ss_pred cccCCCCCCCCccccccc
Q 005415 340 EIDNSDTRDGEVNGALHE 357 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~ 357 (697)
|||+|.+++++++|++..
T Consensus 77 V~d~d~~~~d~~iG~~~i 94 (135)
T cd04017 77 LFDQDSVGKDEFLGRSVA 94 (135)
T ss_pred EEeCcCCCCCccceEEEe
Confidence 999999999999999975
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd04024 C2A_Synaptotagmin-like C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.8e-12 Score=118.18 Aligned_cols=90 Identities=10% Similarity=-0.027 Sum_probs=76.6
Q ss_pred ceeEEEEecc-CcccccC--CCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 266 DYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~--~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
+.|+|.|.+| +|.++|. .|.+||||++++- ..+.+|++.++|+||.|||+|.|. +.. .....|.++|||
T Consensus 1 g~l~v~v~~a~~L~~~~~~~~~~~dPyv~v~~~-----~~~~kT~~~~~t~~P~Wne~f~~~--~~~-~~~~~l~i~v~d 72 (128)
T cd04024 1 GVLRVHVVEAKDLAAKDRSGKGKSDPYAILSVG-----AQRFKTQTIPNTLNPKWNYWCEFP--IFS-AQNQLLKLILWD 72 (128)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCcCCeEEEEEC-----CEEEecceecCCcCCccCCcEEEE--ecC-CCCCEEEEEEEE
Confidence 4688999999 9999999 8999999999983 246789999999999999999998 554 234569999999
Q ss_pred CCCCCCCCcccccccCccccc
Q 005415 343 NSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d 363 (697)
++.+++++++|.+.+...+..
T Consensus 73 ~~~~~~~~~lG~~~i~l~~~~ 93 (128)
T cd04024 73 KDRFAGKDYLGEFDIALEEVF 93 (128)
T ss_pred CCCCCCCCcceEEEEEHHHhh
Confidence 999999999999988765554
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permu |
| >cd08678 C2_C21orf25-like C2 domain found in the Human chromosome 21 open reading frame 25 (C21orf25) protein | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.3e-12 Score=118.09 Aligned_cols=87 Identities=17% Similarity=0.114 Sum_probs=72.5
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
|.|.|.+| ||++ .+|.+||||++++. ....+++|+++++|+||+|||+|.|. +... ...|.+.|||++..
T Consensus 1 l~v~v~~A~~L~~--~~g~~dpyv~v~~~---~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~~~~ 71 (126)
T cd08678 1 LLVKNIKANGLSE--AAGSSNPYCVLEMD---EPPQKYQSSTQKNTSNPFWDEHFLFE--LSPN--SKELLFEVYDNGKK 71 (126)
T ss_pred CEEEEEEecCCCC--CCCCcCCEEEEEEC---CCCcEEEeEEEecCCCCccCceEEEE--eCCC--CCEEEEEEEECCCC
Confidence 57889999 9998 78999999999984 12346899999999999999999998 6432 34599999999999
Q ss_pred CCCCcccccccCccccc
Q 005415 347 RDGEVNGALHEGKADAE 363 (697)
Q Consensus 347 ~~~d~~G~v~~~~~~~d 363 (697)
++++++|.+.....++.
T Consensus 72 ~~~~~lG~~~i~l~~l~ 88 (126)
T cd08678 72 SDSKFLGLAIVPFDELR 88 (126)
T ss_pred CCCceEEEEEEeHHHhc
Confidence 99999999988655444
|
The members in this cd are named after the Human C21orf25 which contains a single C2 domain. Several other members contain a C1 domain downstream of the C2 domain. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 697 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-43 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-43 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-42 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-42 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-42 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-42 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-34 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-34 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-33 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-33 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-30 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-28 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-28 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-28 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-28 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-27 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-27 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-27 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-27 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-27 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-26 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-26 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-26 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-26 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-26 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-26 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-26 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-26 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-26 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-26 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-26 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-26 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-26 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-26 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-26 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-26 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-26 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-26 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-26 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-26 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-26 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-26 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-26 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-26 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-26 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-26 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-26 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-26 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-26 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-26 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-26 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-26 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-26 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-26 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-25 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-25 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-25 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-25 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-25 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-25 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-25 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-25 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-25 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-25 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-25 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-25 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-24 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-24 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-24 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-24 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-24 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-24 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-23 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-23 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-23 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-23 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-23 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-23 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-23 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-23 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-23 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-23 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-23 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-23 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-23 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-23 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-23 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-23 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-23 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-23 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-23 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-22 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-22 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-22 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-22 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-22 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-22 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-22 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-22 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-22 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-22 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-22 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-22 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-22 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-22 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-22 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-22 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-22 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-22 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-22 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-22 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-22 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-22 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-22 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-22 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-22 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-22 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-22 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-22 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-22 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-22 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-22 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-22 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-21 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-21 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-21 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-21 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-21 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-21 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-21 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-20 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-13 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-13 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-13 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-13 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-13 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-13 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-13 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-13 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-13 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 5e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 6e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-123
Identities = 106/285 (37%), Positives = 158/285 (55%), Gaps = 11/285 (3%)
Query: 385 FHLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG 439
F H+K R + ++N D + RY + +G +F +V +A D
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ 79
Query: 440 VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499
V +KIIKN K F +Q+ E++LL+L+NK+D +++I+ L +F HL +V E+L
Sbjct: 80 EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 500 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSY 557
NLY+ + G +L + +Q AL +L + L IIHCDLKPENIL+ +
Sbjct: 140 YNLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617
+R IKI+D GSSC + Y+QSR YR+PEV++G+PYD ID+WSLGCIL E+ TGE
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY 662
LF V + +I+ +LG +L Q + K+F K D +
Sbjct: 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTW 300
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-123
Identities = 99/273 (36%), Positives = 151/273 (55%), Gaps = 5/273 (1%)
Query: 393 KNRTGF-EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 451
N G+ ++ + + +A RY V + +G +F +V +A D V LK+++N+K
Sbjct: 75 PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK 134
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQE 511
F Q+ +EI++L+ + K D + +++ + + F H+ + ELL NLYE K N+
Sbjct: 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF 194
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571
G F+L ++ L+ L+ LH IIHCDLKPENIL+K R IK+ID GSSC
Sbjct: 195 QG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
++ + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P + LA
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYIN 664
+I +LG ++L + + + + Y
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-114
Identities = 81/312 (25%), Positives = 138/312 (44%), Gaps = 35/312 (11%)
Query: 386 HLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV 440
H H R +E ++ + V +G F +V Q +
Sbjct: 2 HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK 61
Query: 441 DVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 500
+K+++N K + + E +LK + +D + ++I++ + F + +H+ ++ E L
Sbjct: 62 YYAVKVVRNIKKYTRSAKIEADILKKIQNDDI-NNNNIVKYHGKFMYYDHMCLIFEPLGP 120
Query: 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---- 556
+LYE N +G F + +++ + L+AL YL + + H DLKPENIL+
Sbjct: 121 SLYEIITRNNYNG----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176
Query: 557 -------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
+ IK+ID G + F++D + +R YRAPEVI+ L +
Sbjct: 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW 236
Query: 598 DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ--EIYKYFT 655
D D+WS GC+LAEL+TG +LF + LA + ++ PI ML + KY
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN 296
Query: 656 KEYDLYYINEVC 667
K+ E
Sbjct: 297 KDELKLAWPENA 308
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-113
Identities = 86/276 (31%), Positives = 141/276 (51%), Gaps = 23/276 (8%)
Query: 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLD 459
+ L V++ RY + + LG AF KV + D G V +KI+KN + + +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 460 EIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
EI++L+ +N DP +++ ++F H H+ IV ELL + Y+F K N F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP----FR 116
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEI 562
L ++ + Q +++ +LHS + H DLKPENIL ++ +I
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
K++D GS+ + ++ V +R YRAPEVI+ L + Q D+WS+GCIL E + G +FP
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY 658
LA + +LGP+ M+ + ++ KYF +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRK-RKYFHHDR 271
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-113
Identities = 87/284 (30%), Positives = 132/284 (46%), Gaps = 23/284 (8%)
Query: 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSL 458
+ L + + RY + LG F KV + D G V LKII+N + + +
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR 64
Query: 459 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
EI +LK + + D ++ + + D+F H+ I ELL N +EF K N +
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP----Y 120
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCE 561
L ++ + Q AL +LH + H DLKPENIL KS +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 562 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I++ D GS+ F ++ V +R YR PEVI+ L + Q D+WS+GCIL E + G LF
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
L + +LGPI M+ + ++ KYF K ++ N
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRK-QKYFYKGGLVWDENS 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-105
Identities = 94/274 (34%), Positives = 146/274 (53%), Gaps = 24/274 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKLL+ VN D
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 472 PADE-----HHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
E +HIL+L D+F H H+ +V E+L NL K + G L
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG----IPLIY 132
Query: 523 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCE----IKIIDLGSSCFQTDNL 577
++ I++Q L L+Y+H GIIH D+KPEN+L++ E IKI DLG++C+ ++
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI------LAR 631
+Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D +A+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
II +LG + +L G+ +F L I++
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 286
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 9e-62
Identities = 89/323 (27%), Positives = 155/323 (47%), Gaps = 64/323 (19%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
+ + + GRY+V LG FS V+ + D+ V +K++K+ + + + +LDEI+L
Sbjct: 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRL 86
Query: 464 LKLVNKNDPADE--HHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAY 517
LK V +DP D +++L D F H+ +V E+L +L ++ + G
Sbjct: 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG---- 142
Query: 518 FTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILI---------------------- 554
L ++ I +Q L+ L+YLH+ IIH D+KPENIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 555 -------------------------KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
K+ ++ ++KI DLG++C+ + +Q+R YR+
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFP------NDAVVMILARIIGMLGPIDLEM 643
EV+IG Y+ D+WS C+ EL TG+ LF +A II +LG + ++
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 644 LMQGQEIYKYFTKEYDLYYINEV 666
++ G+ ++FTK+ DL +I ++
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKL 345
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 71/234 (30%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F E+++++ ++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------ 105
Query: 475 EH-HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+RL +FY +L +V + + +Y + + + +++
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYM 162
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS + + Y+ SR
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
YRAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 70/234 (29%), Positives = 119/234 (50%), Gaps = 24/234 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + +G+ +F VFQA+ + + +V +K + DK F E++++++V
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF---KNRELQIMRIVK------ 90
Query: 475 EH-HILRLYDYFYHLEH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +++ L +FY L +V E + +Y + + + +++
Sbjct: 91 -HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYM 147
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 585
Q L +L Y+HS+GI H D+KP+N+L+ +K+ID GS + Y+ SR
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 586 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
YRAPE+I G Y ID+WS GC++AEL G+ LFP ++ + L II +LG
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 78/247 (31%), Positives = 121/247 (48%), Gaps = 33/247 (13%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY +GS A+ V A D TG+ V +K + F + E++LLK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLK 83
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F +++V L+ A+L K +
Sbjct: 84 HMKHEN-------VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------L 129
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
T +Q + Q L L+Y+HS IIH DLKP N+ + CE+KI+D G + D +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTADEMT 187
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 638 PIDLEML 644
E+L
Sbjct: 248 TPGAELL 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 39/257 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 82
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEAYFT 519
KN I+ L + F + ++IV EL+ ANL + + + E
Sbjct: 83 HKN-------IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------- 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNL 577
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 128 --RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMM 183
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 638 PIDLEMLMQGQEIYKYF 654
E + + Q + +
Sbjct: 244 TPCPEFMKKLQPTVRTY 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 72/249 (28%), Positives = 122/249 (48%), Gaps = 38/249 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y ++GS A+ V A D +G V +K + F + E+ LLK
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLK 78
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEA 516
+ +N ++ L D F + ++V ++ +L + KF++E
Sbjct: 79 HMQHEN-------VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE----- 126
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 576
++Q + Q L+ L+Y+HS G++H DLKP N+ + CE+KI+D G +
Sbjct: 127 -----KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 179
Query: 577 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635
+ YV +R YRAPEVI+ Y+Q +D+WS+GCI+AE+ TG+ LF + L +I+ +
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 636 LGPIDLEML 644
G E +
Sbjct: 240 TGVPGTEFV 248
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
R+ V G F V ++ TG+ V +K + D F ++ L ++ L ++
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------- 76
Query: 475 EHH--ILRLYDYFYHLEH-------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
HH I++L YFY L L +V E + L+ + ++V
Sbjct: 77 -HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA--PPPILIKV 133
Query: 526 ITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYV 581
Q + ++ LH S+ + H D+KP N+L+ + +K+ D GS ++ Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 582 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
SR YRAPE+I G Y +D+WS+GCI AE+ GE +F D L I+ +LG
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 74/247 (29%), Positives = 115/247 (46%), Gaps = 33/247 (13%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +GS A+ V A D TG V +K + F L E++LLK
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLK 79
Query: 466 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
+ +N ++ L D F ++V + +L + K +
Sbjct: 80 HMRHEN-------VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------L 125
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
R+Q + Q L+ L Y+H+ GIIH DLKP N+ + CE+KI+D G + +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMT 183
Query: 579 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPEVI+ Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 638 PIDLEML 644
E +
Sbjct: 244 TPPAEFV 250
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 61/267 (22%), Positives = 106/267 (39%), Gaps = 36/267 (13%)
Query: 394 NRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKD 452
N GF+ + RY + LG VF A D V +K I+ D
Sbjct: 3 NIHGFD------------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ 50
Query: 453 FFDQSLDEIKLLKLVN-KN-------DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 504
+L EIK+++ ++ N + L ++IV E + +L
Sbjct: 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564
+ ++ Q L L+Y+HS ++H DLKP N+ I + + +KI
Sbjct: 111 VLEQGP-------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVLKI 162
Query: 565 IDLG------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 617
D G +L + ++ YR+P +++ Y + ID+W+ GCI AE+ TG+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 618 VLFPNDAVVMILARIIGMLGPIDLEML 644
LF + + I+ + + E
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDR 249
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 1e-42
Identities = 76/245 (31%), Positives = 119/245 (48%), Gaps = 35/245 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 468
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 119
Query: 469 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
KN I+ L + F + +++V EL+ ANL + +
Sbjct: 120 HKN-------IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTP 222
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 640 DLEML 644
E +
Sbjct: 283 CPEFM 287
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 55/270 (20%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ +Y + + LG+ +F V + D+ +G LK + D + E+ ++K+++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD-- 58
Query: 471 DPADEH-HILRLYDYFYHLEH--------------------------------------L 491
H +I++L DYFY L
Sbjct: 59 -----HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551
++ E + L++ K SG + + + Q A+ ++HSLGI H D+KP+N
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRS--IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 552 ILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+L+ S + +K+ D GS ++ Y+ SR YRAPE+++G Y IDLWS+GC
Sbjct: 172 LLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 609 ILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+ EL G+ LF + + L RII ++G
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGT 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 64/254 (25%), Positives = 105/254 (41%), Gaps = 36/254 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------FDQSLD------ 459
+ Y V ++ S ++ V D G+ V +K + N S
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 460 EIKLLKLVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESG 513
EI+LL + N IL L D F + L++V EL+R +L + +
Sbjct: 79 EIRLLNHFHHPN-------ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 571
+ +Q L L LH G++H DL P NIL+ +I I D
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFNLARED 184
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
N YV R YRAPE+++ + + +D+WS GC++AE++ + LF L
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 631 RIIGMLGPIDLEML 644
+I+ ++G +E +
Sbjct: 245 KIVEVVGTPKIEDV 258
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 39/252 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ RY Y+G A+ V A D V V +K I F+ EIK+L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILL 80
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ + D ++ ++IV +L+ +LY+ K +
Sbjct: 81 RFRHEN-------IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------LS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQ 573
+ Q L L+Y+HS ++H DLKP N+L+ + C++KI D G
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDH 184
Query: 574 TDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
T L YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 633 IGMLGPIDLEML 644
+G+LG E L
Sbjct: 245 LGILGSPSQEDL 256
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 466
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 522
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 83 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 128
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 581
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 185
Query: 582 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 627 M-ILARIIGMLGPIDL 641
+ L II I+
Sbjct: 246 ISKLHAIIDPNHEIEF 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ VF+ ++ TG V +K +D +L EI++LK +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--- 60
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + F L +V E + Q ++ IT Q
Sbjct: 61 ----HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQT 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
L+A+ + H IH D+KPENILI IK+ D G +D V +R YR
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
+PE+++G Y +D+W++GC+ AEL +G L+P + V L I LG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 46/252 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I+ + + LG A+ V A TG V +K I+ FD+ L EIK+LK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILK 64
Query: 466 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N I+ +++ + ++I+ EL++ +L+ +
Sbjct: 65 HFKHEN-------IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-------LS 110
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
+Q Q L A++ LH +IH DLKP N+LI S C++K+ D G
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAAD 168
Query: 569 --SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAV 625
Q + +V +R YRAPEV++ Y + +D+WS GCILAEL+ +FP
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 626 VMILARIIGMLG 637
L I G++G
Sbjct: 229 RHQLLLIFGIIG 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 24/239 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ + + P
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENL-RGGP-- 91
Query: 475 EHHILRLYDYFY---HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ L D + + + + + T ++ + L
Sbjct: 92 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEIL 140
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 589
+AL+Y HS+GI+H D+KP N++I + ++++ID G + F V SR ++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 590 EVIIGLP-YDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646
E+++ YD +D+WSLGC+LA + E F L RI +LG DL +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 38/244 (15%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 66 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 105
Query: 520 L---GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 106 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 163
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 629 LARI 632
RI
Sbjct: 224 YLRI 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 466
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 522
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 64 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 109
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 581
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 166
Query: 582 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 626
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 627 M-ILARIIGMLGPIDL 641
+ L II I+
Sbjct: 227 ISKLHAIIDPNHEIEF 242
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 38/244 (15%)
Query: 405 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 460
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 461 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
I + + + H H++ + +F + +F+V EL
Sbjct: 92 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 131
Query: 520 L---GRL-----QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 570
L + RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 189
Query: 571 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249
Query: 629 LARI 632
RI
Sbjct: 250 YLRI 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 46/258 (17%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLL 464
+V Y + + +GS SKVFQ + +K + + + D +EI L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYL 108
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTL 520
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 109 NKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--------- 155
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 156 -ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 211
Query: 580 YVQSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDA 624
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 625 VVM-ILARIIGMLGPIDL 641
+ L II I+
Sbjct: 272 NQISKLHAIIDPNHEIEF 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 471
+Y +G ++ V + ++ TG V +K D ++ EIKLLK +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--- 82
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +++ L + + ++V E + + + + +Q Q
Sbjct: 83 ----HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQI 133
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 587
+ + + HS IIH D+KPENIL+ +K+ D G + + V +R YR
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
APE+++G Y + +D+W++GC++ E++ GE LFP D+ + L I+ LG
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 33/225 (14%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
Y + LG FS V + LH G LK I +++ +++ E + +L N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----- 84
Query: 474 DEH-HILRLYDYFYHLE----HLFIVCEL-LRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +ILRL Y +++ R L+ + ++ G + T ++ +
Sbjct: 85 --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLL 140
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--- 584
LE +H+ G H DLKP NIL+ + ++DLGS ++ Q+
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 585 ---------SYRAPEVIIGLPY---DQKIDLWSLGCILAELWTGE 617
SYRAPE+ + D++ D+WSLGC+L + GE
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 35/255 (13%), Positives = 73/255 (28%), Gaps = 30/255 (11%)
Query: 414 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVN 468
R E L S VF +D+ D LK+ +N + ++ + +
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 469 KNDPADEHHILRLYDYF--------------------YHLEHLFIVCELLRANLYEFQK- 507
P + RL Y + + ++ +L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 508 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567
+ + L ++T Q + L S G++H P+N+ I + + D+
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 568 GSSCFQTDNLCLYVQSRSYRAPEVI--IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
+ +Y E + + ++ W LG + +W + F
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 626 VMILARIIGMLGPID 640
+ + L
Sbjct: 299 GIKGSWKRPSLRVPG 313
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + + LK++ + Q E+++ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-- 523
H +ILRLY YF+ ++++ E G Y L +
Sbjct: 68 ------HPNILRLYGYFHDATRVYLILEYA-------------PLGTVYRELQKLSKFDE 108
Query: 524 ---QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ AL Y HS +IH D+KPEN+L+ S E+KI D G S +
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTD 166
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
LC + Y PE+I G +D+K+DLWSLG + E G+ F + RI
Sbjct: 167 LC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 50/266 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ +Y + + LG A+ V+++ D TG V +K I + F S D EI +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILT 63
Query: 466 LVNKNDPADEHHILRLYDYFY--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
++ ++ +I+ L + + +++V + + +L+ + N
Sbjct: 64 ELSGHE-----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-------LEPVHK 111
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------------- 568
Q + Q ++ ++YLHS G++H D+KP NIL+ + C +K+ D G
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 569 ---------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 618
+ L YV +R YRAPE+++G Y + ID+WSLGCIL E+ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 619 LFPNDAVVMILARIIGMLGPIDLEML 644
+FP + + L RIIG++ E +
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDV 255
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 61/233 (26%), Positives = 90/233 (38%), Gaps = 34/233 (14%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
Y + LG F VF L + V +K+I ++ L E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYF 518
LL V H ++RL D+F E +V E + Y
Sbjct: 86 ALLWKVGA---GGGHPGVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYI 130
Query: 519 TL-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
T G L Q + A+++ HS G++H D+K ENILI +R K+ID GS
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGAL 189
Query: 573 QTDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPND 623
D + +R Y PE I Y +WSLG +L ++ G++ F D
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 57/252 (22%), Positives = 99/252 (39%), Gaps = 33/252 (13%)
Query: 400 ENKDLPIILNTVIAG--RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS 457
E D + VI G + + LG A + + + DV +K I + F +
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFA 64
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF--QKFNQESGG 514
E++LL+ DEH +++R + + +I EL A L E+ QK G
Sbjct: 65 DREVQLLRES------DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL 118
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSC 571
E + +Q L +LHSL I+H DLKP NILI + + + I D G
Sbjct: 119 EP-------ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 572 FQTDNLCLYVQ------SRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPN 622
+ + + + APE++ +D++S GC+ + +
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 623 DAVVMILARIIG 634
++ ++G
Sbjct: 232 KSLQRQANILLG 243
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 461
+ +Y V LGS F V+ + + V +K ++ D+ L E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 462 KLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFT 519
LLK V+ ++RL D+F + ++ E E + + T
Sbjct: 98 VLLKKVSSGFS----GVIRLLDWFERPDSFVLILERP------------EPVQDLFDFIT 141
Query: 520 L-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573
G LQ Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALL 200
Query: 574 TDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPND 623
D + + +R Y PE I Y + +WSLG +L ++ G++ F +D
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 36/232 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ + LG + V Q G V +K + DF D +L EIKLL
Sbjct: 13 LKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTES---- 65
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
D+H +++R Y L+I EL NL + + N + RQ
Sbjct: 66 --DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-----------YQRCEIKIIDLGSSCFQTDNLC 578
+ +LHSL IIH DLKP+NIL+ + + I I D G
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 579 LYVQSRS-------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG 616
+ + + +RAPE++ + ID++S+GC+ + +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-37
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 39/244 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
R V L F+ V++AQD+ +G + LK + N+++ + E+ +K ++ +
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 474 DEHHILRLYDYFYHLEH--------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
+I++ + ++ EL + L + + + +
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL--VEFLKKMESRG-PLSCDTVLK 140
Query: 526 ITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
I Q A++++H IIH DLK EN+L+ + IK+ D GS+ + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 584 R---------------SYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
+ YR PE+I P +K D+W+LGCIL L + F + A
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 626 VMIL 629
+ I+
Sbjct: 259 LRIV 262
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 70/230 (30%), Positives = 114/230 (49%), Gaps = 16/230 (6%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
++ E LG+ ++ V++ + TGV V LK +K D + ++ EI L+K +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK---- 61
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+RLYD + L +V E + +L ++ L ++ Q L
Sbjct: 62 ---HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
+ L + H I+H DLKP+N+LI R ++K+ D G + + + V + YRA
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
P+V++G Y ID+WS GCILAE+ TG+ LFP L I ++G
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 42/237 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ + LG F V+ A++ + LK++ + Q EI++ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H +ILR+Y+YF+ + ++++ E GE Y L GR
Sbjct: 73 ------HPNILRMYNYFHDRKRIYLMLEFA-------------PRGELYKELQKHGRFDE 113
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 576
+ +AL Y H +IH D+KPEN+L+ + E+KI D G S
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRT 171
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+C + Y PE+I G +D+K+DLW G + E G F + + RI+
Sbjct: 172 MC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-37
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 21/236 (8%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
T G + + E LG+ F V + TG V +K + + ++ EI+++K +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 468 NKNDPADEH-HILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTL 520
N H +++ + L+ L + E + +K+ +
Sbjct: 70 N-------HPNVVSAREVPDGLQKLAPNDLPLLAMEY--CEGGDLRKYLNQFENCCGLKE 120
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCL 579
G ++ + AL YLH IIH DLKPENI+++ QR KIIDLG +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 580 --YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+V + Y APE++ Y +D WS G + E TG F + + +
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
+ V LG +F+ V++A+ +HTG++V +K+I + +E+K+ +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H IL LY+YF ++++V E+ E ++ + F+ +
Sbjct: 70 ------HPSILELYNYFEDSNYVYLVLEMCHNG--EMNRYLKNRVK--PFSENEARHFMH 119
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQ--SRS 585
Q + + YLHS GI+H DL N+L+ IKI D G ++ + + Y + +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
Y +PE+ + + D+WSLGC+ L G F D V L ++
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 36/229 (15%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 467
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 468 NKNDPADEH-HILRLYDYF--YHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 577
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 578 CLYVQ--SRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTG 616
+ Y P++ Y +DLWS+G TG
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
I + E LGS AFS+VF + TG LK IK F D SL +EI +LK +
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-- 64
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLG 521
H +I+ L D + H ++V +L+ SGGE +T
Sbjct: 65 -----HENIVTLEDIYESTTHYYLVMQLV-------------SGGELFDRILERGVYTEK 106
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCL 579
++ +Q L A++YLH GI+H DLKPEN+L + + +I I D G S Q +
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV+ PY + +D WS+G I
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 24/237 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ----SLDEIKLLKLVN 468
RY +G A+ V++A+D H+G V LK ++ N ++ E+ LL+ +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 469 KNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+ H +++RL D + +V E + +L + +
Sbjct: 70 AFE----HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAET 121
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--Y 580
++ + RQ L L++LH+ I+H DLKPENIL+ S +K+ D G + + + L
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMALTPV 179
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 39/255 (15%), Positives = 79/255 (30%), Gaps = 40/255 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK--------LLKL 466
LG +A D TG + + + ++ ++K L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------LYEFQKFNQESGGEAY 517
N+ + +D + ++ L LY + N ++ GE
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 518 FTLGRLQ---------VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ +T Q + L LH G++H L+P +I++ R + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ--RGGVFLTGFE 251
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVII-----------GLPYDQKIDLWSLGCILAELWTGE 617
+ + SR + PE+ D W+LG ++ +W +
Sbjct: 252 HLV-RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 618 VLFPNDAVVMILARI 632
+ DA + I
Sbjct: 311 LPITKDAALGGSEWI 325
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 65/261 (24%), Positives = 99/261 (37%), Gaps = 57/261 (21%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
+ A + LG AF +V +A++ +K I++ ++ L E+ LL +N
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 469 KNDPADEH-HILRLYDYFYHLEH-------------LFIVCEL-----LRANLYEFQKFN 509
H +++R Y + + LFI E L ++
Sbjct: 61 -------HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
Q + RQ LEAL Y+HS GIIH DLKP NI I +KI D G
Sbjct: 114 QRD---------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGL 162
Query: 570 SCFQTDNLCLYVQSRS-----------------YRAPEVIIGLP-YDQKIDLWSLGCILA 611
+ +L + Y A EV+ G Y++KID++SLG I
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 612 ELWTGEVLFPNDAVVMILARI 632
E+ V IL ++
Sbjct: 223 EMIYP--FSTGMERVNILKKL 241
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-35
Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 36/229 (15%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 467
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 468 NKNDPADEH-HILRLYDYFYHL--EHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 577
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 578 CL--YVQSRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTG 616
+ Y P++ Y +DLWS+G TG
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 21/230 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 472
Y + LG ++ V++ + T V LK I+ + + ++ E+ LLK +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK---- 58
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H +I+ L+D + + L +V E L +L ++ + +++ Q L
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 588
L Y H ++H DLKP+N+LI R E+K+ D G + ++ Y V + YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 36/253 (14%)
Query: 398 FEENKDLPIILN----TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIK 448
FE LP I + + YV LG AF++V++A D LK+ K
Sbjct: 45 FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYE 504
+ + +L+ + P+ +H ++ Y +V EL N
Sbjct: 105 PANPW-----EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 505 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--- 561
K E G + + L +E +H IIH D+KP+N ++ + +
Sbjct: 160 LYKNTPEKV----MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 562 ------IKIIDLGSSCF-----QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ +IDLG S + ++ ++ E++ P++ +ID + + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 611 AELWTGEVLFPND 623
+ G + +
Sbjct: 276 YCMLFGTYMKVKN 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 36/230 (15%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 466
++ + E +GS F +VF+A+ G +K +K + + ++ E+K L
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAK 60
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH----------------LFIVCELL-RANLYEFQKF 508
++ H +I+ + ++ LFI E + L ++ +
Sbjct: 61 LD-------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + Q + ++Y+HS +I+ DLKP NI + + ++KI D G
Sbjct: 114 RRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFG 167
Query: 569 SSCF--QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+ Y +PE I Y +++DL++LG ILAEL
Sbjct: 168 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 22/217 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ LG ++ +VF+ + G +K KD + L E+ + V ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 529
+RL + L++ EL +L + + + ++ R
Sbjct: 117 P-----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA------SLPEAQVWGYLRD 165
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYR 587
L AL +LHS G++H D+KP NI + R K+ D G VQ Y
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
APE++ G Y D++SLG + E+ L
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 41/237 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G Y + + +G F+KV A+ + TG +V +KII DK + + E++++K++N
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILN 72
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ 524
H +I++L++ + L+++ E SGGE + L GR++
Sbjct: 73 -------HPNIVKLFEVIETEKTLYLIMEYA-------------SGGEVFDYLVAHGRMK 112
Query: 525 -----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--L 577
RQ + A++Y H I+H DLK EN+L+ + IKI D G S T L
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKL 170
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ + Y APE+ G YD ++D+WSLG IL L +G + F + + R++
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG +FS + + +KII K + EI LKL +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLC------EG 64
Query: 476 H-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVI 526
H +I++L++ F+ H F+V ELL GGE +F+ I
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLN-------------GGELFERIKKKKHFSETEASYI 111
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCLY--VQ 582
R+ + A+ ++H +G++H DLKPEN+L EIKIID G + DN L
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APE++ YD+ DLWSLG IL
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 58/234 (24%), Positives = 111/234 (47%), Gaps = 24/234 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
RY LG + +V++A D T V +K I+ ++++ ++ E+ LLK +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--- 91
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L +H L ++ E +L ++ N + ++ ++ Q
Sbjct: 92 ----HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQL 141
Query: 531 LEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
+ + + HS +H DLKP+N+L+ + + +KI D G + + + + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YR PE+++G Y +D+WS+ CI AE+ LFP D+ + L +I +LG
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-35
Identities = 72/246 (29%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ RY LG +F +V +D TG + +K+I K + L E++LLK +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
D +I++LY++F + ++V E+ +GGE F+
Sbjct: 84 ------DHPNIMKLYEFFEDKGYFYLVGEVY-------------TGGELFDEIISRKRFS 124
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
I RQ L + Y+H I+H DLKPEN+L++S + I+IID G S +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ + + Y APEV+ G YD+K D+WS G IL L +G F IL ++
Sbjct: 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EK 241
Query: 637 GPIDLE 642
G E
Sbjct: 242 GKYTFE 247
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 52/228 (22%), Positives = 103/228 (45%), Gaps = 23/228 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+Y + +G +F K + G +K I + K+ ++S E+ +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-- 81
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ + F L+IV + +L F++ N + G F ++
Sbjct: 82 -----HPNIVQYRESFEENGSLYIVMDYCEGGDL--FKRINAQKGV--LFQEDQILDWFV 132
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 585
Q AL+++H I+H D+K +NI + +++ D G + + + +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPY 190
Query: 586 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE+ PY+ K D+W+LGC+L EL T + F ++ ++ +II
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 38/246 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
++ Y + LGS A+ +V +D T V+ +KII + L+E+ +LKL++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I++LYD+F + ++V E GGE F
Sbjct: 95 -------HPNIMKLYDFFEDKRNYYLVMECY-------------KGGELFDEIIHRMKFN 134
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 576
VI +Q L + YLH I+H DLKPEN+L++S + IKI+D G S
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
+ + + Y APEV+ YD+K D+WS+G IL L G F IL ++
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EK 251
Query: 637 GPIDLE 642
G +
Sbjct: 252 GKYTFD 257
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 390 IHRKNRTGFEENKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIK 448
H + +G E P + Y ++ + LG KV + TG LK++
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63
Query: 449 NDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLY 503
+ E+ + HI+ + D + + L I+ E +
Sbjct: 64 DSPKARQ----EVDHHWQASG------GPHIVCILDVYENMHHGKRCLLIIMECME---- 109
Query: 504 EFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553
GGE FT I R A+++LHS I H D+KPEN+L
Sbjct: 110 ---------GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 554 IKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
S + +K+ D G + + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 65/259 (25%), Positives = 102/259 (39%), Gaps = 67/259 (25%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
+ Y + +G ++ V+ A D +T +V +K + F+ +D EI +L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILN 80
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+ +I+RLYD + L+IV E+ ++L + K + T
Sbjct: 81 RLK-------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI------FLT 127
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ I L ++H GIIH DLKP N L+ C +K+ D G
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSVKVCDFGLARTINSEKDT 185
Query: 569 --------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 613
+ L +V +R YRAPE+I+ Y + ID+WS GCI AEL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 614 WTGEV-----------LFP 621
LFP
Sbjct: 246 LNMLQSHINDPTNRFPLFP 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 42/237 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
+G +F +V + +D TG +K + ++E+ ++ I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLS-------SPRI 112
Query: 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAY--FTLGRLQVITRQC 530
+ LY + I ELL GG + R Q
Sbjct: 113 VPLYGAVREGPWVNIFMELL-------------EGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS---- 585
LE LEYLH+ I+H D+K +N+L+ S + D G + C Q D L + +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ APEV++G P D K+D+WS C++ + G + + +I PI
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I+ + + + + EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I++LYD + + L +V E L +L + + + Q
Sbjct: 59 ----HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQL 109
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + Y H ++H DLKP+N+LI E+KI D G + + Y + + YR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
AP+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 21/230 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 469
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H ++++ Y F L IV EL A +L K ++ +
Sbjct: 91 ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPERTVWKYF 142
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSR 584
Q ALE++HS ++H D+KP N+ I + +K+ DLG F + V +
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARII 633
Y +PE I Y+ K D+WSLGC+L E+ + F D + + L + I
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 250
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIKLL 464
+Y LGS AF V+ A D +V +K IK +K D ++ EI +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFTL- 520
V H +I+++ D F + +V E SG + A+
Sbjct: 84 SRVE-------HANIIKVLDIFENQGFFQLVMEK------------HGSGLDLFAFIDRH 124
Query: 521 GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
RL I RQ + A+ YL IIH D+K ENI+I IK+ID GS+ +
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLER 182
Query: 576 NLCLYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF 620
Y + Y APEV++G PY ++++WSLG L L E F
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 41/248 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
Y V E +G ++S + T ++ +KII K +EI++L +
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQ-- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
H +I+ L D + +++++V EL++ GGE +F+
Sbjct: 75 ----HPNIITLKDVYDDGKYVYVVTELMK-------------GGELLDKILRQKFFSERE 117
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTDNLCL 579
+ + +EYLH+ G++H DLKP NIL +S I+I D G + + +N L
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 580 Y--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF---PNDAVVMILARIIG 634
+ ++ APEV+ YD D+WSLG +L + TG F P+D ILARI
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-- 235
Query: 635 MLGPIDLE 642
G L
Sbjct: 236 GSGKFSLS 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K E ++ + +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 64 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 103
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKN 470
I Y + +G ++ +V A T + K I + D+ EI+++K +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL--- 63
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
D +I+RLY+ F +++V EL +GGE F
Sbjct: 64 ---DHPNIIRLYETFEDNTDIYLVMELC-------------TGGELFERVVHKRVFRESD 107
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDNLCLY- 580
I + L A+ Y H L + H DLKPEN L + +K+ID G + +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 581 -VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
V + Y +P+V+ G Y + D WS G ++
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 41/268 (15%), Positives = 83/268 (30%), Gaps = 40/268 (14%)
Query: 403 DLPIILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFD 455
P + + + R LG +A D TG + + + +
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 456 QSLDEIKLLKLV----NKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------L 502
Q +E+ L+L+ N+ + +D + ++ L L
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 503 YEFQKFNQESGGEAYFTLGRLQV---------ITRQCLEALEYLHSLGIIHCDLKPENIL 553
Y + N ++ GE + +T Q + L LH G++H L+P +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 554 IKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLP-----YDQKIDLW 604
+ QR + + + A ++ D W
Sbjct: 244 LD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 605 SLGCILAELWTGEVLFPNDAVVMILARI 632
+LG + +W ++ +DA + I
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGSEWI 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 70/232 (30%), Positives = 110/232 (47%), Gaps = 23/232 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D + +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+RL+D + + L +V E +L ++ ++ Q
Sbjct: 60 ----HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQL 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L+ L + HS ++H DLKP+N+LI E+K+ + G + + Y V + YR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637
P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
++ + V LG A S V++ + T LK++K D EI +L +
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRL---- 105
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
+I++L + F + +V EL+ +GGE Y++
Sbjct: 106 --SHPNIIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDA 150
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLCLY-- 580
+Q LEA+ YLH GI+H DLKPEN+L + +KI D G S + +
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APE++ G Y ++D+WS+G I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---------NDKDFFDQSLDEIK 462
+ Y +++ LGS A +V A + T V +KII + D EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 68 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 106
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 610
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 23/231 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 471
+Y E +G + V++A+D G V LK I+ + + ++ EI LLK ++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +I+ L D + L +V E + +L + N+ ++++ Q
Sbjct: 78 ----HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQL 128
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 587
L + + H I+H DLKP+N+LI S +K+ D G + + Y V + YR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 588 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
AP+V++G Y +D+WS+GCI AE+ TG+ LFP L +I +LG
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 67/235 (28%), Positives = 120/235 (51%), Gaps = 22/235 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKN 470
+Y +G A+ KVF+A+DL + G V LK ++ ++ ++ E+ +L+ +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 471 DPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+ H +++RL+D L +V E + +L + + E ++
Sbjct: 72 E----HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIK 123
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+ Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + + + L V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
+ YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 73/235 (31%), Positives = 108/235 (45%), Gaps = 38/235 (16%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR- 69
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY F+V E + SGGE + + GR++
Sbjct: 70 ------HPHIIKLYQVISTPTDFFMVMEYV-------------SGGELFDYICKHGRVEE 110
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L A++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 168
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
S +Y APEVI G Y ++D+WS G IL L G + F ++ V + +I
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 68/257 (26%), Positives = 112/257 (43%), Gaps = 49/257 (19%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--------------NDKDFFDQS 457
I Y+ LGS A+ +V ++ + + +K+IK N + F ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 458 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE- 515
+EI LLK ++ H +I++L+D F ++ ++V E GGE
Sbjct: 94 YNEISLLKSLD-------HPNIIKLFDVFEDKKYFYLVTEFY-------------EGGEL 133
Query: 516 -------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567
F I +Q L + YLH I+H D+KPENIL+++ IKI+D
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 568 GSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
G S F + + L + + Y APEV+ Y++K D+WS G I+ L G F
Sbjct: 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
Query: 626 VMILARIIGMLGPIDLE 642
I+ ++ G +
Sbjct: 253 QDIIKKV--EKGKYYFD 267
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 52/242 (21%), Positives = 95/242 (39%), Gaps = 29/242 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
Y V +G+ ++ + + + G + K + + + + E+ LL+ +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK-- 63
Query: 471 DPADEH-HILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H +I+R YD L+IV E +L + Y + +
Sbjct: 64 -----HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRV 116
Query: 527 TRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 579
Q AL+ H ++H DLKP N+ + Q +K+ D G + +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAK 174
Query: 580 -YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLG 637
+V + Y +PE + + Y++K D+WSLGC+L EL F + + +I G
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 638 PI 639
I
Sbjct: 235 RI 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 73/234 (31%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ------SLDEIKLLKLVN 468
RY ++LG F+ V++A+D +T V +K IK + +L EIKLL+ ++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D F H ++ +V + + +L K N T ++
Sbjct: 71 -------HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYM 118
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 584
L+ LEYLH I+H DLKP N+L+ +K+ D G + Y V +R
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 585 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YRAPE++ G Y +D+W++GCILAEL P D+ + L RI LG
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H R A RY + LG +F +V + +D T + +K+I
Sbjct: 7 HSSGRENLYFQGT--------FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
+GGE F+ I +Q + Y+H I+H DLKPENIL++S +
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 559 R-CEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRA 111
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 112 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECLD-------------GGELFSRIQD 152
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S +K+ D G +
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 572 FQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
T + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 76/267 (28%), Positives = 116/267 (43%), Gaps = 42/267 (15%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 447
H + + EN + A RY + LG +F +V + +D T + +K+I
Sbjct: 3 HHHHHSSGREN----LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 448 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 506
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 507 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-Y 557
+GGE F+ I +Q + Y+H I+H DLKPENIL++S
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 558 QRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL L +
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 616 GEVLFPNDAVVMILARIIGMLGPIDLE 642
G F IL R+ G +
Sbjct: 218 GTPPFYGKNEYDILKRV--ETGKYAFD 242
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 47/239 (19%), Positives = 87/239 (36%), Gaps = 30/239 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
++ E +GS F VF+ G +K K +L E+ ++ ++
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H++R + + +H+ I E +L + N YF L+ + Q
Sbjct: 72 -----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAELKDLLLQV 124
Query: 531 LEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEIKIIDLGSSCFQ 573
L Y+HS+ ++H D+KP NI I + + KI DLG +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 574 TDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631
+ + + A EV+ + K D+++L + E L N + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 468
+ Y V E LG AFS V + TG++ KII K F + E ++ + +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 87 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 126
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 578
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 579 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-33
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 45/223 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIK 462
+ Y +++ LGS A +V A + T V ++II K + + EI+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 463 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 515
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 193 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 231
Query: 516 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 572
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 610
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 38/239 (15%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 468
G+Y + + LG ++ KV + D T +KI+K K + + EI+LL+ +
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 469 KNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 525
H ++++L D Y+ E +++V E + E + R V
Sbjct: 65 -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM--LD-------SVPEKRFPV 108
Query: 526 IT-----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS----CFQTDN 576
Q ++ LEYLHS GI+H D+KP N+L+ + +KI LG + F D+
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADD 166
Query: 577 LCLYVQ-SRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
C Q S +++ PE+ GL + K+D+WS G L + TG F D + + I
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 64/264 (24%), Positives = 105/264 (39%), Gaps = 72/264 (27%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 465
I RY + +G+ ++ V +A D V +K I F+ +D EI +L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILN 107
Query: 466 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 519
+N H H++++ D + L++V E+ ++ + + Y T
Sbjct: 108 RLN-------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLT 154
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 568
++ + L ++Y+HS GI+H DLKP N L+ C +K+ D G
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYPENG 212
Query: 569 -------------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 608
+ L +V +R YRAPE+I+ Y + ID+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 609 ILAEL-----------WTGEVLFP 621
I AEL LFP
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFP 296
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEI 461
Y E LG S V + T + +KII ++ + +L E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 462 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE----- 515
+L+ V H +I++L D + F+V +L+ GE
Sbjct: 75 DILRKV------SGHPNIIQLKDTYETNTFFFLVFDLM-------------KKGELFDYL 115
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572
+ + I R LE + LH L I+H DLKPENIL+ IK+ D G SC
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQ 173
Query: 573 QTDNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + SY APE+I Y +++D+WS G I+
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 25/232 (10%)
Query: 386 HLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK 445
H H R I + LGS AF V ++ +G++ +K
Sbjct: 2 HHHHHHSSGRENLYFQGT--------IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 446 IIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANL 502
I D+ EI++LK ++ H +I+++++ F +++IV E
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLD-------HPNIIKIFEVFEDYHNMYIVMETCEGG- 105
Query: 503 YE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRC 560
E ++ + G + + +Q + AL Y HS ++H DLKPENIL +
Sbjct: 106 -ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 561 EIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
IKIID G + + + Y APEV K D+WS G ++
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 41/224 (18%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIK 462
+ + Y + E +G FS V + + TG +KI+ K L E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+ ++ HI+ L + + L++V E + G +
Sbjct: 79 ICHML------KHPHIVELLETYSSDGMLYMVFEFM-------------DGADLCFEIVK 119
Query: 516 -----AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 569
++ RQ LEAL Y H IIH D+KP +L+ S + +K+ G
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 570 SCFQTDNLCLY---VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ ++ + V + + APEV+ PY + +D+W G IL
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 32/209 (15%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
RY + +GS F +D T V +K I+ + EI + +
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR----- 74
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT-- 527
H +I+R + HL I+ E SGGE Y + GR
Sbjct: 75 --HPNIVRFKEVILTPTHLAIIMEYA-------------SGGELYERICNAGRFSEDEAR 119
Query: 528 ---RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 582
+Q L + Y HS+ I H DLK EN L+ +KI D G S + V
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 583 SRSYRAPEVIIGLPYD-QKIDLWSLGCIL 610
+ +Y APEV++ YD + D+WS G L
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLG 521
H +IL L++ F +E L ++ E + SG +
Sbjct: 60 ----HRNILHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNER 102
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
+ Q EAL++LHS I H D++PENI+ ++ + IKII+ G + +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 582 Q--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ Y APEV D+WSLG ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 43/237 (18%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLV 467
G Y + E LG +F KV A T V LK I + +S EI LKL+
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLL 66
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL 523
H HI++LYD + +V E +GGE + + R+
Sbjct: 67 R-------HPHIIKLYDVITTPTDIVMVIEY--------------AGGELFDYIVEKKRM 105
Query: 524 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 578
+Q + A+EY H I+H DLKPEN+L+ +KI D G S TD
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163
Query: 579 LYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
L S +Y APEVI G Y ++D+WS G +L + G + F ++ + + ++
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 43/232 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ + LG F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61
Query: 473 ADEH-HILRLYDYF------------YHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF 518
H I+R ++ + +L+I +L + NL ++
Sbjct: 62 ---HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN---GRCTIEER 115
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF------ 572
I Q EA+E+LHS G++H DLKP NI +K+ D G
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEE 173
Query: 573 ---------QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 615
V ++ Y +PE I G Y K+D++SLG IL EL
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-32
Identities = 74/237 (31%), Positives = 107/237 (45%), Gaps = 38/237 (16%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 469
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR- 74
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 524
H HI++LY +F+V E + SGGE + + GRL
Sbjct: 75 ------HPHIIKLYQVISTPSDIFMVMEYV-------------SGGELFDYICKNGRLDE 115
Query: 525 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
+ +Q L ++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 173
Query: 581 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
S +Y APEVI G Y ++D+WS G IL L G + F +D V + +I
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-32
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 468
Y + E LG AFS V + + G + II K E ++ +L+
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 519
H +I+RL+D H +++ +L+ +GGE Y++
Sbjct: 69 -------HPNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYS 108
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNL 577
+Q LEA+ + H +G++H +LKPEN+L+ S + +K+ D G + + +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 578 CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + Y +PEV+ PY + +DLW+ G IL
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK + + E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +++ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HHNVITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/261 (22%), Positives = 106/261 (40%), Gaps = 36/261 (13%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKII-- 447
+N+ + + + GR+ +G +F V++ D T V+V +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 448 -KNDKDFFDQSLDEIKLLK-LVNKNDPADEHHILRLYDYFYHL----EHLFIVCEL---- 497
K K + +E ++LK L + N I+R YD + + + +V EL
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPN-------IVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 498 -LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILI 554
L+ L F+ + L+ RQ L+ L++LH+ IIH DLK +NI I
Sbjct: 115 TLKTYLKRFKVMK----------IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 555 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY-RAPEVIIGLPYDQKIDLWSLGCILAEL 613
+KI DLG + + + V APE+ YD+ +D+++ G + E+
Sbjct: 165 TGPT-GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222
Query: 614 WTGEVLFPNDAVVMILARIIG 634
T E + + R +
Sbjct: 223 ATSEYPYSECQNAAQIYRRVT 243
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 59/287 (20%), Positives = 100/287 (34%), Gaps = 44/287 (15%)
Query: 391 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND 450
H + + EN + +Y++ +G ++ V A + T +KI+ +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 451 KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL------------ 498
K D ++ V +I RLY+ + +++ +V EL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 499 -----------------------RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+ + I RQ AL
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYVQSRSYRA 588
YLH+ GI H D+KPEN L + + EIK++D G S + + + + A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 589 PEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
PEV+ Y K D WS G +L L G V FP +++++
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ Y + E LG+ AF V + + TG + K + +DK+ + EI+ + ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AY 517
H ++ L+D F + ++ E + SGGE
Sbjct: 212 R-------HPTLVNLHDAFEDDNEMVMIYEFM-------------SGGELFEKVADEHNK 251
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTD 575
+ RQ + L ++H +H DLKPENI+ + + E+K+ID G +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 576 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
++ + + + APEV G P D+WS+G +
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 467
Y + E LGS F+ V + + TG + K IK + + E+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D F + + ++ EL+ SGGE
Sbjct: 66 R-------HPNIITLHDIFENKTDVVLILELV-------------SGGELFDFLAEKESL 105
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
T +Q L+ + YLHS I H DLKPENI++ K+ IK+ID G +
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 34/248 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 471
+Y +G F +VF+A+ TG V LK + N+K+ F +L EIK+L+L+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--- 74
Query: 472 PADEH-HILRLYD--------YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
H +++ L + Y +++V + +L + FTL
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVK-FTLSE 125
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLC 578
++ + + L L Y+H I+H D+K N+LI +K+ D G S +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPN 183
Query: 579 LY---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
Y V + YR PE+++G Y IDLW GCI+AE+WT + + LA I
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 635 MLGPIDLE 642
+ G I E
Sbjct: 244 LCGSITPE 251
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIK 462
+Y + +G S V + TG + +KI++ + + + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 463 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
+L+ V A HI+ L D + +F+V +L+ GE
Sbjct: 152 ILRQV-----AGHPHIITLIDSYESSSFMFLVFDLM-------------RKGELFDYLTE 193
Query: 516 -AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
+ + I R LEA+ +LH+ I+H DLKPENIL+ +I++ D G SC
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQIRLSDFGFSCHLE 251
Query: 575 DNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 610
L + Y APE++ Y +++DLW+ G IL
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 41/240 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 634
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKNDPA 473
Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106
Query: 474 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRL 523
H ++ L+D F + ++ E L SGGE + +
Sbjct: 107 --HPKLINLHDAFEDKYEMVLILEFL-------------SGGELFDRIAAEDYKMSEAEV 151
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ- 582
RQ E L+++H I+H D+KPENI+ ++ + +KIID G + + + V
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 583 -SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P D+W++G +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 34/247 (13%)
Query: 417 YVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPA 473
Y +G + V++A+ D LK I+ + EI LL+ L + N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPN--- 79
Query: 474 DEHHILRLYDYFYH--LEHLFIVCELLRANLY---EFQKFNQESGGEAYFTLGRLQVITR 528
++ L F ++++ + +L+ +F + ++ + G ++ +
Sbjct: 80 ----VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q L+ + YLH+ ++H DLKP NIL+ +R +KI D+G + L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 586 -----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMI---------LA 630
YRAPE+++G Y + ID+W++GCI AEL T E +F + L
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 631 RIIGMLG 637
RI ++G
Sbjct: 256 RIFNVMG 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------A 516
K + +++ L++ + + + ++ EL+ +GGE
Sbjct: 69 KEI------QHPNVITLHEVYENKTDVILILELV-------------AGGELFDFLAEKE 109
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQT 574
T +Q L + YLHSL I H DLKPENI++ ++ + IKIID G +
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 575 DNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APE++ P + D+WS+G I
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-------NDKDFFDQSLDEIKLLKLV 467
Y + E LGS F+ V + ++ TG++ K IK ++ E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 518
H +I+ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HPNIITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 519 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 576
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 577 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 395 RTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDF 453
R+ E + + ++ LG + V+ +DL V + +K I D +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 454 FDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLR----ANLYEFQKF 508
+EI L K + H +I++ F + I E + + L K+
Sbjct: 63 SQPLHEEIALHKHLK-------HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKW 114
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
E + T+Q LE L+YLH I+H D+K +N+LI +Y +KI D G
Sbjct: 115 GPLKDNEQT-----IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFG 168
Query: 569 SSCFQTDNLCLYVQSRS----YRAPEVIIGLP--YDQKIDLWSLGCILAELWTGE 617
+S + + ++ + Y APE+I P Y + D+WSLGC + E+ TG+
Sbjct: 169 TSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+ LG A ++V +L T + +KII K + E+++L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRN 72
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVITRQ 529
+L L ++F + ++V E +R GG +F V+ +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMR-------------GGSILSHIHKRRHFNELEASVVVQD 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 585
AL++LH+ GI H DLKPENIL + Q +KI D S + + C + +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 586 -------YRAPEVIIGL-----PYDQKIDLWSLGCIL 610
Y APEV+ YD++ DLWSLG IL
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 41/240 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 527
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 528 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 577
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 578 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 634
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 391 HRKNRTGFEENKDLPIILNTV--IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII 447
H + + + + ++ Y +T + LG F+ V Q TG + K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 448 KNDKDFFDQSLD---EIKLLKLVNKNDPADEHH--ILRLYDYFYHLEHLFIVCELLRANL 502
K + D + EI +L+L ++ L++ + + + ++ E
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAK-------SCPRVINLHEVYENTSEIILILEYA---- 111
Query: 503 YEFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552
+GGE + + + +Q LE + YLH I+H DLKP+NI
Sbjct: 112 ---------AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 553 LIKS-YQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCI 609
L+ S Y +IKI+D G S L + Y APE++ P D+W++G I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 610 L 610
Sbjct: 223 A 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPAD 474
TE LG F +V + ++ TG+ + KIIK DK+ +EI ++ ++
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQLD------ 144
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRLQ 524
H ++++LYD F + +V E + GGE T
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYV-------------DGGELFDRIIDESYNLTELDTI 190
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-- 582
+ +Q E + ++H + I+H DLKPENIL + +IKIID G + L V
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
+ + APEV+ D+WS+G I
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 44/249 (17%), Positives = 90/249 (36%), Gaps = 43/249 (17%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK------------------NDKDFFD 455
Y + L F+K+ + LK + + K +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 456 QSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEF--QKFNQE 511
+E++++ + + + L + + ++I+ E + ++ +F F +
Sbjct: 89 DFKNELQIITDIK-------NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 512 SGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ + ++ I + L + Y+H+ I H D+KP NIL+ +K+ D G S
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGES 199
Query: 571 CFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDA 624
+ D + + PE K+D+WSLG L ++ V F
Sbjct: 200 EYMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 625 VVMILARII 633
++ L I
Sbjct: 257 SLVELFNNI 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
V E +G AF V +A+ DV +K I+++ + + E++ L VN H
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER-KAFIVELRQLSRVN-------HP 61
Query: 477 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+I++LY L + +V E +LY + Y+T QC + +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLY---NVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 536 YLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 592
YLHS+ +IH DLKP N+L+ + +KI D G++C ++ S ++ APEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEVF 175
Query: 593 IGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
G Y +K D++S G IL E+ T F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 73/267 (27%), Positives = 107/267 (40%), Gaps = 37/267 (13%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKN 470
Y + E +GS A + V A V +K I +K D+ L EI+ + +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-- 71
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ--VI 526
H +I+ Y F + L++V +LL ++ + K G L I
Sbjct: 72 -----HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ LE LEYLH G IH D+K NIL+ ++I D G S F +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKV-- 182
Query: 587 R----------APEVII-GLPYDQKIDLWSLGCILAELWTGE----VLFPNDAVVMILAR 631
R APEV+ YD K D+WS G EL TG P +++ L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 632 IIGMLGPIDLEMLMQGQEIYKYFTKEY 658
P LE +Q +E+ K + K +
Sbjct: 243 -----DPPSLETGVQDKEMLKKYGKSF 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 51/262 (19%), Positives = 102/262 (38%), Gaps = 65/262 (24%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------------------------- 447
+Y + + +G ++ V A + + +K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 448 -KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLY 503
+ +Q EI +LK ++ H ++++L + HL++V EL+
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-------HPNVVKLVEVLDDPNEDHLYMVFELV----- 120
Query: 504 EFQKFNQESGGE--AYFTLGRLQVIT-----RQCLEALEYLHSLGIIHCDLKPENILIKS 556
+ G TL L + ++ +EYLH IIH D+KP N+L+
Sbjct: 121 --------NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 557 YQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGL--PYD-QKIDLWSLGCIL 610
IKI D G S + L V + ++ APE + + + +D+W++G L
Sbjct: 173 DGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 611 AELWTGEVLFPNDAVVMILARI 632
G+ F ++ ++ + ++I
Sbjct: 231 YCFVFGQCPFMDERIMCLHSKI 252
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 34/223 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E LG F + + TG + +K + D++ L E+K+++ + H +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-------HPN 68
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+L+ Y + L + E + L K ++ + + + + Y
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAY 123
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--------- 587
LHS+ IIH DL N L++ + + D G + D RS +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNV--VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 588 --------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
APE+I G YD+K+D++S G +L E+ P+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 52/270 (19%), Positives = 88/270 (32%), Gaps = 74/270 (27%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + +G F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 474 DEHH---------------------------------------------------ILRLY 482
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 483 DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+L+I +L + NL ++ G I Q EA+E+LHS G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLG---------------SSCFQTDNLCLYVQSRSY 586
++H DLKP NI +K+ D G + V ++ Y
Sbjct: 185 LMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
+PE I G Y K+D++SLG IL EL
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 59/219 (26%)
Query: 409 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 467
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRA 67
Query: 468 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 515
++ HI+R+ D + + L IV E L GGE
Sbjct: 68 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQD 108
Query: 516 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSC 571
FT I + EA++YLHS+ I H D+KPEN+L S + +K+ D G
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--- 165
Query: 572 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 610
A E G YD+ D+WSLG I+
Sbjct: 166 ---------------FAKET-TGEKYDKSCDMWSLGVIM 188
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 52/237 (21%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKN--DKDFFDQSLDEIKLLKL 466
++AG+Y V + ++ A D + G V LK + + D + ++ E + L
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 467 VNKNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTL 520
V H I++++++ H + +IV E + GG+ +L
Sbjct: 136 VV-------HPSIVQIFNFVEHTDRHGDPVGYIVMEYV--------------GGQ---SL 171
Query: 521 -----GRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-- 568
+L V + L AL YLHS+G+++ DLKPENI++ Q +K+IDLG
Sbjct: 172 KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ---LKLIDLGAV 228
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625
S L + ++APE++ P D++++G LA L V
Sbjct: 229 SRINSFGYL---YGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKN 470
+ E +G +F +VF+ D T V +KII + +D + EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC--- 77
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 526
D ++ + Y + L+I+ E L +L E + E + I
Sbjct: 78 ---DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQ-----IATI 124
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
R+ L+ L+YLHS IH D+K N+L+ E+K+ D G + TD
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQ-------IK 175
Query: 587 R----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
R APEVI YD K D+WSLG EL GE
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 50/223 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+G + V A++ H+G V +K++ + + +E+ +++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-------- 97
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
D H ++ +Y + E L+++ E L GG + ++
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFL-------------QGGALTDIVSQVRLNEEQIA 144
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ L+AL YLH+ G+IH D+K ++IL+ +K+ D G C Q
Sbjct: 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFG-FCAQISK------DV 195
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
R APEVI Y ++D+WSLG ++ E+ GE
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 50/223 (22%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-------- 72
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 524
+ + I+ D + + L++V E L +GG E G++
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIA 119
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q +
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFG-FCAQITP------EQ 170
Query: 585 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGE 617
S R APEV+ Y K+D+WSLG + E+ GE
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG+ VF+ +G+ + K+I +Q + E+++L + +I+
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH------ECNSPYIV 94
Query: 480 RLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
Y FY + I E + + + E L ++ ++ L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIKGLT 145
Query: 536 YLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVII 593
YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +PE +
Sbjct: 146 YLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 594 GLPYDQKIDLWSLGCILAELWTGEVLFP 621
G Y + D+WS+G L E+ G +P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR--YP 229
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 42/222 (18%), Positives = 78/222 (35%), Gaps = 31/222 (13%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD--------EIKLLKLVNK 469
+ +G F V + + + V +K + + + E+ ++ +N
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++LY +V E + +LY +
Sbjct: 82 ------HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLM 128
Query: 528 RQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLCLYVQ 582
+EY+ + I+H DL+ NI ++S K+ D G S ++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 583 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ + APE I Y +K D +S IL + TGE F
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
E +G+ +F V +A+ G DV +KI+ + ++ L E+ ++K + H
Sbjct: 43 EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-------H 93
Query: 477 -HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ +L IV E L R +LY + +SG R + + +
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY---RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 535 EYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR-SYR--AP 589
YLH+ I+H +LK N+L+ K+ D G S + + + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTV--KVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
EV+ P ++K D++S G IL EL T + + N
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ V E LG ++ V++A TG V +K + + D + + EI +++ D
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQ------QCD 82
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H+++ Y ++ L+IV E A ++ + + ++ E + I + L+
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKG 137
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPE 590
LEYLH + IH D+K NIL+ + K+ D G + TD + + + + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGE 617
VI + Y+ D+WSLG E+ G+
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 53/243 (21%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQSLDEIKLLKL 466
G Y + +G V++A+D V LK++ +D F + L
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-- 91
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLG 521
E H++ ++D+ L++ L L A L G
Sbjct: 92 -------QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---------------G 129
Query: 522 RLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------S 569
L I RQ AL+ H+ G H D+KPENIL+ + ++D G
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDE 187
Query: 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 629
Q N V + Y APE + D+++L C+L E TG + D + ++
Sbjct: 188 KLTQLGNT---VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244
Query: 630 ARI 632
A I
Sbjct: 245 AHI 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 473
+GS +V++ + TG + +K ++ +K+ + L ++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
D +I++ + F +FI EL+ + +K Q E L +T ++A
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----LGKMTVAIVKA 136
Query: 534 LEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPE 590
L YL G+IH D+KP NIL+ R +IK+ D G S D+ +Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 591 VI-----IGLPYDQKIDLWSLGCILAELWTGEVLFP 621
I YD + D+WSLG L EL TG+ FP
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG A+ V + + + +G + +K I+ + + L ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-----F 67
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---EAYFTLGRLQVITRQCLEAL 534
+ Y + ++I EL+ +L +F K + G E L I ++AL
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI-----LGKIAVSIVKAL 122
Query: 535 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEV 591
E+LHS L +IH D+KP N+LI + ++K+ D G S + D++ + + Y APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 592 IIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 629
I Y K D+WSLG + EL FP D+
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPF 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + K + + + E++ L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ----- 109
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ ++ + ++V E + + + +++ E + +T
Sbjct: 110 -KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGA 163
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
L+ L YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSAS-IMAPANSFVGTPYWMAPE 220
Query: 591 VIIGL---PYDQKIDLWSLGCILAELWTGE 617
VI+ + YD K+D+WSLG EL +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK-----KY 77
Query: 473 ADEHHILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGR 522
+ +I Y F + L++V E A +L + K N E +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEW----- 130
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--- 579
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 580 YVQSRSYRAPEVI-----IGLPYDQKIDLWSLGCILAELWTGE 617
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 59/223 (26%), Positives = 82/223 (36%), Gaps = 39/223 (17%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----FFDQSLDEIKLLKLVNKNDPAD 474
E +G F KV++A G +V +K ++D D + E KL ++
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------ 64
Query: 475 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +I+ L +L +V E L + L Q
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIAR 116
Query: 533 ALEYLHSLG---IIHCDLKPENILI------KSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
+ YLH IIH DLK NILI +KI D G + S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMS 173
Query: 584 R--SYR--APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+Y APEVI + + D+WS G +L EL TGEV F
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 21/215 (9%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIK-LLKLVNKNDPADEH 476
+G A+ V + +G + +K I+ D+ Q L ++ +++ D
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS------DCP 81
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I++ Y + +I EL+ + +F K+ + L IT ++AL +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNH 140
Query: 537 LHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVI- 592
L L IIH D+KP NIL+ IK+ D G S D++ R Y APE I
Sbjct: 141 LKENLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 593 ---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624
YD + D+WSLG L EL TG FP
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR--FPYPK 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +FS V A++L T + +KI++ ++ E ++ ++ H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--------H 89
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC----- 530
++LY F E L+ GE + ++ C
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYA-------------KNGELLKYIRKIGSFDETCTRFYT 136
Query: 531 ---LEALEYLHSLGIIHCDLKPENILIKSYQRCEI------KIIDLGSSCFQTDNLCLYV 581
+ ALEYLH GIIH DLKPENIL+ +I K++ S + ++
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Q Y +PE++ + DLW+LGCI+ +L G
Sbjct: 197 Q---YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL- 464
+I RY + + LG S V+ A+D + V +K I ++ + E+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 519
+L + +I+ + D + ++V E L + +
Sbjct: 67 QL---SHQ----NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HGPLS 109
Query: 520 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCF 572
+ T Q L+ +++ H + I+H D+KP+NILI S + +KI D G +S
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT 167
Query: 573 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
QT+++ + + Y +PE G D+ D++S+G +L E+ GE F + V I
Sbjct: 168 QTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 46/241 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPADEH 476
E +G F +V+ + H +V +++I ++D DQ E+ +
Sbjct: 39 ELIGKGRFGQVYHGR-WHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT--------R 87
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++ HL I+ L LY + + + + + I ++ ++
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIVKG 142
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYR 587
+ YLH+ GI+H DLK +N+ + + + I D G + +
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 588 --APEVI---------IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636
APE+I LP+ + D+++LG I EL E F II +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT----QPAEAIIWQM 255
Query: 637 G 637
G
Sbjct: 256 G 256
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG AF KV++A++ TG K+I+ ++ + + EI++L +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--- 74
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H +I++L +YH L+I+ E + E +QV+ RQ
Sbjct: 75 ----HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQ 125
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
LEAL +LHS IIH DLK N+L+ +I++ D G S + R
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLK-------TLQKRDS 176
Query: 588 --------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 617
APEV++ PYD K D+WSLG L E+ E
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 44/213 (20%), Positives = 78/213 (36%), Gaps = 30/213 (14%)
Query: 423 GSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 478
G V A+ TG V ++ I + E+ + KL N H +I
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-------HPNI 88
Query: 479 LRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 537
+ F L++V + + + + G + I + L+AL+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 538 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---------- 587
H +G +H +K +ILI ++ + L S+ + +
Sbjct: 145 HHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 588 APEVI--IGLPYDQKIDLWSLGCILAELWTGEV 618
+PEV+ YD K D++S+G EL G V
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 476
+ +GS +F V++ H DV +K++ +E+ +L+
Sbjct: 30 QRIGSGSFGTVYKG-KWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--------R 78
Query: 477 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H IL Y L IV + ++LY E F + +L I RQ
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIARQTARG 132
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 588
++YLH+ IIH DLK NI + KI D G + ++ + + + A
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 589 PEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPN 622
PEVI PY + D+++ G +L EL TG++ + N
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 72/261 (27%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQ----- 456
+ ++ RY + E LG S+V A+DL DV +K+++ D F F +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 457 -SLDEIKLLKLVNKNDPADEHHILRLYDY----FYHLEHLFIVCEL-----LRANLYEFQ 506
+L N P I+ +YD +IV E LR ++
Sbjct: 67 AAL-----------NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE- 110
Query: 507 KFNQESGGEAYFTLGRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561
G + + +AL + H GIIH D+KP NI+I +
Sbjct: 111 --------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-- 154
Query: 562 IKIIDLG---------SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE 612
+K++D G +S QT + + + Y +PE G D + D++SLGC+L E
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAV---IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 613 LWTGEVLFPND-AVVMILARI 632
+ TGE F D V + +
Sbjct: 212 VLTGEPPFTGDSPVSVAYQHV 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 7e-22
Identities = 46/220 (20%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ ++ + +GS +F +++ ++ T +V +K+ Q L E K+ +++
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQG- 61
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQ 529
I + + ++ +V +LL +L + F +++ +L + ++ Q
Sbjct: 62 ----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQ 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
+ +E++HS +H D+KP+N L+ +R ++ IID G + D Q YR
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRE 169
Query: 589 PEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 28/223 (12%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
N V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLA 63
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I +Y + H +V +LL +L + F++ + + +
Sbjct: 64 GC-----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAK 113
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q L ++ +H +++ D+KP+N LI S I ++D G F D + Q
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--KQHIP 171
Query: 586 YRAPEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
YR + + G L +Q + DL +LG + G
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 468
++ + V + +G F ++ ++L+T V +K+ Q E + K +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLG 62
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
I ++Y + ++ +V ELL +L + + F+L + +I
Sbjct: 63 SG-----DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-----FSLKTVLMIAI 112
Query: 529 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + +EY+HS +I+ D+KPEN LI + + I IID ++
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKE 159
Query: 586 YRAPEVIIGLPYDQKI-----------------------DLWSLGCILAELWTG 616
Y PE +PY + DL +LG + G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 32/226 (14%), Positives = 62/226 (27%), Gaps = 45/226 (19%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ GRY + + G + +QA D V L + D ++L L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQ 524
++ P + R+ D + +V E +R +L E ++ +
Sbjct: 87 RID--KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--- 133
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
+ A + H G+ P + + + +
Sbjct: 134 -AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------------- 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630
+ + D+ +G L L P V LA
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + +G +KI+ + +L+E ++L+ VN
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--------F 100
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+++L F +L++V E + +GGE + L R+ +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-------------AGGEMFSHLRRIGRFSEPHARFYA 147
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q + EYLHSL +I+ DLKPEN+LI Y I++ D G V+ R+
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFG--------FAKRVKGRT 195
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APE+I+ Y++ +D W+LG ++ E+ G F D + I +I+
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I + ++ +V ELL +L + F F+L + ++ Q
Sbjct: 65 -----VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQM 114
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
+ +EY+HS IH D+KP+N L+ ++ + IID G + D Q YR
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYREN 172
Query: 590 EVIIG----------LPYDQ--KIDLWSLGCILAELWTG 616
+ + G L +Q + DL SLG +L G
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 38/219 (17%), Positives = 72/219 (32%), Gaps = 33/219 (15%)
Query: 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPAD 474
L ++++ G D+ +K++K +S D E L++ +
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS------ 65
Query: 475 EH-HILRLYDYFYH--LEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H ++L + H ++ + +LY G +
Sbjct: 66 -HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKFALDM 120
Query: 531 LEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
+ +LH+L I L +++I +I +Y +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA--RISMADVKFSFQSPGRMY----APAW 174
Query: 588 -APEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPN 622
APE + P D + D+WS +L EL T EV F +
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 42/310 (13%), Positives = 88/310 (28%), Gaps = 65/310 (20%)
Query: 392 RKNRTGFEENKDLP--IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 449
+ ++ P +L+ + ++ + + +GS F ++ A + ++K
Sbjct: 13 LGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV 72
Query: 450 DKDFFDQSLDEIKLLKLVNKNDPADEHH---------ILRLYDYFYHL----EHLFIVCE 496
+ E+K + V K D + I Y + F+V E
Sbjct: 73 EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132
Query: 497 LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
L +L + N F + + + L+ LEY+H +H D+K N+L+
Sbjct: 133 RLGIDLQKISGQNGT------FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI--------------- 601
++ + D G S Y + +
Sbjct: 187 KNPDQVYLADYGL-------------SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK 233
Query: 602 --------DLWSLGCILAEL------WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
D+ LG + W + P + + +
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293
Query: 648 --QEIYKYFT 655
EI ++
Sbjct: 294 SCCEIAQFLV 303
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 57/219 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ +F +V + H G +K++K + + + DE +L +V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------H 65
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR--- 528
I+R++ F + +F++ + + GGE + L + Q + +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYI-------------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ ALEYLHS II+ DLKPENIL+ + IKI D G YV +
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFG--------FAKYVPDVT 160
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ PY++ ID WS G ++ E+ G
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + +V++ G +V +KI ++K +F ++ E+ ++ H
Sbjct: 14 ECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRET--ELYNTVMLR-------HE 62
Query: 477 HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+IL + L+++ +LY++ + I
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIA 115
Query: 532 EALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 583
L +LH I H DLK +NIL+K +C I DLG + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC--CIADLGLAVMHSQSTNQLDVG 173
Query: 584 RS-------YRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEV 618
+ Y APEV+ +++D+W+ G +L E+ V
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +V Q TG K ++ + +L+E ++L+ VN
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--------S 243
Query: 478 --ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++ L + + L +V L+ +L KF+ G+A F R + L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 588
E LH I++ DLKPENIL+ + I+I DLG + + + Y A
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG----QTIKGRVGTVGYMA 353
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
PEV+ Y D W+LGC+L E+ G+ F
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 6e-19
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G F +V+ + TG +K + K +L+E +L LV+ D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----C 251
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
I+ + F+ + L + +L+ +GG+ ++ L + V +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLM-------------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQS 583
+ + LE++H+ +++ DLKP NIL+ + ++I DLG +C +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHG- 355
Query: 584 RSYRAPEVII-GLPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G+ YD D +SLGC+L +L G
Sbjct: 356 --YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 49/224 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T +K++K + + D E + + + H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 116
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 169
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 45/245 (18%)
Query: 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 462
LP+++ IA + + + +G + +V+ + G V +K+ ++ EI
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIY 83
Query: 463 LLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEA 516
L+ H +IL L+++ + +LY++ K
Sbjct: 84 QTVLMR-------HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------ 130
Query: 517 YFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + L +LH+ I H DLK +NIL+K C I DLG
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC--CIADLG 187
Query: 569 SSC-FQTDNLCLYVQSRS------YRAPEVIIG------LPYDQKIDLWSLGCILAELWT 615
+ F +D + + + Y PEV+ D++S G IL E+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 616 GEVLF 620
V
Sbjct: 248 RCVSG 252
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 60/229 (26%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------H 64
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
+ L F + L V E +GGE +F L R +V T
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFTEERARFYG 111
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQ 582
+ + ALEYLHS +++ D+K EN+++ + IKI D G LC +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDK----DGHIKITDFG--------LCKEGISDG 159
Query: 583 SRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F +VF Q TG K + + + ++ E K+L V+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--------S 244
Query: 478 --ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
I+ L F L +V ++ Y ++++ G F R T Q +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVSG 301
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YR 587
LE+LH II+ DLKPEN+L+ ++I DLG + + +++ +
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
APE+++G YD +D ++LG L E+ F
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 49/242 (20%)
Query: 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEI 461
LP+++ IA + E +G F +V++ + G +V +KI ++ +F ++ EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA--EI 87
Query: 462 KLLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGE 515
++ H +IL L++V + +L+++
Sbjct: 88 YQTVMLR-------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----- 135
Query: 516 AYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQRCEIKIIDL 567
T+ + + L +LH I H DLK +NIL+K C I DL
Sbjct: 136 --VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC--CIADL 191
Query: 568 GSSCFQTDNLCLYVQSRS-------YRAPEVIIG------LPYDQKIDLWSLGCILAELW 614
G + + + Y APEV+ ++ D++++G + E+
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 615 TG 616
Sbjct: 252 RR 253
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 55/227 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KVF A+ T +K +K D D + ++ E ++L L ++ P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-P----F 79
Query: 478 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 529
+ ++ F E+LF V E L +GG+ + + +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYL-------------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQSR 584
+ L++LHS GI++ DLK +NIL+ + IKI D G +C + ++
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDK----DGHIKIADFG--------MCKENMLGDAK 174
Query: 585 --------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+++G Y+ +D WS G +L E+ G+ F
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV A+ TG +K++K D D + ++ E ++L L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
+ +L+ F + LF V E + +GG+ F R +
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYA 130
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL +LH GII+ DLK +N+L+ K+ D G + +C V + +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMC---KEGICNGVTTATFC 185
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ + Y +D W++G +L E+ G F +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +++KV + T ++++K ND + D E + + + H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 527
++ L+ F LF V E + +GG+ + +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 159
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 585
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 212
Query: 586 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 9e-18
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 402
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ L +L S GII+ DLK +N+++ S IKI D G +N+ V +++
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENIWDGVTTKTFCG 504
Query: 586 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 71/326 (21%)
Query: 345 DTRDGEVNGALHEGKADAEEHGVATPDLL-MFDNLEEECEIFHLRIIHRKNRTGFEENKD 403
+ R ++ + +G A + LL + L +EC LR KN + E
Sbjct: 3 EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRRE--KNILEYLEWAK 60
Query: 404 LPIILNTVIAGRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 458
+ V R + ++ +G AF +V + + +KI+ K
Sbjct: 61 P--FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KW------ 110
Query: 459 DEIKLLKLVNKNDPA---DEHHILRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQ---- 510
+++ + + A +E +L + + +I L Y FQ N
Sbjct: 111 ------EMLKRAETACFREERDVLV------NGDSKWIT------TLHYAFQDDNNLYLV 152
Query: 511 ---ESGGEAYFTLGRLQVI---------TRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558
GG+ L + + + + A++ +H L +H D+KP+NIL+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 559 RCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLP-----YDQKIDLWSLG 607
I++ D GS VQS Y +PE++ + Y + D WSLG
Sbjct: 213 --HIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 608 CILAELWTGEVLFPNDAVVMILARII 633
+ E+ GE F +++V +I+
Sbjct: 269 VCMYEMLYGETPFYAESLVETYGKIM 294
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 46/216 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G +F KV Q T +K + ++ E+++++ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--------H 74
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 528
++ L+ F E +F+V +LL GG+ + L +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLL-------------LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 529 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 585
+ + AL+YL + IIH D+KP+NIL+ + I D + + + +
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQIT--TMAGT 177
Query: 586 --YRAPEVI---IGLPYDQKIDLWSLGCILAELWTG 616
Y APE+ G Y +D WSLG EL G
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 81
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 585
+ L +L S GII+ DLK +N+++ S IKI D G +C ++ +
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFG--------MCKENIWDGVTT 178
Query: 586 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 55/227 (24%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-------HP 208
Query: 478 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 528
+ L F + L V E +GGE +F L R +V +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 255
Query: 529 QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSR 584
+ + AL+YLHS +++ DLK EN+++ IKI D G LC + +
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFG--------LCKEGIKDGAT 305
Query: 585 S--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 70/236 (29%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478
LG + KVFQ + + +TG +K++K K ++ + K E +I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTK--------AERNI 74
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L ++H FIV +L Y FQ SGGE + L R +
Sbjct: 75 LE------EVKHPFIV------DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL +LH GII+ DLKPENI++ + +K+ D G LC
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH----QGHVKLTDFG--------LC 168
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
++ + + Y APE+++ +++ +D WSLG ++ ++ TG F +
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 53/240 (22%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AFS+V + TG +KI+ + +E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--------R 120
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI--------- 526
I +L+ F +L++V E GG+ L +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYY-------------VGGDLLTLLSKFGERIPAEMARFY 167
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
+ + A++ +H LG +H D+KP+NIL+ I++ D GS V+S
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSC--LKLRADGTVRSLVA 223
Query: 586 -----YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PE++ + Y + D W+LG E++ G+ F D+ +I+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 73/236 (30%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA---DEHHI 478
+G +F KV A+ V +K+++ K ++ K + E ++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ--KKA------------ILKKKEEKHIMSERNV 91
Query: 479 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 528
L +++H F+V L + FQ + +GGE ++ L R +
Sbjct: 92 LLK-----NVKHPFLV------GLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 529 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 578
+ AL YLHSL I++ DLKPENIL+ S + I + D G LC
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS----QGHIVLTDFG--------LC 186
Query: 579 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ S + Y APEV+ PYD+ +D W LG +L E+ G F +
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
LG + +V++ + V +K +K D ++F L E ++K + H
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIK-------HP 276
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
++++L +I+ E + NL ++ + + L + Q A+E
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 332
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL IH +L N L+ K+ D G S T + Y + AP
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAP 388
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
E + + K D+W+ G +L E+ T G +P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 49/235 (20%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
+G AF +V + T +K++ + +E ++ N
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--------S 128
Query: 478 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV---ITR---- 528
+++L+ F +L++V E + GG+ + V R
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEKWARFYTA 175
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
+ + AL+ +HS+G IH D+KP+N+L+ + +K+ D G+ V+ +
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKE--GMVRCDTAVG 231
Query: 586 ---YRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 66/233 (28%)
Query: 422 LGSAAFSKVFQAQ---DLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPA 473
LG +F KVF + +K++K K + E +L VN
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK--KATLKVRDRVRTKMERDILVEVN----- 84
Query: 474 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 523
H I++L+ F L+++ + L GG+ FT +
Sbjct: 85 ---HPFIVKLHYAFQTEGKLYLILDFL-------------RGGDLFTRLSKEVMFTEEDV 128
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC--- 578
+ + AL++LHSLGII+ DLKPENIL+ E IK+ D G L
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDE----EGHIKLTDFG--------LSKES 176
Query: 579 LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623
+ + ++ Y APEV+ + Q D WS G ++ E+ TG + F
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 32/215 (14%), Positives = 76/215 (35%), Gaps = 39/215 (18%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEI 461
I+ + A + V +G F ++ A + + + +K+ +D E+
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTEL 84
Query: 462 KLLKLVNKNDPADEHH---------ILRLYDYFYH----LEHLFIVCELLRANLYEFQKF 508
K + K + + + + + H + F++ + ++L + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
N + F+ + ++ + L+ LEY+H +H D+K N+L+ ++ ++D G
Sbjct: 145 NAKR-----FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDL 603
+ Y V D K
Sbjct: 200 L-------------AYRYCPEGVHKAYAADPKRCH 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 273 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 325
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 436
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L EL T G V +P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 41/250 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQ---- 69
Query: 473 ADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H +I++ Y +L ++ E L +L ++ + ++E +L T
Sbjct: 70 ---HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTS 121
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q + +EYL + IH DL NIL+++ R KI D G + + +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGP 638
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 639 IDLEMLMQGQ 648
+E+L
Sbjct: 240 HLIELLKNNG 249
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 46/224 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 477
E F V++AQ V +KI DK + E+ L + +H +
Sbjct: 30 EVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEY-EVYSLPGM-------KHEN 79
Query: 478 ILRLYDY----FYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
IL+ L+++ + +L +F K N + L I
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNELCHIAETMAR 132
Query: 533 ALEYLHS----------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L YLH I H D+K +N+L+K+ I D G +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDT 190
Query: 583 SRS-----YRAPEVIIG-----LPYDQKIDLWSLGCILAELWTG 616
Y APEV+ G +ID++++G +L EL +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 190 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 242
Query: 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 538
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 539 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 592
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 353
Query: 593 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L EL T G V +P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 39/249 (15%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSL----- 99
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I++ Y +L ++ E L +L ++ + ++E +L T Q
Sbjct: 100 -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQ 153
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL + IH DL NIL+++ R KI D G + + Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGPI 639
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 640 DLEMLMQGQ 648
+E+L
Sbjct: 272 LIELLKNNG 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
LG+ F +V+ A + V +K +K + L E ++K + +++L
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKL 248
Query: 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 540
+ E ++I+ E + +L +F K S + L +L + Q E + ++
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 541 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVIIG 594
IH DL+ NIL+ + C KI D G + DN Y + APE I
Sbjct: 304 NYIHRDLRAANILVSASLVC--KIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINF 359
Query: 595 LPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ K D+WS G +L E+ T G + +P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +G+ F +V + + V +K +K +DF L E ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQF--- 103
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D +I+RL + + IV E + F ++ + FT+ +L + R
Sbjct: 104 ---DHPNIIRLEGVVTKSKPVMIVTEYME--NGSLDSFLRKHDAQ--FTVIQLVGMLRGI 156
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 587
++YL +G +H DL NILI S C K+ D G D+ +R +
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVC--KVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 588 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+PE I + D+WS G +L E+ + GE +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 38/248 (15%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 472
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQILKAL----- 81
Query: 473 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
I++ Y + L +V E L + L +F + ++ RL + + Q
Sbjct: 82 -HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQ 135
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ +EYL S +H DL NIL++S KI D G + + YV +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHV--KIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEV--LFPNDAVVMILARIIGMLGPID 640
APE + + ++ D+WS G +L EL+T + + + M+
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 641 LEMLMQGQ 648
LE+L +GQ
Sbjct: 254 LELLEEGQ 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 35/221 (15%)
Query: 420 EYLGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNK 469
+ +G+ F +V++ V V +K +K DF L E ++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQF-- 103
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H+I+RL + + I+ E + L +F + F++ +L + R
Sbjct: 104 ----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLR 154
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
++YL ++ +H DL NIL+ S C K+ D G S D+ + +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + D+WS G ++ E+ T GE +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 57/243 (23%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 476
E +G + V++ V +K+ N ++F ++ I + L+ EH
Sbjct: 19 ELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEK--NIYRVPLM-------EHD 67
Query: 477 HILRLY-----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+I R +V E +L ++ + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSV 120
Query: 531 LEALEYLHS---------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 581
L YLH+ I H DL N+L+K+ C I D G S T N +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC--VISDFGLSMRLTGNRLVRP 178
Query: 582 QSRS-----------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG-EVLFPN 622
Y APEV+ G +++D+++LG I E++ LFP
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 623 DAV 625
++V
Sbjct: 239 ESV 241
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 34/220 (15%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+ +GS +V + G V V +K +K +DF L E ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQF--- 107
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
D +I+RL IV E + +L F + + FT+ +L + R
Sbjct: 108 ---DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRG 159
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 587
+ YL LG +H DL N+L+ S C K+ D G S D+ + +
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVC--KVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + D+WS G ++ E+ GE + N
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 32/215 (14%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADE 475
+ LGS F V + DV +K+IK +F E + + +
Sbjct: 14 KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEF----FQEAQTMMKL------SH 62
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++ Y ++IV E + L + + + + +L + E +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGM 117
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 588
+L S IH DL N L+ K+ D G + + D+ YV S + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCV--KVSDFGMTRYVLDD--QYVSSVGTKFPVKWSA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
PEV Y K D+W+ G ++ E+++ G++ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 30/213 (14%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG + +V++ + V +K +K D ++F L E ++K + +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEI------KHPN 70
Query: 478 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++L +I+ E + NL ++ + + L + Q A+EY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L IH DL N L+ K+ D G S T + Y + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+W+ G +L E+ T G +P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 34/216 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADE 475
+G F +VF + V +K + F L E ++LK
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY------SH 171
Query: 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+RL + ++IV EL++ + F + + L + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------- 587
EYL S IH DL N L+ KI D G S + D +Y S R
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVL--KISDFGMSREEADG--VYAASGGLRQVPVKWT 282
Query: 588 APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + Y + D+WS G +L E ++ G +PN
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 68/230 (29%)
Query: 422 LGSAAFSKVFQAQDL---HTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDP 472
LG+ A+ KVF + + TG +K++K K + + E ++L+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR---- 116
Query: 473 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 522
++ L+ F L ++ + + +GGE FT
Sbjct: 117 ---QSPFLVTLHYAFQTETKLHLILDYI-------------NGGELFTHLSQRERFTEHE 160
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC-L 579
+Q+ + + ALE+LH LGII+ D+K ENIL+ S + + D G L
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS----NGHVVLTDFG--------LSKE 208
Query: 580 YVQSRS-----------YRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 616
+V + Y AP+++ G +D+ +D WSLG ++ EL TG
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 46/218 (21%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH-H 477
+G F V + G V +K IKND + F L E ++ + H +
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQLR-------HSN 247
Query: 478 ILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+++L + L+IV E + +L ++ + S G + L +
Sbjct: 248 LVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 299
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
EA+EYL +H DL N+L+ K+ D G + + +
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLTKE------ASSTQDTGKLPVK 351
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE + + K D+WS G +L E+++ G V +P
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 25/179 (13%), Positives = 59/179 (32%), Gaps = 24/179 (13%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV--------DVCLKIIKNDKDFFDQSL 458
+L ++ + + +++A T LK+ D F++
Sbjct: 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN 94
Query: 459 --------DEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHLFIVCELLRANLYEFQKFN 509
++ K + I + H ++ F+V L +L +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTP---LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LD 149
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
+ + + + L+ALE+LH +H ++ ENI + + ++ + G
Sbjct: 150 VSPKHV--LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 476
+GS F V V +K I+ +DF ++E +++ ++ H
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF----IEEAEVMMKLS-------HP 63
Query: 477 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
+++LY + +V E + L ++ + + F L + E +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMA 118
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 589
YL +IH DL N L+ Q K+ D G + F D+ Y S + +P
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVI--KVSDFGMTRFVLDD--QYTSSTGTKFPVKWASP 174
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
EV Y K D+WS G ++ E+++ G++ + N
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 41/250 (16%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + +TG V +K +K + D EI++L+ +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLY--- 81
Query: 472 PADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I++ + ++ E L + +L E+ N+ L +
Sbjct: 82 ----HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 132
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 587
Q + ++YL S +H DL N+L++S + KI D G + + Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQV--KIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGP 638
APE ++ + D+WS G L EL T + A+ + + M
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 639 IDLEMLMQGQ 648
+ L +G+
Sbjct: 251 RLVNTLKEGK 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F +V+ + V +K +K F L E L+K +
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQL------QHQR 69
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++RLY E ++I+ E + +L +F K + T+ +L + Q E + +
Sbjct: 70 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
+ IH DL+ NIL+ C KI D G + DN Y + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
I + K D+WS G +L E+ T G + +P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG+ F V + DV +K+IK +F ++E K++ +
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF----IEEAKVMMNL------SHEK 80
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+++LY +FI+ E + L + + + F +L + + EA+EY
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L S +H DL N L+ K+ D G S + D+ Y S + PE
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVV--KVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 191
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
V++ + K D+W+ G ++ E+++ G++ +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 36/213 (16%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHI 478
+G F V + G V +K IKND + F L E ++ + ++
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQL------RHSNL 76
Query: 479 LRLYDY-FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
++L L+IV E + +L ++ + S G + L + EA+EY
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H DL N+L+ K+ D G + + + + APE
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLT---KE---ASSTQDTGKLPVKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ + K D+WS G +L E+++ G V +P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 55/249 (22%), Positives = 89/249 (35%), Gaps = 41/249 (16%)
Query: 422 LGSAAFSKVFQAQ----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LG F KV + TG V +K +K D + EI +L+ +
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTL---- 90
Query: 472 PADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
HI++ L +V E + +L ++ + L +L + +
Sbjct: 91 --YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQ 141
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q E + YLH+ IH DL N+L+ + + KI D G + + Y
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLV--KIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGPI 639
APE + + D+WS G L EL T + + L I M
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 640 DLEMLMQGQ 648
E+L +G+
Sbjct: 260 LTELLERGE 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 47/225 (20%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKN 470
LG +F V + V V +K +K D DF + E+ + ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVNAMHSLD-- 79
Query: 471 DPADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
H +++RLY + +V EL +L + + +Q F LG L
Sbjct: 80 -----HRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLS 124
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
Q E + YL S IH DL N+L+ + KI D G N YV
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV--KIGDFGLMRALPQNDDHYVMQE 182
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE + + D W G L E++T G+ +
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 53/259 (20%), Positives = 96/259 (37%), Gaps = 62/259 (23%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS F V + + + VC+K+I++ + D + + +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLAIGSL---- 72
Query: 472 PADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI+RL L +V + L +L + + ++ + L
Sbjct: 73 --DHAHIVRLLGLCPG-----SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNW 120
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS 585
Q + + YL G++H +L N+L+KS + ++ D G + D+ +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV--QVADFGVADLLPPDD--KQLLYSE 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML-- 636
+ A E I Y + D+WS G + EL T G + + LA + +L
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEK 232
Query: 637 G---------PIDLEMLMQ 646
G ID+ M+M
Sbjct: 233 GERLAQPQICTIDVYMVMV 251
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 36/218 (16%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+KN+ D+ L E +++ + D
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNP 78
Query: 477 HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+R+ E +V E+ L ++ + N+ + + Q
Sbjct: 79 YIVRMIGICEA-----ESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVS 127
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 587
++YL +H DL N+L+ + KI D G S + Y +
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + K D+WS G ++ E ++ G+ +
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
LG F V Q +DV +K++K + D + E +++ + D
Sbjct: 344 LGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNP 396
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+RL E L +V E+ A KF E + + + Q ++Y
Sbjct: 397 YIVRLIGVCQA-EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKY 451
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 590
L +H +L N+L+ + KI D G S + Y + + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
I + + D+WS G + E + G+ +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 52/260 (20%), Positives = 99/260 (38%), Gaps = 64/260 (24%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 636
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 637 -G---------PIDLEMLMQ 646
G ID+ M+M+
Sbjct: 234 KGERLPQPPICTIDVYMIMR 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 41/231 (17%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 420 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND-----KDFFDQSLDEIKLLKLV 467
E LG F+K+F+ G +V LK++ + F + ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAASMMSKL 69
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 526
H++ Y + +V E ++ +L + K N+ + +
Sbjct: 70 ------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEV 118
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE------IKIIDLGSSCFQTDNLCLY 580
+Q A+ +L +IH ++ +NIL+ + + IK+ D G + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISIT 170
Query: 581 VQSRSYR-------APEVII-GLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
V + PE I + D WS G L E+ + G+
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-10
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 42/221 (19%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
LG F V Q +DV +K++K ++ + E +++ ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLD----- 68
Query: 474 DEH-HILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +I+RL E L +V E+ A KF E + + +
Sbjct: 69 --NPYIVRLIGVCQA-----EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLH 117
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 587
Q ++YL +H DL N+L+ + KI D G S + Y + +
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKW 175
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
APE I + + D+WS G + E + G+ +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 85
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRAN----LYEFQKFNQESGGEAYFTL 520
H +I+ L ++ E LR + E L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L + Q + + +L S IH DL NIL+ + KI D G + N
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN-- 200
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
YV + R APE I Y + D+WS G L EL++
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 43/223 (19%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 448
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
D HI++L + ++I+ EL E + F Q L L +
Sbjct: 449 ---DHPHIVKLIGVITE-----NPVWIIMELCTLG--ELRSFLQVRKFS--LDLASLILY 496
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 586
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASKG 552
Query: 587 R------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE I + D+W G + E+ G F
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG+ AF KV +A G + V +K++K+ ++ + E+K++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 475 EH-HILRLYDYFYHLEHLFIVCEL---------LRANLYEFQKFNQESGGEAYFTLGRLQ 524
H +I+ L H + ++ E LR + + + + L
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+ Q + + +L S IH D+ N+L+ + KI D G + N Y+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA--KIGDFGLARDIMNDSN---YIV 222
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ R APE I Y + D+WS G +L E+++
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 64/260 (24%)
Query: 422 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 471
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 472 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 584
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 585 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 636
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 637 -G---------PIDLEMLMQ 646
G ID+ M+M
Sbjct: 234 KGERLPQPPICTIDVYMIMV 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 44/251 (17%), Positives = 74/251 (29%), Gaps = 59/251 (23%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLK 465
+ E +G F +VFQ HT V +KII + F++ L EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIV-----CELLRANLYEFQKFNQESGGEAYF-- 518
++ + + F L + V LL+A + + +F
Sbjct: 79 ELSLLSGEVCNRT----EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 519 ------------------------TLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENIL 553
+L + I Q +L SL H DL N+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 554 IKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 613
+K ++ G S + S + + Y + ++
Sbjct: 195 LKKTSLKKLHYTLNGKS--------STIPSCGLQVSII----DYTLSRLERDGIVVFCDV 242
Query: 614 WTGEVLFPNDA 624
E LF D
Sbjct: 243 SMDEDLFTGDG 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 39/218 (17%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V + Q+ T + V +K +K D ++F L E +K
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDF---- 93
Query: 472 PADEHHILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
+++RL + ++ ++ +L+ + +++ G + L L
Sbjct: 94 --SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQS 583
+EYL + +H DL N +++ + D G S + D Y Q
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV--CVADFGLSKKIYSGD---YYRQG 206
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R + A E + Y K D+W+ G + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V A + V +K++K+D D + E++++K++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIG 132
Query: 469 KNDPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEA 516
K H +I+ L L+++ E L+A +N E
Sbjct: 133 K------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 517 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQT 574
+ L Q +EYL S IH DL N+L+ KI D G +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHI 244
Query: 575 DNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
D Y ++ + R APE + Y + D+WS G +L E++T
Sbjct: 245 DY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 45/224 (20%)
Query: 420 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
+G F V Q + + V +K KN + F L E ++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 73
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
D HI++L + ++I+ EL L F + + S L L +
Sbjct: 74 ---DHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 120
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASK 176
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
+ APE I + D+W G + E+ G F
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 471
LG F V +A Q+ + V V +K++K D ++F L E +K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEF---- 82
Query: 472 PADEHHILRLY------DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
D H+ +L L ++ ++ +L+ F ++ L L
Sbjct: 83 --DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 582
+EYL S IH DL N ++ + + + D G S + D Y Q
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMT-VCVADFGLSRKIYSGD---YYRQ 195
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ + A E + Y D+W+ G + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 45/224 (20%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F +V++ ++V +K K D + F + E ++K +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNL--- 70
Query: 471 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 525
D HI++L + E +I+ EL L + + N+ S + L +
Sbjct: 71 ---DHPHIVKLIGIIEE-----EPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVL 117
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
+ Q +A+ YL S+ +H D+ NIL+ S + K+ D G S + D Y ++
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECV--KLGDFGLSRYIEDE--DYYKASV 173
Query: 586 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 622
R +PE I + D+W + E+ + G+ F
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
LG AF +V A V V +K++K +KD D + E++++K++ K+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 101
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
+I+ L L+++ E LRA ++ E T
Sbjct: 102 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 578
L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNIDY-- 212
Query: 579 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 40/219 (18%)
Query: 422 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 473
+G F +V +A+ +D +K +K +DF E+++L + +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHP-- 86
Query: 474 DEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTLGR 522
+I+ L H +L++ E LR + L F + + + +
Sbjct: 87 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
L ++YL IH DL NIL+ KI D G S + YV+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLS-RGQEV---YVK 197
Query: 583 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
R A E + Y D+WS G +L E+ +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 422 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG F +V A V V +K++K+D D + E++++K++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
K+ +I+ L L+++ E LRA ++ E
Sbjct: 145 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
T L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNID 257
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 258 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LGS AF KV A + V +K++K + + E+K++ + +
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSH 108
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN---------LYEFQKFNQES 512
+ +I+ L ++++ E LR+ YE QK +E
Sbjct: 109 E-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-- 570
T L Q + +E+L +H DL N+L+ + KI D G +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV--KICDFGLARD 221
Query: 571 CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
N YV + R APE + Y K D+WS G +L E+++
Sbjct: 222 IMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 54/228 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K+ KDF E +LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNL---- 74
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 520
HI++ Y + L +V E LRA+ Q + L
Sbjct: 75 --QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 521 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 580
++ I Q + YL S +H DL N L+ + +KI D G +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFG--------MSRD 182
Query: 581 VQSRSY-----------R--APEVIIGLPYDQKIDLWSLGCILAELWT 615
V S Y R PE I+ + + D+WS G IL E++T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 52/230 (22%), Positives = 88/230 (38%), Gaps = 55/230 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG AF +V +A T V +K++K + + E+K+L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHH 90
Query: 471 DPADEHHILRLY------DYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESG 513
+++ L L ++ E LR+ + K E
Sbjct: 91 L-----NVVNLLGACTKPG-----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--C 571
+ + TL L + Q + +E+L S IH DL NIL+ KI D G +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDI 198
Query: 572 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 199 YKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 27/210 (12%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 148
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 203
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYR---- 587
+++L S +H DL N ++ K+ D G + +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 588 --APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 42/214 (19%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
LG +F V++ V +K + ++ L+E ++K N
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 475 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
HH++RL + ++ EL L++ L + + A +L ++ + +
Sbjct: 88 -HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 587
+ + YL++ +H DL N ++ KI D G + ++TD Y +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTV--KIGDFGMTRDIYETDY---YRKGGKGL 201
Query: 588 ------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+PE + + D+WS G +L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 470
LG F KV +A V +K++K + +D L E +LK VN
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVN-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFNQ 510
H H+++LY L ++ E LR + +
Sbjct: 85 -----HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 511 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570
+ E T+G L Q + ++YL + ++H DL NIL+ ++ KI D G S
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLS 197
Query: 571 --CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
++ D+ YV+ R A E + Y + D+WS G +L E+ T
Sbjct: 198 RDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 55/228 (24%)
Query: 422 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 471
LG AF KVF A+ + V +K +K +DF E +LL ++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTML---- 100
Query: 472 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN-LYEFQKFNQESGGEAYFTLG 521
HI+R + L +V E LR++ E LG
Sbjct: 101 --QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCL 579
+L + Q + YL L +H DL N L+ +KI D G S + TD
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGDFGMSRDIYSTD---- 212
Query: 580 YVQSRSYR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y YR PE I+ + + D+WS G +L E++T
Sbjct: 213 Y-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 55/231 (23%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
E LG F KV++ V +K +K+ ++F E L +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARL- 69
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 517
+++ L + L ++ L + + + ++
Sbjct: 70 -----QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 577
+ Q +EYL S ++H DL N+L+ KI DLG L
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV--KISDLG--------L 174
Query: 578 CLYVQSRS-YR------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
V + Y+ APE I+ + D+WS G +L E+++
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 44/223 (19%), Positives = 75/223 (33%), Gaps = 45/223 (20%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++ N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 132
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+I+R FI+ EL+ +L F ++ + + L +
Sbjct: 133 ------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 585
R +YL IH D+ N L+ KI D G + +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAG 238
Query: 586 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 615
Y PE + + K D WS G +L E+++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 33/213 (15%)
Query: 420 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 474
E +G F V+ + + +K + D + S L E ++K
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 84
Query: 475 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR--- 587
++YL S +H DL N ++ K+ D G + + + Y
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKE---YYSVHNKTGAKL 194
Query: 588 -----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 43/218 (19%), Positives = 77/218 (35%), Gaps = 35/218 (16%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
LG AF +V++ Q + + + V +K + DF L E ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKF- 90
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 526
+ +I+R FI+ EL+ +L F ++ + + L +
Sbjct: 91 -----NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSS--CFQTDNLCLYVQS 583
R +YL IH D+ N L+ KI D G + ++ Y +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKG 202
Query: 584 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
PE + + K D WS G +L E+++
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 39/212 (18%), Positives = 74/212 (34%), Gaps = 35/212 (16%)
Query: 422 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 476
+G F V+ + + + +K + + L E L++ + +
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHP 82
Query: 477 HILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++L L E ++ + +L +F + Q + T+ L Q +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGM 137
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR----- 587
EYL +H DL N ++ K+ D G + + Y + +R
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTV--KVADFGLARDILDRE----YYSVQQHRHARLP 191
Query: 588 ----APEVIIGLPYDQKIDLWSLGCILAELWT 615
A E + + K D+WS G +L EL T
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 58/414 (14%), Positives = 117/414 (28%), Gaps = 129/414 (31%)
Query: 323 GSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAE-EHGVATPD-----LLMFD 376
G +K A +DN D +D V + E +H + + D L +F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKD--VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 377 NLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDL 436
L K ++ + V+ Y ++L S + +
Sbjct: 70 TLL------------SKQEEMVQK------FVEEVLRINY---KFLMSP-----IKTEQR 103
Query: 437 HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 496
+ + + D +L N N ++++ R ++
Sbjct: 104 QPSMM---------TRMYIEQRD-----RLYNDNQVFAKYNVSR--------LQPYLK-- 139
Query: 497 LLRANLYEFQKFNQESGGEAYFTL------GRLQVITRQCLEALEYLHSLGII------- 543
LR L E + + G + + AL+ S +
Sbjct: 140 -LRQALLELRP-------AKNVLIDGVLGSG------KTWV-ALDVCLSYKVQCKMDFKI 184
Query: 544 ------HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 597
+C+ PE +L + + S + N+ L + S ++ PY
Sbjct: 185 FWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 598 DQKIDLWSLGCILAELWTGEVL--FPNDAVVMILAR---IIGMLGP-----IDLEMLMQG 647
+ L +L + + F +++ R + L I L+
Sbjct: 244 EN-----CL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 648 QEIYKYFTKEY--DLY--YIN--------EVCFANIF-ISLVVIRLTLEYAALW 688
T + L Y++ EV N +S++ + + A W
Sbjct: 298 ------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATW 344
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 93/627 (14%), Positives = 164/627 (26%), Gaps = 206/627 (32%)
Query: 114 HGNSEASSESLSQFDTARDY--DLQNDFYWHDEKDE--GYFMTPSYGGSDFFGCPSEDKF 169
H + E D + ++F D +D
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAV-- 61
Query: 170 IMTSEADRLFE--------------------------NPLAVYDQSEGLHSEASTDYLDK 203
S RLF +P+ + + + + D+
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 204 PCLFHIVPLNDDKEVGVTDYYRFEKTNQPEAGGIKEKL------------------KDC- 244
L++ + V R + + +++ L K
Sbjct: 119 --LYNDNQVFAKYNV-----SRLQPYLK-----LRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 245 AAYGCSEPLCKCCAGEGK--INNDYGYLSSKEADLIDLQ---HNVVGDSSTDCD------ 293
A C +C +N +S E L LQ + + + ++ D
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 294 LAPHPGTEKSSSYSSSKRGSS----ID--W----IEGFKGSSDLHFKGAEKDLMPAEIDN 343
L H + SK + + F S K L+
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC--------KILLT----- 271
Query: 344 SDTRDGEVN---GALHEGKADAEEHGVA-TPD----LLM------FDNL-EEECEI--FH 386
TR +V A + H + TPD LL+ +L E
Sbjct: 272 --TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 387 LRIIHRKNRTGFEENKDLPII----LNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLH 437
L II R G + + L T+I L A + K+F H
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSAH 386
Query: 438 TGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKN-------------------DPADEH 476
+ L +I D D ++++ LV K +
Sbjct: 387 IPTIL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 477 H--------ILRLYD-----------YFY-HLE-HLFIV-----CELLRANLY---EF-- 505
H I + +D YFY H+ HL + L R ++ F
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLE 504
Query: 506 QK-----FNQESGGEAYFTLGRLQV----ITRQCLEALEYLHSLGIIHCDLKPENILIKS 556
QK + G TL +L+ I + +++ I+ K E LI S
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLICS 562
Query: 557 YQRCEIKIIDLGSSCFQTDNLCLYVQS 583
++I ++ ++ ++
Sbjct: 563 KYTDLLRIA------LMAEDEAIFEEA 583
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 518 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 575
TL L + Q + +E+L S IH DL NIL+ KI D G + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDP 247
Query: 576 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
+ YV+ R APE I Y + D+WS G +L E+++
Sbjct: 248 D---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 53/234 (22%)
Query: 420 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 468
+G AF +VFQA+ V +K++K + DF E L+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEF- 107
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFN 509
D +I++L + + ++ E LR+ +
Sbjct: 108 -----DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
S G + I RQ + YL +H DL N L+ KI D G
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGL 220
Query: 570 S--CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 615
S + D Y + PE I Y + D+W+ G +L E+++
Sbjct: 221 SRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2z0u_A | 155 | WW domain-containing protein 1; C2 domain, alterna | 99.67 | |
| 1v27_A | 141 | Regulating synaptic membrane exocytosis protein 2; | 99.61 | |
| 3fbk_A | 153 | RGS3, RGP3, regulator of G-protein signaling 3; al | 99.6 | |
| 3rdl_A | 137 | Protein kinase C alpha type; protein kinase PKC, t | 99.6 | |
| 1a25_A | 149 | CALB, protein kinase C (beta); calcium++/phospholi | 99.59 | |
| 2bwq_A | 129 | Regulating synaptic membrane exocytosis protein 2; | 99.58 | |
| 2dmg_A | 142 | KIAA1228 protein; beta-sandwich, structural genomi | 99.58 | |
| 2b3r_A | 134 | Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA | 99.58 | |
| 3fdw_A | 148 | Synaptotagmin-like protein 4; structural genomics, | 99.57 | |
| 1wfm_A | 138 | Synaptotagmin XIII; C2 domain, exocytosis, neurotr | 99.57 | |
| 1w15_A | 153 | Synaptotagmin IV; metal binding protein, endocytos | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 1ugk_A | 138 | Synaptotagmin IV, KIAA1342; beta sandwich, structu | 99.55 | |
| 3n5a_A | 138 | Synaptotagmin-7; calcium/phospholipid binding prot | 99.55 | |
| 2enp_A | 147 | B/K protein; C2 type 1,beta sandwich, structural g | 99.55 | |
| 3f04_A | 143 | Synaptotagmin-1; C2A, calcium, cell junction, cyto | 99.54 | |
| 2cm5_A | 166 | Rabphilin-3A; protein transport, zinc-finger, Ca2+ | 99.54 | |
| 1rsy_A | 152 | Synaptotagmin I; calcium/phospholipid binding prot | 99.53 | |
| 1tjx_A | 159 | Similar to synaptotagmini/P65; C2B domain, calcium | 99.53 | |
| 2q3x_A | 171 | Regulating synaptic membrane exocytosis protein 1; | 99.52 | |
| 2d8k_A | 141 | Synaptotagmin VII; exocytosis, calcium binding, ly | 99.52 | |
| 2chd_A | 142 | Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium | 99.52 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.51 | |
| 1rh8_A | 142 | Piccolo protein; beta-sandwich, metal binding prot | 99.49 | |
| 1rlw_A | 126 | Phospholipase A2, CALB domain; hydrolase, C2 domai | 99.45 | |
| 1dqv_A | 296 | Synaptotagmin III; beta sandwich, calcium ION, C2 | 99.43 | |
| 2fk9_A | 157 | Protein kinase C, ETA type; ATP-binding, metal-bin | 99.43 | |
| 3pyc_A | 132 | E3 ubiquitin-protein ligase smurf1; phospholipid b | 99.42 | |
| 2dmh_A | 140 | Myoferlin; beta-sandwich, FER-1-like protein 3, mu | 99.42 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.41 | |
| 3b7y_A | 153 | E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL- | 99.41 | |
| 3m7f_B | 176 | E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB1 | 99.4 | |
| 1gmi_A | 136 | Protein kinase C, epsilon type; PKC, C2 domain, X- | 99.4 | |
| 2ep6_A | 133 | MCTP2 protein; beta sandwich, Ca2+ binding, membra | 99.39 | |
| 2r83_A | 284 | Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cel | 99.38 | |
| 1wfj_A | 136 | Putative elicitor-responsive gene; C2 domain, rike | 99.37 | |
| 3nsj_A | 540 | Perforin-1; pore forming protein, immune system; H | 99.35 | |
| 3kwu_A | 148 | MUNC13-1; calcium binding protein, phospholipid bi | 99.32 | |
| 2nq3_A | 173 | Itchy homolog E3 ubiquitin protein ligase; C2 doma | 99.28 | |
| 2cjt_A | 131 | UNC-13 homolog A, MUNC13-1; phorbol-ester binding, | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 2cjs_A | 167 | UNC-13 homolog A, MUNC13-1; neurotransmitter trans | 99.14 | |
| 1cjy_A | 749 | CPLA2, protein (cytosolic phospholipase A2); lipid | 99.08 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.05 | |
| 3jzy_A | 510 | Intersectin 2; C2 domain, structural genomics cons | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3l9b_A | 144 | Otoferlin; C2-domain, beta-sheets, cell membrane, | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3bxj_A | 483 | RAS GTPase-activating protein syngap; GTPase activ | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 98.19 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.86 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.08 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.91 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.35 | |
| 2enj_A | 138 | NPKC-theta, protein kinase C theta type; beta-sand | 95.16 | |
| 1yrk_A | 126 | NPKC-delta, protein kinase C, delta type; C2 domai | 94.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.4 |
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=521.60 Aligned_cols=463 Identities=20% Similarity=0.262 Sum_probs=352.7
Q ss_pred CCCccCCCCCCCCCCCCCCCCeeeecc--cccccccCceeecccccccccccccccCCCccccccccCCCCCccccccee
Q 005415 147 EGYFMTPSYGGSDFFGCPSEDKFIMTS--EADRLFENPLAVYDQSEGLHSEASTDYLDKPCLFHIVPLNDDKEVGVTDYY 224 (697)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~ 224 (697)
.|.|....|..+- -|+-+.+++.|. ...+|..|...+| +.|..+++++|+.+.+...+..
T Consensus 102 ~h~~~~~~~~~~~--~C~~C~~~l~g~~~qg~~C~~C~~~~H----------------~~C~~~v~~~C~~d~~~~~g~i 163 (674)
T 3pfq_A 102 KHKFKIHTYSSPT--FCDHCGSLLYGLIHQGMKCDTCMMNVH----------------KRCVMNVPSLCGTDHTERRGRI 163 (674)
T ss_dssp CCCCCEECCSSCC--CCSSSCSCCBBSSSCEECCSSSCCCBC----------------SSTTSSSCCCSSSCSSCCSCEE
T ss_pred CcceeecCCCCCC--CCCccccccchhhcCccccccCCcchh----------------hhhhhccCcccccccccccccc
Confidence 4777776665555 688888887764 5778888888888 8999999999998666555433
Q ss_pred eccccCCCccCCccccccccccccCCCCCccccCCCCccccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccc
Q 005415 225 RFEKTNQPEAGGIKEKLKDCAAYGCSEPLCKCCAGEGKINNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKS 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k 303 (697)
. -... | ..+.|+|.|.+| +|.+||.+|.+|||||+.++|+++...+
T Consensus 164 ~-------------~~~~----~----------------~~~~L~V~v~~a~~L~~~d~~g~sDPyvkv~l~p~~~~~~k 210 (674)
T 3pfq_A 164 Y-------------IQAH----I----------------DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESK 210 (674)
T ss_dssp E-------------EEEE----E----------------CSSEEEEEEEEEESCCCCSTTSSCCEEEEEEEESCSSCCSC
T ss_pred c-------------ccce----e----------------ccceeeeeeecccccCCCCcccccCcccccccccCcccccc
Confidence 2 1111 1 346899999999 9999999999999999999999988889
Q ss_pred cceeecccCCCcceecccccCccccccccccccccccccCCCCCCCCcccccccCcccccccCCCCcccccchhhHhHhh
Q 005415 304 SSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 383 (697)
Q Consensus 304 ~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~e~~~~~~~l~~~~l~ee~e 383 (697)
+||+++++|+||+|||+|.|. +.....++.|.++|||+|.+++++++|++.++..++......+|..++-. ++-+
T Consensus 211 ~kT~v~~~tlnP~wne~f~f~--~~~~~~~~~L~v~v~d~d~~~~dd~iG~~~i~l~~l~~~~~~~w~~Lls~---~~g~ 285 (674)
T 3pfq_A 211 QKTKTIKSSLNPEWNETFRFQ--LKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQ---EEGE 285 (674)
T ss_dssp EECCCCSSCSSCEEEEEEEEE--CCSTTTTCEEEEEEEECCSSSCCEECCBCCCBTTHHHHCCEEEEEECBCT---TGGG
T ss_pred ccccccccccCCCccceeeee--cccCCccceeeeEEeecccccccccccccccchhhhccCCcccceeeccc---ccce
Confidence 999999999999999999998 77666667799999999999999999999988877776665554433211 1111
Q ss_pred hhhhhh-------------hhcccC--CCc---CC--CCCc-----ceeeCceecCceEEEEEeccCCCCceEEEEECCC
Q 005415 384 IFHLRI-------------IHRKNR--TGF---EE--NKDL-----PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT 438 (697)
Q Consensus 384 ~~~lri-------------i~~~~~--~~~---~~--~~~~-----pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~ 438 (697)
.+.... ..+... .+. .. .... ......+..++|++++.||+|+||+||+|+++.+
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~ 365 (674)
T 3pfq_A 286 YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGT 365 (674)
T ss_dssp TCCEECCC----------------------------------------------CTTEEEEEESSBTTTBCEEEEEESSS
T ss_pred ecccCCCCccccccHHHHHHHhhccccCCCCCcccccccccccccccCccccccccceEEEEEEccCCCEEEEEEEECCC
Confidence 110000 000000 000 00 0000 0001122347899999999999999999999999
Q ss_pred CcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcccc-chHHHHHhhhccC
Q 005415 439 GVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG 513 (697)
Q Consensus 439 g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~ 513 (697)
++.||||++++.. ........|..++..+. .||+|+++++++...+.+||||||+.+ +|..++.....
T Consensus 366 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-- 438 (674)
T 3pfq_A 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-- 438 (674)
T ss_dssp CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT-----CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS--
T ss_pred CcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc-----CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC--
Confidence 9999999998532 23455667777776553 489999999999999999999999975 67666654332
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccc---cccccccccCCCCCch
Q 005415 514 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPE 590 (697)
Q Consensus 514 ~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~---~~~~~~~gt~~Y~APE 590 (697)
+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.... ......+||+.|+|||
T Consensus 439 ----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~--~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE 512 (674)
T 3pfq_A 439 ----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512 (674)
T ss_dssp ----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS--SSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHH
T ss_pred ----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC--CCcEEEeecceeeccccCCcccccccCCCcccCHh
Confidence 899999999999999999999999999999999999985 7899999999997532 2344578999999999
Q ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHH
Q 005415 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFAN 670 (697)
Q Consensus 591 ~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~ 670 (697)
++.+..|+.++|||||||+||||++|++||.+.+..+++.+|+.....+|. .+.....+....
T Consensus 513 ~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----------------~~s~~~~~li~~ 575 (674)
T 3pfq_A 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK-----------------SMSKEAVAICKG 575 (674)
T ss_dssp HHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT-----------------TSCHHHHHHHHH
T ss_pred hhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc-----------------cCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999988764443332 222334445555
Q ss_pred HHHHhhhhccCH-----HHHH--HhhcccCCC
Q 005415 671 IFISLVVIRLTL-----EYAA--LWLFGIDQN 695 (697)
Q Consensus 671 l~~~~~~~r~t~-----e~~~--~wl~~~~~n 695 (697)
++...|..|++. ++++ +|+..++|.
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 666678889886 7777 999987764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=405.73 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=215.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+++.||||++.+. ......+.+|+++++.++ |||||+++++|.+.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC------CTTBCCEEEEEECSS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEeCC
Confidence 5799999999999999999999999999999999753 234467888999988774 899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+||||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~--~g~vKl~DFG 177 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 177 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC--CCCEEEEEcC
Confidence 9999999997 578888765432 899999999999999999999999999999999999985 8899999999
Q ss_pred Ccccccc-----ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+|+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|++.--.+|.
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~-- 255 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE-- 255 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence 9976532 234578999999999999999999999999999999999999999999999999998764333321
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHH------H--HhhcccCCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYA------A--LWLFGIDQNKI 697 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~------~--~wl~~~~~n~~ 697 (697)
.+..-.++...+++...|..|+|++++ + ||+.+++|++|
T Consensus 256 ---------------~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 256 ---------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ---------------TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ---------------ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 122334555666777778999999875 3 89999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=393.73 Aligned_cols=247 Identities=29% Similarity=0.442 Sum_probs=198.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+++.++ |||||++++++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR------HPHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 6899999999999999999999999999999999753 233457889999999885 899999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+||||||++|+|.+++..... +++..++.+++||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~--~~~vkl~DFGl 158 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 158 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TCCEEECCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC--CCCEEEeecCC
Confidence 9999999999999988865432 899999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|+..... ....+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+..+.+..|....-++|.
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----- 233 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----- 233 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 9765432 345789999999999998886 57999999999999999999999999988888888664333321
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+..-..+...+++...|..|+|+++++ +|++.
T Consensus 234 ------------~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 234 ------------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1222334445555666799999999999 99963
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=404.42 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=204.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++++.||+|+||+||+|+++.+|+.||||++... ......+.+|+.+++.|+ |||||+++++|.+.+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK------HPNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC------CCCCCcEEEEEEECCE
Confidence 6899999999999999999999999999999999753 334567889999999985 8999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+||||||+. |+|.+++..... ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGl 171 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQLGDFGI 171 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT--TCCEEECSTTE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCCEEEccccc
Confidence 999999997 578888764432 23789999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|+..... ....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|+....++...
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~---- 247 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---- 247 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT----
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc----
Confidence 9876543 234689999999999999999999999999999999999999999999999999887643322110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.....+..++..| +...|..|+|+++++ +|+..
T Consensus 248 --------~~s~~~~~li~~~----L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 248 --------HYSYDLRSLVSQL----FKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------TSCHHHHHHHHHH----TCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------cCCHHHHHHHHHH----ccCChhHCcCHHHHhcCHHhhc
Confidence 1123444444444 445688999999999 99863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=401.90 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=208.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.+|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++ |||||+++++|.+.+.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCEEE
Confidence 57999999999999999999999999999999997532 33466789999999885 899999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
|||||+.+ +|.+++.. . .+++..++.++.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+
T Consensus 148 ivmEy~~gg~L~~~l~~-~------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~DFGla~ 218 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-T------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 218 (346)
T ss_dssp EEECCCTTEEHHHHHHH-S------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHHc-C------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC--CCCEEEecCcCce
Confidence 99999985 56665542 1 2899999999999999999999999999999999999985 7899999999997
Q ss_pred ccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.....+....
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~------ 292 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKN------ 292 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSC------
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc------
Confidence 65432 445789999999999999999999999999999999999999999999998888886643222111
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
...+..-..+...+++...|..|+|+++++ +|+..
T Consensus 293 --------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 293 --------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 111222333444445556689999999999 99974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=396.86 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=202.3
Q ss_pred CceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++|++++.||+|+||+||+|++. .+++.||||++++.. ....++.+|+.+++.+ +|||||+++++|.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------NHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC------CCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC------CCCCCCeEEEEEEE
Confidence 57999999999999999999874 468899999997532 2223455666666544 59999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+.+||||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~vKl~D 169 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTD 169 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TSCEEEES
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC--CCCEEecc
Confidence 999999999998 578888765432 899999999999999999999999999999999999985 78999999
Q ss_pred CCCcccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+++.+|.+...++|..
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~- 248 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc-
Confidence 999976432 2345789999999999999999999999999999999999999999999999999987654333321
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQNK 696 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n~ 696 (697)
....+..++..||. ..|..|+| +++++ +|+.+++|++
T Consensus 249 ------------~s~~~~~li~~~L~----~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 249 ------------LSPEAQSLLRMLFK----RNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp ------------SCHHHHHHHHHHTC----SSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred ------------CCHHHHHHHHHHcc----cCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 12344455555544 55777876 68888 9999988764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=402.99 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=208.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
++|+++++||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++ |||||+++++|.+.+.+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC------CCCCCceEEEEEECCEEE
Confidence 57999999999999999999999999999999997533 34467889999999985 899999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
||||||.+ +|.+++... .+++..++.+++||+.||.|||++|||||||||+||||+. ++.+||+|||+|.
T Consensus 225 iVmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~--~g~vKl~DFGla~ 295 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCA 295 (423)
T ss_dssp EEEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT--TCCEEECCCTTCE
T ss_pred EEEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC--CCCEEEecCccce
Confidence 99999985 566665422 1899999999999999999999999999999999999985 7899999999997
Q ss_pred cccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 572 FQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 572 ~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.....+...
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~------- 368 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK------- 368 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-------
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc-------
Confidence 6543 244578999999999999999999999999999999999999999999999888888654322111
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
....+..-..+....++...|..|+|+++++ +|+...
T Consensus 369 -------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 369 -------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1112222333444445556689999999999 999753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=402.47 Aligned_cols=267 Identities=29% Similarity=0.450 Sum_probs=218.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
+.++|++++.||+|+||+||+|+++.+|+.||||+++... ....++.+|+++|+.++ |||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK------HDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC------CCCcceEeeeeecc
Confidence 4578999999999999999999999999999999997532 33456788999999885 8899999999864
Q ss_pred -----cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 488 -----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 488 -----~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
.+.+||||||++|+|.+++.... .+++..++.+++||+.||.|||++|||||||||+|||++. ++.+
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~--~~~~ 197 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCEL 197 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCE
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC--CCCE
Confidence 36799999999999988886432 3999999999999999999999999999999999999995 8899
Q ss_pred EEeeCCCcccccc-------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 563 KIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 563 KL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
||+|||+|+.... .....+||+.|+|||++.+. .++.++||||||||+|||++|++||.+.+..+++..|+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999976432 23457899999999999876 469999999999999999999999999999999999999
Q ss_pred hhCCCCHHHHhhccc--ccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 635 MLGPIDLEMLMQGQE--IYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~--~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..|.++...+..... ...++.. ...+..-..+...+++...|..|+|+++++ +|+...
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 999998776543211 0000000 011223344556666677789999999999 999854
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=385.16 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=200.2
Q ss_pred ceecCce-EEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 410 TVIAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 410 ~~i~~rY-~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
....+|| ++.++||+|+||+||+|.++.+++.||+|++... ......+.+|+.+++.++ |||||+++++|
T Consensus 21 ~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~ 94 (290)
T 3fpq_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSW 94 (290)
T ss_dssp ECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEE
Confidence 3345676 6788899999999999999999999999999753 334567888999998875 89999999999
Q ss_pred Ee----cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccC
Q 005415 486 YH----LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQ 558 (697)
Q Consensus 486 ~~----~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~ 558 (697)
.. ...+||||||+. |+|.+++..... +++..++.|+.||+.||.|||+++ ||||||||+|||++. .
T Consensus 95 ~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-~ 167 (290)
T 3fpq_A 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-P 167 (290)
T ss_dssp EEEETTEEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-T
T ss_pred eeccCCCcEEEEEEeCCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-C
Confidence 75 356899999998 577777764332 899999999999999999999998 999999999999973 3
Q ss_pred cceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 559 RCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
++.+||+|||+|+..... ....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+......+.+.+.. +
T Consensus 168 ~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~ 245 (290)
T 3fpq_A 168 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G 245 (290)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T
T ss_pred CCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C
Confidence 678999999999765443 345789999999999875 6999999999999999999999999876544444333222 2
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..|..... ...+.+..++..||. ..|..|+|+++++ +|+..
T Consensus 246 ~~~~~~~~---------~~~~~~~~li~~~L~----~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 VKPASFDK---------VAIPEVKEIIEGCIR----QNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCGGGGG---------CCCHHHHHHHHHHSC----SSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCCc---------cCCHHHHHHHHHHcc----CChhHCcCHHHHhcCccccC
Confidence 22221110 112355666666665 4588999999999 99974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.35 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=209.0
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|.+.+.||+|+||+||+|++. .+++.||||+++.. ......+.+|+++++.++ |||||++++++.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~------HpnIV~l~g~~~ 85 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ------HEHIVKFYGVCV 85 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC------CCCCccEEEEEe
Confidence 467999999999999999999875 35789999999754 334567888999888774 899999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhc-------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~-------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
+.+.++|||||++ |+|.+++..... ......+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~-- 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-- 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC--
Confidence 9999999999997 678888765321 122334899999999999999999999999999999999999985
Q ss_pred cceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 005415 559 RCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I 632 (697)
++.+||+|||+|+...... ....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+++..|
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 8899999999997543321 22468999999999999999999999999999999999 99999999999888888
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.+...++.+ -.....+..++..||... |..|+|++++..||..
T Consensus 244 ~~~~~~~~p------------~~~~~~~~~li~~cl~~d----P~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 244 TQGRVLQRP------------RTCPQEVYELMLGCWQRE----PHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHTCCCCCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCC------------ccchHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHH
Confidence 664322111 124567889999999765 8889999999988864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=389.74 Aligned_cols=240 Identities=22% Similarity=0.272 Sum_probs=193.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.+ +|||||+++++|.+.+.+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l------~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL------SSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC------CCTTBCCEEEEEEETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC------CCCCCCcEEEEEEECCEEEE
Confidence 569999999999999999999999999999999986532 24677777665 48999999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc-eEEEeeCCCcc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSC 571 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~-~vKL~DFGla~ 571 (697)
||||+. ++|.+++..... +++..++.++.||+.||.|||++|||||||||+||||+. ++ .+||+|||+|+
T Consensus 128 vmEy~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~--~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHAL 199 (336)
T ss_dssp EECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT--TSCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC--CCCEEEEeeCCCCe
Confidence 999998 578888765432 899999999999999999999999999999999999985 55 69999999997
Q ss_pred ccccc--------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 572 FQTDN--------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 572 ~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
..... ....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+++.+|... +++..
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~~- 276 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPIR- 276 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGGG-
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCch-
Confidence 65432 12357999999999999999999999999999999999999999988777777777552 22211
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYA 685 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~ 685 (697)
.+ +..+.....+...+.+...|..|+|++++
T Consensus 277 --------~~---~~~~s~~~~~li~~~L~~dP~~R~sa~el 307 (336)
T 4g3f_A 277 --------EI---PPSCAPLTAQAIQEGLRKEPVHRASAMEL 307 (336)
T ss_dssp --------GS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --------hc---CccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 01 11222333334444455668889999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=379.88 Aligned_cols=256 Identities=19% Similarity=0.195 Sum_probs=208.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
-...+++.++||+|+||+||+|... .+++.||||+++.. ....+.+.+|+.++..++ |||||+++++
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~------HpNIV~l~g~ 97 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ------HPNVVCLLGV 97 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC------CCCCCCcceE
Confidence 3467899999999999999999853 46789999999743 234567889999999885 8999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
+.....++|||||++ |+|.+++...... .....+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999997 6788888643211 11234899999999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHH
Q 005415 554 IKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVM 627 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e 627 (697)
++. ++.+||+|||+++..... .....||+.|+|||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus 178 l~~--~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 178 VYD--KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp ECG--GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred ECC--CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 995 889999999999764322 233578999999999999999999999999999999999 999999999988
Q ss_pred HHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
++..|......+.+ -.....++.+|..||... |..|+|++++...|..
T Consensus 256 ~~~~i~~~~~~~~p------------~~~~~~~~~li~~C~~~d----P~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 256 VVEMIRNRQVLPCP------------DDCPAWVYALMIECWNEF----PSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCc------------ccchHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHh
Confidence 88887653322211 134567889999999876 7788888888755543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=380.63 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=204.7
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++++.++ |||||++++++.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~------HpnIV~l~g~~~ 113 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ------HQHIVRFFGVCT 113 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEE
Confidence 357899999999999999999864 36889999999754 344567888999988774 899999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhcc---------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQES---------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~---------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
+...++|||||++ |+|.+++...... .....+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999998 5787877643221 11234899999999999999999999999999999999999985
Q ss_pred cCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~ 630 (697)
++.+||+|||+|+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 194 --~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 --GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp --TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred --CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 889999999999764322 223578999999999999999999999999999999999 999999999988888
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.|.+...++.+ -.....+..++..||... |..|+|++++..+|..
T Consensus 272 ~i~~g~~~~~p------------~~~~~~~~~li~~cl~~d----P~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 272 CITQGRELERP------------RACPPEVYAIMRGCWQRE----PQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHTCCCCCC------------TTCCHHHHHHHHHHCCSS----TTTSCCHHHHHHHHHH
T ss_pred HHHcCCCCCCc------------ccccHHHHHHHHHHcCcC----hhHCcCHHHHHHHHHH
Confidence 88664322111 124567889999999865 8889999999877654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=382.01 Aligned_cols=265 Identities=18% Similarity=0.280 Sum_probs=208.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++.++||+|+||+||+|+++ .+++.||||++..... ..+..+|+++++.+. +||||++++++|.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~-----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAG-----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTC-----SBTTBCCCSEEEEET
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhc-----CCCCCceEEEEEEEC
Confidence 3578999999999999999999874 4678999999876543 356788999998874 489999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+++|+||||++ ++|.+++. .+++..++.+++||+.||.|||++||+||||||+|||++. +.+.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-RLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-CCCeEEECcC
Confidence 99999999997 56766652 1889999999999999999999999999999999999985 3479999999
Q ss_pred CCccccccc-------------------------------cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHh
Q 005415 568 GSSCFQTDN-------------------------------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWT 615 (697)
Q Consensus 568 Gla~~~~~~-------------------------------~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELlt 615 (697)
|+|+..... ....+||+.|+|||++.+. .|+.++||||+|||+|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999653321 2235799999999999876 48999999999999999999
Q ss_pred CCCCC-CCCcHHHHHHHHHHhhCCCCHHHHhhccccccc-------------------------------------ccCC
Q 005415 616 GEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY-------------------------------------FTKE 657 (697)
Q Consensus 616 G~~PF-~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~-------------------------------------~~~~ 657 (697)
|++|| .+.+..+++.+|...+|+++............. ....
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999 566788999999999886554333211000000 0001
Q ss_pred chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 658 YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 658 ~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..+..-..+...+++..-|..|+|+++++ ||+.+.
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 11223334556666777788999999999 999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.80 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=194.5
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
++-.+++++.++||+|+||+||+|++. ..||||+++. +......+.+|+.+++.++ |||||++++++.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~------HpNIV~l~g~~~ 102 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR------HVNILLFMGYMT 102 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEE
Confidence 344578899999999999999999853 3599999874 2344567888999888774 899999999875
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
. +.++|||||++ |+|.+++..... .+++..+..|+.||+.||.|||+++||||||||+|||++. ++.+||+
T Consensus 103 ~-~~~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~--~~~~Ki~ 174 (307)
T 3omv_A 103 K-DNLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE--GLTVKIG 174 (307)
T ss_dssp S-SSCEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET--TEEEEEC
T ss_pred C-CeEEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC--CCcEEEe
Confidence 4 56899999998 577777754322 2899999999999999999999999999999999999985 8899999
Q ss_pred eCCCcccccc-----ccccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 566 DLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 566 DFGla~~~~~-----~~~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
|||+|+.... .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 9999976432 23346899999999999743 589999999999999999999999998776666655554322
Q ss_pred CCC-HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 638 PID-LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 638 ~~p-~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.+| ... ..-.....+..++..||... |..|+|++++.
T Consensus 255 ~~p~~~~--------~~~~~~~~l~~li~~cl~~d----P~~RPs~~ei~ 292 (307)
T 3omv_A 255 ASPDLSK--------LYKNCPKAMKRLVADCVKKV----KEERPLFPQIL 292 (307)
T ss_dssp CCCCSTT--------SCTTSCHHHHHHHHHHTCSS----STTSCCHHHHH
T ss_pred CCCCccc--------ccccchHHHHHHHHHHcCCC----HhHCcCHHHHH
Confidence 222 110 01123457888999999866 78888988877
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=379.63 Aligned_cols=282 Identities=36% Similarity=0.570 Sum_probs=242.4
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..++.+..+|++++.||+|+||.||+|.+..+++.||||+++..........+|+.+++.+++....+|+||+++++++.
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34677889999999999999999999999999999999999987777788899999999999988889999999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...++++||||+.++|.+++....... +++..++.++.||+.||.|||++||+||||||+|||++.+....+||+|
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNKFQG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTTTCC----CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred cCCeEEEEEeccCCCHHHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999999999999887654322 8999999999999999999999999999999999999963333499999
Q ss_pred CCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 567 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 567 FGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
||++...........+|+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..|++.++.++.+++..
T Consensus 246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 246 FGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 99998877777778899999999999999999999999999999999999999999999999999999999999998877
Q ss_pred cccccccccCCch----------------------------------h--------hhhHHHHHHHHHHHhhhhccCHHH
Q 005415 647 GQEIYKYFTKEYD----------------------------------L--------YYINEVCFANIFISLVVIRLTLEY 684 (697)
Q Consensus 647 ~~~~~~~~~~~~~----------------------------------l--------~~i~~~cw~~l~~~~~~~r~t~e~ 684 (697)
......++..... + .....+...+.+...|..|+|+++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 6655554432210 0 112233444445566889999999
Q ss_pred HH--Hhhccc
Q 005415 685 AA--LWLFGI 692 (697)
Q Consensus 685 ~~--~wl~~~ 692 (697)
++ +|+...
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 99 999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=371.31 Aligned_cols=294 Identities=30% Similarity=0.491 Sum_probs=241.1
Q ss_pred cCCCcCCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCC-
Q 005415 394 NRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP- 472 (697)
Q Consensus 394 ~~~~~~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~- 472 (697)
....+.....+|+.+++++.++|+++++||+|+||+||+|++..+++.||||+++........+.+|+.+++.+++...
T Consensus 17 ~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 96 (397)
T 1wak_A 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96 (397)
T ss_dssp -----CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTT
T ss_pred ccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCC
Confidence 3456677788999999999999999999999999999999999999999999998877677888999999999987532
Q ss_pred -CCCCceeEEEEEEE----ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccC
Q 005415 473 -ADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCD 546 (697)
Q Consensus 473 -~~hpnIv~l~~~f~----~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrD 546 (697)
.+|+||+++++++. ....+++||||+++++++.+...... .+++..++.++.||+.||.|||++ ||+|||
T Consensus 97 ~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~givHrD 172 (397)
T 1wak_A 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ----GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTD 172 (397)
T ss_dssp CGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECCC
T ss_pred CCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 34889999999998 45689999999999998887654322 289999999999999999999998 999999
Q ss_pred CCCccccccccC-----------------------------------------------cceEEEeeCCCcccccccccc
Q 005415 547 LKPENILIKSYQ-----------------------------------------------RCEIKIIDLGSSCFQTDNLCL 579 (697)
Q Consensus 547 LKP~NILl~~~~-----------------------------------------------~~~vKL~DFGla~~~~~~~~~ 579 (697)
|||+|||++.++ ...+||+|||++.........
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~ 252 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE 252 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCS
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCcc
Confidence 999999998521 137999999999887776667
Q ss_pred ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHHHhhCCCCHHHHhhccccccc
Q 005415 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA------VVMILARIIGMLGPIDLEMLMQGQEIYKY 653 (697)
Q Consensus 580 ~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~------~~e~l~~I~~~lg~~p~e~~~~~~~~~~~ 653 (697)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+.+..+.+.++.+|..++..+.....+
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 789999999999999999999999999999999999999997654 67888999999999999988777666565
Q ss_pred ccCCchhh-------------------------hhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 654 FTKEYDLY-------------------------YINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 654 ~~~~~~l~-------------------------~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
|.....+. ..+.+...+.+...|..|+|+++++ +|+..
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 55432211 1122333333444578899999999 99863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=363.75 Aligned_cols=251 Identities=24% Similarity=0.264 Sum_probs=184.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC--
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~-- 489 (697)
++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+++.++ |||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~------HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEecCcc
Confidence 4699999999999999999999999999999998743 233456788888888774 899999999998654
Q ss_pred ----------eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 490 ----------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 490 ----------~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++||||||+. ++|.+++..... ........++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-- 153 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-- 153 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC--
Confidence 4799999997 567777754322 112556778899999999999999999999999999999985
Q ss_pred cceEEEeeCCCccccccc---------------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005415 559 RCEIKIIDLGSSCFQTDN---------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 623 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~---------------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~ 623 (697)
++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 789999999999765432 123579999999999999999999999999999999996 88654
Q ss_pred cHH-HHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 624 AVV-MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 624 ~~~-e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
... ..+..+.. +..|+.+... .+....++..| +...|..|+|+++++ +|+...++
T Consensus 231 ~~~~~~~~~~~~--~~~p~~~~~~----------~~~~~~li~~~----L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 231 MERVRTLTDVRN--LKFPPLFTQK----------YPCEYVMVQDM----LSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHHHHHHT--TCCCHHHHHH----------CHHHHHHHHHH----TCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred cHHHHHHHHHhc--CCCCCCCccc----------CHHHHHHHHHH----cCCChhHCcCHHHHhcCHhhCCCCC
Confidence 322 22222221 2333322111 11233344444 445588999999999 89987664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=392.62 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=215.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+.++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+|+.+|+.++ |||||+++++|.+...
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCE
Confidence 3478999999999999999999999999999999997543 34567788999999885 8999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+||||||+. |+|.+++.... ..+++..++.+++||+.||.|||++||+||||||+|||++....+.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 999999997 47777765322 128999999999999999999999999999999999999875568999999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++...+..
T Consensus 304 a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 382 (573)
T 3uto_A 304 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG- 382 (573)
T ss_dssp CEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT-
T ss_pred eeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC-
Confidence 9876543 3456899999999999999999999999999999999999999999999999999877665555433221
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
-......+ ..+++...|..|+|+++++ +|+....
T Consensus 383 --------~s~~~~dl----i~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 383 --------ISEDGKDF----IRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp --------SCHHHHHH----HHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred --------CCHHHHHH----HHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 11122333 3344555688999999999 8998543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=371.38 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=202.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+-.++|++.+.||+|+||+||+|.+..+ ++.||||+++... .....+.+|++++..+.+ |||||++++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h-----hpnIV~l~g 135 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 135 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC-----CCcEEEEEE
Confidence 3457899999999999999999987543 4689999997542 334678899999999974 589999999
Q ss_pred EEEec-CeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 484 YFYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 484 ~f~~~-~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
+|... ..++||||||+ |+|.+++...... .....+++..+..++.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98764 67899999997 6788888654321 112348999999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcH
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~ 625 (697)
||++. ++.+||+|||+|+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 216 ILl~~--~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 216 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeeCC--CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99995 889999999999765332 223568999999999999999999999999999999998 9999998765
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.+.+.+++.....++. + -.....++.+|..||... |..|+|++++.
T Consensus 294 ~~~~~~~i~~g~~~~~---------p--~~~~~~~~~li~~c~~~d----P~~RPt~~eil 339 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRA---------P--DYTTPEMYQTMLDCWHGE----PSQRPTFSELV 339 (353)
T ss_dssp SHHHHHHHHHTCCCCC---------C--TTCCHHHHHHHHHHTCSS----GGGSCCHHHHH
T ss_pred HHHHHHHHHcCCCCCC---------C--ccCCHHHHHHHHHHcCcC----hhHCcCHHHHH
Confidence 4444444332211111 1 123567889999999865 78888888887
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=366.80 Aligned_cols=287 Identities=36% Similarity=0.538 Sum_probs=243.9
Q ss_pred CcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 403 ~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.+++..++.+.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+++.....|++|++++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 45677788899999999999999999999999999999999999998777777888999999999877666778899999
Q ss_pred EEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--hcCccccCCCCccccccccCcc
Q 005415 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH--s~gIvHrDLKP~NILl~~~~~~ 560 (697)
+++...+..++||||++++|.+++...... .+++..++.++.||+.||.||| +.||+||||||+|||++.+.++
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999999999988755422 2889999999999999999999 5799999999999999755678
Q ss_pred eEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 561 EIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.+|++.++.++
T Consensus 199 ~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred cEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 89999999998877766677899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcccccccccCCch----------------------hh-------------------------hhHHHHHHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYD----------------------LY-------------------------YINEVCFANIFI 673 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~----------------------l~-------------------------~i~~~cw~~l~~ 673 (697)
...+.......++|...+. +. ....+...+.+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 9887765544443332110 00 122344445555
Q ss_pred HhhhhccCHHHHH--HhhcccC
Q 005415 674 SLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 674 ~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..|..|+|+++++ +|+....
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC--
T ss_pred CChhhCCCHHHHhcCcccccCC
Confidence 5688899999999 9998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=391.56 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=205.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+|..++..++. .+|||||+++++|.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~---~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECSS
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh---CCCCCEeEEEEEEEECC
Confidence 57999999999999999999999999999999997532 223445666666766654 35999999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+||||||+. |+|..++..... +++..++.++.||+.||.|||++|||||||||+||||+. +|.+||+|||
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~------l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~--~G~vKL~DFG 337 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLG 337 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC--CCCEEecccc
Confidence 9999999998 567777764432 899999999999999999999999999999999999995 8899999999
Q ss_pred Ccccccc-ccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTD-NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~---~~e~l~~I~~~lg~~p~e~ 643 (697)
+|+.... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.+ ..++...+...--..|
T Consensus 338 lA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p--- 414 (689)
T 3v5w_A 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--- 414 (689)
T ss_dssp TCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC---
T ss_pred eeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC---
Confidence 9976544 3456799999999999974 579999999999999999999999997643 3333444433221111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQNK 696 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n~ 696 (697)
..+..-..+....++...|..|++ +++++ +|+.+++|++
T Consensus 415 --------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 415 --------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp --------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred --------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 123334455666667777888988 68888 9999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.66 Aligned_cols=283 Identities=28% Similarity=0.475 Sum_probs=236.2
Q ss_pred CcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 403 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 403 ~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.+....+.++.++|+++++||+|+||.||+|++..+++.||||+++...........|+.+++.+.. ....||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~-~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN-DDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC-CSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc-cCCCCCCeeccc
Confidence 3455667889999999999999999999999999999999999998776666778889999999975 345799999999
Q ss_pred EEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc------
Q 005415 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS------ 556 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~------ 556 (697)
+++...+..++||||++++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 999999999999999988999988755432 2889999999999999999999999999999999999974
Q ss_pred -----------------cCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005415 557 -----------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 619 (697)
Q Consensus 557 -----------------~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~P 619 (697)
...+.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 236789999999998777666677899999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHHhhCCCCHHHHhhcccc--cccccCC---------ch-h-----------------hhhHHHHHHH
Q 005415 620 FPNDAVVMILARIIGMLGPIDLEMLMQGQEI--YKYFTKE---------YD-L-----------------YYINEVCFAN 670 (697)
Q Consensus 620 F~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~--~~~~~~~---------~~-l-----------------~~i~~~cw~~ 670 (697)
|.+.+..+.+..+....+++|..++...... ..++... .. . .....+...+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 9999999999999999999998876643211 1111110 00 0 0122244444
Q ss_pred HHHHhhhhccCHHHHH--Hhhc
Q 005415 671 IFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 671 l~~~~~~~r~t~e~~~--~wl~ 690 (697)
.+...|..|+|+++++ +|+.
T Consensus 339 ~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGC
T ss_pred HhcCChhhCCCHHHHhcCcccC
Confidence 4556688999999999 9974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.97 Aligned_cols=287 Identities=30% Similarity=0.480 Sum_probs=242.2
Q ss_pred cceeeCceecCceEEEEEeccCCCCceEEEEE-CCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQD-LHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 404 ~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d-~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++...++++.++|++++.||+|+||.||+|.+ ..+++.||||+++..........+|+.+++.+++.....|++|++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 45667889999999999999999999999998 56889999999987776677889999999999998888889999999
Q ss_pred EEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC----
Q 005415 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---- 558 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~---- 558 (697)
+++......++||||++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99999999999999999999998875432 2388999999999999999999999999999999999998533
Q ss_pred -------------cceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 559 -------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 559 -------------~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998777666677899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhCCCCHHHHhhccccccccc---------------------------CCchhhhhHHHHHHHHHHHhhhh
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFT---------------------------KEYDLYYINEVCFANIFISLVVI 678 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~---------------------------~~~~l~~i~~~cw~~l~~~~~~~ 678 (697)
.+.+..+...++++|..++........+.. ........+.+.....+...|..
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 999999999999999988765432221110 01111122334444555556888
Q ss_pred ccCHHHHH--HhhcccCC
Q 005415 679 RLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 679 r~t~e~~~--~wl~~~~~ 694 (697)
|+|+++++ +|+...++
T Consensus 320 Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 320 RITLREALKHPFFDLLKK 337 (339)
T ss_dssp SCCHHHHTTSGGGGGGGC
T ss_pred ccCHHHHhcCHHHHHHhc
Confidence 99999999 99987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.80 Aligned_cols=290 Identities=29% Similarity=0.447 Sum_probs=244.9
Q ss_pred CCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCC-cEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCce
Q 005415 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 478 (697)
Q Consensus 400 ~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g-~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnI 478 (697)
..+.+++.+++.+.++|++++.||+|+||.||+|.+..++ +.||||+++........+.+|+.+++.+++.....++++
T Consensus 5 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 84 (355)
T 2eu9_A 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84 (355)
T ss_dssp TTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred cCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeE
Confidence 4566788899999999999999999999999999998776 799999998776667788899999999998877778889
Q ss_pred eEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc--
Q 005415 479 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-- 556 (697)
Q Consensus 479 v~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-- 556 (697)
+.+++++....+.++||||+++++.+.+...... .+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp CCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCC
T ss_pred EEeeeeeeeCCeEEEEEeccCCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccc
Confidence 9999999999999999999999998887654322 2899999999999999999999999999999999999943
Q ss_pred ---------------cCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 557 ---------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 557 ---------------~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
...+.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 14678999999999877766667789999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccC---------------------------CchhhhhHHHHHHHHHHH
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK---------------------------EYDLYYINEVCFANIFIS 674 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~---------------------------~~~l~~i~~~cw~~l~~~ 674 (697)
+.+..+.+..+...++++|..++........++.. .......+.+.....+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 99999999999999999999887665433222211 011111233444455556
Q ss_pred hhhhccCHHHHH--HhhcccC
Q 005415 675 LVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 675 ~~~~r~t~e~~~--~wl~~~~ 693 (697)
.|..|+|+++++ +|+.+.+
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCC
T ss_pred ChhhCcCHHHHhcChhhcCCC
Confidence 688999999999 9998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.62 Aligned_cols=279 Identities=25% Similarity=0.382 Sum_probs=218.2
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+++++.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.++.. .||||+++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~niv~~ 79 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF---EHPNVVRL 79 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH---CCTTBCCE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc---CCCCeEEe
Confidence 46778899999999999999999999999999999999987422 2234677888888888753 48999999
Q ss_pred EEEEEecC-----eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 482 YDYFYHLE-----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 482 ~~~f~~~~-----~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
++++.... ..++||||+.++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 99998764 58999999999999888754332 2899999999999999999999999999999999999985
Q ss_pred cCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++.+
T Consensus 156 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 156 --GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp --TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred --CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 789999999999765432 3446789999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCHHHHhhccccccc-ccC---------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 635 MLGPIDLEMLMQGQEIYKY-FTK---------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~-~~~---------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
.++.++...+.......+. +.. ...+.....+...+++...|..|.|+++++ +|+...+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~ 306 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence 9998887665433221110 100 112233334455556666789999999999 999987765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.65 Aligned_cols=250 Identities=19% Similarity=0.198 Sum_probs=181.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (697)
..+|.+.++||+|+||+||+|++ +|+.||||+++.... .....|.+++. ....+|||||++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~----~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQ----TVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHH----HhcCCCCCCCcEEEEEEecCCCc
Confidence 56799999999999999999986 689999999976543 23333333322 22346999999999998653
Q ss_pred -eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc--------CccccCCCCccccccccCc
Q 005415 490 -HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 490 -~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~--------gIvHrDLKP~NILl~~~~~ 559 (697)
.+||||||++ |+|.+++... .+++..+..++.|++.||.|||++ +||||||||+|||++. +
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~--~ 144 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--N 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT--T
T ss_pred eEEEEEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC--C
Confidence 6899999998 5777777532 188999999999999999999987 8999999999999985 8
Q ss_pred ceEEEeeCCCccccccc-------cccccccCCCCCchhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCc--
Q 005415 560 CEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDA-- 624 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~-------~~~~~gt~~Y~APE~l~~~------~~s~ksDIWSLGviL~ELltG~~PF~~~~-- 624 (697)
+.+||+|||+|+..... ....+||+.|+|||++.+. .++.++|||||||+||||+||.+||....
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 89999999999765432 1235799999999999764 36779999999999999999977663221
Q ss_pred -------------HHHHHHHHHHhhCCCC-HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 625 -------------VVMILARIIGMLGPID-LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 625 -------------~~e~l~~I~~~lg~~p-~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..+....+....-.|+ +..... ......+..++..||... |..|+|++++..-|.
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~-------~~~~~~l~~li~~cl~~d----P~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS-------CEALRVMAKIMRECWYAN----GAARLTALRIKKTLS 293 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGS-------SHHHHHHHHHHHTTCCSS----GGGSCCHHHHHHHHH
T ss_pred cccchhcccccchHHHHHHHHhcccCCCCCCccccc-------hHHHHHHHHHHHHHcccC----HhHCcCHHHHHHHHH
Confidence 1222222221111111 110000 011235678899999865 788889988875444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=367.52 Aligned_cols=276 Identities=28% Similarity=0.466 Sum_probs=219.8
Q ss_pred CCCcceeeCc---eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCC
Q 005415 401 NKDLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPAD 474 (697)
Q Consensus 401 ~~~~pv~~~~---~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~ 474 (697)
...+++.+++ .+.++|++++.||+|+||+||+|.+..+++.||||++... .....++.+|+.+++.++
T Consensus 46 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------ 119 (464)
T 3ttj_A 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------ 119 (464)
T ss_dssp CCEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC------
T ss_pred ccceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC------
Confidence 4456666665 4578999999999999999999999999999999999753 334567788999998874
Q ss_pred CCceeEEEEEEEec------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 475 EHHILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 475 hpnIv~l~~~f~~~------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
||||+++++++... ..+|+||||+++++...+.. .+++..++.++.||+.||.|||++||+|||||
T Consensus 120 hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk 191 (464)
T 3ttj_A 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 191 (464)
T ss_dssp CTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 88999999999754 46899999999998777642 18899999999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~ 626 (697)
|+|||++. ++.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 192 p~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 192 PSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp GGGEEECT--TSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hHhEEEeC--CCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999995 789999999999776543 34568999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCHHHHhhcccc-cccccC--------------------Cchh----hhhHHHHHHHHHHHhhhhccC
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEI-YKYFTK--------------------EYDL----YYINEVCFANIFISLVVIRLT 681 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~-~~~~~~--------------------~~~l----~~i~~~cw~~l~~~~~~~r~t 681 (697)
+++.+|++.+|.++.+++...... ..++.. .... .....+...+++...|..|+|
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 999999999999998877653211 111111 0001 122345555566666888999
Q ss_pred HHHHH--Hhhccc
Q 005415 682 LEYAA--LWLFGI 692 (697)
Q Consensus 682 ~e~~~--~wl~~~ 692 (697)
+++++ +|+..+
T Consensus 350 a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 350 VDDALQHPYINVW 362 (464)
T ss_dssp HHHHHTSTTTGGG
T ss_pred HHHHhcChhhhhc
Confidence 99999 999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.24 Aligned_cols=276 Identities=27% Similarity=0.369 Sum_probs=221.5
Q ss_pred eeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 406 v~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
...++.+.++|+++++||+|+||+||+|.+. +++.||||+++... .....+.+|+.+++.++ ||||++++
T Consensus 13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 85 (311)
T 3niz_A 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH------HPNIVSLI 85 (311)
T ss_dssp --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC------CCCEeeee
Confidence 3445677899999999999999999999985 58999999997532 23456788999999884 88999999
Q ss_pred EEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 483 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
+++......++||||+++++.+.+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~--~~~~ 158 (311)
T 3niz_A 86 DVIHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGAL 158 (311)
T ss_dssp EEECCSSCEEEEEECCSEEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred eEEccCCEEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC--CCCE
Confidence 99999999999999999998888765432 2889999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCcccccc---ccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 563 KIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 563 KL~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+...++.
T Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp EECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred EEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 9999999976542 2334578999999999987 45899999999999999999999999999999999999999998
Q ss_pred CCHHHHhhccccccccc-------CC------chhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 639 IDLEMLMQGQEIYKYFT-------KE------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~-------~~------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
++...+........+.. .. .....-..+...+++...|..|+|+++++ +|+...+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 87765554333222111 10 01112234455555666688999999999 999988764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=336.07 Aligned_cols=266 Identities=28% Similarity=0.372 Sum_probs=218.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++++.||+|+||+||+|.+..+++.||||+++... .......+|+.+++.++ ||||+++++++.....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC------CCCEeeEEeEEEeCCE
Confidence 58999999999999999999999999999999997532 23456677888887764 8999999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+++++...+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeecccc
Confidence 999999999998888765332 2899999999999999999999999999999999999995 789999999999
Q ss_pred cccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~P-F~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.++.+.+.
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 765432 33457799999999998766 89999999999999999987666 78888899999999999988887665
Q ss_pred hcccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 646 QGQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 646 ~~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.......+... ...+.....+...+++...|..|+|+++++ +|+..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 54433222111 112333445555666667799999999999 999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.99 Aligned_cols=270 Identities=27% Similarity=0.437 Sum_probs=210.4
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+..+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.+++.+. +||||+++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHENIVNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc-----CCCCCCeeeeEE
Confidence 455678999999999999999999999999999999998642 334456778999998875 489999999999
Q ss_pred EecC--eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 486 YHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 486 ~~~~--~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...+ .+|+||||++++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~k 149 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVK 149 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEE
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC--CCCEE
Confidence 8653 79999999999988887642 2889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCcccccc------------------------ccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCC
Q 005415 564 IIDLGSSCFQTD------------------------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEV 618 (697)
Q Consensus 564 L~DFGla~~~~~------------------------~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~ 618 (697)
|+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|++
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999965421 1233578999999999987 578999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHHhhCCCCHHHHhhccc--------------------cccccc----------CCchhhhhHHHHH
Q 005415 619 LFPNDAVVMILARIIGMLGPIDLEMLMQGQE--------------------IYKYFT----------KEYDLYYINEVCF 668 (697)
Q Consensus 619 PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~--------------------~~~~~~----------~~~~l~~i~~~cw 668 (697)
||.+.+..+++.+|++.++.|+.+.+..... ....|. ..........+..
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 9999999999999999999999877643211 000000 0001122334455
Q ss_pred HHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 669 ANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 669 ~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.+++...|..|+|+++++ +|+..+
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHhhccCcccCCCHHHHhCCHHHHHh
Confidence 555666689999999999 998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.83 Aligned_cols=274 Identities=28% Similarity=0.407 Sum_probs=209.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.++|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK------HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC------BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC------CCCcceEEEEEEECCe
Confidence 468999999999999999999999999999999997543 23456778888887764 8899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+.++|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCSSC
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC--CCCEEECcCccc
Confidence 999999999999998876654333344899999999999999999999999999999999999985 789999999999
Q ss_pred cccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..|.+.++.++...+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence 765432 3345789999999999874 589999999999999999999999999999999999999999888766654
Q ss_pred cccccccccC-----------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 647 GQEIYKYFTK-----------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 647 ~~~~~~~~~~-----------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
......+... ...+.....+...+++...|..|+|+++++ +|+..+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 4333222110 001222334444555556689999999999 99987644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.22 Aligned_cols=291 Identities=32% Similarity=0.507 Sum_probs=232.6
Q ss_pred cCCCCCcceeeCcee-cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCC----
Q 005415 398 FEENKDLPIILNTVI-AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP---- 472 (697)
Q Consensus 398 ~~~~~~~pv~~~~~i-~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~---- 472 (697)
|.+.+.+|+..++.+ .++|++++.||+|+||.||+|.+..+++.||||++...........+|+.+++.+++...
T Consensus 2 y~~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp -----CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCCCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchh
Confidence 455677888887776 479999999999999999999999999999999998777667788899999999986432
Q ss_pred -CCCCceeEEEEEEEecC----eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccC
Q 005415 473 -ADEHHILRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCD 546 (697)
Q Consensus 473 -~~hpnIv~l~~~f~~~~----~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrD 546 (697)
..||||+++++++.... ..++|||+++++|.+++...... .+++..+..++.||+.||.|||++ ||+|||
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 23889999999998754 79999999988999988754332 288999999999999999999998 999999
Q ss_pred CCCccccccc----cCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 547 LKPENILIKS----YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 547 LKP~NILl~~----~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
|||+|||++. ...+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999963 134589999999998777666667899999999999999999999999999999999999999986
Q ss_pred Cc------HHHHHHHHHHhhCCCCHHHHhhcccccccccCCc-------------------------hhhhhHHHHHHHH
Q 005415 623 DA------VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY-------------------------DLYYINEVCFANI 671 (697)
Q Consensus 623 ~~------~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~-------------------------~l~~i~~~cw~~l 671 (697)
.+ ..+.+..+++.++.+|..++..+.....+|.... .......+...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 54 5678889999999999988877665544443221 1111222233333
Q ss_pred HHHhhhhccCHHHHH--Hhhccc
Q 005415 672 FISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 672 ~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+...|..|+|+++++ +|+...
T Consensus 318 L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hccCccccCCHHHHhhChhhhcc
Confidence 344577899999999 999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.74 Aligned_cols=275 Identities=23% Similarity=0.337 Sum_probs=215.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
....++|+++++||+|+||+||+|.+..+++.||||+++.... ....+.+|+.+++.++ ||||+++++++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 103 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ------HRNIIELKSVIH 103 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC------CTTBCCEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC------CCCcceEEEEEe
Confidence 3445789999999999999999999999999999999975432 2345567888877764 899999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc---CcceEE
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIK 563 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~vK 563 (697)
.....++||||+.++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+|
T Consensus 104 ~~~~~~lv~e~~~~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 104 HNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred cCCEEEEEEecCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEE
Confidence 9999999999999999988865432 8899999999999999999999999999999999999631 355799
Q ss_pred EeeCCCcccccc---ccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 564 IIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 564 L~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|+|||++..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp ECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999999876542 233456799999999998754 8999999999999999999999999999999999999999988
Q ss_pred CHHHHhhcccccccccCCch-------------hhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYD-------------LYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~-------------l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
+...+........+...... +.....+...+++...|..|+|+++++ +|+...+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 87665543332222111100 112233444555556688999999999 9999988763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.72 Aligned_cols=276 Identities=29% Similarity=0.473 Sum_probs=214.9
Q ss_pred CCCcceeeCc---eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCC
Q 005415 401 NKDLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPAD 474 (697)
Q Consensus 401 ~~~~pv~~~~---~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~ 474 (697)
...+++.+++ .+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++
T Consensus 9 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------ 82 (371)
T 2xrw_A 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------ 82 (371)
T ss_dssp GGEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC------
T ss_pred CcceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC------
Confidence 4556666666 3568999999999999999999999999999999999753 233456778999888874
Q ss_pred CCceeEEEEEEEecC------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 475 EHHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 475 hpnIv~l~~~f~~~~------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
||||+++++++.... ..++||||+.++|.+.+.. .+++..+..++.||+.||.|||++||+|||||
T Consensus 83 hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 154 (371)
T 2xrw_A 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 154 (371)
T ss_dssp CTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred CCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 889999999998654 7899999999998887741 18899999999999999999999999999999
Q ss_pred CccccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH
Q 005415 549 PENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (697)
Q Consensus 549 P~NILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~ 626 (697)
|+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 155 p~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 155 PSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp GGGEEECT--TSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHEEEcC--CCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999995 789999999999765443 33467899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCHHHHhhccccc-ccc--------------------cCCch----hhhhHHHHHHHHHHHhhhhccC
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEIY-KYF--------------------TKEYD----LYYINEVCFANIFISLVVIRLT 681 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~~-~~~--------------------~~~~~----l~~i~~~cw~~l~~~~~~~r~t 681 (697)
+.+.++++.++.++++++....... .++ ..... ......+...+++...|..|+|
T Consensus 233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 312 (371)
T 2xrw_A 233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312 (371)
T ss_dssp HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence 9999999999999887765432111 000 00000 0122344455555566888999
Q ss_pred HHHHH--Hhhccc
Q 005415 682 LEYAA--LWLFGI 692 (697)
Q Consensus 682 ~e~~~--~wl~~~ 692 (697)
+++++ +|+..+
T Consensus 313 ~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 313 VDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHhCCcchhhh
Confidence 99999 998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.18 Aligned_cols=264 Identities=28% Similarity=0.401 Sum_probs=210.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++++.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC------CCCEeeeeeEEccCCe
Confidence 5899999999999999999998 6789999999975432 2356678888887764 8999999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||||+.++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred EEEEEEecCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEeECccc
Confidence 999999999998888765332 2889999999999999999999999999999999999985 789999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+.++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 764422 2345789999999999764 589999999999999999999999999999999999999888877655443
Q ss_pred cccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
......+-.. ...+.....+...+.+...|..|+|+++++ +|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 3222211000 011223334445555556689999999999 99875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=347.60 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=206.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++++.||+|+||+||+|+++.+++.||||++++. .........|..+++.+. +||||+++++++..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLFCCFQT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT-----TCTTBCCEEEEEEC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc-----CCCceeeEEEEEEe
Confidence 347899999999999999999999999999999999853 233456778888888764 48999999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...+|+||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~--~g~ikL~D 167 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLAD 167 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC--CCCEEEcc
Confidence 9999999999985 67666654332 899999999999999999999999999999999999985 78999999
Q ss_pred CCCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+.+|......+|.
T Consensus 168 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~-- 245 (353)
T 3txo_A 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT-- 245 (353)
T ss_dssp CTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred ccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 99987532 2234568999999999999988999999999999999999999999999999999888764433332
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH------HHHH--HhhcccCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL------EYAA--LWLFGIDQN 695 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~------e~~~--~wl~~~~~n 695 (697)
.+.....+...+++...|..|++. ++++ +|+..++|.
T Consensus 246 ---------------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 246 ---------------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ---------------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ---------------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 122233444455556668889887 7777 999887653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.24 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=210.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++++.||+|+||.||+|++..+++.||||+++... .......+|+.+++.+ +||||+++++++.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV------THPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CBTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC------CCCCCceEeEEEEeC
Confidence 368999999999999999999999999999999997542 2345667788887765 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~Df 150 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDF 150 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC--CCCEEEeec
Confidence 999999999975 7777776432 2889999999999999999999999999999999999985 789999999
Q ss_pred CCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
|++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.+|+......|.
T Consensus 151 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~------ 224 (318)
T 1fot_A 151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP------ 224 (318)
T ss_dssp SSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT------
T ss_pred CcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 99988776666778999999999999999999999999999999999999999999988888888764333321
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n 695 (697)
.+..-..+...+++...|..|+ ++++++ +|+..++|.
T Consensus 225 -----------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 225 -----------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp -----------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 1122233344444555677787 888888 999877654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.76 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=203.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++++.||+|+||+||+|.+..+++.||||++... .....++.+|+++++.++ ||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN------HDHVVKVLDIVIPK 124 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCCS
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC------CCCCCceEEEEecC
Confidence 457999999999999999999999999999999998753 334567889999999884 88999999999543
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
..+|+||||++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~--~~~~k 196 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVK 196 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TCCEE
T ss_pred CcccCceEEEEEeccccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC--CCCEe
Confidence 5799999999999988886432 2899999999999999999999999999999999999995 78999
Q ss_pred EeeCCCcccccc------------------------------ccccccccCCCCCchhhc-CCCCCchhhHHHHHHHHHH
Q 005415 564 IIDLGSSCFQTD------------------------------NLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAE 612 (697)
Q Consensus 564 L~DFGla~~~~~------------------------------~~~~~~gt~~Y~APE~l~-~~~~s~ksDIWSLGviL~E 612 (697)
|+|||+++.... .....+||+.|+|||++. +..++.++|||||||||||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 999999976431 123457899999999874 5569999999999999999
Q ss_pred HHh-----------CCCCCCCCc--------------------HHHHHHHHHHhhCCCCHHHHhhccc--ccccc-----
Q 005415 613 LWT-----------GEVLFPNDA--------------------VVMILARIIGMLGPIDLEMLMQGQE--IYKYF----- 654 (697)
Q Consensus 613 Llt-----------G~~PF~~~~--------------------~~e~l~~I~~~lg~~p~e~~~~~~~--~~~~~----- 654 (697)
|++ |++||++.+ ..+++..|.+.+|.++.+.+..... ...+.
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 999 888887754 3678899999999999887764321 11110
Q ss_pred -------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 655 -------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 655 -------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
...+.......+...+++...|..|+|+++++ +|+..+.
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 01112233445556666667788999999999 9998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.98 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=216.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.++ ||||+++++++.....+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC------CCCCCeEeEEEecCCEE
Confidence 457999999999999999999999999999999999876666667889999998874 89999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||++...++.+||+|||++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999975 7777764322 2389999999999999999999999999999999999998655789999999999
Q ss_pred cccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.+.+..
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-- 229 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-- 229 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT--
T ss_pred eECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhcc--
Confidence 765432 3446789999999999998899999999999999999999999999999999999887766666544321
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
....+..++..| +...|..|+|+++++ +|+...
T Consensus 230 -------~s~~~~~li~~~----L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 230 -------ISIEAMDFVDRL----LVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------SCHHHHHHHHTT----SCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------CCHHHHHHHHHH----cCCChhHCcCHHHHhcChhhccC
Confidence 122344444444 445588999999999 999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.08 Aligned_cols=266 Identities=29% Similarity=0.484 Sum_probs=216.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++++.||+|+||.||+|.+..+|+.||||++... .....++.+|+.+++.++ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HENVIGLLDVFTPD 96 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTTBCCCSEEECSC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CcCCCCceeeEecC
Confidence 457899999999999999999999999999999998642 334467788999999885 78999999999865
Q ss_pred ------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
..+|+||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 167 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCEL 167 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC--CCCE
Confidence 346999999988888877642 2889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||+++..........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|++.+|.++.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 168 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999887766667789999999999987 67999999999999999999999999999999999999999999999
Q ss_pred HHHhhcccc--ccc-----------cc-CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQEI--YKY-----------FT-KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~~--~~~-----------~~-~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+++...... ..+ |. ..........+...+++...|..|.|+++++ +|+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 887643210 000 00 0112233445555666667788999999999 999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.21 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=208.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+++++.++ ||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN------HPNIVKLFEVIETE 86 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEC
Confidence 357899999999999999999999999999999999753 234566788999998885 78999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DF 158 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADF 158 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECST
T ss_pred CEEEEEEECCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC--CCCEEEeec
Confidence 99999999996 577777765432 889999999999999999999999999999999999985 789999999
Q ss_pred CCcccccc--ccccccccCCCCCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s-~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+...++.......|.
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--- 235 (328)
T 3fe3_A 159 GFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--- 235 (328)
T ss_dssp TCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT---
T ss_pred cCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 99975443 34456899999999999988865 7899999999999999999999999988888887664433332
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....+..+ ..+.+...|..|.|+++++ +|+...
T Consensus 236 ----------~~s~~~~~l----i~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 236 ----------YMSTDCENL----LKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp ----------TSCHHHHHH----HHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred ----------CCCHHHHHH----HHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 112233334 4444556689999999999 999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.02 Aligned_cols=259 Identities=26% Similarity=0.396 Sum_probs=214.8
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
..+.++|++.+.||+|+||.||+|.++.+|+.||+|+++.... ....+.+|+.+++.++ ||||++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~ 81 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL------HPNIITLH 81 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC------CTTBCCEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC------CcCCCcEE
Confidence 3456789999999999999999999999999999999985432 2356788998887764 89999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC--c
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--R 559 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~--~ 559 (697)
+++.....+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+.... .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence 99999999999999996 67777775322 289999999999999999999999999999999999998522 1
Q ss_pred ceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
..+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 27999999999765443 3456799999999999999999999999999999999999999999999999999887666
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.++.+.+.. ......+....++...|..|+|+++++ +|+...+
T Consensus 236 ~~~~~~~~~-------------~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 236 DFDEEFFSQ-------------TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CCCHHHHTT-------------SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCCchhccC-------------CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 666554321 122334445555566788999999999 9998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.59 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=206.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++++.||+|+||+||+|+++.+++.||||++++. ........+|+.+++.+ .||||+++++++...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC------CCCcCcceEEEEEeC
Confidence 46899999999999999999999999999999999753 23345677888888765 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+++||||+.+ +|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~DF 149 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC--CCCEEEeec
Confidence 999999999975 6666665432 2899999999999999999999999999999999999985 789999999
Q ss_pred CCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....|......+|.
T Consensus 150 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--- 226 (337)
T 1o6l_A 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--- 226 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT---
T ss_pred cchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 9987532 2344568999999999999999999999999999999999999999998888888777653322221
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n 695 (697)
.....+..++ .+++...|..|+ ++++++ +|+..++|+
T Consensus 227 ----------~~s~~~~~li----~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 227 ----------TLSPEAKSLL----AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ----------TSCHHHHHHH----HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------CCCHHHHHHH----HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 1122334444 444455688888 899998 999877653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.63 Aligned_cols=267 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++|++++.||+|+||.||+|.+..+++.||||+++.... ....+.+|+.+++.++ ||||+++++++......
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC------CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC------CCCCCeeeeEEeeCCEE
Confidence 579999999999999999999999999999999975432 1123446787777663 89999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLAR 148 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT--TCCEEECSSSEEE
T ss_pred EEEecccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC--CCCEEEccCcccc
Confidence 99999999999888875432 2889999999999999999999999999999999999985 7899999999987
Q ss_pred ccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++.+.+...
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 149 AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp CC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence 54432 233567999999999987 56899999999999999999999999999999999999999998887766533
Q ss_pred ccccccc-------------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYF-------------TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~-------------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.....+. .....+..-..+...+++...|..|+|+++++ +|+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 2111110 00112223334555555666788999999999 9998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.25 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=210.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEcC
Confidence 478999999999999999999999999999999997542 2345667788777665 489999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~DF 185 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDF 185 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC--CCCEEEccc
Confidence 99999999996 577777764432 899999999999999999999999999999999999985 789999999
Q ss_pred CCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
|++..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.+|......+|.
T Consensus 186 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~------ 259 (350)
T 1rdq_E 186 GFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS------ 259 (350)
T ss_dssp TTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT------
T ss_pred ccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC------
Confidence 99987776666778999999999999999999999999999999999999999999998888888764333321
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
.....+..++. +++...|..|++ +++++ +|+...+|.
T Consensus 260 -------~~~~~~~~li~----~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 260 -------HFSSDLKDLLR----NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp -------TCCHHHHHHHH----HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred -------CCCHHHHHHHH----HHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 11223444444 444455778887 88888 999887753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.44 Aligned_cols=270 Identities=28% Similarity=0.474 Sum_probs=214.2
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (697)
...++|++++.||+|+||.||+|.+..+++.||||++..+... ..+|+.+++.+ +||||++++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l------~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL------DHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC------CCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc------CCCCccchhheeeecCc
Confidence 3457899999999999999999999999999999999765432 23688888776 489999999999543
Q ss_pred ------------------------------------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHH
Q 005415 489 ------------------------------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532 (697)
Q Consensus 489 ------------------------------------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~ 532 (697)
..+++||||++++|.+.+....... ..+++..++.++.||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~--~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcC--CCCCHHHHHHHHHHHHH
Confidence 3489999999999887776533222 23899999999999999
Q ss_pred HHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc--ccccccccCCCCCchhhcCCC-CCchhhHHHHHHH
Q 005415 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCI 609 (697)
Q Consensus 533 aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGvi 609 (697)
||.|||++||+||||||+|||++. .++.+||+|||++..... ......+|+.|+|||++.+.. ++.++|||||||+
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEET-TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcC-CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999974 367999999999976433 334567899999999998754 8999999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccccc------C------CchhhhhHHHHHHHHHHHhhh
Q 005415 610 LAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT------K------EYDLYYINEVCFANIFISLVV 677 (697)
Q Consensus 610 L~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~------~------~~~l~~i~~~cw~~l~~~~~~ 677 (697)
+|+|++|++||.+.+..+.+.+|++.+|.++.+.+.........+. . .........+...+++...|.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999887665322111000 0 011122244555555566689
Q ss_pred hccCHHHHH--Hhhccc
Q 005415 678 IRLTLEYAA--LWLFGI 692 (697)
Q Consensus 678 ~r~t~e~~~--~wl~~~ 692 (697)
.|.|+++++ +|+...
T Consensus 312 ~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GSCCHHHHHTSGGGHHH
T ss_pred hCCCHHHHhcCHHHHHH
Confidence 999999999 998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=347.10 Aligned_cols=271 Identities=27% Similarity=0.418 Sum_probs=216.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++++.||+|+||.||+|.+..+++.||||++... .....++.+|+++++.++ ||||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK------SDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC------CTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC------CCCcceEEEEEec
Confidence 3568999999999999999999999999999999999753 234467789999999885 7899999999987
Q ss_pred c-----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 488 L-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 488 ~-----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
. ..+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~--~~~~ 168 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSV 168 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCE
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC--CCCE
Confidence 6 5799999999999988886432 2899999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCccccccc-------------------------cccccccCCCCCchhh-cCCCCCchhhHHHHHHHHHHHHh-
Q 005415 563 KIIDLGSSCFQTDN-------------------------LCLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWT- 615 (697)
Q Consensus 563 KL~DFGla~~~~~~-------------------------~~~~~gt~~Y~APE~l-~~~~~s~ksDIWSLGviL~ELlt- 615 (697)
||+|||+++..... ....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999765322 2456889999999997 45569999999999999999998
Q ss_pred ----------CCCCCCCCc-----------------HHHHHHHHHHhhCCCCHHHHhhccc--ccccccC----------
Q 005415 616 ----------GEVLFPNDA-----------------VVMILARIIGMLGPIDLEMLMQGQE--IYKYFTK---------- 656 (697)
Q Consensus 616 ----------G~~PF~~~~-----------------~~e~l~~I~~~lg~~p~e~~~~~~~--~~~~~~~---------- 656 (697)
|.++|++.+ ..+++..|++.+|.|+.+.+..... ..++...
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence 556665543 4688999999999999887654221 1111100
Q ss_pred --CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 657 --EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 657 --~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
...+.....+...+++...|..|+|+++++ +|+....+.
T Consensus 329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 012333444555666666788999999999 999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.63 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=207.9
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+..++|++.+.||+|+||.||+|+++.+++.||||+++... ........|..++..+. +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~-----~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-----TCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC-----CCCCCCcEEEEEE
Confidence 34578999999999999999999999999999999998642 33456778888888763 4899999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
....+|+||||+. ++|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC--CCCEEEe
Confidence 9999999999997 577777654332 899999999999999999999999999999999999985 7899999
Q ss_pred eCCCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 566 DLGSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 566 DFGla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|.......|.
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~- 239 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR- 239 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc-
Confidence 999997532 2344568999999999999999999999999999999999999999999988888887653322221
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHH-HHH--HhhcccCCC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLE-YAA--LWLFGIDQN 695 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e-~~~--~wl~~~~~n 695 (697)
.+.....+...+++...|..|++.+ +++ +|+.+++|.
T Consensus 240 ----------------~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 240 ----------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ----------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ----------------ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 1222333444555556688899886 666 999877653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.53 Aligned_cols=266 Identities=30% Similarity=0.509 Sum_probs=201.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEecC
Confidence 458999999999999999999999999999999999753 234466778999998874 78999999999754
Q ss_pred ------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
...++|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~ 171 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 171 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC--CCCE
Confidence 568999999998888877531 2899999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||+++..........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|++.+|.++.
T Consensus 172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877766667789999999999987 67899999999999999999999999999999999999999999998
Q ss_pred HHHhhccc--ccccccCC------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQE--IYKYFTKE------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~--~~~~~~~~------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+.+..... ...+.... ........+...+++...|..|+|+++++ +|+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 87764321 11111000 01122334455555666688999999999 999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.18 Aligned_cols=268 Identities=28% Similarity=0.434 Sum_probs=214.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~---- 488 (697)
..+|++.+.||+|+||.||+|++..+++.||||++..... ...+|+++++.++ ||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~------hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLD------HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCC------CTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcC------CCCccceeeEEeccCCCC
Confidence 3579999999999999999999999999999999976543 2346888888774 89999999998642
Q ss_pred --CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 489 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 489 --~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..+++||||+.+++...+....... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-TTTEEEECC
T ss_pred cceeEEeehhcccccHHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-CCCeEEecc
Confidence 2478999999998887765433222 23899999999999999999999999999999999999985 346789999
Q ss_pred CCCcccccc--ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||+++.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.+|++.+|.++.+.
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999976432 23446789999999999875 699999999999999999999999999999999999999999999887
Q ss_pred HhhcccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 644 LMQGQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 644 ~~~~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+........-+.. .........+...+++...|..|+|+++++ +|+...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 7543211110100 011223445555666666788999999999 999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.26 Aligned_cols=267 Identities=24% Similarity=0.376 Sum_probs=215.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
.++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCcccHhheeeccc
Confidence 378999999999999999999999999999999986432 23356778999999885 7899999999987
Q ss_pred ------cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ------~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
.+.+++||||+++++...+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~--~~~ 162 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 162 (351)
T ss_dssp -------CEEEEEEECCSEEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSC
T ss_pred cccccCCceEEEEEeccCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCC
Confidence 356899999999998888764432 2899999999999999999999999999999999999985 789
Q ss_pred EEEeeCCCcccccc-------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 562 vKL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999875431 22345679999999999864 58999999999999999999999999999999999999
Q ss_pred HhhCCCCHHHHhhcccccccccC------Cchh---------hhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTK------EYDL---------YYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~------~~~l---------~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
...+.++.+.+........+-.. ...+ .....+...+++...|..|+|+++++ +|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 99998888776543322111000 0000 11233444555556688999999999 999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.16 Aligned_cols=273 Identities=26% Similarity=0.389 Sum_probs=208.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~-- 490 (697)
.++|++.+.||+|+||.||+|.+..+++.||||++..+........++++.+..++ ||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~------h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH------HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHC------CTTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcC------CCCcccHHHhhhcccccc
Confidence 36899999999999999999999999999999999876655566667777777664 8999999999976433
Q ss_pred -----EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--hcCccccCCCCccccccccCcceEE
Q 005415 491 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 491 -----l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH--s~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+++||||+.+++...+...... ...+++..+..++.||+.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE-ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-TTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-CCCcEE
Confidence 8999999999887766533222 223889999999999999999999 999999999999999984 367999
Q ss_pred EeeCCCccccccc--cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+++.++.++
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999999765433 33457899999999997655 89999999999999999999999999999999999999999999
Q ss_pred HHHHhhcccccc---cccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 641 LEMLMQGQEIYK---YFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 641 ~e~~~~~~~~~~---~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.+.+........ ++.. .......+.+...+.+...|..|+|+++++ +|+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 988765322111 1100 001122344455555556689999999999 99986643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.88 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=206.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+++.++ ||||++++++|.+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLFYAFQD 140 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC------CCCCCeEEEEEEE
Confidence 3478999999999999999999999999999999997532 22345778999988774 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC--CCCEEEec
Confidence 999999999996 5677766421 1889999999999999999999999999999999999985 88999999
Q ss_pred CCCccccccc----cccccccCCCCCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~----~~~~~gt~~Y~APE~l~~~~----~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+.+|+.....
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 9999765433 23568999999999998765 789999999999999999999999999999988888753211
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhh--ccCHHHHH--HhhcccCCCC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVI--RLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~--r~t~e~~~--~wl~~~~~n~ 696 (697)
+.. +....-...+..++..|+. ..+.. |.++++++ +|+.+++|..
T Consensus 292 ~~~---------p~~~~~s~~~~~li~~lL~----~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 292 LTF---------PDDNDISKEAKNLICAFLT----DREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp CCC---------CTTCCCCHHHHHHHHHHSS----CGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ccC---------CCcccccHHHHHHHHHHcc----ChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 110 0000112344445544443 33444 89999999 9999887753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.66 Aligned_cols=267 Identities=27% Similarity=0.366 Sum_probs=207.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC------CCCccchhheeecCC
Confidence 478999999999999999999999999999999986543 23456778999998885 789999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
..++||||++++++..+..... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 148 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGF 148 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTT
T ss_pred eEEEEEEeCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC--CCCEEEeeCCC
Confidence 9999999999775554433221 2889999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc---cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 570 SCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 570 a~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.+.++..++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 9765432 234578999999999986 568999999999999999999999999999999999999988887775543
Q ss_pred hcccccccccC---------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 646 QGQEIYKYFTK---------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 646 ~~~~~~~~~~~---------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..... .++.. ...+.....+...+.+...|..|+|+++++ +|+....
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 229 VFSTN-QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HHHTC-GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccc-cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 21110 00000 011112223333444445688999999999 9998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=339.83 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=206.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++++.||+|+||.||+|+++.+++.||||++++.. ........|..++..+. .||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-----CCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-----CCCEEeeEEEEEEcC
Confidence 478999999999999999999999999999999998642 23345667777765543 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+|+||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL~DF 165 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADF 165 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC--CCcEEEEeC
Confidence 999999999975 77777654332 899999999999999999999999999999999999985 789999999
Q ss_pred CCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|++.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+++.+|+.....+|.
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--- 242 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--- 242 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT---
T ss_pred CcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 9997532 2344568999999999999999999999999999999999999999999998888888764333331
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
.+.....+...+++...|..|++ +++++ +|+.+++|.
T Consensus 243 --------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 243 --------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp --------------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred --------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 12223333444445556778884 57777 999887754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.31 Aligned_cols=253 Identities=20% Similarity=0.218 Sum_probs=206.4
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+. +||||+++++++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLG-----SGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHC-----SCTTSCCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhh-----CCCCCCEEEEEEecCCc
Confidence 456899999999999999999999999999999999975432 356889999999984 37899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce-----EEEe
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE-----IKII 565 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~-----vKL~ 565 (697)
.++||||++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++. +||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~--~~~~~~~~~kl~ 152 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR--PGNKTQQVIHII 152 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC--GGGTCTTSEEEC
T ss_pred cEEEEEeCCCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc--CCCCCCceEEEE
Confidence 999999998889888875422 2899999999999999999999999999999999999985 444 9999
Q ss_pred eCCCccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHH
Q 005415 566 DLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN---DAVVMILARI 632 (697)
Q Consensus 566 DFGla~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~---~~~~e~l~~I 632 (697)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+ ....+.+..+
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 99999764332 1346789999999999999999999999999999999999999987 4455566666
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.....+.+.+... ...+.+..++..||... +..|.+++++...|
T Consensus 233 ~~~~~~~~~~~~~---------~~~p~~~~li~~~l~~~----p~~RP~~~~l~~~l 276 (330)
T 2izr_A 233 GDTKRATPIEVLC---------ENFPEMATYLRYVRRLD----FFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHHHSCHHHHT---------TTCHHHHHHHHHHHHCC----TTCCCCHHHHHHHH
T ss_pred HhhhccCCHHHHh---------ccChHHHHHHHHHHhCC----CCCCCCHHHHHHHH
Confidence 5544444443321 12236778888888754 77788887776433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.49 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=205.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++...+..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC------CCCCCeEeEEEEECCEE
Confidence 468999999999999999999999999999999987533 33456778999888874 88999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC--CCCEEEeeCCCc
Confidence 99999996 5677766532 2889999999999999999999999999999999999985 788999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.....+... .
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~---- 238 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-N---- 238 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-C----
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-C----
Confidence 765432 33457899999999999999999999999999999999999999998887777766543222111 0
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.-.....+..++..|| ...|..|.|+++++ +|+....
T Consensus 239 -----~~~~~~~~~~li~~~l----~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 239 -----PEKLSAIFRDFLNRCL----EMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -----GGGSCHHHHHHHHHHS----CSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----ccccCHHHHHHHHHHc----cCChhHCcCHHHHhhChhhcccC
Confidence 0011223444555554 45589999999999 9998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.67 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=212.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++ ||||+++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~ 81 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLHE 81 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 456789999999999999999999999999999999975321 2467889999999885 789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC--cc
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RC 560 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~--~~ 560 (697)
++......++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++... ..
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSC
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCC
Confidence 9999999999999996 57777765322 289999999999999999999999999999999999998522 22
Q ss_pred eEEEeeCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 561 EIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 561 ~vKL~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 156 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 799999999976542 334467899999999999999999999999999999999999999999988888888776655
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
++...... ....+..++..| +...|..|+|+++++ +|+...+
T Consensus 236 ~~~~~~~~---------~~~~~~~li~~~----L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 236 FEDEYFSN---------TSALAKDFIRRL----LVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCHHHHTT---------SCHHHHHHHHHH----SCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCcccccc---------CCHHHHHHHHHH----ccCChhhCCCHHHHhcCCCccCCc
Confidence 55544321 122334444444 445689999999999 9997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.13 Aligned_cols=265 Identities=29% Similarity=0.477 Sum_probs=214.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC------CCCchhhhhheecc
Confidence 568999999999999999999999999999999999753 333567778999998885 78999999999877
Q ss_pred CeE------EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 EHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~~l------~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
... ++||||+.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~ 183 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 183 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred CCcccceeEEEEEccccccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC--CCCE
Confidence 654 9999999998776652 11889999999999999999999999999999999999985 7889
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+++..+.++.
T Consensus 184 kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 184 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp EECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999999887776677789999999999987 67899999999999999999999999999999999999999999998
Q ss_pred HHHhhccccc--cc------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQEIY--KY------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~~~--~~------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+++....... .+ ............+...+++...|..|.|+++++ +|+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 8765432100 00 000011223344455555566688999999999 999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=348.00 Aligned_cols=261 Identities=19% Similarity=0.247 Sum_probs=207.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|+++++||+|+||+||+|+++.+++.||||++++.. .....+.+|+.++..++ ||||++++++|.+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD------SKWITTLHYAFQD 145 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEee
Confidence 3478999999999999999999999999999999997532 22344778888888764 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...+|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~--~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC--CCCEEEcc
Confidence 999999999996 577777754221 2899999999999999999999999999999999999985 88999999
Q ss_pred CCCccccccc----cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 567 LGSSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 567 FGla~~~~~~----~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
||++...... ....+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+.+.+|+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 9999665332 22357999999999997 45689999999999999999999999999999999888865322
Q ss_pred --CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCCC
Q 005415 638 --PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 638 --~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~~ 697 (697)
++|... -........++..++.. ......|.++++++ +|+.+++|+++
T Consensus 299 ~~~~p~~~----------~~~s~~~~dLi~~lL~~--~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 RFQFPTQV----------TDVSENAKDLIRRLICS--REHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HCCCCSSC----------CCSCHHHHHHHHTTSSC--GGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred cccCCccc----------ccCCHHHHHHHHHHhcc--cccccCCCCHHHHhCCCccCCCCHHHH
Confidence 111100 01123344444444321 12223388899998 99999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.63 Aligned_cols=265 Identities=20% Similarity=0.175 Sum_probs=205.9
Q ss_pred CCcCCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCC
Q 005415 396 TGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDP 472 (697)
Q Consensus 396 ~~~~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~ 472 (697)
..+......|...++++.++|+++++||+|+||+||+|.+..+++.||||++.... ........|+..+..+.
T Consensus 39 ~~~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~---- 114 (311)
T 3p1a_A 39 ETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG---- 114 (311)
T ss_dssp SSCCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC----
T ss_pred cccCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc----
Confidence 34556677888889999999999999999999999999999999999999986532 22233444554444442
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
.||||+++++++.....+++||||++++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 115 -~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 188 (311)
T 3p1a_A 115 -QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188 (311)
T ss_dssp -CCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred -CCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 48999999999999999999999999999888765532 289999999999999999999999999999999999
Q ss_pred cccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~ 630 (697)
|++. ++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.....
T Consensus 189 ll~~--~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--- 262 (311)
T 3p1a_A 189 FLGP--RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ--- 262 (311)
T ss_dssp EECG--GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---
T ss_pred EECC--CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 9985 789999999998765433 233568999999999886 78999999999999999999977766543322
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+.. +..+.++.. .....+..++..| +...|..|.|+++++ +|+..
T Consensus 263 ~~~~--~~~~~~~~~---------~~~~~l~~li~~~----L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 263 QLRQ--GYLPPEFTA---------GLSSELRSVLVMM----LEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHTT--TCCCHHHHT---------TSCHHHHHHHHHH----SCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHhc--cCCCccccc---------CCCHHHHHHHHHH----cCCChhhCcCHHHHHhCccccC
Confidence 2211 223332221 1123444455444 445689999999999 99975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=335.17 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=211.4
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~ 97 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSI 97 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEE
Confidence 4455678999999999999999999999999999999997532 34456788999999884 88999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceEE
Q 005415 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIK 563 (697)
Q Consensus 486 ~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~vK 563 (697)
......++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++... .+.+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 999999999999975 6767665332 389999999999999999999999999999999999998632 35799
Q ss_pred EeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 564 L~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 172 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 251 (362)
T 2bdw_A 172 LADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251 (362)
T ss_dssp ECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9999999765543 23467899999999999999999999999999999999999999999988888888765544443
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..+. .....+..++. +++...|..|+++++++ +|+..
T Consensus 252 ~~~~---------~~~~~~~~li~----~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 252 PEWD---------TVTPEAKSLID----SMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp TGGG---------GSCHHHHHHHH----HHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred cccc---------CCCHHHHHHHH----HHcCCChhhCcCHHHHhcCcccCC
Confidence 2221 11223344444 44455688999999999 99864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.75 Aligned_cols=274 Identities=28% Similarity=0.464 Sum_probs=220.1
Q ss_pred cceeeCceec--CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005415 404 LPIILNTVIA--GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (697)
Q Consensus 404 ~pv~~~~~i~--~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv 479 (697)
.....++++. ++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+++++.++ ||||+
T Consensus 15 ~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv 88 (364)
T 3qyz_A 15 PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENII 88 (364)
T ss_dssp CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBC
T ss_pred eEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC------CCCCc
Confidence 3444455553 7999999999999999999999999999999999743 334467788999999885 88999
Q ss_pred EEEEEEEec-----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 480 RLYDYFYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 480 ~l~~~f~~~-----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
++++++... ...++||||++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 161 (364)
T ss_dssp CCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred cceeEEecCCccccceEEEEEcccCcCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE
Confidence 999999765 468999999999988887532 28899999999999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCccccccc------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
+. ++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+
T Consensus 162 ~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 162 NT--TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp CT--TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred CC--CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 85 788999999999765432 233578999999998765 458999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCCHHHHhhccccc--cccc------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIY--KYFT------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~--~~~~------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+..|+..++.++.+.+....... .+.. .......-..+...+++...|..|+|+++++ +|+..
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 999999999999988765422110 0000 0011222334445555566688999999999 99986
Q ss_pred c
Q 005415 692 I 692 (697)
Q Consensus 692 ~ 692 (697)
+
T Consensus 320 ~ 320 (364)
T 3qyz_A 320 Y 320 (364)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.47 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=197.8
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.+++++.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~ 77 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL------SHQNIVSMI 77 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CBTTBCCEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC------CCCCCceEE
Confidence 45788899999999999999999999999999999999998642 23345667777777666 489999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
+++...+..++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~--~~~ 149 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS--NKT 149 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSC
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCC
Confidence 999999999999999975 7777776443 2899999999999999999999999999999999999985 788
Q ss_pred EEEeeCCCccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 562 IKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 562 vKL~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...+++....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 150 LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp EEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred EEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 999999999765432 2235689999999999999999999999999999999999999999887776655543322
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-CHHHHH
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-TLEYAA 686 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-t~e~~~ 686 (697)
+...... .. .....+..++..|| ...|..|. +++++.
T Consensus 230 ~~~~~~~--~~------~~~~~l~~li~~~l----~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 230 PNVTTDV--RK------DIPQSLSNVILRAT----EKDKANRYKTIQEMK 267 (294)
T ss_dssp CCHHHHS--CT------TSCHHHHHHHHHHS----CSSGGGSCSSHHHHH
T ss_pred CCcchhc--cc------CCCHHHHHHHHHHh----cCCHhHccccHHHHH
Confidence 2111110 00 11234445555554 45588887 666666
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=335.93 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=193.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..++|++++.||+|+||.||+|++..+++.||||++.........+.+|+.+++.++ ||||+++++++......
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR------HPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC------CTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC------CCCCCcEEEEEeeCCEE
Confidence 357999999999999999999999999999999999876666677889999998874 88999999999999999
Q ss_pred EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||++
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGR------FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEeCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 99999996 577777654332 89999999999999999999999999999999999998645556999999998
Q ss_pred cccc--cccccccccCCCCCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHHHhhCCCCHHH
Q 005415 571 CFQT--DNLCLYVQSRSYRAPEVIIGLPYDQK-IDLWSLGCILAELWTGEVLFPNDAVV----MILARIIGMLGPIDLEM 643 (697)
Q Consensus 571 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIWSLGviL~ELltG~~PF~~~~~~----e~l~~I~~~lg~~p~e~ 643 (697)
.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..+......+|.
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--
Confidence 7432 23344678999999999998887666 89999999999999999999875543 333333332222221
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.......+..++..| +...|..|+|+++++ +|+..
T Consensus 244 ---------~~~~s~~~~~li~~~----L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 244 ---------DIRISPECCHLISRI----FVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp ---------TSCCCHHHHHHHHHH----SCSCTTTSCCHHHHHTSHHHHT
T ss_pred ---------cCCCCHHHHHHHHHH----ccCChhHCcCHHHHHhCcchhc
Confidence 111123344444444 445689999999999 99853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.76 Aligned_cols=272 Identities=28% Similarity=0.431 Sum_probs=214.2
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
++....+|++++.||+|+||.||+|++..+++ ||+|.+...... ..+|+.+++.++ ||||+++++++...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~------h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVK------HPNVVDLKAFFYSN 104 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCC------CTTBCCEEEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCC------CCCcceEEEEEEec
Confidence 45567789999999999999999999877666 888887654432 236888888774 89999999999754
Q ss_pred C------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
. .+++||||+.+++...+....... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLK--QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC-CCCcE
Confidence 3 388999999998877665433222 23899999999999999999999999999999999999983 37899
Q ss_pred EEeeCCCccccc--cccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 563 KIIDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 563 KL~DFGla~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+|||+++... .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..|++.+|.+
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999997643 233456789999999999775 48999999999999999999999999999999999999999999
Q ss_pred CHHHHhhcccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+.+.+............ ......-..+...+++...|..|+|+++++ +|+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 98876543211100000 001222334445555556689999999999 9998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.22 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=208.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++++.||+|+||+||+|+++.+++.||||++++.. .....+.+|..++..++ ||||++++++|.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~------hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD------RRWITQLHFAFQD 132 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC------TTTBCCEEEEEEC
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEee
Confidence 3478999999999999999999999999999999997532 23345778888887764 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+.+|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~--~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR--CGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC--CCCEEEee
Confidence 999999999995 677777764322 2899999999999999999999999999999999999985 78999999
Q ss_pred CCCcccccccc----ccccccCCCCCchhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 567 LGSSCFQTDNL----CLYVQSRSYRAPEVII-------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 567 FGla~~~~~~~----~~~~gt~~Y~APE~l~-------~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
||++....... ...+||+.|+|||++. +..++.++|||||||++|||++|++||.+.+..+.+.+|+..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99997654332 2358999999999997 356899999999999999999999999999999888888753
Q ss_pred hC--CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhc---cCHHHHH--HhhcccCCCCC
Q 005415 636 LG--PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIR---LTLEYAA--LWLFGIDQNKI 697 (697)
Q Consensus 636 lg--~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r---~t~e~~~--~wl~~~~~n~~ 697 (697)
.. ..|.. .. .....+..++..|+. .+..| .++++++ +|+.+++|+++
T Consensus 286 ~~~~~~p~~--------~~--~~s~~~~dli~~lL~-----~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 286 KEHLSLPLV--------DE--GVPEEARDFIQRLLC-----PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp HHHCCCC--------------CCCHHHHHHHHTTSS-----CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ccCcCCCcc--------cc--CCCHHHHHHHHHHcC-----ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 21 11110 00 112345555555554 35555 5899988 99999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.55 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=207.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.+.++|++.+.||+|+||.||+|.++.+++.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~ 94 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK------HPHIVELLET 94 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 34678999999999999999999999999999999997432 13467889999999884 8899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 562 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~v 562 (697)
+.....+++||||+. ++|.+.+...... ...+++..+..++.||+.||.|||++||+||||||+|||++... ...+
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcE
Confidence 999999999999998 5676666544322 12388999999999999999999999999999999999998532 3459
Q ss_pred EEeeCCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 563 KL~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+.+..+.......
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99999999765543 234578999999999999999999999999999999999999998754 45566665544444
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+...+. .....+..++..| +...|..|.|+++++ +|+...
T Consensus 252 ~~~~~~---------~~s~~~~~li~~~----L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 NPRQWS---------HISESAKDLVRRM----LMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CHHHHT---------TSCHHHHHHHHHH----TCSSTTTSCCHHHHHTSHHHHTH
T ss_pred Cccccc---------cCCHHHHHHHHHH----CCCChhHCcCHHHHhcChhhcCC
Confidence 443321 1122344444444 445688999999999 999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.75 Aligned_cols=267 Identities=30% Similarity=0.403 Sum_probs=211.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 82 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAFG 82 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC------CCCCCeEEEEEe
Confidence 4789999999999999999999999999999999874321 2246778999998874 789999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.....++||||+.++|...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~--~~~~kl~D 155 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLAD 155 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECC
T ss_pred eCCceEEEEEcCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC--CCCEEEEe
Confidence 999999999999998887775432 23788899999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 567 FGla~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.++.+
T Consensus 156 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 156 FGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp CGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 9999765432 3345789999999999765 48999999999999999999999999999999999999999988776
Q ss_pred HHhhcccccccccCC-----------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 643 MLMQGQEIYKYFTKE-----------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~-----------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.+........+.... ......+.+.....+...|..|+|+++++ +|+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 655432222221110 11122334444444556689999999999 999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.50 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=199.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++++.||+|+||.||+|+++.+++.||||++++. ......+.+|+.+++.+. +||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC-----CCCccCeEEEEEEeC
Confidence 46899999999999999999999999999999999853 233456778888888763 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+|+||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~g~~kL~DF 154 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDY 154 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCG
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEEec
Confidence 999999999975 67666654322 899999999999999999999999999999999999985 789999999
Q ss_pred CCccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHHHh
Q 005415 568 GSSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---------AVVMILARIIGM 635 (697)
Q Consensus 568 Gla~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~---------~~~e~l~~I~~~ 635 (697)
|++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+...
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred cccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence 9997532 2344568999999999999999999999999999999999999999652 222333344332
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH------HHHH--HhhcccCCC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL------EYAA--LWLFGIDQN 695 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~------e~~~--~wl~~~~~n 695 (697)
.-..|. .+.....+...+++...|..|++. ++++ +|+.+++|+
T Consensus 235 ~~~~p~-----------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 235 QIRIPR-----------------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp CCCCCT-----------------TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCCC-----------------CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 212111 122223333444445568888874 6777 999887753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.76 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=210.3
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~ 80 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK------HPNIVRLHDSIS 80 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC------BTTBCCEEEEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CcCCCeEEEEEE
Confidence 345678999999999999999999999999999999997543 33456788999998884 889999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEE
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL 564 (697)
.....++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.. .++.+||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999975 6777766432 28999999999999999999999999999999999999853 3578999
Q ss_pred eeCCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 565 ~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 999999765443 23467899999999999999999999999999999999999999999999998888776554443
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..+. .....+..+ ...++...|..|+|+++++ +|+..
T Consensus 235 ~~~~---------~~s~~~~~l----i~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 235 PEWD---------TVTPEAKDL----INKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTT---------TSCHHHHHH----HHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccc---------cCCHHHHHH----HHHHcCCChhHCCCHHHHhcCccccC
Confidence 2221 112233344 4444556689999999999 99864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.04 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=200.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ........|..+++.+. +||||++++++|...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~-----~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT-----TCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC-----CCCCcCeeEEEEEEC
Confidence 468999999999999999999999999999999998542 23355778888888774 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~--~g~ikL~DF 197 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDY 197 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC--CCCEEEeec
Confidence 999999999975 66666654322 899999999999999999999999999999999999985 789999999
Q ss_pred CCcccc---ccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---------HHHHHHHHHHh
Q 005415 568 GSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---------VVMILARIIGM 635 (697)
Q Consensus 568 Gla~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---------~~e~l~~I~~~ 635 (697)
|+++.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||.... .......|...
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 999752 233455789999999999999999999999999999999999999996431 22233334332
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCH------HHHH--HhhcccCCC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL------EYAA--LWLFGIDQN 695 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~------e~~~--~wl~~~~~n 695 (697)
.-.+|. .+..-..+...+++...|..|+++ ++++ +|+..++|.
T Consensus 278 ~~~~p~-----------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 278 QIRIPR-----------------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp CCCCCT-----------------TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ccCCCC-----------------cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 222221 122233344455555668888874 6666 999887754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.46 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcc-cCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK-NDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~-~~~~~hpnIv~l~~~f~~~~~ 490 (697)
..++|++++.||+|+||.||+|+++.+++.||||++++....... .+..++.+... ....+||||++++++|...+.
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 347899999999999999999999999999999999864321111 11122222221 234579999999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+|+||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~ikL~DFG~ 185 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGL 185 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCCB
T ss_pred EEEEEeCCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC--CCCEEEeeCcc
Confidence 9999999975 67666654322 889999999999999999999999999999999999985 78999999999
Q ss_pred ccccc---cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.+|+...-..+.
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 260 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----- 260 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS-----
T ss_pred ccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC-----
Confidence 97532 2344578999999999999999999999999999999999999999999998888888663222211
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCH----HHHH--HhhcccCCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTL----EYAA--LWLFGIDQN 695 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~----e~~~--~wl~~~~~n 695 (697)
.....+..++..| +...+..|++. +++. +|+..++|.
T Consensus 261 --------~~~~~~~~li~~l----L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 261 --------NITNSARHLLEGL----LQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp --------SSCHHHHHHHHHH----TCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred --------CCCHHHHHHHHHH----cccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 1122344444444 44456666664 5666 998877653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.04 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=208.5
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
++++.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+ |+||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG-----CTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT-----CTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhc-----CCCCCeEEeecCCC
Confidence 5678899999999999999999999999999999999987543 23567889999998853 78999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc---CcceEEEe
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKII 565 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~vKL~ 565 (697)
...++||||++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ....+||+
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ceeEEEEEecCCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999998899988875432 28999999999999999999999999999999999999852 12349999
Q ss_pred eCCCccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHH
Q 005415 566 DLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARI 632 (697)
Q Consensus 566 DFGla~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~---~~~e~l~~I 632 (697)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. ...+.+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999765432 23456899999999999999999999999999999999999999874 455566666
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
......++...... .....+..++..||... |..|++++++...
T Consensus 234 ~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~d----p~~RP~~~~l~~~ 277 (298)
T 1csn_A 234 GEKKQSTPLRELCA--------GFPEEFYKYMHYARNLA----FDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHSCHHHHTT--------TSCHHHHHHHHHHHHCC----TTCCCCHHHHHHH
T ss_pred HhhccCccHHHHHh--------hCcHHHHHHHHHHhcCC----cccCCCHHHHHHH
Confidence 55444344332211 23456778888888754 8888888887733
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=339.03 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=199.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~ 79 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR------HPHIIKLYDVIT 79 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC------CCCCCeEEEEEE
Confidence 34578999999999999999999999999999999997532 22346778888887764 899999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.....++||||++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 80 ~~~~~~lv~E~~~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~D 151 (336)
T 3h4j_B 80 TPTDIVMVIEYAGGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD--NLNVKIAD 151 (336)
T ss_dssp CSSEEEEEECCCCEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT--TCCEEECC
T ss_pred eCCEEEEEEECCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC--CCCEEEEE
Confidence 9999999999999999988865432 899999999999999999999999999999999999995 78999999
Q ss_pred CCCccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 567 FGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......|
T Consensus 152 FG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 228 (336)
T 3h4j_B 152 FGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--- 228 (336)
T ss_dssp SSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC---
T ss_pred eccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc---
Confidence 9999765433 345678999999999988776 7899999999999999999999986543322222111111111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. .....+..++..| +...|..|+|+++++ +|+..
T Consensus 229 --------~--~~s~~~~~li~~~----L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 229 --------D--FLSPGAQSLIRRM----IVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp --------T--TSCHHHHHHHHTT----SCSSGGGSCCHHHHTTCHHHHT
T ss_pred --------c--cCCHHHHHHHHHH----cCCChhHCcCHHHHHhChhhcc
Confidence 0 0122333444444 445688999999999 99874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.77 Aligned_cols=273 Identities=26% Similarity=0.402 Sum_probs=218.4
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-CCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-- 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-- 486 (697)
.++|++++.||+|+||.||+|.+. .+++.||||+++... .......+|+.+++.+... .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc---CCCCeEeeeeeeeec
Confidence 478999999999999999999995 678999999987432 2234677889988888643 4899999999997
Q ss_pred ---ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 487 ---HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 487 ---~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
.....++||||+.++|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~--~~~~k 160 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 160 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC--CCCEE
Confidence 45779999999999998888654322 2889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 564 L~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+.+++..++.++.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999999765432 33457899999999999999999999999999999999999999999999999999998888776
Q ss_pred HHHhhccccccc-cc---------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 642 EMLMQGQEIYKY-FT---------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 642 e~~~~~~~~~~~-~~---------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
..+.......+. +. ....+...+.+...+.+...|..|.++++++ +|+...++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 655432111110 00 0111222333444444455689999999999 99987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.32 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=199.2
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
+..++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++.++ ||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 87 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK------HPFIVDLI 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC------CTTBCCEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC------CCCcccee
Confidence 44578999999999999999999985 689999999997542 23345678999998874 88999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
+++...+.+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~--~~~ 159 (327)
T 3a62_A 88 YAFQTGGKLYLILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH--QGH 159 (327)
T ss_dssp EEEECSSCEEEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT--TSC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC--CCc
Confidence 99999999999999997 577777654322 889999999999999999999999999999999999985 789
Q ss_pred EEEeeCCCcccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 562 IKIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 562 vKL~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|......
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 239 (327)
T 3a62_A 160 VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239 (327)
T ss_dssp EEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred EEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999865332 233467899999999999999999999999999999999999999999988888888765433
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~ 694 (697)
.|.. ....+..++..||. ..|..|+ ++++++ +|+..+++
T Consensus 240 ~p~~-------------~~~~~~~li~~~L~----~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 240 LPPY-------------LTQEARDLLKKLLK----RNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp CCTT-------------SCHHHHHHHHHHSC----SCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred CCCC-------------CCHHHHHHHHHHHh----cCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 3321 12344455555544 4566776 788888 99987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.47 Aligned_cols=265 Identities=28% Similarity=0.476 Sum_probs=212.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ------HENVIGLLDVFTPA 95 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCcccHhheEecc
Confidence 468999999999999999999999999999999999753 233456778999998874 78999999999876
Q ss_pred Ce------EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 489 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~~------l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
.. .++||||+.++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~--~~~~ 165 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCEL 165 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT--TCCE
T ss_pred cccccceeEEEEeccccCCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC--CCcE
Confidence 43 599999999887765421 2889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+++..|.++.
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 166 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp EECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred EEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877666666788999999999987 67899999999999999999999999999999999999999999998
Q ss_pred HHHhhcccc--------------cccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQEI--------------YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~~--------------~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+++...... ..+-.........+.+...+++...|..|+|+++++ +|+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 876543211 000000112233344445555556688999999999 999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.79 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=209.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR------HENLVNLLEVCKKKK 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEETT
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC------CCCEeeEEEEeecCC
Confidence 478999999999999999999999999999999986532 23455678999998885 789999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
..++||||+.++++..+..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 170 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGF 170 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCTT
T ss_pred EEEEEEecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC--CCcEEEEeCCC
Confidence 9999999999877665543322 2899999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 570 SCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 570 a~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+...... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..++...+..++....
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp C------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 9764432 2345789999999999876 68999999999999999999999999999999999999988887775543
Q ss_pred hccccccc--------ccC------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 646 QGQEIYKY--------FTK------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 646 ~~~~~~~~--------~~~------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.......+ -.. ...+...+.+.....+...|..|+|+++++ +|+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 21111000 000 011222333444444456689999999999 999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.02 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=208.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEC
Confidence 45799999999999999999999999999999999743 223456788999998884 78999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
...++||||+.+++.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG 199 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFG 199 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCT
T ss_pred CeEEEEEecCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEEeecc
Confidence 99999999999998888764432 2899999999999999999999999999999999999985 7899999999
Q ss_pred CccccccccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
++...... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+....+..+.....+...
T Consensus 200 ~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 274 (348)
T 1u5q_A 200 SASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---- 274 (348)
T ss_dssp TCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC----
T ss_pred CceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----
Confidence 99765543 3467899999999985 456899999999999999999999999998887777776553322111
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.-.....+..++..||.. .|..|+|+++++ +|+....
T Consensus 275 -------~~~~~~~l~~li~~~l~~----dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 275 -------SGHWSEYFRNFVDSCLQK----IPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp -------CTTSCHHHHHHHHHHTCS----SGGGSCCHHHHTTCHHHHSCC
T ss_pred -------CCCCCHHHHHHHHHHccc----ChhhCcCHHHHhhChhhhccC
Confidence 001234566677777764 489999999999 9987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.43 Aligned_cols=268 Identities=24% Similarity=0.349 Sum_probs=207.7
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY- 486 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~- 486 (697)
+..+.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVFEILGP 79 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC------CTTBCCEEEEECT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC------CCCeeEEEEeccc
Confidence 556789999999999999999999999999999999998754 344567788998888774 889999999873
Q ss_pred -------------ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 487 -------------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 487 -------------~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
.....++||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 3467899999999998887742 12889999999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCccccccc------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH
Q 005415 554 IKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~ 626 (697)
++. .++.+||+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 153 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 153 INT-EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EET-TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcC-CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 974 3578999999999765321 233466889999999876 67899999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCHHHHhhcccc-cc---------------cc-cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--H
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEI-YK---------------YF-TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--L 687 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~-~~---------------~~-~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~ 687 (697)
+.+..+.+..+.+..+........ .. .+ .....+..++..|| ...|..|.|+++++ +
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L----~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL----TFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS----CSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc----CCCccccCCHHHHhCCc
Confidence 999999888776666544321110 00 00 01223334444444 44588899999999 9
Q ss_pred hhcccCC
Q 005415 688 WLFGIDQ 694 (697)
Q Consensus 688 wl~~~~~ 694 (697)
|+.....
T Consensus 308 ~~~~~~~ 314 (320)
T 2i6l_A 308 YMSIYSF 314 (320)
T ss_dssp HHHTTCC
T ss_pred ccccccC
Confidence 9987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.52 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=213.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
..+.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++ ||||++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~ 81 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL------HHNVITLH 81 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC------CCCcceEE
Confidence 4567889999999999999999999999999999999975321 2456889999999885 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc-
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC- 560 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~- 560 (697)
+++......++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~--~~~ 153 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD--KNI 153 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC--TTS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec--CCC
Confidence 99999999999999996 57877775432 2889999999999999999999999999999999999985 33
Q ss_pred ---eEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 561 ---EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 561 ---~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+...
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 7999999999765433 23457899999999999999999999999999999999999999999998888888776
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
...++.+.... ....+..++..||. ..|..|+|+++++ +|+...+
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~li~~~l~----~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 234 SYDFDEEFFSH---------TSELAKDFIRKLLV----KETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CCCCCHHHHTT---------CCHHHHHHHHTTSC----SSTTTSCCHHHHHHSTTTSCSS
T ss_pred ccccChhhhcc---------cCHHHHHHHHHHcC----CChhhCcCHHHHhcCccccCCC
Confidence 66665544321 12334445554444 4588899999999 9997643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=334.52 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=210.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++.....
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECSSE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC------CCcCCCeEEEEEEeCCE
Confidence 3478999999999999999999999999999999997643 2334677888888766 48999999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++....+.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999974 6766664322 238999999999999999999999999999999999999865567899999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+.
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 275 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-- 275 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT--
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc--
Confidence 9765433 234578999999999999999999999999999999999999999999888888876544333321110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.....+..++..|| ...|..|+|+++++ +|+.+...
T Consensus 276 -------~~s~~~~~li~~~L----~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 276 -------SVSPEAKDFIKNLL----QKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp -------TSCHHHHHHHHTTS----CSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred -------cCCHHHHHHHHHHc----CCChhHCcCHHHHhhCccccCCcc
Confidence 12234455555554 45588999999999 99986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.29 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=211.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEEEc
Confidence 35689999999999999999999999999999999997543 33456778999998884 7899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceEEEe
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKII 565 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~vKL~ 565 (697)
....++||||+.+ +|.+.+..... +++..+..++.||+.||.|||++||+||||||+||+++.+. .+.+||+
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999975 66666654422 89999999999999999999999999999999999998532 3459999
Q ss_pred eCCCcccccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 566 DLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 566 DFGla~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+...
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T 3kk8_A 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230 (284)
T ss_dssp CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh
Confidence 999997654432 345789999999999999999999999999999999999999999998888888766554444322
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
+. .....+..++..|| ...|..|+|+++++ +|+...++
T Consensus 231 ~~---------~~~~~~~~li~~~l----~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 231 WD---------TVTPEAKSLIDSML----TVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp TT---------TSCHHHHHHHHHHS----CSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred hc---------ccCHHHHHHHHHHc----ccChhhCCCHHHHhcCccccCChh
Confidence 11 11234444544444 45689999999999 99987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.67 Aligned_cols=275 Identities=24% Similarity=0.348 Sum_probs=203.2
Q ss_pred ecCceEE-EEEeccCCCCceEEEEEC--CCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 412 IAGRYYV-TEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 412 i~~rY~i-~e~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
+.+.|++ .++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+++.++ ||||+++++++..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSH 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCC------CTTBCCCCEEEEET
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcC------CCCeeeEeeEEecC
Confidence 3456777 457999999999999965 5789999999975432 356788999999985 8899999999965
Q ss_pred -cCeEEEEEEccccchHHHHHhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc--cCcce
Q 005415 488 -LEHLFIVCELLRANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCE 561 (697)
Q Consensus 488 -~~~l~LVmEyl~gsL~~~l~~~~~~~---~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~ 561 (697)
...+++||||+.++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||+.. ...+.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 57899999999999998887544321 1223889999999999999999999999999999999999943 24689
Q ss_pred EEEeeCCCccccccc------cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---------
Q 005415 562 IKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV--------- 625 (697)
Q Consensus 562 vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~--------- 625 (697)
+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999765432 2346789999999999875 489999999999999999999999987654
Q ss_pred HHHHHHHHHhhCCCCHHHHhhccccccccc-----------CCc----------hhhhhHHHHHHHHHHHhhhhccCHHH
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFT-----------KEY----------DLYYINEVCFANIFISLVVIRLTLEY 684 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~-----------~~~----------~l~~i~~~cw~~l~~~~~~~r~t~e~ 684 (697)
.+++.+|++.+|.++...+........+.. ... .......+....++...|..|+|+++
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 488999999999888766544322211110 000 00122334455566667889999999
Q ss_pred HH--HhhcccC
Q 005415 685 AA--LWLFGID 693 (697)
Q Consensus 685 ~~--~wl~~~~ 693 (697)
++ +|+....
T Consensus 331 ~L~hp~f~~~~ 341 (405)
T 3rgf_A 331 AMQDPYFLEDP 341 (405)
T ss_dssp HHTSGGGTSSS
T ss_pred HhcChhhccCC
Confidence 99 9998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.66 Aligned_cols=271 Identities=23% Similarity=0.288 Sum_probs=215.9
Q ss_pred cceeeCceecCceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005415 404 LPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (697)
Q Consensus 404 ~pv~~~~~i~~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv 479 (697)
......+.+.++|.+. +.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+.+ ||||+
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~~iv 92 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS-----CPRVI 92 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT-----CTTBC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC-----CCCEE
Confidence 3444556678899998 89999999999999999999999999997532 234677889999988763 68999
Q ss_pred EEEEEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-
Q 005415 480 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY- 557 (697)
Q Consensus 480 ~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~- 557 (697)
++++++......++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 999999999999999999975 6666553221 1238999999999999999999999999999999999999842
Q ss_pred CcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 558 QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
..+.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 2578999999999765443 23457899999999999999999999999999999999999999999988888888776
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
...++.+... .....+..++.. .+...|..|+|+++++ +|+..+++..
T Consensus 249 ~~~~~~~~~~---------~~~~~~~~li~~----~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 249 NVDYSEETFS---------SVSQLATDFIQS----LLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp CCCCCTTTTT---------TSCHHHHHHHHH----HSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred ccccCchhhc---------ccCHHHHHHHHH----HcCCChhhCcCHHHHhCCHhhccccccc
Confidence 5555443221 112234444444 4455689999999999 9999877643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.67 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=202.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
++..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||++++++|
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~ 84 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE------HPFLVNLWYSF 84 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC------CCCCCcEEEEE
Confidence 344578999999999999999999999999999999997532 33456778888888774 89999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.....+++||||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~--~g~vkL 156 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHI 156 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC--CCCEEE
Confidence 999999999999964 6666665322 2899999999999999999999999999999999999985 889999
Q ss_pred eeCCCcccccc--ccccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHHHhh
Q 005415 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARIIGML 636 (697)
Q Consensus 565 ~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~---~~~e~l~~I~~~l 636 (697)
+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ...+.+..+....
T Consensus 157 ~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 236 (384)
T 4fr4_A 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236 (384)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred eccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence 99999976543 3445789999999999974 45899999999999999999999999753 3344444443333
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-HHHHH--HhhcccCCC
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-LEYAA--LWLFGIDQN 695 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-~e~~~--~wl~~~~~n 695 (697)
...|.. ....+..++ ..++...|..|++ +++++ +|+..++|+
T Consensus 237 ~~~p~~-------------~s~~~~~li----~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 237 VTYPSA-------------WSQEMVSLL----KKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp CCCCTT-------------SCHHHHHHH----HHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred cCCCCc-------------CCHHHHHHH----HHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 222211 122344444 4444556888988 77777 999887764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=340.40 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=213.3
Q ss_pred cceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--------------hhhHhHHHHHHHHHHhcc
Q 005415 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNK 469 (697)
Q Consensus 404 ~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--------------~~~~~~~~Ei~iL~~L~~ 469 (697)
+.......+.++|+++++||+|+||+||+|.++.+++.||||++.... .....+.+|+.+++.++
T Consensus 26 ~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 104 (504)
T 3q5i_A 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD- 104 (504)
T ss_dssp GCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-
T ss_pred eeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-
Confidence 334445567789999999999999999999999999999999997542 23456778999888874
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCC
Q 005415 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 548 (697)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLK 548 (697)
||||+++++++......++||||+.+ +|.+.+..... +++..+..++.||+.||.|||++||+|||||
T Consensus 105 -----hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 173 (504)
T 3q5i_A 105 -----HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHKHNIVHRDIK 173 (504)
T ss_dssp -----CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred -----CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCc
Confidence 89999999999999999999999975 67777754432 8999999999999999999999999999999
Q ss_pred CccccccccCc-ceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 549 PENILIKSYQR-CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 549 P~NILl~~~~~-~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
|+|||++..+. ..+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999986322 37999999999765433 344678999999999874 689999999999999999999999999999
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.+++..+......++...+.. ....+..+ ...++...|..|+|+++++ +|+.....
T Consensus 253 ~~~~~~i~~~~~~~~~~~~~~---------~s~~~~~l----i~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 253 QDIIKKVEKGKYYFDFNDWKN---------ISDEAKEL----IKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHHHHHHCCCCCCHHHHTT---------SCHHHHHH----HHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHHHHHcCCCCCCccccCC---------CCHHHHHH----HHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 999999877665555544321 11233334 4444556688999999999 99986544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.11 Aligned_cols=264 Identities=14% Similarity=0.131 Sum_probs=198.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC-----CcEEEEEEEecchhhhHhHHHHHHHHHHhcc---------cCCCCCC
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK---------NDPADEH 476 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~-----g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~---------~~~~~hp 476 (697)
+..++|++.+.||+|+||.||+|.+..+ ++.||||++.... .....|+++++.+.+ .....||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3446999999999999999999998764 5889999998654 245566776666544 3456799
Q ss_pred ceeEEEEEEEec----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 477 HILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 477 nIv~l~~~f~~~----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
||+++++++... ...+|||||++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 999999999875 56899999998888888765322 289999999999999999999999999999999999
Q ss_pred cccccCcceEEEeeCCCcccccccc----------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~~~----------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
|++...++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9985457899999999996543221 234589999999999999999999999999999999999999986
Q ss_pred CcH-HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 623 DAV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 623 ~~~-~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
... ......+.........++....- ..-.....+..++..||... +..|.+++++...|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~----p~~RP~~~~l~~~l 324 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLD----YTEKPLYENLRDIL 324 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCC----TTCCCCHHHHHHHH
T ss_pred cccCHHHHHHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCC----CCCCCCHHHHHHHH
Confidence 432 22222222222222222221110 00123457778888888754 77888888777433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=329.71 Aligned_cols=260 Identities=26% Similarity=0.331 Sum_probs=193.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.+.++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+.+|+.+++.++ ||||+++++++....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLS------HPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCC------CTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-HHHHHHHHHHHHhCC------CCCCcceeeeEecCC
Confidence 3456789999999999999999999999999999999986532 356778999999885 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DF 567 (697)
..++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +.++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999997 57777765322 2899999999999999999999999999999999999974 34788999999
Q ss_pred CCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e-~l~~I~~~lg~~p~e~~ 644 (697)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ .+..+......++..++
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275 (349)
T ss_dssp C----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT
T ss_pred ccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh
Confidence 998765433 234678999999999999999999999999999999999999997765443 55555543333222111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
. .....+..++..|| ...|..|+|+++++ +|+.+...|
T Consensus 276 ~---------~~~~~~~~li~~~L----~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 276 D---------EVSLNAKDLVRKLI----VLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp T---------TSCHHHHHHHHTTS----CSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred h---------hCCHHHHHHHHHHc----cCChhhCcCHHHHhcCcccCCCccc
Confidence 0 11223444444444 45589999999999 999877655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.86 Aligned_cols=273 Identities=27% Similarity=0.405 Sum_probs=213.6
Q ss_pred eeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 406 v~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
..+...+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++
T Consensus 3 ~~~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 76 (353)
T 2b9h_A 3 KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK------HENIITIFN 76 (353)
T ss_dssp TTCCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred cccccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc------CCCcCCeee
Confidence 334556778999999999999999999999999999999999743 233456778999998874 889999999
Q ss_pred EEEec-----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 484 YFYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 484 ~f~~~-----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++... ...++||||+.++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~-- 147 (353)
T 2b9h_A 77 IQRPDSFENFNEVYIIQELMQTDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS-- 147 (353)
T ss_dssp ECCCSCSTTCCCEEEEECCCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--
T ss_pred eecccccCccceEEEEEeccCccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC--
Confidence 88754 679999999999988877642 2889999999999999999999999999999999999985
Q ss_pred cceEEEeeCCCccccccc-------------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 559 RCEIKIIDLGSSCFQTDN-------------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-------------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 788999999998764421 122467999999999865 678999999999999999999999999999
Q ss_pred HHHHHHHHHHhhCCCCHHHHhhcc----------cccccccC-----CchhhhhHHHHHHHHHHHhhhhccCHHHHH--H
Q 005415 625 VVMILARIIGMLGPIDLEMLMQGQ----------EIYKYFTK-----EYDLYYINEVCFANIFISLVVIRLTLEYAA--L 687 (697)
Q Consensus 625 ~~e~l~~I~~~lg~~p~e~~~~~~----------~~~~~~~~-----~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~ 687 (697)
..+.+..+....+.++........ ....+-.. ...+...+.+...+.+...|..|.|+++++ +
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 999999999888877632211110 00000000 011222233344444455688999999999 9
Q ss_pred hhcccC
Q 005415 688 WLFGID 693 (697)
Q Consensus 688 wl~~~~ 693 (697)
|+....
T Consensus 308 ~~~~~~ 313 (353)
T 2b9h_A 308 YLQTYH 313 (353)
T ss_dssp GGTTTC
T ss_pred cccccC
Confidence 998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.70 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=206.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~ 97 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH------HPNIARLYEVY 97 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC------CCCcceeehhh
Confidence 457899999999999999999999999999999999753 234567888999999885 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc----------------------------------CCCcccCHHHHHHHHHHH
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES----------------------------------GGEAYFTLGRLQVITRQC 530 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------------------------------~~~~~ls~~~i~~i~~qI 530 (697)
......++||||+. ++|.+++...... .....+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999996 5676665321100 001124677888999999
Q ss_pred HHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccccc-------ccccccccCCCCCchhhcC--CCCCchh
Q 005415 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIG--LPYDQKI 601 (697)
Q Consensus 531 a~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~--~~~s~ks 601 (697)
+.||.|||++||+||||||+|||++.++.+.+||+|||++..... ......||+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999999999999999999999864555899999999975432 1234578999999999975 5789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC
Q 005415 602 DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT 681 (697)
Q Consensus 602 DIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t 681 (697)
|||||||++|+|++|+.||.+.+..+.+.++......++..... .....+..++..|| ...|..|++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l----~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN---------VLSPLARDLLSNLL----NRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGG---------GSCHHHHHHHHHHS----CSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccc---------cCCHHHHHHHHHHc----CCChhHCCC
Confidence 99999999999999999999999988888887654443322211 11234444544444 456899999
Q ss_pred HHHHH--HhhcccCC
Q 005415 682 LEYAA--LWLFGIDQ 694 (697)
Q Consensus 682 ~e~~~--~wl~~~~~ 694 (697)
+++++ +|+....+
T Consensus 325 ~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 325 AMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHSHHHHTTSS
T ss_pred HHHHhcChhhccChH
Confidence 99999 99987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.88 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=199.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+..++|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++ ...||||+++++++.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~------~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ------NSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCC------CCSCTTSCCEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHH------hCCCCeEeeEEEEEe
Confidence 34578999999999999999999999999999999997532 12233344444443 446999999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEE
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
..+.+++||||+.+ +|...+.... .+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~--~~~~kl 290 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKI 290 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS--SSCEEE
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC--CCCEEE
Confidence 99999999999985 6666665432 28999999999999999999998 99999999999999985 789999
Q ss_pred eeCCCcccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 565 IDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 565 ~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|.
T Consensus 291 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 370 (446)
T 4ejn_A 291 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370 (446)
T ss_dssp CCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred ccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 99999975322 234568999999999999999999999999999999999999999999888888887654433332
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCCC
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQN 695 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~n 695 (697)
. ....+..++..| +...|..|+ ++++++ +|+.+.++.
T Consensus 371 ~-------------~~~~~~~li~~~----L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 371 T-------------LGPEAKSLLSGL----LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp T-------------SCHHHHHHHHHH----TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred c-------------CCHHHHHHHHHH----cccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 1 123344444444 445688898 999999 999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.67 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=195.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---------------------------hhHhHHHHHHHH
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------------------------FFDQSLDEIKLL 464 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---------------------------~~~~~~~Ei~iL 464 (697)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45789999999999999999999999999999999975421 124577888888
Q ss_pred HHhcccCCCCCCceeEEEEEEEe--cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC
Q 005415 465 KLVNKNDPADEHHILRLYDYFYH--LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541 (697)
Q Consensus 465 ~~L~~~~~~~hpnIv~l~~~f~~--~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g 541 (697)
+.++ ||||+++++++.. ....++||||+.+ +|.++.. ...+++..+..++.||+.||.|||++|
T Consensus 91 ~~l~------h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 91 KKLD------HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HTCC------CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhCC------CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8774 8899999999987 5789999999975 4443221 123899999999999999999999999
Q ss_pred ccccCCCCccccccccCcceEEEeeCCCccccccc---cccccccCCCCCchhhcCCC---CCchhhHHHHHHHHHHHHh
Q 005415 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWT 615 (697)
Q Consensus 542 IvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~---~s~ksDIWSLGviL~ELlt 615 (697)
|+||||||+|||++. ++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECT--TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECC--CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999985 789999999999765432 23457899999999998765 3778999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 616 GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 616 G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
|+.||.+.........+.......+. .-.....+..++..|| ...|..|+++++++ +|+.
T Consensus 236 g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l----~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 236 GQCPFMDERIMCLHSKIKSQALEFPD-----------QPDIAEDLKDLITRML----DKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCS-----------SSCCCHHHHHHHHHHT----CSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCCCCccHHHHHHHHhcccCCCCC-----------ccccCHHHHHHHHHHh----hcChhhCCCHHHHhcCcccc
Confidence 99999988877766666543322221 0012234555555555 45589999999999 9985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.84 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=212.0
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
.+..+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~ 93 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD------HPNIMKLYE 93 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 3456778999999999999999999999999999999999743 234567788998888773 899999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcce
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCE 561 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~ 561 (697)
++......++||||+. ++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ..++.
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 94 FFEDKGYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 9999999999999997 56767665332 2899999999999999999999999999999999999963 24678
Q ss_pred EEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+......+
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp EEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999998765433 344678999999999977 68999999999999999999999999999999988887655444
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+...+. .+.....+...+.+...|..|+|+++++ +|+....
T Consensus 247 ~~~~~~-------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 247 ELPQWK-------------KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CSGGGG-------------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCcccc-------------cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 332211 1222333444445556699999999999 9998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.21 Aligned_cols=255 Identities=26% Similarity=0.325 Sum_probs=201.9
Q ss_pred CceEE--EEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYV--TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i--~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
..|.+ .+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL------DHANLIQLYDAFESKND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEECSSE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC------CCCCCCeEEEEEEECCE
Confidence 44555 678999999999999999999999999998643 3445677888888776 48999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+. ++|.+.+..... .+++..+..++.||+.||.|||++||+||||||+|||+..+..+.+||+|||+
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred EEEEEeCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 999999997 577777754332 28899999999999999999999999999999999999654578999999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..|......++.+.+.
T Consensus 236 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 313 (373)
T 2x4f_A 236 ARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ-- 313 (373)
T ss_dssp CEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT--
T ss_pred ceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc--
Confidence 9765433 334568999999999999889999999999999999999999999999999998887765444432211
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....+..++..| +...|..|+++++++ +|+...
T Consensus 314 -------~~~~~~~~li~~~----L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 -------DISEEAKEFISKL----LIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -------TSCHHHHHHHHTT----SCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -------cCCHHHHHHHHHH----cCCChhhCCCHHHHhcCcCcCCC
Confidence 1122344444444 445588899999999 898754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.26 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=196.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+..++|++++.||+|+||.||+|.+ .+++.||||++... ......+.+|+.+++.+++. ||||+++++++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEIT 80 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEEC
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc----CCceEEEeeeEee
Confidence 3467899999999999999999997 56899999999753 23446778899999999753 5899999999999
Q ss_pred cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 488 ~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---~~~~kl~DF 151 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDF 151 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEECCC
T ss_pred CCEEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE---CCcEEEeec
Confidence 99999999988889998887533 288999999999999999999999999999999999997 678999999
Q ss_pred CCcccccccc-----ccccccCCCCCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHH
Q 005415 568 GSSCFQTDNL-----CLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILA 630 (697)
Q Consensus 568 Gla~~~~~~~-----~~~~gt~~Y~APE~l~~-----------~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~ 630 (697)
|++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+.
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 231 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH
Confidence 9997654322 24578999999999965 668999999999999999999999997643 333333
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.++....... .. -.....+..++..||. ..|..|+|+++++ +|+...
T Consensus 232 ~~~~~~~~~~---------~~--~~~~~~l~~li~~~L~----~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 232 AIIDPNHEIE---------FP--DIPEKDLQDVLKCCLK----RDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHCTTSCCC---------CC--CCSCHHHHHHHHHHTC----SSTTTSCCHHHHHTSHHHHSC
T ss_pred HHhcCCcccC---------Cc--ccCCHHHHHHHHHHcC----CChhHCCCHHHHHhCcccccc
Confidence 3322111110 00 0112345566666654 4588999999999 998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.11 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=187.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhH--hHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~--~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+..++|++++.||+|+||.||+|.+..+++.||||+++....... ....|..+ .+ ...+||||+++++++...
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~--~~---~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI--SM---RTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHH--HH---TTCCCTTBCCEEEEEECS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHH--HH---HhCCCCeEEEEeeeeecc
Confidence 456899999999999999999999999999999999975432211 22222221 12 234699999999999999
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||++++|.+++....... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~lv~e~~~~~l~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~Df 154 (290)
T 3fme_A 79 GDVWICMELMDTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDF 154 (290)
T ss_dssp SSEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT--TCCEEBCCC
T ss_pred CCEEEEEehhccchHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeec
Confidence 9999999999999888776533222 2389999999999999999999998 9999999999999985 789999999
Q ss_pred CCcccccccc--ccccccCCCCCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCCC
Q 005415 568 GSSCFQTDNL--CLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPID 640 (697)
Q Consensus 568 Gla~~~~~~~--~~~~gt~~Y~APE~l----~~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~p 640 (697)
|++....... ....+++.|+|||++ .+..++.++|||||||++|+|++|+.||.. ......+..+.....+..
T Consensus 155 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 155 GISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred CCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 9987654432 234789999999997 456789999999999999999999999986 344444544433222111
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.. -.....+..++..||. ..|..|+|+++++ +|+...+
T Consensus 235 ~~-----------~~~~~~~~~li~~~l~----~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 235 PA-----------DKFSAEFVDFTSQCLK----KNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CT-----------TTSCHHHHHHHHHHTC----SSGGGSCCHHHHTTSHHHHHHH
T ss_pred cc-----------ccCCHHHHHHHHHHhh----cChhhCcCHHHHHhCcccccCc
Confidence 10 0112345555555554 5589999999999 8997543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.33 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=193.6
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
...+.++|++.+.||+|+||.||+|++..+++.||||+++.... ....+.+|+.++ ...+||||++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l------~~l~hp~iv~~~~~ 80 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA------AALNHPAIVAVYDT 80 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTC------CCCCCTTBCCEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHH------HcCCCCCcceEEEe
Confidence 45678899999999999999999999999999999999976432 222334444443 44569999999999
Q ss_pred EEecC----eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 485 FYHLE----HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 485 f~~~~----~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+.... ..++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus 81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~ 152 (311)
T 3ork_A 81 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--T 152 (311)
T ss_dssp EEEEETTEEEEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--T
T ss_pred eeccCCCCcccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC--C
Confidence 98654 3599999996 57777776443 2899999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 153 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp SCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 88999999999764432 223468999999999999999999999999999999999999999998888777766
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
.....++..... .....+..++..||. ..|..|.+..+++ +|+.
T Consensus 233 ~~~~~~~~~~~~---------~~~~~l~~li~~~l~----~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 233 REDPIPPSARHE---------GLSADLDAVVLKALA----KNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HCCCCCHHHHST---------TCCHHHHHHHHHHTC----SSGGGSCSSHHHHHHHHHH
T ss_pred cCCCCCcccccC---------CCCHHHHHHHHHHHh----cCHhhChhhHHHHHHHHHH
Confidence 544333322111 123345566666655 3477887665555 6665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.76 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=203.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL------RHPNILRLYGYFHD 80 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC------CCCCCcchhheEec
Confidence 3478999999999999999999999999999999997532 2234566777777665 48999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+. ++|.+.+..... +++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~~l~D 152 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIAD 152 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT--TSCEEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC--CCCEEEEe
Confidence 999999999998 467776654322 889999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 567 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 567 FGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......|..
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 229 (279)
T 3fdn_A 153 FGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--- 229 (279)
T ss_dssp CCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred ccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc---
Confidence 9988654433 344678999999999999999999999999999999999999999998888888876644433321
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
....+..++..|| ...|..|.++++++ +|+.....
T Consensus 230 ----------~~~~~~~li~~~l----~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 230 ----------VTEGARDLISRLL----KHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ----------SCHHHHHHHHHHC----CSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ----------CCHHHHHHHHHHh----ccChhhCCCHHHHhhCccccCCcc
Confidence 1234445555554 45589999999999 99986443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.88 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=208.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
++.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+|+.+++.++ ||||+++++
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~ 75 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR------HPNIITLHD 75 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC------CCCeeehhh
Confidence 356789999999999999999999999999999999875321 2467888999999885 789999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC--cc
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RC 560 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~--~~ 560 (697)
++......++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++... ..
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 9999999999999996 67777775432 289999999999999999999999999999999999998522 23
Q ss_pred eEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+......
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 7999999999765432 23456899999999999999999999999999999999999999999888888887665555
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.+.+... .....+..++..||. ..|..|+++++++ +|+...
T Consensus 230 ~~~~~~~---------~~~~~~~~li~~~l~----~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 230 FDEEYFS---------NTSELAKDFIRRLLV----KDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHT---------TCCHHHHHHHHTTSC----SSGGGSCCHHHHHHCHHHHHH
T ss_pred Ccchhcc---------cCCHHHHHHHHHHcc----CCHhHCcCHHHHHhCHHHHHH
Confidence 5544322 122345555555554 4588999999999 898754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.02 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=205.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--cCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--~~~ 490 (697)
.++|++++.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++.++ +||||+++++++.. ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC-----CCCCEEEeeeeeccCCCCc
Confidence 578999999999999999999999999999999997543 367889999999996 37899999999997 577
Q ss_pred EEEEEEccccc-hHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~gs-L~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.++ |.+++. . +++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||+
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---T------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 177 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---G------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCCTT
T ss_pred eEEEEeccCchhHHHHHH---h------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-CCCEEEEEeCCC
Confidence 99999999854 444332 1 788999999999999999999999999999999999985 234899999999
Q ss_pred cccccc--ccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 570 SCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 570 a~~~~~--~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF-~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+.+..+...++.++.....
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 976443 2344678999999999987 66899999999999999999999999 4566777788877777654332211
Q ss_pred hccc------------------ccccccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 646 QGQE------------------IYKYFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 646 ~~~~------------------~~~~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
.... ...++.. ...+.....+...+++...|..|+|+++++ +|+....++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 1000 0000000 001222333344444455688899999999 999987765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.00 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=210.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+.++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD------HPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC------CTTBCCEEEEEECSSE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC------CCCEeeEEEEEecCCe
Confidence 467899999999999999999999999999999998753 234567888999988874 8899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG 568 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DFG 568 (697)
.++||||+.+ +|.+.+..... +++..+..++.|++.||.|||++||+||||||+|||+.. +.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999975 67676654332 889999999999999999999999999999999999932 147889999999
Q ss_pred Cccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 569 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 569 la~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
++...... .....+++.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+.+..+......++...+..
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T 3f3z_A 155 LAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLN 233 (277)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred cceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhc
Confidence 98764432 3446789999999998765 89999999999999999999999999999988888887766666654321
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
....+..++..|| ...|..|+++++++ +|+..
T Consensus 234 ---------~~~~~~~li~~~l----~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 234 ---------VSPQAESLIRRLL----TKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------SCHHHHHHHHHHT----CSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------CCHHHHHHHHHHc----cCChhhCcCHHHHhcCHHHhc
Confidence 2234445554444 45689999999999 99864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.86 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=203.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+.++|++.+.||+|+||.||+|.++.+++.||||++..... ...+|+.++..+. +||||+++++++.+...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG-----QHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT-----TSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc-----CCCCcCeEEEEEEcCCEE
Confidence 45789999999999999999999999999999999986543 3456888887774 489999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc--CcceEEEeeCC
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLG 568 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~--~~~~vKL~DFG 568 (697)
|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||+... ..+.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999974 7777765432 28999999999999999999999999999999999998542 22469999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHHHhhCCCCHH
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN---DAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~---~~~~e~l~~I~~~lg~~p~e 642 (697)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+ ....+++..|......++..
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 99765432 3346789999999999988889999999999999999999999976 35566666665433222211
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
. | ..+.....+...+++...|..|+++++++ +|+..++
T Consensus 246 ~----------~---~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 246 Y----------W---NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp T----------T---TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred c----------c---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 1 1 12223344445555566689999999999 9997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=338.35 Aligned_cols=257 Identities=30% Similarity=0.452 Sum_probs=209.4
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~ 92 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD------HPNIMKLFEILED 92 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC------CCCcCeEEEEEEc
Confidence 4568999999999999999999999999999999999743 233467889999999884 8899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEe
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~ 565 (697)
....++||||+.+ +|.+.+..... +++..+..++.||+.||.|||++||+||||||+|||++.. .++.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999974 67676654432 8999999999999999999999999999999999999642 35689999
Q ss_pred eCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 566 DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+......++...
T Consensus 167 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245 (486)
T ss_dssp SCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred ECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 99999765433 334678999999999986 589999999999999999999999999999999888876554444322
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+. .....+..+ ..+.+...|..|+|+++++ +|+....
T Consensus 246 ~~---------~~s~~~~~l----i~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 246 WR---------TISDDAKDL----IRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp GG---------GSCHHHHHH----HHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred cC---------CCCHHHHHH----HHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 21 112233344 4444456689999999999 9998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.20 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=196.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++....
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC------CCCCCeEEEEEecCC
Confidence 3478999999999999999999999999999999997533 23456788999998874 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Dfg 150 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFG 150 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC--CCCEEEEEee
Confidence 99999999975 666665432 22899999999999999999999999999999999999985 7899999999
Q ss_pred Cccccccc-----cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHhhCCCCH
Q 005415 569 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDL 641 (697)
Q Consensus 569 la~~~~~~-----~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e-~l~~I~~~lg~~p~ 641 (697)
++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ....+.......+
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 229 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN- 229 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST-
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC-
Confidence 99754321 234678999999999988775 778999999999999999999998765432 2222221111111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
....+.....+...+.+...|..|.|+++++ +|+...
T Consensus 230 --------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 230 --------------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp --------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 1111222333444445556699999999999 999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.90 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=202.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++ ||||+++++++...
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD------HPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC------CTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC------CchHHhHHHheecC
Confidence 45689999999999999999999999999999999997643 23467788999998874 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEee
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIID 566 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~D 566 (697)
...++||||+.+ +|.+.+....... ..+++..+..++.||+.||.|||++||+||||||+|||++.. ..+.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999975 7777775543222 228999999999999999999999999999999999999642 357899999
Q ss_pred CCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 567 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 567 FGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
||++...... .....+++.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.......+...
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 248 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC- 248 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---
T ss_pred eecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-
Confidence 9999764432 33467899999999986 4689999999999999999999999999888777666544322222111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
......+..++..|| ...|..|+++++++ +|+..
T Consensus 249 ---------~~~~~~~~~li~~~L----~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 ---------RPLTPQAVDLLKQML----TKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------CCCCHHHHHHHHHHT----CSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------CcCCHHHHHHHHHHc----cCChhhCcCHHHHhcCHHhhc
Confidence 011234445555444 45689999999999 99874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.66 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=207.2
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch------------hhhHhHHHHHHHHHHhcccCCCCCCce
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------------DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~------------~~~~~~~~Ei~iL~~L~~~~~~~hpnI 478 (697)
.+.++|++.+.||+|+||.||+|.+.. ++.||||++.... .....+.+|+.+++.++ ||||
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i 91 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH------HPNI 91 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC------CTTB
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC------CcCc
Confidence 345789999999999999999999754 9999999986421 12367788999999885 8899
Q ss_pred eEEEEEEEec-----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccc
Q 005415 479 LRLYDYFYHL-----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 553 (697)
Q Consensus 479 v~l~~~f~~~-----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 553 (697)
+++++++... ..+++||||+.++|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEE
Confidence 9999999643 4689999999999998887432 23899999999999999999999999999999999999
Q ss_pred ccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q 005415 554 IKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 630 (697)
Q Consensus 554 l~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~ 630 (697)
++. ++.+||+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 167 ~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LAD--NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECT--TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcC--CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 985 788999999999754332 334578899999999987 678999999999999999999999999999999999
Q ss_pred HHHHhhCCCCHHHHhhcc--ccccccc-------------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 631 RIIGMLGPIDLEMLMQGQ--EIYKYFT-------------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~--~~~~~~~-------------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.+++..+.++.+...... ....++. ..........+...+.+...|..|+|+++++ +|+...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 999999998877543211 0001100 0011122334445555556689999999999 999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.19 Aligned_cols=253 Identities=17% Similarity=0.176 Sum_probs=195.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEE------
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY------ 482 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~------ 482 (697)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.+.. ..||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG---IKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT---CCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc---cCCHHHHHHHhhhhhh
Confidence 4789999999999999999999989999999999973 23345667788877766653 4699999998
Q ss_pred -EEEEecC-----------------eEEEEEEccccchHHHHHhhhccCC-CcccCHHHHHHHHHHHHHHHHHHHhcCcc
Q 005415 483 -DYFYHLE-----------------HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGII 543 (697)
Q Consensus 483 -~~f~~~~-----------------~l~LVmEyl~gsL~~~l~~~~~~~~-~~~ls~~~i~~i~~qIa~aL~yLHs~gIv 543 (697)
+++...+ ..++||||++++|.+++........ ...+++..+..|+.||+.||.|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 6666543 3899999999999999876543211 12344578888999999999999999999
Q ss_pred ccCCCCccccccccCcceEEEeeCCCccccccccccccccCCCCCchhhcCC-----------CCCchhhHHHHHHHHHH
Q 005415 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAE 612 (697)
Q Consensus 544 HrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDIWSLGviL~E 612 (697)
||||||+|||++. ++.+||+|||++...........| +.|+|||++.+. .++.++|||||||++|+
T Consensus 229 HrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQ--RGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECT--TCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcC--CCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999995 789999999999876666666778 999999999887 79999999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 613 LWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 613 LltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
|++|+.||.+......+..+.... -.....+..++..||. ..|..|+++++++ +|+.
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~----~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIFRSC-----------------KNIPQPVRALLEGFLR----YPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHSSCCC------CCSGGGGSSC-----------------CCCCHHHHHHHHHHTC----SSGGGCCCHHHHHTSHHHH
T ss_pred HHHCCCCCcccccccchhhhhhhc-----------------cCCCHHHHHHHHHHcC----CCchhCCCHHHHhhChHHH
Confidence 999999997655433222221110 1123455566666655 4589999999999 8987
Q ss_pred cc
Q 005415 691 GI 692 (697)
Q Consensus 691 ~~ 692 (697)
..
T Consensus 365 ~~ 366 (377)
T 3byv_A 365 QL 366 (377)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.29 Aligned_cols=208 Identities=23% Similarity=0.297 Sum_probs=176.7
Q ss_pred cCceEEEEEeccC--CCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G--~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++|+++++||+| +||.||+|++..+++.||||+++.. ......+.+|+.+++.++ ||||+++++++..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN------HPNIVPYRATFIA 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCCCcEeEEEEE
Confidence 4789999999999 9999999999999999999999754 234466778999999885 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+.+++||||+. ++|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~--~~~~kl~d 171 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSG 171 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 999999999997 5677776543222 2899999999999999999999999999999999999985 78999999
Q ss_pred CCCcccccc----------ccccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q 005415 567 LGSSCFQTD----------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632 (697)
Q Consensus 567 FGla~~~~~----------~~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I 632 (697)
||.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 998754321 1223478889999999987 57899999999999999999999999887665555444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.38 Aligned_cols=210 Identities=26% Similarity=0.386 Sum_probs=178.5
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
++++..++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 100 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAF 100 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC------CCTTBCCEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC------CCCCEEEEeEEE
Confidence 4567778999999999999999999999999999999999864 33345667777777665 489999999999
Q ss_pred EecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEE
Q 005415 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 486 ~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vK 563 (697)
......++||||+.+ +|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+|
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~k 172 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIK 172 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEE
T ss_pred EECCEEEEEEECCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC--CCCEE
Confidence 999999999999975 78777764432 88999999999999999999996 9999999999999985 78899
Q ss_pred EeeCCCcccccc-ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 564 IIDLGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 564 L~DFGla~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 173 l~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 173 LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp ECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred EEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999865432 23446789999999999999999999999999999999999999998776654433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.62 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=204.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++++.||+|+||+||+|++..++..||||+++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 107 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL------DHPNIMKLYDFFED 107 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC------CCTTBCCEEEEEEC
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC------CCCCCCeEEEEEEe
Confidence 45678999999999999999999999999999999997532 2345677888888776 48999999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEe
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKII 565 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~ 565 (697)
....++||||+.+ +|.+.+..... +++..+..++.||+.||.|||++||+||||||+|||++.. ..+.+||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEE
Confidence 9999999999975 67676654422 8899999999999999999999999999999999999752 24679999
Q ss_pred eCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 566 DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+......++...
T Consensus 182 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (494)
T 3lij_A 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260 (494)
T ss_dssp CCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred ECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 99998765433 344678999999999864 689999999999999999999999999999999988877655554433
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+. .....+..++ .+++...|..|+|+++++ +|+..
T Consensus 261 ~~---------~~s~~~~~li----~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 WK---------NVSEGAKDLI----KQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp GT---------TSCHHHHHHH----HHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred cc---------cCCHHHHHHH----HHHCCCChhhCccHHHHhcCccccc
Confidence 21 1122334444 444455688999999999 99974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=328.61 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=197.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..+|++++.||+|+||.||+|.+.. ++.||||++... ......+.+|+.+++.+++. ||||+++++++....
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~----~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDYEITDQ 129 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT----CTTBCCEEEEEECSS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccC----CCeEEEEEEEEecCC
Confidence 4579999999999999999999754 899999999753 33456788999999999752 689999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~kl~DFG~ 200 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGI 200 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES---SSCEEECCCSS
T ss_pred EEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE---CCeEEEEecCc
Confidence 999999988888988887543 278889999999999999999999999999999999996 57899999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHH
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARI 632 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e~l~~I 632 (697)
+...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ....+..+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 9765432 234578999999999975 368899999999999999999999998753 33444444
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+.....++. .. .....+..++..||. ..|..|+++++++ +|+...
T Consensus 281 ~~~~~~~~~---------~~--~~~~~~~~li~~~L~----~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 281 IDPNHEIEF---------PD--IPEKDLQDVLKCCLK----RDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HCTTSCCCC---------CC--CSCHHHHHHHHHHTC----SSTTTSCCHHHHHTSHHHHSC
T ss_pred hCccccCCC---------Cc--cchHHHHHHHHHHcc----cChhhCCCHHHHhhCcCcccc
Confidence 322111110 00 112345556666654 4588999999999 998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.73 Aligned_cols=268 Identities=19% Similarity=0.253 Sum_probs=202.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 78 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEEE 78 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCcceEEEEeec
Confidence 456789999999999999999999999999999999997533 23466778999999884 7899999999987
Q ss_pred cC--eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc--cCcceE
Q 005415 488 LE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEI 562 (697)
Q Consensus 488 ~~--~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~--~~~~~v 562 (697)
.. ..++||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceE
Confidence 64 7899999997 5787777654332 12889999999999999999999999999999999999821 246789
Q ss_pred EEeeCCCccccccc--cccccccCCCCCchhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHH
Q 005415 563 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII--------GLPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMI 628 (697)
Q Consensus 563 KL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~--------~~~~s~ksDIWSLGviL~ELltG~~PF~~~~----~~e~ 628 (697)
||+|||++...... .....+|+.|+|||++. +..++.++|||||||++|+|++|+.||.... ..+.
T Consensus 156 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred EEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 99999999765433 33457899999999986 5678999999999999999999999996432 3445
Q ss_pred HHHHHHhhCCCCHHHHhhccc-cccc--c--------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 629 LARIIGMLGPIDLEMLMQGQE-IYKY--F--------TKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~-~~~~--~--------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+++... |...+..... .... | .....+...+.+...+++...|..|+|+++++.-.
T Consensus 236 ~~~~~~~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 236 MYKIITGK---PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHC---CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHhcCC---CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 55554432 2211111100 0000 1 11123444555566666667788999999998433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=336.80 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=206.6
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+.+..++|.+.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~~~ 84 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF------RHPHIIKLYQV 84 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC------CCCCCCcEEEE
Confidence 4556689999999999999999999999999999999997542 2345677888888766 48999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~--~~~vk 156 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAK 156 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT--TCCEE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec--CCCeE
Confidence 999999999999996 5777766432 22899999999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.+|.......|
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 236 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236 (476)
T ss_dssp ECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC
T ss_pred EEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 9999999765432 345679999999999998775 6899999999999999999999999888888877765433322
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. .....+..++..| +...|..|.|+++++ +|+..
T Consensus 237 ~-------------~~s~~~~~Li~~~----L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 237 Q-------------YLNPSVISLLKHM----LQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp T-------------TCCHHHHHHHHHH----TCSSTTTSCCHHHHHTCHHHHT
T ss_pred c-------------cCCHHHHHHHHHH----cCCCchhCcCHHHHHhCHHhhh
Confidence 1 1122344444444 456689999999999 99874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=309.35 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=205.3
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..++|++++.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++.++ ||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC------CCCEeeEEEEEecCCce
Confidence 3478999999999999999999976 5778999999876655677889999998875 78999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMT 153 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--GGCEEECCTTGG
T ss_pred EEEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--CCCEEecccccc
Confidence 999999975 67777654322 2889999999999999999999999999999999999985 789999999999
Q ss_pred cccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 230 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR--- 230 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT---
T ss_pred ccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC---
Confidence 765432 222445678999999999999999999999999999999 999999999888888776543322211
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.....+..++..||. ..|..|+++++++..|..
T Consensus 231 ---------~~~~~~~~li~~~l~----~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 231 ---------LASTHVYQIMNHCWR----ERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp ---------TSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHHH
T ss_pred ---------cCCHHHHHHHHHHcc----CCcccCcCHHHHHHHHHH
Confidence 123456666666665 458889999998865543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=317.32 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=201.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.|...+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++......++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ------HFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC------CCCcceEEEEEEECCEEEE
Confidence 4888899999999999999999999999999997543 33456778888887664 8999999999999999999
Q ss_pred EEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 120 v~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQ 190 (321)
T ss_dssp EECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCcEEEeeeeeeee
Confidence 9999975 55555432 12899999999999999999999999999999999999985 78899999999876
Q ss_pred cccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 573 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 573 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....+...
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 262 (321)
T 2c30_A 191 ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK-------- 262 (321)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT--------
T ss_pred cccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC--------
Confidence 5432 33467899999999999999999999999999999999999999998888777776543221111
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
........+..++..|| ...|..|.|+++++ +|+...
T Consensus 263 --~~~~~~~~l~~li~~~l----~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 263 --NSHKVSPVLRDFLERML----VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --TGGGSCHHHHHHHHHHS----CSSTTTSCCHHHHHTSGGGGGC
T ss_pred --ccccCCHHHHHHHHHHc----cCChhhCcCHHHHhcChhhccC
Confidence 00112234555555554 45688999999999 999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.39 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=194.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
++..++|++.+.||+|+||+||+|.+ +++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~ 104 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR------HPNIVLFMGAVT 104 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEE
Confidence 34467899999999999999999986 68899999997542 33456788999999885 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcceEE
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~vK 563 (697)
.....++||||+.+ +|.+++..... ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~--~~~~k 179 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVK 179 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT--TCCEE
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC--CCcEE
Confidence 99999999999975 77777754321 123889999999999999999999999 999999999999985 78999
Q ss_pred EeeCCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9999999764433 2346789999999999999999999999999999999999999999888877776643322221
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
.. -.....+..++..||.. .|..|.++++++..
T Consensus 260 ~~-----------~~~~~~l~~li~~~l~~----dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 260 IP-----------RNLNPQVAAIIEGCWTN----EPWKRPSFATIMDL 292 (309)
T ss_dssp CC-----------TTSCHHHHHHHHHHTCS----SGGGSCCHHHHHHH
T ss_pred CC-----------ccCCHHHHHHHHHHccC----ChhhCcCHHHHHHH
Confidence 10 12234566777777754 48888898888733
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=320.17 Aligned_cols=267 Identities=16% Similarity=0.172 Sum_probs=197.4
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECC---CCcEEEEEEEecchhhhHhHHHHHHHHHHhc---------ccCCCCC
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN---------KNDPADE 475 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~---~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~---------~~~~~~h 475 (697)
+.++..++|++.+.||+|+||.||+|.+.. ++..||||++..... ....|+.+++.+. ......|
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDY 107 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence 344556899999999999999999999987 889999999986532 2233333333322 1223469
Q ss_pred CceeEEEEEEEe----cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 476 HHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 476 pnIv~l~~~f~~----~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
|||+++++++.. ....++||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 181 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN 181 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHH
Confidence 999999999988 68899999999878888776443 28999999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
||++.+..+.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998644459999999999654321 134578999999999999999999999999999999999999996
Q ss_pred C--CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 622 N--DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 622 ~--~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
+ ................++........ .-.....+..++..||.. .|..|++++++...|..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~----dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSL----AYDEKPNYQALKKILNP 325 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTC----CTTCCCCHHHHHHHHCT
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhcc----ccccHHHHHHHHHHHhhc----CcccCCCHHHHHHHHhc
Confidence 5 33333443333444444443332111 002344677788877764 48899999999976654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.85 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=205.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+..++|++++.||+|+||.||+|.+. ++..||+|+++........+.+|+.+++.++ ||||+++++++.....
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS------HPKLVKFYGVCSKEYP 77 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSS
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCc
Confidence 34578999999999999999999865 5778999999877666677889999999885 7899999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||++ ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg~ 150 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR--DLCVKVSDFGM 150 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT--TCCEEECCTTC
T ss_pred eEEEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC--CCCEEEccCcc
Confidence 999999996 567777765432 2889999999999999999999999999999999999985 78999999999
Q ss_pred cccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
+....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 228 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH-- 228 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT--
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC--
Confidence 87654332 12344667999999999889999999999999999999 999999988888777765443322211
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.....+..++..||. ..|..|+|+++++.-|..
T Consensus 229 ----------~~~~~l~~li~~~l~----~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 229 ----------LASDTIYQIMYSCWH----ELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp ----------TSCHHHHHHHHHTTC----SSGGGSCCHHHHHHHHGG
T ss_pred ----------cChHHHHHHHHHHcC----CChhhCcCHHHHHHHHHH
Confidence 123356667777765 448899999999955543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=314.77 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=197.2
Q ss_pred eecCceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 411 ~i~~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+. +||||+++++++...
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~-----~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-----GHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence 356789996 78999999999999999999999999997543 33567888999988753 489999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc-ceEEEee
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIID 566 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~-~~vKL~D 566 (697)
+..++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.. ..+||+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999997 67877776543 2889999999999999999999999999999999999985222 3499999
Q ss_pred CCCcccccc----------ccccccccCCCCCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCc-------
Q 005415 567 LGSSCFQTD----------NLCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDA------- 624 (697)
Q Consensus 567 FGla~~~~~----------~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIWSLGviL~ELltG~~PF~~~~------- 624 (697)
||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999865431 1223468999999999975 457899999999999999999999997753
Q ss_pred --------HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 625 --------VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 625 --------~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
....+..+......+|...+. .....+..++.. .+...|..|+|+++++ +|+.+..+
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~---------~~~~~~~~li~~----~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGKYEFPDKDWA---------HISCAAKDLISK----LLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCCCCCHHHHT---------TSCHHHHHHHHH----HSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ccccchhHHHHHHHHHhccCcccCchhcc---------cCCHHHHHHHHH----HhhCChhhCCCHHHHhcChhhcCCCC
Confidence 233444554444444433221 112234444444 4445689999999999 99986543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.52 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=206.8
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.......++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~ 81 (294)
T 2rku_A 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFH 81 (294)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEE
T ss_pred eeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC------CCCEeeee
Confidence 33445568999999999999999999999999999999998754 234456777888887763 89999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
+++...+..++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~ 153 (294)
T 2rku_A 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLE 153 (294)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCC
T ss_pred eeeccCCEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC--CCC
Confidence 99999999999999998 56666665432 2889999999999999999999999999999999999985 788
Q ss_pred EEEeeCCCcccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 562 IKIIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 562 vKL~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+||+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 233 (294)
T ss_dssp EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred EEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC
Confidence 99999999876432 233457899999999999988999999999999999999999999998887777666543222
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.|. .....+..++..|| ...|..|.++++++ +|+..
T Consensus 234 ~~~-------------~~~~~~~~li~~~l----~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 234 IPK-------------HINPVAASLIQKML----QTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp CCT-------------TSCHHHHHHHHHHT----CSSGGGSCCGGGGGGSHHHHT
T ss_pred Ccc-------------ccCHHHHHHHHHHc----ccChhhCcCHHHHhhChheec
Confidence 221 11234555555555 45588999999999 88864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.03 Aligned_cols=257 Identities=28% Similarity=0.361 Sum_probs=208.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||||+++.... ....+.+|+.+++.++ ||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK------HENIVTLEDIYESTT 79 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC------CTTBCCEEEEEECSS
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC------CCCeeehhhhcccCC
Confidence 456789999999999999999999999999999999986432 2345778999998874 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DF 567 (697)
..++||||+. ++|.+.+..... +++..+..++.||+.||.|||++||+||||||+||++.. +.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGV------YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEEEEcCCCccHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999997 577777754332 889999999999999999999999999999999999932 24788999999
Q ss_pred CCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 568 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 568 Gla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+.+....++.....
T Consensus 154 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~- 232 (304)
T 2jam_A 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD- 232 (304)
T ss_dssp STTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT-
T ss_pred CcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc-
Confidence 998765433 334568999999999999999999999999999999999999999998888888887654443322111
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....+..++..|| ...|..|+++++++ +|+...
T Consensus 233 --------~~~~~~~~li~~~l----~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 233 --------DISESAKDFICHLL----EKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp --------TSCHHHHHHHHHHH----CSSTTTSCCHHHHHTSHHHHSS
T ss_pred --------cCCHHHHHHHHHHc----CCChhHCcCHHHHhcCccccCC
Confidence 11234455555554 45688999999999 999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.34 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=203.3
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
.++..++|++.+.||+|+||.||+|.+..+++ .||||+++.. ......+.+|+.+++.++ ||||+++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD------HPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC------CTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 45567899999999999999999999976554 5999999853 334456778888887763 899999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++......++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~ 190 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS--NLVC 190 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCE
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC--CCCE
Confidence 99999999999999975 77777753322 2899999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHh
Q 005415 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 563 KL~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~ 635 (697)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 999999997654321 12334668999999998899999999999999999999 99999999888888877654
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
...+.. ......+..++..||... |..|.++++++..|.
T Consensus 271 ~~~~~~------------~~~~~~l~~li~~~l~~d----p~~Rps~~eil~~L~ 309 (325)
T 3kul_A 271 YRLPAP------------MGCPHALHQLMLDCWHKD----RAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCCCCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CCCCCC------------CCcCHHHHHHHHHHccCC----hhhCcCHHHHHHHHH
Confidence 332221 123456777888777644 888889988885444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.27 Aligned_cols=255 Identities=29% Similarity=0.380 Sum_probs=185.0
Q ss_pred CceEEE---EEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~---e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|.+. +.||+|+||.||+|.+..+++.||||++.... .....+|+.+++.+. +||||+++++++.....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCE-----GHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCE
Confidence 567775 78999999999999999999999999997543 356778999998885 48999999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEeeCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLG 568 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~DFG 568 (697)
.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.. ....+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999999975 7777776432 28999999999999999999999999999999999999852 13389999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHHHHhhCC
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-------VMILARIIGMLGP 638 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~-------~e~l~~I~~~lg~ 638 (697)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+.....+
T Consensus 155 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp TCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred cceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 99764432 3345779999999999999999999999999999999999999986543 4455555443333
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
++.+.+.. ....+..++..| +...|..|+|+++++ +|+....+
T Consensus 235 ~~~~~~~~---------~s~~~~~li~~~----L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 235 FEGEAWKN---------VSQEAKDLIQGL----LTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp CCSHHHHT---------SCHHHHHHHHHH----HCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCcccccC---------CCHHHHHHHHHH----CCCChhHCCCHHHHhcChhhccCcc
Confidence 33333211 122344444444 445689999999999 99986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.21 Aligned_cols=260 Identities=13% Similarity=0.074 Sum_probs=186.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEE-------
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLY------- 482 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~------- 482 (697)
..|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++. .||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~----~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG----ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------------CBCCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc----cChhhhhhceeEEeee
Confidence 45999999999999999999999999999999998733 345567788888888875 489988755
Q ss_pred EEEEec-----------------CeEEEEEEccccchHHHHHhhhccCCCcccCHHHH------HHHHHHHHHHHHHHHh
Q 005415 483 DYFYHL-----------------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL------QVITRQCLEALEYLHS 539 (697)
Q Consensus 483 ~~f~~~-----------------~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i------~~i~~qIa~aL~yLHs 539 (697)
+++... ..+++||||++++|.+++...... +....+ ..++.||+.||.|||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-----~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-----YVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-----cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 444432 348999999999999998765432 333334 5677999999999999
Q ss_pred cCccccCCCCccccccccCcceEEEeeCCCccccccccccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCC
Q 005415 540 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGE 617 (697)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~ 617 (697)
+||+||||||+|||++. ++.+||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 213 ~~ivHrDikp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMP--DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TTEEETTCSGGGEEECT--TSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCcCCHHHEEECC--CCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999995 789999999999877665545667799999999987 67999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHHhhCCCCHHHHhh-cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQ-GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 618 ~PF~~~~~~e~l~~I~~~lg~~p~e~~~~-~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.||.+...... ............. .......-.....+..++..|| ...|..|+|+++++ +|+....
T Consensus 291 ~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L----~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 291 LPFGLVTPGIK-----GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL----NFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CSTTBCCTTCT-----TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHT----CSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCCcCcccc-----cchhhhhhhhccccccchhhccCCCHHHHHHHHHHc----CCChhhCCCHHHHhcCHHHHHHH
Confidence 99987642210 0000000000000 0000000112234444555444 45689999999999 9987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=328.41 Aligned_cols=259 Identities=27% Similarity=0.323 Sum_probs=192.6
Q ss_pred eeCceecCceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 407 ILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 407 ~~~~~i~~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..+.++ ++|.+. +.||+|+||+||+|.+..+++.||||+++.. ....+|+.++..+. +||||++++++|
T Consensus 55 ~~~~~~-~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~-----~hp~iv~l~~~~ 124 (400)
T 1nxk_A 55 KKNAII-DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVY 124 (400)
T ss_dssp BCSCGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEE
T ss_pred CCCccc-ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc-----CCCCcceEeEEE
Confidence 334433 567776 7999999999999999999999999999754 34567888776553 489999999998
Q ss_pred Ee----cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-c
Q 005415 486 YH----LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R 559 (697)
Q Consensus 486 ~~----~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~ 559 (697)
.. ...+||||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++... +
T Consensus 125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~ 200 (400)
T 1nxk_A 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 200 (400)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTT
T ss_pred eecccCCcEEEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCC
Confidence 76 567999999997 578887764322 2389999999999999999999999999999999999998532 6
Q ss_pred ceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM----ILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e----~l~~I~ 633 (697)
+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 201 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 201 AILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred ccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 78999999999765432 345678999999999999999999999999999999999999997754322 233333
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....++...+ -.....+..++..||. ..|..|.|+++++ +|+...
T Consensus 281 ~~~~~~~~~~~---------~~~s~~~~~li~~~L~----~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 281 MGQYEFPNPEW---------SEVSEEVKMLIRNLLK----TEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HTCCCCCTTTT---------TTSCHHHHHHHHTTSC----SSGGGSCCHHHHHHSHHHHTT
T ss_pred cCcccCCCccc---------ccCCHHHHHHHHHHCC----CChhHCcCHHHHhcCccccCC
Confidence 22222221110 0112345555555554 4588899999999 999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.36 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=208.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----------hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. +||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 34589999999999999999999999999999999997532 23456778999998885 3789999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+++++......++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++. +
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~ 160 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--D 160 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC--C
Confidence 9999999999999999997 57878776432 2889999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCccccccc--cccccccCCCCCchhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~------~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
+.+||+|||++...... .....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+..+.+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 88999999998765432 33457899999999985 45688999999999999999999999999888888777
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
+......++...+. .....+..++..|| ...|..|.++++++ +|+.......
T Consensus 241 ~~~~~~~~~~~~~~---------~~~~~l~~li~~~l----~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 241 IMSGNYQFGSPEWD---------DYSDTVKDLVSRFL----VVQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp HHHTCCCCCTTTGG---------GSCHHHHHHHHHHC----CSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred HhcCCcccCccccc---------ccCHHHHHHHHHHc----cCCcccCCCHHHHHhChHhhhccchh
Confidence 76654433321110 11233444544444 45689999999999 9998776543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.49 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=198.5
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+.+..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 79 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR------HPHIIKLYQV 79 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC------CCCEeEEEEE
Confidence 4556789999999999999999999999999999999997532 23456778888887764 8899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+......++||||+. ++|.+++..... +++..+..++.||+.||.|||++||+|+||||+||+++. ++.+|
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~ 151 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHGR------VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAK 151 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT--TSCEE
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC--CCCEE
Confidence 999999999999997 578787764432 889999999999999999999999999999999999985 78899
Q ss_pred EeeCCCccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||........+..+.......|
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc
Confidence 9999998765443 234568899999999988765 6899999999999999999999998888777777655433222
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
. .....+..++..|| ...|..|.++++++ +|+...
T Consensus 232 ~-------------~~~~~l~~li~~~l----~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 232 E-------------YLNRSVATLLMHML----QVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp T-------------TSCHHHHHHHHHHT----CSSGGGSCCHHHHHHSHHHHTT
T ss_pred h-------------hcCHHHHHHHHHHc----cCChhhCCCHHHHHhChhhccC
Confidence 1 11234444555444 45689999999999 998743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=328.51 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=204.5
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+..++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.++ ||||+++++++...
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS------HPNIVRLIGVCTQK 184 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC------CTTBCCEEEEECSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEecC
Confidence 4457899999999999999999999989999999998754 233456778888887764 89999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+++||||+. ++|.+++...... +++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~--~~~~kl~Df 257 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE--KNVLKISDF 257 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCG
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC--CCcEEECcC
Confidence 99999999997 6788877654322 889999999999999999999999999999999999985 789999999
Q ss_pred CCcccccccccc-----ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 568 GSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 568 Gla~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|++......... ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+......+.+
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP 337 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998764433211 234667999999998889999999999999999998 99999998887766655433221111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..++..||... |..|+|++++...|.
T Consensus 338 ------------~~~~~~l~~li~~cl~~d----P~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 338 ------------ELCPDAVFRLMEQCWAYE----PGQRPSFSTIYQELQ 370 (377)
T ss_dssp ------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred ------------CCCCHHHHHHHHHHcCCC----chhCcCHHHHHHHHH
Confidence 123457888899998754 888999998885554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=323.79 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=203.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~-------~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
..++|++.+.||+|+||.||+|.+. .++..||||+++.. ......+.+|+.+++.+. +||||++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~ 153 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLL 153 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC-----CCTTBCCEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc-----CCCCEeeEE
Confidence 3578999999999999999999874 34568999999754 234567889999999884 389999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
+++.....+|+||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 999999999999999975 788887654321 112337899999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcH
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~ 625 (697)
||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 234 Ill~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEECT--TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEECC--CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99985 789999999999754432 222456788999999999999999999999999999999 9999998877
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.+.+..+........ .......+..++..||... |..|.+++++...|
T Consensus 312 ~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~d----P~~Rpt~~ell~~L 359 (370)
T 2psq_A 312 EELFKLLKEGHRMDK------------PANCTNELYMMMRDCWHAV----PSQRPTFKQLVEDL 359 (370)
T ss_dssp GGHHHHHHTTCCCCC------------CTTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence 776666544322111 1123456778888888644 78889998887443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.73 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=206.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR------HPNILRMYNYFHD 85 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEEEC
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC------CCCEeeEEEEEEc
Confidence 3478999999999999999999999999999999997532 22356778888888774 8899999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~D 157 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGR------FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIAD 157 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC--CCCEEEec
Confidence 999999999997 478777765432 889999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccc-ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 567 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 567 FGla~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.......|.
T Consensus 158 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 233 (284)
T 2vgo_A 158 FGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP---- 233 (284)
T ss_dssp CTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----
T ss_pred ccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----
Confidence 999865443 233467899999999999999999999999999999999999999998888777776553322221
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.....+..++..| +...|..|.++++++ +|+....+
T Consensus 234 ---------~~~~~~~~li~~~----l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 234 ---------FLSDGSKDLISKL----LRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ---------TSCHHHHHHHHHH----SCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ---------cCCHHHHHHHHHH----hhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0122344444444 445689999999999 99986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.76 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=206.7
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.....++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++ ||||++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 109 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA------HQHVVGFHGF 109 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 344467899999999999999999999999999999999754 234456778888888764 8899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+...+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~~k 181 (335)
T 2owb_A 110 FEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVK 181 (335)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEE
T ss_pred EecCCeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC--CCCEE
Confidence 999999999999998 56777665432 2889999999999999999999999999999999999985 78899
Q ss_pred EeeCCCcccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 564 IIDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 564 L~DFGla~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.......+
T Consensus 182 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 261 (335)
T 2owb_A 182 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 261 (335)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred EeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999999976532 23345789999999999999999999999999999999999999999888777776654332222
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. .....+..++..||. ..+..|.++++++ +|+..
T Consensus 262 ~-------------~~~~~~~~li~~~l~----~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 262 K-------------HINPVAASLIQKMLQ----TDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp T-------------TSCHHHHHHHHHHTC----SSGGGSCCGGGGGGSHHHHT
T ss_pred c-------------cCCHHHHHHHHHHcc----CChhHCcCHHHHhcCccccC
Confidence 1 122345556665554 5588899999999 89874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.09 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=196.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.++|++.+.||+|+||+||+|.+..+++.||+|++.. +......+.+|+.+++.++ ||||+++++++......
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE------HPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CcCcccEEEEEecCCee
Confidence 4789999999999999999999999999999998864 3445567788888887774 89999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 155 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE--NKNVVVADFGLA 155 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT--TSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC--CCCEEEeecccc
Confidence 999999975 77777764322 2899999999999999999999999999999999999985 788999999998
Q ss_pred cccccccc-----------------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-----H
Q 005415 571 CFQTDNLC-----------------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-----I 628 (697)
Q Consensus 571 ~~~~~~~~-----------------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e-----~ 628 (697)
........ ...||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 76433211 3568999999999999999999999999999999999999997542210 0
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
......... .-.....+..++..||.. .|..|.+++++..||..
T Consensus 236 ~~~~~~~~~---------------~~~~~~~l~~li~~~l~~----dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 236 VRGFLDRYC---------------PPNCPPSFFPITVRCCDL----DPEKRPSFVKLEHWLET 279 (310)
T ss_dssp HHHHHHHTC---------------CTTCCTTHHHHHHHHTCS----SGGGSCCHHHHHHHHHH
T ss_pred hhccccccC---------------CCCCCHHHHHHHHHHccC----ChhhCcCHHHHHHHHHH
Confidence 011100000 012234667777777764 47788888888877653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=324.31 Aligned_cols=258 Identities=19% Similarity=0.200 Sum_probs=204.6
Q ss_pred ceecCceEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~-----d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++++.||+|+||.||+|. +..+++.||||+++.. ......+.+|+.+++.++ ||||++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~ 140 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN------HQNIVRCI 140 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC------CCCCCeEE
Confidence 3456789999999999999999999 4457889999999753 334456778999988874 88999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-c
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R 559 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~ 559 (697)
+++......++||||+. ++|.+++....... ....+++..++.++.||+.||.|||++||+||||||+|||++..+ .
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 99999999999999996 58888887654321 123488999999999999999999999999999999999998522 3
Q ss_pred ceEEEeeCCCcccccc-----ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~ 633 (697)
..+||+|||+++.... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 4699999999864321 2233567889999999999999999999999999999998 999999999888887776
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
......+. ......+..++..||... |..|.++++++..|
T Consensus 301 ~~~~~~~~------------~~~~~~l~~li~~~l~~d----P~~Rps~~eil~~l 340 (367)
T 3l9p_A 301 SGGRMDPP------------KNCPGPVYRIMTQCWQHQ----PEDRPNFAIILERI 340 (367)
T ss_dssp TTCCCCCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred cCCCCCCC------------ccCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence 54332221 122345777777777644 88899998888433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.93 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=194.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+++. ++|..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCC-----CCCCeeeeecCCCCc
Confidence 356899999999999999999999999999999998765433 35678899999998743 355566666677889
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeCCC
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DFGl 569 (697)
.++||||++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEccCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999998899888864332 2899999999999999999999999999999999999931 1478899999999
Q ss_pred cccccccc----------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHhh
Q 005415 570 SCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGML 636 (697)
Q Consensus 570 a~~~~~~~----------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~---~e~l~~I~~~l 636 (697)
+....... ....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ...+.++....
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 97654321 245789999999999999999999999999999999999999976432 23334443333
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
.+.+.+.... .....+..++..||... |..|++++++...
T Consensus 235 ~~~~~~~~~~--------~~~~~l~~li~~~l~~~----p~~Rpt~~~l~~~ 274 (296)
T 4hgt_A 235 MSTPIEVLCK--------GYPSEFATYLNFCRSLR----FDDKPDYSYLRQL 274 (296)
T ss_dssp HHSCHHHHTT--------TSCHHHHHHHHHHHTSC----TTCCCCHHHHHHH
T ss_pred ccchhhhhhc--------cCCHHHHHHHHHHHhcC----CCCCCCHHHHHHH
Confidence 2333222211 12346777888888644 8888898887743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.09 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=201.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+++. +++..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTS-----TTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcC-----CCCCccccccCCCCc
Confidence 456899999999999999999999999999999999876443 35688999999999743 345555555567788
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeCCC
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DFGl 569 (697)
.++||||++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 80 NVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eEEEEEecCCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 999999998899888864332 2899999999999999999999999999999999999941 1377899999999
Q ss_pred ccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHhh
Q 005415 570 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGML 636 (697)
Q Consensus 570 a~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---~~e~l~~I~~~l 636 (697)
+...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 8765432 234578999999999999999999999999999999999999998643 233444444433
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
...+.+.... .....+..++..||.. .|..|.+++++...|.
T Consensus 235 ~~~~~~~~~~--------~~~~~l~~li~~~l~~----dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 235 MSTPIEVLCK--------GYPSEFATYLNFCRSL----RFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHSCHHHHTT--------TSCHHHHHHHHHHHTS----CTTCCCCHHHHHHHHH
T ss_pred cCCchHHHHh--------hCCHHHHHHHHHHHhc----CcCcCCCHHHHHHHHH
Confidence 3333322211 1234677777888764 4888999888874443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.66 Aligned_cols=250 Identities=24% Similarity=0.255 Sum_probs=190.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (697)
.++|++++.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.++ ||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE------HPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC------CTTBCCEEEEEEECCS
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC------CCCEeeEEEEEEEecc
Confidence 46899999999999999999999999999999999743 334567788888888774 899999999986543
Q ss_pred --------------------------------------------------------eEEEEEEcccc-chHHHHHhhhcc
Q 005415 490 --------------------------------------------------------HLFIVCELLRA-NLYEFQKFNQES 512 (697)
Q Consensus 490 --------------------------------------------------------~l~LVmEyl~g-sL~~~l~~~~~~ 512 (697)
..++||||+.+ +|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~- 157 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS- 157 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-
Confidence 38999999975 67777654322
Q ss_pred CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc---------------c
Q 005415 513 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---------------L 577 (697)
Q Consensus 513 ~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~---------------~ 577 (697)
....++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .
T Consensus 158 --~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 158 --LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp --GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEECCCTTCEECSCC--------------CC
T ss_pred --ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC--CCCEEEeecCcccccccchhhccccccccccccc
Confidence 223567778999999999999999999999999999999985 789999999998765432 1
Q ss_pred ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCC
Q 005415 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKE 657 (697)
Q Consensus 578 ~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~ 657 (697)
....||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ....+..+. .+..+..... ..
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~----------~~ 299 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR--NLKFPLLFTQ----------KY 299 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH--TTCCCHHHHH----------HC
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh--ccCCCccccc----------CC
Confidence 234689999999999999999999999999999999998776531 122222221 1233322211 12
Q ss_pred chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 658 YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 658 ~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..+..++..|| ...|..|+++++++ +|+.+
T Consensus 300 ~~~~~li~~~l----~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 300 PQEHMMVQDML----SPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHHHH----CSSGGGSCCHHHHHHSTTCCC
T ss_pred hhHHHHHHHHc----cCCCCcCCCHHHHhhchhhhc
Confidence 23444555554 45689999999999 89865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=309.05 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=201.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~---- 487 (697)
..++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.+. .||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC-----CSTTBCCEEEEEEECC--
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc-----CCCCeeeeeeEEeeccCc
Confidence 458899999999999999999999999999999999876666678889999999884 38999999999987
Q ss_pred --cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 --~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
...+++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~--~~~~kl 170 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKL 170 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC--CCCEEE
Confidence 4689999999975 78888765432 23889999999999999999999999999999999999985 788999
Q ss_pred eeCCCccccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 565 IDLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 565 ~DFGla~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
+|||++...... .....+++.|+|||++. +..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999998765432 23457899999999997 5568999999999999999999999999888777666554322
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.+... .-.....+..++..||. ..|..|+++++++ +|+....
T Consensus 251 ~~~~~-----------~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 APRLK-----------SKKWSKKFQSFIESCLV----KNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCCS-----------CSCSCHHHHHHHHHHCC----SSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCC-----------ccccCHHHHHHHHHHhc----cChhhCCCHHHHhhChHHhhCc
Confidence 11100 00112345555555554 4588999999999 8987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=337.88 Aligned_cols=257 Identities=22% Similarity=0.235 Sum_probs=203.0
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++|++++.||+|+||.||+|+++.+|+.||||++.... .....+..|+.+++.++ ||||+++++++..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH------SRFIVSLAYAFET 256 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC------CCCEeeEEEEEee
Confidence 3478999999999999999999999999999999997542 23456788999998874 8899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
...+|+||||+.+ +|..++..... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~--~g~vkL~D 332 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD--DGNVRISD 332 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC--CCCEEEee
Confidence 9999999999984 66666553321 1223899999999999999999999999999999999999985 88999999
Q ss_pred CCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND----AVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~----~~~e~l~~I~~~lg~~ 639 (697)
||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|++||.+. ...++...+.......
T Consensus 333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~ 412 (543)
T 3c4z_A 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412 (543)
T ss_dssp CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC
T ss_pred cceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC
Confidence 9999765433 23358999999999999999999999999999999999999999875 3455555554432222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQN 695 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~n 695 (697)
|. .....+..++ ..++...|..|++ +++++ +|+..++|.
T Consensus 413 p~-------------~~s~~~~~li----~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 413 PD-------------KFSPASKDFC----EALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp CT-------------TSCHHHHHHH----HHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred Cc-------------ccCHHHHHHH----HHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 21 0122333444 4444556777875 46676 999877653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=311.87 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=200.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~ 76 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR------HKNVIQLVDVLY 76 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC------CCCeeEEEEEEE
Confidence 4578999999999999999999999999999999997542 23456777888777663 899999999985
Q ss_pred --ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 487 --HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 487 --~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.....++||||+.+++.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~--~~~~kl 150 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKI 150 (305)
T ss_dssp CC---CEEEEEECCSEEHHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEE
T ss_pred cCCCCeEEEEehhccCCHHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC--CCcEEe
Confidence 4467999999999988887765432 23899999999999999999999999999999999999985 789999
Q ss_pred eeCCCcccccc-----ccccccccCCCCCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 565 IDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 565 ~DFGla~~~~~-----~~~~~~gt~~Y~APE~l~~~~--~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|||++..... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....-
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC
Confidence 99999876432 123456899999999998754 37799999999999999999999999888877777654322
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+.+. .....+..++..||. ..|..|.++++++ +|+....
T Consensus 231 ~~~~-------------~~~~~l~~li~~~l~----~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 AIPG-------------DCGPPLSDLLKGMLE----YEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CCCS-------------SSCHHHHHHHHHHTC----SSTTTSCCHHHHHHSHHHHSCC
T ss_pred CCCC-------------ccCHHHHHHHHHHcc----CChhhCCCHHHHhcCcccccCC
Confidence 2211 123345555555554 4588999999999 9997543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.70 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=202.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+..++|++++.||+|+||.||+|.+. ++..||||+++........+.+|+++++.++ ||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQR 92 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC------CCCEeeEEEEEecCC
Confidence 344578999999999999999999875 6788999999876655677889999998875 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~--~~~~kl~Dfg 165 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFG 165 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TSCEEECSTT
T ss_pred CeEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC--CCCEEEcccc
Confidence 9999999996 577777764332 2899999999999999999999999999999999999985 7899999999
Q ss_pred Cccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+........+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 244 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH- 244 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC-
Confidence 99765432 122345678999999999899999999999999999998 999999988888888776654333221
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.....+..++..||.. .|..|+++++++.-|
T Consensus 245 -----------~~~~~l~~li~~~l~~----~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 245 -----------LASEKVYTIMYSCWHE----KADERPTFKILLSNI 275 (283)
T ss_dssp -----------TCCHHHHHHHHHTTCS----SGGGSCCHHHHHHHH
T ss_pred -----------cCCHHHHHHHHHHccC----ChhHCcCHHHHHHHH
Confidence 1234566777777764 488899999888444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.84 Aligned_cols=253 Identities=19% Similarity=0.240 Sum_probs=206.3
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++...+|++.+.||+|+||.||+|.+..++..||+|++..+......+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 82 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEccCC
Confidence 45568899999999999999999999999999999999987777788899999999985 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~~l~Dfg 156 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFG 156 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred CEEEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC--CCCEEEccCc
Confidence 9999999998 688887764322 23899999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 234 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-- 234 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC--
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC--
Confidence 997655332 22345778999999999999999999999999999999 99999988776666655443221111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..++..||. ..|..|++++++...|.
T Consensus 235 ----------~~~~~~l~~li~~~l~----~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 235 ----------EGCPEKVYELMRACWQ----WNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp ----------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHhC----CChhhCcCHHHHHHHHH
Confidence 1122345555555554 45888888888875443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.08 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=207.7
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
+.++|++.+.||+|+||.||+|.+..+|+.||||+++... .....+.+|+.+++.+. +||||++++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~ 166 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA-----GHPHIITLI 166 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCEE
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc-----CCCCEeEEE
Confidence 4578999999999999999999999999999999997542 12456678999998884 378999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
+++......++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++. ++.
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~--~~~ 238 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQ 238 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCC
Confidence 999999999999999985 7777765432 2899999999999999999999999999999999999985 789
Q ss_pred EEEeeCCCccccccc--cccccccCCCCCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 562 vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~------~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.
T Consensus 239 ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999998765432 344678999999999863 358889999999999999999999999988888888877
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
.....++...+. .....+..++..||. ..|..|.++++++ +|+.
T Consensus 319 ~~~~~~~~~~~~---------~~~~~~~~li~~~L~----~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 319 EGQYQFSSPEWD---------DRSSTVKDLISRLLQ----VDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HTCCCCCHHHHS---------SSCHHHHHHHHHHSC----SSTTTSCCHHHHHHSGGGC
T ss_pred hCCCCCCCcccc---------cCCHHHHHHHHHHcC----CChhHCcCHHHHhcCcccC
Confidence 655555543321 122345555555544 5689999999999 9985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.36 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=183.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+..++|++.+.||+|+||.||+|.+..++. .||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD------HPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC------CTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC------CCceehhhce
Confidence 345789999999999999999999877665 8999999753 334566778888887763 8999999999
Q ss_pred EEecCeE------EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 485 FYHLEHL------FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 485 f~~~~~l------~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+...... ++||||+.+ +|.+++...........+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~- 172 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE- 172 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-
Confidence 9877554 999999975 77777765543333334899999999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~ 631 (697)
++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 173 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 173 -DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp -TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred -CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 7899999999997653321 22345778999999999999999999999999999999 9999998887777777
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHH-------HH--HhhcccCCCCC
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEY-------AA--LWLFGIDQNKI 697 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~-------~~--~wl~~~~~n~~ 697 (697)
+......... -.....+..++..||. ..|..|.++++ ++ +|+....+|++
T Consensus 252 ~~~~~~~~~~------------~~~~~~l~~li~~~l~----~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 252 LIGGNRLKQP------------PECMEEVYDLMYQCWS----ADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HHTTCCCCCC------------TTCCHHHHHHHHHTTC----SSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HhcCCCCCCC------------CccCHHHHHHHHHHcc----CChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 6543321111 1123456667676765 44788888444 44 78877777653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.98 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=203.4
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+....++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD------HPYIVKLLGAYYH 87 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC------CTTBCCEEEEEEC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC------CCCEeeeeeeeee
Confidence 344568999999999999999999999999999999998753 334567788999988874 8899999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|..++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~D 160 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLAD 160 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TSCEEECC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC--CCCEEEEE
Confidence 9999999999975 55555543222 2899999999999999999999999999999999999985 78899999
Q ss_pred CCCcccccc---ccccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~---~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||++..... ......+++.|+|||++. +..++.++|||||||++|+|++|..||...+....+..+.....+
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240 (302)
T ss_dssp CHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc
Confidence 998754322 223457899999999984 667899999999999999999999999998887777766543222
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
... ..-.....+..++..||. ..|..|+|+++++ +|+....+++
T Consensus 241 ~~~----------~~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 241 TLL----------TPSKWSVEFRDFLKIALD----KNPETRPSAAQLLEHPFVSSITSNK 286 (302)
T ss_dssp CCS----------SGGGSCHHHHHHHHHHSC----SCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred ccC----------CccccCHHHHHHHHHHcc----cChhhCCCHHHHhcChHHhhhccch
Confidence 110 000112345556666654 5589999999999 9998876653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.47 Aligned_cols=258 Identities=23% Similarity=0.212 Sum_probs=189.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (697)
.++|++.+.||+|+||.||+|++. ++.||||++............|+.+++.+ .||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM------KHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC------CCTTBCCEEEEEEEECSSS
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC------CCCCchhhcceeccCCCCC
Confidence 468999999999999999999864 79999999986655444555566655544 5899999999998753
Q ss_pred -eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc----------CccccCCCCcccccccc
Q 005415 490 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL----------GIIHCDLKPENILIKSY 557 (697)
Q Consensus 490 -~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~----------gIvHrDLKP~NILl~~~ 557 (697)
.+++||||+.+ +|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~- 166 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN- 166 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-
T ss_pred ceEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-
Confidence 47999999975 788877532 188999999999999999999999 9999999999999985
Q ss_pred CcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~-----~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
++.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 167 -~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 167 -NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp -TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred -CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 789999999999654332 2235789999999999873 45668899999999999999999997653321
Q ss_pred HHHHHHHhhCCCCHHHHhhc-------ccccccccC---CchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 628 ILARIIGMLGPIDLEMLMQG-------QEIYKYFTK---EYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~-------~~~~~~~~~---~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.+.........+....+... ......+.. ...+..++..||.. .|..|+|+++++..|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~----dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH----DAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCS----SGGGSCCHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccC----ChhhCcCHHHHHHHHHH
Confidence 11111111222222211110 011111111 12366667777664 48899999999866553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.53 Aligned_cols=255 Identities=23% Similarity=0.263 Sum_probs=202.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+..++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~ 254 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYE 254 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC------CCCEeeEEEEEe
Confidence 34578999999999999999999999999999999997532 23456778999998874 789999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
....+|+||||+. ++|..++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~--~g~vKL~ 328 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD--HGHIRIS 328 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC--CCCeEEE
Confidence 9999999999997 567666653322 23899999999999999999999999999999999999985 7899999
Q ss_pred eCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~----~~e~l~~I~~~lg~~ 639 (697)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.. ..++...+.......
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence 99999765433 344689999999999999899999999999999999999999998753 233333333221111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~ 694 (697)
+ ..+.....+...+++...|..|+ ++++++ +|+...+|
T Consensus 409 p-----------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 409 S-----------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp C-----------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred C-----------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 1 11223334444445556688888 788888 99987664
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.55 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=199.1
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.....++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++ ||||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 96 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCD------SPHVVKYYGSYFKN 96 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTCC------CTTBCCEEEEEEET
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhCC------CCCCccEEEEEEeC
Confidence 34456789999999999999999999999999999999986542 456788998888774 88999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
...++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.+||+||
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~df 169 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT--EGHAKLADF 169 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCC
T ss_pred CEEEEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC--CCCEEEeec
Confidence 999999999975 77777653322 2899999999999999999999999999999999999985 788999999
Q ss_pred CCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 568 Gla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||........+..+.....+.. .
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~-- 246 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-R-- 246 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-S--
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-C--
Confidence 998765433 2345789999999999999999999999999999999999999998877666555433211100 0
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
... .....+..++..||. ..|..|+|+++++ +|+....
T Consensus 247 -----~~~--~~~~~l~~li~~~l~----~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 247 -----KPE--LWSDNFTDFVKQCLV----KSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----SGG--GSCHHHHHHHHHHTC----SCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----Ccc--cCCHHHHHHHHHHcc----CChhhCcCHHHHHhCHHHhcCC
Confidence 000 112345555555554 4588999999999 9988654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=302.05 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=204.8
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK------HPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC------CCCCCeEEEEEecCC
Confidence 46899999999999999999999999999999999753 334566788999998874 7899999998864
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC-----ccccCCCCccccccccCcce
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g-----IvHrDLKP~NILl~~~~~~~ 561 (697)
....++||||+. ++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~--~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS--SSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC--CCC
Confidence 578999999997 4888887654432 223889999999999999999999999 999999999999985 788
Q ss_pred EEEeeCCCcccccccc---ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 562 IKIIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 562 vKL~DFGla~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.....+
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 234 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence 9999999987654332 2357899999999999999999999999999999999999999998887777776553221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
... ......+..++..||. ..|..|+++++++ +|.++..
T Consensus 235 ~~~------------~~~~~~l~~li~~~l~----~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 235 RIP------------YRYSDELNEIITRMLN----LKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CCC------------TTSCHHHHHHHHHHTC----SSGGGSCCHHHHHTSTTCCGGG
T ss_pred cCC------------cccCHHHHHHHHHHcC----CCcccCCCHHHHHhChhhhhhc
Confidence 110 1223456666666665 4588999999999 7777654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.28 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=194.5
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh---------hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~---------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
+.++|++++.||+|+||.||+|.+..+++.||||+++.... ....+.+|+.+++.++ ||||++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~~~ 95 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE------HANIIKVL 95 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC------CTTBCCEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC------CCCEeeEE
Confidence 45789999999999999999999999999999999986431 2345667898888774 88999999
Q ss_pred EEEEecCeEEEEEEcccc--chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc
Q 005415 483 DYFYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g--sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (697)
+++......++||||+.. +|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~ 167 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DF 167 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TS
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC--CC
Confidence 999999999999999864 6666665332 2899999999999999999999999999999999999985 78
Q ss_pred eEEEeeCCCccccccc--cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 561 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... +.....
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~ 241 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI 241 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc
Confidence 9999999999765433 334678999999999998876 7899999999999999999999975221 100000
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+ .......+..++..|| ...|..|+|+++++ +|+..
T Consensus 242 ~~-------------~~~~~~~l~~li~~~L----~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 242 HP-------------PYLVSKELMSLVSGLL----QPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CC-------------SSCCCHHHHHHHHHHT----CSSGGGSCCHHHHHHCTTTTC
T ss_pred CC-------------CcccCHHHHHHHHHHc----cCChhhCcCHHHHhcCccccC
Confidence 00 0112234445555444 45588999999999 99865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=302.88 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
...|++.+.||+|+||.||+|.+..++..||+|++... ......+.+|+.+++.++ ||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeecccc
Confidence 35689999999999999999999999999999999753 333456677888877663 8999999999876
Q ss_pred --cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcceE
Q 005415 488 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 488 --~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~v 562 (697)
...+++||||+.+ +|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++. .++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~ 171 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSV 171 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TTSCE
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccC------CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC-CCCCE
Confidence 3568999999964 77777764322 889999999999999999999999 999999999999973 36789
Q ss_pred EEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 563 KL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
||+|||++...... .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+... ..+.
T Consensus 172 kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 249 (290)
T 1t4h_A 172 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA 249 (290)
T ss_dssp EECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG
T ss_pred EEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCcc
Confidence 99999999765443 334578999999998875 58999999999999999999999998754443333322211 1111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
... ......+..++..||. ..|..|+++++++ +|+..
T Consensus 250 ~~~---------~~~~~~l~~li~~~l~----~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 250 SFD---------KVAIPEVKEIIEGCIR----QNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGG---------GCCCHHHHHHHHHHSC----SSGGGSCCHHHHHTSGGGC-
T ss_pred ccC---------CCCCHHHHHHHHHHcc----CChhhCCCHHHHhhCccccc
Confidence 110 0112356666666665 4589999999999 99875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.77 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=203.2
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC-
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 489 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~- 489 (697)
+..++|++.+.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+++.++ ||||+++++++....
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCC------CTTBCCEEEEEECTTS
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhcc------CCCEEEEEEEEEcCCC
Confidence 34578999999999999999999864 7899999998654 4567889999998874 889999999987765
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 334 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 334 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TSCEEECCCT
T ss_pred ceEEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC--CCCEEEeeCC
Confidence 7999999997 588888865432 22788999999999999999999999999999999999985 7899999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+++..........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+......+.
T Consensus 335 ~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~------- 407 (450)
T 1k9a_A 335 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------- 407 (450)
T ss_dssp TCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC-------
T ss_pred CcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 99865554444567889999999999999999999999999999998 9999998877777666644322111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.-.....+..+|..||... |..|+|++++...|..
T Consensus 408 -----p~~~~~~l~~li~~cl~~d----p~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 408 -----PDGCPPAVYDVMKNCWHLD----AATRPTFLQLREQLEH 442 (450)
T ss_dssp -----CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHH
T ss_pred -----CCcCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHH
Confidence 1123567888999999754 8889999888865543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.94 Aligned_cols=258 Identities=20% Similarity=0.230 Sum_probs=205.4
Q ss_pred ceecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++++.||+|+||.||+|.+. .+++.||||+++.. ......+.+|+.+++.++ ||||++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~ 116 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------NPNIVKLL 116 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEEEEE
Confidence 445689999999999999999999986 45589999999753 234466788999888874 88999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHhcCcc
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~------------------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIv 543 (697)
+++......++||||+.+ +|.+++....... ....+++..++.++.||+.||.|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999999999999999975 8888876532110 113489999999999999999999999999
Q ss_pred ccCCCCccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 005415 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (697)
Q Consensus 544 HrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~ 617 (697)
||||||+|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 197 H~Dlkp~NIl~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEECC--CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999985 789999999998654322 223466888999999999899999999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 618 ~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.||.+....+.+..+........+ -.....+..++..||.. .|..|.+++++..+|..
T Consensus 275 ~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~----~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGNILACP------------ENCPLELYNLMRLCWSK----LPADRPSFCSIHRILQR 332 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHHH
T ss_pred CcCCCCChHHHHHHHhCCCcCCCC------------CCCCHHHHHHHHHHccc----CcccCCCHHHHHHHHHH
Confidence 999998888877776543221111 02234667777777764 48889999998866653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.82 Aligned_cols=254 Identities=20% Similarity=0.215 Sum_probs=196.2
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh--------hHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--------FDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~--------~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
..+..++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+|+.+++.++ ||||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~ 87 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN------HPNIVK 87 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC------CTTBCC
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC------CCCchh
Confidence 345568999999999999999999999999999999998643221 156677888887763 899999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCcccccccc
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSY 557 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~ 557 (697)
+++++.... ++||||+. ++|.+.+..... .+++..+..++.||+.||.|||++| |+||||||+|||++..
T Consensus 88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEEETTTT--EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC
T ss_pred hheeecCCC--eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc
Confidence 999987655 69999998 677777654322 3899999999999999999999999 9999999999999852
Q ss_pred C---cceEEEeeCCCccccccccccccccCCCCCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH--HHHH
Q 005415 558 Q---RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV--MILA 630 (697)
Q Consensus 558 ~---~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~--e~l~ 630 (697)
. ...+||+|||++...........+++.|+|||++. ...++.++|||||||++|+|++|+.||...... ....
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred CCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 2 12399999999987777666778999999999984 455789999999999999999999999765432 2233
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+......++. .-.....+..++..||. ..|..|.+++++...|.
T Consensus 241 ~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 241 MIREEGLRPTI-----------PEDCPPRLRNVIELCWS----GDPKKRPHFSYIVKELS 285 (287)
T ss_dssp HHHHSCCCCCC-----------CTTSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred HHhccCCCCCC-----------CcccCHHHHHHHHHHhc----CChhhCcCHHHHHHHHH
Confidence 33222111110 01223456666666665 45899999999886664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.64 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=174.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK------HPSILELYNYFEDSN 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC------CTTBCCEEEEEECSS
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC------CCCeEeEEEEEccCC
Confidence 57999999999999999999999999999999997542 22356677888777664 899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg 157 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFG 157 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT--TCCEEECCCT
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEEEeec
Confidence 9999999997 46776665322 23899999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||......+.+..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 231 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM------ 231 (278)
T ss_dssp TCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC------
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC------
Confidence 98765422 234578999999999999889999999999999999999999998765544433321110000
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.. .....+..++..|| ...|..|+++++++ +|+....+
T Consensus 232 -----~~--~~~~~~~~li~~~l----~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 232 -----PS--FLSIEAKDLIHQLL----RRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp -----CT--TSCHHHHHHHHHHS----CSSGGGSCCHHHHTTSTTTC----
T ss_pred -----cc--ccCHHHHHHHHHHc----ccCHhhCCCHHHHhcCccccCCCC
Confidence 00 11223444555444 45689999999999 89986544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=317.32 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=206.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECC-------CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
++..++|++.+.||+|+||.||+|.+.. .+..||||+++.. ......+.+|+.+++.+. +||||++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~ 139 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 139 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc-----CCchhhh
Confidence 4556899999999999999999999754 3367999999754 334467889999999984 3889999
Q ss_pred EEEEEEecCeEEEEEEcccc-chHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 481 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
+++++......++||||+.+ +|.+++...... .....+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999975 888887754321 1123489999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~ 623 (697)
+|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECT--TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC--CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999985 789999999999765432 223456788999999999999999999999999999999 99999999
Q ss_pred cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 624 ~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+..+....+......... -.....+..++..||.. .|..|.++++++..|
T Consensus 298 ~~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~----dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDKP------------SNCTNELYMMMRDCWHA----VPSQRPTFKQLVEDL 347 (382)
T ss_dssp CHHHHHHHHHTTCCCCCC------------SSCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCC------------ccCCHHHHHHHHHHcCC----ChhhCcCHHHHHHHH
Confidence 888877776543322111 12344677777777764 478888888887433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.39 Aligned_cols=254 Identities=18% Similarity=0.237 Sum_probs=209.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++...+|++.+.||+|+||.||+|.+..++..||||+++........+.+|+.+++.++ ||||+++++++....
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREP 289 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC------CCCEeeEEEEEecCC
Confidence 34457899999999999999999999989999999999877666778899999999985 889999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.++|||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG 363 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE--NHLVKVADFG 363 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--GGCEEECCTT
T ss_pred cEEEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC--CCcEEEeecc
Confidence 9999999997 688888764322 22889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.......
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---- 439 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---- 439 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC----
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence 997654322 12334678999999999899999999999999999999 999999887766665554322211
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
..-.....+..++..||... |..|.+++++...|..
T Consensus 440 --------~~~~~~~~l~~li~~cl~~d----P~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 440 --------RPEGCPEKVYELMRACWQWN----PSDRPSFAEIHQAFET 475 (495)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHcCcC----hhHCcCHHHHHHHHHH
Confidence 11123457788888888754 8889999988865553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=301.50 Aligned_cols=255 Identities=21% Similarity=0.202 Sum_probs=195.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+.++|++++.||+|+||.||+|.+..+++.||||++... ........+|+.++..+. .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-----QHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-----SCTTBCCEEEEEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeeec
Confidence 3457899999999999999999999999999999999853 233456677777777763 48999999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc---------
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--------- 557 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~--------- 557 (697)
.+..++||||+.+ +|.+++....... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIM--SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 9999999999975 8888887553321 228999999999999999999999999999999999999842
Q ss_pred --------CcceEEEeeCCCccccccccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 558 --------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 558 --------~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
....+||+|||.+....... ...+++.|+|||++.+. .++.++|||||||++|+|++|.+|+......
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-- 237 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-- 237 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred cccccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence 24479999999987665433 34689999999999876 5668999999999999999999887655432
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..+.....+. ... .....+..++..|| ...|..|+++++++ +|+...
T Consensus 238 -~~~~~~~~~~----------~~~--~~~~~~~~li~~~l----~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 -HEIRQGRLPR----------IPQ--VLSQEFTELLKVMI----HPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -HHHHTTCCCC----------CSS--CCCHHHHHHHHHHT----CSSGGGSCCHHHHHTCTTC---
T ss_pred -HHHHcCCCCC----------CCc--ccCHHHHHHHHHHh----CCCcccCCCHHHHhhChHhhhh
Confidence 2222211100 000 12234555555554 45589999999999 998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.76 Aligned_cols=252 Identities=18% Similarity=0.241 Sum_probs=197.9
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCC-------cEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g-------~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
.++..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.++ ||||++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~ 76 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS------HKHLVL 76 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC------CTTBCC
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC------CCCEeE
Confidence 3455689999999999999999999988777 479999997543 44567788998888874 889999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+++++...+..++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.+..
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 9999999999999999997 588888765432 2889999999999999999999999999999999999985222
Q ss_pred ------ceEEEeeCCCccccccccccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 005415 560 ------CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 631 (697)
Q Consensus 560 ------~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~ 631 (697)
+.+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...........
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccccccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 12999999998655433 23467889999999987 679999999999999999999 5666666555544433
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+ ......+. .....+..++..||.. .|..|.|+++++..|.
T Consensus 231 ~-~~~~~~~~-------------~~~~~l~~li~~~l~~----dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 231 Y-EDRHQLPA-------------PKAAELANLINNCMDY----EPDHRPSFRAIIRDLN 271 (289)
T ss_dssp H-HTTCCCCC-------------CSSCTTHHHHHHHSCS----SGGGSCCHHHHHHHHH
T ss_pred h-hccCCCCC-------------CCCHHHHHHHHHHcCC----ChhHCcCHHHHHHHHH
Confidence 3 22221111 1234677777777754 4888999999885554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.09 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=200.5
Q ss_pred eecCceEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~-----d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||+|+||.||+|. +..+++.||||+++... .....+.+|+++++.+. +||||+++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~~ 93 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLG 93 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc-----CCcceeeeee
Confidence 446899999999999999999998 45677999999998642 33457889999999985 3799999999
Q ss_pred EEEecC-eEEEEEEccc-cchHHHHHhhhccC------------------------------------------------
Q 005415 484 YFYHLE-HLFIVCELLR-ANLYEFQKFNQESG------------------------------------------------ 513 (697)
Q Consensus 484 ~f~~~~-~l~LVmEyl~-gsL~~~l~~~~~~~------------------------------------------------ 513 (697)
++.... ..++||||+. ++|.+++.......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998764 4899999997 47888776543210
Q ss_pred ------------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccccccc-----
Q 005415 514 ------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----- 576 (697)
Q Consensus 514 ------------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~----- 576 (697)
....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCGGGSCTTSCTTCEE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCcEEEEeccceeeecccccchh
Confidence 0122889999999999999999999999999999999999985 789999999999754322
Q ss_pred cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccccccccc
Q 005415 577 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 655 (697)
Q Consensus 577 ~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~ 655 (697)
.....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+.....++.. -.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 320 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP-----------DY 320 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC-----------TT
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC-----------CC
Confidence 223467888999999999999999999999999999998 999998876554444443322211110 11
Q ss_pred CCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 656 KEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 656 ~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
....+..++..||.. .|..|+|+++++..|.
T Consensus 321 ~~~~l~~li~~~l~~----dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHG----EPSQRPTFSELVEHLG 351 (359)
T ss_dssp CCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHccC----ChhhCCCHHHHHHHHH
Confidence 234566777777654 5888999999885543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.59 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=203.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD------SPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCCe
Confidence 46799999999999999999999999999999999754 234567888999988874 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+++ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~Dfg~ 165 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGV 165 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC--CCCEEEeeccc
Confidence 9999999985 66666542 12889999999999999999999999999999999999985 78899999999
Q ss_pred ccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||........+..+.....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 239 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL------ 239 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC------
Confidence 8765432 2345789999999999999999999999999999999999999998887776666543211100
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
. -.....+..++..||. ..|..|+|+++++ +|+...
T Consensus 240 ----~--~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 240 ----E--GNYSKPLKEFVEACLN----KEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----C--SSCCHHHHHHHHHHCC----SSGGGSCCHHHHTTCHHHHHH
T ss_pred ----c--cccCHHHHHHHHHHcC----CChhhCcCHHHHhhChhhhcC
Confidence 0 0122345566666654 4588999999999 888643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.90 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=206.7
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+..++|++.+.||+|+||.||+|.+. .+..||||+++......+.+.+|+.+++.++ ||||+++++++. ..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVT-KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCC------CTTBCCEEEEEC-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCC------CCCEeeEEEEEe-CC
Confidence 344678999999999999999999975 5788999999876666678889999988774 889999999986 66
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+. ++|.+++....... +++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DFG 329 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 329 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHT----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT--TCCEEECSTT
T ss_pred ccEEEEeecCCCcHHHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC--CCcEEEeeCC
Confidence 7899999997 58888886543222 788899999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+......+.+
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~-- 407 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-- 407 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC--
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 997654321 22345678999999998899999999999999999999 99999999888888777654332221
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..++..||... |..|+|++++...|.
T Consensus 408 ----------~~~~~~l~~li~~cl~~d----p~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 408 ----------ENCPEELYNIMMRCWKNR----PEERPTFEYIQSVLD 440 (454)
T ss_dssp ----------TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHccCC----hhHCcCHHHHHHHHH
Confidence 123457888899998755 888999988885444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.87 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=179.9
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE---
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY--- 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~--- 486 (697)
+...+|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. +||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS-----GHPNIVQFCSAASIGK 99 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT-----TSTTBCCEEEEEEECT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc-----cCCChhhccccccccc
Confidence 3346899999999999999999999999999999988643 344567788999999885 3899999999995
Q ss_pred -----ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCc
Q 005415 487 -----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQR 559 (697)
Q Consensus 487 -----~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~ 559 (697)
.....++||||+.++|.+++...... ..+++..+..++.||+.||.|||++| |+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~--~ 174 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN--Q 174 (337)
T ss_dssp TTSTTSSEEEEEEEECCSEEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT--T
T ss_pred cccccCCceEEEEEEecCCCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC--C
Confidence 33458999999999999888654322 23899999999999999999999999 999999999999995 7
Q ss_pred ceEEEeeCCCccccccccc---------------cccccCCCCCchhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 560 CEIKIIDLGSSCFQTDNLC---------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~~~---------------~~~gt~~Y~APE~l---~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
+.+||+|||++........ ...+++.|+|||++ .+..++.++|||||||++|+|++|+.||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 8999999999976543211 34588999999998 56678999999999999999999999997
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+......+... ...+ ........+..++..||. ..|..|+++++++..|.
T Consensus 255 ~~~~~~~~~~~----~~~~-----------~~~~~~~~~~~li~~~l~----~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 255 DGAKLRIVNGK----YSIP-----------PHDTQYTVFHSLIRAMLQ----VNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------CCCC-----------TTCCSSGGGHHHHHHHSC----SSGGGSCCHHHHHHHHH
T ss_pred chhHHHhhcCc----ccCC-----------cccccchHHHHHHHHHcc----CChhhCcCHHHHHHHHH
Confidence 65543322221 1111 011122345566666665 45888999988884443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.13 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=207.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..+.++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 91 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD------HPNIMKLFEILE 91 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc------CCCccEEEEEEe
Confidence 445679999999999999999999999999999999997532 23467788998888774 889999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-cceEEE
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKI 564 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~-~~~vKL 564 (697)
.....++||||+. ++|.+.+..... +++..+..++.||+.||.|||++||+||||||+||+++... .+.+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEE
Confidence 9999999999996 567676654322 88999999999999999999999999999999999997532 457999
Q ss_pred eeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 565 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 565 ~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
+|||++...... .....+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+.+..+......++..
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred eccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 999998765433 2334678999999998764 8999999999999999999999999998888887776543333321
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.+ -.....+..++..|| ...|..|.|+++++ +|+.....
T Consensus 245 ~~---------~~~~~~~~~li~~~l----~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 245 QW---------RTISDDAKDLIRKML----TFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp GG---------TTSCHHHHHHHHHHT----CSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred hh---------hhcCHHHHHHHHHHc----ccChhhCcCHHHHhcCHHHhcccc
Confidence 11 011234444554444 45589999999999 89986543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=315.38 Aligned_cols=207 Identities=20% Similarity=0.315 Sum_probs=172.8
Q ss_pred ceecCceEEEEEeccCCCCceEEE-----EECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a-----~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.+..++|++.+.||+|+||.||+| .+..+++.||||+++... ...+..|+.+++.++.. .|+||++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~---~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS---MQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG---GGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh---hhhhhhhhhee
Confidence 344688999999999999999999 467789999999998653 35677888888888643 48999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-------
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS------- 556 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~------- 556 (697)
+...+..++||||+. ++|.+++...... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999997 6788887654322 2234999999999999999999999999999999999999984
Q ss_pred --cCcceEEEeeCCCccccc-----cccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 557 --YQRCEIKIIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 557 --~~~~~vKL~DFGla~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
...+.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 116889999999996532 223446789999999999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.65 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=195.7
Q ss_pred cCceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++.+. .||||++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~ 127 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYA 127 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-----TCTTBCCEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc-----CCCceeEEEEE
Confidence 468999999999999999999984 589999999987432 23456678999999986 37899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+......++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~k 199 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 199 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCcEE
Confidence 9999999999999975 77777764432 889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCccccccc----cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHH
Q 005415 564 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMILARII 633 (697)
Q Consensus 564 L~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~~----~~e~l~~I~ 633 (697)
|+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+...+.
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 9999998754322 2345789999999999863 47899999999999999999999997543 333444443
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
....+.+. .....+..++..|| ...|..|+ ++++++ +|+...+
T Consensus 280 ~~~~~~~~-------------~~~~~~~~li~~~L----~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 280 KSEPPYPQ-------------EMSALAKDLIQRLL----MKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HCCCCCCT-------------TSCHHHHHHHHHHT----CSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ccCCCCCc-------------ccCHHHHHHHHHHh----hhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 32222211 11223444444444 45588888 999998 8988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.31 Aligned_cols=261 Identities=14% Similarity=0.119 Sum_probs=193.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECC--------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccC---------CCCC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND---------PADE 475 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~--------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~---------~~~h 475 (697)
.++|++.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.+++.+++.+ ...+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5799999999999999999999987 4889999999865 46778999999886321 1112
Q ss_pred CceeEEEEEEEe-cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 476 HHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 476 pnIv~l~~~f~~-~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
++++++++++.. ....++||||++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 334447888876 688999999998899998875422 228999999999999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCcccccccc----------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~~----------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
+.+....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 96222389999999997644321 23478999999999999999999999999999999999999998753
Q ss_pred --HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 625 --VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 625 --~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.......+......++. +.... ...-.....+..++..||. ..|..|.+++++...|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~~l~----~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGP-FVGPC---GHWIRPSETLQKYLKVVMA----LTYEEKPPYAMLRNNL 331 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCC-EECTT---SCEECCCHHHHHHHHHHHT----CCTTCCCCHHHHHHHH
T ss_pred cCHHHHHHHHHhccCChhh-hhhhc---cccCCCcHHHHHHHHHHHh----CChhhCCCHHHHHHHH
Confidence 33333333222211111 10000 0000123566677777776 4588899999888444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.94 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=203.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++ ||||+++++++......+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC------CTTBCCEEEEECSSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEccCCCeE
Confidence 468999999999999999999985 6788999999876655677889999988874 889999999999999999
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTR 152 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--GGCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--CCCEEEccccccc
Confidence 9999997 578777764322 2889999999999999999999999999999999999985 7889999999987
Q ss_pred ccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 572 FQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 572 ~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
..... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~---- 228 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---- 228 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT----
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc----
Confidence 65432 122455678999999998899999999999999999999 999999988888777775543221110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.....+..++..||.. .|..|+++++++..|.
T Consensus 229 --------~~~~~l~~li~~~l~~----~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 229 --------LASTHVYQIMNHCWRE----RPEDRPAFSRLLRQLA 260 (267)
T ss_dssp --------TSCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred --------cCcHHHHHHHHHHccC----ChhhCcCHHHHHHHHH
Confidence 1234566677777654 4888999999885554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.85 Aligned_cols=251 Identities=22% Similarity=0.247 Sum_probs=189.3
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
++..++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 84 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGV 84 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCccceEEEE
Confidence 45568999999999999999999998653 567999998753 334456778888887763 8999999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+. .+..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~k 156 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 156 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC--CCCEE
Confidence 84 5678999999985 77777764332 2889999999999999999999999999999999999995 78999
Q ss_pred EeeCCCcccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 564 L~DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+......
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~ 236 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC
Confidence 99999997654322 22345678999999999899999999999999999997 99999988777777666543221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+.. -.....+..++..||. ..|..|++++++...|.
T Consensus 237 ~~~------------~~~~~~l~~li~~~l~----~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 237 PMP------------PNCPPTLYSLMTKCWA----YDPSRRPRFTELKAQLS 272 (281)
T ss_dssp CCC------------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred CCC------------CCCCHHHHHHHHHHcc----CChhhCcCHHHHHHHHH
Confidence 110 1223456666666665 45888999988885443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.85 Aligned_cols=257 Identities=30% Similarity=0.410 Sum_probs=191.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l 205 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN------HPCIIKI 205 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC------CTTBCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC------CCCEeeE
Confidence 45678999999999999999999999999999999997532 12235778999999884 8899999
Q ss_pred EEEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-Cc
Q 005415 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR 559 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~ 559 (697)
++++. ....++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ..
T Consensus 206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 206 KNFFD-AEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp CEEEE-SSEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSS
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCc
Confidence 99975 4568999999975 666555422 238999999999999999999999999999999999999752 24
Q ss_pred ceEEEeeCCCccccccc--cccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e-~l~~I~ 633 (697)
..+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..... ....+.
T Consensus 279 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~ 358 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358 (419)
T ss_dssp CCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred ceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence 56999999999876543 234678999999999864 568889999999999999999999998754433 333333
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
......+++.+.. ....+..++ .+++...|..|+++++++ +|+...+
T Consensus 359 ~~~~~~~~~~~~~---------~~~~~~~li----~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 359 SGKYNFIPEVWAE---------VSEKALDLV----KKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp TTCCCCCHHHHTT---------SCHHHHHHH----HHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred cCCCCCCchhhcc---------cCHHHHHHH----HHHccCChhHCcCHHHHhCCcccCChh
Confidence 3333333332211 122334444 444455689999999999 9997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.48 Aligned_cols=257 Identities=29% Similarity=0.381 Sum_probs=196.5
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~ 79 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN------HPCIIK 79 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC------CTTBCC
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC------CCCCce
Confidence 345678999999999999999999999999999999987532 12345778999998874 889999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC-
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ- 558 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~- 558 (697)
+++++.... .++||||+. ++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence 999987654 899999997 47777765332 289999999999999999999999999999999999998522
Q ss_pred cceEEEeeCCCcccccccc--ccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHH
Q 005415 559 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARI 632 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~--~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I 632 (697)
.+.+||+|||++....... ....|++.|+|||++. ...++.++|||||||++|+|++|..||...... .....+
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 3469999999997665432 3457899999999984 456899999999999999999999999765433 233333
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.........+.+. .....+..++..|| ...|..|.++++++ +|+...
T Consensus 233 ~~~~~~~~~~~~~---------~~~~~~~~li~~~l----~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 233 TSGKYNFIPEVWA---------EVSEKALDLVKKLL----VVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHTCCCCCHHHHT---------TSCHHHHHHHHHHS----CSSTTTSCCHHHHHTSGGGCCH
T ss_pred HhCccccCchhhh---------hcCHHHHHHHHHHc----ccCHhhCCCHHHHhhCcCcCCH
Confidence 3333333332221 11234445555544 45588999999999 998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=299.72 Aligned_cols=249 Identities=24% Similarity=0.266 Sum_probs=188.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
..++|++.+.||+|+||.||+|.+. ++.||||+++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 76 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------HPNIIALRGVCL 76 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC------CTTBCCEEEEEC
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC------CCCEeeEEEEEe
Confidence 3578999999999999999999974 8899999987532 22456778999988875 789999999999
Q ss_pred ecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC---ccccCCCCcccccccc-----
Q 005415 487 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSY----- 557 (697)
Q Consensus 487 ~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g---IvHrDLKP~NILl~~~----- 557 (697)
.....++||||+.+ +|.+++. . ..+++..+..++.||+.||.|||++| |+||||||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-G------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-S------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhh-c------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 99999999999975 5555543 1 12899999999999999999999999 8999999999999842
Q ss_pred -CcceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 558 -QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 558 -~~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
.++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp CSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred ccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 2678999999999765433 23457899999999999999999999999999999999999999988877766665433
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
...++. .-.....+..++..||. ..|..|.++++++..|.
T Consensus 230 ~~~~~~-----------~~~~~~~~~~li~~~l~----~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 230 KLALPI-----------PSTCPEPFAKLMEDCWN----PDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCCCCC-----------CTTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred CCCCCC-----------CcccCHHHHHHHHHHhc----CCcccCcCHHHHHHHHh
Confidence 222211 01223456677777765 45889999999886654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=302.49 Aligned_cols=254 Identities=28% Similarity=0.328 Sum_probs=192.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~---- 487 (697)
+.++|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN------HQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEECCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcC------chHHHHHHHHHHhhcch
Confidence 346899999999999999999999999999999999876666677888888887763 8999999999865
Q ss_pred ---------cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 488 ---------LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 488 ---------~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
....++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~- 151 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE- 151 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC-
Confidence 357899999997 588888764322 2788899999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCcccccc-----------------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Q 005415 558 QRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVL 619 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~-----------------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~P 619 (697)
++.+||+|||++..... ......+++.|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 152 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 152 -SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp -TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred -CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 78899999999876432 12335688999999999865 68999999999999999998 6
Q ss_pred CCCC-cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 620 FPND-AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 620 F~~~-~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
|... +..+.+..+.......|.... -.....+..++..|| ...|..|+|+++++ +|+....+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~~l----~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSIEFPPDFD---------DNKMKVEKKIIRLLI----DHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTCCCCTTCC---------TTTSHHHHHHHHHHT----CSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred cCCchhHHHHHHhccccccccCcccc---------ccchHHHHHHHHHHH----hcCcccCcCHHHHhCCCCcCCCCh
Confidence 6543 333444444433222222110 011123444555544 45589999999999 99976543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=307.51 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=196.2
Q ss_pred CceecCceEEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
.++..++|++++.||+|+||.||+|+ +..+++.||||++... ......+.+|+.+++.++ ||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ------HDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEE
Confidence 34567899999999999999999998 5678999999999754 334467788999998874 889999999
Q ss_pred EEEec--CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc
Q 005415 484 YFYHL--EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 484 ~f~~~--~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (697)
++... ..+++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~ 151 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--EN 151 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TT
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC--CC
Confidence 98654 56899999996 588888765433 2889999999999999999999999999999999999985 78
Q ss_pred eEEEeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Q 005415 561 EIKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~ 634 (697)
.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~--- 226 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR--- 226 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---
Confidence 99999999997654321 2234567799999999999999999999999999999999999754321 111
Q ss_pred hhCCCCH---------HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 635 MLGPIDL---------EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 635 ~lg~~p~---------e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
..+..+. +.+.........-.....+..++..||.. .|..|+|++++...|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~----dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN----NVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS----SGGGSCCHHHHHHHHHH
T ss_pred hhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCC----ChhhCCCHHHHHHHHHH
Confidence 1111111 00011111111122345677788888764 48889999998865543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.96 Aligned_cols=257 Identities=26% Similarity=0.326 Sum_probs=198.7
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
...+..++|++++.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+++. ||||++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~----~~~iv~~~~~ 96 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH----SDKIIRLYDY 96 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG----CTTBCCEEEE
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc----CCceEEEEEE
Confidence 34455678999999999999999999974 5899999999643 33456788999999999753 6899999999
Q ss_pred EEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 485 FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 485 f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
+......++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 97 ~~~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKL 167 (313)
T ss_dssp EECSSEEEEEECCCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTEEEE
T ss_pred eecCCEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE---CCeEEE
Confidence 99999999999988889998887543 288999999999999999999999999999999999996 588999
Q ss_pred eeCCCcccccccc-----ccccccCCCCCchhhcC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHH
Q 005415 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIG-----------LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVM 627 (697)
Q Consensus 565 ~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~-----------~~~s~ksDIWSLGviL~ELltG~~PF~~~~-~~e 627 (697)
+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 9999997654322 23468999999999976 468889999999999999999999997653 333
Q ss_pred HHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
.+..++......+ .. -.....+..++..||. ..|..|.++++++ +|+....
T Consensus 248 ~~~~~~~~~~~~~---------~~--~~~~~~l~~li~~~l~----~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 248 KLHAIIDPNHEIE---------FP--DIPEKDLQDVLKCCLK----RDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHHHCTTSCCC---------CC--CCSCHHHHHHHHHHTC----SSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHhcccccC---------Cc--ccchHHHHHHHHHHcc----CCcccCcCHHHHhcCccccCCC
Confidence 3333322111110 00 0113356666666665 4588999999999 9998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=309.30 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=200.9
Q ss_pred CCCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccC
Q 005415 399 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKND 471 (697)
Q Consensus 399 ~~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~ 471 (697)
...+..|...++.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+++
T Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-- 105 (320)
T 3a99_A 28 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-- 105 (320)
T ss_dssp ------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS--
T ss_pred hhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc--
Confidence 334555667778889999999999999999999999999999999999975431 22456689999999975
Q ss_pred CCCCCceeEEEEEEEecCeEEEEEEccc--cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 472 PADEHHILRLYDYFYHLEHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 472 ~~~hpnIv~l~~~f~~~~~l~LVmEyl~--gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
.|+||+++++++...+..++|||++. ++|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 106 --~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 177 (320)
T 3a99_A 106 --GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177 (320)
T ss_dssp --SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred --CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCH
Confidence 47999999999999999999999997 678887765332 88999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
+|||++. +++.+||+|||++...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 178 ~NIll~~-~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 254 (320)
T 3a99_A 178 ENILIDL-NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-- 254 (320)
T ss_dssp GGEEEET-TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred HHEEEeC-CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence 9999983 3678999999998765443 334578999999999987765 6789999999999999999999975421
Q ss_pred HHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+.......+ -.....+..++..||. ..|..|.++++++ +|+...
T Consensus 255 ----~~~~~~~~~-------------~~~~~~~~~li~~~l~----~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 255 ----IIRGQVFFR-------------QRVSSECQHLIRWCLA----LRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ----HHHCCCCCS-------------SCCCHHHHHHHHHHTC----SSGGGSCCHHHHHTSGGGSSC
T ss_pred ----hhccccccc-------------ccCCHHHHHHHHHHcc----CChhhCcCHHHHhcCHhhcCc
Confidence 111110000 0123455666666665 4588999999999 898754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.36 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=193.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcE----EEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~----VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|++++.||+|+||.||+|.+..+++. ||+|.+... ......+.+|+.+++.++ ||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD------HAHIVRLLGLCP 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC------CTTBCCEEEEEC
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC------CCCcCeEEEEEc
Confidence 57899999999999999999999888776 777776532 223356677888887763 899999999886
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
....++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~kl~ 157 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS--PSQVQVA 157 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS--SSCEEEC
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC--CCeEEEC
Confidence 467899999997 678887764322 2888899999999999999999999999999999999985 7889999
Q ss_pred eCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 566 DLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 566 DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC
Confidence 99999765432 233456789999999999999999999999999999999 999999887666665554322111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.+ -.....+..++..||.. .|..|.+++++...|
T Consensus 238 ~~------------~~~~~~~~~li~~~l~~----dp~~Rps~~el~~~l 271 (325)
T 3kex_A 238 QP------------QICTIDVYMVMVKCWMI----DENIRPTFKELANEF 271 (325)
T ss_dssp CC------------TTBCTTTTHHHHHHTCS----CTTTSCCHHHHHHHH
T ss_pred CC------------CcCcHHHHHHHHHHcCC----ChhhCcCHHHHHHHH
Confidence 11 12344677788888765 478888888887443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.17 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=202.8
Q ss_pred ceecCceEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d-----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+. +||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~ 93 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc-----cCCCeeeEE
Confidence 34467999999999999999999985 4577899999998543 33467889999999984 388999999
Q ss_pred EEEEecCeEEEEEEcccc-chHHHHHhhhcc------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 483 DYFYHLEHLFIVCELLRA-NLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
+++......++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999974 888887654321 1122488999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~ 623 (697)
+|||++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 174 ~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 174 RNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEEcC--CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999985 7899999999987654432 22345778999999999999999999999999999999 99999887
Q ss_pred cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 624 ~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.....+..++.....++. .-.....+..++..||. ..|..|+++++++..|.
T Consensus 252 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~----~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLS-----------PEHAPAEMYDIMKTCWD----ADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp CSSHHHHHHHHHTCCCCC-----------CTTSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred cchhHHHHHhccCCCCCC-----------cccCCHHHHHHHHHHcC----CCchhCcCHHHHHHHHH
Confidence 655555444432221110 01123456666666665 45888999999885554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=325.05 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=202.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+.+++.++ ||||+++++++.. .
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-E 251 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-S
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEcC-C
Confidence 3456789999999999999999999864 567999999876555678899999999985 8899999999876 6
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG 325 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 325 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC--CCCEEECCCc
Confidence 7899999997 5888887643322 2889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
++....... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+......+.+
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~-- 403 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-- 403 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 997654321 12345678999999999999999999999999999999 99999999888887777544322211
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..++..||... |..|+|++++...|.
T Consensus 404 ----------~~~~~~l~~li~~cl~~d----P~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 404 ----------PECPESLHDLMCQCWRKE----PEERPTFEYLQAFLE 436 (452)
T ss_dssp ----------TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHccCC----hhhCcCHHHHHHHHH
Confidence 123456788888888755 888999998885554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.27 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=196.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC------CTTBCCEEEEEEETTE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC------CCCceeeeeEEEcCCE
Confidence 468999999999999999999999999999999997533 33466778888887763 8899999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++. ++.+||+|||.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl~dfg~ 151 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGL 151 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCCEEECCCTT
T ss_pred EEEEEEecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc--CCCEEEeeCCC
Confidence 9999999975 676665422 23889999999999999999999999999999999999985 78899999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHhhCCCCHH
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDLE 642 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I~~~lg~~p~e 642 (697)
+...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..+..+.......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 229 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-- 229 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST--
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC--
Confidence 8754321 234568999999999988765 77899999999999999999999876543 22223222111110
Q ss_pred HHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 643 MLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 643 ~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..-.....+..++..| +...|..|+|+++++ +|+....
T Consensus 230 ---------~~~~~~~~~~~li~~~----l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 230 ---------PWKKIDSAPLALLHKI----LVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ---------TGGGSCHHHHHHHHHH----SCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------chhhcCHHHHHHHHHH----CCCCchhCCCHHHHhcCccccChh
Confidence 0001123344444444 445689999999999 9987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.95 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=202.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..+.++|+++++||+|+||.||+|.+..+++.||||++..... ..++..|+++++.+++ +++|..+..++....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~-----~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQG-----GTGIPNVRWFGVEGD 76 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTT-----STTCCCEEEEEEETT
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcC-----CCCCCeEEEEEeeCC
Confidence 3567899999999999999999999999999999999875433 3567899999999875 357777777778889
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DFG 568 (697)
..+|||||++++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||||+. +..+.+||+|||
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 9999999998899998875432 2899999999999999999999999999999999999942 147899999999
Q ss_pred Ccccccccc----------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHHHh
Q 005415 569 SSCFQTDNL----------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGM 635 (697)
Q Consensus 569 la~~~~~~~----------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~---~~e~l~~I~~~ 635 (697)
++....... ....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.. ..+.+.++...
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 997654332 14578999999999999999999999999999999999999998743 34455555443
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
....+.+.+.. .....+..++..||... +..|.+++++.
T Consensus 232 ~~~~~~~~l~~--------~~p~~l~~li~~cl~~d----P~~RPs~~el~ 270 (483)
T 3sv0_A 232 KVATSIEALCR--------GYPTEFASYFHYCRSLR----FDDKPDYSYLK 270 (483)
T ss_dssp HHHSCHHHHHT--------TSCHHHHHHHHHHHTCC----TTCCCCHHHHH
T ss_pred cccccHHHHhc--------CCcHHHHHHHHHHhcCC----hhhCcCHHHHH
Confidence 32222222211 22446778888888644 77788887766
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.66 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=191.8
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+..+.++|++++.||+|+||+||+|.+ +++.||||++.... ......|.+++.... .+||||+++++++...
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM----LRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC----CCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh----ccCcCeeeEEEeeccc
Confidence 456788999999999999999999986 68999999997543 345566777777643 3599999999997653
Q ss_pred ----CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------hcCccccCCCCcccccc
Q 005415 489 ----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCDLKPENILIK 555 (697)
Q Consensus 489 ----~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH--------s~gIvHrDLKP~NILl~ 555 (697)
...++||||+.+ +|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred cCCCceeEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 568999999975 787777421 2899999999999999999999 99999999999999998
Q ss_pred ccCcceEEEeeCCCcccccccc-------ccccccCCCCCchhhcCC------CCCchhhHHHHHHHHHHHHhC------
Q 005415 556 SYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTG------ 616 (697)
Q Consensus 556 ~~~~~~vKL~DFGla~~~~~~~-------~~~~gt~~Y~APE~l~~~------~~s~ksDIWSLGviL~ELltG------ 616 (697)
. ++.+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 148 ~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 148 K--NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp T--TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred C--CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 5 7899999999986544322 224789999999999876 445789999999999999999
Q ss_pred ----CCCCCCCc----HHHHHHHHHHhhCCCCHHHHhhccccccccc--CCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 617 ----EVLFPNDA----VVMILARIIGMLGPIDLEMLMQGQEIYKYFT--KEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 617 ----~~PF~~~~----~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~--~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
..||.... ....+..+....+..+.- ....+. ....+..++..||.. .|..|+|++++.
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~----dP~~Rps~~~i~ 294 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI-------PNRWFSDPTLTSLAKLMKECWYQ----NPSARLTALRIK 294 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC-------CGGGGGSHHHHHHHHHHHHHCCS----SGGGSCCHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCC-------ChhhccCccHHHHHHHHHHHhhc----ChhhCCCHHHHH
Confidence 89996532 223333332222211100 000000 113466677777754 488999999998
Q ss_pred Hhhccc
Q 005415 687 LWLFGI 692 (697)
Q Consensus 687 ~wl~~~ 692 (697)
..|..+
T Consensus 295 ~~L~~i 300 (301)
T 3q4u_A 295 KTLTKI 300 (301)
T ss_dssp HHHHHH
T ss_pred HHHhcc
Confidence 666543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=321.01 Aligned_cols=267 Identities=19% Similarity=0.258 Sum_probs=200.8
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
+.++.++|++.+.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++.++ ||||+++++++.
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~ 77 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN------HKNIVKLFAIEE 77 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC------CTTBCCEEEEEE
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC------CCCCCeEEEeec
Confidence 3456789999999999999999999999999999999997533 23456778999999884 889999999998
Q ss_pred ecC--eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccc--ccCcce
Q 005415 487 HLE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK--SYQRCE 561 (697)
Q Consensus 487 ~~~--~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~--~~~~~~ 561 (697)
... ..++||||+. ++|.+++...... ..+++..++.++.||+.||.|||++||+||||||+|||+. .+..+.
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp CTTTCCEEEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE
T ss_pred cCCCCeeEEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee
Confidence 764 7899999997 5777776543322 1288999999999999999999999999999999999982 124678
Q ss_pred EEEeeCCCccccccc--cccccccCCCCCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC----cHHH
Q 005415 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVLFPND----AVVM 627 (697)
Q Consensus 562 vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~--------~~~s~ksDIWSLGviL~ELltG~~PF~~~----~~~e 627 (697)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+
T Consensus 155 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp EEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred EEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 999999999765433 234578999999999875 45788999999999999999999999642 2344
Q ss_pred HHHHHHHhhCCCCHHHHhhccc---ccccc--------cCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 628 ILARIIGMLGPIDLEMLMQGQE---IYKYF--------TKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~---~~~~~--------~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
.+.+++.. .|...+..... ....| .....+...+.+...+.+...|..|++++++..
T Consensus 235 ~~~~~~~~---~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 235 VMYKIITG---KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHS---CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHHhcC---CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 55555432 22221111110 00001 111234445556666666677889999998863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=306.44 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=200.8
Q ss_pred ceecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++.+.||+|+||.||+|.+. .+++.||||+++.. ......+.+|+.+++.+ +||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 92 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV------NHPHVIKLY 92 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC------CCCceeeEE
Confidence 344678999999999999999999873 45689999999753 23445677888888776 389999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHhcCcc
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESG------------------GEAYFTLGRLQVITRQCLEALEYLHSLGII 543 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~------------------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIv 543 (697)
+++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 99999999999999997 67888876543211 123388999999999999999999999999
Q ss_pred ccCCCCccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CC
Q 005415 544 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 617 (697)
Q Consensus 544 HrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~ 617 (697)
||||||+|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 173 H~dikp~NIli~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 173 HRDLAARNILVAE--GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCCSGGGEEEET--TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchheEEEcC--CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999985 788999999998765432 122355778999999999889999999999999999999 99
Q ss_pred CCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 618 ~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.||.+.........+........ .-.....+..++..||. ..|..|.+++++...|.
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~----~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLKTGHRMER------------PDNCSEEMYRLMLQCWK----QEPDKRPVFADISKDLE 307 (314)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHhhcCCcCCC------------CccCCHHHHHHHHHHcc----CChhhCcCHHHHHHHHH
Confidence 99998877666655543221111 01223455666666665 45888999999885544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=310.19 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=200.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d-----~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.+++.+. .||||+++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 116 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLG 116 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3457899999999999999999997 346678999999753 234567889999999984 3889999999
Q ss_pred EEEecCeEEEEEEccc-cchHHHHHhhhccC-----------------CCcccCHHHHHHHHHHHHHHHHHHHhcCcccc
Q 005415 484 YFYHLEHLFIVCELLR-ANLYEFQKFNQESG-----------------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 545 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-----------------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHr 545 (697)
++...+..++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999997 58888876543210 01237899999999999999999999999999
Q ss_pred CCCCccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005415 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVL 619 (697)
Q Consensus 546 DLKP~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~P 619 (697)
||||+|||++. ++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 Dikp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcC--CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999985 7899999999997654322 22456788999999999999999999999999999998 9999
Q ss_pred CCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 620 FPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 620 F~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
|.+......+..++.....++. .......+..++..||.. .|..|++++++..+|.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~----dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQ-----------PFYATEEIYIIMQSCWAF----DSRKRPSFPNLTSFLG 330 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCC-----------CTTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCC-----------CCCCCHHHHHHHHHHcCC----CchhCcCHHHHHHHHH
Confidence 9887655555554432211111 112345677777777764 4888999998885544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.38 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=202.4
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~-------~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+..++|++.+.||+|+||.||+|.+. .+++.||||+++... .....+.+|+.+++.+. +||||+++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~ 106 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 106 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh-----cCCCEeeE
Confidence 44579999999999999999999975 467889999997542 34567889999999984 38899999
Q ss_pred EEEEEecCeEEEEEEcccc-chHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCc
Q 005415 482 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 550 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~ 550 (697)
++++...+..++||||+.+ +|.+++....... ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999975 8888876543211 1123889999999999999999999999999999999
Q ss_pred cccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCc
Q 005415 551 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 624 (697)
Q Consensus 551 NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~ 624 (697)
|||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 187 NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTE--NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECT--TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC--CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999985 789999999998765432 222355778999999998889999999999999999999 999999988
Q ss_pred HHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 625 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 625 ~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..+....+........ .......+..++..||... |..|.+++++...|
T Consensus 265 ~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~d----p~~Rps~~ell~~L 313 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDK------------PANCTNELYMMMRDCWHAV----PSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHHHHHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCC------------CccCCHHHHHHHHHHccCC----hhhCcCHHHHHHHH
Confidence 8877776655332111 1123346677777777644 78888888887443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.40 Aligned_cols=269 Identities=25% Similarity=0.327 Sum_probs=182.3
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++ ...||||+++++++..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~------~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS------QCHHPNIVSYYTSFVV 84 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCC------CCCCTTBCCEEEEEES
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHh------hcCCCCEeeEEEEEee
Confidence 345689999999999999999999998899999999986532 22233444444443 4469999999999999
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~--~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.+..++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT--TCCEEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC--CCCEEE
Confidence 999999999996 57777776432211 1234899999999999999999999999999999999999985 788999
Q ss_pred eeCCCccccccc--------cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 565 IDLGSSCFQTDN--------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 565 ~DFGla~~~~~~--------~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........+......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 999988654321 223568999999999976 56899999999999999999999999887766555444332
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
..+.......... .. -.....+..++..||. ..|..|+++++++ +|+...+
T Consensus 243 ~~~~~~~~~~~~~-~~--~~~~~~~~~li~~~l~----~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 243 DPPSLETGVQDKE-ML--KKYGKSFRKMISLCLQ----KDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SCCCTTC-----C-CC--CCCCHHHHHHHHHHCC----SSGGGSCCHHHHHTSTTC----
T ss_pred CCCccccccccch-hh--hhhhHHHHHHHHHHcc----CChhhCcCHHHHhhChhhhcCC
Confidence 2211111110000 00 0112345556666654 4589999999999 8987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.27 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=192.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+...+|++.+.||+|+||.||+|++. .++..||||+++.. ......+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~ 115 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF------DHPNIIRLEGVV 115 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 34578999999999999999999876 46778999999753 33445677888888776 489999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
......++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kl 188 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS--NLVCKV 188 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEE
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC--CCCEEE
Confidence 99999999999996 57887775432 12899999999999999999999999999999999999985 789999
Q ss_pred eeCCCccccccccc------cccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhC
Q 005415 565 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 565 ~DFGla~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|||++........ ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+.....
T Consensus 189 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 189 SDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred CcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999976543221 1234678999999999999999999999999999998 9999999888877777654332
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.++ .......+..++..||... |..|++++++...|.
T Consensus 269 ~~~------------~~~~~~~l~~li~~cl~~d----p~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 269 LPP------------PMDCPAALYQLMLDCWQKD----RNNRPKFEQIVSILD 305 (373)
T ss_dssp CCC------------CTTCBHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CCC------------CccccHHHHHHHHHHhCcC----hhhCcCHHHHHHHHH
Confidence 221 1123456778888888654 778888888874443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=300.29 Aligned_cols=257 Identities=26% Similarity=0.330 Sum_probs=189.1
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+....++|++.+.||+|+||.||+|.+..+++.||||+++. .......+.+|+.+++.++ ||||++++++
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~ 100 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN------HPNVIKYYAS 100 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEE
Confidence 33445789999999999999999999999999999999974 2334566778888888774 8899999999
Q ss_pred EEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+...+..++||||+.+ +|.+++....... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+|
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~--~~~~k 176 (310)
T 2wqm_A 101 FIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVK 176 (310)
T ss_dssp EEETTEEEEEEECCCSCBHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEE
T ss_pred EEcCCcEEEEEecCCCCCHHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC--CCCEE
Confidence 9999999999999985 7777776533222 23889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHhhCC
Q 005415 564 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGP 638 (697)
Q Consensus 564 L~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~--~~e~l~~I~~~lg~ 638 (697)
|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+... ..
T Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 255 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DY 255 (310)
T ss_dssp ECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CS
T ss_pred EEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cC
Confidence 9999998765432 233568999999999999999999999999999999999999997643 33333333221 11
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
++.. .-.....+..++..||.. .|..|.+++++...|.
T Consensus 256 ~~~~----------~~~~~~~l~~li~~~l~~----dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 256 PPLP----------SDHYSEELRQLVNMCINP----DPEKRPDVTYVYDVAK 293 (310)
T ss_dssp CCCC----------TTTSCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred CCCc----------ccccCHHHHHHHHHHcCC----ChhhCCCHHHHHHHHH
Confidence 1100 001234566777777654 4888999988874443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.24 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=199.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++..++|++++.||+|+||.||+|.+. ++..||||++.......+.+.+|+.+++.++ ||||+++++++. .+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVT-QE 80 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC------CcCcceEEEEEc-CC
Confidence 445679999999999999999999964 5778999999876655678889999999884 789999999986 45
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+. ++|.+++...... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~Dfg 154 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFG 154 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred CcEEEEecCCCCCHHHHHhcCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC--CCCEEECCCc
Confidence 6899999996 5787777543321 2889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.+..+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 232 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP-- 232 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc--
Confidence 997654332 22345778999999998889999999999999999999 99999998888777776543221111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
-.....+..++..||. ..|..|.+++++...
T Consensus 233 ----------~~~~~~l~~li~~~l~----~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 233 ----------DNCPEELYQLMRLCWK----ERPEDRPTFDYLRSV 263 (279)
T ss_dssp ----------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHH
T ss_pred ----------ccccHHHHHHHHHHhc----cChhhCCCHHHHHHH
Confidence 1223456666666665 448889999888733
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.82 Aligned_cols=258 Identities=17% Similarity=0.196 Sum_probs=202.2
Q ss_pred CceecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
.++..++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|+.+++.+ +||||+++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~ 93 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRL 93 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc------CCCCEeee
Confidence 4566789999999999999999999876 467899999997543 2334566777777766 48899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHHhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
++++......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence 999999999999999997 5888877653321 11123688999999999999999999999999999999999995
Q ss_pred cCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~ 630 (697)
++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 174 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 174 --DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp --TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred --CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 7899999999987554322 22355788999999999999999999999999999999 999999988887777
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+......... -.....+..++..||. ..|..|.++++++..|.
T Consensus 252 ~~~~~~~~~~~------------~~~~~~l~~li~~~l~----~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 252 FVMEGGLLDKP------------DNCPDMLFELMRMCWQ----YNPKMRPSFLEIISSIK 295 (322)
T ss_dssp HHHTTCCCCCC------------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHG
T ss_pred HHHcCCcCCCC------------CCCCHHHHHHHHHHcC----CCcccCcCHHHHHHHHH
Confidence 76543211110 1223456666666665 44888999988885443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.97 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=180.3
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh--hHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~--~~~~~~Ei~-iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.++|++++.||+|+||.||+|.+..+++.||||++...... ..+...|.. +++. .+||||+++++++....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~------~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS------HDCPYIVQCFGTFITNT 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHT------TTCTTBCCEEEEEECSS
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHh------cCCCceeeEEEEEecCC
Confidence 46899999999999999999999999999999999864322 122222332 2332 35899999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+++.+..+...... .+++..+..++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg 170 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFG 170 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT--TSCEEECCCT
T ss_pred cEEEEEeccCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC--CCCEEEEECC
Confidence 9999999996555554443222 288999999999999999999995 9999999999999985 7899999999
Q ss_pred Cccccccc--cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCCC
Q 005415 569 SSCFQTDN--LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPID 640 (697)
Q Consensus 569 la~~~~~~--~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~p 640 (697)
++...... .....+++.|+|||++. +..++.++|||||||++|+|++|+.||.. ....+.+..+.....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 98654432 23457899999999994 45688999999999999999999999987 455566666544322111
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.........+..++..||. ..|..|+++++++ +|+...
T Consensus 251 ----------~~~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 251 ----------PGHMGFSGDFQSFVKDCLT----KDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ----------CSSSCCCHHHHHHHHHHTC----SCTTTSCCHHHHTTSHHHHHH
T ss_pred ----------CccCCCCHHHHHHHHHHcc----CChhHCcCHHHHhhCHHHHhc
Confidence 1111233456666666665 4588999999999 888643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.42 Aligned_cols=257 Identities=19% Similarity=0.201 Sum_probs=199.4
Q ss_pred CceecCceEEEEEeccCCCCceEEEE-----ECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~-----d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
.++..++|++++.||+|+||.||+|. +..+++.||||++... ......+.+|+.+++.++ ||||+++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~ 98 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN------HQNIVRC 98 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC------CTTBCCE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC------CCCCCeE
Confidence 34567899999999999999999998 5567889999999643 334456778998888874 8899999
Q ss_pred EEEEEecCeEEEEEEccc-cchHHHHHhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-C
Q 005415 482 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-Q 558 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~-~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~ 558 (697)
++++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+||||||+|||++.. .
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 999999999999999995 68888887544221 11348899999999999999999999999999999999999843 2
Q ss_pred cceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q 005415 559 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I 632 (697)
...+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 457999999998643221 223466889999999999899999999999999999998 99999998888777766
Q ss_pred HHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHH
Q 005415 633 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687 (697)
Q Consensus 633 ~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~ 687 (697)
.......+. -.....+..++..||.. .|..|.++++++.
T Consensus 259 ~~~~~~~~~------------~~~~~~l~~li~~~l~~----dp~~Rps~~~ll~ 297 (327)
T 2yfx_A 259 TSGGRMDPP------------KNCPGPVYRIMTQCWQH----QPEDRPNFAIILE 297 (327)
T ss_dssp HTTCCCCCC------------TTCCHHHHHHHHHHTCS----SGGGSCCHHHHHH
T ss_pred hcCCCCCCC------------CCCCHHHHHHHHHHhcC----ChhhCcCHHHHHH
Confidence 543322211 12234566676666654 4888999988883
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.27 Aligned_cols=273 Identities=18% Similarity=0.268 Sum_probs=204.8
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh------------------hHhHHHHHHHHHHhcc
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------------------FDQSLDEIKLLKLVNK 469 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~------------------~~~~~~Ei~iL~~L~~ 469 (697)
.++...++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+|+.+++.++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 101 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK- 101 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-
Confidence 3456678999999999999999999998 8999999999754221 167788888888774
Q ss_pred cCCCCCCceeEEEEEEEecCeEEEEEEcccc-chHHHHHhhhc--cCCCcccCHHHHHHHHHHHHHHHHHHHh-cCcccc
Q 005415 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQE--SGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHC 545 (697)
Q Consensus 470 ~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~--~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHr 545 (697)
||||+++++++...+..++||||+.+ +|.+++..... ......+++..+..++.||+.||.|||+ +||+||
T Consensus 102 -----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 102 -----NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp -----CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred -----CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 88999999999999999999999986 77665221100 1112348999999999999999999999 999999
Q ss_pred CCCCccccccccCcceEEEeeCCCcccccc-ccccccccCCCCCchhhcCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCC
Q 005415 546 DLKPENILIKSYQRCEIKIIDLGSSCFQTD-NLCLYVQSRSYRAPEVIIGL-PYDQ-KIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 546 DLKP~NILl~~~~~~~vKL~DFGla~~~~~-~~~~~~gt~~Y~APE~l~~~-~~s~-ksDIWSLGviL~ELltG~~PF~~ 622 (697)
||||+||+++. ++.+||+|||++..... ......+++.|+|||++.+. .++. ++|||||||++|+|++|..||..
T Consensus 177 dl~p~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 177 DVKPSNILMDK--NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CCCGGGEEECT--TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChHhEEEcC--CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999985 78999999999976533 33446789999999999887 5666 99999999999999999999988
Q ss_pred CcH-HHHHHHHHHhhCCCCHHHHhhccccc------ccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 623 DAV-VMILARIIGMLGPIDLEMLMQGQEIY------KYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 623 ~~~-~e~l~~I~~~lg~~p~e~~~~~~~~~------~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
... .+.+..+.......|........... ..-.....+..++..| +...|..|.++++++ +|+...+
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~----L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF----LRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHH----CCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHH----ccCChhhCCCHHHHhcCccccCCC
Confidence 766 66666664433333311000000000 0001123344444444 455689999999999 9998765
Q ss_pred C
Q 005415 694 Q 694 (697)
Q Consensus 694 ~ 694 (697)
+
T Consensus 331 ~ 331 (348)
T 2pml_X 331 I 331 (348)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.49 Aligned_cols=246 Identities=23% Similarity=0.263 Sum_probs=185.7
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL------QEPHVVPIHDFGEID 106 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEET
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc------CCCCeeEEEEEEeeC
Confidence 478999999999999999999999999999999997542 2235667787777766 489999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+..++||||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~--~~~~kl~Df 178 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA--DDFAYLVDF 178 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSC
T ss_pred CeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC--CCCEEEecC
Confidence 999999999985 7877776432 2889999999999999999999999999999999999985 788999999
Q ss_pred CCccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 568 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 568 Gla~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|++...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+ ....+.+...
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~ 257 (309)
T 2h34_A 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257 (309)
T ss_dssp CC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGT
T ss_pred ccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCcccc
Confidence 998765432 22356889999999999989999999999999999999999999987765333333 2222211111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-CHHHHH
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-TLEYAA 686 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-t~e~~~ 686 (697)
. -.....+..++..||.. .|..|+ +++++.
T Consensus 258 ~---------~~~~~~l~~li~~~l~~----dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 258 R---------PGIPVAFDAVIARGMAK----NPEDRYVTCGDLS 288 (309)
T ss_dssp S---------TTCCTHHHHHHHHHTCS----SGGGSCSSHHHHH
T ss_pred C---------CCCCHHHHHHHHHhccC----CHHHHHHhHHHHH
Confidence 0 11234556666666654 478888 787777
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=302.19 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=192.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-C
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-E 489 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-~ 489 (697)
+..++|++.+.||+|+||.||++.+ +++.||||+++... ....+.+|+.+++.++ ||||+++++++... .
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCC------CTTBCCEEEEECCC--
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCC------CCCEeeEEEEEEcCCC
Confidence 3457899999999999999999986 48899999998654 3466778888887764 88999999997654 5
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
..++||||+.+ +|.+++...... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg 162 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 162 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred ceEEEEecCCCCCHHHHHHhcccc----cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC--CCcEEEeecc
Confidence 78999999975 888887654321 2788899999999999999999999999999999999985 7899999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
++...........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------- 235 (278)
T 1byg_A 163 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------- 235 (278)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC-------
T ss_pred ccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence 99876655555677889999999999999999999999999999998 9999998776666655533221111
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
.-.....+..++..||.. .|..|++++++...|..+
T Consensus 236 -----~~~~~~~l~~li~~~l~~----~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 -----PDGCPPAVYEVMKNCWHL----DAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -----CTTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHHHH
T ss_pred -----cccCCHHHHHHHHHHhcC----ChhhCCCHHHHHHHHHHH
Confidence 012234566777777654 488899999998666544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.26 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=203.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCc-----EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~-----~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+|+.+++.+. +||||+++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 117 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-----QHENIVNLLG 117 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 345789999999999999999999876654 79999997542 34567889999999984 3889999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHHhhhccC--------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESG--------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~--------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
++......++||||+.+ +|.+++....... ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 99999999999999974 8888876543210 01237899999999999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~ 628 (697)
+. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TN--GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EG--GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CC--CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 85 7899999999997543321 22345778999999999999999999999999999999 9999988766555
Q ss_pred HHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+..++.....++. .-.....+..++..||.. .|..|++++++..+|.
T Consensus 276 ~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~----~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 276 FYKLVKDGYQMAQ-----------PAFAPKNIYSIMQACWAL----EPTHRPTFQQICSFLQ 322 (333)
T ss_dssp HHHHHHHTCCCCC-----------CTTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCC-----------CCCCCHHHHHHHHHHhcc----ChhhCcCHHHHHHHHH
Confidence 5555443222111 011234667777777764 4888999999886665
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=296.02 Aligned_cols=245 Identities=21% Similarity=0.253 Sum_probs=193.6
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
+..+.++|++++.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLD------HVNIVHYNGCWDGF 76 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCC------CTTBCCEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCC------CCCEEEEeeeEecc
Confidence 4566789999999999999999999999999999999998654 35678999998884 8899999999864
Q ss_pred ---------------cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 488 ---------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 488 ---------------~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
...+++||||+.+ +|.+++...... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 152 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 4558999999985 888887654322 28899999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 629 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l 629 (697)
||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||... ....
T Consensus 153 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~ 228 (284)
T 2a19_B 153 IFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFF 228 (284)
T ss_dssp EEEEE--TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHH
T ss_pred EEEcC--CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHH
Confidence 99985 789999999998765432 33457899999999999999999999999999999999999988532 1222
Q ss_pred HHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 630 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 630 ~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..+.. +..+ . .....+..++..||. ..|..|+++++++..|
T Consensus 229 ~~~~~--~~~~-----------~--~~~~~~~~li~~~l~----~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 229 TDLRD--GIIS-----------D--IFDKKEKTLLQKLLS----KKPEDRPNTSEILRTL 269 (284)
T ss_dssp HHHHT--TCCC-----------T--TSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHH
T ss_pred HHhhc--cccc-----------c--cCCHHHHHHHHHHcc----CChhhCcCHHHHHHHH
Confidence 22211 1111 1 112345555555554 5588899999988333
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.18 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=187.7
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.+++..++|++.++||+|+||.||+|.+. ..||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~ 88 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR------HVNILLFMGY 88 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCC------CCcEEEEEee
Confidence 35677899999999999999999999853 35999999753 233456778888877664 8899999996
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
. .....++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~--~~~~k 160 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE--DNTVK 160 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TTEEE
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC--CCCEE
Confidence 5 5567899999997 56666664332 22889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCcccccc-----ccccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 564 IIDLGSSCFQTD-----NLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 564 L~DFGla~~~~~-----~~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
|+|||++..... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||.+....+.+..++..
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 999999865432 123356899999999997 567889999999999999999999999886665555554433
Q ss_pred hC-CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 636 LG-PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 636 lg-~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.. .++.... .-.....+..++..||. ..|..|.++++++..|..
T Consensus 241 ~~~~~~~~~~--------~~~~~~~l~~li~~~l~----~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 241 GSLSPDLSKV--------RSNCPKRMKRLMAECLK----KKRDERPSFPRILAEIEE 285 (289)
T ss_dssp TSCCCCTTSS--------CTTSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHHH
T ss_pred cccCcchhhc--------cccCCHHHHHHHHHHcc----CChhhCCCHHHHHHHHHH
Confidence 22 1111100 01223456667777665 458889999998866654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.57 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=188.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcE----EEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~----VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..++|+++++||+|+||+||+|.+..+++. ||+|.++.. ......+.+|+.+++.++ ||||+++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 86 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGIC 86 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC------BTTBCCEEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC------CCCEeEEEEEE
Confidence 357899999999999999999999877765 477776532 234467888999999885 78999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.... .++|+||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~--~~~~kl 158 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKI 158 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEE
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC--CCCEEE
Confidence 8765 678888886 677777764332 2889999999999999999999999999999999999985 789999
Q ss_pred eeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||+++...... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3poz_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC
Confidence 9999987643321 22345778999999999999999999999999999999 99999987766655554333221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+.. -.....+..++..||... |..|.++++++
T Consensus 239 ~~~------------~~~~~~~~~li~~~l~~~----p~~Rps~~ell 270 (327)
T 3poz_A 239 PQP------------PICTIDVYMIMVKCWMID----ADSRPKFRELI 270 (327)
T ss_dssp CCC------------TTBCHHHHHHHHHHTCSC----GGGSCCHHHHH
T ss_pred CCC------------ccCCHHHHHHHHHHcCCC----hhhCCCHHHHH
Confidence 111 123346777777777654 77888888777
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.91 Aligned_cols=261 Identities=24% Similarity=0.291 Sum_probs=172.4
Q ss_pred ceeeCceecCceEEEE-EeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 405 PIILNTVIAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 405 pv~~~~~i~~rY~i~e-~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
|......+.++|++++ .||+|+||.||+|.+..+++.||||++..... ..+|+..+..+ ..||||+++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~-----~~h~~i~~~~~ 89 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQA-----SGGPHIVCILD 89 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHH-----TTSTTBCCEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHh-----cCCCChHHHHH
Confidence 3334456778999965 69999999999999999999999999976543 22333333222 25899999999
Q ss_pred EEEe----cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-
Q 005415 484 YFYH----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY- 557 (697)
Q Consensus 484 ~f~~----~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~- 557 (697)
++.. ...+++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred HHhhccCCCceEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC
Confidence 9986 4568999999975 78887764332 238999999999999999999999999999999999999853
Q ss_pred CcceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH--
Q 005415 558 QRCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG-- 634 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~-- 634 (697)
..+.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 2567999999999765433 3446789999999999888899999999999999999999999987655443222211
Q ss_pred --hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 635 --MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 635 --~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.....+... +-.....+..++..| +...|..|+|+++++ +|+..
T Consensus 246 ~~~~~~~~~~~---------~~~~~~~~~~li~~~----L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 246 RLGQYGFPNPE---------WSEVSEDAKQLIRLL----LKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -----CCCTTT---------STTCCHHHHHHHHHH----SCSSGGGSCCHHHHHHSHHHHT
T ss_pred hccccccCchh---------hccCCHHHHHHHHHH----CCCChhHCcCHHHHhcCccccc
Confidence 111111100 001123444444444 445689999999999 99975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.12 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=194.6
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCC----cEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g----~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
++...+|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.++ ||||+++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCCCcEEE
Confidence 445678999999999999999999876543 46999999753 233456778888888764 899999999
Q ss_pred EEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 484 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 484 ~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
++......++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~ 186 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVC 186 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCE
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC--CCcE
Confidence 99999999999999975 77777754322 2889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHh
Q 005415 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 563 KL~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~ 635 (697)
||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 999999997654321 11234678999999999999999999999999999999 99999988888777776543
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
...+.. ......+..++..||... |..|.+++++...|
T Consensus 267 ~~~~~~------------~~~~~~l~~li~~~l~~~----p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 267 FRLPTP------------MDCPSAIYQLMMQCWQQE----RARRPKFADIVSIL 304 (333)
T ss_dssp CCCCCC------------TTCBHHHHHHHHHHTCSS----TTTSCCHHHHHHHH
T ss_pred CcCCCc------------ccCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence 322211 123446777777777644 77788888777433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.98 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=206.2
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++..++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.+++.++ ||||+++++++.. .
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVSE-E 334 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-S
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC------CCCEeeEEEEEee-c
Confidence 4556789999999999999999999864 567999999876555678899999999985 7899999999866 6
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.++|||||+. ++|.+++...... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~--~~~~kl~DFG 408 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 408 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC--CCcEEEcccc
Confidence 7899999997 5888888644322 2889999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+++...... ....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+......+..
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~-- 486 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-- 486 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCC--
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 997654321 22345678999999999999999999999999999999 99999999888887777543321111
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
-.....+..+|..||... +..|.|++++...|.
T Consensus 487 ----------~~~~~~l~~li~~cl~~d----P~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 487 ----------PECPESLHDLMCQCWRKE----PEERPTFEYLQAFLE 519 (535)
T ss_dssp ----------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHHH
Confidence 123456888888888754 888999998885554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.55 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=197.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEE--EEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDV--CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~V--AVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.++|++.+.||+|+||.||+|.+..++..+ |+|.++.. ......+.+|+.+++.+. +||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc-----CCCchhhhceeeeeC
Confidence 368999999999999999999998888865 99988752 234456778888887763 489999999999999
Q ss_pred CeEEEEEEccc-cchHHHHHhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~----------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+..++||||+. ++|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~- 177 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE- 177 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC-
Confidence 99999999996 588888764431 011223899999999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~ 634 (697)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 178 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 178 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp -GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred -CCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 789999999998654322 223456788999999998889999999999999999998 9999999888777666543
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
..... ........+..++..||. ..|..|+++++++..|
T Consensus 257 ~~~~~------------~~~~~~~~l~~li~~~l~----~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 257 GYRLE------------KPLNCDDEVYDLMRQCWR----EKPYERPSFAQILVSL 295 (327)
T ss_dssp TCCCC------------CCTTBCHHHHHHHHHHTC----SSGGGSCCHHHHHHHH
T ss_pred CCCCC------------CCCCCCHHHHHHHHHHcc----CChhhCcCHHHHHHHH
Confidence 32111 111223455666666664 4588899999888443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=296.46 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=195.8
Q ss_pred cCceEEEE-EeccCCCCceEEEEEC--CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e-~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++.. ......+.+|+.+++.++ ||||+++++++ .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~-~ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVC-Q 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEE-E
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEe-c
Confidence 46788887 9999999999999864 46888999999863 344567888999999884 78999999999 5
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+..++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~D 153 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISD 153 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC--CCCEEECc
Confidence 5679999999985 6777664322 22899999999999999999999999999999999999985 78999999
Q ss_pred CCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+.....+.
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC
Confidence 99997654321 22345788999999998889999999999999999998 999999888777766664432111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
. .-.....+..++..||.. .|..|++++++...
T Consensus 234 ~------------~~~~~~~l~~li~~~l~~----~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 234 C------------PPECPPELYALMSDCWIY----KWEDRPDFLTVEQR 266 (287)
T ss_dssp C------------CTTCCHHHHHHHHHTTCS----SGGGSCCHHHHHHH
T ss_pred C------------CCCcCHHHHHHHHHHcCC----ChhhCcCHHHHHHH
Confidence 1 012345667777777764 47888899888733
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=300.17 Aligned_cols=262 Identities=20% Similarity=0.231 Sum_probs=195.6
Q ss_pred eeCceecCceEEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 407 ~~~~~i~~rY~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
..+.+...+|++++.||+|+||.||+|+ +..+++.||||+++... .....+.+|+.+++.++ ||||++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~ 87 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENIVK 87 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC------CTTBCC
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC------CCCeee
Confidence 3344556789999999999999999998 56789999999997542 33467788999988874 789999
Q ss_pred EEEEEEec--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 481 LYDYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 481 l~~~f~~~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+++++... ..+++||||+.+ +|.+++...... +++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~- 161 (302)
T 4e5w_A 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES- 161 (302)
T ss_dssp EEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-
T ss_pred eeeEEecCCCceEEEEEEeCCCCcHHHHHHhcccc-----CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC-
Confidence 99999876 678999999975 788877544322 889999999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
++.+||+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..|+.... . .
T Consensus 162 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~ 235 (302)
T 4e5w_A 162 -EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM--A---L 235 (302)
T ss_dssp -TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---H
T ss_pred -CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh--h---H
Confidence 789999999999765432 223456778999999999899999999999999999999999875321 1 1
Q ss_pred HHHhhCCCCHHHHh--------hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 632 IIGMLGPIDLEMLM--------QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 632 I~~~lg~~p~e~~~--------~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+....++....... ........-.....+..++..||. ..|..|.|+++++..|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE----FQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC----SSGGGSCCHHHHHHHHH
T ss_pred HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcC----CCCCCCCCHHHHHHHHH
Confidence 11222222211100 011111111223456666666665 45888999999885543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=290.87 Aligned_cols=251 Identities=15% Similarity=0.151 Sum_probs=194.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+..++|++.+.||+|+||.||+|.+. ++.||||+++... .....+.+|+.+++. .+||||+++++++..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~------l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRI------FSHPNVLPVLGACQS 78 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCC------CSCTTEECEEEEECT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHh------cCCCchhheEEEEcc
Confidence 34578999999999999999999974 8899999998543 223344555555444 459999999999987
Q ss_pred c--CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccCcceE
Q 005415 488 L--EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 488 ~--~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~~~~v 562 (697)
. ...++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~ 152 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTA 152 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT--TSCE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC--Ccce
Confidence 7 78899999997 588888764322 23899999999999999999999999 999999999999995 6778
Q ss_pred EEeeCCCccccccccccccccCCCCCchhhcCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 563 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQ---KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 563 KL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~---ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+|+|||++..... ....+|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 153 ~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 153 RISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp EEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred eEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 8887777644322 2346799999999998765444 7999999999999999999999988887777665433222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
+.. -.....+..++..||. ..|..|.|+++++..|...
T Consensus 231 ~~~-----------~~~~~~~~~li~~~l~----~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 TIP-----------PGISPHVSKLMKICMN----EDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCC-----------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----------CCCCHHHHHHHHHHcC----CChhhCcCHHHHHHHHHHh
Confidence 110 0123456666666665 4588999999999777643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.20 Aligned_cols=253 Identities=19% Similarity=0.246 Sum_probs=191.5
Q ss_pred cCceEEEEEeccCCCCceEEEEECC---CCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~---~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|++.+.||+|+||.||+|.+.. +++.||||+++.. ......+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~ 106 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS------HPNVIRLLGVCI 106 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC------CCCeeeeeEEEe
Confidence 4789999999999999999998755 5568999998753 233456778888888774 899999999998
Q ss_pred ecC-----eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcc
Q 005415 487 HLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 560 (697)
Q Consensus 487 ~~~-----~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 560 (697)
... ..++||||+.+ +|.+++...........+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~ 184 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--DM 184 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT--TS
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CC
Confidence 754 45999999984 78777765443334455999999999999999999999999999999999999985 78
Q ss_pred eEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHH
Q 005415 561 EIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 634 (697)
Q Consensus 561 ~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~ 634 (697)
.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 8999999998765332 223456788999999999999999999999999999999 9999998877776666654
Q ss_pred hhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 635 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 635 ~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
....... -.....+..++..||.. .|..|++++++...|
T Consensus 265 ~~~~~~~------------~~~~~~l~~li~~~l~~----dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 265 GHRLKQP------------EDCLDELYEIMYSCWRT----DPLDRPTFSVLRLQL 303 (313)
T ss_dssp TCCCCCB------------TTCCHHHHHHHHHTTCS----SGGGSCCHHHHHHHH
T ss_pred CCCCCCC------------ccccHHHHHHHHHHcCC----ChhhCcCHHHHHHHH
Confidence 3221111 11234566677777654 488899998888444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.50 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=180.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
++..++|++++.||+|+||.||+|.+..+++.||||+++... ....+...|+..+. ...+||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-----~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-----RSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHH-----SSCCCTTBCCEEEEEEC
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHH-----HcCCCCcEeeeeeEEEe
Confidence 445688999999999999999999999999999999997643 22233344443221 23469999999999999
Q ss_pred cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc-CccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+..++||||+.++|.+++...... ....+++..+..++.|++.||.|||+. ||+||||||+|||++. ++.+||+|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~--~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR--SGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSEEHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET--TTEEEECC
T ss_pred CCceEEEEeecCCChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC--CCCEEEcc
Confidence 9999999999999988887653321 122388999999999999999999998 9999999999999985 78999999
Q ss_pred CCCccccccc--cccccccCCCCCchhh----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDN--LCLYVQSRSYRAPEVI----IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~--~~~~~gt~~Y~APE~l----~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I~~~lg~~ 639 (697)
||++...... .....|++.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... +.+..+.. +.+
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~ 247 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP 247 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCC
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCC
Confidence 9999765433 2234789999999998 4566899999999999999999999999875432 22222111 111
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
+. .. ..........+..++..||. ..|..|.++++++ +|+...+++
T Consensus 248 ~~-~~-----~~~~~~~~~~l~~li~~~l~----~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 248 PQ-LS-----NSEEREFSPSFINFVNLCLT----KDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp CC-CC-----CCSSCCCCHHHHHHHHHHTC----SSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred CC-CC-----CcccccCCHHHHHHHHHHhh----CChhhCcCHHHHHhChHHHHhHhh
Confidence 10 00 00001123456666666665 4588999999999 999866543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=294.65 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=195.0
Q ss_pred eecCceEEEEEeccCCCCceEEEEECC---CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~---~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.++ ||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~ 82 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD------HPHIVKLIGII 82 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC------CTTBCCEEEEE
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC------CCCcceEEEEE
Confidence 445789999999999999999998643 3456999999864 334567888999999984 78999999998
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.. ...++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 154 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS--PECVKL 154 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE--TTEEEE
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC--CCcEEe
Confidence 65 45689999998 577777764432 2889999999999999999999999999999999999985 789999
Q ss_pred eeCCCcccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 565 IDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 565 ~DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+......+
T Consensus 155 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234 (281)
T ss_dssp CCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred CccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC
Confidence 9999987654322 22455778999999998899999999999999999998 999998776666665554432221
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.. -.....+..++..||. ..|..|++++++...|.
T Consensus 235 ~~------------~~~~~~l~~li~~~l~----~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 235 KP------------DLCPPVLYTLMTRCWD----YDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CC------------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred CC------------CCCCHHHHHHHHHHcc----CCchhCcCHHHHHHHHH
Confidence 11 0123456666666665 45888999988885443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=297.49 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=194.7
Q ss_pred cCceEEEE-EeccCCCCceEEEEE--CCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTE-YLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e-~LG~G~fG~Vy~a~d--~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.++|++.+ .||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.++ ||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~- 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGIC- 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC------CTTBCCEEEEE-
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEE-
Confidence 46899998 999999999999954 5678999999997542 33567788888888774 88999999999
Q ss_pred ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 487 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 487 ~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
.....++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~--~~~~kl~ 159 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKIS 159 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC--CCcEEEc
Confidence 5677899999997 57777776432 2889999999999999999999999999999999999985 7899999
Q ss_pred eCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 566 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 566 DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+.....+
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999987654322 12345678999999998889999999999999999999 99999998887776665442211
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
..+ -.....+..++..||... |..|++++++...|.
T Consensus 240 ~~~------------~~~~~~l~~li~~~l~~d----p~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 240 GCP------------AGCPREMYDLMNLCWTYD----VENRPGFAAVELRLR 275 (291)
T ss_dssp CCC------------TTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHHHH
T ss_pred CCC------------CCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHHH
Confidence 100 122345667777777644 888899988875443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.29 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=198.7
Q ss_pred eecCceEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d-----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
+..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.+. +||||+++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~ 98 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLG 98 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc-----cCCCeeeEEE
Confidence 3457899999999999999999985 4567899999998643 33457788999999985 3789999999
Q ss_pred EEEecC-eEEEEEEccc-cchHHHHHhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcc
Q 005415 484 YFYHLE-HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 551 (697)
Q Consensus 484 ~f~~~~-~l~LVmEyl~-gsL~~~l~~~~~~~----------~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~N 551 (697)
++...+ ..++||||+. ++|.+++....... ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988754 5899999997 57888776543210 01227889999999999999999999999999999999
Q ss_pred ccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcH
Q 005415 552 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 625 (697)
Q Consensus 552 ILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~ 625 (697)
||++. ++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 179 il~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 179 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EEECG--GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEECC--CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99985 789999999998765332 123456788999999999999999999999999999998 9999987664
Q ss_pred HHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 626 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 626 ~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+.+...+.....++. .-.....+..++..||.. .|..|+++++++..|.
T Consensus 257 ~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~----dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRA-----------PDYTTPEMYQTMLDCWHG----EPSQRPTFSELVEHLG 306 (316)
T ss_dssp SHHHHHHHHHTCCCCC-----------CTTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred hHHHHHHhccCccCCC-----------CCCCCHHHHHHHHHHcCC----ChhhCcCHHHHHHHHH
Confidence 4433333322211110 011234566777777654 4888999999885443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.30 Aligned_cols=248 Identities=20% Similarity=0.246 Sum_probs=189.5
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEE----EEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDV----CLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~V----AVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..++|++++.||+|+||.||+|.+..+++.| |+|.+... ......+.+|+.+++.++ ||||+++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~ 86 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGIC 86 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC------BTTBCCCCEEE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC------CCCeeEEEEEE
Confidence 3578999999999999999999998888765 66666432 234567788888887764 88999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.... .++|+|++. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~--~~~~kL 158 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKI 158 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEE
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC--CCCEEE
Confidence 8765 777888876 577777765432 2889999999999999999999999999999999999985 789999
Q ss_pred eeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 565 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 565 ~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999997654321 22345778999999999999999999999999999999 99999988777666555433222
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.. -.....+..++..||.. .|..|.++++++..|
T Consensus 239 ~~~------------~~~~~~l~~li~~~l~~----dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 239 PQP------------PICTIDVYMIMRKCWMI----DADSRPKFRELIIEF 273 (327)
T ss_dssp CCC------------TTBCHHHHHHHHHHTCS----SGGGSCCHHHHHHHH
T ss_pred CCC------------ccCCHHHHHHHHHHcCC----ChhHCcCHHHHHHHH
Confidence 111 11234566777777754 478888888887443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=296.10 Aligned_cols=252 Identities=25% Similarity=0.287 Sum_probs=192.8
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC-CC--cEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~-~g--~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
..++|++++.||+|+||.||+|.+.. ++ ..||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 89 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGV 89 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC------CCCcccEEEE
Confidence 35789999999999999999998643 33 36899998753 234567788999998874 8899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+.... .++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+|
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~--~~~~k 161 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVK 161 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEE
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC--CCCEE
Confidence 98755 889999997 578887765432 2889999999999999999999999999999999999985 78999
Q ss_pred EeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhh
Q 005415 564 IIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 564 L~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~l 636 (697)
|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+.+..+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 99999987654322 22356778999999998889999999999999999999 999999998888777775433
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
..++. .-.....+..++..||. ..|..|++++++..+|...
T Consensus 242 ~~~~~-----------~~~~~~~l~~li~~~l~----~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 242 ERLPR-----------PEDCPQDIYNVMVQCWA----HKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp CCCCC-----------CTTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC-----------CcCcCHHHHHHHHHHcc----CCcccCcCHHHHHHHHHHh
Confidence 22221 01223456666666665 4588999999999877644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=299.39 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=183.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
.++|++.+.||+|+||.||+|.+ .++.||||++.... ....+.+|+.+++.++ ||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~------hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-ERKAFIVELRQLSRVN------HPNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-HHHHHHHHHHHHHHCC------CTTBCCEEEBCT--TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-HHHHHHHHHHHHhcCC------CCCcCeEEEEEc--CCcE
Confidence 46899999999999999999986 47899999997543 3467888999998874 889999999886 4579
Q ss_pred EEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh---cCccccCCCCccccccccCcc-eEEEeeC
Q 005415 493 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---LGIIHCDLKPENILIKSYQRC-EIKIIDL 567 (697)
Q Consensus 493 LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs---~gIvHrDLKP~NILl~~~~~~-~vKL~DF 567 (697)
+||||+. ++|.+++..... ...++...+..++.||+.||.|||+ +||+||||||+|||++. ++ .+||+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Df 150 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDF 150 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCC
T ss_pred EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEccc
Confidence 9999997 578777764321 1237888999999999999999999 89999999999999985 44 4899999
Q ss_pred CCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHhhCCCCHHHHh
Q 005415 568 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 568 Gla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~--~~e~l~~I~~~lg~~p~e~~~ 645 (697)
|++...........|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.....++.
T Consensus 151 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 225 (307)
T 2eva_A 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----- 225 (307)
T ss_dssp CC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC-----
T ss_pred ccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc-----
Confidence 999876665556678999999999999999999999999999999999999997543 2233322222111110
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.-.....+..++..||. ..|..|.+++++...|.
T Consensus 226 -------~~~~~~~l~~li~~~l~----~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 226 -------IKNLPKPIESLMTRCWS----KDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp -------BTTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred -------ccccCHHHHHHHHHHhc----CChhhCcCHHHHHHHHH
Confidence 01123456667776665 45888999988874443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.58 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=190.9
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
|.....||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++......++|
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK------HKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC------CTTBCCEEEEEEETTEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC------CCCEeeEeeEEEeCCcEEEE
Confidence 333448999999999999999999999999997543 34466778888888774 88999999999999999999
Q ss_pred EEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||+. ++|.+++.... ....+++..+..++.||+.||.|||++||+|+||||+||+++. .++.+||+|||++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRL 173 (295)
T ss_dssp EECCSEEEHHHHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTCCEEECCTTTCEES
T ss_pred EEeCCCCCHHHHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-CCCCEEEeeccccccc
Confidence 99996 57777765432 1223678899999999999999999999999999999999984 3678999999998765
Q ss_pred ccc---cccccccCCCCCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHhhCCCCHHHHhhc
Q 005415 574 TDN---LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 574 ~~~---~~~~~gt~~Y~APE~l~~~~--~s~ksDIWSLGviL~ELltG~~PF~~~~~~e-~l~~I~~~lg~~p~e~~~~~ 647 (697)
... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ..... ......+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~------- 245 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHP------- 245 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCCC-------
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-ccccccc-------
Confidence 432 23457899999999997653 8899999999999999999999997543222 22221 1111110
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQN 695 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n 695 (697)
... -.....+..++..||. ..|..|.++++++ +|+....+.
T Consensus 246 -~~~--~~~~~~~~~li~~~l~----~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 246 -EIP--ESMSAEAKAFILKCFE----PDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp -CCC--TTSCHHHHHHHHHTTC----SSTTTSCCHHHHHTSGGGCC----
T ss_pred -ccc--ccCCHHHHHHHHHHcc----CChhhCCCHHHHhcChhhhhcccc
Confidence 000 0123455566666664 4588999999999 999866544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.58 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=190.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~---- 487 (697)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.++ ||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN------HPNILRLVAYCLRERGA 101 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEEEETT
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC------CCCeeeEEEEEEeccCC
Confidence 4789999999999999999999999999999998864 3344567788988888773 8999999999973
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|.+++...... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~--~~~~kl~d 177 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD--EGQPVLMD 177 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSCEEECC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCCEEEEe
Confidence 3578999999985 787777654322 223899999999999999999999999999999999999985 78899999
Q ss_pred CCCccccccc------------cccccccCCCCCchhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHH
Q 005415 567 LGSSCFQTDN------------LCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILA 630 (697)
Q Consensus 567 FGla~~~~~~------------~~~~~gt~~Y~APE~l~~~~---~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~ 630 (697)
||++...... .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..+.
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 9988654321 12245689999999997654 688999999999999999999999532110 0111
Q ss_pred HHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 631 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 631 ~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
..+.....++ ..-.....+..++..||. ..|..|+++++++..|..
T Consensus 258 ~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~----~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 258 LAVQNQLSIP-----------QSPRHSSALWQLLNSMMT----VDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp HHHHCC--CC-----------CCTTSCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHHH
T ss_pred HHhhccCCCC-----------ccccCCHHHHHHHHHHhh----cChhhCCCHHHHHHHhhh
Confidence 1111111111 001123456666666665 458889999999866653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=309.62 Aligned_cols=262 Identities=24% Similarity=0.254 Sum_probs=187.6
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+...+|+.+++.+. +||||+++++++....
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESD-----DHPNVIRYYCSETTDR 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECSS
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCC
Confidence 4456778889999999999998764 5679999999987543 356778999998763 4899999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCC-cccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-----------
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY----------- 557 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~-~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~----------- 557 (697)
.+++||||++++|.+++......... ...++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 99999999999999988754332111 011333467899999999999999999999999999999752
Q ss_pred CcceEEEeeCCCccccccc-------cccccccCCCCCchhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005415 558 QRCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPN 622 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~-------~~~~~gt~~Y~APE~l~~-------~~~s~ksDIWSLGviL~ELlt-G~~PF~~ 622 (697)
..+.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 2458999999999765432 123578999999999976 568999999999999999999 9999976
Q ss_pred CcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 623 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 623 ~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
....+ ..++......+.. ... ....+.....+...+.+...|..|+|+++++ +|+..
T Consensus 243 ~~~~~--~~i~~~~~~~~~~---------~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEM---------KCL-HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCC---------TTC-CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH--HHHhcCCCCcccc---------ccc-ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 54332 2232222111110 000 0112222233334444455688999999998 88853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=298.82 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=188.7
Q ss_pred CceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 409 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 409 ~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
.+.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+|+.+++.+... .+||||+++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~~h~~i~~~ 103 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG--GGHPGVIRL 103 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS--CCCSSBCCE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc--CCCCCeeeE
Confidence 45677899999999999999999999999999999999975432 223456789999888542 258999999
Q ss_pred EEEEEecCeEEEEEEc-cc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 482 YDYFYHLEHLFIVCEL-LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 482 ~~~f~~~~~l~LVmEy-l~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
++++...+..++|||+ +. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++. .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGP------LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-TT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-CC
Confidence 9999999999999998 44 678887765332 899999999999999999999999999999999999983 37
Q ss_pred ceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC
Q 005415 560 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s-~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg 637 (697)
+.+||+|||++...... .....+++.|+|||++.+..+. .++|||||||++|+|++|+.||..... +.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~ 250 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAEL 250 (312)
T ss_dssp TEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC
T ss_pred CeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc
Confidence 78999999998765443 3446789999999999877654 589999999999999999999975321 211111
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
..+. .....+..++..||. ..+..|.++++++ +|+.....
T Consensus 251 ~~~~-------------~~~~~~~~li~~~l~----~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 251 HFPA-------------HVSPDCCALIRRCLA----PKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CCCT-------------TSCHHHHHHHHHHTC----SSTTTSCCHHHHHHSTTTCC---
T ss_pred CCcc-------------cCCHHHHHHHHHHcc----CChhhCcCHHHHhcChhhcCchh
Confidence 1110 122345556666554 4588999999999 89886543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.80 Aligned_cols=247 Identities=19% Similarity=0.230 Sum_probs=192.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-e
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-H 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-~ 487 (697)
.+|++.+.||+|+||.||+|.+..+ ...||+|.+... ......+.+|+.+++.++ ||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC------CCCEeeeeeEEEcC
Confidence 5799999999999999999997543 346899998753 234466788888888774 889999999865 4
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~--~~~~kl~D 171 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE--KFTVKVAD 171 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECS
T ss_pred CCceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC--CCCEEECc
Confidence 5678999999986 78777754322 2789999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc-------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999764332 222456778999999999999999999999999999999 78888887776666666544332
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+. .....+..++..||.. .|..|.++++++..|
T Consensus 252 ~~~~------------~~~~~l~~li~~~l~~----~p~~Rps~~ell~~L 286 (298)
T 3f66_A 252 LQPE------------YCPDPLYEVMLKCWHP----KAEMRPSFSELVSRI 286 (298)
T ss_dssp CCCT------------TCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHH
T ss_pred CCCc------------cCCHHHHHHHHHHcCC----ChhhCcCHHHHHHHH
Confidence 2211 1234566677777654 488889998888443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=306.44 Aligned_cols=264 Identities=20% Similarity=0.245 Sum_probs=184.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 487 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~---- 487 (697)
..++|++++.||+|+||.||+|.+ +++.||||++..... .....|..++. .....||||+++++.+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~----~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYR----VPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHH----HHhccCcchhhheecccccccC
Confidence 357899999999999999999975 689999999975433 33334433332 223569999999986653
Q ss_pred -cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc---------CccccCCCCccccccc
Q 005415 488 -LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---------GIIHCDLKPENILIKS 556 (697)
Q Consensus 488 -~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~---------gIvHrDLKP~NILl~~ 556 (697)
....++||||+. ++|.+++.... .++..+..++.||+.||.|||+. ||+||||||+|||++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 236799999996 57888775332 57888999999999999999999 9999999999999985
Q ss_pred cCcceEEEeeCCCccccccc-----------cccccccCCCCCchhhcC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 005415 557 YQRCEIKIIDLGSSCFQTDN-----------LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWTGEV 618 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~-----------~~~~~gt~~Y~APE~l~~-------~~~s~ksDIWSLGviL~ELltG~~ 618 (697)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 156 --~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 156 --DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp --TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred --CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 789999999999764321 123468999999999987 346678999999999999999966
Q ss_pred CC-CCCcHHHHHHHHHHhhC-CCCHHHHhh----c---ccccccccCC----chhhhhHHHHHHHHHHHhhhhccCHHHH
Q 005415 619 LF-PNDAVVMILARIIGMLG-PIDLEMLMQ----G---QEIYKYFTKE----YDLYYINEVCFANIFISLVVIRLTLEYA 685 (697)
Q Consensus 619 PF-~~~~~~e~l~~I~~~lg-~~p~e~~~~----~---~~~~~~~~~~----~~l~~i~~~cw~~l~~~~~~~r~t~e~~ 685 (697)
|| .+....+....+....+ .+..+.+.. . ......+... ..+..++..||.. .|..|.|++++
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~----dP~~Rps~~e~ 309 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ----DAEARLTAQXA 309 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS----SGGGSCCHHHH
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC----ChhhCcchHHH
Confidence 65 33322111111111111 222221111 0 1111111111 1466666666654 47888888887
Q ss_pred H----HhhcccCCCC
Q 005415 686 A----LWLFGIDQNK 696 (697)
Q Consensus 686 ~----~wl~~~~~n~ 696 (697)
+ .++..+++|+
T Consensus 310 l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 310 EERMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHHHCCCC--
T ss_pred HHHHHHHHHHHHhcc
Confidence 7 6777888875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.88 Aligned_cols=247 Identities=19% Similarity=0.211 Sum_probs=191.2
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+|++.++||+|+||.||+|.+..++. .||+|++.... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN------HPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC------CTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC------CCCeeeEEEEEecCC
Confidence 57888999999999999999755544 79999987532 34467778888888774 899999999998765
Q ss_pred eE-EEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 490 HL-FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 490 ~l-~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
.. ++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~--~~~~kl~Df 168 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE--SFTVKVADF 168 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECCT
T ss_pred CCcEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCcEEeCcC
Confidence 54 99999996 67777775422 22789999999999999999999999999999999999985 789999999
Q ss_pred CCccccccc-------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 568 GSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 568 Gla~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
|++...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP 248 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence 999754322 223456788999999999999999999999999999999 566666666666555554433222
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.. -.....+..++..||. ..|..|.|+++++..|.
T Consensus 249 ~~------------~~~~~~l~~li~~~l~----~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 249 QP------------EYCPDSLYQVMQQCWE----ADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CC------------TTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred CC------------ccchHHHHHHHHHHcc----CChhhCcCHHHHHHHHH
Confidence 11 1123356666666665 45888999988884443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=301.98 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=193.7
Q ss_pred CCCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005415 400 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 479 (697)
Q Consensus 400 ~~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv 479 (697)
.....|......+.++|++++.||+|+||.||+|.+. ++.||||++..... .....|..++..+ ...||||+
T Consensus 23 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~----~~~h~~i~ 94 (337)
T 3mdy_A 23 SGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTV----LMRHENIL 94 (337)
T ss_dssp SCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTST----TCCCTTBC
T ss_pred CCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHH----hhcCCCee
Confidence 3445566677788899999999999999999999874 89999999975543 3344455554443 24699999
Q ss_pred EEEEEEEec----CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc--------CccccC
Q 005415 480 RLYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCD 546 (697)
Q Consensus 480 ~l~~~f~~~----~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~--------gIvHrD 546 (697)
++++++... ...++||||+.+ +|.+++... .+++..+..++.|++.||.|||++ ||+|||
T Consensus 95 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 167 (337)
T 3mdy_A 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167 (337)
T ss_dssp CEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSC
T ss_pred eEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecc
Confidence 999999987 789999999975 888877532 288999999999999999999998 999999
Q ss_pred CCCccccccccCcceEEEeeCCCcccccccc-------ccccccCCCCCchhhcCCCCCch------hhHHHHHHHHHHH
Q 005415 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLPYDQK------IDLWSLGCILAEL 613 (697)
Q Consensus 547 LKP~NILl~~~~~~~vKL~DFGla~~~~~~~-------~~~~gt~~Y~APE~l~~~~~s~k------sDIWSLGviL~EL 613 (697)
|||+|||++. ++.+||+|||++....... ....||+.|+|||++.+..+..+ +|||||||++|||
T Consensus 168 ikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 168 LKSKNILVKK--NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp CCGGGEEECT--TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred cchHHEEECC--CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 9999999985 7899999999996543321 23578999999999988766654 9999999999999
Q ss_pred HhC----------CCCCCCCc----HHHHHHHHHHhhC---CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhh
Q 005415 614 WTG----------EVLFPNDA----VVMILARIIGMLG---PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLV 676 (697)
Q Consensus 614 ltG----------~~PF~~~~----~~e~l~~I~~~lg---~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~ 676 (697)
++| +.||.... ....+..++.... .++..+.. -.....+..++..||. ..|
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~----~dP 313 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSS--------DECLRQMGKLMTECWA----HNP 313 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGG--------SHHHHHHHHHHHHHSC----SSG
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchh--------hHHHHHHHHHHHHhhh----hCh
Confidence 999 77775431 2222333222111 11110000 0112345666677765 448
Q ss_pred hhccCHHHHHHhhc
Q 005415 677 VIRLTLEYAALWLF 690 (697)
Q Consensus 677 ~~r~t~e~~~~wl~ 690 (697)
..|+|++++...|.
T Consensus 314 ~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 314 ASRLTALRVKKTLA 327 (337)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCCCHHHHHHHHH
Confidence 88999999885544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=308.28 Aligned_cols=201 Identities=23% Similarity=0.310 Sum_probs=167.9
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
....++|++.+.||+|+||.||+|.+ .+++.||||++..... ....+.+|+.+++.+ .||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA------VHRNLLRLRGFCMT 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC------CCTTBCCCCEEECC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc------cCCCccceEEEEec
Confidence 34567899999999999999999984 5789999999975432 223566777776655 48999999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhc---CccccCCCCccccccccCcceEE
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~---gIvHrDLKP~NILl~~~~~~~vK 563 (697)
....++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||++ ||+||||||+|||++. ++.+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~--~~~~k 174 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE--EFEAV 174 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT--TCCEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC--CCCEE
Confidence 9999999999975 77777764332 223489999999999999999999999 9999999999999985 78999
Q ss_pred EeeCCCccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 564 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 564 L~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999765422 223458999999999998889999999999999999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.56 Aligned_cols=202 Identities=22% Similarity=0.286 Sum_probs=169.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC------RHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC------CCTTBCCEEEECCCTTC
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC------CCCCEeeEEEEEcCCCe
Confidence 457899999999999999999995 478999999987543 3345677787777655 48999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+. ++|.+++..... ....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE--NFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT--TCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 999999997 477666543221 1234889999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 624 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~ 624 (697)
+...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 8754321 223458999999999999899999999999999999999999997654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.38 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=195.3
Q ss_pred Ccee-cCceEEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 409 NTVI-AGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 409 ~~~i-~~rY~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.+++ .++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+|+.+++.++ ||||++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~ 90 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH------SDFIVKYR 90 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC------CTTBCCEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC------CCceeEEE
Confidence 3444 4789999999999999999998 56789999999997543 34456788999998874 78999999
Q ss_pred EEEE--ecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 483 DYFY--HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 483 ~~f~--~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+++. .....++||||++ ++|.+++...... +++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~--~ 163 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES--E 163 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--T
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC--C
Confidence 9987 4467999999995 6788877654332 899999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 164 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-- 241 (327)
T 3lxl_A 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-- 241 (327)
T ss_dssp TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--
T ss_pred CCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--
Confidence 899999999997654322 224567789999999998899999999999999999999999975443211110
Q ss_pred HhhCCCCH--HHH---hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 634 GMLGPIDL--EML---MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 634 ~~lg~~p~--e~~---~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
......+. ... .........-.....+..++..||. ..|..|.++++++..|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~----~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWA----PSPQDRPSFSALGPQLD 299 (327)
T ss_dssp C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC----SSGGGSCCHHHHHHHHH
T ss_pred ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcC----CChhhCcCHHHHHHHHH
Confidence 00000110 000 0111111111223456666666664 45888999998874443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.46 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=186.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|.+.+.||+|+||+||.. ...+++.||||++.... .....+|+.+++.+. +||||+++++++......++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~-----~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC--FSFADREVQLLRESD-----EHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT--EEECHHHHHHHHHSC-----CCTTBCCEEEEEEETTEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCcCeEEEEEecCCEEEE
Confidence 46999999999999997643 35689999999997543 234568999998874 48999999999999999999
Q ss_pred EEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc---cCcceEEEeeCCCc
Q 005415 494 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSS 570 (697)
Q Consensus 494 VmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~---~~~~~vKL~DFGla 570 (697)
||||++++|.+++...... +....+..++.||+.||.|||++||+||||||+|||++. +....+||+|||++
T Consensus 96 v~E~~~g~L~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCAATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCSEEHHHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCCCCHHHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999999888754322 344456789999999999999999999999999999953 23456889999999
Q ss_pred cccccc------cccccccCCCCCchhhc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 571 CFQTDN------LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 571 ~~~~~~------~~~~~gt~~Y~APE~l~---~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
...... .....||+.|+|||++. +..++.++|||||||++|+|++ |..||......... .+ .+...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~ 246 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACS 246 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCC
Confidence 765422 23457899999999997 4567889999999999999999 99999655433322 11 11111
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.. .............+...+.+...|..|+|+++++ +|+...
T Consensus 247 ~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 LD----------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp CT----------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cc----------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 11 1111112222233444445556689999999999 888654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.56 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=199.4
Q ss_pred CCCcceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 401 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 401 ~~~~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
....|+..+..+.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|.++++.+. ..||||++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~----l~h~ni~~ 100 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM----LRHENILG 100 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC----CCCTTBCC
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh----cCCCcEEE
Confidence 44677778888899999999999999999999987 58999999997543 356678888887753 35899999
Q ss_pred EEEEEEecC----eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------hcCccccCC
Q 005415 481 LYDYFYHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH--------SLGIIHCDL 547 (697)
Q Consensus 481 l~~~f~~~~----~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH--------s~gIvHrDL 547 (697)
+++++.... ..++||||+.+ +|.+++... .+++..+..++.||+.||.||| +.+|+||||
T Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred EEeeecccCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 999998875 89999999985 888877532 2889999999999999999999 899999999
Q ss_pred CCccccccccCcceEEEeeCCCcccccccc-------ccccccCCCCCchhhcCCC------CCchhhHHHHHHHHHHHH
Q 005415 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELW 614 (697)
Q Consensus 548 KP~NILl~~~~~~~vKL~DFGla~~~~~~~-------~~~~gt~~Y~APE~l~~~~------~s~ksDIWSLGviL~ELl 614 (697)
||+|||++. ++.+||+|||++....... ....+++.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 174 kp~NIll~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 174 KSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp SGGGEEECT--TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHEEECC--CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 999999985 7899999999987654322 3357899999999998763 336899999999999999
Q ss_pred hC----------CCCCCCCc-----HHHHHHHHHHhhCCCC-HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhh
Q 005415 615 TG----------EVLFPNDA-----VVMILARIIGMLGPID-LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVI 678 (697)
Q Consensus 615 tG----------~~PF~~~~-----~~e~l~~I~~~lg~~p-~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~ 678 (697)
+| ..||.... .......+......+. ...+.. ......+..++..||. ..|..
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~----~dp~~ 320 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS-------CEALRVMAKIMRECWY----ANGAA 320 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGT-------SHHHHHHHHHHHHHCC----SSGGG
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccc-------hhHHHHHHHHHHHHhc----cChhh
Confidence 99 88996542 2233322222111111 100000 0111245566666665 45899
Q ss_pred ccCHHHHHHhhc
Q 005415 679 RLTLEYAALWLF 690 (697)
Q Consensus 679 r~t~e~~~~wl~ 690 (697)
|+|++++...|.
T Consensus 321 Rps~~~i~~~L~ 332 (342)
T 1b6c_B 321 RLTALRIKKTLS 332 (342)
T ss_dssp SCCHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 999999985555
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=323.65 Aligned_cols=247 Identities=20% Similarity=0.226 Sum_probs=195.0
Q ss_pred cCceEEEE-EeccCCCCceEEEEEC--CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTE-YLGSAAFSKVFQAQDL--HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e-~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
..++.+.+ .||+|+||.||+|.+. .++..||||+++.. ......+.+|+++++.++ ||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~~~~~~ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC------CTTBCCEEEEEES
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCEeeEEEEecc
Confidence 35566666 8999999999999875 35678999999863 234567888999888764 8999999999976
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
+.+++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~vkL~D 479 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN--RHYAKISD 479 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC--CCcEEEee
Confidence 569999999975 6766664322 23899999999999999999999999999999999999985 78999999
Q ss_pred CCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..|......+
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 559 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99997654321 11234678999999999999999999999999999998 999999988877777765432211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
. .-.....+..++..||... |..|.+++++...|
T Consensus 560 ~------------p~~~~~~l~~li~~cl~~d----P~~RPs~~~l~~~L 593 (613)
T 2ozo_A 560 C------------PPECPPELYALMSDCWIYK----WEDRPDFLTVEQRM 593 (613)
T ss_dssp C------------CTTCCHHHHHHHHHTTCSS----TTTSCCHHHHHHHH
T ss_pred C------------CCcCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence 1 1134567889999999765 77888888876433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.49 Aligned_cols=258 Identities=23% Similarity=0.288 Sum_probs=194.2
Q ss_pred eecCceEEEEEeccCCCCceEEEE----ECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~----d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+..++|++++.||+|+||.||+|. +..+++.||||++... ......+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~ 111 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ------HDNIVKYKGVC 111 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCeeeEEEEE
Confidence 345789999999999999999998 4668999999999754 334567788999988774 78999999998
Q ss_pred EecC--eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 486 YHLE--HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 486 ~~~~--~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
.... ..++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~--~~~~ 184 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--ENRV 184 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEE
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC--CCcE
Confidence 7653 7899999997 488888765432 2889999999999999999999999999999999999985 7899
Q ss_pred EEeeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh
Q 005415 563 KIIDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 636 (697)
Q Consensus 563 KL~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l 636 (697)
||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||...... .. +..
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~---~~~ 259 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMI 259 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HH---HHH
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HH---Hhh
Confidence 999999997654332 2234567799999999888999999999999999999999998643211 11 111
Q ss_pred CCCCH---------HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 637 GPIDL---------EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 637 g~~p~---------e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+.... +.+.........-.....+..++..||.. .|..|++++++...|.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~----dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN----NVNQRPSFRDLALRVD 318 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCS----SGGGSCCHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCC----ChhhCcCHHHHHHHHH
Confidence 11110 01111111111112345677777777764 4888999998885554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.66 Aligned_cols=247 Identities=19% Similarity=0.217 Sum_probs=184.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
.+|++.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+|+.+++.+ .||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC------CCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcC
Confidence 3589999999999999999987543 346899998743 23345566677666655 48999999998754
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC--CCCEEEee
Confidence 4678999999975 78887754322 2788999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc-------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 567 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 567 FGla~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
||+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 315 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999754322 122355778999999999999999999999999999999 88999887666655555443221
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+ -.....+..++..||... |..|.+++++...|
T Consensus 316 ~~p------------~~~~~~l~~li~~cl~~d----p~~RPs~~ell~~L 350 (373)
T 3c1x_A 316 LQP------------EYCPDPLYEVMLKCWHPK----AEMRPSFSELVSRI 350 (373)
T ss_dssp CCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred CCC------------CCCCHHHHHHHHHHcCCC----hhhCcCHHHHHHHH
Confidence 111 123456778888888754 77888888877333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.61 Aligned_cols=257 Identities=24% Similarity=0.278 Sum_probs=192.7
Q ss_pred ceecCce-EEEEEeccCCCCceEEEEE----CCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRY-YVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY-~i~e~LG~G~fG~Vy~a~d----~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.++.++| ++++.||+|+||+||++.. ..+++.||||+++... .....+.+|+.+++.++ ||||++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~ 99 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY------HEHIIKYK 99 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC------CTTBCCEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC------CcchhhEE
Confidence 3456676 9999999999999988753 4578999999998643 34567889999999885 78999999
Q ss_pred EEEEec--CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCc
Q 005415 483 DYFYHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 483 ~~f~~~--~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~ 559 (697)
+++... ..+++||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~--~ 170 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN--D 170 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--T
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC--C
Confidence 999974 679999999975 777766432 1889999999999999999999999999999999999985 7
Q ss_pred ceEEEeeCCCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 560 CEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~- 247 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--L- 247 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--H-
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--h-
Confidence 88999999999765432 22345678899999999988999999999999999999999999754322100 0
Q ss_pred HhhCCCCH--------HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 634 GMLGPIDL--------EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 634 ~~lg~~p~--------e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+.... +...........-.....+..++..||.. .|..|+++++++.+|.
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~----dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 248 --IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET----EASFRPTFENLIPILK 306 (318)
T ss_dssp --HCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS----SGGGSCCHHHHHHHHH
T ss_pred --hcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCC----CcccCcCHHHHHHHHH
Confidence 000000 01111111111112334666777777764 5888999999886654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=321.16 Aligned_cols=244 Identities=21% Similarity=0.250 Sum_probs=193.9
Q ss_pred ceEEE-EEeccCCCCceEEEEE--CCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 415 RYYVT-EYLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 415 rY~i~-e~LG~G~fG~Vy~a~d--~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
.+.+. +.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.++ ||||+++++++..
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICEA- 441 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC------CTTBCCEEEEEES-
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEec-
Confidence 34443 4899999999999954 4567899999998542 33567889999999985 7899999999864
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+..++||||+. ++|.+++.... .+++..+..|+.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~--~~~~kL~DF 513 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDF 513 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEECCT
T ss_pred CCEEEEEEccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC--CCCEEEEEc
Confidence 56899999997 56777775332 2889999999999999999999999999999999999995 789999999
Q ss_pred CCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 568 GSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 568 Gla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+........
T Consensus 514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 593 (635)
T ss_dssp THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9987654321 22345678999999999999999999999999999998 9999999988887777755432211
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+ -.....+..++..||... |..|.+++++...|
T Consensus 594 p------------~~~~~~l~~li~~cl~~d----P~~RPs~~~l~~~L 626 (635)
T 4fl3_A 594 P------------AGCPREMYDLMNLCWTYD----VENRPGFAAVELRL 626 (635)
T ss_dssp C------------TTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHHH
T ss_pred C------------CCCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence 1 123457888888888654 88899998887444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.12 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=194.8
Q ss_pred eCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 408 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 408 ~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
..++..++|++.+.||+|+||.||+|.+.. .||+|+++... .....+.+|+.+++.+ .||||++++++
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~ 97 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT------RHENVVLFMGA 97 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC------CCTTBCCCCEE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC------CCCCEeEEEEE
Confidence 344556889999999999999999998753 49999987432 2234455677766655 48999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+......++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~---~~~~~ 169 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD---NGKVV 169 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCE
T ss_pred EecCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---CCCEE
Confidence 999999999999997 56776664322 2388899999999999999999999999999999999998 57899
Q ss_pred EeeCCCccccc--------cccccccccCCCCCchhhcC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH
Q 005415 564 IIDLGSSCFQT--------DNLCLYVQSRSYRAPEVIIG---------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 626 (697)
Q Consensus 564 L~DFGla~~~~--------~~~~~~~gt~~Y~APE~l~~---------~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~ 626 (697)
|+|||++.... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999876532 12223467899999999974 35789999999999999999999999998888
Q ss_pred HHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
.....+.....+... .......+..++..||.. .|..|.|+++++..|...
T Consensus 250 ~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~----~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 250 AIIWQMGTGMKPNLS-----------QIGMGKEISDILLFCWAF----EQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp HHHHHHHTTCCCCCC-----------CSSCCTTHHHHHHHHHCS----STTTSCCHHHHHHHHTTC
T ss_pred HHHHHhccCCCCCCC-----------cCCCCHHHHHHHHHHhcC----ChhhCcCHHHHHHHHHHH
Confidence 777766443222111 012345677788888764 488899999999666543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=290.74 Aligned_cols=257 Identities=19% Similarity=0.244 Sum_probs=191.3
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
|...+.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ------HENLVELLGFSSDGDD 104 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSS
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC------CCCeEEEEEEEecCCc
Confidence 33457899999999999985 6889999998743 234567888999999884 7899999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+. ++|.+++...... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~Dfg~ 179 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE--AFTAKISDFGL 179 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred eEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC--CCcEEEeeccc
Confidence 999999996 6777777643321 23889999999999999999999999999999999999985 78999999999
Q ss_pred ccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC--CHH
Q 005415 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI--DLE 642 (697)
Q Consensus 570 a~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~--p~e 642 (697)
+...... .....|++.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+.+..... ...
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE 258 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence 8764432 223568999999999876 47899999999999999999999998765544333333322111 111
Q ss_pred HHhhccccccc-ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 643 MLMQGQEIYKY-FTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 643 ~~~~~~~~~~~-~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
..... ..... -.....+..++..||. ..|..|++++++...|..
T Consensus 259 ~~~~~-~~~~~~~~~~~~l~~li~~cl~----~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 259 DYIDK-KMNDADSTSVEAMYSVASQCLH----EKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HHSCS-SCSCCCHHHHHHHHHHHHHHTC----SSTTTSCCHHHHHHHHHH
T ss_pred hhccc-cccccchHHHHHHHHHHHHHcC----CCcccCcCHHHHHHHHHH
Confidence 11000 00000 0011234556666655 458889999998866554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-32 Score=316.60 Aligned_cols=251 Identities=22% Similarity=0.248 Sum_probs=199.4
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
.+..++|++.+.||+|+||.||+|.+..+ +..||||+++.. ......+.+|+.+++.++ ||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEE
Confidence 34467899999999999999999998643 567999998753 334467788999998874 8999999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
+. .+..++||||+. ++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~--~~~vk 531 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 531 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC--CCCEE
Confidence 85 467899999998 577777764322 2889999999999999999999999999999999999995 78999
Q ss_pred EeeCCCcccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCC
Q 005415 564 IIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 564 L~DFGla~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~ 611 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 611 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999997654332 12345678999999999999999999999999999997 99999999888888777654322
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+.+ -.....+..++..||... |..|++++++...|.
T Consensus 612 ~~~------------~~~~~~l~~li~~~l~~d----P~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 612 PMP------------PNCPPTLYSLMTKCWAYD----PSRRPRFTELKAQLS 647 (656)
T ss_dssp CCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CCC------------ccccHHHHHHHHHHcCCC----hhHCcCHHHHHHHHH
Confidence 111 122356777777777644 888999988884443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=302.55 Aligned_cols=254 Identities=16% Similarity=0.147 Sum_probs=183.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCC----------C------
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDP----------A------ 473 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~----------~------ 473 (697)
..|++.+.||+|+||.||+|.+..+|+.||||+++.. ....+.+.+|+.+++.+++... .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999998832 2224667788888887764210 0
Q ss_pred CCCceeEEEEEEEe-----cCeEEEEEEccccchHHHHHhhhc-cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCC
Q 005415 474 DEHHILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQE-SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (697)
Q Consensus 474 ~hpnIv~l~~~f~~-----~~~l~LVmEyl~gsL~~~l~~~~~-~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDL 547 (697)
..++...+..++.. ....+++|+++.++|.+++..... ......+++..+..++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 00111111122222 235789999999999988854321 112334778889999999999999999999999999
Q ss_pred CCccccccccCcceEEEeeCCCccccccccccccccCCCCCchhh----------cCCCCCchhhHHHHHHHHHHHHhCC
Q 005415 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI----------IGLPYDQKIDLWSLGCILAELWTGE 617 (697)
Q Consensus 548 KP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~ksDIWSLGviL~ELltG~ 617 (697)
||+|||++. ++.+||+|||+++..........| +.|+|||++ .+..++.++|||||||++|+|++|+
T Consensus 238 Kp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQ--RGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECT--TCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEec--CCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999995 778999999999877766666778 999999999 5556888999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 618 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 618 ~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.||.+.+..+....+.. ..-.....+..++..||. ..|..|+++++++ +|+..
T Consensus 315 ~Pf~~~~~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~----~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 315 LPNTDDAALGGSEWIFR-----------------SCKNIPQPVRALLEGFLR----YPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp CCCCTTGGGSCSGGGGS-----------------SCCCCCHHHHHHHHHHTC----SSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCCcchhhhHHHHHh-----------------hcccCCHHHHHHHHHHcc----CChhhCcCHHHHHhCHHHHH
Confidence 99987654322221111 001122345555555554 4588899998888 77754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=282.90 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=178.8
Q ss_pred ceeeCceecCceEEE-EEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005415 405 PIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 483 (697)
Q Consensus 405 pv~~~~~i~~rY~i~-e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~ 483 (697)
++..+.++ ++|.++ +.||+|+||.||+|.+..+++.||||+++.. ....+|+.++..+. .||||+++++
T Consensus 9 ~~~~~~~~-~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~-----~h~~i~~~~~ 78 (299)
T 3m2w_A 9 QIKKNAII-DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVD 78 (299)
T ss_dssp CCBCSCGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEE
T ss_pred cCcccccc-cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc-----cCCCchhHHh
Confidence 33444444 567776 8899999999999999999999999999754 35567888775553 4899999999
Q ss_pred EEEe----cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 484 YFYH----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 484 ~f~~----~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
++.. ....++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 154 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC
Confidence 9987 6789999999975 88888765432 2389999999999999999999999999999999999998532
Q ss_pred -cceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh-
Q 005415 559 -RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML- 636 (697)
Q Consensus 559 -~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l- 636 (697)
++.+||+|||++.... +..++.++|||||||++|+|++|..||.+.........+....
T Consensus 155 ~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 215 (299)
T 3m2w_A 155 PNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215 (299)
T ss_dssp TTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred CCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence 6789999999885433 2346789999999999999999999998765543322211111
Q ss_pred ---CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 637 ---GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 637 ---g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
...+...+ -.....+..++..|| ...|..|+|+++++ +|+...
T Consensus 216 ~~~~~~~~~~~---------~~~~~~~~~li~~~l----~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 216 MGQYEFPNPEW---------SEVSEEVKMLIRNLL----KTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp TTCCSSCHHHH---------TTSCHHHHHHHHHHT----CSSTTTSCCHHHHHTSHHHHTG
T ss_pred hccccCCchhc---------ccCCHHHHHHHHHHc----ccChhhCCCHHHHhcChhhccc
Confidence 11111111 012234455555554 45588999999999 999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=288.08 Aligned_cols=235 Identities=16% Similarity=0.162 Sum_probs=178.0
Q ss_pred cceeeCc-eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCce
Q 005415 404 LPIILNT-VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHI 478 (697)
Q Consensus 404 ~pv~~~~-~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnI 478 (697)
-++..|+ ++.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ .||||
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~i 93 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI------DKPGV 93 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC------CCTTB
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC------CCCCc
Confidence 3455677 78899999999999999999999999999999999998542 3345677788877665 48999
Q ss_pred eEEEEEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 479 LRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 479 v~l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+++++++...+..|+||||+. ++|.+++.. . .....+..++.||+.||.|||++||+||||||+|||++.
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~- 164 (286)
T 3uqc_A 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI- 164 (286)
T ss_dssp CCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET-
T ss_pred ceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC-
Confidence 999999999999999999997 567777632 1 345578889999999999999999999999999999995
Q ss_pred CcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH-hh
Q 005415 558 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG-ML 636 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~-~l 636 (697)
++.+||++++ |++| ++.++|||||||++|+|++|+.||.+.+..+.+..... ..
T Consensus 165 -~g~~kl~~~~-----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 219 (286)
T 3uqc_A 165 -DGDVVLAYPA-----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219 (286)
T ss_dssp -TSCEEECSCC-----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT
T ss_pred -CCCEEEEecc-----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc
Confidence 7888988543 3333 68999999999999999999999987654321110000 01
Q ss_pred C-CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 637 G-PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 637 g-~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
+ .++..... -.....+..++..||... |..| |++++..+|..
T Consensus 220 ~~~~~~~~~~--------~~~~~~l~~li~~~l~~d----P~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 220 GQPIEPADID--------RDIPFQISAVAARSVQGD----GGIR-SASTLLNLMQQ 262 (286)
T ss_dssp SCBCCHHHHC--------TTSCHHHHHHHHHHHCTT----SSCC-CHHHHHHHHHH
T ss_pred cCCCChhhcc--------cCCCHHHHHHHHHHcccC----CccC-CHHHHHHHHHH
Confidence 1 11111110 012345667777777644 8889 99999866653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-33 Score=294.77 Aligned_cols=198 Identities=23% Similarity=0.256 Sum_probs=159.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCC---CCCCceeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDP---ADEHHILR 480 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~---~~hpnIv~ 480 (697)
.++|++.+.||+|+||+||+|++ +++.||||++.... .....+.+|+.+++.++.... ..||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999997 68999999998542 223678899999998874221 23566666
Q ss_pred EEEEE-----------------Ee-------------cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHH
Q 005415 481 LYDYF-----------------YH-------------LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529 (697)
Q Consensus 481 l~~~f-----------------~~-------------~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~q 529 (697)
+++.+ .. ...++|||||+.+ ++++.+.. ..+++..++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHH
Confidence 66554 32 6789999999965 35555422 12889999999999
Q ss_pred HHHHHHHHH-hcCccccCCCCccccccccC------------------cceEEEeeCCCccccccccccccccCCCCCch
Q 005415 530 CLEALEYLH-SLGIIHCDLKPENILIKSYQ------------------RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590 (697)
Q Consensus 530 Ia~aL~yLH-s~gIvHrDLKP~NILl~~~~------------------~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE 590 (697)
|+.||.||| ++||+||||||+|||++..+ ...+||+|||+|+..... ..+||+.|+|||
T Consensus 170 i~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE 247 (336)
T 2vuw_A 170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSG
T ss_pred HHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChh
Confidence 999999999 99999999999999999632 128999999999876543 347999999999
Q ss_pred hhcCCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 005415 591 VIIGLPYDQKIDLWSLGCI-LAELWTGEVLFPN 622 (697)
Q Consensus 591 ~l~~~~~s~ksDIWSLGvi-L~ELltG~~PF~~ 622 (697)
++.+.. +.++|||||+++ .+++++|..||.+
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 998877 899999998777 7788889999954
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=316.45 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=166.2
Q ss_pred eeeCceecCceEEEEEeccCCCCceEEEEECC-CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 406 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 406 v~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~-~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
+..++++.++|++.+.||+|+||.||+|.+.. +++.||||++... ......+.+|+.+++.+ .||||++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 145 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV------VHPSIVQIF 145 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC------CCTTBCCEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc------CCCCcCeEe
Confidence 34577888999999999999999999999976 7899999998643 23345566777777665 489999999
Q ss_pred EEEEecCe-----EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 483 DYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 483 ~~f~~~~~-----l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
+++..... .||||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC
Confidence 99997655 7999999985 55544321 2899999999999999999999999999999999999984
Q ss_pred cCcceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005415 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~ 622 (697)
+.+||+|||++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+
T Consensus 218 ---~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 218 ---EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ---SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ---CcEEEEecccchhcccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 48999999999776544 4567999999999997754 8899999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=317.94 Aligned_cols=278 Identities=21% Similarity=0.201 Sum_probs=192.2
Q ss_pred cceeeCceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005415 404 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481 (697)
Q Consensus 404 ~pv~~~~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l 481 (697)
+|...+.. .++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.++ ||||+++
T Consensus 5 ~p~~pg~~-~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~------HpnIV~l 77 (676)
T 3qa8_A 5 SPSLPTQT-CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN------HPNVVSA 77 (676)
T ss_dssp -------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC------BTTBCCE
T ss_pred CCCCCCCC-CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC------CCCCCce
Confidence 34444443 48999999999999999999999999999999998753 344567888999999884 8899999
Q ss_pred EEEEEe------cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 482 YDYFYH------LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 482 ~~~f~~------~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
++++.. ....++||||+. ++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 78 ~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl 154 (676)
T 3qa8_A 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154 (676)
T ss_dssp EECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEE
T ss_pred eeeecccccccCCCeEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEe
Confidence 999765 677899999996 578777764322 1237888999999999999999999999999999999999
Q ss_pred cccC-cceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 005415 555 KSYQ-RCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 631 (697)
Q Consensus 555 ~~~~-~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~ 631 (697)
+.++ ...+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+......+..
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred ecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 8532 235899999999775443 3346789999999999999999999999999999999999999987644332211
Q ss_pred HHHhhCCCCHHHHh---h----cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 632 IIGMLGPIDLEMLM---Q----GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 632 I~~~lg~~p~e~~~---~----~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.+............ . .......-.....+...+.+.....+...|..|.|+++++ +|+..
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11000000000000 0 0000000011122334445555555666788899998877 77653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.3e-27 Score=267.33 Aligned_cols=181 Identities=19% Similarity=0.075 Sum_probs=125.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecc-----------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-----------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
..++.|+.|.+..++....|+.|++|++..+ .....++.+|+++|+++. .|+||+++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP-----AGFDAPAVLAHGENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC-----TTCCCCCEEEEEECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEEEC
Confidence 3467788888888777788999999999753 123456888999999875 378999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
..+||||||++| +|.+++..... ++.. .|++||+.||.|||++|||||||||+|||++. ++.+||+||
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~--dg~vKL~DF 383 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA--RQHARLIDF 383 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT--TSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC--CCCEEEeec
Confidence 999999999985 67777754322 5543 58899999999999999999999999999985 789999999
Q ss_pred CCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCC
Q 005415 568 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 617 (697)
Q Consensus 568 Gla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~ 617 (697)
|+|+..... ....+||+.|+|||++.+. +..++|+||+|+++++|.++.
T Consensus 384 GlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 384 GSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 999765432 3457899999999999774 567899999999987765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.2e-23 Score=233.61 Aligned_cols=179 Identities=17% Similarity=0.156 Sum_probs=139.3
Q ss_pred EEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 417 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 417 ~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
...+.||+|+||.||+|. ..++.+++|...... ....++.+|+++++.++ ||||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------h~nIv~~~~~~~~ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK------DFGIPAPYIFDVD 410 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG------GGTCCCCCEEEEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC------CCCcCceEEEEEe
Confidence 345689999999999994 567889999865321 11345789999999985 7899966666667
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
....+|||||++ ++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~D 472 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIID 472 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEE
Confidence 777899999997 677766542 4579999999999999999999999999999993 899999
Q ss_pred CCCccccccc----------cccccccCCCCCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 567 LGSSCFQTDN----------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 567 FGla~~~~~~----------~~~~~gt~~Y~APE~l~~--~~~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
||+++..... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999876543 134678999999999987 568888999999999988888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=197.42 Aligned_cols=143 Identities=20% Similarity=0.229 Sum_probs=111.5
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------------------hhHhHHHHHHHHHHhcccCCCCC
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------------------~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ....+.+|+.+++.++ |
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------~ 163 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------G 163 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------T
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc------C
Confidence 466779999999999999999 8899999999974321 2356788999999986 1
Q ss_pred CceeEEEEEEEecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccc
Q 005415 476 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 554 (697)
Q Consensus 476 pnIv~l~~~f~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 554 (697)
+++.. ++.. +..++||||+++ +|.+ +. . .....++.||+.||.|||++||+||||||+|||+
T Consensus 164 ~~v~~---~~~~-~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl 226 (282)
T 1zar_A 164 LAVPK---VYAW-EGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 226 (282)
T ss_dssp SSSCC---EEEE-ETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CCcCe---EEec-cceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence 33444 3333 456999999975 6655 21 1 1245799999999999999999999999999999
Q ss_pred cccCcceEEEeeCCCccccccccccccccCCCCCchhhcC
Q 005415 555 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG 594 (697)
Q Consensus 555 ~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~ 594 (697)
+ ++.+||+|||+++. +..+.|||.+..
T Consensus 227 ~---~~~vkl~DFG~a~~----------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S---EEGIWIIDFPQSVE----------VGEEGWREILER 253 (282)
T ss_dssp E---TTEEEECCCTTCEE----------TTSTTHHHHHHH
T ss_pred E---CCcEEEEECCCCeE----------CCCCCHHHHHHH
Confidence 8 68899999999853 345789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.9e-18 Score=173.71 Aligned_cols=137 Identities=18% Similarity=0.245 Sum_probs=104.6
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcE--EEEEEEecchhh-------------------------hHhHHHHHHHHHHhc
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKNDKDF-------------------------FDQSLDEIKLLKLVN 468 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~--VAVKii~~~~~~-------------------------~~~~~~Ei~iL~~L~ 468 (697)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ...+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778999 999997643211 125678999999998
Q ss_pred ccCCCCCCceeEEEEEEEecCeEEEEEEcccc------chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-hcC
Q 005415 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA------NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-SLG 541 (697)
Q Consensus 469 ~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~g------sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLH-s~g 541 (697)
+.. ..+|.++ +. ...+|||||+++ .|.+.... .++..+..++.||+.||.||| +.|
T Consensus 129 ~~~-i~~p~~~---~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 129 EAG-VSVPQPY---TY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HTT-CCCCCEE---EE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred hCC-CCCCeEE---Ec----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 652 2334433 22 356899999953 34433211 223457789999999999999 999
Q ss_pred ccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 542 IvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|+||||||+|||++ . .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~---~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYI---D-KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEES---S-SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEc---C-cEEEEECcccccC
Confidence 99999999999998 3 8999999999654
|
| >2z0u_A WW domain-containing protein 1; C2 domain, alternative splicing, coiled coil, cytoplasm, phosphorylation, polymorphism, lipid binding protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-18 Score=164.35 Aligned_cols=98 Identities=13% Similarity=0.042 Sum_probs=86.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCC-CCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHP-GTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~-~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|.+| ||+++|.+|.+|||||++|+|.. .+..++||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 41 ~~~~L~V~Vi~a~~L~~~d~~g~sDPyVkv~l~~~~~~~~~~~kT~v~~~tlnP~wnE~F~f~--v~~~~l~~~~L~~~V 118 (155)
T 2z0u_A 41 KNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVS--MSYPALHQKTLRVDV 118 (155)
T ss_dssp TTTEEEEEEEEEECGGGTCCSCCSEEEEEEEEESCSCHHHHEEECCCEECCSSEEEEEEEEEE--CCHHHHHHCEEEEEE
T ss_pred CCCEEEEEEEEccCcCCcccCCCCCEEEEEEEecCCCCCccceeCCcCCCCCCCccccEEEEE--cCHHHhCcCEEEEEE
Confidence 568999999999 99999999999999999999843 23348899999999999999999999 887666 56799999
Q ss_pred ccCCCCCCCCcccccccCccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d 363 (697)
||+|++++++++|++.++..+..
T Consensus 119 ~d~d~~~~~d~iG~~~i~l~~l~ 141 (155)
T 2z0u_A 119 CTTDRSHLEECLGGAQISLAEVC 141 (155)
T ss_dssp EEECTTSCEEEEEEEEEECTTSC
T ss_pred EECCCCCCCcEEEEEEEEHHHcc
Confidence 99999999999999988766653
|
| >1v27_A Regulating synaptic membrane exocytosis protein 2; RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-16 Score=146.31 Aligned_cols=101 Identities=16% Similarity=0.114 Sum_probs=87.0
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| +|+++|.+|.+||||++++.+++....+++|+++++|+||+|||+|.|.. ++.+.+ ...|.++||
T Consensus 19 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 97 (141)
T 1v27_A 19 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 97 (141)
T ss_dssp TTTEEEEEEEEEESCCCCSSSCCCCEEEECCCSSCCSSSSCCBCCCCSSCSSCCCCCCCEECS-CCTTGGGTCEEEEEEE
T ss_pred CCCEEEEEEEEccCCCCcCCCCCCCCEEEEEEecCCCCCcceeCccccCCCCCccccEEEEcc-CCHHHhcCCEEEEEEE
Confidence 567899999999 99999999999999999999988777899999999999999999999982 344444 566999999
Q ss_pred cCCCCCC--CCcccccccCccccccc
Q 005415 342 DNSDTRD--GEVNGALHEGKADAEEH 365 (697)
Q Consensus 342 D~d~~~~--~d~~G~v~~~~~~~d~e 365 (697)
|+|.+++ ++++|.+.+...++...
T Consensus 98 d~d~~~~~~~~~lG~~~i~l~~l~~~ 123 (141)
T 1v27_A 98 DQARVREEESEFLGEILIELETALLD 123 (141)
T ss_dssp EBCSSSSCCBCCCEEEEEEGGGCCCS
T ss_pred ECCCCcCCCCceEEEEEEEccccCCC
Confidence 9999997 99999998766555443
|
| >3fbk_A RGS3, RGP3, regulator of G-protein signaling 3; all beta-sheet fold, structural genomics, PSI-2, protein structure initiative; 2.00A {Homo sapiens} SCOP: b.7.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-16 Score=150.67 Aligned_cols=98 Identities=14% Similarity=0.102 Sum_probs=88.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
..+.|+|.|.+| +|+++| +|.+||||++.+.++.....++||+++++|+||+|||+|.|. ++.....+.|.++|||
T Consensus 25 ~~~~L~V~v~~a~~L~~~d-~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 101 (153)
T 3fbk_A 25 QDRVLLLHIIEGKGLISKQ-PGTCDPYVKISLIPEDSRLRHQKTQTVPDCRDPAFHEHFFFP--VQEEDDQKRLLVTVWN 101 (153)
T ss_dssp SSSEEEEEEEEEESCCCCS-SSCCCEEEEEEEESCSCCTTCEECCCCTTCSSCEEEEEEEEE--CCGGGTTSEEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCC-CCCCCEEEEEEEEcCCCCccEEeccccCCCCCCccccEEEEe--cccHHhCCEEEEEEEe
Confidence 568899999999 999999 799999999999999877789999999999999999999999 7777776669999999
Q ss_pred CCCCCC-CCcccccccCcccccc
Q 005415 343 NSDTRD-GEVNGALHEGKADAEE 364 (697)
Q Consensus 343 ~d~~~~-~d~~G~v~~~~~~~d~ 364 (697)
+|.+++ ++++|.+.++..++..
T Consensus 102 ~d~~~~~d~~lG~~~i~l~~l~~ 124 (153)
T 3fbk_A 102 RASQSRQSGLIGCMSFGVKSLLT 124 (153)
T ss_dssp CCSSGGGCEEEEEEEEEHHHHTC
T ss_pred CCCCCCCCcEEEEEEEEHHHhcC
Confidence 999987 9999999887766654
|
| >1a25_A CALB, protein kinase C (beta); calcium++/phospholipid binding protein, calcium-binding protein; HET: PSE; 2.70A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.59 E-value=2.8e-16 Score=148.68 Aligned_cols=101 Identities=20% Similarity=0.296 Sum_probs=89.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
+.+.|+|.|.+| +|+++|.+|.+||||++++.++.+...++||+++++|+||+|||+|.|. +.....+..|.++|||
T Consensus 29 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 106 (149)
T 1a25_A 29 DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWD 106 (149)
T ss_dssp SSSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEE
T ss_pred cCCEEEEEEEEeeCCCCCCCCCCcCeEEEEEEECCCCCcceEecceeCCCCCCcCCcEEEEE--eccccCCCEEEEEEEE
Confidence 356899999999 9999999999999999999998877789999999999999999999999 7765556679999999
Q ss_pred CCCCCCCCcccccccCcccccccC
Q 005415 343 NSDTRDGEVNGALHEGKADAEEHG 366 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d~e~ 366 (697)
+|.+++++++|++.+...++....
T Consensus 107 ~d~~~~~~~iG~~~i~l~~l~~~~ 130 (149)
T 1a25_A 107 WDLTSRNDFMGSLSFGISELQKAG 130 (149)
T ss_dssp CCSSSCCEEEEEEEEEHHHHTTCC
T ss_pred CCCCCCCCEEEEEEEEHHHhCcCc
Confidence 999999999999988766655443
|
| >2bwq_A Regulating synaptic membrane exocytosis protein 2; C2 domain, neurotransmitter release, transport protein; 1.41A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.58 E-value=4.6e-16 Score=143.07 Aligned_cols=102 Identities=16% Similarity=0.113 Sum_probs=83.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|.+|.+||||++.+.|++....++||+++++|+||+|||+|.|.. ++.+.. ...|.++||
T Consensus 16 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~~~V~ 94 (129)
T 2bwq_A 16 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 94 (129)
T ss_dssp TTTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECS-CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCEEEEEEecCCCCCcceecccccCCCCCccccEEEEcc-CCHHHhcCCeEEEEEE
Confidence 457899999999 99999999999999999999988777899999999999999999999982 344444 556999999
Q ss_pred cCCCCCC--CCcccccccCcccccccC
Q 005415 342 DNSDTRD--GEVNGALHEGKADAEEHG 366 (697)
Q Consensus 342 D~d~~~~--~d~~G~v~~~~~~~d~e~ 366 (697)
|+|.+++ ++++|.+.+...++...+
T Consensus 95 d~d~~~~~~~~~lG~~~i~l~~l~~~~ 121 (129)
T 2bwq_A 95 DQARVREEESEFLGEILIELETALLDD 121 (129)
T ss_dssp EC-------CEEEEEEEEEGGGCCCSS
T ss_pred ECCcCcCcCCceeEEEEEEccccCCCc
Confidence 9999997 999999988766655443
|
| >2dmg_A KIAA1228 protein; beta-sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.8e-16 Score=144.15 Aligned_cols=97 Identities=14% Similarity=0.098 Sum_probs=84.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|.+| +||||++++.++.++..+++|+++++|+||+|||+|.|. ++.+.+ .+.|.++||
T Consensus 22 ~~~~L~v~v~~a~~L~~~d~~g-~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 98 (142)
T 2dmg_A 22 QRNKLIVVVHACRNLIAFSEDG-SDPYVRMYLLPDKRRSGRRKTHVSKKTLNPVFDQSFDFS--VSLPEVQRRTLDVAVK 98 (142)
T ss_dssp TTTEEEEEEEEEECCCCSSTTC-CCEEEEEEEESCCCSSSCEECCCCCSCSSCEEEEEEEEC--CCHHHHHHCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCC-CCeeEEEEEEcCCCCCCcccCCccCCCCCCCcCceEEEE--ecHHHhCcCEEEEEEE
Confidence 457899999999 999999999 999999999998887789999999999999999999999 776666 456999999
Q ss_pred cCCCCCC--CCcccccccCccccc
Q 005415 342 DNSDTRD--GEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~--~d~~G~v~~~~~~~d 363 (697)
|+|.++. ++++|.+.+......
T Consensus 99 d~d~~~~~~~~~iG~~~i~l~~~~ 122 (142)
T 2dmg_A 99 NSGGFLSKDKGLLGKVLVALASEE 122 (142)
T ss_dssp ECCCSSCCSCCCCEEEEEECCCST
T ss_pred ECCCccccCCcEEEEEEEeccccc
Confidence 9999864 579999987654443
|
| >2b3r_A Phosphatidylinositol-4-phosphate 3-kinase C2 DOMA containing alpha polypeptide; C2 domain, lipid binding, PI3-kinase, transferase; 2.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-16 Score=144.65 Aligned_cols=99 Identities=12% Similarity=0.099 Sum_probs=85.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||++ |.+|.+||||+++++|+.....++||+++++|+||+|||+|.|.. ++.+.+ ...|.++||
T Consensus 18 ~~~~L~V~V~~a~~L~~-~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~~-v~~~~l~~~~L~~~V~ 95 (134)
T 2b3r_A 18 RNGTLFIMVMHIKDLVT-EDGADPNPYVKTYLLPDTHKTSKRKTKISRKTRNPTFNEMLVYSG-YSKETLRQRELQLSVL 95 (134)
T ss_dssp ETTEEEEEEEEEECCCC-TTSCCCCEEEEEEEESCSSSCCCEECCCCCSCSSCEEEEEEEEES-CCHHHHTTCEEEEEEE
T ss_pred cCCEEEEEEEEeeCCCC-CCCCCCCeEEEEEEEcCCCCCceecCCcCcCCCCCCCccEEEECC-cCHHHhCcCEEEEEEE
Confidence 558999999999 9997 899999999999999988777899999999999999999999972 344443 456999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|.+++++++|++.+...++..
T Consensus 96 d~d~~~~~~~lG~~~i~l~~l~~ 118 (134)
T 2b3r_A 96 SAESLRENFFLGGITLPLKDFNL 118 (134)
T ss_dssp ECCSSSCCEEEEEEEEEGGGSCT
T ss_pred ECCCCCCCcEEEEEEEEhhhccC
Confidence 99999999999999876655543
|
| >3fdw_A Synaptotagmin-like protein 4; structural genomics, phospholipid binding, alternative splicing, cell membrane, cytoplasmic vesicle, membrane; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-16 Score=146.87 Aligned_cols=98 Identities=9% Similarity=-0.019 Sum_probs=87.6
Q ss_pred ccceeEEEEecc-Cccccc-CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d-~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
..+.|+|.|.+| ||+++| .+|.+||||++++.|++++..++||+++++|+||+|||+|.|. ++.+.+ .+.|.++|
T Consensus 21 ~~~~L~V~v~~a~~L~~~d~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~~L~~~V 98 (148)
T 3fdw_A 21 QTQSLVVHVKECHQLAYADEAKKRSNPYVKTYLLPDKSRQGKRKTSIKRDTVNPLYDETLRYE--IPESLLAQRTLQFSV 98 (148)
T ss_dssp TTTEEEEEEEEEESCCCSBTTTTBCCEEEEEEEETCCSGGGEEECCCCSSCSSCEEEEEEEEE--CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEecCCCCcccCCCCCCeEEEEEEEcCCcccCccccccCCCCCCCcEeeEEEEE--eChhHhCceEEEEEE
Confidence 467899999999 999999 6899999999999999887789999999999999999999999 887776 55699999
Q ss_pred ccCCCCCCCCcccccccCccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d 363 (697)
||+|.+++++++|++.++..+..
T Consensus 99 ~d~d~~~~~~~iG~~~i~l~~l~ 121 (148)
T 3fdw_A 99 WHHGRFGRNTFLGEAEIQMDSWK 121 (148)
T ss_dssp EEECGGGCEEEEEEEEEEHHHHH
T ss_pred EECCCCcCCcEEEEEEEEccccc
Confidence 99999999999999977654443
|
| >1wfm_A Synaptotagmin XIII; C2 domain, exocytosis, neurotransmitter release, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.57 E-value=7.6e-16 Score=144.01 Aligned_cols=95 Identities=18% Similarity=0.140 Sum_probs=82.1
Q ss_pred ccceeEEEEeccCcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccccc
Q 005415 264 NNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~D 342 (697)
..+.|+|.|.+|. ++|.+|.+||||+++++|+.+ +.++||+++++|+||+|||+|.|. ++.+.+ ...|.++|||
T Consensus 24 ~~~~L~V~v~~a~--~~d~~g~sDPyv~v~l~~~~~-~~~~kT~v~~~tlnP~wnE~f~f~--v~~~~l~~~~L~~~V~d 98 (138)
T 1wfm_A 24 QKAELFVTRLEAV--TSNHDGGCDCYVQGSVANRTG-SVEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLRT 98 (138)
T ss_dssp TTTEEEEEEEEEE--CCCCSSCCCEEEEEEEEETTE-EEEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEEE
T ss_pred CCCEEEEEEEEEE--cCCCCCCcceEEEEEEEcCCC-cccEecccCcCCCCCcCCceEEEE--ecHHHcCCCEEEEEEEE
Confidence 4678999999995 489999999999999998643 347889999999999999999999 887776 5569999999
Q ss_pred CCCCCCCCcccccccCccccc
Q 005415 343 NSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d 363 (697)
+|++++++++|++.+...++.
T Consensus 99 ~d~~~~dd~lG~~~i~l~~l~ 119 (138)
T 1wfm_A 99 CDRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp CCSSCTTSCSEEEEEESSSSS
T ss_pred CCCCCCCcEEEEEEEEccccc
Confidence 999999999999988766554
|
| >1w15_A Synaptotagmin IV; metal binding protein, endocytosis/exocytosis neurotransmitter release, transmembrane; 1.93A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1w16_A | Back alignment and structure |
|---|
Probab=99.57 E-value=7.1e-16 Score=146.41 Aligned_cols=96 Identities=15% Similarity=0.041 Sum_probs=80.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||++++.+++++..++||+++++|+||+|||+|.|. ++...++ ..|.++||
T Consensus 28 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~v~V~ 105 (153)
T 1w15_A 28 TTNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVL 105 (153)
T ss_dssp TTTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCCCeEEEEEEEeCCeEeceEecCcccCCCCCeecceEEEE--CCHHHhCceEEEEEEE
Confidence 557899999999 9999999999999999999998777678899999999999999999999 7777764 55999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|+|.+++++++|.+.++..+
T Consensus 106 d~d~~~~~~~lG~~~i~l~~ 125 (153)
T 1w15_A 106 DSERGSRNEVIGRLVLGATA 125 (153)
T ss_dssp ECCTTSCCEEEEEEEESTTC
T ss_pred eCCCCCCCcEEEEEEECCCC
Confidence 99999999999999876543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-15 Score=164.57 Aligned_cols=138 Identities=19% Similarity=0.168 Sum_probs=95.8
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhh---------------h--------HhHHHHHHHHHHhcccCC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------F--------DQSLDEIKLLKLVNKNDP 472 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~---------------~--------~~~~~Ei~iL~~L~~~~~ 472 (697)
|+|.++||.|++|.||+|.+ .+|+.||||+++..... . -....|...|..+....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g- 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG- 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 99999999999999999997 47999999998642110 0 01234666676665321
Q ss_pred CCCCceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 473 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 473 ~~hpnIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
. .+...++. ...+|||||++|..+..+ ........++.||+.+|.+||++|||||||||.||
T Consensus 175 v---~vp~p~~~----~~~~LVME~i~G~~L~~l-----------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 175 F---PVPEPIAQ----SRHTIVMSLVDALPMRQV-----------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp C---SCCCEEEE----ETTEEEEECCSCEEGGGC-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred C---CCCeeeec----cCceEEEEecCCccHhhh-----------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 1 12222322 123799999987533211 11123467889999999999999999999999999
Q ss_pred cccccCc--------ceEEEeeCCCcccc
Q 005415 553 LIKSYQR--------CEIKIIDLGSSCFQ 573 (697)
Q Consensus 553 Ll~~~~~--------~~vKL~DFGla~~~ 573 (697)
|++.++. ..+.|+||+-+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 9986322 14899999987543
|
| >1ugk_A Synaptotagmin IV, KIAA1342; beta sandwich, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-15 Score=140.43 Aligned_cols=98 Identities=12% Similarity=0.083 Sum_probs=84.1
Q ss_pred ccceeEEEEecc-CcccccCC-CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~-g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
....|+|.|.+| ||+++|.+ |.+||||++++.++++ .++||+++++|+||+|||+|.|.. ++.+.+ ...|.++|
T Consensus 20 ~~~~L~v~v~~a~~L~~~d~~~~~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~~-v~~~~~~~~~l~i~V 96 (138)
T 1ugk_A 20 ERKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKK--HKVKTRVLRKTLDPAFDETFTFYG-IPYTQIQELALHFTI 96 (138)
T ss_dssp GGTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTC--SEEECCCCSSCSSCEEEEEEEEEC-CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCCEEEEEEecCCC--ceEecCcCcCCCCCcEeeEEEEcC-cCHHHhccCEEEEEE
Confidence 457899999999 99999995 9999999999998765 489999999999999999999941 666665 45699999
Q ss_pred ccCCCCCCCCcccccccCcccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
||+|.+++++++|.+.+...++..
T Consensus 97 ~d~d~~~~~~~lG~~~i~l~~l~~ 120 (138)
T 1ugk_A 97 LSFDRFSRDDIIGEVLIPLSGIEL 120 (138)
T ss_dssp EEECSSCCCCCCEEEEEECTTCCC
T ss_pred EECCCCCCCcEEEEEEEehhHccC
Confidence 999999999999999876655543
|
| >3n5a_A Synaptotagmin-7; calcium/phospholipid binding protein, protein transport; 1.44A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-15 Score=141.14 Aligned_cols=95 Identities=13% Similarity=0.068 Sum_probs=85.9
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||++++.++.++..++||+++++|+||+|||+|.|. ++...+ +..|.++||
T Consensus 14 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~~~~~t~nP~wne~f~f~--v~~~~l~~~~l~~~V~ 91 (138)
T 3n5a_A 14 SANSIIVNIIKARNLKAMDIGGTSDPYVKVWLMYKDKRVEKKKTVTKKRNLNPIFNESFAFD--IPTEKLRETTIIITVM 91 (138)
T ss_dssp TTTEEEEEEEEEESCCCCBTTTBCCEEEEEEEEETTEEEEEEECCCCSSCSSCEEEEEEEEE--CCGGGGGGEEEEEEEE
T ss_pred CCCeEEEEEEEeeCCCCcCCCCCcCeEEEEEEEeCCCccceEeCccccCCCCCcCcceEEEE--CChhhcCceEEEEEEE
Confidence 457899999999 9999999999999999999998777789999999999999999999999 877776 455999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|.+++++++|.+.++..
T Consensus 92 d~~~~~~~~~lG~~~i~l~ 110 (138)
T 3n5a_A 92 DKDKLSRNDVIGKIYLSWK 110 (138)
T ss_dssp ECCSSSCCEEEEEEEESSS
T ss_pred ECCCCCCCcEEEEEEEccc
Confidence 9999999999999987643
|
| >2enp_A B/K protein; C2 type 1,beta sandwich, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.4e-15 Score=141.74 Aligned_cols=97 Identities=15% Similarity=0.129 Sum_probs=83.5
Q ss_pred ccceeEEEEecc-Cccc-ccCCC------CCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cc
Q 005415 264 NNDYGYLSSKEA-DLID-LQHNV------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EK 334 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~-~d~~g------~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~ 334 (697)
..+.|+|.|.+| ||++ ||.+| .+||||++++.++.+. +++|+++++|+||+|||+|.|. ++.+.+ .+
T Consensus 24 ~~~~L~V~v~~a~~L~~~~d~~g~~~~~~~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~ 99 (147)
T 2enp_A 24 LHNHLTVRVIEARDLPPPISHDGSRQDMAHSNPYVKICLLPDQKN--SKQTGVKRKTQKPVFEERYTFE--IPFLEAQRR 99 (147)
T ss_dssp TTTEEEEEEEEEECCCCSCSSCCSSCTTCCCCCEEEEEEETCCSS--CEECCCCCSCSSCCCCBCCEEC--CCHHHHHHS
T ss_pred CCCEEEEEEEEEeCCCCccccccccccCCCCCcEEEEEEEeCCCc--ceEeecccCCCCCeEeeeEEEE--eChHHhccC
Confidence 567899999999 9999 67765 7999999999987764 7899999999999999999999 777665 45
Q ss_pred ccccccccCCCCCCCCcccccccCcccccc
Q 005415 335 DLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 335 ~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
.|.++|||+|.+++++++|.+.+...++..
T Consensus 100 ~L~~~V~d~d~~~~~~~iG~~~i~l~~l~~ 129 (147)
T 2enp_A 100 TLLLTVVDFDKFSRHCVIGKVSVPLCEVDL 129 (147)
T ss_dssp EEEEEEECCSTTCCSCCCEEEEEETTTSCT
T ss_pred EEEEEEEECCCCcCCcEEEEEEEechhcCC
Confidence 699999999999999999999876655543
|
| >3f04_A Synaptotagmin-1; C2A, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal- binding, palmitate, phosphoprotein; 1.35A {Homo sapiens} SCOP: b.7.1.2 PDB: 3f01_A 3f05_A 3f00_A 1byn_A 2k45_A 2k4a_A 2k8m_A 2ki6_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-15 Score=141.55 Aligned_cols=96 Identities=15% Similarity=0.111 Sum_probs=85.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||++++.+++++ +++|+++++|+||+|||+|.|. ++...+ ...|.++||
T Consensus 32 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 107 (143)
T 3f04_A 32 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 107 (143)
T ss_dssp TTTEEEEEEEEEECCCCBGGGBCCCEEEEEEEESCCSC--CEECCCCCSCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCcCcEEEEEEECCCCc--cEECccCcCCCCCcCcCeEEEe--ecHhhcCCCEEEEEEE
Confidence 567899999999 9999999999999999999988765 8899999999999999999999 776665 456999999
Q ss_pred cCCCCCCCCcccccccCccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|+|.+++++++|++.+...++.
T Consensus 108 d~d~~~~~~~iG~~~i~l~~l~ 129 (143)
T 3f04_A 108 DFDRFSKHDIIGEFKVPMNTVD 129 (143)
T ss_dssp ECCSSSCCEEEEEEEEEGGGCC
T ss_pred eCCCCCCCceEEEEEEEHHHcc
Confidence 9999999999999987655443
|
| >2cm5_A Rabphilin-3A; protein transport, zinc-finger, Ca2+ binding, metal-binding, synaptic exocytosis, C2A-C2B linker fragment, C2B, zinc, synapse; 1.28A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 2cm6_A 3rpb_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2.3e-15 Score=144.99 Aligned_cols=95 Identities=15% Similarity=0.102 Sum_probs=83.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|. +..+.+ ...|.++||
T Consensus 35 ~~~~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 112 (166)
T 2cm5_A 35 QQGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVW 112 (166)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCccCCCCCCcEEEEEEECCCCccceEeCCcccCCCCCcccceEEEE--cchHhcCCCEEEEEEE
Confidence 467899999999 9999999999999999999998777779999999999999999999999 776665 566999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|.+++++++|.+.++..
T Consensus 113 d~d~~~~~~~iG~~~i~l~ 131 (166)
T 2cm5_A 113 DYDIGKSNDYIGGCQLGIS 131 (166)
T ss_dssp ECCSSSCCEEEEEEEEETT
T ss_pred ECCCCCCCcEEEeEEEecc
Confidence 9999999999999977543
|
| >1rsy_A Synaptotagmin I; calcium/phospholipid binding protein; 1.90A {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-15 Score=142.54 Aligned_cols=95 Identities=15% Similarity=0.103 Sum_probs=84.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| ||+++|.+|.+||||++++.++++. ++||+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 40 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 115 (152)
T 1rsy_A 40 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 115 (152)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCCS--CEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCccCCCCcCeEEEEEEEcCCCc--eEeccccCCCCCCcCcccEEEe--ecHHHcCCCEEEEEEE
Confidence 457899999999 9999999999999999999987654 7889999999999999999998 776665 566999999
Q ss_pred cCCCCCCCCcccccccCcccc
Q 005415 342 DNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|+|.+++++++|.+.+...++
T Consensus 116 d~d~~~~~~~iG~~~i~l~~l 136 (152)
T 1rsy_A 116 DFDRFSKHDIIGEFKVPMNTV 136 (152)
T ss_dssp ECCSSSCCEEEEEEEEEGGGC
T ss_pred ECCCCCCCcEEEEEEEEchhc
Confidence 999999999999998765554
|
| >1tjx_A Similar to synaptotagmini/P65; C2B domain, calcium binding, endocytosis-EX complex; HET: GOL; 1.04A {Rattus norvegicus} SCOP: b.7.1.2 PDB: 1tjm_A* 1uov_A 1uow_A 1k5w_A 2lha_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-15 Score=143.54 Aligned_cols=95 Identities=14% Similarity=0.111 Sum_probs=85.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|.+|.+||||++++.++.++..++||+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 23 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~ 100 (159)
T 1tjx_A 23 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 100 (159)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCceeceeeCceecCCCCCcccceEEEE--cCHHHhCCcEEEEEEE
Confidence 567899999999 9999999999999999999988766678999999999999999999999 877766 455999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|+|.+++++++|.+.++..
T Consensus 101 d~d~~~~~~~iG~~~i~l~ 119 (159)
T 1tjx_A 101 DYDKIGKNDAIGKVFVGYN 119 (159)
T ss_dssp ECCSSSCCEEEEEEEEETT
T ss_pred ECCCCCCCceEEEEEECCC
Confidence 9999999999999977554
|
| >2q3x_A Regulating synaptic membrane exocytosis protein 1; C2 domain dimer, neurotransmitter release, transport protein; HET: MSE; 1.73A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-15 Score=146.45 Aligned_cols=96 Identities=7% Similarity=-0.096 Sum_probs=83.2
Q ss_pred ccceeEEEEecc-CcccccC-CCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~-~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|. +|.+||||++++.+++++..++||+++++|+||+|||+|.|. +... ...|.++||
T Consensus 28 ~~~~L~V~v~~a~~L~~~d~~~g~~DPyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~--~~~L~~~V~ 103 (171)
T 2q3x_A 28 KKGQLEVEVIRARSLTQKPGSKSTPAPYVKVYLLENGACIAKKKTRIARKTLDPLYQQSLVFD--ESPQ--GKVLQVIVW 103 (171)
T ss_dssp ETTEEEEEEEEEESCCCCC---CCCEEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEECS--SCCT--TEEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCcCCCCCCceEEEEEECCCccccceeCccCCCCCCCCCCcEEEEE--ecCC--CCEEEEEEE
Confidence 467899999999 9999996 799999999999998776678999999999999999999999 6433 456999999
Q ss_pred -cCCCCCCCCcccccccCccccc
Q 005415 342 -DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 -D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|+|.+++++++|.+.+...+..
T Consensus 104 ~d~d~~~~d~~iG~~~i~l~~l~ 126 (171)
T 2q3x_A 104 GDYGRMDHKCFMGVAQILLEELD 126 (171)
T ss_dssp EECSTTCSSEEEEEEEECGGGSC
T ss_pred EcCCCCCCCCEEEEEEEEHHHcc
Confidence 9999999999999988766554
|
| >2d8k_A Synaptotagmin VII; exocytosis, calcium binding, lysosome, C2 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.9e-15 Score=139.29 Aligned_cols=98 Identities=11% Similarity=0.093 Sum_probs=83.7
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| +|+++|.+|.+||||++++.++++. ++||+++++|+||+|||+|.|.. ++.+.+ ...|.++||
T Consensus 24 ~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~--~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 100 (141)
T 2d8k_A 24 QESTLTVKIMKAQELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEG-FPYEKVVQRILYLQVL 100 (141)
T ss_dssp SSCCEEEEEEEEESCCCCSSSSCCCEEEEEEEESCCSS--EEECCCCTTCSSCCCCEEEEECS-CCHHHHTTSEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCCCCCcEEEEEEECCCCc--cEeCceEcCCCCCccccEEEECc-cCHHHcccCEEEEEEE
Confidence 567899999999 9999999999999999999987654 78899999999999999999982 344444 556999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|.+++++++|.+.+...++..
T Consensus 101 d~d~~~~~~~iG~~~i~l~~l~~ 123 (141)
T 2d8k_A 101 DYDRFSRNDPIGEVSIPLNKVDL 123 (141)
T ss_dssp ECCSSSSCEEEEEEEEETTTSCT
T ss_pred ECCCCCCCcEEEEEEEEhhhhcC
Confidence 99999999999999876555443
|
| >2chd_A Rabphilin-3A, exophilin-1; C2 domain, C2A, calcium binding, synaptic EXOC metal-binding, protein transport, synapse, transport, zinc-; 1.92A {Rattus norvegicus} PDB: 2k3h_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.9e-15 Score=141.50 Aligned_cols=100 Identities=14% Similarity=0.106 Sum_probs=86.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| +|+++|.+|.+||||++++.++..+..++||+++++|+||+|||+|.|.. ++.+.+ ...|.++||
T Consensus 27 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~~~~l~i~V~ 105 (142)
T 2chd_A 27 DNSNLQCTIIRAKGLKPMDSNGLADPYVKLHLLPGASKSNKLRTKTLRNTRNPVWNETLQYHG-ITEEDMQRKTLRISVC 105 (142)
T ss_dssp GGTEEEEEEEEEESCCCCCTTSCCCEEEEEEEESCCSGGGEEECCCCCSCSSCEEEEEEEEES-CCHHHHHHCEEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCCCCEEEEEEEcCCCCcceeeCCcCCCCCCCcCcCEEEEcc-cCHHHccCCEEEEEEE
Confidence 567899999999 99999999999999999999988777899999999999999999999972 444444 456999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|.+++++++|.+.+...++..
T Consensus 106 d~d~~~~d~~iG~~~i~l~~l~~ 128 (142)
T 2chd_A 106 DEDKFGHNEFIGETRFSLKKLKA 128 (142)
T ss_dssp EECTTSCEEEEEEEEEEGGGCCT
T ss_pred ECCCCCCCcEEEEEEEEHHHcCC
Confidence 99999999999999876655543
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-15 Score=156.29 Aligned_cols=96 Identities=16% Similarity=0.072 Sum_probs=87.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
+.+.|+|.|.+| +|+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 150 ~~~~l~v~v~~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~i~V~ 227 (296)
T 1dqv_A 150 TAGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVV 227 (296)
T ss_dssp TTTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEE
T ss_pred ccceeEEEEEEeecCCccCCCCCCCcEEEEEEEeCCcCccceecceecCCCCCeECceEEEE--cCHHHccCcEEEEEEE
Confidence 457899999999 9999999999999999999998887789999999999999999999999 887776 446999999
Q ss_pred cCCCCCCCCcccccccCccc
Q 005415 342 DNSDTRDGEVNGALHEGKAD 361 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~ 361 (697)
|+|.+++++++|.+.++..+
T Consensus 228 d~d~~~~~~~iG~~~i~l~~ 247 (296)
T 1dqv_A 228 DYDCIGHNEVIGVCRVGPEA 247 (296)
T ss_dssp ECCSSSCCEEEEECCCSSCT
T ss_pred eCCCCCCCceEEEEEECCcc
Confidence 99999999999999876543
|
| >1rh8_A Piccolo protein; beta-sandwich, metal binding protein; NMR {Rattus norvegicus} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.49 E-value=3e-15 Score=140.05 Aligned_cols=99 Identities=14% Similarity=0.123 Sum_probs=83.7
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCC---------ccccceeecccCCCcceecccccCcccccccc-c
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT---------EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-E 333 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~---------~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~ 333 (697)
.+.|+|.|.+| ||+++|.+|.+||||++++.++.+. ..++||+++++|+||+|||+|.|.. ++.+.+ .
T Consensus 17 ~~~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-v~~~~l~~ 95 (142)
T 1rh8_A 17 LGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKS-ISMEQLMK 95 (142)
T ss_dssp TTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECS-CCHHHHTT
T ss_pred CCEEEEEEEEecCCCCCCCCCCCCceEEEEEecCCCcccccccccccceeeccccCCCCCCCCCCEEEECC-cCHHHccC
Confidence 56899999999 9999999999999999999987643 3578999999999999999999962 454444 5
Q ss_pred cccccccccCCCCCCCCcccccccCcccccc
Q 005415 334 KDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 334 ~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
..|.++|||+|.+++++++|.+.+...+...
T Consensus 96 ~~l~i~V~d~d~~~~~~~lG~~~i~l~~l~~ 126 (142)
T 1rh8_A 96 KTLEVTVWDYDRFSSNDFLGEVLIDLSSTSH 126 (142)
T ss_dssp CEEEEEEEEECSSSCEEEEEEEEEETTSCGG
T ss_pred CEEEEEEEECCCCCCCceEEEEEEecccccc
Confidence 5699999999999999999999876655433
|
| >1rlw_A Phospholipase A2, CALB domain; hydrolase, C2 domain; 2.40A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=2.9e-14 Score=130.46 Aligned_cols=93 Identities=13% Similarity=0.011 Sum_probs=78.2
Q ss_pred ccceeEEEEecc-Ccccc---cCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDL---QHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~---d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~ 339 (697)
|.+.|+|.|.+| +|++| |.+|.+||||++++.+.++ .++||+++++|+||+|||+|.|. +.... ...|.++
T Consensus 1 S~~~L~v~v~~a~~L~~~~~~d~~g~~dpyv~v~~~~~~~--~~~kT~v~~~t~nP~wne~f~f~--v~~~~-~~~l~i~ 75 (126)
T 1rlw_A 1 SSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPNQ-ENVLEIT 75 (126)
T ss_dssp CCEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTTS-CCEEEEE
T ss_pred CCcEEEEEEEeeeCCCCCCccccCCCCCCEEEEEEccCCC--ceEEccccCCCCCCcccceEEEE--ecCCC-CCEEEEE
Confidence 457899999999 99995 7889999999999988664 58899999999999999999999 64332 3459999
Q ss_pred cccCCCCCCCCcccccccCcccc
Q 005415 340 EIDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|||+|.++ ++++|.+.+...++
T Consensus 76 V~d~d~~~-~~~iG~~~i~l~~l 97 (126)
T 1rlw_A 76 LMDANYVM-DETLGTATFTVSSM 97 (126)
T ss_dssp EEECCSSC-CEEEEEEEEEGGGS
T ss_pred EEECCCCC-CceeEEEEEEHHHc
Confidence 99999885 88999997765444
|
| >1dqv_A Synaptotagmin III; beta sandwich, calcium ION, C2 domain, endocytosis/exocytosis complex; 3.20A {Rattus rattus} SCOP: b.7.1.2 b.7.1.2 PDB: 3hn8_A | Back alignment and structure |
|---|
Probab=99.43 E-value=9.4e-14 Score=146.23 Aligned_cols=91 Identities=15% Similarity=0.076 Sum_probs=82.4
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||+++++|+++. +++|+++++|+||+|||+|.|. ++.+.+ .+.|.++||
T Consensus 18 ~~~~L~v~v~~a~~L~~~d~~g~~dPyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~L~~~V~ 93 (296)
T 1dqv_A 18 GSDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVY 93 (296)
T ss_dssp SSCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCcCeEEEEEEEcCCCe--eEeCCccCCCCCCcEeeEEEEE--ecHHHhcCCEEEEEEE
Confidence 457899999999 9999999999999999999998764 7899999999999999999999 777666 456999999
Q ss_pred cCCCCCCCCcccccccC
Q 005415 342 DNSDTRDGEVNGALHEG 358 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~ 358 (697)
|+|++++++++|++.+.
T Consensus 94 d~d~~~~~~~iG~~~i~ 110 (296)
T 1dqv_A 94 DFDRFSRHDLIGQVVLD 110 (296)
T ss_dssp ECCSSSCCCEEEEEECC
T ss_pred EcCCCCCCceEEEEEec
Confidence 99999999999999774
|
| >2fk9_A Protein kinase C, ETA type; ATP-binding, metal-binding, nucleotide-binding, diacylglycerol binding, serine/threonine-protein kinase, transferase; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.3e-14 Score=137.24 Aligned_cols=88 Identities=13% Similarity=0.015 Sum_probs=74.6
Q ss_pred cccceeEEEEecc-CcccccCC----------CCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHN----------VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG 331 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~----------g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~ 331 (697)
...++|+|.|.+| +|+++|.+ |.+||||++++-. ++..||+++++|+||+|||+|.|. +..
T Consensus 26 ~~~g~L~V~VieA~~L~~~D~~~~~~~f~~~~g~sDPYv~v~l~~----~~~~kT~v~~ktlnP~WNE~F~f~--v~~-- 97 (157)
T 2fk9_A 26 KFNGYLRVRIGEAVGLQPTRWSLRHSLFKKGHQLLDPYLTVSVDQ----VRVGQTSTKQKTNKPTYNEEFCAN--VTD-- 97 (157)
T ss_dssp CEEEEEEEEEEEEECCCCCHHHHHTTTSSSSCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEE--
T ss_pred cCccEEEEEEEEEECCCCccccccccccccCCCCCCeEEEEEECC----EeeEEeeecCCCCCCccCcEEEEE--cCC--
Confidence 4678999999999 99999943 7899999999842 234688999999999999999998 653
Q ss_pred cccccccccccCCCCCCCCcccccccCc
Q 005415 332 AEKDLMPAEIDNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 332 ~~~~L~~~V~D~d~~~~~d~~G~v~~~~ 359 (697)
...|.++|||+|.+++++++|.+.+..
T Consensus 98 -~~~L~~~V~D~d~~~~dd~iG~~~i~l 124 (157)
T 2fk9_A 98 -GGHLELAVFHETPLGYDHFVANCTLQF 124 (157)
T ss_dssp -ECEEEEEEEECCSSSSCEEEEEEEEEH
T ss_pred -CCEEEEEEEECCCCCCCCEEEEEEEEH
Confidence 245999999999999999999997754
|
| >3pyc_A E3 ubiquitin-protein ligase smurf1; phospholipid binding, membrane associate, lipid binding PROT; 1.96A {Homo sapiens} PDB: 2jqz_A | Back alignment and structure |
|---|
Probab=99.42 E-value=5.9e-14 Score=129.72 Aligned_cols=89 Identities=9% Similarity=-0.018 Sum_probs=75.8
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
...|+|.|.+| +|.++|.+|.+||||++.+.+.. .+++|+++++|+||+|||+|.|. +... ..|.++|||+
T Consensus 4 ~~~L~V~v~~a~~L~~~d~~g~sDpyv~v~~~~~~---~~~kT~v~~~t~nP~wne~f~f~--v~~~---~~l~~~v~d~ 75 (132)
T 3pyc_A 4 FIKIRLTVLCAKNLAKKDFFRLPDPFAKIVVDGSG---QCHSTDTVKNTLDPKWNQHYDLY--VGKT---DSITISVWNH 75 (132)
T ss_dssp EEEEEEEEEEEESCCCCSTTCCCCEEEEEEETTTC---CEEECCCCSSCSSCEEEEEEEEE--EETT---CCEEEEEEEG
T ss_pred eEEEEEEEEEeECCCCCCCCCCcCeEEEEEECCCC---ceEECCccCCCCCCCccCEEEEE--eCCC---CEEEEEEEEC
Confidence 36789999999 99999999999999999997652 47889999999999999999997 5432 2399999999
Q ss_pred CCCCC---CCcccccccCccc
Q 005415 344 SDTRD---GEVNGALHEGKAD 361 (697)
Q Consensus 344 d~~~~---~d~~G~v~~~~~~ 361 (697)
|.+++ ++++|.+.+...+
T Consensus 76 d~~~~~~~d~~lG~~~i~l~~ 96 (132)
T 3pyc_A 76 KKIHKKQGAGFLGCVRLLSNA 96 (132)
T ss_dssp GGTTSSTTTTEEEEEEECHHH
T ss_pred CCCCCCCCCCceEEEEEeHHH
Confidence 99987 6999999775433
|
| >2dmh_A Myoferlin; beta-sandwich, FER-1-like protein 3, muscular dystrophy, cardiomyopathy, membrane fusion, dystrophin, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=128.63 Aligned_cols=91 Identities=10% Similarity=-0.026 Sum_probs=78.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc--cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA--EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~--~~~L~~~V 340 (697)
..+.|+|.|.+| +|+++|. |.+||||++++.. .+++|+++++|+||+|||+|.|. +..... ...|.++|
T Consensus 5 ~~g~L~v~v~~a~~L~~~~~-g~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~~~l~i~V 76 (140)
T 2dmh_A 5 SSGMLRVIVESASNIPKTKF-GKPDPIVSVIFKD-----EKKKTKKVDNELNPVWNEILEFD--LRGIPLDFSSSLGIIV 76 (140)
T ss_dssp BCCEEEEEEEEEESCCCCSS-SCCCEEEEEECSS-----CEEECCCCCSCSSCEEEEEEEEE--CSSCCCCTTCEEEEEE
T ss_pred CCcEEEEEEEEeeCCCCCCC-CCCCeEEEEEECC-----EeEEeeeecCCCCCccCcEEEEE--ecccccCCCCEEEEEE
Confidence 346899999999 9999999 9999999999983 36899999999999999999999 665433 45599999
Q ss_pred ccCCCCCCCCcccccccCcccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
||+|.+++++++|.+.+...++
T Consensus 77 ~d~d~~~~~~~lG~~~i~l~~l 98 (140)
T 2dmh_A 77 KDFETIGQNKLIGTATVALKDL 98 (140)
T ss_dssp EETTCSSSCCCCEEEEEEGGGT
T ss_pred EECCCCCCCceEEEEEEEHHHh
Confidence 9999999999999997755443
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.41 E-value=6.1e-14 Score=146.24 Aligned_cols=94 Identities=14% Similarity=0.113 Sum_probs=85.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+|||||+++.+++++..++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 148 ~~~~l~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~l~~~~l~i~V~ 225 (284)
T 2r83_A 148 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 225 (284)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCTTTGGGEEEEEEEE
T ss_pred cCCceEEEEEEeECCCCcCCCCCcCeEEEEEEEeCCcEeeeeccceecCCCCCEEceeEEEe--CCHHHhCceEEEEEEE
Confidence 457899999999 9999999999999999999998777678999999999999999999999 887776 445999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|.+++++++|.+.++.
T Consensus 226 d~d~~~~~~~iG~~~i~l 243 (284)
T 2r83_A 226 DYDKIGKNDAIGKVFVGY 243 (284)
T ss_dssp ECCSSSCCCEEEEEEEET
T ss_pred eCCCCCCCcEEEEEEECC
Confidence 999999999999997754
|
| >3b7y_A E3 ubiquitin-protein ligase NEDD4; C2 domain, UBL-conjugation pathway, structural genomics consortium, SGC, cytoplasm; 1.80A {Homo sapiens} PDB: 2nsq_A | Back alignment and structure |
|---|
Probab=99.41 E-value=6.4e-14 Score=132.75 Aligned_cols=97 Identities=12% Similarity=0.046 Sum_probs=75.6
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCC-CccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~-~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
....|+|.|.+| +|+++|.+|.+||||++.+.+... ...+++|+++++|+||+|||+|.|. +... +..|.++||
T Consensus 18 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~--~~~l~~~V~ 93 (153)
T 3b7y_A 18 NSRIVRVRVIAGIGLAKKDILGASDPYVRVTLYDPMNGVLTSVQTKTIKKSLNPKWNEEILFR--VHPQ--QHRLLFEVF 93 (153)
T ss_dssp TCEEEEEEEEEEESCC-------CCEEEEEEEEETTTEEEEEEECCCCSSCSSCCCCEEEEEE--ECTT--TCEEEEEEE
T ss_pred CccEEEEEEEEeeCCCCCCCCCCCCcEEEEEEECCCCccceeeeCccccCCCCCCCCCEEEEE--ecCC--CCEEEEEEE
Confidence 567899999999 999999999999999999986543 2357899999999999999999998 5543 456999999
Q ss_pred cCCCCCCCCcccccccCcccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
|+|.+++++++|.+.+...++..
T Consensus 94 d~d~~~~d~~iG~~~i~l~~l~~ 116 (153)
T 3b7y_A 94 DENRLTRDDFLGQVDVPLYPLPT 116 (153)
T ss_dssp ECCSSSCCEEEEEEEEECCSCCB
T ss_pred ECCCCcCCCeeEEEEEEHHHccc
Confidence 99999999999999876655444
|
| >3m7f_B E3 ubiquitin-protein ligase NEDD4; C2 domain, GRB10, SH2 domain, phosphoprotein, conjugation pathway, signaling protein-ligase complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-14 Score=136.07 Aligned_cols=99 Identities=9% Similarity=-0.012 Sum_probs=76.5
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCC-ccccceeecccCCCcceecccccCcccccccccccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~-~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
+..+.|+|.|.+| +|+++|..|.+||||++.+.....+ ..+++|+++++|+||+|||+|.|. +... ...|.++|
T Consensus 5 ~~~g~L~V~v~~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--v~~~--~~~L~~~V 80 (176)
T 3m7f_B 5 DDTRVVRVKVIAGIGLAKKDILGASDPYVRVTLYDPMSGILTSVQTKTIKKSLNPKWNEEILFR--VLPQ--RHRILFEV 80 (176)
T ss_dssp TTCEEEEEEEEEEESCC---CCCCCCEEEEEEEEETTTEEEEEEECCCCSSCSSCEEEEEEEEE--ECTT--TCEEEEEE
T ss_pred CCcEEEEEEEEEeeCCCCcCCCCCcCcEEEEEEECCCCCcccceeCceECCCCCCcccceEEEE--EcCC--CCEEEEEE
Confidence 4568899999999 9999999999999999999965432 257899999999999999999998 5532 34599999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
||+|.+++++++|.+.+....+...
T Consensus 81 ~d~d~~~~d~~lG~~~i~l~~l~~~ 105 (176)
T 3m7f_B 81 FDENRLTRDDFLGQVDVPLYPLPTE 105 (176)
T ss_dssp EECC----CEEEEEEEEESCSCCBC
T ss_pred EECCCCCCCcEEEEEEEEHHHcccc
Confidence 9999999999999998766555443
|
| >1gmi_A Protein kinase C, epsilon type; PKC, C2 domain, X-RAY, phospholipids, PKC epsilon.; 1.7A {Rattus rattus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-14 Score=132.69 Aligned_cols=89 Identities=10% Similarity=0.067 Sum_probs=74.2
Q ss_pred cceeEEEEecc-CcccccCCCC-----------CCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVV-----------GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~-----------sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~ 332 (697)
.+.|+|.|.+| +|+++|.+|. +||||++.+-. ....+|+++++|+||+|||+|.|. +...
T Consensus 5 ~g~L~v~v~~a~~L~~~d~~~~~~~g~~~~~~~~DPyv~v~l~~----~~~~~T~~~~~t~nP~WnE~f~f~--v~~~-- 76 (136)
T 1gmi_A 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNVDD----SRIGQTATKQKTNSPAWHDEFVTD--VCNG-- 76 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEETT----EEEEECCCCSSCSSCEEEEEEEEE--EEEE--
T ss_pred ceEEEEEEEeCcCCCCcccccccccccccCCcCcCcEEEEEECC----eEeeeeeEECCCcCCccCCEEEEE--ecCC--
Confidence 46899999999 9999997665 99999999832 235678889999999999999998 6543
Q ss_pred ccccccccccCCCCCCCCcccccccCcccc
Q 005415 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 333 ~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
..|.++|||+|.+++++++|.+.+...+.
T Consensus 77 -~~L~~~V~d~d~~~~dd~iG~~~i~l~~l 105 (136)
T 1gmi_A 77 -RKIELAVFHDAPIGYDDFVANCTIQFEEL 105 (136)
T ss_dssp -CEEEEEEEECCSSSSCEEEEEEEEEHHHH
T ss_pred -CEEEEEEEeCCCCCCCCEEEEEEEEHHHh
Confidence 56999999999999999999997754433
|
| >2ep6_A MCTP2 protein; beta sandwich, Ca2+ binding, membrane binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=7.8e-14 Score=129.11 Aligned_cols=92 Identities=11% Similarity=0.044 Sum_probs=79.7
Q ss_pred ccccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccc
Q 005415 262 KINNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 262 ~~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
....+.|+|.|.+| +|+++|..|.+||||++.+.+ .+++|+++++|+||+|||+|.|. +.. ....|.++|
T Consensus 9 ~~~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~--~~~--~~~~l~i~V 79 (133)
T 2ep6_A 9 VKDVGILQVKVLKAADLLAADFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTV 79 (133)
T ss_dssp CCCSEEEEEEEEEEESCCCSSSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEE
T ss_pred cCCceEEEEEEEeeECCCCCCCCCCcCeEEEEEECC-----EEEEeeeecCCCCCccccEEEEE--ecC--CCCEEEEEE
Confidence 35778999999999 999999999999999999965 26789999999999999999998 553 345699999
Q ss_pred ccCCCCCCCCcccccccCcccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
||+|.+++++++|.+.+...++
T Consensus 80 ~d~d~~~~~~~lG~~~i~l~~l 101 (133)
T 2ep6_A 80 FDEDGDKPPDFLGKVAIPLLSI 101 (133)
T ss_dssp EEEETTEEEEECCBCEEEGGGC
T ss_pred EECCCCCCCCeeEEEEEEHHHc
Confidence 9999999999999997765444
|
| >2r83_A Synaptotagmin-1; C2A-C2B, exocytosis, calcium, cell junction, cytoplasmic vesicle, glycoprotein, lipoprotein, membrane, metal-binding palmitate; 2.70A {Homo sapiens} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.38 E-value=2.6e-13 Score=141.43 Aligned_cols=96 Identities=15% Similarity=0.111 Sum_probs=84.9
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| +|+++|.+|.+||||++.+.+++++ +++|+++++|+||+|||+|.|. ++.+.+ ...|.++||
T Consensus 17 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~~T~~~~~~~nP~wne~f~f~--v~~~~~~~~~l~~~V~ 92 (284)
T 2r83_A 17 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELAGKTLVMAVY 92 (284)
T ss_dssp TTTEEEEEEEEEECCCCCSSSSSCCEEEEEEEETCTTS--CEECCCCCSCSSCEEEEEEEEC--CCGGGCTTCEEEEEEE
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCeEEEEEEEcCCCc--eEeCCcccCCCCCeeCceEEEE--echHHhCcCEEEEEEE
Confidence 557899999999 9999999999999999999987655 7789999999999999999999 887766 466999999
Q ss_pred cCCCCCCCCcccccccCccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|+|.+++++++|++.+...++.
T Consensus 93 d~d~~~~~~~lG~~~i~l~~l~ 114 (284)
T 2r83_A 93 DFDRFSKHDIIGEFKVPMNTVD 114 (284)
T ss_dssp ECCSSSCCCEEEEEEEEGGGCC
T ss_pred ECCCCCCCceeEEEEEcchhcc
Confidence 9999999999999987655543
|
| >1wfj_A Putative elicitor-responsive gene; C2 domain, riken structural genomics/proteomics initiative, RSGI, structural genomics, plant protein; NMR {Arabidopsis thaliana} SCOP: b.7.1.2 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.6e-13 Score=125.82 Aligned_cols=88 Identities=13% Similarity=0.051 Sum_probs=76.6
Q ss_pred cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecc-cCCCcceecccccCcccccccccccccccc
Q 005415 263 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 263 ~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k-~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
...+.|+|.|.+| +|+++|..|.+||||++.+.+. +++|++.+ +|+||+|||+|.|. +.. ....|.++|
T Consensus 7 ~~~~~L~v~v~~a~~L~~~d~~g~~dpyv~v~~~~~-----~~kT~~~~~~~~nP~Wne~f~f~--v~~--~~~~l~~~V 77 (136)
T 1wfj_A 7 GPHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRTQ-----DQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKI 77 (136)
T ss_dssp CCEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSSC-----EEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEE
T ss_pred CCcEEEEEEEEeccCCCCcccCCCcCceEEEEECCc-----cceeEeccCCCCCCccCcEEEEE--ECC--CCCEEEEEE
Confidence 3567899999999 9999999999999999999753 56788877 99999999999998 654 445599999
Q ss_pred ccCCCCCCCCcccccccCc
Q 005415 341 IDNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~ 359 (697)
||+|.+++++++|.+.+..
T Consensus 78 ~d~~~~~~d~~lG~~~i~l 96 (136)
T 1wfj_A 78 FDKDVGTEDDAVGEATIPL 96 (136)
T ss_dssp CCSSSCTTTCCSEEEEEES
T ss_pred EECCCCCCCceEEEEEEEH
Confidence 9999999999999997654
|
| >3nsj_A Perforin-1; pore forming protein, immune system; HET: NAG; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3e-13 Score=153.20 Aligned_cols=100 Identities=12% Similarity=0.097 Sum_probs=81.2
Q ss_pred CCccc-cCCCCc---------cccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecc
Q 005415 252 PLCKC-CAGEGK---------INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEG 320 (697)
Q Consensus 252 ~~c~~-~~~~~~---------~s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~ 320 (697)
-.|.| |+..-- ...++|+|.|.+| +|++ |..|.+|||||+++.. .+.||+++++|+||+|||+
T Consensus 370 ~~C~C~C~~~~~t~~~~C~~~~~~~~L~V~V~~A~~L~~-D~~g~sDPYV~v~l~~-----~~~kTkvik~tlNP~Wne~ 443 (540)
T 3nsj_A 370 DSCQCECQDSKVTNQDCCPRQRGLAHLVVSNFRAEHLWG-DYTTATDAYLKVFFGG-----QEFRTGVVWNNNNPRWTDK 443 (540)
T ss_dssp CTTCEEESCTTTBCGGGCBSSTTEEEEEEEEEEEESCCC-SSCSCCCEEEEEEETT-----EEEECCCBCSCSSCBCCCC
T ss_pred CceEeeCCCCCCcccccccccCcccEEEEEEEEccCCCc-ccCCCcCeEEEEEECC-----EeeeeeeecCCCCCCCCeE
Confidence 35777 766411 1356899999999 9999 9999999999999962 3589999999999999999
Q ss_pred cccCccccccccccccccccccCCCCCCCCcccccccCc
Q 005415 321 FKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 321 f~f~~~v~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~ 359 (697)
|.|. +........|.++|||+|.++++|++|.+.+..
T Consensus 444 f~f~--~~~~~~~~~L~~~V~D~D~~~~dD~LG~~~~~L 480 (540)
T 3nsj_A 444 MDFE--NVLLSTGGPLRVQVWDADYGWDDDLLGSCDRSP 480 (540)
T ss_dssp EEEE--EEETTTCCCEEEEEEECCSSSCCEEEEEEEECC
T ss_pred EEEE--EecCCCCCEEEEEEEECCCCCCCCEEEEEEEEe
Confidence 9997 432224556999999999999999999997654
|
| >3kwu_A MUNC13-1; calcium binding protein, phospholipid binding protein, metal binding protein; HET: GOL; 1.37A {Rattus norvegicus} SCOP: b.7.1.0 PDB: 3kwt_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.1e-13 Score=125.76 Aligned_cols=90 Identities=11% Similarity=0.043 Sum_probs=76.6
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
..+.|+|.|.+| +|+++|.+|.+||||++.+- ..+++|+++++|+||+|||+|.|. +... ...|.++|||
T Consensus 15 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~~~~~t~nP~Wne~f~f~--v~~~--~~~l~~~v~d 85 (148)
T 3kwu_A 15 WSAKISITVVCAQGLQAKDKTGSSDPYVTVQVG-----KTKKRTKTIYGNLNPVWEENFHFE--CHNS--SDRIKVRVLD 85 (148)
T ss_dssp CCEEEEEEEEEEESCCCCSTTSCCCEEEEEEET-----TEEEECCCCCSCSSCEEEEEEEEE--ECST--TCEEEEEEEE
T ss_pred cccEEEEEEEeeeCCCCCCCCCCcCeEEEEEEC-----CEEEECCccCCCCCCCcccEEEEE--ecCC--CCEEEEEEEE
Confidence 357899999999 99999999999999999992 247789999999999999999998 5433 2459999999
Q ss_pred CCCC-----------CCCCcccccccCcccc
Q 005415 343 NSDT-----------RDGEVNGALHEGKADA 362 (697)
Q Consensus 343 ~d~~-----------~~~d~~G~v~~~~~~~ 362 (697)
+|.+ ++++++|.+.+...++
T Consensus 86 ~d~~~~~~~~~~~~~~~~~~lG~~~i~l~~l 116 (148)
T 3kwu_A 86 EDDDIKSRVKQRFKRESDDFLGQTIIEVRTL 116 (148)
T ss_dssp CCCSHHHHHHTTTSSCSSEEEEEEEEEGGGC
T ss_pred CCCCccccccccccCCCCccEEEEEEEHHHC
Confidence 9986 7899999997765444
|
| >2nq3_A Itchy homolog E3 ubiquitin protein ligase; C2 domain, UBL conjugation pathway, structural genomics consortium, SGC; 1.80A {Homo sapiens} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-12 Score=127.78 Aligned_cols=85 Identities=7% Similarity=-0.064 Sum_probs=71.4
Q ss_pred ccceeEEEEecc-Ccc-cccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLI-DLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~-~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
....|+|.|.+| +|+ ++|..+ +||||++++.. .++||+++++|+||+|||+|.|. +.. ...|.++||
T Consensus 34 ~~~~L~V~V~~A~~L~~~~~~~~-sDPYv~v~~~~-----~~~kT~v~~~tlnP~Wne~f~f~--v~~---~~~L~~~V~ 102 (173)
T 2nq3_A 34 MKSQLQITVISAKLKENKKNWFG-PSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VTP---VSKLHFRVW 102 (173)
T ss_dssp CCEEEEEEEEEEEECCCC--CCC-CCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ECT---TCEEEEEEE
T ss_pred CceEEEEEEEEeECCCCcccCCC-CCeEEEEEECC-----EEeEccccCCCCCCeECCEEEEE--eCC---CCEEEEEEE
Confidence 456799999999 999 666655 99999999954 58899999999999999999998 632 556999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|.+++++++|.+.+..
T Consensus 103 D~d~~~~dd~lG~~~i~l 120 (173)
T 2nq3_A 103 SHQTLKSDVLLGTAALDI 120 (173)
T ss_dssp ECCSSSCCEEEEEEEEEH
T ss_pred ECCCCCCCceEEEEEEEH
Confidence 999999999999997644
|
| >2cjt_A UNC-13 homolog A, MUNC13-1; phorbol-ester binding, neurotransmitter release, RIM, MUNC13 domains, exocytosis, metal-binding; 1.44A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-12 Score=120.80 Aligned_cols=88 Identities=10% Similarity=0.007 Sum_probs=68.7
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceee-cccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSS-SKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v-~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
+...|+|+|++| +|.+ +|.+||||++. . + +.||++ +++|+||+|||+|.|. +.. .+..|.++||
T Consensus 3 ~~~~L~V~V~~A~~l~~---~g~~DPYv~v~-~-----~-~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~ 68 (131)
T 2cjt_A 3 VMSLLCVGVKKAKFDGA---QEKFNTYVTLK-V-----Q-NVKSTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVW 68 (131)
T ss_dssp CCEEEEEEEEEEECSSC---GGGCEEEEEEE-E-----T-TEEEECCCEESSSCEEEEEEEEE--ECC--CSSEEEEEEE
T ss_pred cceEEEEEEEEeECCCC---CCCcCeEEEEE-e-----c-CEEEeEecCCCCCceECCEEEEE--EeC--CCCeEEEEEE
Confidence 457899999999 7753 78999999999 1 1 234444 5589999999999998 653 3445999999
Q ss_pred cCCCCCCCCcccccccCcccccccC
Q 005415 342 DNSDTRDGEVNGALHEGKADAEEHG 366 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d~e~ 366 (697)
|+| +++++++|.+.+...++...+
T Consensus 69 D~d-~~~dd~iG~~~i~l~~l~~~~ 92 (131)
T 2cjt_A 69 NKG-LIWDTMVGTVWIPLRTIRQSN 92 (131)
T ss_dssp ECC-SSCEEEEEEEEEEGGGSCBCS
T ss_pred ECC-CCCCCeEEEEEEEHHHhhhcC
Confidence 999 889999999988766655444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.1e-10 Score=117.21 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=106.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
..|++...++.|+.+.||++.. .+..+++|+..... .....+.+|..+++.+.. +..+.++++++......|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-----KLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-----TSCCCCEEEEEEETTEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-----CCCCCeEEEEEecCCceE
Confidence 3588999999999999999974 36889999987521 223568899999999964 245778888888888999
Q ss_pred EEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 005415 493 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------------------------------- 539 (697)
Q Consensus 493 LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs--------------------------------- 539 (697)
+|||+++|..+.... .+......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~----------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEY----------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHC----------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhcc----------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999975433221 1112234688899999999998
Q ss_pred --------------------------cCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 540 --------------------------~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
..++|+|++|.|||++. ...+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD--GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET--TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC--CcEEEEEEchhcc
Confidence 45899999999999973 4455799999764
|
| >2cjs_A UNC-13 homolog A, MUNC13-1; neurotransmitter transport, zinc finger, synapto phorbol-ester binding; 1.78A {Rattus norvegicus} SCOP: b.7.1.1 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.7e-11 Score=118.48 Aligned_cols=84 Identities=11% Similarity=-0.017 Sum_probs=66.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceee-cccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSS-SKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v-~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
....|+|.|++| +|. .+|.+||||++. . .+.||++ +++|+||+|||+|.|. +.. .+..|.++||
T Consensus 12 ~~~~L~V~V~~A~~l~---~~g~~DPYV~v~--~-----~~~kt~~~~~~t~nP~WnE~f~f~--v~~--~~~~L~~~V~ 77 (167)
T 2cjs_A 12 ILSLLCVGVKKAKFDG---AQEKFNTYVTLK--V-----QNVESTTIAVRGSQPSWEQDFMFE--INR--LDLGLTVEVW 77 (167)
T ss_dssp CCCEEEEEEEEEECSS---CGGGCEEEEEEE--E-----TTEEEECCCEESSSCEEEEEEEEE--CCC--TTSEEEEEEE
T ss_pred ceEEEEEEEEEEECCC---CCCCCCeEEEEE--e-----cceEEEEecCCCCCCCCCCEEEEE--eeC--CCCEEEEEEE
Confidence 467999999999 774 378999999999 1 1344555 4579999999999999 653 3445999999
Q ss_pred cCCCCCCCCcccccccCcccc
Q 005415 342 DNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|+| +++++++|.+.+...++
T Consensus 78 D~d-~~~dd~iG~~~i~L~~l 97 (167)
T 2cjs_A 78 NKG-LIWDTMVGTVWIPLRTI 97 (167)
T ss_dssp ECC-SSCCEEEEEEEEEGGGS
T ss_pred ECC-CCCCceEEEEEEEHHHh
Confidence 999 88999999997755443
|
| >1cjy_A CPLA2, protein (cytosolic phospholipase A2); lipid-binding, hydrolase; HET: MES; 2.50A {Homo sapiens} SCOP: b.7.1.1 c.19.1.2 PDB: 1bci_A | Back alignment and structure |
|---|
Probab=99.08 E-value=4e-11 Score=140.00 Aligned_cols=93 Identities=13% Similarity=0.005 Sum_probs=80.9
Q ss_pred ccceeEEEEecc-Cccc---ccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~---~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~ 339 (697)
..+.|+|.|.+| +|++ +|.+|.+||||++++.+++. .++||+++++|+||+|||+|.|. +... ....|.++
T Consensus 16 ~~g~L~V~Vi~A~nL~~~~~~D~~g~sDPYV~V~l~~~~~--~k~kTkvik~tlNPvWNEtF~F~--v~~~-~~~~L~~~ 90 (749)
T 1cjy_A 16 YSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPD--SRKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEIT 90 (749)
T ss_dssp CCEEEEEEEEEEECCCSCHHHHHHCCCCEEEEEECTTSTT--CCEECCCCTTCSSCEEEEEEEEE--ECTT-SCCBCEEE
T ss_pred CccEEEEEEEEEECCCCccccCCCCCcCeEEEEEEecCCC--CeEecceEcCCCCCeeeeEEEEE--ecCC-CCCEEEEE
Confidence 457899999999 9999 99999999999999998655 58899999999999999999998 6543 23459999
Q ss_pred cccCCCCCCCCcccccccCcccc
Q 005415 340 EIDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|||+|.++ ++++|++.+...++
T Consensus 91 V~D~D~~~-ddfIG~v~I~L~~L 112 (749)
T 1cjy_A 91 LMDANYVM-DETLGTATFTVSSM 112 (749)
T ss_dssp EEECCSSS-CEEEEEECCBSTTS
T ss_pred EEECCCCC-CceeEEEEEEHHHc
Confidence 99999999 99999998866554
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.05 E-value=5.4e-11 Score=137.40 Aligned_cols=93 Identities=9% Similarity=-0.018 Sum_probs=78.9
Q ss_pred ccceeEEEEecc-CcccccC--CCCCCcceEeeccCCCCCccccceeecccC-CCcceecccccCccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRG-SSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~--~g~sDpyVk~~l~pd~~~~~k~kt~v~k~t-lnP~fnE~f~f~~~v~~~~~~~~L~~~ 339 (697)
....|+|.|.+| +|+++|. +|.+||||++.|...+....++||++++++ +||+|||+|.|. +....+ ..|.++
T Consensus 495 ~~~~L~V~Vi~A~~L~~~d~~~~~~~DPYV~V~l~g~~~d~~~~kTkvi~~ng~NP~WnE~f~F~--v~~~el-~~L~~~ 571 (624)
T 1djx_A 495 RPERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFM 571 (624)
T ss_dssp CCEEEEEEEEEEESCCCCSSCSSSCCCEEEEEEEESSGGGCEEEECCCCTTCSSSCEEEEEEEEE--ESCGGG-CEEEEE
T ss_pred cceEEEEEEEEcCCCCcccccccCCCCcEEEEEEecCCCCcceeecccccCCCCCCccCceEEEE--EecCCC-CEEEEE
Confidence 557899999999 9999994 789999999999765555568899998887 999999999998 654443 349999
Q ss_pred cccCCCCCCCCcccccccCc
Q 005415 340 EIDNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~~~ 359 (697)
|||+|.+++++++|.+.+..
T Consensus 572 V~D~D~~~~dd~iG~~~ipl 591 (624)
T 1djx_A 572 VEDYDSSSKNDFIGQSTIPW 591 (624)
T ss_dssp EEECCSSSCCEEEEEEEEEG
T ss_pred EEEcCCCCCCceeEEEEEEH
Confidence 99999999999999986644
|
| >3jzy_A Intersectin 2; C2 domain, structural genomics consortium (SGC), endocytosis; 1.56A {Homo sapiens} PDB: 3qbv_B* 1ki1_B | Back alignment and structure |
|---|
Probab=99.03 E-value=8.2e-11 Score=132.60 Aligned_cols=87 Identities=10% Similarity=-0.005 Sum_probs=74.5
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
.+.|+|.|.+| +|+++|.+|.+||||++.+.+ .+++|+++++|+||+|||+|.|. +... ....|.++|||+
T Consensus 386 ~~~l~v~v~~a~~L~~~d~~~~sdpyv~v~~~~-----~~~~T~~~~~t~nP~w~e~f~f~--~~~~-~~~~l~~~v~d~ 457 (510)
T 3jzy_A 386 IGRLMVHVIEATELKACKPNGKSNPYCEISMGS-----QSYTTRTIQDTLNPKWNFNCQFF--IKDL-YQDVLCLTLFDR 457 (510)
T ss_dssp CEEEEEEEEEEESCCCCSTTSCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ESCT-TTCEEEEEEEEC
T ss_pred CceEEEEeceeecCCCCCCCCCCCeEEEEEECC-----eeccCCccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeC
Confidence 35788999999 999999999999999999942 47899999999999999999998 5422 234599999999
Q ss_pred CCCCCCCcccccccCc
Q 005415 344 SDTRDGEVNGALHEGK 359 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~ 359 (697)
|.+++++++|.+....
T Consensus 458 d~~~~~d~lG~~~~~l 473 (510)
T 3jzy_A 458 DQFSPDDFLGRTEIPV 473 (510)
T ss_dssp CSSSSCCEEEEEEEEH
T ss_pred CCCCCCCceEEEEEEH
Confidence 9999999999996643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=3.1e-09 Score=107.33 Aligned_cols=135 Identities=14% Similarity=0.086 Sum_probs=95.7
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
.|.+....+.|..+.||++. ..+|..+++|+.... ....+..|..+++.+... . -.+.+++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~-~---~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG--ALNELQDEAARLSWLATT-G---VPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT-T---CCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC-C---CCCCeEEEeccCCCCCEEE
Confidence 45655444566679999996 456788999998754 235678899999999753 1 1366678888777889999
Q ss_pred EEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 005415 495 CELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--------------------------------- 541 (697)
Q Consensus 495 mEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--------------------------------- 541 (697)
|||++|.... .. . .. ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~-~~---~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 94 LGEVPGQDLL-SS---H------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EECCSSEETT-TS---C------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEecCCcccC-cC---c------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 9999875333 10 0 11 1245666777777777543
Q ss_pred -------------------------ccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 542 -------------------------IIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 542 -------------------------IvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++|+|++|.|||++. +..+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~--~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN--GRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET--TEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC--CcEEEEEcchhcc
Confidence 999999999999973 4556699999874
|
| >3l9b_A Otoferlin; C2-domain, beta-sheets, cell membrane, synaptic V hearing, membrane, synapse, transmembrane, membrane protein; 1.95A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-10 Score=108.26 Aligned_cols=90 Identities=12% Similarity=-0.001 Sum_probs=75.5
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecc-cCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSK-RGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k-~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
+.+.|+|.|+.| +|+ |.+|||+|+.. +..|+||++.+ +++||+|||.|.|. +.-... +.+|.+.|
T Consensus 19 ~~msL~V~l~~a~~Lp-----g~~Dp~akv~F-----Rg~k~kTkvi~~~~~npvfnE~F~wp--l~~~ld~~e~L~v~V 86 (144)
T 3l9b_A 19 SHMALIVHLKTVSELR-----GRADRIAKVTF-----RGQSFYSRVLENCEDVADFDETFRWP--VASSIDRNEVLEIQI 86 (144)
T ss_dssp CCEEEEEEEEEEESCC-----SCEEEEEEEEE-----TTEEEECCCEEEECSCEEEEEEEEEE--ESSCCCTTCEEEEEE
T ss_pred CcEEEEEEEEEecCCC-----CCCCCeEEEEE-----eccceeeEEeccCCCCceEcceEEec--CCCCCCCCCEEEEEE
Confidence 779999999999 999 68999999999 35699999987 79999999999998 655333 45599999
Q ss_pred ccCCCCCCCCcccccccCccccccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADAEEH 365 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~d~e 365 (697)
.|+++++++.++|++...-.+....
T Consensus 87 ~d~~~v~~nrlIG~~~i~Lq~lv~~ 111 (144)
T 3l9b_A 87 FNYSKVFSNKLIGTFRMVLQKVVEE 111 (144)
T ss_dssp EEECTTSCCEEEEEEEEESHHHHHH
T ss_pred EECccccCCCEEEEEEEEhHHhccC
Confidence 9999999999999997754444443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=5.3e-09 Score=112.17 Aligned_cols=142 Identities=12% Similarity=0.184 Sum_probs=102.5
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEe--cch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec---CeE
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---EHL 491 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~--~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~---~~l 491 (697)
++.|+.|.++.||++.. .+..+++|+.. ... .....+.+|..+++.+... +..+++++.++... ...
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~----~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGT----DVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTS----SSCCCCEEEEECCTTTTSSC
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcC----CCCCCcEEEECCCCCccCCe
Confidence 57789999999999974 34678889876 332 2235778899999999753 34577888887765 448
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-------------------------------- 539 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-------------------------------- 539 (697)
|+|||+++|..... . ....++......++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~----~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 117 FYIMEFVSGRVLWD----Q---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEEECCCCBCCCC----T---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCC----C---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 99999998753210 0 00116677888899999999999997
Q ss_pred --------------------------cCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 540 --------------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 540 --------------------------~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
..++|+|++|.|||++.++...+.|+||+.+...
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 3589999999999998633334689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.3e-09 Score=111.18 Aligned_cols=185 Identities=17% Similarity=0.162 Sum_probs=116.9
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---eEEEEEE
Q 005415 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---HLFIVCE 496 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~---~l~LVmE 496 (697)
+.++.|....||++. ..+++|+.... .....+.+|..+++.+........| +++....... ..|+||+
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP---~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIP---EVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCC---CEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCC---ceEeecCCCCCCCcceEEEc
Confidence 348889999999863 46889987643 3446788999999998654333333 3444333332 3589999
Q ss_pred ccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 005415 497 LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS------------------------------------- 539 (697)
Q Consensus 497 yl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs------------------------------------- 539 (697)
+++|......... .++..+...++.|++..|..||+
T Consensus 97 ~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9987533211110 15666667777777777777775
Q ss_pred ---------------------cCccccCCCCccccccccCcceEEEeeCCCccccccccccccccCCC---CCchhhc--
Q 005415 540 ---------------------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---RAPEVII-- 593 (697)
Q Consensus 540 ---------------------~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y---~APE~l~-- 593 (697)
..++|+|++|.||+++.+....+.|+||+.+........ ....... ..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHH
Confidence 137999999999999853245678999998865432111 1111111 2333221
Q ss_pred --CCC----------CCchhhHHHHHHHHHHHHhCCCCCC
Q 005415 594 --GLP----------YDQKIDLWSLGCILAELWTGEVLFP 621 (697)
Q Consensus 594 --~~~----------~s~ksDIWSLGviL~ELltG~~PF~ 621 (697)
..+ .....+.|+++.++|.+.+|..+|-
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 101 0122689999999999999988763
|
| >3bxj_A RAS GTPase-activating protein syngap; GTPase activation, membrane, phosphoprotein, SH3-binding, signaling protein; 3.00A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.75 E-value=8.9e-10 Score=123.80 Aligned_cols=88 Identities=15% Similarity=0.004 Sum_probs=9.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccC---CCcceecccccCccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRG---SSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~t---lnP~fnE~f~f~~~v~~~~~~~~L~~~ 339 (697)
..+.|+|.|.+| +|+++| ||||++++-. + .+.||+++++| +||+|||+|.|. +... ...|.++
T Consensus 9 ~~~~L~V~VieAk~L~~~d-----dpYv~v~l~~--~--~~~kT~v~~kt~~glnP~WnE~F~f~--~~~~--~~~L~v~ 75 (483)
T 3bxj_A 9 VDNVLKLWIIEARELPPKK-----RYYCELCLDD--M--LYARTTSKPRSASGDTVFWGEHFEFN--NLPA--VRALRLH 75 (483)
T ss_dssp EEECC------------------------------------------------------CCEECC---------------
T ss_pred eccEEEEEEEEcCCcCCCC-----CCeEEEEECC--e--EEeeeeEEeCCCCCCCCccccEEEEe--cCCC--ccEEEEE
Confidence 457899999999 999998 9999999842 2 25689999999 999999999998 3222 2569999
Q ss_pred ccc-CC---CCCCCCcccccccCcccccc
Q 005415 340 EID-NS---DTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 340 V~D-~d---~~~~~d~~G~v~~~~~~~d~ 364 (697)
||| +| ++++++++|.+.++......
T Consensus 76 V~d~~d~~~~~~~d~~lG~v~i~l~~l~~ 104 (483)
T 3bxj_A 76 LYRDSDKKRKKDKAGYVGLVTVPVATLAG 104 (483)
T ss_dssp -----------------------------
T ss_pred EEecCCccccCCCCceEEEEEEEHHHhcC
Confidence 999 45 47889999999887665544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=5.6e-06 Score=86.95 Aligned_cols=74 Identities=18% Similarity=0.089 Sum_probs=51.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-ecCeEEEEEEc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFIVCEL 497 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~-~~~~l~LVmEy 497 (697)
++.++.|....||+. +..+++|+... ......+..|..+|+.|....... +.+++.+.. ..+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEec
Confidence 345788888899987 56788898543 334567889999999998643222 445555543 34567899999
Q ss_pred cccc
Q 005415 498 LRAN 501 (697)
Q Consensus 498 l~gs 501 (697)
++|.
T Consensus 95 i~G~ 98 (306)
T 3tdw_A 95 VQGQ 98 (306)
T ss_dssp CCSE
T ss_pred cCCe
Confidence 9874
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=98.32 E-value=2e-07 Score=110.25 Aligned_cols=84 Identities=13% Similarity=0.071 Sum_probs=64.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCC-Ccccccee-ec-ccCCCcceec-cccc-Cccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYS-SS-KRGSSIDWIE-GFKG-SSDLHFKGAEKDLM 337 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~-~~~k~kt~-v~-k~tlnP~fnE-~f~f-~~~v~~~~~~~~L~ 337 (697)
..+.|+|.|..| +|+. +.+|||||+.|...+. ..+|+||+ +. ++++||+||| +|.| . |....+. .|.
T Consensus 676 ~~~~L~V~Visa~~L~~----~~~DPYV~V~l~g~p~d~~~k~kTk~vv~~n~~NPvWnEe~f~F~~--v~~~el~-~Lr 748 (799)
T 2zkm_X 676 VATTLSITVISGQFLSE----RSVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEK--ILMPELA-SLR 748 (799)
T ss_dssp TCEEEEEEEEEEESCCS----SCCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEE--ESSGGGC-EEE
T ss_pred eeeeEEEEEEeccccCc----cCCCcEEEEEEEecCCCcccceeecccccCCCCCCeeecceEEEEE--EccCCcc-EEE
Confidence 346899999999 9985 5789999999975332 12367888 65 4679999999 7999 6 5544444 489
Q ss_pred cccccCCCCCCCCcccccccC
Q 005415 338 PAEIDNSDTRDGEVNGALHEG 358 (697)
Q Consensus 338 ~~V~D~d~~~~~d~~G~v~~~ 358 (697)
+.|||+| ++++|.+.+.
T Consensus 749 ~~V~D~d----~d~iG~~~ip 765 (799)
T 2zkm_X 749 VAVMEEG----NKFLGHRIIP 765 (799)
T ss_dssp EEEEETT----TEEEEEEEEE
T ss_pred EEEEEeC----CCccceEeee
Confidence 9999997 7899987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1e-05 Score=82.48 Aligned_cols=74 Identities=8% Similarity=0.100 Sum_probs=55.9
Q ss_pred EeccCCCC-ceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 005415 421 YLGSAAFS-KVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (697)
Q Consensus 421 ~LG~G~fG-~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~ 499 (697)
.+..|..+ .||+......+..++||+-.... ...+.+|..+|+.+... --+.+++.++.+.+..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~-----vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAF-----MPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTT-----SCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccC-----CCcCeEEEEEEECCeEEEEEEeeC
Confidence 34445555 58998877778889999876543 35678899999998642 136677888888899999999998
Q ss_pred cc
Q 005415 500 AN 501 (697)
Q Consensus 500 gs 501 (697)
|.
T Consensus 104 G~ 105 (272)
T 4gkh_A 104 GK 105 (272)
T ss_dssp SE
T ss_pred Cc
Confidence 74
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=98.19 E-value=4.8e-07 Score=106.81 Aligned_cols=83 Identities=13% Similarity=-0.014 Sum_probs=62.4
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCC--ccccceeecc-cCCCcceecc-cccCccccccccccccccc
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT--EKSSSYSSSK-RGSSIDWIEG-FKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~--~~k~kt~v~k-~tlnP~fnE~-f~f~~~v~~~~~~~~L~~~ 339 (697)
...|+|.|+.| +|+.+ .+||||++.|...+.. .+|+||++.+ +++||+|||+ |.|.. +....+ ..|.+.
T Consensus 649 ~~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~d~~~~k~kTkvv~~nglNPvWNE~~F~F~~-v~~pel-a~Lrf~ 722 (816)
T 3qr0_A 649 AGTIEIKIISAQFLSDK----QISSYVEVEMYGLPTDTVRKKFKTKIIENNGMDPYYDEKVFVFKK-VVLPDL-AVVRII 722 (816)
T ss_dssp CEEEEEEEEEEECCCSS----CCCEEEEEEEESSGGGCEEEEEECCCBCSCSSCCBCCCCCEEEEE-ESCGGG-CEEEEE
T ss_pred ceEEEEEEEEcccCCCC----CCCCeEEEEEeCCCcccccceeeeEEecCCCCCCeEcCceeEEcc-ccCCCc-cEEEEE
Confidence 46799999999 99853 6899999999864332 2578898866 4799999998 99972 222222 248999
Q ss_pred cccCCCCCCCCccccccc
Q 005415 340 EIDNSDTRDGEVNGALHE 357 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~ 357 (697)
|||++ ++++|...+
T Consensus 723 V~D~d----ddfiG~~~i 736 (816)
T 3qr0_A 723 VSEEN----GKFIGHRVM 736 (816)
T ss_dssp EEETT----SCEEEEEEE
T ss_pred EEecC----CCeeeEEEE
Confidence 99985 788998644
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=8.6e-07 Score=105.30 Aligned_cols=83 Identities=16% Similarity=0.075 Sum_probs=61.5
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCC-Cccccceeeccc-CCCcceec-ccccCcccccccccccccccc
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG-TEKSSSYSSSKR-GSSIDWIE-GFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~-~~~k~kt~v~k~-tlnP~fnE-~f~f~~~v~~~~~~~~L~~~V 340 (697)
...|+|.|+.| +|+.+ .+||||++.|...+. ..+|+||+++++ ++||+||| +|.|.. |....+. .|.+.|
T Consensus 724 ~~~L~V~Visaq~L~~~----~~DPYV~V~l~g~p~D~~~k~kTkvi~~NglNPvWnEe~F~F~~-V~~pela-~Lrf~V 797 (885)
T 3ohm_B 724 ANALRVKVISGQFLSDR----KVGIYVEVDMFGLPVDTRRKYRTRTSQGNSFNPVWDEEPFDFPK-VVLPTLA-SLRIAA 797 (885)
T ss_dssp CEEEEEEEEEEESCCSS----CCCEEEEEEEESSTTTCBCCCCCCCCSSCSSSCBCCCCCEEEEE-ESCGGGC-EEEEEE
T ss_pred ceEEEEEEEEeccCccc----CCCcEEEEEEeCCCcccccceeeEEeeCCCcCCeeccceeEEee-EEcCCcC-EEEEEE
Confidence 35799999999 99853 689999999975322 224678988665 69999999 699972 2222222 489999
Q ss_pred ccCCCCCCCCccccccc
Q 005415 341 IDNSDTRDGEVNGALHE 357 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~ 357 (697)
||+| ++++|.+.+
T Consensus 798 ~D~d----ddfiG~~~l 810 (885)
T 3ohm_B 798 FEEG----GKFVGHRIL 810 (885)
T ss_dssp EETT----TEEEEEEEE
T ss_pred EcCC----ccEEeeEEE
Confidence 9997 789998744
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=3.8e-05 Score=83.23 Aligned_cols=77 Identities=18% Similarity=0.126 Sum_probs=50.9
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecch--------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++.||.|..+.||++.+...++.++||...... ....+...|..+++.+.... ...+.+++.+ +...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~---~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC---CCCcCeEEEE--cCCc
Confidence 567999999999999765567889999865321 12345678999999886532 1234455543 3455
Q ss_pred EEEEEEcccc
Q 005415 491 LFIVCELLRA 500 (697)
Q Consensus 491 l~LVmEyl~g 500 (697)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 6899999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00034 Score=73.20 Aligned_cols=77 Identities=21% Similarity=0.298 Sum_probs=45.4
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE-E--EEEecCeEEEEE
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIVC 495 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~-~--~f~~~~~l~LVm 495 (697)
++.|+.|..+.||++.. .+..+++|+..... .....|..+++.|.... ...|.++... + +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g-~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE---KKALFSIFAQDYLAKKG-MNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH---HHHHHHHHHHHHHHHHT-CSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH---HHHHHHHHHHHHHHHcC-CCCCceeecCCCCEEEEECCEEEEEE
Confidence 34566677899999874 23458999997643 34456777777776542 2334444311 0 123456789999
Q ss_pred Eccccc
Q 005415 496 ELLRAN 501 (697)
Q Consensus 496 Eyl~gs 501 (697)
+|++|.
T Consensus 111 ~~i~G~ 116 (346)
T 2q83_A 111 DWIEGR 116 (346)
T ss_dssp ECCCCB
T ss_pred EeecCc
Confidence 999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=8e-05 Score=79.17 Aligned_cols=81 Identities=9% Similarity=0.037 Sum_probs=55.0
Q ss_pred EEEEEe-ccCCCCceEEEEEC--C----CCcEEEEEEEecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 417 YVTEYL-GSAAFSKVFQAQDL--H----TGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 417 ~i~e~L-G~G~fG~Vy~a~d~--~----~g~~VAVKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
..++.| +.|....+|+.... . ++..+++|+...... ....+..|..+++.+...... .+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~v---pvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDV---PVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCS---CCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCC---CCCcEEEEc
Confidence 345678 88889999988642 0 267889998765331 125678899999998764112 355666666
Q ss_pred Eec---CeEEEEEEcccc
Q 005415 486 YHL---EHLFIVCELLRA 500 (697)
Q Consensus 486 ~~~---~~l~LVmEyl~g 500 (697)
... ...++|||+++|
T Consensus 100 ~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp CSSTTTSSCEEEEECCCC
T ss_pred cCCCccCCceEEEEecCC
Confidence 544 346899999976
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0005 Score=71.47 Aligned_cols=69 Identities=16% Similarity=0.132 Sum_probs=45.1
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl 498 (697)
++.|+.|....+|++ ..+++|+.............|..+++.+..... . | +++.. ..+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~-~-P---~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGV-S-P---EVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTS-S-C---CEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCC-C-C---ceEEE--ECCCCEEEEeec
Confidence 567888999999998 568899887543333344678889988876531 1 3 44433 333457899999
Q ss_pred -cc
Q 005415 499 -RA 500 (697)
Q Consensus 499 -~g 500 (697)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.003 Score=65.00 Aligned_cols=80 Identities=10% Similarity=0.110 Sum_probs=56.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
..+..-++.+|.|..+.||+.. ..+|+.|++|+..... .....+..|...|+.|........|.++ .+ +.-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~---~~----~~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVA---GW----DDR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEE---EE----ETT
T ss_pred CCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEE---ec----cCc
Confidence 3456678899999999999997 4678999999876433 2234567899999999765444444443 33 123
Q ss_pred EEEEEcccc
Q 005415 492 FIVCELLRA 500 (697)
Q Consensus 492 ~LVmEyl~g 500 (697)
++|||++.+
T Consensus 86 ~lv~e~l~~ 94 (288)
T 3f7w_A 86 TLAMEWVDE 94 (288)
T ss_dssp EEEEECCCC
T ss_pred eEEEEeecc
Confidence 789999864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0012 Score=72.20 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=46.0
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecc-----hh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-----KD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-----~~---~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++.||.|..+.||++.. +++.++||..... .. .......|.+++..+.... ...+.+++.+. ...
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~---~~~vP~v~~~~--~~~ 111 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS---PDHVPEVYHFD--RTM 111 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS---GGGSCCEEEEE--TTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC---CCCCCeEEEEC--CCc
Confidence 46789999999999963 5678999943211 11 1123334555555443221 12466666654 466
Q ss_pred EEEEEEcc-cc
Q 005415 491 LFIVCELL-RA 500 (697)
Q Consensus 491 l~LVmEyl-~g 500 (697)
.++|||++ ++
T Consensus 112 ~~lv~e~l~~g 122 (420)
T 2pyw_A 112 ALIGMRYLEPP 122 (420)
T ss_dssp TEEEECCCCTT
T ss_pred cEEEEeecCCc
Confidence 78999999 75
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.025 Score=59.51 Aligned_cols=76 Identities=21% Similarity=0.244 Sum_probs=58.6
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl 498 (697)
++.|+.|....+|+... ++..++||+.... ....+..|...|+.|.... ...+++++.+....+..++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~---~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN---SINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT---SSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC---CCCcceEEEEeecCCceEEEEEec
Confidence 56789999999999973 4678899988754 2456788999999987642 235677777777778899999999
Q ss_pred ccc
Q 005415 499 RAN 501 (697)
Q Consensus 499 ~gs 501 (697)
++.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0083 Score=62.56 Aligned_cols=77 Identities=17% Similarity=0.178 Sum_probs=48.8
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE--EEEecCeEEEEEEcc
Q 005415 421 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD--YFYHLEHLFIVCELL 498 (697)
Q Consensus 421 ~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~--~f~~~~~l~LVmEyl 498 (697)
.|+ |....||++.. .+|+.+++|+.+........+..|..+++.+.... ...|.++..-+ +....+..++||+++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g-~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcC-CeecceeecCCcEEEEECCEEEEEEEec
Confidence 455 77888998753 45667999999754333456778999999887642 22233322100 122345678999999
Q ss_pred cc
Q 005415 499 RA 500 (697)
Q Consensus 499 ~g 500 (697)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.004 Score=67.44 Aligned_cols=144 Identities=14% Similarity=0.104 Sum_probs=81.2
Q ss_pred EEeccCCCCceEEEEECC-------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 420 EYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+.|..|....+|++.... +++.+++|+............+|..+++.|..... ..++++.+.. .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv-----~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL-----GPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS-----SCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC-----CCeEEEEcCC----c
Confidence 456678888889887532 35789999875433334566789999999986532 2455665543 2
Q ss_pred EEEEccccchH---------------HHHHhhhccCC--Cccc--CHHHHHHHHHHHHH-------------------HH
Q 005415 493 IVCELLRANLY---------------EFQKFNQESGG--EAYF--TLGRLQVITRQCLE-------------------AL 534 (697)
Q Consensus 493 LVmEyl~gsL~---------------~~l~~~~~~~~--~~~l--s~~~i~~i~~qIa~-------------------aL 534 (697)
+||||++|... ..+........ .... -+.++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 99999976211 11111111110 0111 23455555554422 22
Q ss_pred HHHH----h----cCccccCCCCcccccccc--CcceEEEeeCCCccc
Q 005415 535 EYLH----S----LGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCF 572 (697)
Q Consensus 535 ~yLH----s----~gIvHrDLKP~NILl~~~--~~~~vKL~DFGla~~ 572 (697)
..|. . ..++|+|+.+.|||++.+ ..+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 258999999999999852 136889999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0033 Score=67.14 Aligned_cols=73 Identities=16% Similarity=0.128 Sum_probs=45.0
Q ss_pred EEEeccCCCCceEEEEECC--------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 419 TEYLGSAAFSKVFQAQDLH--------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~--------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++.|+.|....+|++.... .+..+++|+.............|..+++.+..... +.++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-----~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-----APQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-----SCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-----CCceEEec--C--
Confidence 4567888888999987543 13688999886543332334688999998876421 33455443 2
Q ss_pred EEEEEEcccc
Q 005415 491 LFIVCELLRA 500 (697)
Q Consensus 491 l~LVmEyl~g 500 (697)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 2689999876
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.022 Score=59.04 Aligned_cols=149 Identities=11% Similarity=0.080 Sum_probs=79.7
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEE-E--EEEecCeEEEE
Q 005415 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY-D--YFYHLEHLFIV 494 (697)
Q Consensus 418 i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~-~--~f~~~~~l~LV 494 (697)
-++.|+.|....+|+... ..+ .+++|+..... ....+..|..+++.+.... ...|.++... + +....+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g-~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG-LSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT-CCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCC-CCCCcccCCCCCCEEEEECCEEEEE
Confidence 356788888899999874 233 68899987531 2245667888998887642 2334443211 0 11234567899
Q ss_pred EEccccchH----------------HHHHhhhccCCCc--ccCHHHHHH---------------HHHHHHHHHHHHHh--
Q 005415 495 CELLRANLY----------------EFQKFNQESGGEA--YFTLGRLQV---------------ITRQCLEALEYLHS-- 539 (697)
Q Consensus 495 mEyl~gsL~----------------~~l~~~~~~~~~~--~ls~~~i~~---------------i~~qIa~aL~yLHs-- 539 (697)
|++++|... .+........... ......... +...+...+..+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999976311 1111100000000 011111000 00113334445542
Q ss_pred -----cCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 540 -----LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 540 -----~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
.+++|+|+++.|||++. +..+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~--~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLG--DELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeC--CceEEEecchhccC
Confidence 46999999999999984 44457999997753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.016 Score=64.34 Aligned_cols=73 Identities=10% Similarity=0.174 Sum_probs=47.6
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEcc
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 498 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl 498 (697)
++.|+.|-...+|++.....+..+++|+........-....|..+++.|.... -..++++.+. + .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g-----l~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN-----IAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS-----SBCCEEEEET--T--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC-----CCCCEEEEeC--C--eEEEEee
Confidence 56788888899999986444578999988643322222368999999997542 2356666663 2 2599998
Q ss_pred cc
Q 005415 499 RA 500 (697)
Q Consensus 499 ~g 500 (697)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.026 Score=61.87 Aligned_cols=72 Identities=14% Similarity=0.117 Sum_probs=49.1
Q ss_pred EEEeccCCCCceEEEEECC-------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++.|+.|....||++.... .+..+++|+.... .....+..|..+++.+..... ..++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~-----~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL-----GPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS-----SSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCC-----CCcEEEEeCC----
Confidence 4678888889999997542 2578999998542 111455689999999876431 2455655432
Q ss_pred EEEEEcccc
Q 005415 492 FIVCELLRA 500 (697)
Q Consensus 492 ~LVmEyl~g 500 (697)
.+||||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 389999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.018 Score=60.22 Aligned_cols=34 Identities=18% Similarity=0.353 Sum_probs=27.1
Q ss_pred cCccccCCCCccccccccC--cceEEEeeCCCcccc
Q 005415 540 LGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQ 573 (697)
Q Consensus 540 ~gIvHrDLKP~NILl~~~~--~~~vKL~DFGla~~~ 573 (697)
..++|||+.+.|||++.+. ...+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4699999999999998521 257899999988653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.88 E-value=0.058 Score=57.00 Aligned_cols=69 Identities=13% Similarity=0.173 Sum_probs=43.6
Q ss_pred ccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE------EEecCeEEEEEE
Q 005415 423 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY------FYHLEHLFIVCE 496 (697)
Q Consensus 423 G~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~------f~~~~~l~LVmE 496 (697)
|.|....||+... .+| .+++|+...... ..|+.+++.|.... . |++++++.. .......++||+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g-~--~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD-----EINLSIIRLLHDSG-I--KEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC-----CHHHHHHHHHHHTT-C--CSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc-----hHHHHHHHHHHhcC-C--cccccceecCCCCEEEEECCEEEEEEe
Confidence 4444678999973 445 899998875431 46778888886542 2 223333321 223567899999
Q ss_pred ccccc
Q 005415 497 LLRAN 501 (697)
Q Consensus 497 yl~gs 501 (697)
|++|.
T Consensus 102 ~i~G~ 106 (339)
T 3i1a_A 102 FIHAP 106 (339)
T ss_dssp CCCCC
T ss_pred ccCCC
Confidence 99763
|
| >2enj_A NPKC-theta, protein kinase C theta type; beta-sandwich, phosphotyrosine binding, TCR, T-cell, diacylglycerol, phorbol ester, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.16 E-value=0.0055 Score=56.21 Aligned_cols=84 Identities=6% Similarity=-0.019 Sum_probs=55.8
Q ss_pred ccceeEEEEeccCccccc--CCCCCCcceEeeccCCCCCccccce-eecccCCCcceecccccCcccccccccccccccc
Q 005415 264 NNDYGYLSSKEADLIDLQ--HNVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~~L~~~d--~~g~sDpyVk~~l~pd~~~~~k~kt-~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V 340 (697)
....|||.+...++.+.. ..-..|||+.+++--.... .+-+| .++++|..|+|||+|.-+ |. ..+.|.+.|
T Consensus 8 m~~flRi~l~~~~~~~~~~~~~~~lDPY~aV~VdE~~~t-e~gqtl~~KkkT~~P~Wne~Fd~~--V~---~Gr~l~i~V 81 (138)
T 2enj_A 8 MSPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVES-ENGQMYIQKKPTMYPPWDSTFDAH--IN---KGRVMQIIV 81 (138)
T ss_dssp CCCCEEEEEEEEECCCCCCSCCCCCCCEEEEEEEEEEEE-TTEEEEEEEEEEECCCSSSEEEEC--CC---SSCEEEEEE
T ss_pred cCcceEEEeeccccCCCCCcccccCCceEEEEeeeeeec-cCceeecccCCCCCccccceEeee--EE---CCeEEEEEE
Confidence 456899999877554433 1235699998877432221 13455 668899999999999966 32 244588888
Q ss_pred ccCCCCCCCCccccccc
Q 005415 341 IDNSDTRDGEVNGALHE 357 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~ 357 (697)
++... +++..+..
T Consensus 82 fh~a~----~fVAn~tV 94 (138)
T 2enj_A 82 KGKNV----DLISETTV 94 (138)
T ss_dssp ECSSC----SCCEEEEE
T ss_pred EcCCC----CeeeEEEE
Confidence 85444 67776644
|
| >1yrk_A NPKC-delta, protein kinase C, delta type; C2 domain, protein binding; HET: PTR; 1.70A {Homo sapiens} PDB: 1bdy_A | Back alignment and structure |
|---|
Probab=94.86 E-value=0.012 Score=53.36 Aligned_cols=84 Identities=11% Similarity=0.100 Sum_probs=53.6
Q ss_pred ccceeEEEEeccCcccccC-CCCCCcceEeeccCCCCCccccce-eecccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEADLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSY-SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~~L~~~d~-~g~sDpyVk~~l~pd~~~~~k~kt-~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
....|||.+...++.++.. .-..|||+.+++--...-. +-+| .++++|..|+|||+|.-+ |. ..+.|.+.|+
T Consensus 4 m~~flRi~~~~~~~~~~~~~~~~lDPy~aV~vdE~~~~e-~g~t~~~K~kT~~P~Wne~Fd~~--V~---~Gr~l~i~Vf 77 (126)
T 1yrk_A 4 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTE-RGKTLVQKKPTMYPEWKSTFDAH--IY---EGRVIQIVLM 77 (126)
T ss_dssp CCCEEEEEEEEEECSSCCCSSSSCCCEEEEEEEEEEEET-TEEEEECCSCCBCCCTTCEEEEE--CC---TTCEEEEEEE
T ss_pred cCccEEeeeccccccccCCccccCCceEEEEeeeeEEcc-cceeecccCCCCCcCccceEEee--ee---CCEEEEEEEE
Confidence 3468889887774443322 2356999988774321111 2244 668999999999999966 32 2445888888
Q ss_pred cCCCCCCCCccccccc
Q 005415 342 DNSDTRDGEVNGALHE 357 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~ 357 (697)
+... +++..+..
T Consensus 78 h~a~----~fvAn~tV 89 (126)
T 1yrk_A 78 RAAE----EPVSEVTV 89 (126)
T ss_dssp EETT----EEEEEEEE
T ss_pred cCCC----CeeeEEEE
Confidence 5444 66666644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.26 Score=54.00 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=47.9
Q ss_pred EEEeccCCCCceEEEEECC-------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++.|..|-...+|+..... .+..+++|+........-...+|..+++.+..... ..++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-----~P~l~~~~~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-----APNIIADFP----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-----SCCEEEEET----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-----CCCEEEEcC----C
Confidence 4556678888899987542 15789999976543333345689999999876531 344444332 2
Q ss_pred EEEEEcccc
Q 005415 492 FIVCELLRA 500 (697)
Q Consensus 492 ~LVmEyl~g 500 (697)
++||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 789999976
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.57 E-value=0.32 Score=52.51 Aligned_cols=31 Identities=26% Similarity=0.443 Sum_probs=25.4
Q ss_pred ccccCCCCccccccc----cCcceEEEeeCCCccc
Q 005415 542 IIHCDLKPENILIKS----YQRCEIKIIDLGSSCF 572 (697)
Q Consensus 542 IvHrDLKP~NILl~~----~~~~~vKL~DFGla~~ 572 (697)
++|+|+.+.|||+.. .....++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999953 2356799999998854
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.40 E-value=0.57 Score=46.68 Aligned_cols=98 Identities=12% Similarity=0.028 Sum_probs=60.1
Q ss_pred chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEeeCCCcccccccccc
Q 005415 501 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 579 (697)
Q Consensus 501 sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~~~~~~~ 579 (697)
+|.+.+...... +++.+++.++.|.+.+|.-+-. +.-..+=+.|..|++.. +|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~P-----lsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~--dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQP-----INEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR--DGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET--TSCEEECC-C-----------
T ss_pred cHHHHHHHcCCC-----cCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec--CCceeccc-cccc--------
Confidence 577777765543 9999999999999998876622 12123344567777775 66555443 1110
Q ss_pred ccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC
Q 005415 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 616 (697)
Q Consensus 580 ~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG 616 (697)
.....+.|||... ...+.+.=|||||++||..+--
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1223466787753 3446788999999999999973
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 697 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-33 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 6e-48
Identities = 53/240 (22%), Positives = 99/240 (41%), Gaps = 15/240 (6%)
Query: 407 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK 465
I + + Y + E LG+ AF V + + TG + K + + +++ EI+ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 466 LVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
++ H ++ L+D F + ++ E + F+K E +
Sbjct: 79 VLR-------HPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNK---MSEDEAV 127
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQ 582
RQ + L ++H +H DLKPENI+ + + E+K+ID G + + +
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 583 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
+ + APEV G P D+WS+G + L +G F + L + +D
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-47
Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 18/230 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG F V+ A++ + + LK++ Q E+++ +
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+ILRLY YF+ ++++ E + F R +
Sbjct: 66 -----PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITEL 115
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRSYRAP 589
AL Y HS +IH D+KPEN+L+ S E+KI D G S + + Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
E+I G +D+K+DLWSLG + E G+ F + RI +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 2e-45
Identities = 51/236 (21%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 470
+ Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-- 84
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 528
H ++ L+D F + ++ E L L++ + + R
Sbjct: 85 -----HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMR 134
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q E L+++H I+H D+KPENI+ ++ + +KIID G + + + + + +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642
APE++ P D+W++G + L +G F + + L + D +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 14/236 (5%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
+IL L++ F +E L ++ E + +++E + + Q
Sbjct: 60 ---HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQV 111
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRA 588
EAL++LHS I H D++PENI+ ++ + IKII+ G + DN L + Y A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
PEV D+WSLG ++ L +G F + I+ I+ D E
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDP 472
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK---- 75
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ +I+ D + + L++V E L G++ + R+CL
Sbjct: 76 ---NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECL 126
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ALE+LHS +IH D+K +NIL+ +K+ D G + V + + A
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
PEV+ Y K+D+WSLG + E+ GE + N+ + L I
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 2e-44
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 21/228 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 473
+ + LG AF KV++AQ+ T V K+I ++ + + EI +L +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH---- 68
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I++L D FY+ +L+I+ E + E T ++QV+ +Q L+A
Sbjct: 69 --PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDA 122
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
L YLH IIH DLK NIL +IK+ D G S T + ++ + + APE
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 591 VIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
V++ PYD K D+WSLG L E+ E + +L +I
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 23/261 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 472
+ LG+ VF+ +G+ + K+I +Q + E+++L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+ Y FY + I E + + L ++ +
Sbjct: 63 ---SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVI 114
Query: 532 EALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAP 589
+ L YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGMLGPIDLEMLM 645
E + G Y + D+WS+G L E+ G P + +M ++ G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 646 QGQEIYKYFTKEYDLYYINEV 666
G+ + Y I E+
Sbjct: 233 PGRPLSSYGMDSRPPMAIFEL 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 10/258 (3%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 473
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 474 DEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ +++RL+D L +V E + +L + E G ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 123
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L++LHS ++H DLKP+NIL+ S + ++ L L V + YRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G E +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 649 EIYKYFTKEYDLYYINEV 666
+ + I +
Sbjct: 244 ALPRQAFHSKSAQPIEKF 261
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 7e-44
Identities = 87/278 (31%), Positives = 140/278 (50%), Gaps = 17/278 (6%)
Query: 405 PIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 463
P RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKL
Sbjct: 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL 62
Query: 464 LKLVN-----KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 518
L+ VN K D +HIL+L D+F H + ++ L E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 519 TLGRLQVITRQCLEALEYL-HSLGIIHCDLKPENILIKS----YQRCEIKIIDLGSSCFQ 573
L ++ I++Q L L+Y+ GIIH D+KPEN+L++ +IKI DLG++C+
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 574 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV------VM 627
++ +Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 628 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 665
+A+II +LG + +L G+ +F L I++
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-42
Identities = 49/227 (21%), Positives = 94/227 (41%), Gaps = 23/227 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ +G +F V+ A+D+ V +K + + + + E++ L+ +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-- 73
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H + ++ + ++V E + + + +++ + +T
Sbjct: 74 -----HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 123
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 589
L+ L YLHS +IH D+K NIL+ +K+ D GS+ +V + + AP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAP 180
Query: 590 EVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
EVI+ + YD K+D+WSLG EL + N + L I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 73/250 (29%), Positives = 124/250 (49%), Gaps = 21/250 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y T+ +G+ +F V+QA+ +G V +K + DK F ++ E+++++ ++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD------ 71
Query: 475 EHHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+I+RL +FY +L +V + + +Y + + + +++
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 129
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 586
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS+ Y+ SR Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 587 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645
RAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG E +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 646 QGQEIYKYFT 655
+ Y F
Sbjct: 249 EMNPNYTEFK 258
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 19/246 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+ E +G + V++A++ TG V LK I+ + ++ EI LLK +N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++L D + L++V E L +L +F + +G L ++ Q L
Sbjct: 61 ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLL 112
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI + IK+ D G + V + YRA
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 589 PEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
PE+++G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 648 QEIYKY 653
+ Y
Sbjct: 231 TSMPDY 236
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 411 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK 469
I Y VT + LG KV Q + T LK++++ E++L ++
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQ 63
Query: 470 NDPADEHHILRLYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 524
HI+R+ D + +L + L IV E L L+ + G+ FT
Sbjct: 64 CP-----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS 114
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN--LCLYV 581
I + EA++YLHS+ I H D+KPEN+L S +K+ D G + T + L
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ Y APEV+ YD+ D+WSLG I+ L G F ++ + I +
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 3e-41
Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 29/264 (10%)
Query: 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 470
V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGC 60
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
I +Y + H +V +LL +L + F++ + + +Q
Sbjct: 61 -----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQM 110
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLC--------- 578
L ++ +H +++ D+KP+N LI I ++D G F D +
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 579 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP---NDAVVMILARIIG 634
+ Y + +G ++ DL +LG + G + + RI
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 635 MLGPIDLEMLMQG--QEIYKYFTK 656
L L G +E YKY
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 18/225 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLL 464
+ +Y V LGS F V+ + + V +K ++ D+ + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
K V+ ++RL D+F + ++ E F + +
Sbjct: 62 KKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 113
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQS 583
Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS D + + +
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 584 RSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVM 627
R Y PE I Y + +WSLG +L ++ G++ F +D ++
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDPA 473
++LG F+ V++A+D +T V +K IK +L EIKLL+ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 474 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
+I+ L D F H ++ +V + + +L K N + ++ L+
Sbjct: 60 --PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-----HIKAYMLMTLQG 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 590
LEYLH I+H DLKP N+L+ +K+ D G + V +R YRAPE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 591 VIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649
++ G Y +D+W++GCILAEL P D+ + L RI LG E
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 650 IYKYFTKEYDLYYINEVCFANI 671
+ Y T + F+
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAA 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ RY Y+G A+ V A D V V +K I + + ++L EIK+L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64
Query: 470 NDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ + D ++ +++V L+ A+LY+ K + +
Sbjct: 65 -----HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHIC 112
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LC 578
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + L
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLT 170
Query: 579 LYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 637
YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I+G+LG
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISL 675
E + K L + N+V + +F +
Sbjct: 231 SPSQED-LNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 24/236 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ + LG +FS V A++L T + +KI++ ++ E ++ ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 471 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H ++LY F E L+ + S F + T +
Sbjct: 67 -----HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAE 116
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSR 584
+ ALEYLH GIIH DLKPENIL+ I+I D G++ + +V +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
Y +PE++ + DLW+LGCI+ +L G F +I +II +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP 230
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 8e-40
Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 22/232 (9%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ--- 60
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
I + ++ +V ELL +L + F F+L + ++ Q +
Sbjct: 61 --GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMI 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN----------LCLY 580
+EY+HS IH D+KP+N L+ + + IID G + D
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 581 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
+ Y + +G+ ++ DL SLG +L G + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 1e-39
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEIKLL 464
Y E LG S V + T + +KII ++ + +L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 465 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRL 523
+ V+ +I++L D + F+V +L++ L+++ +
Sbjct: 64 RKVS-----GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKET 112
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYV 581
+ I R LE + LH L I+H DLKPENIL+ IK+ D G SC + L
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 582 QSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ SY APE+I Y +++D+WS G I+ L G F + +++L I+
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 50/228 (21%), Positives = 92/228 (40%), Gaps = 21/228 (9%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKND 471
+ + + LG A+ +V A + T V +KI+ K D + EI + K++N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 61
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
++++ Y + ++ E F + + G Q Q +
Sbjct: 62 ---HENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG----MPEPDAQRFFHQLM 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRSY 586
+ YLH +GI H D+KPEN+L+ R +KI D G + + L + Y
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 587 RAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
APE++ + + +D+WS G +L + GE+ + +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 2e-39
Identities = 67/240 (27%), Positives = 107/240 (44%), Gaps = 20/240 (8%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNK 469
I Y + LG+ AFS+V A+D T V +K I + +EI +L +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 527
H +I+ L D + HL+++ +L+ L++ ++T +
Sbjct: 66 ------HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLI 113
Query: 528 RQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDN--LCLYVQSR 584
Q L+A++YLH LGI+H DLKPEN+L S + +I I D G S + L +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 644
Y APEV+ PY + +D WS+G I L G F ++ + +I+ D
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 3e-39
Identities = 52/235 (22%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 410 TVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLK 465
GR+ +G +F V++ D T V+V +++ K + +E ++LK
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 466 LVNKNDPADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+ +I+R YD + + + +V EL+ + + + +
Sbjct: 64 GLQ------HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIK 112
Query: 522 RLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 578
L+ RQ L+ L++LH+ IIH DLK +NI I +KI DLG + + +
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFAK 171
Query: 579 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ + + APE+ YD+ +D+++ G + E+ T E + + R +
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (363), Expect = 3e-39
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 23/236 (9%)
Query: 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 465
+ ++ RY + E LG S+V A+DL DV +K+++ D F+ + E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 466 LVNKNDPADEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLG 521
+N I+ +YD +IV E + + T
Sbjct: 63 ALN------HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPK 111
Query: 522 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----L 577
R + +AL + H GIIH D+KP NI+I + ++ + + + N
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 578 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ + Y +PE G D + D++SLGC+L E+ TGE F D+ V + + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 20/253 (7%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKN 470
+Y +G F +VF+A+ TG V LK + + + F +L EIK+L+L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 471 DPADEHHILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + I R Y+ +++V + +L FTL ++ + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQ 124
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-------CFQTDNLCLYV 581
L L Y+H I+H D+K N+LI + +K+ D G + Q + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 582 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640
+ YR PE+++G Y IDLW GCI+AE+WT + + LA I + G I
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 641 LEMLMQGQEIYKY 653
E+ Y
Sbjct: 243 PEVWPNVDNYELY 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 24/232 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 472
Y V +G+ ++ + + + G + K + + + E+ LL+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---- 61
Query: 473 ADEHHILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+I+R YD L+IV E +L + Y + + Q
Sbjct: 62 --HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRVMTQ 117
Query: 530 CLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YV 581
AL+ H ++H DLKP N+ + + +K+ D G + + +V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 582 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ Y +PE + + Y++K D+WSLGC+L EL F + + +I
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (360), Expect = 2e-38
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 19/223 (8%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 471
+ + LG+ +F +V + H G +K++K + + DE +L +V
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 62
Query: 472 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H I+R++ F + +F++ + + + F + +
Sbjct: 63 ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEV 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 590
ALEYLHS II+ DLKPENIL+ IKI D G + + D + Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPE 171
Query: 591 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
V+ PY++ ID WS G ++ E+ G F + + +I+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 11/253 (4%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY + +GS A V A D +V +K + ++ ++ E+ L+K VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ ++ + +++V EL+ ANL + + R+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLY 126
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L +++LHS GIIH DLKP NI++KS +I L + + + YV +R YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648
PEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG E + + Q
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 649 EIYKYFTKEYDLY 661
+ + + Y
Sbjct: 247 PTVRNYVENRPKY 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (349), Expect = 3e-37
Identities = 70/246 (28%), Positives = 113/246 (45%), Gaps = 21/246 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 471
+Y+ E +G + V++AQ+ + G LK I K D+ ++ EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I++LYD + + L +V E L +L + + + Q L
Sbjct: 59 ---HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRA 588
+ Y H ++H DLKP+N+LI E+KI D G + + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 589 PEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
P+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 648 QEIYKY 653
E+ KY
Sbjct: 229 TELPKY 234
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 14/268 (5%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 468
+ RY +GS A+ V A D TG+ V +K + ++ E++LLK +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 469 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
+ + +++V L+ A+L K + T +Q +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIY 128
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 588
Q L L+Y+HS IIH DLKP N+ + KI+D G + D + YV +R YRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 589 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647
PE+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G E+L +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 648 QEIYKYFTKEYDLYYINEVCFANIFISL 675
+ L + ++ FAN+FI
Sbjct: 247 SSESARNYIQ-SLTQMPKMNFANVFIGA 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 24/244 (9%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-------LDEIKLL 464
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 465 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 523
K + H +++ L++ + + + ++ EL+ +ES E
Sbjct: 68 KEIQ-------HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-----A 115
Query: 524 QVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCF--QTDNLCL 579
+Q L + YLHSL I H DLKPENI++ ++ + IKIID G + +
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 580 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639
+ + APE++ P + D+WS+G I L +G F D LA + +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 640 DLEM 643
+ E
Sbjct: 236 EDEY 239
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 78/274 (28%), Positives = 130/274 (47%), Gaps = 26/274 (9%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVN 468
+ Y + +GS A+ V A D TG V +K + + F ++ E++LLK +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 469 KNDPADEHHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 522
+++ L D F E ++V + +L + K + R
Sbjct: 76 ------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDR 122
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+Q + Q L+ L Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVV 180
Query: 583 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641
+R YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISL 675
E + + Q + L + + FA+I +
Sbjct: 241 EFVQRLQSDEAKNYMK-GLPELEKKDFASILTNA 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (349), Expect = 2e-36
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 16/230 (6%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 470
+ V +G F +V+ + TG +K + K +L+E +L LV+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
D I+ + F+ + L + +L+ + EA ++ +
Sbjct: 65 D---CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEI 116
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAP 589
+ LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y AP
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 590 EVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638
EV+ G+ YD D +SLGC+L +L G F L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 21/226 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKN 470
+ + + LG +F KVF A+ T +K +K D D + ++ E ++L L ++
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 471 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+ ++ F E+LF V E L +L + + F L R +
Sbjct: 63 P-----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAE 111
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSY 586
+ L++LHS GI++ DLK +NIL+ KI D G + + Y
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 587 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 632
APE+++G Y+ +D WS G +L E+ G+ F + I
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 68/247 (27%), Positives = 108/247 (43%), Gaps = 21/247 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 471
+Y E +G + VF+A++ T V LK ++ +D+ +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+I+RL+D + + L +V E +L ++ ++ Q L
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLL 111
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 588
+ L + HS ++H DLKP+N+LI K+ + G + V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 589 PEVIIGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQ 646
P+V+ G Y ID+WS GCI AEL LFP + V L RI +LG E
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 647 GQEIYKY 653
++ Y
Sbjct: 230 MTKLPDY 236
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ + +G F V + G V +K IKND L E ++ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA-QAFLAEASVMTQLR------ 58
Query: 475 EH-HILRLYDYFYHLE-HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
H ++++L + L+IV E + + +L ++ + S G + L +
Sbjct: 59 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 113
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 591
EA+EYL +H DL N+L+ K+ D G + + + APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171
Query: 592 IIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
+ + K D+WS G +L E+++ G V +P + ++ R+
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 27/232 (11%)
Query: 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDV-CLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 472
G+ V + +GS +F V++ + H V V L + +E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---- 62
Query: 473 ADEH-HILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 530
H +IL Y L IV + ++LY + F + +L I RQ
Sbjct: 63 ---HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQT 113
Query: 531 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRS 585
+ ++YLH+ IIH DLK NI + +KI D G + + S
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 586 YRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 634
+ APEVI PY + D+++ G +L EL TG++ + N + ++G
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (330), Expect = 4e-34
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 18/251 (7%)
Query: 393 KNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK- 451
K + F + + P NT ++ + LG+ +F +V + +G +KI+ K
Sbjct: 21 KAKEDFLKKWETPS-QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 452 ---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKF 508
+ +L+E ++L+ VN +++L F +L++V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
F+ + Q + EYLHSL +I+ DLKPEN+LI Q+ I++ D G
Sbjct: 134 RIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFG 186
Query: 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628
+ + APE+I+ Y++ +D W+LG ++ E+ G F D + I
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 629 LARIIGMLGPI 639
+I+
Sbjct: 247 YEKIVSGKVRF 257
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 7e-34
Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 18/277 (6%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 90
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+I+ L D N +F++ Q T ++ + L+AL
Sbjct: 91 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVI 592
+Y HS+GI+H D+KP N++I + ++++ID G + F + V SR ++ PE++
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 593 IGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 650
+ YD +D+WSLGC+LA + + F L RI +LG DL + I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 651 YKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAAL 687
L + + S ++ E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 18/224 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG F +V+ T V +K +K + L E +++K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLR------ 70
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
+++LY E ++IV E + + Y L +L + Q +
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGM 126
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPE 590
Y+ + +H DL+ NIL+ K+ D G + DN + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633
+ + K D+WS G +L EL T G V +P +L ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 20/225 (8%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKND 471
+ + LG F KV ++ TG +KI++ + KD ++ E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--- 63
Query: 472 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 531
+ L F + L V E F + FT R + + +
Sbjct: 64 ---HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 532 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQSRSYRA 588
ALEYLHS +++ D+K EN+++ IKI D G + + + Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
PEV+ Y + +D W LG ++ E+ G + F N + I+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 7e-33
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 18/223 (8%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ E LG+ F +V+ + V +K +K D L E L+K +
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------ 66
Query: 475 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 534
++RLY E ++I+ E + T+ +L + Q E +
Sbjct: 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGM 122
Query: 535 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YRAPE 590
++ IH DL+ NIL+ C KI D G + DN + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
I + K D+WS G +L E+ T G + +P ++ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 4e-32
Identities = 41/224 (18%), Positives = 80/224 (35%), Gaps = 17/224 (7%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ LG + +V++ + V +K +K D ++ L E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------ 71
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H ++++L +I+ E + + L + Q A
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSA 127
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL IH DL N L+ +K+ D G S T + + AP
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
E + + K D+W+ G +L E+ T + + + ++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-31
Identities = 47/224 (20%), Positives = 93/224 (41%), Gaps = 22/224 (9%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ LG+ F V + DV +K+IK D+ ++E K++ ++
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57
Query: 476 H-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 533
H +++LY +FI+ E + L + + + F +L + + EA
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEA 112
Query: 534 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 589
+EYL S +H DL N L+ + +K+ D G S + D+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
EV++ + K D+W+ G ++ E+++ G++ + I
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 42/225 (18%), Positives = 83/225 (36%), Gaps = 21/225 (9%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 474
+ +GS F V L V +K I+ + ++E +++ ++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------ 58
Query: 475 EH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 532
H +++LY + +V E + L ++ + + L + E
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112
Query: 533 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRA 588
+ YL +IH DL N L+ + IK+ D G + F D+ + +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 589 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
PEV Y K D+WS G ++ E+++ + + + I
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 38/250 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLV 467
+ LGS AF KV A + V +K++K D + + E+K++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL------------------RANLYEFQKFN 509
++ +I+ L ++++ E YE QK
Sbjct: 98 GSHE-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+E T L Q + +E+L +H DL N+L+ +KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH--GKVVKICDFGL 210
Query: 570 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623
+ + + APE + Y K D+WS G +L E+++ G +P
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 624 AVVMILARII 633
V ++I
Sbjct: 271 PVDANFYKLI 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 6e-30
Identities = 53/234 (22%), Positives = 86/234 (36%), Gaps = 29/234 (12%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ---DLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 467
+ E LG +F V + + V V +K +K + + D + E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 468 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ H +++RLY + +L + + +Q F LG L
Sbjct: 69 D-------HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 116
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 585
Q E + YL S IH DL N+L+ R +KI D G N YV
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 586 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 633
+ APE + + D W G L E++T G+ + IL +I
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-29
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIK-----NDKDFFDQSLDEIKLLKL 466
+ + + LG+ A+ KVF + + TG +K++K + + E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 467 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 526
+ ++ L+ F L ++ + + +E FT +Q+
Sbjct: 85 IR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 527 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQ 582
+ + ALE+LH LGII+ D+K ENIL+ S + + D G S +T+ +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 583 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ Y AP+++ G +D+ +D WSLG ++ EL TG F D A I
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 24/229 (10%)
Query: 416 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 469
+ + LGS AF V++ + G + V +K ++ + LDE ++ V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
H+ RL I + L ++ + ++++ G Y L Q
Sbjct: 71 ------PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQ 119
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSR 584
+ + YL ++H DL N+L+K+ +KI D G + + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ A E I+ Y + D+WS G + EL T + ++ I+
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 26/223 (11%)
Query: 422 LGSAAFSKVFQA--QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH 476
LGS F V + Q V +KI+K ND D+ L E +++ ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------P 68
Query: 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
+I+R+ E +V E+ + + + Q ++Y
Sbjct: 69 YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKY 122
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + + KI D G S + Y + APE
Sbjct: 123 LEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
I + K D+WS G ++ E ++ G+ + + A +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (283), Expect = 3e-28
Identities = 43/232 (18%), Positives = 87/232 (37%), Gaps = 26/232 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND--KDFFDQSLDEIKLLKLVNK 469
+ + +G+ F +V G + V +K +K+ + L E ++ +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 470 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 529
+++ L + I+ E + + + FT+ +L + R
Sbjct: 86 -----HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRG 136
Query: 530 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---- 585
++YL + +H DL NIL+ S K+ D G S F D+ + +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 586 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
+ APE I + D+WS G ++ E+ + GE + + ++ I
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 26/223 (11%)
Query: 422 LGSAAFSKVFQAQDLHT--GVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 477
LG F V Q +DV +K++K +K ++ + E +++ + D +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPY 70
Query: 478 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 536
I+RL E L +V E+ L++F G + + + Q ++Y
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAELLHQVSMGMKY 124
Query: 537 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 590
L +H DL N+L+ + R KI D G S + Y + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 591 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 632
I + + D+WS G + E + G+ + ++A I
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-28
Identities = 42/231 (18%), Positives = 84/231 (36%), Gaps = 29/231 (12%)
Query: 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471
IA + E +G F +V++ + G +V +KI + ++ E ++ + V
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRH 56
Query: 472 PADEHHILRLYDYFYH----LEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQV 525
+IL L++V + +L+++ ++ G L
Sbjct: 57 E----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 526 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY----- 580
+ +E + I H DLK +NIL+K I DLG +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 581 --VQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPND 623
V ++ Y APEV+ ++ D++++G + E+ +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-28
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 33/245 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
R + LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-------------RANLYEFQKFNQESGG 514
+ +I+ L ++ E + +
Sbjct: 84 -----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E L L + Q + + +L S IH DL NIL+ KI D G +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIK 196
Query: 575 DNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 628
++ V+ + + APE I Y + D+WS G L EL++ G +P V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 629 LARII 633
++I
Sbjct: 257 FYKMI 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 39/229 (17%), Positives = 73/229 (31%), Gaps = 20/229 (8%)
Query: 420 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADE 475
+ +G F +V +A+ G+ + I + KD E+++L + +
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP---- 71
Query: 476 HHILRLYDYFYHLEHLFIVCELL-----------RANLYEFQKFNQESGGEAYFTLGRLQ 524
+I+ L H +L++ E L F + + + +L
Sbjct: 72 -NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 525 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 584
++YL IH DL NIL+ +I L +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 585 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633
+ A E + Y D+WS G +L E+ + L +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (275), Expect = 3e-27
Identities = 46/251 (18%), Positives = 83/251 (33%), Gaps = 40/251 (15%)
Query: 415 RYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
+G AF +VFQA+ V +K++K + D E L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF------------------QKF 508
+ +I++L + + ++ E + +L EF +
Sbjct: 74 DN------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 509 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568
S G + I RQ + YL +H DL N L+ +KI D G
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE--NMVVKIADFG 185
Query: 569 SSCFQTDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN 622
S + PE I Y + D+W+ G +L E+++ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 623 DAVVMILARII 633
A ++ +
Sbjct: 246 MAHEEVIYYVR 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-27
Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 29/242 (11%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHTGVD-------VCLKIIKND--KDFFDQSLDEIKLLK 465
R + + LG AF +V A+ + D V +K++K+D + + E++++K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 466 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF----------QKFNQESGG 514
++ K+ +I+ L L+++ E + NL E+ +N
Sbjct: 74 MIGKH-----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 515 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 574
E + L Q +EYL S IH DL N+L+ +I L
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 575 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 630
D + APE + Y + D+WS G +L E++T G +P V +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 631 RI 632
+
Sbjct: 249 LL 250
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 45/243 (18%), Positives = 91/243 (37%), Gaps = 26/243 (10%)
Query: 422 LGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADE 475
+G+ F +V++ + V V +K +K + L E ++ +
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH------ 68
Query: 476 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 535
H+I+RL + + I+ E + + ++ F++ +L + R ++
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMK 124
Query: 536 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAP 589
YL ++ +H DL NIL+ S K+ D G S D+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 590 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII--GMLGPIDLEMLMQG 647
E I + D+WS G ++ E+ T + + + I G P ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242
Query: 648 QEI 650
++
Sbjct: 243 YQL 245
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 46/251 (18%), Positives = 85/251 (33%), Gaps = 31/251 (12%)
Query: 401 NKDLPIILNTVIAGRYYVT----EYLGSAAFSKVFQAQDLH---TGVDVCLKIIK--NDK 451
N +L + V+ G + E +G F V+ L + +K + D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 452 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFN 509
Q L E ++K + ++L L E +V ++ +L F +
Sbjct: 70 GEVSQFLTEGIIMKDFSH------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 510 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569
+ T+ L Q + +++L S +H DL N ++ + +K+ D G
Sbjct: 124 THN-----PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176
Query: 570 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 622
+ D + A E + + K D+WS G +L EL T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 623 DAVVMILARII 633
D + +
Sbjct: 237 DVNTFDITVYL 247
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 50/230 (21%), Positives = 80/230 (34%), Gaps = 25/230 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNK 469
R + +G F V Q + + V +K KN ++ L E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 470 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 528
H HI++L I+ L F + + S L L +
Sbjct: 67 ------HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAY 115
Query: 529 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 585
Q AL YL S +H D+ N+L+ S +K+ D G S + D+
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 586 -YRAPEVIIGLPYDQKIDLWSLGCILAE-LWTGEVLFPNDAVVMILARII 633
+ APE I + D+W G + E L G F ++ RI
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 8e-25
Identities = 41/237 (17%), Positives = 91/237 (38%), Gaps = 26/237 (10%)
Query: 415 RYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 467
+ ++ LG +F V++ V +K + ++ L+E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 468 NKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGR 522
N HH++RL + ++ EL L++ L + + A +L +
Sbjct: 81 N------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 523 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 582
+ + + + + YL++ +H DL N ++ +KI D G + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMTRDIYETDYYRKG 192
Query: 583 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARII 633
+ + +PE + + D+WS G +L E+ T E + + +L ++
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-24
Identities = 51/244 (20%), Positives = 92/244 (37%), Gaps = 32/244 (13%)
Query: 415 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 467
R + + LG AF +V +A T V +K++K + E+K+L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 468 NKNDPADEHHILRLYDYFYHL-EHLFIVCELL-----------RANLYEFQKFNQESGGE 515
+++ L L ++ E + N + K E +
Sbjct: 74 G-----HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 516 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 575
+ TL L + Q + +E+L S IH DL NIL+ + +KI D G +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYK 186
Query: 576 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMIL 629
+ + + + APE I Y + D+WS G +L E+++ +P +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 630 ARII 633
R +
Sbjct: 247 CRRL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 4e-18
Identities = 30/191 (15%), Positives = 53/191 (27%), Gaps = 7/191 (3%)
Query: 422 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 481
+G S VF + +K K F + ++ L
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV--LAIRSARNE 64
Query: 482 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 541
+ L+ L + + +V+ LE + + G
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVL-DMILEEVAKFYHRG 123
Query: 542 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI 601
I+H DL N+L+ I IID S + + R R Y +
Sbjct: 124 IVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEK 180
Query: 602 DLWSLGCILAE 612
D+ S + +
Sbjct: 181 DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1a25a_ | 132 | C2 domain from protein kinase c (beta) {Rat (Rattu | 99.69 | |
| d1dqva1 | 130 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.61 | |
| d2bwqa1 | 125 | Regulating synaptic membrane exocytosis protein, r | 99.6 | |
| d1dqva2 | 145 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.59 | |
| d1w15a_ | 138 | Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: | 99.57 | |
| d1uowa_ | 157 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.56 | |
| d2cm5a1 | 137 | C2b-domain of rabphilin {Rat (Rattus norvegicus) [ | 99.54 | |
| d1rsya_ | 143 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.54 | |
| d1rh8a_ | 142 | Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | 99.52 | |
| d1ugka_ | 138 | Synaptotagmin IV {Human (Homo sapiens) [TaxId: 960 | 99.51 | |
| d1wfma_ | 138 | Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9 | 99.47 | |
| d2ep6a1 | 126 | Multiple C2 and transmembrane domain-containing pr | 99.41 | |
| d1qasa2 | 131 | PI-specific phospholipase C isozyme D1 (PLC-D1), C | 99.35 | |
| d1rlwa_ | 126 | Domain from cytosolic phospholipase A2 {Human (Hom | 99.32 | |
| d1wfja_ | 136 | C2 domain protein At1g63220 {Thale cress (Arabidop | 99.27 | |
| d1gmia_ | 136 | Domain from protein kinase C epsilon {Rat (Rattus | 99.18 | |
| d2nq3a1 | 133 | E3 ubiquitin-protein ligase Itchy {Human (Homo sap | 99.12 | |
| d1bdya_ | 123 | Domain from protein kinase C delta {Rat (Rattus no | 99.03 | |
| d2cjta1 | 128 | Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: | 98.83 | |
| d2zkmx2 | 122 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.52 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=378.26 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=207.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+++.||||++.+. ......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR------HPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC------CCCCCeEEEEEEECC
Confidence 5799999999999999999999999999999999743 233456788999988774 899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC--CCCEeecccc
Confidence 9999999998 467777664332 899999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 569 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 569 la~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+|...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+.-.++|..
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 226 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----- 226 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-----
T ss_pred eeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc-----
Confidence 99766443 445689999999999999999999999999999999999999999999988888876543333310
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
....+..+ ..+.+...|..|+|+++++ +|+..
T Consensus 227 --------~s~~~~~l----i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 227 --------VTEGARDL----ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------SCHHHHHH----HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------CCHHHHHH----HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 12233344 4444556689999999999 99874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=379.07 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=206.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ ||||++++++|...+.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC------CCCEeeEeEEEEECCEE
Confidence 357999999999999999999999999999999997533 34467889999999885 89999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
||||||+.+ +|.+++. .. .+++..++.+++||+.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 93 ~ivmEy~~gg~L~~~~~-~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVT-ET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHH-HS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHhh-cc------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC--CCcEeeccchhh
Confidence 999999986 5555443 21 2899999999999999999999999999999999999985 789999999999
Q ss_pred ccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 571 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 571 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.....+.. ..
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~---- 238 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QN---- 238 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SS----
T ss_pred eeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CC----
Confidence 76533 23456799999999999999999999999999999999999999999988888877765432211 10
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccC
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGID 693 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~ 693 (697)
+..+.....+...+.+...|..|+|+++++ +|+...+
T Consensus 239 ---------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 239 ---------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp ---------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 111222333334444455689999999999 9997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=380.55 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=208.7
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+++.||||++... ......+.+|+++++.++ ||||++++++|.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------STTBCCEEEEEECSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC------CCCeeEEEEEEEECC
Confidence 5799999999999999999999999999999999753 233467889999999875 899999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEEccCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC--CceEEecccc
Confidence 99999999984 67777664432 899999999999999999999999999999999999985 7889999999
Q ss_pred Cccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 569 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 569 la~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
+|+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.+.-..+|..
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~- 232 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK- 232 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT-
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc-
Confidence 99765322 234679999999999999999999999999999999999999999999999888886543333311
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHH------H--HhhcccCCCCC
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYA------A--LWLFGIDQNKI 697 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~------~--~wl~~~~~n~~ 697 (697)
-...+..++..| +...|..|+|++++ + +|+.+++|++|
T Consensus 233 ------------~s~~~~~li~~~----L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 233 ------------FFPKARDLVEKL----LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp ------------CCHHHHHHHHTT----SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ------------CCHHHHHHHHHH----ccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 112334444444 44558889988874 3 89988888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-44 Score=384.17 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=209.2
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------HPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------BTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc------CcChhheeeeEeeCC
Confidence 5799999999999999999999999999999999753 233467788999988774 899999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+|+||||+.++.+..+...... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG~ 150 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGF 150 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCSS
T ss_pred eeeeEeeecCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC--CCCEEEecCcc
Confidence 99999999986544443333222 788899999999999999999999999999999999985 78999999999
Q ss_pred ccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhccc
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 649 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~~ 649 (697)
|..........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.+|...-.++|..
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 223 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF------- 223 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT-------
T ss_pred ceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCC-------
Confidence 9988877778899999999999999999999999999999999999999999999999998887654333321
Q ss_pred ccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCC
Q 005415 650 IYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 650 ~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~ 694 (697)
-...+..++..|+ ...|.+|+ |+++++ +|+.+++|
T Consensus 224 ------~s~~~~~li~~~L----~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 224 ------FNEDVKDLLSRLI----TRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp ------SCHHHHHHHHHHT----CSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred ------CCHHHHHHHHHHh----hhCHHhccccchhhHHHHHcCcccccCCH
Confidence 1223444444444 44455564 899998 99988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-44 Score=377.99 Aligned_cols=255 Identities=29% Similarity=0.404 Sum_probs=197.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
+.++|++.+.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK------HPNIVALDDIYESGG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC------CTTBCCEEEEEECSS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECC
Confidence 4678999999999999999999999999999999997543 22345678999998774 899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc-cCcceEEEeeC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 567 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~-~~~~~vKL~DF 567 (697)
.+||||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecc
Confidence 9999999998 67888876432 2899999999999999999999999999999999999974 34688999999
Q ss_pred CCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 568 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 568 Gla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
|+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+....+....|.....+++....
T Consensus 155 G~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~- 233 (307)
T d1a06a_ 155 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW- 233 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT-
T ss_pred ceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc-
Confidence 999765433 34568999999999999999999999999999999999999999999998888888765444433221
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..+.....+.....+...|..|+|+++++ +|+.+
T Consensus 234 ------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 234 ------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11222333444455556699999999999 89975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=373.69 Aligned_cols=275 Identities=26% Similarity=0.385 Sum_probs=222.4
Q ss_pred cCceEEEEEeccCCCCceEEEEECCC-CcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~-g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~- 487 (697)
.++|++++.||+|+||+||+|++..+ ++.||||+++.. ........+|+.+++.+... +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc---CCCCcceeeeeeccc
Confidence 47899999999999999999999765 678999998743 22334677899999988653 49999999999863
Q ss_pred ----cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 488 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 488 ----~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...++++|||+.+++..+....... .+++..++.++.||+.||.|||+++|+||||||+|||++. .+.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC--CCCee
Confidence 3578999999998877665543332 2899999999999999999999999999999999999985 78999
Q ss_pred EeeCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCH
Q 005415 564 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 641 (697)
Q Consensus 564 L~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~ 641 (697)
|+|||++..... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|++.++.++.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 999999876543 344578999999999999999999999999999999999999999999999999999999998887
Q ss_pred HHHhhccccccccc----------CCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 642 EMLMQGQEIYKYFT----------KEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 642 e~~~~~~~~~~~~~----------~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
..+........... ....+.....+...+++..-|..|+|+++++ ||+...++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k 303 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence 66554322111110 0112233344445555666799999999999 9999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=374.05 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=214.5
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ |||||+++++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~ 81 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLHEV 81 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC------CCCCCcEEEE
Confidence 4578999999999999999999999999999999997432 23467889999999985 8899999999
Q ss_pred EEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC--cce
Q 005415 485 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCE 561 (697)
Q Consensus 485 f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~--~~~ 561 (697)
|.+...+||||||+. ++|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++..+ ...
T Consensus 82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~~------l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 82 YENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEECCEEEEEEEcCCCccccchhccccc------cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccc
Confidence 999999999999998 577777765432 89999999999999999999999999999999999998632 236
Q ss_pred EEEeeCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 562 IKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 562 vKL~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..|......+
T Consensus 156 vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp EEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred eEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999999976543 3445678999999999999999999999999999999999999999999999999987766666
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCCCC
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQNK 696 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~n~ 696 (697)
+...... ....+..++..||. ..|..|+|+++++ +|+...++++
T Consensus 236 ~~~~~~~---------~s~~~~~li~~~L~----~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 236 EDEYFSN---------TSALAKDFIRRLLV----KDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp CHHHHTT---------SCHHHHHHHHTTSC----SSGGGSCCHHHHHHSTTTCC-----
T ss_pred CchhcCC---------CCHHHHHHHHHHcc----CChhHCcCHHHHhcCcccCCCChhH
Confidence 6544322 12344555555554 4588999999999 9998776654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-44 Score=383.24 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=213.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+-++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEEETTE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCE
Confidence 3468999999999999999999999999999999997543 33466788999999885 8899999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+..+.++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 999999997 46777764322 128999999999999999999999999999999999999865678999999999
Q ss_pred ccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 570 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 570 a~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|......++......
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 251 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG- 251 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG-
T ss_pred heecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC-
Confidence 9875543 3347899999999999999999999999999999999999999999999999999877665554332211
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
-...+..+ ..+.+..-|..|+|+++++ +|+...
T Consensus 252 --------~s~~~~~l----i~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 252 --------ISEDGKDF----IRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp --------CCHHHHHH----HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred --------CCHHHHHH----HHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11233333 3444455689999999999 999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=383.91 Aligned_cols=201 Identities=28% Similarity=0.414 Sum_probs=174.4
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
+..++|+++++||+|+||+||+|+++.+|+.||+|+++.. .....++.+|+.+|+.++ |||||+++++|.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC------CTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC------CCCCCcEEEEEEEC
Confidence 4467899999999999999999999999999999999753 334567778888887764 89999999999999
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCccccccccCcceEEEee
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.++||||||+.+ +|.+++..... +++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~--~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC--CCCEEEee
Confidence 999999999985 67777654322 8999999999999999999997 59999999999999985 78999999
Q ss_pred CCCcccccc-ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 005415 567 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 625 (697)
Q Consensus 567 FGla~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~ 625 (697)
||+|..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 149 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999976543 34457899999999999999999999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=375.33 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=196.6
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC------CTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC------CCCEeeEeeeeccCce
Confidence 367999999999999999999999999999999997542 33457788999998874 8999999999999999
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+||||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG~ 149 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGL 149 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC--CCCEEEccchh
Confidence 9999999974 7777664322 3899999999999999999999999999999999999985 78899999999
Q ss_pred cccccc-----ccccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 570 SCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 570 a~~~~~-----~~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
|..... .....+||+.|+|||++.+..+ +.++|||||||++|||++|++||...........+..........+
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 976432 2344689999999999998876 5789999999999999999999977654433333222222111110
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
. .-...+..++ .+.+...|..|+|+++++ +|+..
T Consensus 230 ~----------~~s~~~~~li----~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 230 K----------KIDSAPLALL----HKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp G----------GSCHHHHHHH----HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred c----------cCCHHHHHHH----HHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 0112333343 444455689999999999 99963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=372.58 Aligned_cols=251 Identities=28% Similarity=0.368 Sum_probs=204.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
+.|++++.||+|+||+||+|+++.+++.||||+++.. ......+.+|+++++.++ |||||++++++.+.+.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCeEE
Confidence 4699999999999999999999999999999999753 345578889999999885 899999999999999999
Q ss_pred EEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 493 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 493 LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
+||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC--CCCEEEEechhhh
Confidence 99999985 55555443322 2899999999999999999999999999999999999995 7889999999997
Q ss_pred ccccc---cccccccCCCCCchhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHH
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 643 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~ 643 (697)
..... .....||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.++.....+....
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~- 237 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ- 237 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS-
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence 65432 33568999999999984 4568999999999999999999999999988888888876532211110
Q ss_pred HhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 644 LMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 644 ~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.-.....+..++..|| ...|..|+|+++++ +|++.
T Consensus 238 ---------~~~~s~~~~~li~~~L----~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 238 ---------PSRWSSNFKDFLKKCL----EKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------GGGSCHHHHHHHHHHS----CSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------cccCCHHHHHHHHHHc----cCChhHCcCHHHHhcCcccCC
Confidence 0011234444544444 45589999999999 89974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-44 Score=376.54 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=205.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
.+|++++.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++ |||||++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC------CTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC------CCCEeeEEEEEEECC
Confidence 46999999999999999999999999999999997532 33456778888887764 899999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.+|+||||+.++++..+..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCTT
T ss_pred EEEEEEEecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC--CCCEEEeeccc
Confidence 9999999999876665543332 2899999999999999999999999999999999999985 88999999999
Q ss_pred ccccccccccccccCCCCCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
|...... ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.++.....+++..
T Consensus 162 a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 236 (309)
T d1u5ra_ 162 ASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS---- 236 (309)
T ss_dssp CBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC----
T ss_pred ccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC----
Confidence 9766543 34689999999999964 358999999999999999999999999998888888876543322210
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
-.....+..++..||. ..|..|+|+++++ +|+..
T Consensus 237 -------~~~s~~~~~li~~~L~----~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 237 -------GHWSEYFRNFVDSCLQ----KIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------TTSCHHHHHHHHHHTC----SSGGGSCCHHHHTTCHHHHS
T ss_pred -------CCCCHHHHHHHHHHCc----CChhHCcCHHHHHhCHHhcC
Confidence 0112345556555554 5589999999999 89864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=368.01 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=198.3
Q ss_pred ceecCce-EEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 410 TVIAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 410 ~~i~~rY-~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
....+|| ++.++||+|+||+||+|.++.+++.||+|++... ......+.+|+++++.++ ||||++++++|
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~ 77 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ------HPNIVRFYDSW 77 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEE
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC------CCCeeeEEEEE
Confidence 3445677 6778999999999999999999999999998753 233456778888887764 89999999999
Q ss_pred Ee----cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC--ccccCCCCccccccccC
Q 005415 486 YH----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQ 558 (697)
Q Consensus 486 ~~----~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILl~~~~ 558 (697)
.. ...+|+||||+++ +|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 78 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~ 150 (270)
T d1t4ha_ 78 ESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-P 150 (270)
T ss_dssp EEESSSCEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-T
T ss_pred eeccccCCEEEEEEeCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC-C
Confidence 75 3568999999975 67777754432 899999999999999999999998 999999999999963 3
Q ss_pred cceEEEeeCCCccccccc-cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHhh
Q 005415 559 RCEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGML 636 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~-e~l~~I~~~l 636 (697)
++.+||+|||+|...... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.... ++...+..
T Consensus 151 ~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-- 227 (270)
T d1t4ha_ 151 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-- 227 (270)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--
T ss_pred CCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--
Confidence 678999999999765443 345689999999999876 5999999999999999999999999876544 44444433
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhc
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLF 690 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~ 690 (697)
+..|..... ...+.+..++..||. ..|..|+|+++++ +|+.
T Consensus 228 ~~~~~~~~~---------~~~~~~~~li~~~l~----~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 GVKPASFDK---------VAIPEVKEIIEGCIR----QNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp TCCCGGGGG---------CCCHHHHHHHHHHSC----SSGGGSCCHHHHHTSGGGC
T ss_pred CCCCcccCc---------cCCHHHHHHHHHHcc----CCHhHCcCHHHHhCCcccC
Confidence 222222110 123355666666655 4488999999999 8984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-43 Score=382.40 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=212.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+++.++ ||||++++++|.+.+.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH------HPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC------STTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC------CCCCCcEEEEEEECCEE
Confidence 467999999999999999999999999999999997643 33456678888887764 89999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
||||||+.+ +|.+.+.... ..+++..++.|+.||+.||.|||++||+||||||+|||++...++.+||+|||+|
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence 999999985 5656554322 2389999999999999999999999999999999999998656789999999999
Q ss_pred cccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.+|.....+++...+.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--- 253 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS--- 253 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT---
T ss_pred eecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc---
Confidence 876543 344688999999999999999999999999999999999999999999999999987765555432221
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.....+..+ ...++...|..|+|+++++ +|+.+...
T Consensus 254 ------~~s~~~~~l----i~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 254 ------SVSPEAKDF----IKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp ------TSCHHHHHH----HHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ------CCCHHHHHH----HHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 112233333 3444445589999999999 89986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-44 Score=384.00 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=210.8
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+|+++++.+ +||||+++++++....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc------CCCcEeeccccccccc
Confidence 58999999999999999999999999999999997532 3345677888888776 4899999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++||||+.+ +|...+..... +++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DFG 186 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFG 186 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred ccccccccccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC--CCCEEeeece
Confidence 99999999985 55565544322 899999999999999999999999999999999999985 7899999999
Q ss_pred CccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 569 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 569 la~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
+|+..........||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+...++.+|......+|..
T Consensus 187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~------ 260 (350)
T d1rdqe_ 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH------ 260 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT------
T ss_pred eeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc------
Confidence 99888777777899999999999999999999999999999999999999999999999988887654444321
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHh-hhhccCHHHHH--HhhcccCC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISL-VVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~-~~~r~t~e~~~--~wl~~~~~ 694 (697)
....+..++..|+......+ +..|.|+++++ +|+.+++|
T Consensus 261 -------~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 261 -------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 12345555555554443332 22345899999 99987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=372.16 Aligned_cols=250 Identities=21% Similarity=0.269 Sum_probs=193.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--c
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--L 488 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--~ 488 (697)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+++++.+ +||||+++++++.+ .
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL------KHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC------CCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC------CCCCEeeEEEEEEeCCC
Confidence 57999999999999999999999999999999997542 3344566777777665 48999999999975 4
Q ss_pred CeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcC-----ccccCCCCccccccccCcceE
Q 005415 489 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 489 ~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~g-----IvHrDLKP~NILl~~~~~~~v 562 (697)
..+||||||++ ++|.+++....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~v 153 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNV 153 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSCE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC--CCcE
Confidence 56899999997 57888776543322 23899999999999999999999976 999999999999995 7899
Q ss_pred EEeeCCCccccccc---cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 563 KIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 563 KL~DFGla~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+++.+|....-+.
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~ 233 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999999765432 234688999999999999999999999999999999999999999999988888876532211
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhh
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWL 689 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl 689 (697)
.+ ......+..++..||. ..|..|.|+++++ |||
T Consensus 234 ~~------------~~~s~~l~~li~~~L~----~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 IP------------YRYSDELNEIITRMLN----LKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CC------------TTSCHHHHHHHHHHTC----SSGGGSCCHHHHHTSTTC
T ss_pred CC------------cccCHHHHHHHHHHcC----CChhHCcCHHHHHhCCcC
Confidence 11 0112355666666654 4588999999999 886
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=368.07 Aligned_cols=269 Identities=29% Similarity=0.418 Sum_probs=217.4
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
++|++++.||+|+||+||+|+++.+++.||||+++... ....++.+|+++++.++ ||||++++++|.+...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC------CTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC------CCcEEEeccccccccc
Confidence 57999999999999999999999999999999997532 23567888999988774 8999999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
+|+||||+.+++..++....... +++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||.|
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~----l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a 149 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLA 149 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHH
T ss_pred eeEEEeecCCchhhhhhhhcccC----CCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc--cCcceeccCCcc
Confidence 99999999998887775543322 899999999999999999999999999999999999985 778999999999
Q ss_pred cccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++....+.++...+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence 765432 33458899999999987766 57899999999999999999999999999999999999998887765554
Q ss_pred cccccccccCC------------chhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 647 GQEIYKYFTKE------------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 647 ~~~~~~~~~~~------------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
......+.... ..+.....+...+++..-|..|+|+++++ +|+....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 33222211110 11112223344455555688999999999 99976543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=377.82 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=207.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||.||+|+++.+|+.||||++++. .....++.+|+.+|+.++ ||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~------hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR------HPFLTALKYAFQTHD 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------CTTBCCEEEEEECSS
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC------CCCEEEEEeeecccc
Confidence 5799999999999999999999999999999999753 234567788999988764 899999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+.+ +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DFG 150 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFG 150 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred ccccceeccCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC--CCCEEEeecc
Confidence 99999999985 56666554332 899999999999999999999999999999999999985 7899999999
Q ss_pred Ccccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++..+....-++|..
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~--- 227 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--- 227 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred cccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc---
Confidence 9976432 3345789999999999999999999999999999999999999999999988888876644333321
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccCC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGIDQ 694 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~~ 694 (697)
-......+ ..+++...|..|+ ++++++ +|+.+++|
T Consensus 228 ----------~s~~~~dl----i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 228 ----------LSPEAKSL----LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ----------SCHHHHHH----HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ----------CCHHHHHH----HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 11233333 4444555677787 588888 99987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=373.48 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=216.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+-+||++++.||+|+||+||+|.++.+++.||||+++........+.+|+.+|+.++ ||||++++++|.+.+.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC------CCCCCeEEEEEEECCEE
Confidence 347899999999999999999999999999999999877665567889999998875 88999999999999999
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
||||||+.+ +|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++...+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchh
Confidence 999999985 7777775332 1289999999999999999999999999999999999998766778999999999
Q ss_pred cccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 571 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 571 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+.+|.+....++...+...
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 230 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI- 230 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTS-
T ss_pred hccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCC-
Confidence 765433 34467899999999999999999999999999999999999999999999999999887766666554321
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
...+..++.. .+...|..|+|+++++ +|+..
T Consensus 231 --------s~~~~~li~~----~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 231 --------SIEAMDFVDR----LLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp --------CHHHHHHHHT----TSCSSGGGSCCHHHHHHSHHHHS
T ss_pred --------CHHHHHHHHH----HccCChhHCcCHHHHhcCHhhcc
Confidence 1233334433 3455688999999998 89863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=370.12 Aligned_cols=262 Identities=29% Similarity=0.396 Sum_probs=209.8
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEEecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 418 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 418 i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.++ |||||++++++...+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEECCTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC------CCCEeEEEeeeccCCce
Confidence 46899999999999999999999999999874321 2346788999999885 88999999999999999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
||||||+.+++...+.... ..+++..++.+++||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~--~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAK 148 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGS
T ss_pred eehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC--CCccccccCcccc
Confidence 9999999988776654322 23888899999999999999999999999999999999995 7899999999997
Q ss_pred ccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
..... ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+++.+|.+.++.++.+.+...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 65443 3346789999999998754 5899999999999999999999999999999999999999998887665443
Q ss_pred ccccccccCC-----------chhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 648 QEIYKYFTKE-----------YDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 648 ~~~~~~~~~~-----------~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.....+.... ..+..-..+...+.+...|..|.|+++++ +|+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 2221111100 01122233444555566688999999999 999743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=372.84 Aligned_cols=276 Identities=28% Similarity=0.445 Sum_probs=222.4
Q ss_pred CCcceeeCce---ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 005415 402 KDLPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 402 ~~~pv~~~~~---i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
++++..++.+ +.++|+++++||+|+||+||+|.++.+|+.||||+++.. ......+.+|+++|+.++ |
T Consensus 3 ~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------h 76 (346)
T d1cm8a_ 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------H 76 (346)
T ss_dssp SBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------B
T ss_pred CcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC------C
Confidence 4566666666 689999999999999999999999999999999999743 334567889999999885 7
Q ss_pred CceeEEEEEEEecC------eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 476 HHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 476 pnIv~l~~~f~~~~------~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
||||+++++|...+ ++|+||||++.++..+.... .+++..++.+++||+.||.|||++||+||||||
T Consensus 77 pniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp 149 (346)
T d1cm8a_ 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149 (346)
T ss_dssp TTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence 89999999998654 57999999987777665422 289999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 628 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~ 628 (697)
+|||++. ++.+||+|||+|.......+...+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.
T Consensus 150 ~NIL~~~--~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 150 GNLAVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp GGEEECT--TCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred chhhccc--ccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence 9999995 8899999999999888888888999999999999875 578999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCHHHHhhccccc---------c----cc-cCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 629 LARIIGMLGPIDLEMLMQGQEIY---------K----YF-TKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 629 l~~I~~~lg~~p~e~~~~~~~~~---------~----~~-~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
+..+....+.++.+++....... . .+ ...........+...+++..-|..|+|+++++ +|+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 99999999999988776432100 0 00 00112223334445556666788999999999 999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-43 Score=367.25 Aligned_cols=253 Identities=18% Similarity=0.230 Sum_probs=206.6
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+-.++|++.+.||+|+||+||+|.++.+++.||||+++.+....+++.+|+.+++.++ |||||++++++.+.+.
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC------CCCEecCCccEeeCCe
Confidence 3457899999999999999999999999999999999877766778999999999885 8999999999999999
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
++|||||+. |+|..++..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DFG~ 161 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGL 161 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCC
T ss_pred eEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC--CCcEEEccccc
Confidence 999999998 567777654322 23899999999999999999999999999999999999985 78999999999
Q ss_pred cccccccc----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~P-F~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|+...... ....|++.|+|||++.+..++.++|||||||++|||++|..| |.+.+..++...+.....++.+
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~--- 238 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--- 238 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC---
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC---
Confidence 98754432 223568889999999999999999999999999999996555 5556655555444332211111
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
-.....+..++..||... |..|+|++++..||..
T Consensus 239 ---------~~~~~~l~~li~~cl~~d----P~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 239 ---------EGCPEKVYELMRACWQWN----PSDRPSFAEIHQAFET 272 (287)
T ss_dssp ---------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHH
T ss_pred ---------ccchHHHHHHHHHHcCCC----HhHCcCHHHHHHHHHH
Confidence 123456778888888755 8889999999877753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=356.91 Aligned_cols=247 Identities=20% Similarity=0.294 Sum_probs=200.0
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
.+|++++.||+|+||+||+|.+. +++.||||+++......+.+.+|+++++.++ ||||+++++++...+..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC------CCCcccccceeccCCceEE
Confidence 67999999999999999999975 5778999999877666678899999999985 8899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. ++|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++.
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRF 150 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC----
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC--CCCeEecccchhee
Confidence 999997 567776654322 2889999999999999999999999999999999999995 88999999999976
Q ss_pred cccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+++..+......+.+.
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~----- 225 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR----- 225 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT-----
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc-----
Confidence 5432 223567899999999999999999999999999999999 688888888888888776643322211
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.....+..++..||... |..|+|+++++.-|.
T Consensus 226 -------~~~~~l~~li~~cl~~~----p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 226 -------LASTHVYQIMNHCWKER----PEDRPAFSRLLRQLA 257 (263)
T ss_dssp -------TSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred -------ccCHHHHHHHHHHccCC----HhHCcCHHHHHHHHH
Confidence 23457888999998754 889999999886554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-41 Score=355.00 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=209.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++.++. ||||++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-----HPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-----CTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEEE
Confidence 478999999999999999999999999999999997532 123467889999999863 78999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
+++.+.+.+||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ 148 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMN 148 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC--CCC
Confidence 99999999999999997 58888876433 2899999999999999999999999999999999999985 889
Q ss_pred EEEeeCCCccccccc--cccccccCCCCCchhhcC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 562 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 562 vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~------~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+||+|||++...... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+..+.+..|.
T Consensus 149 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 999999999876542 345678999999999863 347889999999999999999999999999988888887
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
..--.++.... ..+.+-..+...+.+...|..|+++++++ +|+..+
T Consensus 229 ~~~~~~~~~~~-------------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 229 SGNYQFGSPEW-------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HTCCCCCTTTG-------------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred hCCCCCCCccc-------------ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 64333332211 12223334444555556699999999999 999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-41 Score=354.08 Aligned_cols=254 Identities=26% Similarity=0.305 Sum_probs=197.1
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
.+.+||++.+.||+|+||+||+|+++.+++.||||+++.. ......+.+|+++++.++ ||||+++++++.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~------hpniv~~~~~~~ 77 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN------HPAIVAVYDTGE 77 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC------CCCCCcccceee
Confidence 4678999999999999999999999999999999999753 233456788888887764 899999999998
Q ss_pred ecC----eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 487 HLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 487 ~~~----~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
..+ .+||||||+.+ +|...+..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~~ 149 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TNA 149 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TSC
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc--ccc
Confidence 754 38999999985 55555543322 899999999999999999999999999999999999985 788
Q ss_pred EEEeeCCCcccccc------ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh
Q 005415 562 IKIIDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 562 vKL~DFGla~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~ 635 (697)
++|+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+.+.+++..
T Consensus 150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc
Confidence 99999998754322 233467899999999999999999999999999999999999999999998888887664
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-CHHHHH-Hhhcc
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-TLEYAA-LWLFG 691 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-t~e~~~-~wl~~ 691 (697)
...++..... .-...+..++.. .+...|..|. +++++. .|+..
T Consensus 230 ~~~~~~~~~~---------~~s~~l~~li~~----~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIPPSARHE---------GLSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCGGGTSS---------SCCHHHHHHHHH----HTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCchhcc---------CCCHHHHHHHHH----HccCCHhHCHhHHHHHHHHHHHH
Confidence 4333321110 112334444444 4445688898 788777 77643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-42 Score=371.05 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=198.6
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+|+.||||++.... .......+|..+++.++. .+||||++++++|...+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~---~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECSS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc---CCCCcEEEEEEEEEECC
Confidence 57999999999999999999999999999999997432 222345567666766654 35999999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~--~g~iKl~DFG 152 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLG 152 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SSCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC--CCcEEEeeec
Confidence 9999999998 567777754432 889999999999999999999999999999999999985 7899999999
Q ss_pred Cccccccc-cccccccCCCCCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 569 SSCFQTDN-LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 569 la~~~~~~-~~~~~gt~~Y~APE~l~~-~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
+|+..... .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+.+..+....+......++.
T Consensus 153 la~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~----- 227 (364)
T d1omwa3 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----- 227 (364)
T ss_dssp TCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC-----
T ss_pred eeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-----
Confidence 99865443 445689999999999974 56899999999999999999999999875543322221111111110
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccC-----HHHHH--HhhcccCC
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLT-----LEYAA--LWLFGIDQ 694 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t-----~e~~~--~wl~~~~~ 694 (697)
+ +..+..-..+.....+...|..|+| +++++ +|+.+++|
T Consensus 228 ------~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 228 ------L---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp ------C---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred ------C---CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 0 1112223334444455566888988 68888 99987764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=364.83 Aligned_cols=274 Identities=28% Similarity=0.463 Sum_probs=215.9
Q ss_pred CCcceeeCce---ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCC
Q 005415 402 KDLPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 475 (697)
Q Consensus 402 ~~~pv~~~~~---i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h 475 (697)
.++|+.+|+. +.++|+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+++.++ |
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------h 75 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------H 75 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC------C
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC------C
Confidence 4679999994 458999999999999999999999999999999999754 334456789999998874 7
Q ss_pred CceeEEEEEEEe------cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 476 HHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 476 pnIv~l~~~f~~------~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
|||++++++|.. ..++|+||||+.++++..+.. .+++..++.+++||+.||.|||++||+||||||
T Consensus 76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP 147 (355)
T d2b1pa1 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCc
Confidence 899999999964 368999999999998776631 289999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccc--cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 627 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e 627 (697)
+|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+...
T Consensus 148 ~Nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 148 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGEEECT--TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccccc--ccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 9999995 788999999988665433 344678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCCHHHHhhccccc-ccccC--------------------Cc----hhhhhHHHHHHHHHHHhhhhccCH
Q 005415 628 ILARIIGMLGPIDLEMLMQGQEIY-KYFTK--------------------EY----DLYYINEVCFANIFISLVVIRLTL 682 (697)
Q Consensus 628 ~l~~I~~~lg~~p~e~~~~~~~~~-~~~~~--------------------~~----~l~~i~~~cw~~l~~~~~~~r~t~ 682 (697)
.+.+++..++.++.+.+....... .+... .. .......+...+++..-|..|+|+
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 999999999988887765432211 00000 00 011223444556666678889999
Q ss_pred HHHH--Hhhcc
Q 005415 683 EYAA--LWLFG 691 (697)
Q Consensus 683 e~~~--~wl~~ 691 (697)
++++ ||+..
T Consensus 306 ~elL~Hpw~~~ 316 (355)
T d2b1pa1 306 DDALQHPYINV 316 (355)
T ss_dssp HHHHTSTTTGG
T ss_pred HHHhcCcccCC
Confidence 9999 99975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=361.35 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=201.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++++.||+|+||+||+|+++.+++.||||+++++. ........|..++... .+||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-----~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-----TTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh-----CCCCcEEEEEEEEccCC
Confidence 57999999999999999999999999999999997532 2334566676665542 24899999999999999
Q ss_pred eEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 490 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 490 ~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+||||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~--~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC--CCceeccccc
Confidence 99999999985 67777664432 889999999999999999999999999999999999995 7899999999
Q ss_pred Ccccccc---ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|...-...|.
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~---- 224 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR---- 224 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----
T ss_pred hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----
Confidence 9975432 234467899999999999999999999999999999999999999999999888888653222221
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHH-HHH--HhhcccC
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLE-YAA--LWLFGID 693 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e-~~~--~wl~~~~ 693 (697)
. ....+..++..| +..-|..|++++ +++ +|+.+++
T Consensus 225 -------~--~s~~~~dli~~~----L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 225 -------W--LEKEAKDLLVKL----FVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -------T--SCHHHHHHHHHH----SCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -------c--CCHHHHHHHHHh----cccCCCCCcCHHHHHHhCchhccCC
Confidence 0 122344444444 445588888885 555 8887653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=361.97 Aligned_cols=266 Identities=29% Similarity=0.460 Sum_probs=213.8
Q ss_pred ceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec------
Q 005415 415 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL------ 488 (697)
Q Consensus 415 rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~------ 488 (697)
+|+.+++||+|+||+||+|+++.+|+.||||+++.+... ..+|+.+++.++ ||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~------h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------HCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCC------CTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcC------CCCCCcEEEEEEecCccCCc
Confidence 799999999999999999999999999999999876533 347999998874 88999999999643
Q ss_pred CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCC
Q 005415 489 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 568 (697)
Q Consensus 489 ~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFG 568 (697)
.+++|||||+++++...+....... ..+++..++.+++||+.||.|||++||+||||||+|||++. +...+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-CCCceeEeccc
Confidence 4589999999988776665432222 23899999999999999999999999999999999999985 23479999999
Q ss_pred Ccccccc--ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 569 SSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 569 la~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
++..... ......|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+++.+|++.+|.++.+.+.
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 9976533 34456889999999998764 68999999999999999999999999999999999999999999998876
Q ss_pred hccccccccc--C----------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 646 QGQEIYKYFT--K----------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 646 ~~~~~~~~~~--~----------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.......... . ...+.....+....++..-|..|+|+++++ +|+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 5432111000 0 011222334444555666689999999999 999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=355.70 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=201.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+..++|++.+.||+|+||+||+|.+. +++.||||+++......+.+.+|+.+++.++ |||||++++++.. +.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECS-SS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC------CCCEeEEEeeecc-CC
Confidence 34578999999999999999999974 6788999999877666678999999999985 7899999998754 56
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+.+ +|.+++...... .+++..+..|+.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~----~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~--~~~~Kl~DFGl 155 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFGL 155 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec--ccceeeccccc
Confidence 7999999985 566655433322 2899999999999999999999999999999999999995 88999999999
Q ss_pred ccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHH
Q 005415 570 SCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 644 (697)
Q Consensus 570 a~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~ 644 (697)
|+..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.+..+.....++.+.
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~-- 233 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD-- 233 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT--
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc--
Confidence 9875433 223567889999999999899999999999999999999 567777788888877776543322211
Q ss_pred hhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 645 MQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 645 ~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.....+..++..||... |..|+|++++.
T Consensus 234 ----------~~~~~l~~li~~cl~~~----P~~Rpt~~ei~ 261 (272)
T d1qpca_ 234 ----------NCPEELYQLMRLCWKER----PEDRPTFDYLR 261 (272)
T ss_dssp ----------TCCHHHHHHHHHHTCSS----GGGSCCHHHHH
T ss_pred ----------cChHHHHHHHHHHcCCC----HhHCcCHHHHH
Confidence 22346778888888765 88889988876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-42 Score=361.74 Aligned_cols=249 Identities=20% Similarity=0.234 Sum_probs=194.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc---EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~---~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.++|++.++||+|+||+||+|+++.+++ .||||.+... ......+.+|+++++.++ |||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD------HPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC------CTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC------CCCCccEEEEEee
Confidence 3679999999999999999999876664 5889988643 344567888998888774 8999999999999
Q ss_pred cCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.+.+++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~D 171 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSD 171 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC--CCcEEECC
Confidence 9999999999985 56565543222 2899999999999999999999999999999999999985 88999999
Q ss_pred CCCcccccccc--------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhC
Q 005415 567 LGSSCFQTDNL--------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 567 FGla~~~~~~~--------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg 637 (697)
||+++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+++..|.+...
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99997654321 12356889999999999999999999999999999998 8999999999888888765443
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+++ ......+..++..||... |..|+|++++...|.
T Consensus 252 ~~~~------------~~~~~~l~~li~~cl~~~----P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 252 LPPP------------MDCPSALHQLMLDCWQKD----RNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCC------------TTCCHHHHHHHHHHTCSS----TTTSCCHHHHHHHHH
T ss_pred CCCC------------ccchHHHHHHHHHHcCCC----HhHCcCHHHHHHHHH
Confidence 3221 134557888999999865 788888888774443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-41 Score=354.66 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=213.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+||+++++||+|+||+||+|+++ +|+.||||+++... ....++.+|+.+++.++ ||||++++++|...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC------CCcEEeeeeecccCCc
Confidence 58999999999999999999985 78999999997542 23467888998888774 8999999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.+++||++.++++..+..... .+++..++.++.||+.||.|||+++||||||||+|||++. ++.+||+|||.+
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a 147 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred eeEEEEeehhhhHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC--CCCEEecccccc
Confidence 999999999988777754332 2999999999999999999999999999999999999985 789999999998
Q ss_pred cccccc---cccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
...... .....+++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+++.++...++.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 765432 3345689999999999765 478999999999999999999999999999999999999999888776654
Q ss_pred cccccccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 647 GQEIYKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 647 ~~~~~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
.....++-.. ...+.....+-...++..-|..|+|+++++ +|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 3332221100 011223334455566666789999999999 99863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=354.77 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=196.1
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
+.++|++.+.||+|+||+||+|+++.+++.||||+++... ....++.+|+.+++.++. .||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc----CCCCccEEEEE
Confidence 4679999999999999999999999999999999997532 112346689999999974 38999999999
Q ss_pred EEecCeEEEEEEcccc--chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceE
Q 005415 485 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 562 (697)
Q Consensus 485 f~~~~~l~LVmEyl~g--sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~v 562 (697)
+.+.+..++||||+.+ .+.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. +++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~~------l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~v 150 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGEL 150 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-CCCeE
Confidence 9999999999999964 45555544322 899999999999999999999999999999999999985 35789
Q ss_pred EEeeCCCccccccc-cccccccCCCCCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 563 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 563 KL~DFGla~~~~~~-~~~~~gt~~Y~APE~l~~~~~-s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
||+|||+|...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ .+....-..+
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~ 224 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR 224 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS
T ss_pred EECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC
Confidence 99999999765443 345789999999999987765 577999999999999999999997642 1222111111
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
. .-...+..++ .+.+...|..|+|+++++ +|+...
T Consensus 225 -----------~--~~s~~~~~li----~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 -----------Q--RVSSECQHLI----RWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------S--CCCHHHHHHH----HHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------C--CCCHHHHHHH----HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0 0122334444 444555689999999999 999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=351.43 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=208.3
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 493 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~L 493 (697)
++|+++++||+|+||+||+|++ .+++.||||+++......+.+.+|+++++.++ ||||+++++++.+...+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~------HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEECCSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcC------CCceeeEEEEEeeCCceEE
Confidence 5788999999999999999997 47889999999987766778899999998875 8899999999999999999
Q ss_pred EEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCccc
Q 005415 494 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 572 (697)
Q Consensus 494 VmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~ 572 (697)
||||+. |++..++...... +++..+..++.||++||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~-----~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGC-----CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCB
T ss_pred EEEccCCCcHHHhhhccccC-----CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC--CCcEEECcchhhee
Confidence 999997 5566665444332 889999999999999999999999999999999999995 78999999999975
Q ss_pred cccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 573 QTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 573 ~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..+|.+....+++.
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~----- 224 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH----- 224 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT-----
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 4432 223567889999999999999999999999999999998 899999999988888887654433321
Q ss_pred ccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 648 QEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 648 ~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
.....+..++..||... |..|+|+++++.-|
T Consensus 225 -------~~~~~l~~li~~cl~~d----P~~RPt~~eil~~L 255 (258)
T d1k2pa_ 225 -------LASEKVYTIMYSCWHEK----ADERPTFKILLSNI 255 (258)
T ss_dssp -------TCCHHHHHHHHHTTCSS----GGGSCCHHHHHHHH
T ss_pred -------cccHHHHHHHHHHccCC----HhHCcCHHHHHHHh
Confidence 23357888999999866 88899999988544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=356.82 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=194.8
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
+-.++|++.+.||+|+||+||+|+. +..||||+++.. ......+.+|+.+++.++ ||||+++++++..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR------HVNILLFMGYSTA 75 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC------CTTBCCEEEEECS
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC------CCCEeeeeEEEec
Confidence 3457899999999999999999974 346999998743 344567788888887764 8999999998754
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
..+++||||++ ++|.+++..... .+++..+..++.||+.||.|||+++||||||||+|||++. ++.+||+|
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~D 147 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGD 147 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEECC
T ss_pred -cEEEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC--CCCEEEcc
Confidence 56899999998 577777754322 2899999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc-----cccccccCCCCCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC-
Q 005415 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG- 637 (697)
Q Consensus 567 FGla~~~~~~-----~~~~~gt~~Y~APE~l~~~---~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg- 637 (697)
||+|+..... .....||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+....+..++....
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9999765432 2345789999999999753 489999999999999999999999998776665555544332
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
++..... .-.....+..++..||... |..|+|++++...|.
T Consensus 228 ~p~~~~~--------~~~~~~~l~~li~~cl~~d----p~~RPt~~~il~~Le 268 (276)
T d1uwha_ 228 SPDLSKV--------RSNCPKAMKRLMAECLKKK----RDERPLFPQILASIE 268 (276)
T ss_dssp CCCGGGS--------CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CCcchhc--------cccchHHHHHHHHHHcCCC----HhHCcCHHHHHHHHH
Confidence 2221111 0123457888999998755 888999988885543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=360.78 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=203.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCc-----EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~-----~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++.+.||+|+||+||+|++..+++ .||+|++... ......+.+|+.++..+. +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~~~~ 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLGAC 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc-----CCCcEeEEEEEE
Confidence 4689999999999999999999865543 6999998643 334457888999998884 389999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhcc-----------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCC
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQES-----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 547 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~-----------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDL 547 (697)
...+.+++||||++ |+|.+++...... .....+++..++.++.||+.||.|||+++||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999997 5788887654321 11123889999999999999999999999999999
Q ss_pred CCccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005415 548 KPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFP 621 (697)
Q Consensus 548 KP~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~ 621 (697)
||+|||++. ++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||+| |++||.
T Consensus 191 Kp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc--CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999985 7899999999997654332 23567899999999999999999999999999999998 999999
Q ss_pred CCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 622 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 622 ~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+..+.+.+++.....++. .......+..++..||... |..|+|+++++..|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~-----------p~~~~~~l~~li~~cl~~d----P~~RPt~~ei~~~L 321 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQ-----------PFYATEEIYIIMQSCWAFD----SRKRPSFPNLTSFL 321 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCC-----------CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCC-----------CCcCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence 87776667776654332221 1123456788888888755 88899999988665
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-41 Score=352.70 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=210.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 487 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-- 487 (697)
.+||+++++||+|+||+||+|+++.+|+.||||++... .....++.+|+++|+.++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc------CCCccceEeeeeccc
Confidence 37999999999999999999999999999999998643 234467889999999885 7899999999865
Q ss_pred ------cCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcce
Q 005415 488 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 561 (697)
Q Consensus 488 ------~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~ 561 (697)
..++++||||+.+++......... .+++..++.+++||+.||.|||++||+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~ 155 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 155 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSC
T ss_pred ccccccCceEEEEEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC--CCc
Confidence 356899999999888776543332 2889999999999999999999999999999999999995 789
Q ss_pred EEEeeCCCcccccc-------ccccccccCCCCCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Q 005415 562 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 633 (697)
Q Consensus 562 vKL~DFGla~~~~~-------~~~~~~gt~~Y~APE~l~~~-~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~ 633 (697)
+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999965432 22335789999999999865 68999999999999999999999999999999999999
Q ss_pred HhhCCCCHHHHhhccccccc--cc----CCchhh---------hhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 634 GMLGPIDLEMLMQGQEIYKY--FT----KEYDLY---------YINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~--~~----~~~~l~---------~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
..++.++.+..........+ +. ....+. ....+...+++..-|..|+|+++++ +|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 99998887765543211111 10 011111 1112334455555688899999999 99874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=362.71 Aligned_cols=254 Identities=27% Similarity=0.340 Sum_probs=195.7
Q ss_pred ecCceEEEE-EeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 005415 412 IAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 487 (697)
Q Consensus 412 i~~rY~i~e-~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~--- 487 (697)
+.++|+|++ .||+|+||+||+|+++.+++.||||+++.. ....+|+.++..+. +||||++++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~-----~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc-----CCCCCCeEEEEEeeccc
Confidence 346799885 599999999999999999999999999754 35667888876653 48999999999976
Q ss_pred -cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEE
Q 005415 488 -LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKI 564 (697)
Q Consensus 488 -~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL 564 (697)
...+|||||||+ |+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 467999999997 58888876432 2239999999999999999999999999999999999999853 2568999
Q ss_pred eeCCCcccccc--ccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhC----C
Q 005415 565 IDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG----P 638 (697)
Q Consensus 565 ~DFGla~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg----~ 638 (697)
+|||+|+.... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+....+..... .
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 99999976543 34456899999999999999999999999999999999999999987765554444432211 1
Q ss_pred CCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 639 IDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 639 ~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
+|...+ ..+.....+...+.+...|..|+|+++++ +|+..
T Consensus 236 ~~~~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 236 FPNPEW-------------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CCTTHH-------------HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CCCccc-------------ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 111110 11222233344555566689999999999 89864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=348.57 Aligned_cols=243 Identities=21% Similarity=0.243 Sum_probs=195.9
Q ss_pred CceEEEEE-eccCCCCceEEEEECC--CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec
Q 005415 414 GRYYVTEY-LGSAAFSKVFQAQDLH--TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 488 (697)
Q Consensus 414 ~rY~i~e~-LG~G~fG~Vy~a~d~~--~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~ 488 (697)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++.. ......+.+|+++++.++ |||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEES-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC------CCCEeeEeeeecc-
Confidence 56888885 9999999999998754 4568999999753 344567889999999885 8899999999865
Q ss_pred CeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeC
Q 005415 489 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 567 (697)
Q Consensus 489 ~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DF 567 (697)
+.+++||||+++ +|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc--CCceeeccc
Confidence 568999999985 67666543222 2899999999999999999999999999999999999985 889999999
Q ss_pred CCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 568 GSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 568 Gla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+++..|.+...++.
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999765432 223467889999999999999999999999999999998 9999999888887777755332211
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+ -.....+..++..||... |..|+|++++.
T Consensus 234 p------------~~~~~~l~~li~~cl~~~----p~~RPs~~~i~ 263 (285)
T d1u59a_ 234 P------------PECPPELYALMSDCWIYK----WEDRPDFLTVE 263 (285)
T ss_dssp C------------TTCCHHHHHHHHHTTCSS----GGGSCCHHHHH
T ss_pred C------------CcCCHHHHHHHHHHcCCC----HhHCcCHHHHH
Confidence 1 123457888999999876 66677766554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-40 Score=343.21 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=203.7
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++++++|+|++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.+++ |+|++.+++++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGL 74 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETT
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcC-----CCCCCEEEEEeecCC
Confidence 4678999999999999999999999999999999999875432 3567789999998874 579999999999999
Q ss_pred eEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc---CcceEEEee
Q 005415 490 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIID 566 (697)
Q Consensus 490 ~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~---~~~~vKL~D 566 (697)
..++||||++++|.+++...... ++...+..++.|++.||.|||++||+||||||+|||++.. ..+.+||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~-----~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred ccEEEEEecCCCHHHHHHhhccc-----hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 99999999999998887654332 8999999999999999999999999999999999999742 356899999
Q ss_pred CCCccccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHH
Q 005415 567 LGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARII 633 (697)
Q Consensus 567 FGla~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~---~~~e~l~~I~ 633 (697)
||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+.++.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999764321 22357999999999999999999999999999999999999999764 3444455554
Q ss_pred HhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 634 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 634 ~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.....++.+.+. -..+..+..++..||+.. +..|++.+.+.
T Consensus 230 ~~~~~~~~~~l~--------~~~p~~l~~ii~~~~~~~----~~~rP~y~~l~ 270 (293)
T d1csna_ 230 EKKQSTPLRELC--------AGFPEEFYKYMHYARNLA----FDATPDYDYLQ 270 (293)
T ss_dssp HHHHHSCHHHHT--------TTSCHHHHHHHHHHHHCC----TTCCCCHHHHH
T ss_pred hccCCCChHHhc--------CCCCHHHHHHHHHHhcCC----cccCcCHHHHH
Confidence 433333332221 122456788888888744 45566665554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=345.10 Aligned_cols=250 Identities=20% Similarity=0.252 Sum_probs=193.0
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCC----cEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 486 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g----~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~ 486 (697)
...|++.++||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.++ |||||++++++.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------H~nIv~~~g~~~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEGVIS 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEEC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC------CCCEeeeeEEEe
Confidence 467999999999999999999876554 47999999753 333456788999888874 889999999999
Q ss_pred ecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 487 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 487 ~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.....++||||+.++++........ ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl~D 153 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKVSD 153 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred cCCceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--CCeEEEcc
Confidence 9999999999998654443332222 12899999999999999999999999999999999999995 88999999
Q ss_pred CCCccccccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 567 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 567 FGla~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+++..+.....++
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 9999765332 122457889999999999999999999999999999999 566666677777776665443322
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+ -.....+..++..||... |..|+|++++...|.
T Consensus 234 ~~------------~~~~~~l~~li~~cl~~~----p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 234 TP------------MDCPSAIYQLMMQCWQQE----RARRPKFADIVSILD 268 (283)
T ss_dssp CC------------TTCBHHHHHHHHHHTCSS----TTTSCCHHHHHHHHH
T ss_pred Cc------------hhhHHHHHHHHHHHCcCC----HhHCcCHHHHHHHHH
Confidence 21 123457888999999855 888899988875553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-40 Score=341.20 Aligned_cols=266 Identities=28% Similarity=0.377 Sum_probs=214.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
+||++++.||+|+||+||+|+++.+++.||||+++... ....++.+|+.+++.++ ||||+++++++.....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC------CTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC------cCCEEeeccccccccc
Confidence 58999999999999999999999999999999997532 34567788998888764 8899999999999999
Q ss_pred EEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 491 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 491 l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
.++||+++.++.+..+..... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a 148 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred eeEEeeecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc--CCceeeeecchh
Confidence 999999998876665544332 2889999999999999999999999999999999999995 778999999999
Q ss_pred cccccc---cccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~P-F~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
...... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.| |.+.+..+.+.++....++++...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 765443 22345678899999998765 68999999999999999998887 56778888899999888887765544
Q ss_pred hccccccc------------ccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 646 QGQEIYKY------------FTKEYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 646 ~~~~~~~~------------~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
.......+ ......+.....+....++...|..|+|+++++ +|+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 32222211 111223334445556666777799999999999 999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=347.81 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=198.2
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
-.++|++.+.||+|+||+||+|++..+ +.||||+++......+.+.+|+.+++.++ |||||++++++. .+..
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~-~~~~ 86 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEPI 86 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SSSC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc------cCCEeEEEEEEe-cCCe
Confidence 347899999999999999999998654 67999999877666678999999999885 789999999985 4568
Q ss_pred EEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCc
Q 005415 492 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla 570 (697)
++||||+.+ ++..++...... .+++..+..++.||+.||.|||+++|+||||||+||||+. ++.+||+|||++
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfGla 160 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLA 160 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCCTT
T ss_pred EEEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC--CCcEEEcccchh
Confidence 999999985 455555443322 2899999999999999999999999999999999999985 789999999999
Q ss_pred cccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHh
Q 005415 571 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 645 (697)
Q Consensus 571 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~ 645 (697)
+..... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+++..+......+.+.
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~--- 237 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP--- 237 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT---
T ss_pred hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc---
Confidence 765332 223567899999999999999999999999999999999 566677788888887776543322211
Q ss_pred hcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 646 QGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 646 ~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.....+..++..||... |..|++++++..+|.
T Consensus 238 ---------~~~~~l~~li~~cl~~d----P~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 238 ---------ECPESLHDLMCQCWRKE----PEERPTFEYLQAFLE 269 (285)
T ss_dssp ---------TSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred ---------ccCHHHHHHHHHHcccC----HhHCcCHHHHHHHHh
Confidence 22456778888888765 888999999875443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=346.73 Aligned_cols=236 Identities=21% Similarity=0.259 Sum_probs=189.3
Q ss_pred EEeccCCCCceEEEEEC--CCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEE
Q 005415 420 EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 494 (697)
Q Consensus 420 e~LG~G~fG~Vy~a~d~--~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LV 494 (697)
++||+|+||+||+|.+. .+++.||||+++.. ....+.+.+|+++++.++ |||||++++++.. +..+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC------CTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC------CCCCceEEEEecc-CCEEEE
Confidence 46999999999999754 45688999999743 234567889999998874 8999999999865 567899
Q ss_pred EEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcccc
Q 005415 495 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 573 (697)
Q Consensus 495 mEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~~~ 573 (697)
|||++ |+|.+++..... +++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++..
T Consensus 86 mE~~~~g~L~~~l~~~~~------l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKAL 157 (277)
T ss_dssp EECCTTEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhccC------CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc--cCcccccchhhhhhc
Confidence 99998 467776654322 899999999999999999999999999999999999995 889999999999764
Q ss_pred ccc------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhh
Q 005415 574 TDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 646 (697)
Q Consensus 574 ~~~------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~ 646 (697)
... .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...|.+...++.+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p----- 232 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP----- 232 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-----
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 332 123467899999999999999999999999999999998 99999999888877776543221111
Q ss_pred cccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 647 GQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 647 ~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
-.....+..++..||... |..|+|++++.
T Consensus 233 -------~~~~~~~~~li~~cl~~d----p~~RPs~~~i~ 261 (277)
T d1xbba_ 233 -------AGCPREMYDLMNLCWTYD----VENRPGFAAVE 261 (277)
T ss_dssp -------TTCCHHHHHHHHHHTCSS----TTTSCCHHHHH
T ss_pred -------cccCHHHHHHHHHHcCCC----HhHCcCHHHHH
Confidence 123457888999998866 77888887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-40 Score=349.70 Aligned_cols=265 Identities=26% Similarity=0.386 Sum_probs=205.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--CeE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EHL 491 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~--~~l 491 (697)
++|+++++||+|+||+||+|+++.+++.||||+++... ..++.+|+.+|+.++ +||||++++++|... ..+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc-----CCCCCcEEEEEEEecCCCce
Confidence 68999999999999999999999999999999997643 367889999999985 378999999999854 569
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCCcc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 571 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGla~ 571 (697)
++||||+.++.+..+ . ..+++..++.+++||+.||.|||++||+||||||+|||++. +++.+||+|||+|.
T Consensus 108 ~~v~e~~~~~~L~~~--~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL--Y------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGT--T------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHH--h------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-CCCeeeecccccce
Confidence 999999986543222 1 12899999999999999999999999999999999999985 34579999999997
Q ss_pred cccc--ccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHHHhhCCCCHHHHhhc
Q 005415 572 FQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQG 647 (697)
Q Consensus 572 ~~~~--~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~-~~~~e~l~~I~~~lg~~p~e~~~~~ 647 (697)
.... ......+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.. .+..++...+...+|.+....+...
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 6543 345567899999999988764 79999999999999999999999965 4566677778777775544332211
Q ss_pred cccc------------------ccccC--CchhhhhHHHHHHHHHHHhhhhccCHHHHH--HhhcccCC
Q 005415 648 QEIY------------------KYFTK--EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGIDQ 694 (697)
Q Consensus 648 ~~~~------------------~~~~~--~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~~~ 694 (697)
.... .++.. ...+..-..+...+++...|.+|+|+++++ +|+....|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1000 00000 011122234445666666689999999999 99986543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=349.32 Aligned_cols=264 Identities=29% Similarity=0.478 Sum_probs=209.1
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec--
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-- 488 (697)
+.||+++++||+|+||+||+|.++.+|+.||||+++.. .....++.+|+.+|+.++ ||||+++++++...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENIIGINDIIRAPTI 80 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBCCCCEEECCSST
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC------CCCCCcEEEEEeeccc
Confidence 47899999999999999999999999999999999753 344567889999999985 78999999999764
Q ss_pred ---CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEe
Q 005415 489 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 565 (697)
Q Consensus 489 ---~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~ 565 (697)
...+++|++.+++|.+++... .+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~--~~~~kl~ 151 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKIC 151 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEEC
T ss_pred cccceEEEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC--CCCEEEc
Confidence 347888888888999888632 2899999999999999999999999999999999999985 7899999
Q ss_pred eCCCccccccc------cccccccCCCCCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCC
Q 005415 566 DLGSSCFQTDN------LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 638 (697)
Q Consensus 566 DFGla~~~~~~------~~~~~gt~~Y~APE~l~-~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~ 638 (697)
|||++...... ....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+....+...++.
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 99998654332 33457899999999985 456789999999999999999999999999999999999999988
Q ss_pred CCHHHHhhcccc--cccccC------------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhcc
Q 005415 639 IDLEMLMQGQEI--YKYFTK------------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFG 691 (697)
Q Consensus 639 ~p~e~~~~~~~~--~~~~~~------------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~ 691 (697)
++.......... ..++.. ...+.....+...+++..-|..|+|+++++ +|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 887665332110 000000 011122233445555566688899999999 99873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-40 Score=350.36 Aligned_cols=265 Identities=31% Similarity=0.502 Sum_probs=212.9
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 488 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~- 488 (697)
.+||+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+|+.++ ||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC------CCCeeeEEEEEeecc
Confidence 57999999999999999999999999999999999753 234457789999999885 78999999998643
Q ss_pred -----CeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEE
Q 005415 489 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 563 (697)
Q Consensus 489 -----~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vK 563 (697)
...++++++.+++|.+++... .+++..++.+++||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~k 161 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELK 161 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred ccccCceEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc--ccccc
Confidence 346666666667888776422 2899999999999999999999999999999999999995 78999
Q ss_pred EeeCCCccccccccccccccCCCCCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhhCCCCHH
Q 005415 564 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 642 (697)
Q Consensus 564 L~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~lg~~p~e 642 (697)
|+|||.+...........|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......|.+..+.++.+
T Consensus 162 l~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 162 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp ECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 999999988877777788999999999987765 6889999999999999999999999999999999999999998887
Q ss_pred HHhhccccc--ccc---cC---------CchhhhhHHHHHHHHHHHhhhhccCHHHHH--Hhhccc
Q 005415 643 MLMQGQEIY--KYF---TK---------EYDLYYINEVCFANIFISLVVIRLTLEYAA--LWLFGI 692 (697)
Q Consensus 643 ~~~~~~~~~--~~~---~~---------~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~--~wl~~~ 692 (697)
......... .+. .. ...+.....+....++...|..|.|+++++ +|+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 765322100 000 00 011223334455566666699999999999 999854
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-39 Score=339.96 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=196.6
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
+++||++++.||+|+||.||+|++..+|+.||||++..... ..++..|+++++.+++ |++|+.+..++...+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~-----~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG-----GVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTT-----STTCCCEEEEEEETTEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccC-----CCcccEEEEEEecCCEE
Confidence 45789999999999999999999999999999999876433 3567889999999864 45677778888888999
Q ss_pred EEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc-CcceEEEeeCCCc
Q 005415 492 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSS 570 (697)
Q Consensus 492 ~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~-~~~~vKL~DFGla 570 (697)
++||||+++++...+..... .+++..+..++.|++.||.|||++||+||||||+|||+... .+..+||+|||+|
T Consensus 79 ~ivme~~~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEECCCCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEcCCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 99999999998877665433 28999999999999999999999999999999999998642 3567999999999
Q ss_pred cccccc----------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHh---hC
Q 005415 571 CFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM---LG 637 (697)
Q Consensus 571 ~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~---lg 637 (697)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .-
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 765432 23357899999999999999999999999999999999999999886655444433221 11
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
.+|.+... -.....+..++..||... |..|++.+++.
T Consensus 234 ~~~~~~~~--------~~~p~~~~~li~~cl~~~----p~~RP~~~~i~ 270 (299)
T d1ckia_ 234 STPIEVLC--------KGYPSEFATYLNFCRSLR----FDDKPDYSYLR 270 (299)
T ss_dssp HSCHHHHT--------TTSCHHHHHHHHHHHHSC----TTCCCCHHHHH
T ss_pred CCChhHhc--------cCCCHHHHHHHHHHccCC----hhHCcCHHHHH
Confidence 12222111 123356788889998854 77777776554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=341.11 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=192.3
Q ss_pred eecCceEEEEEeccCCCCceEEEEECCC---CcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 411 VIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 411 ~i~~rY~i~e~LG~G~fG~Vy~a~d~~~---g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
+..++|++.+.||+|+||.||+|.+..+ +..||||.++.. ......+.+|+.+++.++ ||||+++++++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~ 77 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGVI 77 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 3457899999999999999999998654 456889988643 334567888999988774 89999999998
Q ss_pred EecCeEEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
. .+.+++||||+.+ ++..++..... .+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~Kl 149 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVKL 149 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEEE
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC--CCcEEE
Confidence 5 5678999999985 55555443322 2899999999999999999999999999999999999995 789999
Q ss_pred eeCCCccccccc----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCC
Q 005415 565 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 639 (697)
Q Consensus 565 ~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~ 639 (697)
+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.++.....++
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999765432 233567899999999999999999999999999999998 999999998888888876543221
Q ss_pred CHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 640 DLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 640 p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
.+ -.....+..++..||... |..|+|++++...|.
T Consensus 230 ~~------------~~~~~~~~~li~~cl~~d----p~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 230 MP------------PNCPPTLYSLMTKCWAYD----PSRRPRFTELKAQLS 264 (273)
T ss_dssp CC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CC------------CCCCHHHHHHHHHHcCCC----HhHCcCHHHHHHHHH
Confidence 11 123456778888888755 888999998885553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=343.11 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=197.4
Q ss_pred ecCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-cCe
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEH 490 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~-~~~ 490 (697)
-.++|+++++||+|+||.||+|.+ .|+.||||+++.+. ..+.+.+|+++++.++ ||||+++++++.+ .+.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLR------HSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCC------CTTBCCEEEEECCC--C
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHHHhCC------CCCEeeEEEEEEecCCc
Confidence 346799999999999999999997 47899999997654 3467888998887764 8999999999865 466
Q ss_pred EEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
+++||||+. ++|.+++...... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg~ 149 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGL 149 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCCC
T ss_pred EEEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC--CCCEeeccccc
Confidence 899999997 5777777544322 2889999999999999999999999999999999999995 88999999999
Q ss_pred ccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCCHHHHhhcc
Q 005415 570 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 648 (697)
Q Consensus 570 a~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p~e~~~~~~ 648 (697)
++..........+++.|+|||++.+..++.++|||||||++|||+| |++||...+..+++..|.+...++-
T Consensus 150 s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~-------- 221 (262)
T d1byga_ 150 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-------- 221 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC--------
T ss_pred ceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 9887776666788999999999999999999999999999999998 8999998888777777644222111
Q ss_pred cccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcccC
Q 005415 649 EIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGID 693 (697)
Q Consensus 649 ~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~~ 693 (697)
.-.....+..++..||... |.+|+|++++..+|...+
T Consensus 222 ----~~~~~~~~~~li~~cl~~d----P~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLD----AAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHcccC----HhHCcCHHHHHHHHHHHH
Confidence 1123457788888888765 899999999998886544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-40 Score=346.68 Aligned_cols=243 Identities=21% Similarity=0.251 Sum_probs=190.1
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCc----EEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 487 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~----~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~ 487 (697)
.+|+++++||+|+||+||+|.+..+|+ +||+|.++.. ......+.+|+.+++.++ |||||++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC------CTTBCCEEEEEES
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEEec
Confidence 469999999999999999999988776 5888887643 334567899999999885 8899999999987
Q ss_pred cCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEee
Q 005415 488 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 566 (697)
Q Consensus 488 ~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~D 566 (697)
.. .+++||++. ++|.+.+..... .+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~D 154 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITD 154 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECC
T ss_pred CC-eeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC--CCCeEeec
Confidence 65 455666664 677777654432 2899999999999999999999999999999999999985 78999999
Q ss_pred CCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhCCCC
Q 005415 567 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 640 (697)
Q Consensus 567 FGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg~~p 640 (697)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+.....++.
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999765332 222467999999999999999999999999999999999 8999998877776666654332211
Q ss_pred HHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHH
Q 005415 641 LEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAA 686 (697)
Q Consensus 641 ~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~ 686 (697)
+ -.....+..++..||... |..|+|+++++
T Consensus 235 p------------~~~~~~~~~li~~cl~~d----P~~RPs~~eil 264 (317)
T d1xkka_ 235 P------------PICTIDVYMIMVKCWMID----ADSRPKFRELI 264 (317)
T ss_dssp C------------TTBCHHHHHHHHHHTCSS----GGGSCCHHHHH
T ss_pred C------------cccCHHHHHHHHHhCCCC----hhhCcCHHHHH
Confidence 1 123456778888888755 77788887766
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-39 Score=344.86 Aligned_cols=284 Identities=32% Similarity=0.499 Sum_probs=222.6
Q ss_pred CcceeeCceec-CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCC-----CCC
Q 005415 403 DLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-----DEH 476 (697)
Q Consensus 403 ~~pv~~~~~i~-~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~-----~hp 476 (697)
+||+.+|+.+. +||+++++||+|+||+||+|+++.+|+.||||+++.+....+...+|+++++.+++.... .|+
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 47899999886 689999999999999999999999999999999998876677889999999999876543 578
Q ss_pred ceeEEEEEEEec--CeEEEEEEccc--cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-cCccccCCCCcc
Q 005415 477 HILRLYDYFYHL--EHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPEN 551 (697)
Q Consensus 477 nIv~l~~~f~~~--~~l~LVmEyl~--gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs-~gIvHrDLKP~N 551 (697)
||+++++++... ...+++|+++. ++.......... ..+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 999999998754 45666666654 333333332222 238899999999999999999998 899999999999
Q ss_pred ccccccCc----ceEEEeeCCCccccccccccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCc---
Q 005415 552 ILIKSYQR----CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--- 624 (697)
Q Consensus 552 ILl~~~~~----~~vKL~DFGla~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~~--- 624 (697)
||++..+. ..++|+|||.+..........+||+.|+|||++.+..++.++|||||||++++|++|+.||...+
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred eeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 99985322 35899999999877777777889999999999999999999999999999999999999997543
Q ss_pred ---HHHHHHHHHHhhCCCCHHHHhhcccccccccCCc-------------------------hhhhhHHHHHHHHHHHhh
Q 005415 625 ---VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY-------------------------DLYYINEVCFANIFISLV 676 (697)
Q Consensus 625 ---~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~-------------------------~l~~i~~~cw~~l~~~~~ 676 (697)
..+.+..++..+|.+|.++.........++.... .......+....++...|
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 4577888889999999998876655444443211 011111222222233337
Q ss_pred hhccCHHHHH--Hhhc
Q 005415 677 VIRLTLEYAA--LWLF 690 (697)
Q Consensus 677 ~~r~t~e~~~--~wl~ 690 (697)
..|+|+++++ +|+.
T Consensus 317 ~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLK 332 (362)
T ss_dssp TTCBCHHHHHTCGGGT
T ss_pred hHCcCHHHHhcCcccC
Confidence 8899999999 9997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=337.82 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=194.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECC-C--CcEEEEEEEecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLH-T--GVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~-~--g~~VAVKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++++.||+|+||.||+|+... + ...||||+++.. ....+.+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC------CCCEEEEEEEE
Confidence 3679999999999999999998643 2 347899998743 334567889999999885 88999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.+ ...++||||+. +++.+.+...... +++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~-----l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl 152 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKI 152 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGG-----SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEE
T ss_pred ee-cchheeeeeecCcchhhhhhcccCC-----CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc--ccceee
Confidence 65 56789999997 5666665544332 899999999999999999999999999999999999996 789999
Q ss_pred eeCCCcccccccc------ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHhhC
Q 005415 565 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 637 (697)
Q Consensus 565 ~DFGla~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~~~~e~l~~I~~~lg 637 (697)
+|||++....... ....++..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+.+|.+...
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 9999997654321 22456788999999999999999999999999999998 8999999999998888865433
Q ss_pred CCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhcc
Q 005415 638 PIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFG 691 (697)
Q Consensus 638 ~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~ 691 (697)
.++. .-.....+..++..||... |..|+|++++...|..
T Consensus 233 ~~~~-----------~~~~~~~l~~li~~cl~~d----p~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 RLPR-----------PEDCPQDIYNVMVQCWAHK----PEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCC-----------CTTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHH
T ss_pred CCCC-----------cccccHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHh
Confidence 2221 0122356778888888866 8888999998876653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-39 Score=340.00 Aligned_cols=256 Identities=20% Similarity=0.231 Sum_probs=206.8
Q ss_pred cCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
.++|++++.||+|+||+||+|+++ .+++.||||+++.. .....++.+|+.+++.++ ||||+++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~~ 85 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------NPNIVKLLGVC 85 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC------CCCcccceeee
Confidence 467999999999999999999864 35688999999753 234567889999988874 88999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhc------------------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccC
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQE------------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 546 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~------------------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrD 546 (697)
......++||||+. ++|.+++..... ......+++..+..++.||+.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999997 577777754321 11123378899999999999999999999999999
Q ss_pred CCCccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCC
Q 005415 547 LKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLF 620 (697)
Q Consensus 547 LKP~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG-~~PF 620 (697)
|||+|||++. ++.+||+|||+|+..... .....+++.|+|||++.+..++.++|||||||++|||++| .+||
T Consensus 166 lKp~NILld~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC--CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999995 889999999998654322 2235678899999999999999999999999999999997 5789
Q ss_pred CCCcHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhccc
Q 005415 621 PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLFGI 692 (697)
Q Consensus 621 ~~~~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~~~ 692 (697)
.+.+..+++..+.+...++.+ -.....+..++..||... |..|+|++++...|..+
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~p------------~~~~~~~~~li~~cl~~~----P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILACP------------ENCPLELYNLMRLCWSKL----PADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHcCCCCCCC------------ccchHHHHHHHHHHcCCC----hhHCcCHHHHHHHHHHh
Confidence 999999988887654322111 123457888999999755 89999999998777644
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=335.25 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=190.9
Q ss_pred ecCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005415 412 IAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 484 (697)
Q Consensus 412 i~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~ 484 (697)
..++|++.++||+|+||.||+|.+.. +++.||||+++.. ......+..|..++..+.+ |+||++++++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~-----h~~iv~~~~~ 85 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLGA 85 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCC-----CTTBCCEEEE
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcC-----CCeEEEeeee
Confidence 34689999999999999999999754 4578999998743 2334567778888877753 7899999999
Q ss_pred EEec-CeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccc
Q 005415 485 FYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 552 (697)
Q Consensus 485 f~~~-~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 552 (697)
+... ..+++||||++ ++|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8765 56899999997 6788877654321 1123488999999999999999999999999999999999
Q ss_pred cccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHH
Q 005415 553 LIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVV 626 (697)
Q Consensus 553 Ll~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG-~~PF~~~~~~ 626 (697)
|++. ++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+|| .+||.+.+..
T Consensus 166 Ll~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 166 LLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EECG--GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eECC--CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9985 889999999999754322 2235789999999999999999999999999999999995 6789877655
Q ss_pred HHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 627 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 627 e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+.+++.....++. . -.....+..++..||... |..|+|+++++.-|
T Consensus 244 ~~~~~~~~~~~~~~~---------~--~~~~~~l~~li~~cl~~d----P~~Rpt~~eil~~L 291 (299)
T d1ywna1 244 EEFCRRLKEGTRMRA---------P--DYTTPEMYQTMLDCWHGE----PSQRPTFSELVEHL 291 (299)
T ss_dssp HHHHHHHHHTCCCCC---------C--TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC---------C--ccCCHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence 555554432222111 0 112346778888887754 88899999888443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=332.77 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=201.1
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECCCC-------cEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 480 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~~g-------~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~ 480 (697)
++..++|++.+.||+|+||.||+|++..++ ..||||+++.+. .....+.+|..++..+. +|||||+
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv~ 83 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 83 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCC
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc-----CCCeEEe
Confidence 344679999999999999999999875543 479999997543 34466778888888774 4899999
Q ss_pred EEEEEEecCeEEEEEEccc-cchHHHHHhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 481 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 481 l~~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~----------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
+++++.+...+++||||+. |+|.+++...... .....+++..+..++.||+.||.|||+++||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999997 5677777544311 1223489999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~ 623 (697)
+|||++. ++.+||+|||++...... .....+++.|+|||.+.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 164 ~NiLl~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 164 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GGEEECT--TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeecC--CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999995 789999999998765432 223567889999999999999999999999999999998 79999998
Q ss_pred cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 624 ~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+..+++..+.....++.+ -.....+..++..||... |..|+|+++++..|.
T Consensus 242 ~~~~~~~~i~~~~~~~~p------------~~~~~~l~~li~~cl~~d----P~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 242 PVEELFKLLKEGHRMDKP------------SNCTNELYMMMRDCWHAV----PSQRPTFKQLVEDLD 292 (299)
T ss_dssp CHHHHHHHHHTTCCCCCC------------SSCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCC------------ccchHHHHHHHHHHccCC----HhHCcCHHHHHHHHH
Confidence 888777666543222111 012346778888888755 888999999886653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=333.22 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=199.5
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcE--EEEEEEecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 489 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~--VAVKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~ 489 (697)
++|++.++||+|+||.||+|.++.++.. ||||.++.. ....+.+.+|++++..+. +||||+++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc-----CCCCEeeEEEEEecCC
Confidence 6899999999999999999999888764 677777532 334557889999988763 3899999999999999
Q ss_pred eEEEEEEccc-cchHHHHHhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccC
Q 005415 490 HLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 558 (697)
Q Consensus 490 ~l~LVmEyl~-gsL~~~l~~~~~----------~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~ 558 (697)
.+++||||++ |+|.+++..... ......+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC--
Confidence 9999999998 677777754311 112234899999999999999999999999999999999999995
Q ss_pred cceEEEeeCCCcccccccc--ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHHh
Q 005415 559 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGM 635 (697)
Q Consensus 559 ~~~vKL~DFGla~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG-~~PF~~~~~~e~l~~I~~~ 635 (697)
++.+||+|||+++...... ....+|+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+++..|.+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 7899999999997654332 234678999999999999999999999999999999995 5689988888888777543
Q ss_pred hCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 636 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 636 lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
..++.+ ......+..++..||... |..|+|+++++..
T Consensus 243 ~~~~~~------------~~~~~~~~~li~~cl~~d----P~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKP------------LNCDDEVYDLMRQCWREK----PYERPSFAQILVS 279 (309)
T ss_dssp CCCCCC------------TTBCHHHHHHHHHHTCSS----GGGSCCHHHHHHH
T ss_pred CCCCCC------------ccCCHHHHHHHHHHcCCC----hhHCcCHHHHHHH
Confidence 221111 123456778888888765 8888899888833
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-38 Score=330.88 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=206.8
Q ss_pred ceecCceEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~-----~~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++-.++|++.++||+|+||.||+|++. .+++.||||+++... .....+.+|+.+++.+. +|||||+++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~~ 93 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc-----CCCCEEEEE
Confidence 445689999999999999999999863 467899999997543 34456788999999884 389999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhcc------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCC
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQES------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 549 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~~------------~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP 549 (697)
+++......++||||++ ++|.+++...... .....+++..+..++.||+.||.|||+++||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999997 5666766543321 1223488999999999999999999999999999999
Q ss_pred ccccccccCcceEEEeeCCCcccccccc-----ccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005415 550 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 623 (697)
Q Consensus 550 ~NILl~~~~~~~vKL~DFGla~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELlt-G~~PF~~~ 623 (697)
+|||++. .+.+||+|||.++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.
T Consensus 174 ~NIl~~~--~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccc--cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999985 7899999999997654322 23567899999999999999999999999999999999 78888887
Q ss_pred cHHHHHHHHHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhhc
Q 005415 624 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWLF 690 (697)
Q Consensus 624 ~~~e~l~~I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl~ 690 (697)
+..+.+.+++....+++.. -.....+..++..||... |..|+|+++++..|.
T Consensus 252 ~~~~~~~~~i~~~~~~~~~-----------~~~~~~l~~Li~~cl~~d----P~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSP-----------EHAPAEMYDIMKTCWDAD----PLKRPTFKQIVQLIE 303 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCC-----------TTSCHHHHHHHHHHTCSS----GGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCc-----------ccccHHHHHHHHHHcCCC----hhHCcCHHHHHHHHH
Confidence 7767777665433222210 123457888888888755 889999999886554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-38 Score=334.42 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=196.8
Q ss_pred CceEEEEEeccCCCCceEEEEEC---CCCcEEEEEEEecc-----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 485 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~---~~g~~VAVKii~~~-----~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f 485 (697)
++|++++.||+|+||+||+|++. .+|+.||||+++.. ......+.+|+++++.+++ ||||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-----~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC-----CCeEEEeeeee
Confidence 67999999999999999999874 46899999998642 2334677899999999974 47999999999
Q ss_pred EecCeEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEE
Q 005415 486 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 564 (697)
Q Consensus 486 ~~~~~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL 564 (697)
.+....++||||+. ++|.+++..... +++..++.+++||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vkL 170 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVL 170 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC--CCCEEE
Confidence 99999999999998 467777665443 778899999999999999999999999999999999995 789999
Q ss_pred eeCCCccccccc----cccccccCCCCCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhh--
Q 005415 565 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML-- 636 (697)
Q Consensus 565 ~DFGla~~~~~~----~~~~~gt~~Y~APE~l~~~--~~s~ksDIWSLGviL~ELltG~~PF~~~~~~e~l~~I~~~l-- 636 (697)
+|||++...... .....|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+.+..
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 999998754332 2346789999999999765 46889999999999999999999998776544444443321
Q ss_pred CCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhcc-----CHHHHH--HhhcccC
Q 005415 637 GPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRL-----TLEYAA--LWLFGID 693 (697)
Q Consensus 637 g~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~-----t~e~~~--~wl~~~~ 693 (697)
..++. . -.....+..++..||. ..|..|+ |+++++ +|+..++
T Consensus 251 ~~~~~---------~--~~~s~~~~~li~~~l~----~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 251 SEPPY---------P--QEMSALAKDLIQRLLM----KDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CCCCC---------C--TTSCHHHHHHHHHHTC----SSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCCCC---------c--ccCCHHHHHHHHHHcc----cCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 11110 0 0123344555555544 4577776 689998 9998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=328.67 Aligned_cols=256 Identities=17% Similarity=0.207 Sum_probs=204.4
Q ss_pred ceecCceEEEEEeccCCCCceEEEEECC-----CCcEEEEEEEecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005415 410 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 482 (697)
Q Consensus 410 ~~i~~rY~i~e~LG~G~fG~Vy~a~d~~-----~g~~VAVKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~ 482 (697)
++..++|++.+.||+|+||+||+|.+.. +++.||||+++... .....+.+|+.+++.+ +||||++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~ 89 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 89 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc------CCCCEeeee
Confidence 3445799999999999999999998752 46789999997533 2234567788777766 488999999
Q ss_pred EEEEecCeEEEEEEccc-cchHHHHHhhhc----cCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCcccccccc
Q 005415 483 DYFYHLEHLFIVCELLR-ANLYEFQKFNQE----SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 557 (697)
Q Consensus 483 ~~f~~~~~l~LVmEyl~-gsL~~~l~~~~~----~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~ 557 (697)
+++......++||||+. |+|.+++..... ......+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~- 168 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 168 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC-
Confidence 99999999999999997 567676654321 112233688899999999999999999999999999999999985
Q ss_pred CcceEEEeeCCCccccccc-----cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHH
Q 005415 558 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILAR 631 (697)
Q Consensus 558 ~~~~vKL~DFGla~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG-~~PF~~~~~~e~l~~ 631 (697)
++.+||+|||+++..... .....+++.|+|||.+.+..++.++|||||||++|||+|| ++||.+.+..+.+..
T Consensus 169 -~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 169 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp -TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred -CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 889999999999765433 2234678999999999999999999999999999999997 689999999998888
Q ss_pred HHHhhCCCCHHHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 632 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 632 I~~~lg~~p~e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
+.+...++.+. .....+..++..||... |..|+|++++..-|
T Consensus 248 i~~~~~~~~p~------------~~~~~l~~li~~cl~~~----P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 248 VMEGGLLDKPD------------NCPDMLFELMRMCWQYN----PKMRPSFLEIISSI 289 (308)
T ss_dssp HHTTCCCCCCT------------TCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred HHhCCCCCCcc------------cchHHHHHHHHHHcCCC----hhHCcCHHHHHHHH
Confidence 86533222111 23457888999999866 78888988887433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=321.76 Aligned_cols=244 Identities=19% Similarity=0.216 Sum_probs=186.1
Q ss_pred EEEEEeccCCCCceEEEEECCCC---cEEEEEEEec--chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEec-Ce
Q 005415 417 YVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EH 490 (697)
Q Consensus 417 ~i~e~LG~G~fG~Vy~a~d~~~g---~~VAVKii~~--~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~-~~ 490 (697)
.+.++||+|+||+||+|.+..++ ..||||+++. +.....++.+|+++++.++ ||||+++++++... ..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEETTTE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC------CCCEeEEeEEEEecCCc
Confidence 34678999999999999986543 4689999874 3445577889999998874 89999999998764 68
Q ss_pred EEEEEEcccc-chHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccccCcceEEEeeCCC
Q 005415 491 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 569 (697)
Q Consensus 491 l~LVmEyl~g-sL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~~~~~~vKL~DFGl 569 (697)
.++||||+++ +|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~--~~~~kL~DFG~ 176 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSSGG
T ss_pred eEEEEEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC--CCCEEEecccc
Confidence 9999999985 45555543222 2678889999999999999999999999999999999985 78999999999
Q ss_pred ccccccc-------cccccccCCCCCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHHHhhCCCCH
Q 005415 570 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 641 (697)
Q Consensus 570 a~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIWSLGviL~ELltG~~PF~~~-~~~e~l~~I~~~lg~~p~ 641 (697)
++..... .....||+.|+|||.+.+..++.++||||||+++|||+||..||... +..+....+.....++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9764332 12246789999999999999999999999999999999977776544 444555555443222111
Q ss_pred HHHhhcccccccccCCchhhhhHHHHHHHHHHHhhhhccCHHHHHHhh
Q 005415 642 EMLMQGQEIYKYFTKEYDLYYINEVCFANIFISLVVIRLTLEYAALWL 689 (697)
Q Consensus 642 e~~~~~~~~~~~~~~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~wl 689 (697)
-.....+..++..||... |..|++++++...|
T Consensus 257 ------------~~~~~~l~~li~~cl~~d----P~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 257 ------------EYCPDPLYEVMLKCWHPK----AEMRPSFSELVSRI 288 (311)
T ss_dssp ------------TTCCHHHHHHHHHHTCSS----GGGSCCHHHHHHHH
T ss_pred ------------ccCcHHHHHHHHHHcCCC----HhHCcCHHHHHHHH
Confidence 123457888999999876 77788887777443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-37 Score=324.10 Aligned_cols=248 Identities=20% Similarity=0.222 Sum_probs=182.2
Q ss_pred cCceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecC---
Q 005415 413 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 489 (697)
Q Consensus 413 ~~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~--- 489 (697)
+.+|.+.+.||+|+||.||+|+. +|+.||||+++.... .....|.+++. ....+||||+++++++...+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~----~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQ----TVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHT----STTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHH----HhhCCCCcCcceEEEEEeCCCcc
Confidence 56799999999999999999985 689999999975543 33444443332 22346999999999998653
Q ss_pred -eEEEEEEccc-cchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHh--------cCccccCCCCccccccccCc
Q 005415 490 -HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQR 559 (697)
Q Consensus 490 -~l~LVmEyl~-gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs--------~gIvHrDLKP~NILl~~~~~ 559 (697)
.+++||||+. ++|..++... .+++..+..++.|++.||.|||+ +||+||||||+||||+. +
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~--~ 144 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--N 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT--T
T ss_pred eEEEEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC--C
Confidence 6899999997 4777777532 18899999999999999999996 59999999999999985 8
Q ss_pred ceEEEeeCCCccccccc-------cccccccCCCCCchhhcCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCc--
Q 005415 560 CEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVLFPNDA-- 624 (697)
Q Consensus 560 ~~vKL~DFGla~~~~~~-------~~~~~gt~~Y~APE~l~~~~------~s~ksDIWSLGviL~ELltG~~PF~~~~-- 624 (697)
+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||+||||+||.+||....
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 89999999998765332 22357899999999987653 5678999999999999999998874321
Q ss_pred ------------HHHHHHHHH-HhhCCCCHHHHhhccccccccc---CCchhhhhHHHHHHHHHHHhhhhccCHHHHHHh
Q 005415 625 ------------VVMILARII-GMLGPIDLEMLMQGQEIYKYFT---KEYDLYYINEVCFANIFISLVVIRLTLEYAALW 688 (697)
Q Consensus 625 ------------~~e~l~~I~-~~lg~~p~e~~~~~~~~~~~~~---~~~~l~~i~~~cw~~l~~~~~~~r~t~e~~~~w 688 (697)
..+.+.... .....|+ ....+. ....+..++..||... |.+|+|++++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~---------~~~~~~~~~~~~~l~~li~~cl~~d----p~~Rps~~ei~~~ 291 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPN---------IPNRWQSCEALRVMAKIMRECWYAN----GAARLTALRIKKT 291 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCC---------CCGGGGGCHHHHHHHHHHHTTCCSS----GGGSCCHHHHHHH
T ss_pred ccchhhcccccchHHHHHHHHhccccCCC---------CCcccCChHHHHHHHHHHHHHcccC----HhHCcCHHHHHHH
Confidence 111122211 1111111 011111 1134667888888765 7889999998865
Q ss_pred hc
Q 005415 689 LF 690 (697)
Q Consensus 689 l~ 690 (697)
|.
T Consensus 292 L~ 293 (303)
T d1vjya_ 292 LS 293 (303)
T ss_dssp HH
T ss_pred HH
Confidence 55
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=4.6e-22 Score=193.81 Aligned_cols=164 Identities=18% Similarity=0.160 Sum_probs=114.0
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchh-------------------hhHhHHHHHHHHHHhcccCCCCCC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADEH 476 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~-------------------~~~~~~~Ei~iL~~L~~~~~~~hp 476 (697)
+.+.++||+|+||+||+|.+ .+|+.||||+++.... .......|...+..+. |+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------GL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------TS
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc------CC
Confidence 46789999999999999997 4789999999763211 0122234555565553 56
Q ss_pred ceeEEEEEEEecCeEEEEEEccccchHHHHHhhhccCCCcccCHHHHHHHHHHHHHHHHHHHhcCccccCCCCccccccc
Q 005415 477 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 556 (697)
Q Consensus 477 nIv~l~~~f~~~~~l~LVmEyl~gsL~~~l~~~~~~~~~~~ls~~~i~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl~~ 556 (697)
+++..+++. ..+++|||+++..... ++...+..++.|++.+|.|||++||+||||||+|||++
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~- 137 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 137 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred CcceEEEec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee-
Confidence 777776553 2379999998653211 34445678999999999999999999999999999998
Q ss_pred cCcceEEEeeCCCccccccccccccccCCCCCc--h---hhcCCCCCchhhHHHHHHHH
Q 005415 557 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP--E---VIIGLPYDQKIDLWSLGCIL 610 (697)
Q Consensus 557 ~~~~~vKL~DFGla~~~~~~~~~~~gt~~Y~AP--E---~l~~~~~s~ksDIWSLGviL 610 (697)
+..++|+|||.|.....+.... |... + .+....|+.++|+||+.--+
T Consensus 138 --~~~~~liDFG~a~~~~~~~~~~-----~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 --EEGIWIIDFPQSVEVGEEGWRE-----ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp --TTEEEECCCTTCEETTSTTHHH-----HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred --CCCEEEEECCCcccCCCCCcHH-----HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 3458999999987654332110 1110 0 01234578899999975443
|
| >d1a25a_ b.7.1.2 (A:) C2 domain from protein kinase c (beta) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain from protein kinase c (beta) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=2.7e-18 Score=157.39 Aligned_cols=106 Identities=20% Similarity=0.259 Sum_probs=92.8
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
..+.|+|.|.+| ||+++|.+|.+||||+++|.++.....+++|+++++|+||+|||+|.|. +.....+..|.++|||
T Consensus 13 ~~~~L~V~V~~a~~L~~~d~~g~~DpYv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 90 (132)
T d1a25a_ 13 DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWD 90 (132)
T ss_dssp SSSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEE
T ss_pred cCCEEEEEEEeeeCCCCCCCCCCcCeEEEEEEccCCCCccccEEeeecCCCCCccceEEEEE--eEccccCCEEeEEEEe
Confidence 457899999999 9999999999999999999999888889999999999999999999998 6655555669999999
Q ss_pred CCCCCCCCcccccccCcccccccCCCCcc
Q 005415 343 NSDTRDGEVNGALHEGKADAEEHGVATPD 371 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~~~~~d~e~~~~~~ 371 (697)
+|.+++++++|++.++...+...+...|.
T Consensus 91 ~d~~~~d~~iG~~~i~l~~l~~~~~~~W~ 119 (132)
T d1a25a_ 91 WDLTSRNDFMGSLSFGISELQKAGVDGWF 119 (132)
T ss_dssp CCSSSCCEEEEEEEEEHHHHTTCCEEEEE
T ss_pred cCCCCCCcEeEEEEEeHHHcCCCCCCeEE
Confidence 99999999999999887776555544443
|
| >d1dqva1 b.7.1.2 (A:295-424) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=2.8e-16 Score=143.46 Aligned_cols=92 Identities=15% Similarity=0.078 Sum_probs=83.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|.+|.+||||++.|++++++ ++||+++++|+||+|||+|.|. ++...+ +.+|.++||
T Consensus 16 ~~~~L~V~V~~a~~L~~~~~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~~~~~~L~v~V~ 91 (130)
T d1dqva1 16 GSDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVY 91 (130)
T ss_dssp SSCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEE
T ss_pred CCCEEEEEEEeeeCCccccCCCCcceEEEEEEccCCCc--eEeceeEcCCCCeeeeeEEEEE--EchHHcCCCeEEEEEE
Confidence 567899999999 9999999999999999999998765 7889999999999999999998 777666 455999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|.+++++++|++.+..
T Consensus 92 d~~~~~~d~~iG~~~i~~ 109 (130)
T d1dqva1 92 DFDRFSRHDLIGQVVLDN 109 (130)
T ss_dssp ECCSSSCCCEEEEEECCC
T ss_pred EcCCCCCCceEEEEEECc
Confidence 999999999999998853
|
| >d2bwqa1 b.7.1.2 (A:729-853) Regulating synaptic membrane exocytosis protein, rim2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Regulating synaptic membrane exocytosis protein, rim2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.1e-16 Score=145.12 Aligned_cols=104 Identities=15% Similarity=0.106 Sum_probs=85.2
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
...+|+|.|.+| ||++++.+|.+|||||+.|+|+..+..++||+++++|+||.|||+|.|.. ++.+.+ +++|.++||
T Consensus 12 ~~~~L~V~V~~a~~L~~~~~~~~~dpyVkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~f~~-~~~~~l~~~~L~i~v~ 90 (125)
T d2bwqa1 12 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 90 (125)
T ss_dssp TTTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECS-CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCcCCCCCCCEEEEEEEeCCCCCccccccCEEcCCCCCEEccEEEEee-eChhhcCCCEEEEEEE
Confidence 457899999999 99999999999999999999998888889999999999999999999974 444444 667999999
Q ss_pred cCCCCC--CCCcccccccCcccccccCCC
Q 005415 342 DNSDTR--DGEVNGALHEGKADAEEHGVA 368 (697)
Q Consensus 342 D~d~~~--~~d~~G~v~~~~~~~d~e~~~ 368 (697)
|.+.++ +++++|++.++..++..++..
T Consensus 91 d~~~~~~~~~~~iG~~~i~l~~~~~~~~~ 119 (125)
T d2bwqa1 91 DQARVREEESEFLGEILIELETALLDDEP 119 (125)
T ss_dssp EC-------CEEEEEEEEEGGGCCCSSCE
T ss_pred ECCCCCCCCCeeEEEEEEEchhcCCCCCC
Confidence 999875 467999999877666655443
|
| >d1dqva2 b.7.1.2 (A:425-569) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.3e-16 Score=146.60 Aligned_cols=97 Identities=16% Similarity=0.080 Sum_probs=88.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
.++.|+|.|.+| ||+++|.+|.+||||++.|.++.++..++||+++++|+||.|||+|.|. ++.+.+ ..+|.++||
T Consensus 18 ~~~~L~V~V~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~v~v~ 95 (145)
T d1dqva2 18 TAGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVV 95 (145)
T ss_dssp TTTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEE
T ss_pred CCCEEEEEEEEEeCCCCcCCCCCcCceEEEEEccCCccceeecCEEEeCCCCceecceEEEE--EehhhcCCCEEEEEEE
Confidence 568999999999 9999999999999999999999988889999999999999999999998 887776 445999999
Q ss_pred cCCCCCCCCcccccccCcccc
Q 005415 342 DNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|++.+++++++|++.++...+
T Consensus 96 d~~~~~~~~~iG~~~i~l~~~ 116 (145)
T d1dqva2 96 DYDCIGHNEVIGVCRVGPEAA 116 (145)
T ss_dssp ECCSSSCCEEEEECCCSSCTT
T ss_pred ecCCCCCCcEEEEEEECchHc
Confidence 999999999999998875433
|
| >d1w15a_ b.7.1.2 (A:) Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=3.1e-16 Score=144.55 Aligned_cols=94 Identities=15% Similarity=0.041 Sum_probs=80.6
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
.++.|.|.|.+| ||+++|.+|.+|||||++|.++.++..++||+++++|.||.|||+|.|. ++.+.++ .+|.++||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyvkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~i~v~ 90 (138)
T d1w15a_ 13 TTNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVL 90 (138)
T ss_dssp TTTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEE
T ss_pred CCCEEEEEEEEeECCCCCCCCCCcCEEEEEEEeCCcccCccccceeECCCCCCeECcEEEEE--ecHHHhCccEEEEEEE
Confidence 457899999999 9999999999999999999999888889999999999999999999998 8877774 45999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|.+++++++|++.++.
T Consensus 91 d~~~~~~~~~iG~~~i~l 108 (138)
T d1w15a_ 91 DSERGSRNEVIGRLVLGA 108 (138)
T ss_dssp ECCTTSCCEEEEEEEEST
T ss_pred eCCCCCCCCEEEEEEEcc
Confidence 999999999999998864
|
| >d1uowa_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=4.7e-16 Score=146.61 Aligned_cols=95 Identities=14% Similarity=0.113 Sum_probs=87.0
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~-~~L~~~V~ 341 (697)
.++.|+|.|.+| ||++++.+|.+|||||++|.+++++..++||+++++|+||+|||+|.|. ++.+.++ ..|.++||
T Consensus 23 ~~~~L~V~V~~a~~L~~~~~~~~~dpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~F~--v~~~~l~~~~l~i~v~ 100 (157)
T d1uowa_ 23 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 100 (157)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEEEcccccCCCCCCeeEEEEEecCCccccceecccccCCCCcccCCeEEEE--ecHHHcCccEEEEEEc
Confidence 567999999999 9999999999999999999999888888899999999999999999999 8888774 45999999
Q ss_pred cCCCCCCCCcccccccCcc
Q 005415 342 DNSDTRDGEVNGALHEGKA 360 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~ 360 (697)
|++.+++++++|++.++..
T Consensus 101 d~~~~~~~~~iG~~~i~l~ 119 (157)
T d1uowa_ 101 DYDKIGKNDAIGKVFVGYN 119 (157)
T ss_dssp ECCSSSCCCEEEEEEEETT
T ss_pred ccCCCCCCceeEEEEEecc
Confidence 9999999999999988653
|
| >d2cm5a1 b.7.1.2 (A:541-677) C2b-domain of rabphilin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2b-domain of rabphilin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=9.2e-16 Score=140.76 Aligned_cols=94 Identities=15% Similarity=0.099 Sum_probs=83.9
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
..+.|+|.|.+| ||+++|..|.+|||||+.|.++.+...++||+++++|+||.|||+|.|. ++.+.+ ..+|.++||
T Consensus 13 ~~~~L~V~v~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~v~v~ 90 (137)
T d2cm5a1 13 QQGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVW 90 (137)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCcCeEEEEEEEcCCccceeecCEeEcCCCCCccceEEEEE--eEHHHccccEEEEEee
Confidence 567899999999 9999999999999999999999888889999999999999999999999 887777 455999999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|++.+++++++|++.++.
T Consensus 91 ~~~~~~~~~~iG~~~i~l 108 (137)
T d2cm5a1 91 DYDIGKSNDYIGGCQLGI 108 (137)
T ss_dssp ECCSSSCCEEEEEEEEET
T ss_pred eCCCCCCCCEEEEEEeCc
Confidence 999999999999998864
|
| >d1rsya_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.1e-15 Score=141.78 Aligned_cols=95 Identities=15% Similarity=0.103 Sum_probs=84.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|+|.|.+| ||+++|.+|.+|||||+.|++++++ +++|+++++|+||+|||+|.|. ++...+ +.+|.++||
T Consensus 32 ~~~~L~V~V~~a~~L~~~~~~g~~dpyV~v~l~~~~~~--~~kT~~~~~t~~P~wne~f~f~--i~~~~l~~~~L~i~V~ 107 (143)
T d1rsya_ 32 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 107 (143)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCCS--CEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEEccCCCCCCCCCCCCeEEEEEEcCCCCe--eEEEEEeccccCcceeeeeEEE--EEeeccCCceEEEEEE
Confidence 457899999999 9999999999999999999998765 7889999999999999999998 776665 455999999
Q ss_pred cCCCCCCCCcccccccCcccc
Q 005415 342 DNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|++.+++++++|++.++..++
T Consensus 108 d~d~~~~~~~iG~~~i~L~~~ 128 (143)
T d1rsya_ 108 DFDRFSKHDIIGEFKVPMNTV 128 (143)
T ss_dssp ECCSSSCCEEEEEEEEEGGGC
T ss_pred EcCCCCCCcEEEEEEEEchhc
Confidence 999999999999998865554
|
| >d1rh8a_ b.7.1.2 (A:) Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Piccolo species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=7.4e-16 Score=142.27 Aligned_cols=100 Identities=13% Similarity=0.111 Sum_probs=84.1
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCc---------cccceeecccCCCcceecccccCcccccccc-
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE---------KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA- 332 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~---------~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~- 332 (697)
..+.|+|.|.+| ||+++|..|.+|||||+.|+++.... .+++|+++++|+||.|||+|.|.. ++.+.+
T Consensus 16 ~~~~L~V~V~~A~~L~~~d~~g~~DpyV~v~l~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~ 94 (142)
T d1rh8a_ 16 DLGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKS-ISMEQLM 94 (142)
T ss_dssp ETTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECS-CCHHHHT
T ss_pred eCCEEEEEEEEeECCCCcCCCCCCCcCEEEEEecCcccccccccCCCceeeeccCCcCCCCceeEEEEEEee-ecccccC
Confidence 346899999999 99999999999999999998876543 357899999999999999999974 444444
Q ss_pred ccccccccccCCCCCCCCcccccccCcccccc
Q 005415 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 333 ~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d~ 364 (697)
...|.++|||+|.+++++++|++.+.......
T Consensus 95 ~~~L~i~V~d~d~~~~~~~lG~~~i~L~~l~~ 126 (142)
T d1rh8a_ 95 KKTLEVTVWDYDRFSSNDFLGEVLIDLSSTSH 126 (142)
T ss_dssp TCEEEEEEEEECSSSCEEEEEEEEEETTSCGG
T ss_pred CCEEEEEEEEecCCCCCeeeEEEEEEhHHcCC
Confidence 55699999999999999999999886655443
|
| >d1ugka_ b.7.1.2 (A:) Synaptotagmin IV {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3.2e-15 Score=137.82 Aligned_cols=96 Identities=11% Similarity=0.075 Sum_probs=82.7
Q ss_pred ccceeEEEEecc-CcccccCCCC-CCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-cccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVV-GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 340 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~-sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V 340 (697)
....|+|.|.+| ||+++|..|. +|||||+.|+|+++. ++||+++++++||.|||+|.|.. ++.+.+ +.+|.++|
T Consensus 20 ~~~~L~V~V~~a~~L~~~d~~~~~~dpyV~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~L~~~V 96 (138)
T d1ugka_ 20 ERKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKKH--KVKTRVLRKTLDPAFDETFTFYG-IPYTQIQELALHFTI 96 (138)
T ss_dssp GGTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTCS--EEECCCCSSCSSCEEEEEEEEEC-CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEecCCCCCCCCCCccceEEEEEEcCCCCE--eEeCeeEeCCCCCceeeEEEEee-eCHHHcccceEEEEE
Confidence 557899999999 9999998864 799999999998655 78899999999999999999962 566665 55699999
Q ss_pred ccCCCCCCCCcccccccCcccc
Q 005415 341 IDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 341 ~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
||.|++++++++|++.+...+.
T Consensus 97 ~d~d~~~~~~~iG~~~i~L~~~ 118 (138)
T d1ugka_ 97 LSFDRFSRDDIIGEVLIPLSGI 118 (138)
T ss_dssp EEECSSCCCCCCEEEEEECTTC
T ss_pred EECCCCCCCcEEEEEEEEcccc
Confidence 9999999999999998865554
|
| >d1wfma_ b.7.1.2 (A:) Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin XIII species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=8e-15 Score=135.05 Aligned_cols=94 Identities=18% Similarity=0.156 Sum_probs=81.3
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc-ccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~-~~~L~~~V~ 341 (697)
....|.|.|.+| +| +.+|.+|||||++|+|+.++ .+++|+++++++||+|||+|.|. ++.+.+ ..+|.++||
T Consensus 24 ~~~~L~V~v~~a~~L---~~~g~~dpyVkv~l~~~~~~-~~~kT~v~~~~~~P~wne~f~f~--v~~~~l~~~~L~~~V~ 97 (138)
T d1wfma_ 24 QKAELFVTRLEAVTS---NHDGGCDCYVQGSVANRTGS-VEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLR 97 (138)
T ss_dssp TTTEEEEEEEEEECC---CCSSCCCEEEEEEEEETTEE-EEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEE
T ss_pred CCCEEEEEEEEcCCC---CCCCCcCcEEEEEECCCCCc-cceeeeEECCCCCceEeeeEEEE--eeehhccceEEEEEEe
Confidence 557899999999 98 46789999999999998554 56789999999999999999999 777766 556999999
Q ss_pred cCCCCCCCCcccccccCccccc
Q 005415 342 DNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~~~~d 363 (697)
|++++++++++|++.++..+.+
T Consensus 98 d~~~~~~~~~iG~~~i~L~~l~ 119 (138)
T d1wfma_ 98 TCDRFSRHSVAGELRLGLDGTS 119 (138)
T ss_dssp ECCSSCTTSCSEEEEEESSSSS
T ss_pred eecccccceeeeEEEEEhHHcc
Confidence 9999999999999988765554
|
| >d2ep6a1 b.7.1.1 (A:92-217) Multiple C2 and transmembrane domain-containing protein 2, MCTP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Multiple C2 and transmembrane domain-containing protein 2, MCTP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.2e-14 Score=129.73 Aligned_cols=89 Identities=11% Similarity=0.052 Sum_probs=76.6
Q ss_pred cceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccC
Q 005415 265 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 343 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~ 343 (697)
.+.|+|.|.+| +|+++|..|.+||||++.+.. .+++|+++++|+||.|||+|.|. ++. ....|.++|||+
T Consensus 5 ~G~L~V~v~~A~~L~~~d~~g~~Dpyv~v~~~~-----~~~~T~~~~~t~nP~wne~f~f~--v~~--~~~~L~i~V~d~ 75 (126)
T d2ep6a1 5 VGILQVKVLKAADLLAADFSGKSDPFCLLELGN-----DRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVFDE 75 (126)
T ss_dssp SEEEEEEEEEEESCCCSSSSSCCCEEEEEEETT-----EEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEEEE
T ss_pred cEEEEEEEEEeECCCCCCCCCCcCeEEEEEcCC-----eEEEEEeeCCceeEEEEEEEEEE--Eec--cCceeEEEEEEc
Confidence 46899999999 999999999999999999953 36789999999999999999998 543 234599999999
Q ss_pred CCCCCCCcccccccCcccc
Q 005415 344 SDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 344 d~~~~~d~~G~v~~~~~~~ 362 (697)
+.+++++++|.+.+...+.
T Consensus 76 ~~~~~d~~lG~~~i~l~~l 94 (126)
T d2ep6a1 76 DGDKPPDFLGKVAIPLLSI 94 (126)
T ss_dssp ETTEEEEECCBCEEEGGGC
T ss_pred cCCcCcceEEEEEEEHHHC
Confidence 9999999999997755443
|
| >d1qasa2 b.7.1.1 (A:626-756) PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.35 E-value=1.4e-13 Score=125.48 Aligned_cols=91 Identities=10% Similarity=0.007 Sum_probs=70.7
Q ss_pred ceeEEEEecc-Cccc--ccCCCCCCcceEeeccCCCCCccccceee-cccCCCcceecccccCccccccccccccccccc
Q 005415 266 DYGYLSSKEA-DLID--LQHNVVGDSSTDCDLAPHPGTEKSSSYSS-SKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~--~d~~g~sDpyVk~~l~pd~~~~~k~kt~v-~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
..|+|.|++| +|+. +|.+|.+||||++.|........+++|++ ++.++||.|||+|.|. +..... ..|.++||
T Consensus 4 ~~l~V~Vi~a~~L~~~~~~~~~~~DPyV~v~l~g~~~~~~~~~T~~v~~~~~nP~wne~f~f~--~~~~~~-~~L~~~V~ 80 (131)
T d1qasa2 4 ERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFMVE 80 (131)
T ss_dssp EEEEEEEEEEESCCCCC-----CCCEEEEEEEESSTTTCEEEECCCCSSCSSSCEEEEEEEEE--ESCGGG-CEEEEEEE
T ss_pred EEEEEEEEEeeCCCCCCCCCCCCcCeEEEEEEccCCCCcEEEEEEEEecccCCceEEEEEEEE--EEcchh-ceEEEEEE
Confidence 5799999999 9964 56788899999999987766666788876 4566899999999997 444333 23899999
Q ss_pred cCCCCCCCCcccccccCc
Q 005415 342 DNSDTRDGEVNGALHEGK 359 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~~ 359 (697)
|+|.+++++++|++.+..
T Consensus 81 D~d~~~~d~~iG~~~i~l 98 (131)
T d1qasa2 81 DYDSSSKNDFIGQSTIPW 98 (131)
T ss_dssp ECCTTTCCEEEEEEEEEG
T ss_pred EecCCCCCcEEEEEEEEE
Confidence 999999999999997643
|
| >d1rlwa_ b.7.1.1 (A:) Domain from cytosolic phospholipase A2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from cytosolic phospholipase A2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.4e-13 Score=122.55 Aligned_cols=93 Identities=13% Similarity=0.019 Sum_probs=75.5
Q ss_pred ccceeEEEEecc-Cccc---ccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 339 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~---~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~ 339 (697)
|..+|+|.|.+| ||+. .|..|..||||++++.+++.. +++|+++++++||.|||+|.|. +... ....|.++
T Consensus 1 ss~~l~V~v~~a~~L~~~~~~d~~~~~Dpyv~v~l~~~~~~--~~~T~~~~~t~nP~wne~f~f~--i~~~-~~~~L~v~ 75 (126)
T d1rlwa_ 1 SSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDS--RKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEIT 75 (126)
T ss_dssp CCEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTTC--CEECCCCTTCSSCEEEEEEEEE--ECTT-SCCEEEEE
T ss_pred CCcEEEEEEEEccCCCCccccccCCCCCcEEEEEECCcccc--eeEeeecCCCccceeceeeeec--ccCc-ccCcEEEE
Confidence 457899999999 9976 567789999999999876654 7889999999999999999998 5422 23448999
Q ss_pred cccCCCCCCCCcccccccCcccc
Q 005415 340 EIDNSDTRDGEVNGALHEGKADA 362 (697)
Q Consensus 340 V~D~d~~~~~d~~G~v~~~~~~~ 362 (697)
|||.|.++ ++++|++.+...++
T Consensus 76 V~d~d~~~-d~~lG~~~i~L~~l 97 (126)
T d1rlwa_ 76 LMDANYVM-DETLGTATFTVSSM 97 (126)
T ss_dssp EEECCSSC-CEEEEEEEEEGGGS
T ss_pred EEECCCCC-CCeEEEEEEEHHHc
Confidence 99998765 68999997754443
|
| >d1wfja_ b.7.1.2 (A:) C2 domain protein At1g63220 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain protein At1g63220 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.27 E-value=7.6e-13 Score=120.98 Aligned_cols=86 Identities=13% Similarity=0.070 Sum_probs=71.7
Q ss_pred ccceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeec-ccCCCcceecccccCccccccccccccccccc
Q 005415 264 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 341 (697)
Q Consensus 264 s~~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~-k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~ 341 (697)
+.+.|+|.|.+| +|+++|..|.+||||++.+-. .+++|++. ++++||.|||+|.|. +.. ....|.++||
T Consensus 8 p~G~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~-----~~~~t~~~~~~~~nP~Wne~f~f~--v~~--~~~~L~v~V~ 78 (136)
T d1wfja_ 8 PHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRT-----QDQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKIF 78 (136)
T ss_dssp CEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSS-----CEEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEEC
T ss_pred CcEEEEEEEEEeeCCCCCCCCCCCCccEEEEEee-----eeEEEEEEecCCCcEEEeeEEEEE--EcC--ccceEEEEEE
Confidence 457899999999 999999999999999999853 24556664 579999999999998 553 2334999999
Q ss_pred cCCCCCCCCcccccccC
Q 005415 342 DNSDTRDGEVNGALHEG 358 (697)
Q Consensus 342 D~d~~~~~d~~G~v~~~ 358 (697)
|+|.+++++++|.+.+.
T Consensus 79 d~d~~~~d~~iG~~~i~ 95 (136)
T d1wfja_ 79 DKDVGTEDDAVGEATIP 95 (136)
T ss_dssp CSSSCTTTCCSEEEEEE
T ss_pred EecCCCCCCEEEEEEEE
Confidence 99999999999999664
|
| >d1gmia_ b.7.1.1 (A:) Domain from protein kinase C epsilon {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C epsilon species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.18 E-value=2e-12 Score=118.53 Aligned_cols=90 Identities=10% Similarity=0.073 Sum_probs=74.4
Q ss_pred cceeEEEEecc-Cccccc-----------CCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCcccccccc
Q 005415 265 NDYGYLSSKEA-DLIDLQ-----------HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 332 (697)
Q Consensus 265 ~~~l~v~l~e~-~L~~~d-----------~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~ 332 (697)
++.|+|.|.+| +|++++ .+|.+||||++.+ +. +...+|++++++.||+|||+|.|. ++.
T Consensus 5 ~G~L~v~I~~A~~L~~~~~~~~~~~~~~~~~~~~DPYv~v~l--~~--~~~~~T~~~~~t~~P~Wne~f~f~--v~~--- 75 (136)
T d1gmia_ 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNV--DD--SRIGQTATKQKTNSPAWHDEFVTD--VCN--- 75 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEE--TT--EEEEECCCCSSCSSCEEEEEEEEE--EEE---
T ss_pred EEEEEEEEEEeECCCcccccccccccccCCCCCcCcEEEEEe--CC--CcCcEeeEEcCCCCccCccEEEEE--Eec---
Confidence 47899999999 999987 5677899999999 22 235678889999999999999998 653
Q ss_pred ccccccccccCCCCCCCCcccccccCccccc
Q 005415 333 EKDLMPAEIDNSDTRDGEVNGALHEGKADAE 363 (697)
Q Consensus 333 ~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~d 363 (697)
.+.|.++|||.+.+++++++|.+.+...++.
T Consensus 76 ~~~l~i~V~d~~~~~~d~~iG~~~i~l~~l~ 106 (136)
T d1gmia_ 76 GRKIELAVFHDAPIGYDDFVANCTIQFEELL 106 (136)
T ss_dssp ECEEEEEEEECCSSSSCEEEEEEEEEHHHHT
T ss_pred CCceEEEEEEecCCCCceeEEEEEEEHHHhh
Confidence 3459999999999999999999977554443
|
| >d2nq3a1 b.7.1.1 (A:13-145) E3 ubiquitin-protein ligase Itchy {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: E3 ubiquitin-protein ligase Itchy species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=8e-12 Score=113.96 Aligned_cols=83 Identities=7% Similarity=-0.034 Sum_probs=69.9
Q ss_pred ceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCC
Q 005415 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d 344 (697)
..|.|+|.+| +++..+..+..||||++.+-. .+++|+++++|+||.|||.|.|. +... ..|.++|||+|
T Consensus 6 ~~L~v~v~~A~~~~~~~~~~~~dpyv~v~~~~-----~~~kT~v~~~t~nP~wne~f~f~--~~~~---~~l~~~V~d~d 75 (133)
T d2nq3a1 6 SQLQITVISAKLKENKKNWFGPSPYVEVTVDG-----QSKKTEKCNNTNSPKWKQPLTVI--VTPV---SKLHFRVWSHQ 75 (133)
T ss_dssp EEEEEEEEEEEECCCC--CCCCCEEEEEEETT-----EEEECCCCSSCSSCEEEEEEEEE--ECTT---CEEEEEEEECC
T ss_pred eEEEEEEEEeECCCcCCCCCCcCeEEEEEECC-----eEEeeEEEEecccEEEcceEEEE--EEec---ceeEEEEEEcc
Confidence 5788999999 898888888899999999853 35789999999999999999998 5432 34999999999
Q ss_pred CCCCCCcccccccC
Q 005415 345 DTRDGEVNGALHEG 358 (697)
Q Consensus 345 ~~~~~d~~G~v~~~ 358 (697)
.+++++++|++.+.
T Consensus 76 ~~~~d~~iG~~~i~ 89 (133)
T d2nq3a1 76 TLKSDVLLGTAALD 89 (133)
T ss_dssp SSSCCEEEEEEEEE
T ss_pred CCCCCceEEEEEEE
Confidence 99999999999764
|
| >d1bdya_ b.7.1.1 (A:) Domain from protein kinase C delta {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C delta species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.03 E-value=3e-11 Score=108.72 Aligned_cols=80 Identities=10% Similarity=0.099 Sum_probs=62.0
Q ss_pred eEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCCCC
Q 005415 268 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 346 (697)
Q Consensus 268 l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d~~ 346 (697)
++|.+.++ .+++ ..|.+||||+++|....+..++++|+++|+|+||+|||+|.|. +.. ...|.+.|||+|
T Consensus 7 ~~~~~~~~~~~~~--~~~~~dPY~~v~l~~~~~~~~~~~t~~~kkT~nP~WnE~F~~~--v~~---~~~l~i~V~d~d-- 77 (123)
T d1bdya_ 7 ISFNSYELGSLQA--EDDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAH--IYE---GRVIQIVLMRAA-- 77 (123)
T ss_dssp EEEEEEECCTTCC--CCCSCCCEEEEEEEEECCGGGTTBEEECSCCBCCCTTCEEEEE--CCT---TCEEEEEEEEET--
T ss_pred EEEEEeecccCCC--CCCCCCCEEEEEEcCccccccceEEEEeCCCCCcccceEEEEE--Ecc---ccEEEEEEEEcc--
Confidence 34555666 5554 4789999999999887666667789999999999999999998 543 245899999976
Q ss_pred CCCCcccccccC
Q 005415 347 RDGEVNGALHEG 358 (697)
Q Consensus 347 ~~~d~~G~v~~~ 358 (697)
++++|...++
T Consensus 78 --d~~~g~~~i~ 87 (123)
T d1bdya_ 78 --EDPMSEVTVG 87 (123)
T ss_dssp --TEEEEEEEEE
T ss_pred --ccccCccEEe
Confidence 5677777554
|
| >d2cjta1 b.7.1.1 (A:1-128) Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Unc-13 homolog A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.83 E-value=5.1e-10 Score=101.19 Aligned_cols=85 Identities=11% Similarity=0.026 Sum_probs=68.3
Q ss_pred ceeEEEEecc-CcccccCCCCCCcceEeeccCCCCCccccceeecccCCCcceecccccCccccccccccccccccccCC
Q 005415 266 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 344 (697)
Q Consensus 266 ~~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~pd~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D~d 344 (697)
..|+|.|.+| +|+++| ..||||++.+- ..|.+|++.| +.||.|||+|.|. +.. .+..|.++|||.+
T Consensus 2 ~~L~V~v~~a~~l~~~~---~~dpYv~l~~~-----~~k~~T~~~k-~~nP~Wne~f~f~--v~~--~~~~L~v~V~d~~ 68 (128)
T d2cjta1 2 SLLCVGVKKAKFDGAQE---KFNTYVTLKVQ-----NVKSTTIAVR-GSQPSWEQDFMFE--INR--LDLGLTVEVWNKG 68 (128)
T ss_dssp EEEEEEEEEEECSSCGG---GCEEEEEEEET-----TEEEECCCEE-SSSCEEEEEEEEE--ECC--CSSEEEEEEEECC
T ss_pred eEEEEEEEEEECCCCCC---CcCeEEEEEeC-----CEEEEEEEec-CCCCeEEEEEEEe--ecc--ccceEEEEEEeCC
Confidence 4689999999 999977 57999999993 3477777664 6799999999998 543 3445999999999
Q ss_pred CCCCCCcccccccCcccccc
Q 005415 345 DTRDGEVNGALHEGKADAEE 364 (697)
Q Consensus 345 ~~~~~d~~G~v~~~~~~~d~ 364 (697)
..+ ++++|.+.+...++..
T Consensus 69 ~~~-d~~lG~~~I~L~~l~~ 87 (128)
T d2cjta1 69 LIW-DTMVGTVWIPLRTIRQ 87 (128)
T ss_dssp SSC-EEEEEEEEEEGGGSCB
T ss_pred CcC-CcceEEEEEEehhhcc
Confidence 875 7899999887766643
|
| >d2zkmx2 b.7.1.1 (X:678-799) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=1.9e-09 Score=96.52 Aligned_cols=83 Identities=12% Similarity=0.017 Sum_probs=57.6
Q ss_pred eeEEEEecc-CcccccCCCCCCcceEeeccC---CCCCccccceeecccCCCcceecccccCcccccccccccccccccc
Q 005415 267 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP---HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 342 (697)
Q Consensus 267 ~l~v~l~e~-~L~~~d~~g~sDpyVk~~l~p---d~~~~~k~kt~v~k~tlnP~fnE~f~f~~~v~~~~~~~~L~~~V~D 342 (697)
.|+|.|..| +|+.. ..|||||+.|.. |.+++.|++|.++++++||+|||++.|...+....+ ..|.+.|||
T Consensus 2 tl~V~Visaq~L~~~----~~dPyV~V~l~g~~~D~~~~~~t~~~~~~n~~nP~wne~~~~~~~~~~~~l-~~L~f~V~D 76 (122)
T d2zkmx2 2 TLSITVISGQFLSER----SVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPEL-ASLRVAVME 76 (122)
T ss_dssp EEEEEEEEEESCCSS----CCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEEESSGGG-CEEEEEEEE
T ss_pred EEEEEEEEeeCCCCC----CCCcEEEEEEECcCCCCCccEEEEEEEeCCeecceEcccEeEEEecCCCcc-cEEEEEEEC
Confidence 578999999 99754 479999999963 444444555555789999999987433311222222 248999999
Q ss_pred CCCCCCCCcccccccC
Q 005415 343 NSDTRDGEVNGALHEG 358 (697)
Q Consensus 343 ~d~~~~~d~~G~v~~~ 358 (697)
.| ++++|.+.+.
T Consensus 77 ~d----~~~lG~~~ip 88 (122)
T d2zkmx2 77 EG----NKFLGHRIIP 88 (122)
T ss_dssp TT----TEEEEEEEEE
T ss_pred CC----CCEEEEEEEE
Confidence 75 7888887553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=7e-06 Score=80.82 Aligned_cols=82 Identities=10% Similarity=0.073 Sum_probs=58.9
Q ss_pred CceEEEEEeccCCCCceEEEEECCCCcEEEEEEEecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEE
Q 005415 414 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 492 (697)
Q Consensus 414 ~rY~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~ 492 (697)
..|++++..+-++.+.||+.. ..+..++||+..... .......+|..+++.+... --+.+++.+....+..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~-----vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK-----LPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT-----SCCCCEEEEEEETTEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhcc-----CCCCcEEEEEecCCceE
Confidence 457777766555567899886 456677888876432 3345678899999988642 12567777788888999
Q ss_pred EEEEccccch
Q 005415 493 IVCELLRANL 502 (697)
Q Consensus 493 LVmEyl~gsL 502 (697)
+||++++|..
T Consensus 87 lv~~~l~G~~ 96 (263)
T d1j7la_ 87 LLMSEADGVL 96 (263)
T ss_dssp EEEECCSSEE
T ss_pred EEEEeccccc
Confidence 9999998743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.64 E-value=0.00013 Score=71.02 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=52.6
Q ss_pred EeccCCC-CceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeEEEEEEccc
Q 005415 421 YLGSAAF-SKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 499 (697)
Q Consensus 421 ~LG~G~f-G~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l~LVmEyl~ 499 (697)
.+..|.. +.||+.. ...+..+++|+..... ...+..|..+++.+.... -.+.+++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g----vpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC----CCCCceeeecccccceEEEEEeee
Confidence 4455554 6789887 3567778899876543 346778999999887542 236677777778888999999997
Q ss_pred c
Q 005415 500 A 500 (697)
Q Consensus 500 g 500 (697)
|
T Consensus 90 G 90 (255)
T d1nd4a_ 90 G 90 (255)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.56 E-value=0.00011 Score=77.29 Aligned_cols=77 Identities=19% Similarity=0.160 Sum_probs=50.3
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEEecc--------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCe
Q 005415 419 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 490 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~--------~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~ 490 (697)
.+.||.|....||++.+..+++.|+||.-... ....++...|...|+.+....+ ..+++++.+ +...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p---~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP---HLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG---GGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCC---CCcceEEEE--cCCC
Confidence 45689999999999987777889999975421 1123456678999988865421 245555544 4455
Q ss_pred EEEEEEcccc
Q 005415 491 LFIVCELLRA 500 (697)
Q Consensus 491 l~LVmEyl~g 500 (697)
.++|||++++
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEeccCC
Confidence 6789999864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.002 Score=65.49 Aligned_cols=72 Identities=15% Similarity=0.147 Sum_probs=48.8
Q ss_pred CCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE--EEEEEecCeEEEEEEcccc
Q 005415 427 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL--YDYFYHLEHLFIVCELLRA 500 (697)
Q Consensus 427 fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l--~~~f~~~~~l~LVmEyl~g 500 (697)
--.||++. ..+|+.|++|+.+.......++..|..++..|.... ...+..+.. -..+......+.+++++.|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 35799997 467899999999876655678889999999988653 111111111 1222345678889998865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.0027 Score=66.15 Aligned_cols=72 Identities=14% Similarity=0.122 Sum_probs=49.7
Q ss_pred EEEeccCCCCceEEEEECC-------CCcEEEEEEEecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEecCeE
Q 005415 419 TEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 491 (697)
Q Consensus 419 ~e~LG~G~fG~Vy~a~d~~-------~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~hpnIv~l~~~f~~~~~l 491 (697)
++.|+-|-.-.+|++.... ..+.|++++.-.... .....+|..+++.+.... -..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~g-----l~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERH-----LGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTT-----SSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhCC-----CCCeEEEEcCC----
Confidence 4567888888899987542 346788888764333 345668999999887642 23466776643
Q ss_pred EEEEEcccc
Q 005415 492 FIVCELLRA 500 (697)
Q Consensus 492 ~LVmEyl~g 500 (697)
++||||+.|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 588999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.52 E-value=0.064 Score=53.08 Aligned_cols=53 Identities=6% Similarity=-0.022 Sum_probs=32.8
Q ss_pred eEEEEEeccCCCCceEEEEECCCCcEEEEEEEecchhhhHhHHHHHHHHHHhcccC
Q 005415 416 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 471 (697)
Q Consensus 416 Y~i~e~LG~G~fG~Vy~a~d~~~g~~VAVKii~~~~~~~~~~~~Ei~iL~~L~~~~ 471 (697)
..-.+.|..|---+.|+... ..| .+++|++.... ..+.+..|+.++..|....
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC----CCHHHHHHHHHHHHHHTT
T ss_pred ceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhcc
Confidence 44456677787788899874 334 58999986532 2355667888888887653
|